<?xml version="1.0"?>
<rdf:RDF
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:vocab="file:///home/yin2/Downloads/d2rq-0.8.1/vocab/"
    xmlns:obo="http://purl.obolibrary.org/obo/"
    xmlns:owl="http://www.w3.org/2002/07/owl#"
    xmlns:db="file:///home/yin2/Downloads/d2rq-0.8.1/mpevidence.rdf"
    xmlns:map="file:///home/yin2/Downloads/d2rq-0.8.1/mpevidence.rdf#"
    xmlns:d2r="http://sites.wiwiss.fu-berlin.de/suhl/bizer/d2r-server/config.rdf#"
    xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
    xmlns:j.0="obo:"
    xmlns:meta="http://www4.wiwiss.fu-berlin.de/bizer/d2r-server/metadata#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
  xml:base="file:///home/yin2/Downloads/d2rq-0.8.1/mpevidence.rdf#" > 
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d2525dd5-7a44-473f-af71-9b43ccbc43ea">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/24f5fde0-71a1-4cd8-82ac-d83d04d7523b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/97c5a1d1-4d23-4018-93e1-29b4defea130"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6dba4928-4932-4f9d-834d-d5b33666848e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/18d63868-7cec-4d04-b7ad-3bc4717a6968"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/64e79dac-55ab-4f84-a6ef-a8ca77f2292e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/0cf3eed5-841d-4754-90a8-7f7b7d8f4f2f"/>
    <rdfs:label>citalopram-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/71f6530d-0a99-4f46-a3d2-6cc84ddb2e16">
    <rdf:type rdf:resource="obo:MeSH_C001422"/>
    <rdfs:label>4-hydroxypropranolol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/b8b3352a-eb1c-48f0-983c-adef3890f53b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/036fae46-2788-4598-942e-2430d1a7ca27">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7d4ef7bd-cb1a-4365-8df3-55dcc16ff5a2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/ad38770c-3eb8-45e4-93e3-94294d5bc591">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/41715832-8b0f-4b8a-adef-b5c8254bd94b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/fee655f6-74b7-4dea-9a32-86d25899bdd1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/0ad2caa2-3f9b-4092-b224-eccef3624a69">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/d166e63a-5503-4340-9ff7-94ad4af432f1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ad43b5ef-4aa5-4b91-9fac-b30bd378b96f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/39a36dae-1586-4f4d-ab7b-72dd37730314"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/1c25e792-4209-4317-872e-5696210eff74"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/69b4447f-d50f-41eb-af7c-972baa931ef0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/908e1945-037e-4f71-a0b6-ed6f6ddf17cf"/>
    <rdfs:label>desvenlafaxine-midazolam drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b85f711f-1752-4c94-a5a2-3b294050393a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ae909dc1-d15c-415c-9236-702279ac0173">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a721164b-41de-4a75-af77-2c891e45dfdb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/97a8b9b8-02e6-475d-8775-a13eb15f88be"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b07bdbcc-66d4-42de-9564-301ecb8c40e5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/4ef0b359-01f2-4dfc-a701-353d9d11afda">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/85a42adf-9ac7-46d5-ba4a-f7b5f0897dbf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/8fb0b2c6-f7f9-48a2-a42d-4babfcac5f75">
    <rdf:type rdf:resource="obo:RxNorm_593411"/>
    <rdfs:label>sitagliptin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/95113a80-8d14-4b92-9686-e56c94b2c15c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/04a92d2a-9f92-4587-86b9-411c73a4a7d9"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/d0d96d43-27c2-4c70-aa6e-e9f9f8882205"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7193c1d6-cd91-4d67-b8d7-90877bd6ef2b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2d4ad5ed-47e7-4cbd-a7e1-901ed4efbf21">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/9219c4fc-17d4-4855-a4c9-1e0846c9ac92">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/d5e84ebe-e296-4dfe-b413-27af1d104a1e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/3dbc7e26-0c44-4443-b423-9f0fd9425053"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/b24e5dbc-db7b-44ec-a318-4c77e5a49945"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/fe32d582-57a5-46c4-9f66-98a2b59f5609">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d01de5ba-efd7-43fa-97c8-71f6f252fcde">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2dd63c17-f4df-4a9d-b224-d2da616400d4"/>
    <rdfs:label>nefazodone-triazolam drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/10e484c4-be6e-421e-8eef-99e3db87180c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/53e9241c-817c-470f-95ac-7a4a33ad3e45">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2776f092-4599-45eb-8901-214f86b25f36"/>
    <rdfs:label>4.3 Fold </rdfs:label>
    <obo:OBI_0001937>4.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d533fafc-5d9d-437e-ad97-edc4c2f2bb40">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/97e4f681-b600-4438-8e54-2a1d0176a2fc">
    <rdf:type rdf:resource="obo:RxNorm_1102261"/>
    <rdfs:label>Telaprevir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/e7cc2454-09a1-4c8c-9249-7402eba42252">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/5e901159-15e9-4ac9-a9db-2e4cddddd09e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/3d2c21a0-01f5-4b79-866f-7b47a17e85f1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8345cc16-7dd7-4487-9043-01ddce8b498b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1bfe6027-bf64-4de3-ab08-5317e68bfc2e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0ccf9ee0-4737-4846-a46e-854bbadea0b8">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/47127b9e-437e-4618-8acd-f071a8d8c6fb"/>
    <rdfs:label>Fluoxetine-olanzapine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8337ff93-4162-46ac-ac9f-aa538b92379c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/71206a5f-7abe-4347-8cb0-447e1fc1a158">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/3acf84a7-6b13-4a8e-aa6c-5a0933ccb18d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/4370d149-3ef0-4af5-a6fa-1f86df35226a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/7848d8fa-794b-4b50-b4f8-523573c4f9b6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/cb2b5e29-4b70-4da6-8ed9-b932f5dcfec1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4cd9508a-fc65-4c51-a5ac-ac4ff179f3e6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/475939ae-8b5c-4bd2-b8f1-23ae3e2c80f5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/9a057f85-d994-42b5-9b71-114ad2e5cd03">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5d6f440b-1845-4236-aa0e-1ec06d16bcf4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a2923524-f6b9-4710-af4f-8ac071e94834"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/50493499-cc17-4d23-b7c8-dc8c2d48a34f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d293882a-bb47-41f6-8c99-868b8b99d70a"/>
    <rdfs:label>citalopram-ketoconazole interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/68b10d93-e405-4b40-8363-a3fa4d8a9188">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/e9f02195-f989-434a-82f8-284eb5bfb4d5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/81ad5515-98cf-454c-8a0d-ac8105d694cf"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/a1c1fbcf-f130-4d07-a6db-7e025d2b850e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/1cba581b-8f44-49fb-a329-f66b3314a0bf">
    <rdfs:label>carbamazepine-ziprasidone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/f4673a17-e69d-4d1a-bc6b-7520eee0786f">
    <rdfs:label>pravastatin-NFV DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a2bdaf53-c8e9-429a-aa2a-b8a133df1232">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/e7cc2454-09a1-4c8c-9249-7402eba42252"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/f5f044ba-b90b-4a2a-8905-42abe62f0722"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/da7ce45f-5977-4382-9df5-7fc3f5ee2c93"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/d845f180-8554-48d5-9f8b-0305d20c04e6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/5ff466c2-3f37-426e-a72a-bc559d998b4f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/7ba77864-039d-4382-9a96-345b27125430">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/8ade4d99-ca2e-4d25-8e1c-40699e9d00ed"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/05bcfdde-96a1-4d75-9942-000719a2ae79"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/fffc4de5-cee7-42a5-9793-1e38b2455c8d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/079fe0c2-69e3-42cb-a959-a4c4ad46d950">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/f539f72d-3fcd-4313-a600-93534a8abc0b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/4212c34b-e7e9-4709-a2fd-6f813e52caf8"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/4a2defaf-2faa-4ba1-9c7e-4b173de203ae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/511e8142-9007-417c-a7ae-c84b77cce2e7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/62f2989f-affb-4305-b8ea-bdd084cc79c9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/08fd8833-11be-4b08-acb1-616a72b1453c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/fcfe6ab3-39f9-41e2-ac91-2757b062dd21">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ad01d58d-f033-41a4-9a83-a1f4df4abe04"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1c2861a1-53f2-4d99-a6c6-fac4a2a64a4d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/18cfe96a-6565-4de9-910a-05aee042231d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/a466d2ea-226f-4ec0-acd6-35fa40613f41">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/9432953d-7a15-48a0-916e-110ce5a465eb">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/c52edd28-fe4b-4bc4-8454-a1686fd52533"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/75347561-51bf-4eb8-adc3-e82564ed17be"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/42fb6a7b-4f62-4df4-ac4f-24fb4c103229">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/cf80b867-0403-4494-852a-f970b5efa04c"/>
    <rdfs:label>44.2 Percent </rdfs:label>
    <obo:OBI_0001937>44.2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/da198d51-26ac-4657-81d5-e26697847990">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/af0b2af0-f503-4f80-a6e9-8b3cbb0a634d">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/bd792ab4-d5e4-435e-873c-4d8ec593718f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/de182341-99b7-4d63-9697-ead9ca1cecbd"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/f063b94b-2b1a-4f43-b5b8-8bb00197d5bf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1e6a6067-244e-4329-b36e-f6c790d3dff6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/acbd77ed-c5c2-4821-a1fd-910e701f85c0">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/602dcbf8-c93c-4a80-9447-197b8aaf1082">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e046f9bb-88ac-4705-991e-ae23f1ab356d">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
    <rdfs:label>carbamazepine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/6a5979e9-7238-4a9d-95e5-04244dddc682">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b472ddde-3a82-4a02-a981-6a7fee206efe"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/5bdfe3e9-d0c4-4007-95bc-09fab897ef13"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/512fbf97-9a3d-4c73-b9d2-e5c9e1680848">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/8e92f789-f212-4bd2-92ee-507c1ca3ce45"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/36794ed4-80e8-41c0-985a-4e5732181adb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/d3795d57-444d-418b-aeec-9a3992b3f1de">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/8be66c2b-f3d9-422f-aebf-f09afe1cef54"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/5db2e3b8-971d-4826-aa44-511dd166c402"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/35be9d13-fe90-4235-a313-c135e1f4b945"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/3ab275db-be48-4f58-ac22-3f517feba1b7">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/e5a14f0d-0ee5-41db-a495-fddbb478288c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/bfaa3e34-e32c-4920-b782-1f885142b051"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/67f8c655-1acc-4b54-91e3-0ad4e9676ee8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f0492a34-88a8-46f1-bbae-ac64c1ef14f6">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/9319ab9e-2930-4106-ad4b-b0da0ec667f6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b0bfc90a-21c9-47b6-9fbf-e6b15151ecc0"/>
    <rdfs:label>Gemfibrozil-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/5837d5e6-4c43-425a-80d7-0634dc59a788">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/dd2370b3-6c6f-42bb-84ae-a4bc8ce5cdfe"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/7952b1d0-bab2-47ef-8b48-8c886859a1f3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ac8f7947-63a4-4d3c-83ce-ca80ed766c76">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/2b7ecd10-54af-4171-997f-9c98fa76fa04">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/3e6a56b3-40a0-461d-abd2-d8a581f89dca">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/8aee3c2f-07f8-4799-ab33-ab13ea07474d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/7980fbfe-d35a-4381-b984-ddbf50a5ada4"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/d0676440-7f7d-458a-93ac-5e55b6eeace4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e58bec0c-a869-460f-9caa-d8dc291209ef">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/64d424f2-22d2-47d8-be95-fbcb061a7856">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/8346a232-0e7b-4622-ba65-5ca10c8439a3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/c9f63c85-a568-4085-9c15-7ab9f923312b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3dbe29e9-3afb-48b7-bf4e-cff5e8a01cef">
    <rdf:type rdf:resource="obo:MeSH_D014635"/>
    <rdfs:label>divalproex sodium</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/2f5bd7da-81be-468e-aaf1-933146f42c66">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/255d3d76-0810-4523-8d9a-3635f4eb9cb0">
    <rdf:type rdf:resource="obo:RxNorm_596205"/>
    <rdfs:label>ramelteon</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2a736997-87c0-40b9-85fe-14e7ec136153">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b5354f22-674b-4ef3-bd61-8c01d801251a"/>
    <rdfs:label>1.7 Fold </rdfs:label>
    <obo:OBI_0001937>1.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4cd473f2-d644-47c2-9f4b-ec72aaff58e6">
    <obo:OBI_0001937>800</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/cd466580-f261-42ba-8411-120fa2104aa2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c754f92f-5b30-47b0-b969-3b6ba252e746">
    <rdfs:label>alitretinoin-ciclosporin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/debf7384-7455-46a7-a683-f40cb7d947de">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/530edb0a-6748-44e6-90c8-115ce18f07ab"/>
    <rdfs:label>1 Percent </rdfs:label>
    <obo:OBI_0001937>1</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/eb71cc9d-5a25-4296-b241-6fcc3a08d27e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/851261b7-de5b-47ed-832e-2524e6dbe394">
    <rdf:type rdf:resource="obo:RxNorm_73178"/>
    <rdfs:label>iloperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/92c9a1ad-e462-48e4-a6cf-55239528477d">
    <rdf:type rdf:resource="obo:RxNorm_73178"/>
    <rdfs:label>iloperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/66c12175-fc64-4fef-985d-dfcc1b70f66c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a629cdd6-2ab6-426a-9cc2-050384ec8f72"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/50e2fdde-2541-4e78-886f-19569db82ab4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/fca2de3c-1a7c-43e1-bcdd-021601f59133">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f5f7f259-a039-4f3b-bcc1-5b199b556d62">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/0707be02-c7ba-4038-84ee-45f447132393"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/b7d8fcb4-850a-4c04-b811-af941de32d43"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/1568b15f-9ce5-4c28-a25d-9eab1f01efb1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e7fbf30c-4b2f-42fe-8fb0-28f9567d0226">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/851261b7-de5b-47ed-832e-2524e6dbe394"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/df51b531-c576-4733-9335-e6d0a508400a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/0aafd103-6094-426e-a19b-fd7aed28f5e5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d9411ec5-d158-4861-ae97-9fcd5b1aca37">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6d1d25ae-01c6-4d43-af62-5c57af03e90c"/>
    <rdfs:label>34 Percent </rdfs:label>
    <obo:OBI_0001937>34</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e62c2ee2-fa34-43d7-b596-67a3131fcfdd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/28d39d0e-d2e9-4ce1-a6c8-cf7040c723fd">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/33dc3e9e-ef10-473a-9140-cf57addbac66"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/9df28d1c-7296-4b21-b863-1efc3c158f06"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/153ebb15-6f3f-4798-b374-a2016d1736d7">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/29d72a72-5d41-42b6-945b-c13c85fb4d3a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/5b528b63-9d48-414f-8638-f55cf744b64d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/24d47084-5e97-42b9-82b9-57b47a66c0db">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/7af56365-33a6-483a-b590-cab0591558d4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c25db366-0f2c-4d04-9b5c-7d1f8199ca36">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/75c9ffa0-93e3-40c2-8c78-8685b2399a87">
    <rdf:type rdf:resource="obo:MeSH_C016904"/>
    <rdfs:label>norverapamil</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6d492afa-5702-4970-95e8-a8c819523da9">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/43b5f4d4-25bc-47c0-9b14-306dfc2f8c62"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/b878e64f-e68e-43ff-8f0d-530cb0921a22">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/cc4b9ec1-575a-42d9-9f08-2a767c292165"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/8884151d-2cb9-4452-b463-c5737302fa8c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3102af17-4aba-411a-8ec1-9721b2bedf9a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/5fee5bcd-3303-4dd8-8429-facd3428abf3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/236bb7d9-8953-4144-9d9b-8ac3181feb01"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b5d59481-a0f8-4d2e-a629-adcb77a3f694">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/bc1bf9e9-625e-446a-a668-f6379fa25d2c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/25c269bc-faae-46ef-862c-ab7b5d72fdcf"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a64bb1b5-7dcc-46b2-aff3-5c3544a93b87">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/90790605-e365-438b-92e0-9af4d4a3fd77"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/a3caeb32-d401-4dba-a2cd-4287e1032292"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/8c3d92e7-a430-42ca-958d-99256dc21e70"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f073430d-8e14-4b47-99a3-67ab8f280f1a">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/8e791b05-40b6-45fc-849c-e4fb77e62f81"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/e3171a7e-8fa8-4d09-acab-49169d228d32"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/69abf7c0-1d30-4aec-bb14-680c61109e29"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f087f2a9-24d4-46b8-a40c-d377230ee436">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/c606f8a1-af14-4d1c-a908-5279cc8d36e0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/81f1bd83-9e67-48f8-8a82-2843a473f8c9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f8c2d282-1804-4313-ba9a-eb818fa37c5b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c05b7291-9f8e-464a-a0cd-6a82190f0104"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/422876da-49c3-4391-abfb-ab244933ca71"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7f304db9-bcb1-4455-83fa-5d0e0c42aecd"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c9abe027-0ddc-47c0-bb61-cd82a6640a50"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/dbe348d2-c7c5-4236-a4cf-0b76d4a62a66"/>
    <rdfs:label>clarithromycin-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/42c2e57a-63cd-46ee-a84a-ac1fc868e52e">
    <rdfs:label>carbamazepine-selegiline DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/3d07fae1-7932-497a-b239-29e70d0ff30d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/62695283-adc1-4726-8498-24101ef97cf5">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d9033b06-9758-468a-b500-c16e3191012a"/>
    <rdfs:label>ritonavir-erythrohydrobupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/ae790707-34de-451c-9705-1edf5b6d0b1a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/046159a1-19cf-4d5f-b35a-ce2781b9201f">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/de8c60b1-778b-406c-aeec-fff62659718e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/fc7ff20d-d49f-4342-84aa-0dffa965267e">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/43b7310f-9fc5-4114-ae6b-2397ef4ca381"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/5b8300d8-7f2c-430f-ac70-ef311f79415c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/8f0334ac-09b3-4828-8cae-60bf9a5dd5d0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/18225e84-31ba-491a-8238-b6282d897ff4">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/46390b06-5e9e-421c-93a1-6d8e0040f4d9"/>
    <rdfs:label>10.6 Fold </rdfs:label>
    <obo:OBI_0001937>10.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ff65181a-7a84-4652-8adc-acbb983278c8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/0e57a6b5-e0eb-40f5-b1bd-19a2e8c43315">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/7ca5444b-6a19-4dbe-b927-7d28c507676c">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/e7986ab1-851d-4d8b-91fa-9729d648c1b6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/0e2f183b-e1ed-47e6-922c-d8692e02ba1a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/18e6c8c1-1e1f-4c35-b9ab-2bf28fe06a8e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/7f835c65-9d5e-4d39-b97f-02237b92a2cf">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e1b18179-fdbd-40fb-9c61-a642d0ebf762"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/550941ec-2bd6-48d4-a58e-acea8678345e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/4b16fb41-1a00-4575-a894-1953d176481e">
    <obo:OBI_0001937>250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/17d111e1-f5ae-4877-b9eb-9bc835ad7cca"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d04c33ac-b12f-4142-9c4a-8087c583cb66">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/78882e2f-dd48-4718-9704-bd0451192421"/>
    <rdfs:label>1.3 Fold </rdfs:label>
    <obo:OBI_0001937>1.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/05ce1065-65bc-40a1-b099-df2cc038b6b8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/95166cdd-7f88-4388-9698-4ddb55faaf2f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/4bdd5c87-f40d-4e29-98b1-3fb8760b1a10"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/49c64859-a682-4b52-9f9e-e414be370826">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/1f283a5a-a9ad-418d-a9f6-642f058cab28"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/b74cd949-6618-4ad5-a2b3-37805935f705"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f873bbc7-5a62-4882-89b3-1edc2d77f930">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/901c24ed-a064-4074-92cd-1e8540539835">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2dd63c17-f4df-4a9d-b224-d2da616400d4"/>
    <rdfs:label>nefazodone-triazolam drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a25f9bdc-8968-43e8-9b82-bc8137a32b89"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/de10582f-304b-417e-8792-25d38b2c4c5b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1b466956-de8d-4f99-9a60-7b07d8cd5c77">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/689a120b-302e-4aa6-95a6-4c3d07070b0d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e24f0f0f-9f7b-4ec6-8edc-d38654223a92"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/20b2d06c-d3e3-4d96-89c8-d4f7a342819c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/759ac690-19f8-4367-9f9e-ec7ed5182852"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e45c1048-e2ab-4b71-a53c-1c2d195527ca"/>
    <rdfs:label>paroxetine-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/787019a7-b113-4530-a818-3deffe1768e2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/926aafa9-5f66-4776-b093-522b815dffd4">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/9388f1c3-a7cf-41cf-980f-b71c9742c60d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/208e4614-99de-49d1-8df7-1d716d0deb0d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7867d1ad-8684-49b0-bb03-a3542c6b8358">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/836eee3b-28aa-4361-96c6-4f3c36645e9f"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/eff3cd80-8ed4-4a5a-a319-992b90b71319">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/c388cae5-ba01-4862-b0d7-85102abfdead"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/077ac84e-3db9-4d4e-8bc8-07b4fce34dab"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/208e4614-99de-49d1-8df7-1d716d0deb0d">
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/bc9da8a0-1972-41d7-8ada-2177faa3ed2c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/5da916c9-62a6-4549-804f-f8289e4631f6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/db7a149d-9810-409e-b78b-89fa27aeba74"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/19223920-2898-4e1c-8bcc-cc08d0cc5209"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/a0e2ca6f-95d3-4635-9fe3-529c6d346c00">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/591670f5-ad55-45b8-88fd-49f0c22898c4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2776f092-4599-45eb-8901-214f86b25f36">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/0d42bc7f-069f-4879-b615-32bd07804558">
    <rdf:type rdf:resource="obo:MeSH_C060062"/>
    <rdfs:label>mCPP</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/07389819-477c-4ee4-b44b-007f1fd91385">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/57289382-1e9b-4d53-b489-ec44bc08f604"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/489101ea-590d-4112-b493-97d18c79eae0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/87105ab7-6c3b-4f77-bf0a-c1bed69f15f2">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f0985519-baeb-4d14-9fef-865372d212e7"/>
    <rdfs:label>unmeasurable UNK </rdfs:label>
    <obo:OBI_0001937>unmeasurable</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e66c5a4b-d4a2-4574-a647-8d621d375687">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/2f8f13cd-90eb-43d8-a009-e1d39bdd2993"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/87109388-467f-44aa-9e8e-54e501745aec">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
    <rdfs:label>desipramine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/eb7324c5-8257-454d-978e-f20b9bac51bf">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
    <rdfs:label>carbamazepine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/20114f79-dc8a-43f8-844b-49de03d91fe6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/9420f360-aad6-4b6f-9c38-9e74fbbe17a9"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/9c9e8b41-227a-4dd5-8b84-dd9499bff5cd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/670e19fc-5255-492b-8682-39a835e26595">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/03582a47-3a64-4c98-99fb-18fd2c2d4ed3"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/61019dee-37d9-47c1-b202-554715d95de6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/9af4db3f-c507-4340-a7f1-ceccf2b756bf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/75944c3d-20cd-43f1-81d1-00d12298a50c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/147b3d3c-ec0e-40e6-b1d9-db3735da01bf"/>
    <rdfs:label>35 Percent </rdfs:label>
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/6b9d92f5-b094-4e8d-aa3e-c12d9dfbbe0d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/31dde183-01da-4a9e-8914-cf63c4d904b7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/bb0c25a7-a912-4c41-8355-814be058a78e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/53e309a0-bb6e-468a-b858-ca2524991be5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/ab79a539-6a96-454c-ba44-654d3f0b5cdf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/560e4a07-97e0-4bf2-a933-e61fb9b4ecf5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/3204bb22-906c-478c-b6a3-4b9cf50876fd"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/af26c2c4-c33a-4ac7-b9cf-fe4fc2610626"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d51efbcf-a91a-4e54-83b3-f4f5a5c95938">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/40060fcb-8fbb-4bdc-8772-eca9a2fdc367">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0189cb7f-2358-4888-b6e0-cf10802296bb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/5a8ca62a-f5ad-4bce-9a68-907a35bb5eca"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/b2a85c88-c82d-4045-8e01-08c9eaaafe05">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/5b3ac571-cdf5-4c71-bae9-7edf7078bead">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/85180b33-657f-43f2-b408-33367d10a676">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/254de65d-9796-449c-b4bd-b7d76efbe083">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/68081ccc-8ce3-45c7-ad64-8f18035f4745">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
    <rdfs:label>dabigatran</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/92ab2faf-08df-4b15-b04f-49e495c2610d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/8368f3e9-119b-4c19-9912-bcec9fd28539"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/a402d1ad-8f7b-4f88-8aed-28f4c92ac46f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d7c4dcc8-988b-4926-856d-fe964078a2b8">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/8ffbdadd-c825-4610-a27a-4798eb90f36e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/39fb26db-e6ce-4d3c-a979-5c260a23a7bf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/3c75e4d3-4281-46ba-a7b2-63201b3304d1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/6ad1705a-6a71-49f3-9752-881493d1f5b4">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/e57ef19b-2d55-4136-b93a-7cdec2f61666"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/7ab1df73-fc82-4a62-b9a5-816a2bb0c561"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/6bf8b8f3-eb15-4672-9aaf-b30fc015be89">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/be42344b-e30f-426f-9fbe-151d884fc773"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/e5fdca92-921e-4479-83df-4096103227ae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/e70681b4-54d5-42cb-aa89-4479505ed3a7">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/cbd92749-b5da-4a10-9ebb-5dfc0efddf8d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/05f87028-8f1b-442d-94d6-8b4d54d113f4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c30a690e-8e64-4094-9816-875eb269f419">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/2154bbd3-ba28-443d-b217-89fa898c1d77">
    <rdf:type rdf:resource="obo:RxNorm_195085"/>
    <rdfs:label>efavirenz</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a7bcab3a-a47f-40f9-8711-20d27ba81b5d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/592d613d-e145-4bbd-8290-8d24be5830b5"/>
    <rdfs:label>79 Percent </rdfs:label>
    <obo:OBI_0001937>79</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/85ecf884-17af-4396-9144-b59795fcc30a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/934dd5f6-1507-4ff3-9905-e57861597b32"/>
    <rdfs:label>iloperidone-dextromethorphan drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/17c5cc06-bc63-45df-8ca8-96cd97225f84"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a04d0b31-c9d9-41ac-8393-c1e766ca3639">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/f9c0a7a0-c2e1-4056-9718-2ffb06f3ae28"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/3ac318ee-3987-4611-bdff-d57d21dc577a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/8a8781bc-5d24-4e60-8a7b-b15f1a0f6e51">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/8c48a422-b7e9-4cfc-a52c-82aa3794586e">
    <rdfs:label>buspirone-mCPP DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/889701a0-2949-49ca-a750-869518690b25">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/fe097cd8-bbc5-4676-999d-f3197771d309">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
    <rdfs:label>fluoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/4cf32192-ab77-4c62-aaa9-2278e72a9f0e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/89534875-4dba-4848-8779-47a0490d4a6e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/8336032e-5342-4e3f-b3af-d3fa90de453b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/6f581fcd-fc86-4bc2-be53-665b58ac2336"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/efa0405e-9fb7-4119-b6e4-a75beb17cf7e">
    <rdf:type rdf:resource="obo:MeSH_C040634"/>
    <rdfs:label>sulforidazine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4fda4fa9-66ee-40a2-b8ef-13bbf93b87a9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a621235c-4503-4b1c-9506-96e4e67a415d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/fe70217f-8fac-43ea-bcc4-ff729fd9f5c8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/5d8db9ce-25da-4498-b1fd-5023bf8c0a58">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/292be4f3-197e-41e5-86db-c6f8365fe27e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/eff8e79c-db89-4f71-8202-4e1be9a9eb76"/>
    <rdfs:label>0.23 UNK </rdfs:label>
    <obo:OBI_0001937>0.23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/58c68662-7087-4d4e-bea0-bcbec15c5378">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/670e19fc-5255-492b-8682-39a835e26595"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e9327f07-81df-455e-b0e7-9717bf4c72b0"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/96fe7ac4-c49a-49e6-b431-0e63b0b1576a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/76dc032b-555c-46c2-9cf0-bae64a0903a2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/bb0f2ed5-64ef-4aed-b11d-99c01899d8d5"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/76e1624e-3659-419b-ae7b-9f49741e4dcc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/55dbb47d-5a6f-4d96-9f19-be44f5083b21">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/76135f7b-1a8f-4f4c-872f-98aca086f520">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f0c1176f-229a-4598-ba81-fe232baa08cd"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/e47732ff-b283-4342-801b-47cc4a967f6b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e7d923a7-05fe-4eea-b9e9-833b92421655">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/44ddbeeb-0cb6-48f6-bc27-80833351ffde"/>
    <rdfs:label>cimetidine-threohydrobupropion and erythrohydrobupropion drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/289e3198-8220-4dbc-a303-1acbfeb75752"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1dc14dd4-08a0-4ba3-8118-e2b307754c4a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/afcd4d64-b6dd-4981-804b-a7c5c90eaffe">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/4914ce43-60e0-41e5-bb0e-407e872bf6ea"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/20e42212-8936-4924-b12e-e02505d8191a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/bfbe4b84-0cf3-4954-9195-ef51e7e6eae9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f9f474de-8e90-43ba-b2ee-89c8edc25c34">
    <rdf:type rdf:resource="obo:RxNorm_6960"/>
    <rdfs:label>midazolam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/c9f63c85-a568-4085-9c15-7ab9f923312b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/f9675909-966d-468b-8136-adb0cd5b4992">
    <rdfs:label>carbamazepine-L-amphetamine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d2129154-b28a-4d6c-977a-863700f1d355">
    <rdf:type rdf:resource="obo:RxNorm_1191"/>
    <rdfs:label>low-dose ASA</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/47d864b4-0104-42e6-b688-4790309c49ee">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/4ca773d1-ece5-40a0-b0a6-b6408a1b9e30"/>
    <rdfs:label>ritonavir-erythrohydrobupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5ed8983b-9238-4fbf-af8f-dc55494e572f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/b48a36a5-4cc2-4ae8-b0e7-c13e64026ff7">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/0b5db9c2-bc10-4a71-8d79-01868cc96769"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/6ab6cc44-8377-4835-8ef4-e546c0f3a67f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/b7eefc55-f448-4352-b28b-2ed9b0acb1c6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9388f1c3-a7cf-41cf-980f-b71c9742c60d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b8a23913-2f0c-461e-91dd-506c289930ad">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/87ad09fa-a49f-4df0-804b-9ecd77570b62">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/215e073a-ece1-4050-a6b6-43b79943f649">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a9eddbbe-c945-4995-9e70-8100e9fd4bf2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/2e8f69ce-ddbf-4949-8ee2-789428df0853"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/46797631-4930-4e3d-861b-8d9d9330a32c"/>
    <rdfs:label>nefazodone-haloperidol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b0cad47b-6dff-43f1-8570-9dd28a2c358f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/dc8c1b6e-6382-4903-8683-fe1dedf5ef58">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3f658572-3570-43c6-bb1b-f68ced773c5b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8a7287a8-5c62-4044-80e8-acdf33b77b12"/>
    <rdfs:label>aspirin-rivaroxaban drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1ebbb807-28be-41fd-be3a-3a405f453b0d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/621ad6c9-c520-465a-b950-a3aa47c5f954">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/712f3ee7-eff2-43db-be2d-0523694da65e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1b10023e-e860-4994-a0b5-861763fd36cb"/>
    <rdfs:label>1.6 Fold </rdfs:label>
    <obo:OBI_0001937>1.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/f71dfe9b-2ed4-41de-94c0-26a37ae2d783">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/402af81f-a236-4867-be12-e184371d3210"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/3214796b-5965-414a-8639-807f6d9fe554"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/3a6043f8-e3bd-4893-9993-3c8cfb8b011a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/c170e66f-375a-4f56-a4d0-a7abc78819bd"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/f6edbff3-5ed9-44d2-a019-2ba6c8661cdb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/43b5f4d4-25bc-47c0-9b14-306dfc2f8c62">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/7f2455c3-4d6d-4a59-a0af-a6e50e013f82">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d2cd6695-951a-4dd1-972f-033cb13ed88a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/2d3b2852-1b73-4455-9af7-4fc67c38ef64"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4c50cc0d-5225-4227-9a22-c0bf37b4fa44">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/3a1463a3-f195-4831-83d3-d671d8bfee82">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/42713934-75e9-428b-8ace-89ad25b8bae2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/c6300c70-0f0b-4cea-acec-17a548ab9c1f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/0cca9d1c-48d6-4e2d-8791-d2041d66da2b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b2455b7d-7c63-4fc5-aea9-e13a83098e81">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f58e466b-043e-4d5b-84e4-324ac8283a76"/>
    <rdfs:label>90 Percent </rdfs:label>
    <obo:OBI_0001937>90</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e4be7ef3-dc4d-41cd-a759-79777c174729">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/72904cd1-406f-4d67-9f61-25b6aeb4f56f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/8198ca1d-145a-455d-abd3-3ec987a2d888">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c3093b03-1fd3-43f9-a4d9-7eb239eba970">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/4e3e5eed-2911-49e0-ba0d-84e935fce826">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/aae8c465-0bb7-46d0-9cd8-d8e8fc186736"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/644c1961-fb23-4dcb-8654-e019c1e34d1c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4e718484-4e35-4813-ad83-3b924210c684"/>
    <rdfs:label>desipramine-HO-NEF interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/6754585b-a8c2-41ee-b4e2-aaa0c6c03cfb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/421837fc-e298-4f4d-8232-2e2df0fe2c74"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/a5d95cde-8108-4d03-91f7-18e22317948f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/ac7a02aa-9619-4257-a8d9-bd993890a91a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/e308a137-5190-4d73-8eea-cdbb950b7461"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/c0740c0f-daed-4b5a-90a9-893848cb28f8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/dd4da7bd-6d24-47cf-bdb0-75a392577331">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f9058844-17c3-4c22-82bf-d81732aced29"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/81736fd6-2a8f-42c0-bfca-9c2aff470e2b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/cd3a9351-c4b8-4fb2-854d-8f86bbf945e0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d33d7a19-1f00-46ba-b401-c6f282553736"/>
    <rdfs:label>efavirenz-hydroxybupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/82be4c4d-a1bb-480f-a62b-6e0b7986ab79">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/cd19611c-b028-4bd9-8148-d053bcbdb973"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/23f6aaab-721f-4d84-b3d5-1173780a704a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/3139981e-f21f-4314-ad43-20ebf5b2ddae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/04a92d2a-9f92-4587-86b9-411c73a4a7d9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/1e49b8e6-b0df-406d-a57e-b2120caa1d6d">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/33c09bba-8421-4c69-b48a-43da54b6d981"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/a61a8791-dd65-4ce8-9f5f-01dc698be871"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/e7e20627-4f68-40d2-aaa9-9e70d8f49dbf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/cc112019-1d8f-49b7-a763-3a02d3c11a7e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/470cba1f-3bb7-4ff2-929a-f450ded5a022"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/3125723b-413e-43c9-90e6-478010547b8e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/42411163-8194-4161-b254-e4ae8a1b347f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8a7287a8-5c62-4044-80e8-acdf33b77b12"/>
    <rdfs:label>aspirin-rivaroxaban drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/25f25b65-d53c-4a43-bb4f-f7a5845b8fd1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/2c0c954b-73b7-4dff-9a3e-3a3ef34de67b">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/53482ccb-cf05-4568-a610-77cfa8936625"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/538e7a0f-839e-4948-a11d-fcf862ec0899"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/8455f414-3f0c-4330-a966-cc6e89c0e768"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/ab1e23ea-cce2-4909-a466-94785f6b9e05">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/9cbfb2ff-e030-4456-89af-e0fbc858290f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/a41d12cb-e5b4-431f-8654-5d975d2c6e54"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/400f7305-5003-4119-beee-772bb77bb835"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/e0f0e5ad-2ff1-4afe-a475-4d5c8813f1f8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4dab7ea9-5760-4bc3-923c-257b6605297e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/df904e02-0462-4cf9-b04d-011d59b11524"/>
    <rdfs:label>cimetidine-citalopram drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b4ec486a-ca44-4e85-9b41-81cf409c2fe4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/3090ef0c-f127-4dc4-9886-d4724cd51fcb">
    <obo:OBI_0001937>1250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/9cbf2649-b49e-4b60-9e52-617264d16216"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f28893bc-95cb-4e81-82c4-5f0c768221d7">
    <obo:OBI_0001937>250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/80b2ef04-54ad-4fa7-b879-a58cccb065d9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b22e0088-f641-4103-bf5a-932d116dba50">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d7d8de65-c9d4-4929-a4a9-6e3814d8d033"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/579a8d13-7dee-4733-97c9-7684571d0089"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/559cda18-99bd-4edb-97d9-6e7038d28fa5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/48e1ba8b-16fe-426a-a54a-2a77532a7fd2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f62b9133-9c7e-46d5-9468-a6e191e152a1"/>
    <rdfs:label>nefazodone-alprazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/077ac84e-3db9-4d4e-8bc8-07b4fce34dab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/6004458c-aa89-4660-87b5-22929ec999dc">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/a98d4f7e-7b05-4933-be99-ad92631fcf2c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/eadda66a-07fe-4beb-9652-d63966de13f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/3303906a-a75e-422c-b246-ffb87a13970d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/d8c57d91-7bb9-4e16-b5e7-a727dfd334e6">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/d0aff991-5f73-4b86-8cab-e74474e86403"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/8a4e9345-751d-49c9-bd7b-df60e91db16c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/443acb69-2ccb-427a-b2a9-8cbe2ab6153a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/bb4dff37-c402-4bf6-9b7b-d9e5abff3267"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/ff9c6337-93eb-408b-af73-e44a1756bd7f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/caac560e-044e-4642-8c98-8470c9f27a12"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/616e65fb-9a63-4f18-93df-0bb7865d282b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3dd497f8-2b1a-408c-9f24-802fa75cb78a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/858bf9df-7aed-4af7-be44-42319211d29f"/>
    <rdfs:label>45 Percent </rdfs:label>
    <obo:OBI_0001937>45</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/7773b9f4-49c8-4bf3-8590-4145d7a44d83">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
    <rdfs:label>ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/bde252f0-eed6-425a-93e9-ad4c4821c20e">
    <rdfs:label>nefazodone-simvastatin acid DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/55871332-8a99-4749-93da-968cc526cc32">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/5f80426b-cf8b-4203-a4ab-26d8f534bd41"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/82871b62-132a-439a-8584-4cc12089c2ac">
    <rdfs:label>Gemfibrozil-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/60a9fac4-ba24-44cc-a3ca-05b1bf6d9d7d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/1f423686-f78f-4565-bc19-2acec051e4cd">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>Fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/20b7c307-a02f-4168-a489-b8b343a02515">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/62b5f68f-fc57-4fe4-b007-17956f41fc19"/>
    <rdfs:label>73 Percent </rdfs:label>
    <obo:OBI_0001937>73</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/483cf64d-aa05-45ea-9e88-7985c20ac9f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/5af816bc-c928-46de-9953-07e782969862">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/17e904de-1fdb-4004-af01-4a606e7aa748"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/56eaa93d-0476-4094-887a-87c373519049"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/4e8c7c4c-1cfc-4a11-b7f1-f0886b0125ec">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/76c3cbab-4485-4ce7-b4ce-395d0291e4c5">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6ecd42f8-7fd0-4d98-aeb4-98e00c87a3de"/>
    <rdfs:label>10 UNK </rdfs:label>
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/11f0e2e3-d745-4d84-b953-cfcade826af8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/0b7032f1-c98e-45e9-bb0c-728fc85204b6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e334f69b-2784-4029-b36b-2e53703ea249">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/782bd070-900a-4a36-b04f-25282ec86e28">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0aa07ad8-5f3d-447c-b35f-345664a9d426"/>
    <rdfs:label>42.8 Percent </rdfs:label>
    <obo:OBI_0001937>42.8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/8d28b749-35f3-43ce-9d8d-70e57a9bcd5f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/6be3ffce-c91e-41a2-8e7a-e6f2a989def5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/141693b3-99af-43c6-a9f2-bac9dcd0a5d2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/6b12c9c9-f00c-492e-aa17-d9f4b43d0500"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/bce5b6e7-4d42-47e0-a1b5-a3539a43748d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/cb24a13d-dcd0-404a-a6c6-213042b1f0bf"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/a643c6f9-47f7-4eab-8e3c-299a18fe29d8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/029eb0ed-dcf2-4b53-ad04-759123df7856">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d51c3b8c-7f8f-41e8-b1a8-50b69d593dcd">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0d6030dc-714b-4c09-ba51-5949dfe3ab3a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a6f80cb7-e4f8-4409-a2ec-d25238dd0937">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c9ae98d6-7d2c-4972-9977-efa8331a475d">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/80cb7f28-cd17-47f2-962b-72c7478dc9f9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/6212218e-80c3-4c8f-9fb9-1bf83179d319">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/57910442-4138-46bb-a82a-a4c4c0d0b26e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/2f2bce03-88a2-412d-a22c-01e7dd85090b"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/a44fc3fc-528b-4c97-8d45-0799fef046b9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/daffcc3f-b593-41d4-8c14-573fa04dd466">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a7d415aa-c121-45aa-a948-16e7f661d943"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/0573f16d-6af1-48bb-ad77-e06eff0bdc43"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000221">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/4ef00918-9e65-44ef-91a7-ec19fca8ae1a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/cd277088-8de3-4a6c-ab86-e942f44a2f5e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/615c10bd-dbe5-4f87-be65-84d75eb92b7b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/3602bebc-c734-4e1f-8936-dd65e59759db"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2197e73a-a17a-434c-aa7a-d255563ce64b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/fcf82957-89ec-46c2-aab9-c87046af6ad2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/9950b47c-15ea-4e91-82e4-c3269b06f424">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/869da1b7-5731-46f0-9f33-739570220d8c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/023b99b8-4463-4596-929d-c7422995fd64"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/cc3acd2e-4ee5-46bd-acbc-84eaf2048825">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a7a22757-34c6-4432-9d9d-97753947ea46">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d1ff6bd0-02a5-42c1-a24c-ed414c6fa930">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b70b36cf-6518-47fe-893f-c3417bba5873"/>
    <rdfs:label>rifampicin-rivaroxaban drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1e5173f6-4f0f-4403-9ddb-b1760afbad2e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4c836f74-c1a9-49ec-b939-d0c1ccf7a643">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/2dfcd7d8-bdd4-4436-a140-987f6e80e069">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/83781645-5e59-4cdb-913e-738ec5b8695c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/cb71aefc-42b0-41e8-96ca-bfd64eebc201"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/55d865e4-4bff-4d7e-9bbb-c602673550aa">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/114bfb4c-cf99-4e51-b839-2d26c573ca77"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/75347561-51bf-4eb8-adc3-e82564ed17be">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/8c292608-ecfa-4f68-9aaf-d19dd592e515"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/506c7343-01d0-41db-8650-3624d73e2a7a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b8de460b-ebf6-4fb0-a1b7-9c156dd36e28">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/11f0e2e3-d745-4d84-b953-cfcade826af8"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b472ddde-3a82-4a02-a981-6a7fee206efe">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/8d4457a8-0c10-42ae-bd09-b858be856c93"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/bb3d9548-5397-4293-9f73-97d0a689eacf"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/beca171a-d486-414f-b999-047d82065e00"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ed64e6fa-a2ad-4961-9f74-9137c3ce016e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ac7e6919-e54b-4a66-87c1-e5998312eee4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e9a3eb11-bedd-443b-b424-b8164b4db749"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/338a8392-9bfd-4bf6-abcf-1adcd5ec962c"/>
    <rdfs:label>ritonavir-hydroxybupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/26331295-14b7-41c9-96c9-0910dfa2f56b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/7df05290-0430-4cd4-95bd-43ee32929e31">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/81e121a7-b36c-4ea2-b46b-8f178db8a538">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2a93a852-6fff-4872-8ac9-4b4cdc741e31">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ad0985ac-9d43-4fc3-878e-5fb02f90e340"/>
    <rdfs:label>paroxetine-phenytoin drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/7f14348f-075a-4809-8303-592450d72961"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/c3243589-50c8-43ae-a88e-f35b915c9132">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/0447e8bd-d539-4df7-9580-a7a5c2d52503">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/f65309bf-9aea-4187-87a5-81946729aef5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/89aa9c36-c2b2-4cb2-bab3-f7ab6ffdbfb7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/619fa831-01d7-4513-a519-8f3018019f87"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/06c08fc7-d9f9-4b44-bca7-81524902b90a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/d2055030-fefd-4fd7-98d6-b3d7b91d6f05">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/f7aafae3-c0ee-481d-aa55-84ca429ae3a3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6950ba91-d22f-48f0-8c74-0f6ecb0c7a2c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/322f7a41-991f-43e0-9031-76c933e20dde">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3eb0793d-428a-4e9b-ae32-bf3665f2b90f"/>
    <rdfs:label>phenytoin-mirtazapine drug package clearance Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d1653d38-e43f-4523-bd12-930a98f140bf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c618984a-0db1-4838-b1c8-de21a2383d7c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/887e469d-d33a-4c3b-b9e6-bc64be9c6f49"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/7a76b681-d518-4573-8c26-03d5dac06770"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/83aefdfd-5962-4bbd-8bf2-f68abbefdc7d">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/19be3c64-7445-400a-a573-9a1867a9924e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/ceaa9172-a61c-44c7-baf0-fc4ff68bf806"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/3b48518e-5ae0-44ac-87f9-da15e222b6c8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c98376bc-631d-4608-a8dd-69ceb4320a49">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8a9048d7-76d2-44a4-a048-b859c5d6b2da"/>
    <rdfs:label>20 Percent </rdfs:label>
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0db1c8d8-dc78-40c9-84a2-0bf85a0e9fa9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/dd649ae9-d57e-4b61-a084-86d2cc235261">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/5b275c21-4510-4e0c-9c7f-18de08222817"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/a0c72d6b-f84c-49ad-a5c1-d7d8fdbcce3e"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/92d4e1a0-7e34-472f-9474-7ff6330c6021"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d959fce5-0d27-4f61-82d8-e314108b8b8d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/9d9ac6ff-5d9f-4d39-baab-27f52a8eec8c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/46390b06-5e9e-421c-93a1-6d8e0040f4d9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/134744cf-2421-4d07-a00f-bf5f76be9cda">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/8ccf21e2-4fb4-4084-9a0b-1ed2b53f7d85"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/abf53425-ed16-4263-ab6e-defa9be92790"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/07a56634-0787-4c90-94c6-215b7e9dbffe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7b8ffb36-5e9b-465a-a4d2-2ca851dee6b8">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/315da4c6-f021-4030-94a0-707e49083ad9"/>
    <rdfs:label>10.6 Fold </rdfs:label>
    <obo:OBI_0001937>10.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a49e8ec8-1f5a-459d-ab97-f5b926e3ede8">
    <rdfs:label>carbamazepine-nefazodone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/f6ea9ba8-2b77-4f80-b7a5-6ad8518ee985">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e997b0ef-ee57-4d16-90e5-a959df9ae656">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/8522859e-2d8f-48e4-bb8d-b0d0c62fc0cb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/232ec8d3-c82d-4e0f-adbb-09b2432417ae"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/3aa0a750-c09a-4e0c-afb4-cae3c67758b2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/9c981278-52b9-4f82-bd75-3547d22a3b9e">
    <rdf:type rdf:resource="obo:RxNorm_6816"/>
    <rdfs:label>methamphetamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/eafae043-1744-4ba1-a1bb-af787f4490d1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fa646c6a-0601-4247-8b42-bea37c05de15"/>
    <rdfs:label>cimetidine-sertraline drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a8490762-f846-4ff9-9572-aa46581094e3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e7b48c0c-728f-4c36-9ea1-ca4b757229a9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ad01d58d-f033-41a4-9a83-a1f4df4abe04"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/494d864a-23da-41cb-aecd-ac15babfa489"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/ea5fd7d8-3088-4658-8b6d-51347cf9ca2f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/964dac96-c151-4a18-bb24-b1b888eb61bb"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/6966c772-74c0-4cfe-af2f-b7cccdf4d5ee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f397f428-7cc0-456d-967f-bd8c484dc349">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/391c9975-b850-492f-928d-8a779f9aea9d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a3e8f7fb-e3ad-4316-a028-2f95819f1787">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/c20087d4-6299-45d0-927d-1009e73533c6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/f77180e4-9bfc-4965-870d-b2b61b013b53">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/a0ae8ed5-6952-4c23-b6de-d5ad67152c46">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a44fc3fc-528b-4c97-8d45-0799fef046b9">
    <rdf:type rdf:resource="obo:RxNorm_9384"/>
    <rdfs:label>rifampin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/5e78d210-cbcb-4b42-9f99-8edf10104dc6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/34081298-c803-4882-aed2-362055e2b8ba"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/83ef305f-3c73-40fa-82cb-4e82b56dcce3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1beeede7-3462-4db9-9bef-2c838e6c160d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2d234798-cefd-42bd-b0ef-78286a1aa5c2"/>
    <rdfs:label>51 Percent </rdfs:label>
    <obo:OBI_0001937>51</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/88a68636-bef7-4823-be9c-b60bfd870224">
    <rdf:type rdf:resource="obo:RxNorm_8183"/>
    <rdfs:label>phenytoin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/5c8f6a48-a69c-43da-b940-20bc41db22f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/990e1123-143e-4752-bd33-6f43a93bcb90">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5ef0a918-13c1-4604-aea9-aa0272e6f8ba">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/f9c4bfa3-7acf-427c-bc86-aa86ce18deda">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/400f7305-5003-4119-beee-772bb77bb835">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/3cddeec5-12fa-4d27-a9df-874fce21553f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b0bfc90a-21c9-47b6-9fbf-e6b15151ecc0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/c868a84f-c80a-4c13-92f9-e11e986f2d17"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/8aeec942-1b2a-4bbd-905d-14a28c051d1f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d5ac4a6b-3d44-4150-ac1f-f5bb46f1885f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ac023c99-0d42-48db-9dd5-804affd020da">
    <rdf:type rdf:resource="obo:RxNorm_6918"/>
    <rdfs:label>metoprolol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/578d79a9-202c-4e70-b109-12a86e890355">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/2a0daca1-e6b5-4414-9f28-2d68190eb950">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/46797631-4930-4e3d-861b-8d9d9330a32c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e711cbd3-7dd0-43f4-8f0e-8338d6ef1c8d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/0d40b3ee-a552-4e8a-8e4a-69aba2eec5f5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/81ad5515-98cf-454c-8a0d-ac8105d694cf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a33a43d1-7a3c-43c4-9afa-5d039c7fd59f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f451795a-ba16-4a00-aec4-860f6e93175f"/>
    <rdfs:label>43 Percent </rdfs:label>
    <obo:OBI_0001937>43</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/be91521f-daf8-4383-ab00-5796f06c05da">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/f2e6b029-e1e8-4d94-8939-2f16096d9b77"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/42366b46-18ae-4cf7-8418-d149671971b6">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/d9265aeb-47cd-462a-9762-881726e94eeb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/48d5e0bf-b5e4-4fa1-ab2e-0d5d84b3f69b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/18a47a82-62d9-46fa-9645-75bb5496e989"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ee6bc9ed-cc37-45d2-b620-465b850eb89f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/00ebab02-d14b-4959-9e8a-2a1ad5028281">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/1dc7e990-6bc5-4245-87fb-f72b7ce0f12f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/cda25b24-6d1f-4a02-b326-0f2e7af203b1">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/ded8d6c9-c350-409e-bfc7-f7669e06d04d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/65fd1642-b162-4db7-a8e1-4210affe30c7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/666506b0-c4c3-4f4c-a9b9-7a4895abd93a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/498caf89-b34f-496b-ab9e-6d073461f62e">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/323a0a99-edaa-4cab-924c-fdcf11edf080"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/66fdcbe4-7239-4189-a945-68ed4a141288">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/cb907e93-82c3-4bb5-9aed-b42820a85e0e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/2933851b-5031-4a31-887c-2a2b8f1708ae">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/56bd36bb-ac2a-4b02-b4b5-7ba0eaff36cc"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/7891790e-69d3-4009-ab69-38b81b0c8e01"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c8698b82-e065-431d-b449-2ef4d86d1e30">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/427ea5ac-bd32-4d3d-b984-188c41c69704"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/a8c55db0-8f4b-4228-9509-b058611dab95"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/20da8e88-be33-46c5-971e-1b126069afa6">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/be82b42d-8767-44c4-8c9e-4dcda7abdd22"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e9f97057-0761-4f14-94dc-17338ee76a81"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/2e83bb41-e8fb-40ec-80d3-6a514b58a362"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/32cd239b-e5b8-4a0a-94ca-5dd9b0070160">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/2f19cdab-cf9c-4e11-a0a4-2b20dd555ba8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/e5254f6c-4e81-4987-a39e-ba4ab7cf7a16"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/41a413a3-c28f-4120-bff1-15e6b5c1c803">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1bf4fb39-c810-47c1-83f4-46a0bf6f7ad7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8eb0ed5d-ba39-492e-a39b-c770863ebe96"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d35216ca-0831-4dde-889d-74dd1d7e5471">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c27197d9-f5e6-43b5-b2fc-09fb4ecc8839"/>
    <rdfs:label>6 Fold </rdfs:label>
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/551e25a2-6c80-4dc4-91c6-6cc43ae2ccc1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6bd8e3ca-3181-4f3b-b377-4b2107d616c3">
    <obo:OBI_0001937>250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/6208aeba-0fdb-474b-8e68-b3aed330333a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/68c1aee4-3ea3-47c7-b385-bb2f32f3b5bf">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/74f133d1-d57a-451e-8834-ab0a3ec4da5a"/>
    <rdfs:label>0.97 Fold </rdfs:label>
    <obo:OBI_0001937>0.97</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/4d936401-d7b9-4c05-81bb-59a5a446e603">
    <rdf:type rdf:resource="obo:MeSH_C406672"/>
    <rdfs:label>triazole-dione</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/86e4891d-c9c0-4422-b389-481e61151d90">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/bde252f0-eed6-425a-93e9-ad4c4821c20e"/>
    <rdfs:label>nefazodone-simvastatin acid drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/698b0fd6-5c20-4dd9-9979-1a9d5317d84a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/72e3f3f4-4431-4d0e-bad3-e07845beddc1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/9bccc7cf-f324-4cd0-86ee-b883e07b2975">
    <rdf:type rdf:resource="obo:MeSH_D014859"/>
    <rdfs:label>R-warfarin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/d9a0772a-879b-409e-834b-d5aa31abac20">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/025c3bab-c2da-4f07-ae90-f61237b5442c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/1cd08aa6-a490-4b57-aa25-d8b8a69b9ce6"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/638ad0e6-cbec-4243-b419-850a9b861dde"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/5c2c40c4-c75f-41c3-a4f4-9c1efdffbcb8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b60f6025-ae8a-41db-b6c2-8b17421513b3">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d2e0fd90-17fb-4111-81c9-755e46197d04"/>
    <rdfs:label>paroxetine-iloperidone drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0003f267-35e4-44cb-be12-68482800fe29"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/6071d432-1cb6-465d-bb42-a247bd9a70ad">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/6ee0da9b-3ed1-4baf-8dd1-17d7a08ae1ce"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/18b303b3-9b57-41b8-9676-a6d2a5f8a34e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/dd69a81b-c449-4dcb-aa98-ae0bc8c6ff8c">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/45c8e510-6dcb-4e4c-8840-12b74fc33156">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
    <rdfs:label>desipramine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/523af6cf-e593-49e7-bff7-8fd8bcc2a5a0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/01fe2b4f-4926-4e06-85b8-653c9b9609a0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b0cd8288-8782-4b89-b9da-b9360894ac89">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/c43afa01-dbd1-470b-8c15-0bca8c0f25db"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d9a60053-1fd7-4afc-99b6-4fc4efd20635">
    <rdfs:label>fluvoxamine maleate-propranolol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/42b9c0d4-a175-4d0f-9518-66e851c2816b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ca21ec6f-34af-42ca-bf22-bfe6ddf32374">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fcd6a420-56b0-4981-a7ad-234daee536f8"/>
    <rdfs:label>lopinavir/ritonavir-Rosuvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/16effcdc-afd3-494c-acf8-7588fd72ecdc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/30521945-324d-476d-9791-b98d984c4e66">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/891e9020-3375-4738-bba7-356dae901c19"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ad3211a5-97d4-4b39-b56b-371752b65cb0">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/d52bd24e-4c45-4292-8973-250db4ce4332"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/ea3ff0ff-ab44-4246-bfd7-3a502aa3d85d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/50159e5f-4d2a-4c25-b2f6-ff0a3f685bdb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e14c8dd3-ae4d-42b0-9ae3-fa44e5dadd0b">
    <obo:OBI_0001937>300</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/5aa02787-0896-4f36-beba-55fef5fadb9d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f1f840bc-8618-4b98-9817-24708fba4b55">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/35423c2c-b0df-4b83-92eb-1ffc9d0b058f"/>
    <rdfs:label>4 Fold </rdfs:label>
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/37f0acd6-d3a2-4df3-8f56-de4f9c3b2cce">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/9ca28005-6cc1-4dce-bbb5-a252837854c3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/bc37b6e0-13d3-474c-8680-37693fc26a81"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/6cc0c868-646e-48ea-8697-3f685dba97e0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a3d24f40-0045-481d-845c-6adc6564b3e8">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/710f24ec-ff35-4dc0-8297-d83c8fcd21bb"/>
    <rdfs:label>81 Percent </rdfs:label>
    <obo:OBI_0001937>81</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/702c8c4f-7d22-46b9-bd6f-aa6e75bf9cda">
    <obo:OBI_0001937>75</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/bfe98b32-1062-449f-b94b-e310dc4505a9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b24e5dbc-db7b-44ec-a318-4c77e5a49945">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c632a096-8645-45cd-8344-e13dd6a831eb">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/60945d33-3131-43a3-88c8-a95f761f07b4"/>
    <rdfs:label>Ticagrelor-atorvastatin drug package halflife  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/720ba1f8-a346-4c9f-8ef3-ce7c55faa527"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/1b637a73-022a-4459-86db-02bd01068a30">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d619061f-2d7c-4aba-abc2-109207d4b8a8">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
    <rdfs:label>fluoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/3fc8c60b-f4c9-47f2-850e-49cc78c789a5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ba108e83-9376-4cf3-b59a-293ab9d69896"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/79df6c4f-f1b5-4819-b898-6ff51c295180"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/4c8d4938-e15c-431c-8e80-672139bdc67a">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/3a6043f8-e3bd-4893-9993-3c8cfb8b011a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/9d6100b6-18c9-4ee9-b53e-6ac29fe28433"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/231cfea1-4248-4b7e-9b3d-9004ad668f9c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/86bbb725-07a9-4f1b-a35f-11765c6f6d8f">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/869a67fe-83fe-4e4e-befa-b6632175d063"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/52e494b9-f528-4cef-96d5-7038db2eb0bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/320434b5-89bb-4f97-a96b-0f480f37772a">
    <rdf:type rdf:resource="obo:MeSH_C558933"/>
    <rdfs:label>fimasartan</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/dd25b3ab-ce64-4300-a493-0476f44855aa">
    <rdf:type rdf:resource="obo:RxNorm_40254"/>
    <rdfs:label>valproate</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e265cc0b-3217-49e1-8be3-79feec619e5c">
    <rdfs:label>fenofibrate-pravastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0003f267-35e4-44cb-be12-68482800fe29">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/dcf422b3-ea04-4302-bc85-d6668308b139"/>
    <rdfs:label>1.6 Fold </rdfs:label>
    <obo:OBI_0001937>1.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/5bdfe3e9-d0c4-4007-95bc-09fab897ef13">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a649b8eb-caec-4dc4-adcc-c8ff15f0736b">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/84330d55-8ca9-4262-8b74-21ad663f281c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/6bd80d6d-862a-40e5-a75b-11a290672c60">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/c62d3bd3-b50e-4081-8062-2b8eff28d12f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/eee2f389-7778-4f3f-b866-1a2113840ae4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f0985519-baeb-4d14-9fef-865372d212e7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/85e7a603-e56c-49fb-ba67-b91151f558cf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8d54e831-ee06-4ccd-a6a4-a445d4037886">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1f581833-80cc-4056-a07f-52eb6183dbe9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/663288c1-224f-434f-97c1-96867af94715"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ce79a32c-f0d6-4aef-99a6-ba668e49d075"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1c8a365c-63b9-4a16-97a0-ff26ff8ea945"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/d5e84ebe-e296-4dfe-b413-27af1d104a1e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/6a790eb1-6e25-4957-aa3f-7f290f0efeec"/>
    <rdfs:label>rifampin-zolpidem interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/05c0bbba-8a9c-4fcd-a1b7-340b8bd6abfc">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/9bb9ef81-61d4-46ad-b88f-a760f36af046"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/4c258f21-64e0-4176-b488-e4e10ebb933f">
    <rdfs:label>nefazodone-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/219b1fe3-3b08-4a6b-96e5-9ee784c5dc82">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ca9c213e-d1e7-4d41-a829-8b7b2387f762">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/7bf8e37e-2afc-4442-88e0-8aaa83e71b1d">
    <rdfs:label>ticlopidine-bupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ebc555f9-5d0a-43b4-85a6-784b6b2c4d75">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/061155ce-0ef8-4c2c-926b-06f3a0e8d18e"/>
    <rdfs:label>98.6 UNK </rdfs:label>
    <obo:OBI_0001937>98.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8ed98b81-7862-4370-b88b-92cd493c609f">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f61da29e-c8a1-4dc3-80be-3047c60b5389"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/1f8d4745-41d4-4898-a2ce-31669393f0f0">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/d61a6200-c723-4f43-8ff8-6b91a59b9870"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/4135826a-af9e-4d4f-acdc-229715130fd8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/46eb4abe-ebf0-475c-91cb-20719ac6a39c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e9d9b2a5-76b4-40cf-aa26-e5df8b943446">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/b734200b-bc7c-430d-bc1f-81a28f0ac127">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/fa17d7aa-ea5b-45ce-bc75-f2b124ed1b13"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/769b416b-b84e-4f3b-8cff-e1a8ee6cbdf5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/938723cc-ffff-4f3a-a948-3c8c0bbc31e2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d50db35d-9b77-4aa2-aaff-9b68ee55463b">
    <rdfs:label>fluoxetine-triazole-dione DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/65f1b8f6-153b-41fa-ad6f-9b9ea931102d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ee40d925-1d8c-4dca-bfc2-89e9f3147630"/>
    <rdfs:label>telaprevir-amlodipine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4899a86b-4c33-4509-b47f-96f67a60262f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/9949c376-5458-44b2-b545-c16c0b5289a7">
    <obo:OBI_0001937>150</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/27ac3dbc-98fe-43f6-8ea0-1f7767ef57b7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d670942d-5f49-4576-891d-b74a314d2c7c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e63ece20-8c98-4385-ba1a-084dadeceb7f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/52bd0ef8-7c5b-4d8a-b88e-54529c9d4586"/>
    <rdfs:label>7-20 Percent </rdfs:label>
    <obo:OBI_0001937>7-20</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/61d873c8-1b14-4e44-9f75-f8dfc8a36982">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ffcdb82c-733a-43a4-a2de-8850dcd18b27">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/591457cc-229b-430c-9fa5-942e441f83ea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9d0076b7-4e84-41bc-94ff-c34debe9a7f9">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/4040ba33-7602-440e-9def-174b92313bb1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e9fa9b60-adba-4cd2-94ae-ca93694fb916"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/aa7a65cd-42dc-4910-8e84-55049a42116c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e35dc0b7-23c2-40f5-b8a8-19c0c35a1ff4">
    <rdf:type rdf:resource="obo:RxNorm_17767"/>
    <rdfs:label>Amlodipine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a5d80ccb-95d3-41f6-b0d9-96301b156463">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3a13fd86-489d-4fd3-b3d8-1b26bfaf06ef"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2b091b26-4614-4dc0-90d4-8bf881ac7c14">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fcd2a123-c960-46b4-86bf-97cb7bf892f6"/>
    <rdfs:label>Boceprevir-Atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/eb8889c6-a395-47b0-9a83-afe80162cd93"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/a377992b-39f9-4d84-a43e-11afacfdcf2e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/5c77d9d1-78f3-4192-b074-0a0417cc2169"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/cf656625-6afe-4660-a48f-8e3689883e69"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/523d3c6f-0ae3-4003-bdc8-af7d4c0284e1">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/cc5318ed-a2af-4622-ad72-7cc4e81cb3dd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/b4e524bc-5d99-4d4c-afcb-d6c8f321d1cd">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/b29721f1-d5e9-42b9-8713-efd7e1ea0307"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/61fa0a3e-b59a-4a89-a4a9-94b7ba69e4db">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
    <rdfs:label>carbamazepine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b8112419-680c-49a3-a96d-a1260c2db47f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/436220e8-bdcb-4b8d-99c4-21d5f0c2d634"/>
    <rdfs:label>41 Percent </rdfs:label>
    <obo:OBI_0001937>41</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/dd5ec11e-e42c-4d58-9879-518f11931166">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a05a1c82-9bc4-479b-8e12-abc695bf86bb">
    <rdfs:label>paroxetine-procyclidine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8664dca2-9e96-45f0-abbc-c985debff92d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7706fb73-4a06-4001-a221-fd1d8a4a07a7">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2420a771-1948-4dac-88a0-6d2a8f48030d"/>
    <rdfs:label>fluoxetine-mCPP drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c25ee9ba-031e-4690-9991-b65b718ea5ce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ecaa1e0a-ee71-4f59-b72d-d85210d82aa2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b7101a9f-feee-4478-928a-2b21b74dc0ec"/>
    <rdfs:label>carbamazepine-mirtazapine drug package clearance Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b808507a-43ae-420a-b61b-37b85f4403ef"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/71da2bc1-0bd4-4e5f-ad4b-9cbf39b5d984">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e5f246a4-1887-4242-8fd5-1626e0d219f1">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/51b50b55-5628-4e30-8dc3-b6dd920550bd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/f32cbff7-b32f-4ab7-b03d-6d74b490c6ff"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/fb3da981-0846-4844-8ef4-b613e253b72f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/6d953cc5-d4a6-4e7c-b40e-b3112c153007">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/7e1646fc-9aef-45f9-9820-7f40d77cbafe"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/c53f7921-2f2c-4678-98d2-ca63fd7f0510"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/59d59245-dbca-4a90-b5c9-a2c940e5ff41"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/7de722c6-7599-4947-8814-76137e93fc3a">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2c424594-5269-4331-b59f-5a66d4096b0b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/bc1bf9e9-625e-446a-a668-f6379fa25d2c">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/ef146f1a-785f-49a8-b611-86138269ce5a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/34e37a92-6366-41a2-883c-b24a697753a7"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/dc4b81d2-1aba-474a-a55e-9325eefc0715"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f233df73-3efc-48b3-aeed-a0b72bba09f5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/7df78c44-1eee-4b14-81bb-228cc78c71d9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/03f4940c-4482-4122-9d73-11ea143b4a81">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/c5a6d3d4-0f6a-49df-bd8c-8047d7ab34a2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/6a5f8b40-60b7-46be-be52-0a4e3aedacdb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/96e267d1-b942-4dd2-a219-c1b9fc006a4e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3b19c6d1-f905-4ab4-9a01-cbe3a946ddd6"/>
    <rdfs:label>clopidogrel-bupropion drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5d320d83-77f6-4f32-8c1d-3263c8c6ad65"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8a1c8e23-c0da-4508-876b-9d2a2230cf61">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7193c1d6-cd91-4d67-b8d7-90877bd6ef2b"/>
    <rdfs:label>55 Percent </rdfs:label>
    <obo:OBI_0001937>55</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/147b3d3c-ec0e-40e6-b1d9-db3735da01bf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b57e2ff1-6152-466e-aa65-a35cc7eaa0a3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/fb8f62d5-cf82-4f49-8226-a5cb2705a9cc">
    <rdf:type rdf:resource="obo:RxNorm_3407"/>
    <rdfs:label>digoxin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/15540575-8c26-4155-853a-b6f4f3764dc7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b628e2a8-2e1c-4c03-9188-1c8e9cfb724b">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/4a8714fe-d147-41bd-9094-2df82390e448"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/056cc22e-a0c8-4089-b98b-a7d1a0d17ee9"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/f99ec1cb-2129-4086-b132-06c29a301df2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7a004510-f9af-4b52-8b78-4b0cf4b51a0a">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/305ee911-27bc-4366-ad84-84b16553da96"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/fee655f6-74b7-4dea-9a32-86d25899bdd1">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/8b3679dc-4e1d-4e95-b29b-7864ce021845"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b801783a-3e4b-403b-8da2-e5ccf80f3ed3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/11b89e9b-b02a-4172-a889-f2727c30ef2e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a2cab852-5f4d-4fad-80ea-5097e1e5cef7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/19f12591-7008-46a9-b995-fd57a9ea3577"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/511e8142-9007-417c-a7ae-c84b77cce2e7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/85075b38-bf4c-4ddc-a4c9-4a694391056a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b628e2a8-2e1c-4c03-9188-1c8e9cfb724b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/86b33ec0-9f8c-4290-ab79-fced6bb55d97"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c79f9069-ffae-436c-97f8-293c03c5e3dd">
    <rdf:type rdf:resource="obo:RxNorm_85248"/>
    <rdfs:label>alosetron</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/a6a23ea3-baf0-4500-84a5-88f53939c453">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/426c3576-a138-4f98-87d3-2e5c7368c1a9"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/86dda032-8a39-4a25-bf29-b724542990ea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/38befda2-0eb2-4a31-b3a1-f37a2913fb26">
    <obo:OBI_0001937>9</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/8f0a9023-a8a7-42b6-a874-85604c916e7b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/bdf5d18c-5c3c-496e-ab0c-f9311360d44c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/153243ba-b722-4a3d-821f-25638e830ea0"/>
    <rdfs:label>ritonavir-bupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/72e047a0-b781-4acf-aaba-26a550c2f9b0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/543e695f-73a5-47ee-b86e-82a5d1743511">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/8c97e556-167d-40d5-9ff8-cbcb3d93a927">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/5b6cb5d1-38bd-4b44-8a5b-81e9d2e1e88a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/bed3aed7-9f47-4d63-8ae8-3a943fcd3030">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/50e0893d-3c9e-488f-9390-c7068dd3e481"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/b25f3690-8f76-4118-9515-1bf8ae2b7f53"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/94416516-9401-4330-824b-142bc1e143bc"/>
    <rdfs:label>ambrisentan-warfarin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/5c63f7e5-f818-4012-be1b-9ac10f8b0665">
    <rdfs:label>bupropion-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b347895e-1ce5-4a82-b4eb-e22065f17aa4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7dec54ee-627e-4b70-9c8c-8a651b9570d8">
    <obo:OBI_0001937>150</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/846c61e3-7269-4cab-b284-b9519ece5066"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/51752c9b-6006-49d9-b2f9-49bcadb59a70">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d4b6cc8f-c54c-4ff9-a67d-9ba4dad7122f"/>
    <rdfs:label>fluvoxamine-ramelteon drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f118f7f3-0c3b-480d-bd44-16468e0c7cfd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/4914ce43-60e0-41e5-bb0e-407e872bf6ea">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
    <rdfs:label>rivaroxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/2c9e1229-a0b6-4026-8ef3-4e1d6346a330">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/85495b94-2b61-41e2-a860-d47ef4e089cb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1feb46e1-d072-4e8d-bc7e-431bc1469fd2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/26fffdab-c35d-4db8-b8b7-206531703686"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/3693ef20-5581-41dd-89a9-9168719b7a66"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/2197dee0-bcf6-4ac2-88df-e76d077721e7"/>
    <rdfs:label>sertraline-cisapride interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/9affe979-aab9-4d4d-ba87-457dcb4c510b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/57b99c65-64aa-4294-b00e-01ab1d41705e">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d912e803-5e71-4049-a5c6-369f036b6480"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/8be5524f-039a-4fe7-bbd8-aa7c6e6a5bb7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/328a8627-ea34-4814-b59f-3acbd9cc3035">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/45c8e510-6dcb-4e4c-8840-12b74fc33156"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/0e2404a0-06e1-4b1f-81f7-a53e53c911d7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/e49e9675-cfe4-4615-9e28-6f1d5823e306"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/99469024-0e7e-4c27-81fe-cfb49084d458">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/d17bf65c-559e-4ae0-9609-89aa37acb076"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/72b575af-124a-4a2d-bb8a-0a137b63bff3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/40c4eb5f-56b4-4b10-8198-b0e25cb13f3b">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/1f222d38-f26e-411c-b098-e8de46bba663"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/bc59b83d-98f8-4469-9b95-7d703adeae88"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/636667fa-c882-4599-9ff1-f04677d81a80"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c3199a21-8db8-41c1-b3e4-1b985257c91a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/8c0d75c3-d798-47dc-84f6-d0c63fdd0a26">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/6212218e-80c3-4c8f-9fb9-1bf83179d319"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/4c96701c-e1c3-45b4-8319-2bff1f82970a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/f6bb234c-ca30-47e1-ae91-392929baeb6f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/8bb2d1b4-f80b-48ac-b568-90c7674739f8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/b722300b-f881-4654-9738-934f655377e6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/29d72a72-5d41-42b6-945b-c13c85fb4d3a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/3c4b9fd7-a712-4c77-a9db-bfe9fd7bd16c"/>
    <rdfs:label>4.23 UNK </rdfs:label>
    <obo:OBI_0001937>4.23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8c453d91-8c0d-4011-aedb-5b79e716289e">
    <rdf:type rdf:resource="obo:RxNorm_1599538"/>
    <rdfs:label>Edoxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c05b7291-9f8e-464a-a0cd-6a82190f0104">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/df7cae32-0e77-49a5-8080-6c7c8788a50d"/>
    <rdfs:label>clarithromycin-rivaroxaban drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1681220d-b990-40f8-9d4c-78463d750b95"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3044281d-34e8-4489-9ff6-1f8b9143a147">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6132b4db-6d8f-4beb-a6fa-30979592e089"/>
    <rdfs:label>simvastatin-bosentan drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/df173eee-fc4c-4f35-bdd2-e0207a2af365"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/2917b8b7-ebf5-4907-9bbe-04cb23dfc14c">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/9711f25c-5683-4218-974b-d527d8e0e4ce"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/397c5432-36d5-4c50-98ee-813b6d73f999"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/089d85fb-e0e5-48de-a02a-e824bb5cc766"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a281ef46-8121-49e7-8822-7ee41c8c2abc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/530b462b-312b-434c-ac7e-b9213d01be7f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/fece39f3-33c3-49b8-b794-4ddb0d6f04b1">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/6b07d894-1561-4903-a9c8-f93b43048e46"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/505dd6e9-6055-4278-a21a-50c1cd7c1992"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/6d73f9ab-7cdd-441c-a8a7-a601db8567dc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b4838738-8a70-4de4-a485-cd971d1172e3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/bc0c6876-be29-47e4-816e-54a27b9ce13a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/fdc0bcc0-dbe5-4845-8b48-b2eeeb6682fe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ce03e7b2-4ff9-4b19-b09c-a6725a0a5925">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b8ecbb8a-0f93-475b-ad8f-3a45b780c3d0"/>
    <rdfs:label>rifampin-zaleplon drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/23b88546-3d0d-4f88-b547-e693da288c41"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b55a04f9-58d9-47bb-9ff6-d9fd34ded394">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/32da601a-9cdf-4945-8daa-2039c07bea8b"/>
    <rdfs:label>573.5 Percent </rdfs:label>
    <obo:OBI_0001937>573.5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6fa31c6d-0bbe-49ec-8e28-40101d465648">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/14b7e968-40ef-45c7-9800-05cfa07ab122">
    <rdf:type rdf:resource="obo:RxNorm_6960"/>
    <rdfs:label>midazolam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6249dfa4-79eb-4b3a-9f4a-e369e8ba065d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2bcdf79d-4d3b-4e51-aef5-7293b192c93f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/0bb2ba9c-a625-4542-a514-13ed81f4cefb"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/77d932e2-155d-40a9-9043-d56b24901701"/>
    <rdfs:label>BRINTELLIX-salicylic acid interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/1f61fe30-6e89-4ebc-832b-a11aa728730d">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4afe8cc5-696c-4842-a754-80b19ebe5bad">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/11e14d20-d442-4944-b120-7721887d5215">
    <rdf:type rdf:resource="obo:RxNorm_8183"/>
    <rdfs:label>phenytoin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/bc6dc3a7-a2df-4407-8b5c-8f63b8930ead">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/036fae46-2788-4598-942e-2430d1a7ca27"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/55dbb47d-5a6f-4d96-9f19-be44f5083b21"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/5e93378d-2564-4e63-b459-6580867e7584"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ded8d6c9-c350-409e-bfc7-f7669e06d04d">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>Atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d9033b06-9758-468a-b500-c16e3191012a">
    <rdfs:label>ritonavir-erythrohydrobupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/d1ad57dc-0421-4908-b15f-578e5f3bc24e">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/5ac2bcdb-c43b-43d7-a69e-74ff421aa991"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/0e85c164-6da9-47f0-a6a2-e6003d3aa34d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/7f8b3c5f-05bc-41dd-97d7-1cd8d3b2039b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/a4fbb28b-2f1b-4c11-8016-96c811e7bd12"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/b3af23ab-2a28-4ad3-89b6-10253f91b3d0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a3b09ccc-47ed-41ba-9acd-5eea7cfc40a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b648b864-cc41-4e37-a8b3-c63a8f598e81">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/71da2bc1-0bd4-4e5f-ad4b-9cbf39b5d984"/>
    <rdfs:label>4 Fold </rdfs:label>
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/21a06d23-4037-47ec-852d-1521a20b0fa2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/4d01aeda-1916-4a63-9b28-002cb8297999"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/0c9cfb22-8d5c-466b-b240-1c897121df17"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/84a892cb-385f-4244-bc8b-6d41702ece31">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
    <rdfs:label>desipramine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/969f31a6-5be6-4479-905d-8f474849bc8f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/831a01ff-87c0-4443-bff1-fbdf89fc04e2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/d29434f7-56d0-410b-9c53-9b1b24c23005"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/f83867b4-02bc-4096-874d-b9d72b365a92"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/d23c0de0-c28f-4744-a0d8-cbef49e081bf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9868be4e-ff5f-41aa-9732-1578dcbb01fe">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/54631c1c-f416-4f24-b89d-e87bfeb6c3c3"/>
    <rdfs:label>20 Percent </rdfs:label>
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/efeb072c-bd36-4dd6-a9cd-a4d7618ca670">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/f701f60b-84ca-4f87-8f14-4a54dc69add0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/1138e1a2-deea-4049-bcf9-2a64de32fb0f"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/328bda45-1a12-416f-9fc7-33552c303e94"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/2f823a2a-09c5-4e62-873a-1d8201d9a5d4">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
    <rdfs:label>ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/4982b7bd-c864-44de-888f-1187b4809b65">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f2bb2e21-e9cf-4719-a652-5b84aab8618e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/0e0852d3-ff7a-4941-8b0d-9308d7b6ce67"/>
    <rdfs:label>naproxen-Edoxaban drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/85d45ff5-8e0e-4516-bfa9-58af5290c1a2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/3b3d404c-bb35-45b1-a982-cf063e0ce858">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/7fb2df72-8fe1-4eae-853b-44f58e0459a2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/9e62d6a8-f187-491d-8c26-1904a0995a48">
    <rdfs:label>lopinavir/ritonavir-bupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e179a2c0-4353-46f5-ad45-79c657342011">
    <rdf:type rdf:resource="obo:MeSH_C558899"/>
    <rdfs:label>lopinavir/ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b7a9132c-e2c3-4caa-8d72-967e2414e86e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/54a1bbe2-608a-460a-905f-121979eb0d49"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/475939ae-8b5c-4bd2-b8f1-23ae3e2c80f5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/9364dea1-ab9b-42d4-936f-48eb415c914a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/adb9b935-65ac-410f-9feb-bfc6f8d85d24">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/652d4679-d3e7-473b-a0a2-81e9f4956ce7">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/6b6e8327-e1d8-4864-9c97-977501a0bc74"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/29975cb0-70fe-4b4f-8e18-2be6faadebb5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/9110ab6b-16f6-4767-b257-27ff4c8d2310"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/1597caad-d2d7-4e29-bb29-1fa88bbb3c98">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b9862b54-0134-4b8a-875f-7a4e3bea8dde"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/52cdc325-f0f4-447c-8bd6-631ec57f76f8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d0f0c9c5-b09f-4a78-af0d-b9942692f84b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ecc41041-c82e-4561-932a-a9deaa3ec2bb"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d1ff6bd0-02a5-42c1-a24c-ed414c6fa930"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/bdb5d62b-65ce-4ceb-8ddd-d33d585b74b4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/0739f80c-e44e-4e26-8c93-a3bd11e38ee4"/>
    <rdfs:label>rifampicin-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c27197d9-f5e6-43b5-b2fc-09fb4ecc8839">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/72ba9c9b-bb41-4c1e-a853-38c38270d8d8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d833ab23-2da4-446c-8866-428cf4ab5739">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f1372d3e-f259-4e96-892c-f113729db207"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/f7248a0d-eb5a-49f8-9d1e-54b9888ca391"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/abeed22a-bb9c-4dfc-ae63-ee5b46e5c59f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/c50de28e-5f74-4099-96e2-1b727ac48a87"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/58d4a660-539a-4006-b5a8-b098e63ff8cc"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/0ed06111-401c-4c12-814d-1f9ca61958d9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ed493891-24b8-4365-9df4-6eb559b144dd"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/565ac880-dbe2-4073-980d-ba6fdbb7a7b3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/5e92bb22-9a5f-44f7-a011-aa0644ba14c4"/>
    <rdfs:label>Carbamazepine-olanzapine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2a7c8724-2c33-49a9-96fe-2c360b9ce568">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/ef7394a4-ae4c-4d2d-9186-7c7521e9c24d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a1e55b43-a646-4434-86f0-8c7fac1b591e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a6b5b4a5-2f0b-4a92-830c-c3815a9d1b50"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/1bce7b62-1f62-41d1-978e-fbb62fc40d4f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e72ccc36-509e-45c2-a4f3-b723488eabe6">
    <rdf:type rdf:resource="obo:RxNorm_61381"/>
    <rdfs:label>olanzapine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/677a829b-eb86-4761-a2cf-c14b15762341">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c51f2f9f-75c8-4fb3-9b9f-74c9bd5a6dbe">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
    <rdfs:label>rivaroxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c48b6a1b-2f53-452a-8bc5-3a0af7fba119">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/acd69e49-dca0-4f6d-9e50-63df8bea4d61"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/a0fed08c-3a45-4227-8465-fc7bdea7d925"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/8fe11237-6bc7-4121-86f1-3d63a00107e4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ddae3568-3e3e-4a68-90eb-567b683459ac">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/f675f5a3-687d-4566-99ef-848276fc6b63"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/f3aea126-cc66-4b3c-9a3f-cccf2a2f60b2"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/d619061f-2d7c-4aba-abc2-109207d4b8a8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/3f6d1e0c-7c86-434b-b7ef-776d0cc98fa0">
    <rdfs:label>ketoconazole-citalopram DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/57eb8a14-4870-45d3-a2b3-4adc8ec1dc35">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/9f3707e0-5667-43fd-85a4-9e9ce1e10439">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4156dd23-8501-4570-b3a2-82872b6e0d2f">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f975533f-18b0-4155-9114-48533e71f5c8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/6b6e8327-e1d8-4864-9c97-977501a0bc74">
    <rdf:type rdf:resource="obo:RxNorm_596"/>
    <rdfs:label>alprazolam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/530d49e8-7970-4ea9-a02c-4decff16e95d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d9a60053-1fd7-4afc-99b6-4fc4efd20635"/>
    <rdfs:label>fluvoxamine maleate-propranolol drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c61220d4-9f25-483d-a6e1-a4f5e5ae3af6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/828ab0ba-9138-4c6a-85f6-b660e3e70d14">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/bcb9198b-a97a-4138-92dc-a86127f5dbd9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b2b74e37-5444-47ed-bb7a-e27ed07ea868">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/2cd2d2da-dc16-4200-ba10-fcba6e5cc7ed"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/a418e565-d409-4a9a-95dc-2cd6239fd623"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/088b3470-73de-416d-aeef-1f2fdc83dac8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e5c118c2-83c5-4a33-9834-181aaa6c4cee">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/de790b04-6914-434f-85c4-0edb668e3cd0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/fed71a47-bcb7-4dcb-b43f-6b184b0a15d8">
    <rdf:type rdf:resource="obo:RxNorm_1102129"/>
    <rdfs:label>Boceprevir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/2601961e-a0b3-44da-a16e-4fab6e8c76fe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e73f301b-8df9-4df0-9c2e-7e76b685fd42">
    <rdfs:label>desvenlafaxine succinate-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b9de9d9a-8ff4-4006-8849-5106825cc4ed">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/895980da-6815-4c04-a50a-eab49468e654">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c25db366-0f2c-4d04-9b5c-7d1f8199ca36"/>
    <rdfs:label>unchanged None </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/6db815bf-a566-4d71-9ee9-23a696315c7b">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/7ae2c55d-77b6-4221-a8e1-eba65fccb4ea"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/5c8f6a48-a69c-43da-b940-20bc41db22f2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/66e70b9f-4d63-4869-9345-6cff9281e2a1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/eaf941ab-1269-46c9-9242-7a78379bbc85">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/98d6a8be-1734-4012-813f-e362fb8b3a81">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5123f702-c224-4323-b87a-1a6985be25f2"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/78eb169d-891a-434b-844d-8b283545dfb4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9e5963ba-5023-46c3-adc5-c660279f4782">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/46612123-b294-470d-ab78-0e986d2df2b4"/>
    <rdfs:label>45 Percent </rdfs:label>
    <obo:OBI_0001937>45</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/daa0a8f8-96e6-4462-8c1a-00b463b14f2c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1fa15e43-158e-4e24-9314-d43f3577077d"/>
    <rdfs:label>rifampin-dabigatran drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4a2bb54e-7133-4422-8f6c-338d4f95f84a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/4fd77eb9-71ea-4cb8-9609-bd7573e2a5a4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a8015da3-f974-4dd0-8816-7a15d6d39b4f">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/5d3cfdcd-2b0a-4520-872a-0d2f233915dd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/232ec8d3-c82d-4e0f-adbb-09b2432417ae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/710f24ec-ff35-4dc0-8297-d83c8fcd21bb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/930158f6-d8ac-44cb-a0ff-f0789c519a29">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/eb534b59-132b-4201-a8ff-258f73a00ddc"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7da3f221-31ae-4740-9da8-cc725e27122c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d92ef654-8b0a-4cb6-9ac9-fece5365026d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/153243ba-b722-4a3d-821f-25638e830ea0">
    <rdfs:label>ritonavir-bupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/7079a409-31ba-4938-bf2c-be8407dc31bd">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/dd6d3ba5-7045-409b-8bd0-80502d140a5b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/1464ff70-3f99-4e74-ab1f-7ce261f37d02"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/9bca3a1e-2d63-4644-af2f-9208f78b756d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/0df8cbe3-c798-4427-aa5e-0c425169d362">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/52cc5444-8034-4c9e-8370-7c7eff7617ba">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/39c2505b-11e6-4956-9a31-c869d948bd8a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b5660b09-a1e1-431f-9302-612356dc800b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/c52939dd-0c9a-4bfe-b6c2-e13d5e68d2c6">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/02577fb0-a03b-4d8e-8807-88c769444945"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/c9b878b9-ce63-4fa6-be31-f6320de1f5d5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/8bece738-38a0-4d50-94f7-f246f9216428"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1af66747-7a2d-47ea-8cc5-fab2850e36d2">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/38d38f64-f8f7-49d9-9337-391bf5ff22fc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ae6723b4-cc46-449d-a821-59f52a5eb8b5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/320699c3-0ad8-4c23-af4c-603244ef7790"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/50d7908d-40a1-48e0-bbd6-df7b5ad1ddfa"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/efc8bf2c-5e08-48ac-9b1a-c854011c8d28">
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/c8b631a8-a39c-4138-ba6f-6b33de9a8282"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/53d76f76-8700-45ba-b781-80f346e012be">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
    <rdfs:label>dabigatran</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1d702a15-3f2f-4b88-996b-ddf23b25cbee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/54f88c1e-6716-44b1-b70f-2f7da8be0ffc">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a419b44f-a0a8-4839-942d-30dbe9f6ec11"/>
    <rdfs:label>ticagrelor-simvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/500c184f-4619-4670-b571-c7d36f472a53"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e3e5acda-13b1-4d2a-a864-3821f77fc4c5">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/30a5d0b6-d1a6-4da9-aae7-1de854642709"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e58bec0c-a869-460f-9caa-d8dc291209ef"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/a67dbd2a-6bba-4d2a-b3e8-fba226a09109"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/5d3cfdcd-2b0a-4520-872a-0d2f233915dd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f5a755df-0b08-4a11-8ae3-7136bb4a9863">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/4f5ad196-23ac-4943-a567-b1ed094d72ea"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/d52b451c-0c89-4822-87f4-c85899b5ce79"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/6673f6c9-b5e0-4500-ac8c-3f1d82d8aac3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e14325c8-7367-4c68-822c-dded191a8393">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b1bb9f21-6e6b-49aa-b058-6e4739b1be94"/>
    <rdfs:label>fenofibrate-atorvastatin drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/73ef8910-101d-4482-9e03-3694cdf47d34"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/a6005e41-3668-490c-bfdf-8eaf034af1b5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/6b12c9c9-f00c-492e-aa17-d9f4b43d0500">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/029eb0ed-dcf2-4b53-ad04-759123df7856"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/5d39958f-1434-4cda-9e7b-45f96119663d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/49050239-4ff7-4eff-a9ea-c1769190e554">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/619011b3-c39a-4535-93bc-f2b667dcef89">
    <rdfs:label>S-warfarin-nefazodone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/169893d8-d8d8-4c16-9b25-a9bd1442d285">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b4ec486a-ca44-4e85-9b41-81cf409c2fe4">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d694321d-a22e-44e5-bb34-ecb347f4ed8e"/>
    <rdfs:label>39 Percent </rdfs:label>
    <obo:OBI_0001937>39</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/f701f60b-84ca-4f87-8f14-4a54dc69add0">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/fcf82957-89ec-46c2-aab9-c87046af6ad2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/b9327431-66db-4575-a448-f472f6b010fe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/0cab961a-ee41-4f2e-8bfc-8d0b3e6b6f84">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2f5cdbb3-95cc-4cab-9b5b-1d85481ac4ca">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/3a2734af-5668-49c0-86f6-fd016421d321"/>
    <rdfs:label>1.5 Fold </rdfs:label>
    <obo:OBI_0001937>1.5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/699f4a31-a360-4d78-891d-e7f208ade776">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ad31d4de-8e22-4b01-8a59-8c7212930710"/>
    <rdfs:label>1.7 Fold </rdfs:label>
    <obo:OBI_0001937>1.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/62c2af75-ce36-444e-a18d-70baa33460d6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/41d8da0b-994b-42c8-a2bc-346b78f6d57c">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/b37c3d2d-5408-4163-a94f-ef0463e7766d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/55c66822-a06f-470f-baa9-9b98b19746db"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/48bf28c0-0313-4cd6-a483-7e1f1bc373ff"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/201bcf07-089b-4a11-8320-a0a5546177d4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/aa6e5542-6920-401b-996b-5541cbda3cb2">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/74734c2b-565e-427d-bf95-227fc3a8ba28">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/33988fb5-f597-41b7-964c-ee30bec536e9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/f8c2abeb-5893-4df1-9538-2ca6a26ab01b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/95987da4-f1c8-4724-ab53-69416d4ec554">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e6240256-50f1-4a58-bda2-e480e2e0480d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8611d363-7f29-4d70-b969-9e574ffa5f04"/>
    <rdfs:label>65.1 Percent </rdfs:label>
    <obo:OBI_0001937>65.1</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/fa17d7aa-ea5b-45ce-bc75-f2b124ed1b13">
    <rdf:type rdf:resource="obo:RxNorm_42347"/>
    <rdfs:label>bupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/cd4c00e4-5db3-4d69-9424-888d7dd0d155">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d075c62b-6ae9-40fb-b5b0-67cb5a9cab17">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/42c2e57a-63cd-46ee-a84a-ac1fc868e52e"/>
    <rdfs:label>carbamazepine-selegiline drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a2199924-0124-42a0-9882-13348081d798"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/83c175a3-c31e-4552-ba48-8b6e56edf5d7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/0178833f-5573-4691-b56f-6d12b6807c63">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/bbba346f-ad08-4759-9a23-85d8d448463b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/13ca81fd-3527-4bfa-bad6-4bd611898c89"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/e5c118c2-83c5-4a33-9834-181aaa6c4cee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/fbf23bc3-c9c2-432b-a00d-45b65c62d658">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
    <rdfs:label>ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/4a9c7949-4da6-4b80-851a-221747c17356">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/83f52a78-7140-4d0f-ac53-a63f264e6b77"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0ae11e13-9134-41a7-a80c-cb26b5e363df"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c632a096-8645-45cd-8344-e13dd6a831eb"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/4a5510ce-cb80-458a-9277-b2386e9cafa4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e9202c2e-a556-452d-8141-f4d3757c5c69"/>
    <rdfs:label>Ticagrelor-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f668815a-26dd-4a0c-bd7b-4ee5dc278d74">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c3d03a88-168c-4d67-96a5-2ed57ab69108"/>
    <rdfs:label>35 Percent </rdfs:label>
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/fcdd3edb-2616-44d5-bd8f-1897ab8bb5ea">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/430a145b-07f2-4586-8f1c-e874afc56054"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/ac0727da-0655-4805-a051-5c35becc2b62"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/28099ae6-da34-418c-9fb5-6566dda628cd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/dc59e485-13bf-49e1-b469-d38ab0148154"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/d980c166-5571-4c57-8bc5-51c2d4588f82"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b575b6f4-446e-4f12-b049-0a4854b266c0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7a50843d-479f-4676-b619-f0fb78402f3f">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/8b948550-b03f-469a-818f-aa45165ce4dd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/487ba226-9eb7-4ce7-b306-2ed54765e28e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6ddecc6c-5ae0-46aa-ab98-abc45272c3cd">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/32a26e41-2356-43f7-a95c-c8be417ca09e"/>
    <rdfs:label>2.53 Fold </rdfs:label>
    <obo:OBI_0001937>2.53</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/3c821f4b-d9d7-4b5c-804c-edd8d1085aa7">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/483cf64d-aa05-45ea-9e88-7985c20ac9f2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/2a29f221-639a-4ad0-acb9-d62934cb124f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/21876c45-f64f-43a5-9e9b-1c2a59903c2e">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/390541df-1ac8-4c37-9474-9e1b635cb2ef"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/78e8f6c3-adb3-4c74-93b2-ba7b4699c86a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/d12409e7-01e9-45da-b475-1702507b83f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8fffa662-e96b-468c-8796-67c913d573b5">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d8b8cc74-6eac-4a45-9e3e-086d7f736335">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a45e66ef-8eef-497b-bce6-f619f0b4c901">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/beeb996d-ac6f-4e00-abec-8a36703b1dda"/>
    <rdfs:label>cimetidine-zaleplon drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/7a371f4c-e859-42fc-a9cf-1cd462443274"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/061ef076-8002-46f6-9bb9-9ad62001dba3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1c3171e1-59f6-438d-96fa-1a1b005f317e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/66679f5e-1470-4170-bddd-d47d1e9faf1b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/35423c2c-b0df-4b83-92eb-1ffc9d0b058f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9889c4e6-0a62-4fab-9a0a-fdca0f1aca88">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/48684781-3261-4643-9168-009ab61ddd45"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/d3ad5f6c-f82a-46de-9892-d6958be42603"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/a4d4fd3b-6a1c-49eb-87d1-b57d07956bd1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8a925687-0fdb-469c-8a73-e95cad07345e">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/998f6972-c216-404a-9f25-d4f1c698c11a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/86acd64c-2517-4454-b3f5-26086cfabac4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/58c68662-7087-4d4e-bea0-bcbec15c5378"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/b4a77a95-e26d-490f-ac2d-1ea9d8438432"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a6b5b4a5-2f0b-4a92-830c-c3815a9d1b50">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/ef8024cf-c6e9-4993-a6f2-06ca59e31715"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/435e4634-9940-48a4-8544-d5c456eb6976"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/ccf2c937-66ab-4bab-938e-5ba2623c6822"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a609868a-88a5-406f-a5b9-2e8f8f67d55a">
    <rdfs:label>atorvastatin-aliskiren DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/16ae7387-79bc-4598-add3-cf2ccbecbb47">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/16eaab52-3584-4be1-aa74-4225961d80e4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/0e46fe02-2b55-46c0-ad5c-3d72f587416c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/b66f1494-d378-4440-ab43-837dcc75637c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/652d4679-d3e7-473b-a0a2-81e9f4956ce7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/d6532c26-d3cf-4ac8-9a4d-090225a61c77"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/77a3d07c-a79f-435f-b4c5-0543680e5b60">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/c8335632-be19-4b8b-8ce0-df46cde493a0"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/fe196a03-7052-451f-a199-f4c62cafb3b6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2bc1c347-b8e6-4385-8e97-f66e8142907a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/639a1984-c34b-42f1-9019-057ba85f227d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/a3fa2361-7e26-4946-8486-9bb82ce6be5e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3eca0aab-9c52-407c-99c5-8939f7854d44">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ff7eb9dd-f05b-4ac8-b18d-4650f4c803ad"/>
    <rdfs:label>itraconazole-zolpidem drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/acdc7d4d-6b5c-4d05-941c-e119a768ec10"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/5125b280-7fe1-4432-bd58-e63834949de3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/93256f47-1291-45c0-a9b9-48a4ac7ed3c6">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/76d42296-4ad8-4fb1-a6b2-6b1ac72cb568"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4135826a-af9e-4d4f-acdc-229715130fd8">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/c8c37092-cda2-4407-a5e2-2897e15df769"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/dc8abc97-952c-4c43-8e63-bb739de8726b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/2ef1a9a6-3323-4227-af2f-44e7933826e0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/ce832e81-d2e9-4d30-9b20-75572a03cc1c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/0a552900-5d1f-4e9b-af00-cafe4c321ae8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9da54d10-9195-426e-8c35-b60ae49694d9">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2684942b-d0b4-4010-9ad8-d88df2bd1bf1"/>
    <rdfs:label>40 Percent </rdfs:label>
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/402af81f-a236-4867-be12-e184371d3210">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/67901149-79cb-40c5-892f-6aae73f17248">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/856d2073-a881-4106-a0eb-ec45fee9e72b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/7cd78f40-794c-4f73-80a6-8e84ad0f160f"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/f9c8c86e-de1e-4e18-a476-e636a35bb488"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/79800ed2-2318-42d3-849f-52e54e1bc1dd">
    <rdf:type rdf:resource="obo:RxNorm_461016"/>
    <rdfs:label>eszopiclone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0a1b68f9-fcff-4def-8bba-c7e0473ebf26">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/a5f3cc07-c393-47a7-b9b5-aa922e9e76dc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/2df98180-5fe3-4f8a-9a17-1984ffd2b64f"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/42952752-b0d0-4df5-874f-93e4d1c26268"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e162af22-3aa9-4d9f-98b4-c57859dc2e26">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8854a81a-2267-49ff-9058-7ed90e28de33"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/5e286d1b-04ae-4202-a80b-f2004e35e9af">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ef198c29-d768-464d-bd1f-d64c0215422f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/78eac13d-9ac6-416d-be28-a2b7b4adc660"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/542fde14-d959-4cba-9e31-4fac06f8c00b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/bb33d718-b920-4a84-954d-e3b4f3628c1a"/>
    <rdfs:label>lopinavir/ritonavir-bupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/04dec075-7054-476a-a70f-d82d3ad7b209">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9fbfbfca-3e19-4bbb-a7f8-af6a9d2a38e7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/96afb92c-c262-42c6-8d4d-749b7bec3bae">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/767dcdc5-b3ec-4464-a99e-c6959560eeed"/>
    <rdfs:label>34 Percent </rdfs:label>
    <obo:OBI_0001937>34</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4b39aac7-f0dd-4a7a-a7a0-c1cc9a46d042">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/4c74463f-9670-4bb7-a47c-006dfeeb2afc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/9646aac4-d530-42dc-808a-5dc925fcdd75"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4dae4de4-72cb-43fd-9824-6e9b94e35da1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/4d7173ff-e59e-4f51-9d99-906b960d3908"/>
    <rdfs:label>paroxetine-P95 drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/7b6d3db8-e7fd-4ab6-a8bd-479d716a6952"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/277f7f19-8b6e-41e8-80a0-e95ddf8f8d6d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/046273b4-ce8b-4922-aaac-38d53b84e80e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/8696cec6-ef4f-4794-a3ff-355394836d75"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/8ed8ef97-0bb0-4b54-bde6-749406efd7f1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/2d1854cd-4769-4711-97cb-dc057f42fa7a">
    <rdf:type rdf:resource="obo:RxNorm_325646"/>
    <rdfs:label>aliskiren</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7d6315cd-5ac1-4d5e-ac9f-2d515be6d0ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/f25d3706-6aac-4f81-8acb-7f5a50f9718e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/327e5390-9ce7-46d8-a5d0-4d98f3a13731"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/cc04ba8a-5ec6-4698-bfba-4986198fe5f6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/eadda66a-07fe-4beb-9652-d63966de13f9">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/1e18d667-5d7d-4f2d-a179-34d70ba320aa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d226a71e-cbab-4ea8-afc3-a695ca60e98d">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/b1aa04d6-9b48-4b07-bdf9-72015afe6cc0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/82386ec2-0818-44d3-948a-99a889be93d7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/a14bfb9d-a062-423e-b600-b7bbc55d7efe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/bef3e7b4-41a7-4846-abfc-53a6195235db">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/81d2b292-ff86-49f2-ad75-21bb2e015a7f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b7d90297-4d1c-488f-8608-0fa0a53123d3">
    <rdfs:label>ketoconazole-iloperidone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ff2e4c38-dbfe-49a0-b869-a2f0183631f5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ae8125ef-5367-4b32-9e32-40ba799b95db">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/02722441-7c50-4043-b099-b986214b424a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5a744869-b20e-406e-8403-38b23ee43c7b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/28fed70f-3c2d-4920-9cdc-514366cc8d8f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b261b172-211d-4d96-b9a8-1335579fb3ea"/>
    <rdfs:label>cimetidine-citalopram interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/cadb2229-b1f5-4305-a7ce-0945f4a1323a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6cce4d88-abdb-4abe-ad22-b4cdb542e747"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/64d424f2-22d2-47d8-be95-fbcb061a7856"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d4d247bd-aa07-4ea1-9b11-b9419f80c753"/>
    <rdfs:label>warfarin-Rosuvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/35d4f6cb-b98a-4031-bba3-fef342015132">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/741b82ac-5e57-415a-ab33-8e557a276e4b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/1ceb0d43-4fbf-4d40-a495-ccbfe299a533">
    <rdf:type rdf:resource="obo:RxNorm_39993"/>
    <rdfs:label>zolpidem</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3de7b2ab-a707-4a36-8f31-39079cd7b1f4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/5e448837-828c-4440-bf7e-92e549d95098">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/19193560-58c7-4e38-8052-7c44d2666a80"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/f9dee834-b7ca-4c8c-8ad4-7cb14cbe5341"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/016d2e86-f457-4c8e-b04e-f3de4ac92ee3">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4ecf5a61-4f23-4726-977f-d5be052694ae"/>
    <rdfs:label>40 Percent </rdfs:label>
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/73867458-1cea-40ce-9302-55de86df8ac9">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/1bbc41a6-0674-49c2-af5a-557b1bcf14c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0c19da04-e693-496b-bd6f-f7a454e549f1">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d962cf96-0f28-469d-a9d9-4a1a601a2896"/>
    <rdfs:label>65 Percent </rdfs:label>
    <obo:OBI_0001937>65</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e798a672-c708-4d27-a40a-b1c09bb1aba9">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/367b9d4d-5d81-4ef6-b484-7247fde28882">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8d22d984-86dd-4776-afca-130cfe844433">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ad4ea86c-f5f7-4c12-8f26-0a0115a6e144">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/19f16cee-18e1-4b36-a4bd-84ff21ae8cf5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/2c424594-5269-4331-b59f-5a66d4096b0b"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/9332be77-16c2-4316-9ded-67a2d4b9edea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ad5631fd-6399-4814-a067-6b98401182e3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/538d9915-cc6e-401a-a8a8-9b0f86768584">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/42c2e57a-63cd-46ee-a84a-ac1fc868e52e"/>
    <rdfs:label>carbamazepine-selegiline drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/31694e6b-9309-470f-8bcc-f2a88efd25f6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/f2b79b07-5c81-47ef-a118-9b088da25290">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/ad9ee930-7a71-4945-bbc6-d8d92fbbc5aa">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/c45f8516-07ec-44aa-b3da-dd37673addfa"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/393b97e1-193a-4969-b156-efc737d397bb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2604a06c-24ea-4f4d-90e5-e367a6ff5ac1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/92a9d96e-270c-4adc-a435-f16103be265b"/>
    <rdfs:label>clarithromycin-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c43db15b-8469-45b9-8de9-5c30c5f3808c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f70610bd-e26e-4484-9b74-ba497a528d6d">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
    <rdfs:label>rivaroxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/fbe24418-47bb-4aef-a125-26ce430f79cf">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/df70ecf2-d0b7-454e-a9ff-2b1208de1ab4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/3a806ac5-327e-4012-860f-f671ca8ad7c7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ec1556d4-16a0-48dc-ad37-98b278ba2161"/>
    <rdfs:label>cimetidine-mirtazapine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/4fc58038-be7b-40fa-a2cd-e8693db1211f">
    <rdfs:label>efavirenz-hydroxybupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f6f86114-07eb-4136-a456-4e9b3cabad25">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/67122db7-ba09-441c-a245-4f68575873a6"/>
    <rdfs:label>43 Percent </rdfs:label>
    <obo:OBI_0001937>43</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/442ae97d-c217-4c5e-be9d-aa4ee615a336">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/395453d8-de56-4bf7-b079-5c1e4d3d3f71"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/21208c87-ffaa-4715-a456-33fb9b24d452"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/847062a3-8989-4d5f-8064-194eb9237fff"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/8f216ab6-b6b2-4727-ab88-fad00b248a71"/>
    <rdfs:label>sitagliptin-simvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7239fe7f-968f-4962-aa44-22da17afe21a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/87128548-c1c4-44c4-8fb9-d63d30e84e10"/>
    <rdfs:label>carbamazepine-INVEGA drug package clearance Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/ea1eec9b-50e3-4501-a633-012cb8e5e71f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/61019dee-37d9-47c1-b202-554715d95de6">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b2707862-9b2f-4613-80eb-64329cf76d5d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/916ef748-9898-47ba-a727-ed98e4919dd4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/fcfb2075-d07a-405c-868b-16a95e6b5fac">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/c71ea55a-dbdc-4ab7-8134-425920525a7e">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/f71dfe9b-2ed4-41de-94c0-26a37ae2d783"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/1a291661-cb02-4cd8-883d-ecb6a986be87"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/fd5321e8-3dd4-4c11-8bcf-87d33c4e3442"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/02d2cf27-1d7b-4ac0-a32c-e465fa218ddd">
    <rdfs:label>efavirenz-bupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/23a361e3-8b4f-46f4-9423-ddb4415ceab7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b1dd137d-2ead-439c-b3df-73acdaf16c0d">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
    <rdfs:label>rivaroxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/505cd36a-be94-4bc0-aecb-903ca49fd1e6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/ef608786-2e28-4d58-ae27-347ed82299f5">
    <rdf:type rdf:resource="obo:RxNorm_352393"/>
    <rdfs:label>ABILIFY</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/2364646f-2dba-4ace-9608-fc8060089e93">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/9601fe3e-604c-4c2e-98ce-1301b4ae984f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/6302507b-e1b6-4acb-ae89-ddbe3bd3944c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/19193560-58c7-4e38-8052-7c44d2666a80">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/7f2826af-5530-45e8-ad5b-982346e7b9f3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/4916cbd0-9e4e-4e8b-86c4-fa986b30db1f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/aaf9d309-e75c-4460-a047-579da1e3ad96"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a4fa3cc1-00dc-4070-b7c9-b1ebfd17786b">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/002f6283-eca7-4c69-87ce-c9b2599e0f91"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/a2c475ce-3af9-4f3d-bdf7-fc23417b85dc">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f5dd14a6-2e65-46ff-85ec-1db2b7ae570d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/ec3be7ff-b6be-4c14-81d6-20804ffb2a08"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b152c67e-b9ac-4c69-9680-cf486da68706">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/c8cc53c1-07b6-406a-aaee-8cf8c9f0a5d1">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/d5db7234-410c-4a6b-af2a-0b63800eaed5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a67dbd2a-6bba-4d2a-b3e8-fba226a09109">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>Fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c7f99f46-1359-4b71-a1a4-4ab95df20877">
    <rdf:type rdf:resource="obo:MeSH_C062257"/>
    <rdfs:label>P95</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f8c2d282-1804-4313-ba9a-eb818fa37c5b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/df7cae32-0e77-49a5-8080-6c7c8788a50d"/>
    <rdfs:label>clarithromycin-rivaroxaban drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/095c612d-47f8-4751-9fad-d1d7c5f12b0c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/bb69fb4d-8b36-4d61-b0f3-0dd946732738">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/48b93051-449b-4809-8c12-af67e85ef377"/>
    <rdfs:label>3 to 4 Fold </rdfs:label>
    <obo:OBI_0001937>3 to 4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b101e39b-088d-4350-9a24-e5bbe3b40dda">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/2b419ad7-358c-422c-9b28-886da41976df">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/83ce02be-af18-4227-9b92-6b13124fc72b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/2156fb64-cd2a-4759-9a4c-a132c1634d72">
    <rdfs:label>paroxetine-tramadol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d293882a-bb47-41f6-8c99-868b8b99d70a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a53fcd30-3add-4892-84dd-f71e09906256"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/2b419ad7-358c-422c-9b28-886da41976df"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/766c6788-df80-4afc-9cea-1811fa9792f5">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/844d48ac-fa0b-4b2f-bbbb-ce0b4e1af820"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/315c971a-70cb-42d0-8c64-6fff9a496591">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d8aa6048-7aff-4e8e-a864-88e146073d46"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a2923524-f6b9-4710-af4f-8ac071e94834">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a99ee8ed-db0b-49de-81cc-6caa96fcc430"/>
    <rdfs:label>citalopram-ketoconazole drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/cf0a94f5-5f4c-4daf-976f-b9a310ad2f62"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b1748cb3-fe2e-4c77-8a0d-a26010937772">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/f9dee834-b7ca-4c8c-8ad4-7cb14cbe5341">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e78dc6bf-40a0-4482-8f78-af82d9098c0d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e7030372-ac39-4bcc-b3b1-e7585463d394"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/b575b6f4-446e-4f12-b049-0a4854b266c0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b34bbda0-405e-46e4-8924-08f016524ef2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/494d864a-23da-41cb-aecd-ac15babfa489">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/bcb9198b-a97a-4138-92dc-a86127f5dbd9"/>
    <rdfs:label>61 Percent </rdfs:label>
    <obo:OBI_0001937>61</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/9762fecf-1ff1-4a7a-82bc-1df8d409fe01">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6d3b62d6-b8ab-4537-828f-a2ccdf37b511">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/82871b62-132a-439a-8584-4cc12089c2ac"/>
    <rdfs:label>Gemfibrozil-atorvastatin drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/ccc88e80-4437-4c93-bf07-1cfac4e53649"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f3edd6a6-854a-4aa9-b734-d74d1ada296e">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/9a301705-c045-488e-aed7-aa5a572e1c17"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/984e571d-9746-4109-acd7-0b6223a4da9b">
    <rdf:type rdf:resource="obo:RxNorm_41127"/>
    <rdfs:label>fluvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/98b8b23b-0450-44ff-959c-f7e04e819fd3">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/da8af416-ee61-40a4-afc1-c1708041904d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/b101e39b-088d-4350-9a24-e5bbe3b40dda"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/0dbf698c-7f2e-4d48-9907-a52393e75ef1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/9b0c25a5-c3a5-474c-93dd-a243a886786c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/3af69189-bef6-478d-9c50-bcdfc7b95173"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/342197eb-f2b0-41e9-a7c0-2975cc0bb447"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/1ed585f9-7832-483f-8370-49afe316d2a0">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/351c181a-14c6-438b-9361-5188fc32ef92"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/b07bdbcc-66d4-42de-9564-301ecb8c40e5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/a6a23ea3-baf0-4500-84a5-88f53939c453"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/be039064-ca8d-4221-bf70-aa4348545a54">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/fc89183d-f731-42a6-908d-2adfc6910a4f">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/52aa070a-6385-449b-8e0f-8181e7b89bbf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/5667dc57-9237-422b-a89d-0050dbf7206e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/2e5f6d19-6b30-4446-9e87-eb888d8ae03c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/d3c03b92-4460-4ee4-9446-bbad45dd5a9a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/35fa2d32-2cb0-435f-ae32-b1c628e68380">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/4b8a2828-2de3-4ba5-8cae-ad9a8822133d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/6bf4f2bb-400a-4e58-9480-afdfa108cd66"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/d8606589-1cae-4839-b7ee-923d54f9f5a4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/72dd7db5-fc85-4b9b-9ad4-a1dfc04bf0c2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/5c9c6f2b-3179-44e3-b442-88826c8e543b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/7e36584f-f4a3-465b-ac30-bc0ed9c90b4b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/95166cdd-7f88-4388-9698-4ddb55faaf2f">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/2911c829-0833-471f-baec-b8cc7ea36f58"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/cac8ce52-30b8-49fc-b962-3ba9fa199510"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/0c88304a-bd20-419b-8152-ecdbc946d1ad"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/18d184dc-620a-4047-9008-bc8d8c861aab">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6bc964b6-9f6e-4965-adc2-e9b44ee856e7">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f42948e5-b056-4c35-ae4d-4328cea662f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/61613245-17ba-4a81-ba74-f8ed1accf480">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/50d0523d-0855-426f-919a-dfe63f19b2a5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/93e3b072-4a80-4b6f-b48c-f9f04f44d2ac">
    <rdf:type rdf:resource="obo:MeSH_C558933"/>
    <rdfs:label>fimasartan</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/b062e5c3-96d5-4774-8e1a-5bb32bf7ee49">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/9031542c-d547-4662-a57f-20c701315ca5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/77925fbc-6d4c-46a9-8bb4-9acf17857f26">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e005cd01-2e93-46ea-834f-5d03343b436d">
    <rdf:type rdf:resource="obo:RxNorm_41127"/>
    <rdfs:label>Fluvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/19445e2a-7aca-4b5a-8f34-f3efbe425d10">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a419b44f-a0a8-4839-942d-30dbe9f6ec11"/>
    <rdfs:label>ticagrelor-simvastatin drug package halflife  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0e6be0df-486b-4ef6-9769-f4a7634a858d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c192d3ce-3d01-4990-99d0-b1ad3f1de8fb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9889c4e6-0a62-4fab-9a0a-fdca0f1aca88"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/d2ffdb82-4856-450e-b991-59d18c75c4c4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/b21bf82b-f6c9-4215-b6ea-58f98a8c655b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/8f2b6154-c3b2-4b9e-b6ae-892da0a584a4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/7a806c9f-6b8a-4ed9-8ec2-2ec31d09fd4b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/4c74463f-9670-4bb7-a47c-006dfeeb2afc">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/9186b9db-a0e7-449f-82cc-bf292b8f5912"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/47075e5e-3afe-4b4c-927d-a6ac825e5f34"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/b6d05029-a465-49b6-aa94-f41a18f38a58"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a5a88f39-c781-467b-b2c8-e707dc57e620">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/42c2b4eb-7efe-4462-8bbf-888a0291665e">
    <rdfs:label>ciclosporin-alitretinoin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6234162a-7034-4da8-9aef-a72f01d770be">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/75817aec-80b5-4f3f-a101-c856712ef944">
    <obo:OBI_0001937>180</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/c6c84e4e-19ed-4315-b1e1-218aa8fd14f3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/054b8240-cfdf-4d8a-b65a-9ce905c6ce13">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ceeb02a6-66b4-4ca8-96fc-2051271abba8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/ad13c11e-af6d-4e8c-ac8b-34173c0f8454"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/343ed9c3-3007-4e61-9d1b-183820d80811">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/b1f068f0-83ba-4a8e-921a-f0016dbb286f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/041d5651-53f2-4430-85fa-719de137999b"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/29c0c9e5-2736-4cc2-be6f-db978c36b11b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/982f5b0b-6bb4-4185-bb9f-7992dc51eb8e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/af561cad-7645-4eb2-af6f-46aea18532bf"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f4d53510-2ac5-4d58-a27d-d029fc5dc52f">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/16bccc54-22d3-4dac-8c29-ccdc68b4e5bd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d7a34f8e-d3fd-4701-8f87-3088d5758c44">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b6cd5b13-beb3-473c-8cb6-f571431136f9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/c77a1f6d-aaba-413b-bd9b-db05182e7a7e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/0cf3eed5-841d-4754-90a8-7f7b7d8f4f2f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/1c4326d2-a70e-4356-b635-daa07eb02fa7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/fe70217f-8fac-43ea-bcc4-ff729fd9f5c8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/538d2414-8551-4186-bd0d-bb5bb7a2fcba">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/342197eb-f2b0-41e9-a7c0-2975cc0bb447">
    <obo:OBI_0001937>400/100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/9286d137-3a09-4a07-b863-1a8d442564aa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/05f87028-8f1b-442d-94d6-8b4d54d113f4">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/379b79f3-f9fe-41c3-b290-666fdd8f6a7c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/542fde14-d959-4cba-9e31-4fac06f8c00b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/b734200b-bc7c-430d-bc1f-81a28f0ac127"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/fc49c8eb-8a0a-4a91-b33f-9883abf748e0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0a821336-e6ed-4654-a24e-e8b2419cfce4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/bf10ab87-698d-4d63-a6a0-93c3b1d0419d">
    <rdf:type rdf:resource="obo:RxNorm_10689"/>
    <rdfs:label>tramadol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/607c4a64-a38f-41ab-95be-420568c37afd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/feddb42f-69a6-4c4a-ab09-9ddf52f65534">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/c20746a8-81d9-45e0-9094-09f1311135d6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ae388dff-9aec-4f5c-bfa8-4a7942301fc4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/160a0c61-845c-40c5-b298-734500382978">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/b8a32154-44b9-4cd1-a3ea-0a252ad82edc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a7d5209f-d164-4cd2-a44e-393080fb4775">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/47f4c33f-230f-4d45-9ba6-dc86047c6f39"/>
    <rdfs:label>UNKUNUNK UNK </rdfs:label>
    <obo:OBI_0001937>UNKUNUNK</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/791bb5a3-bd10-4755-bad5-a1166c237533">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/de3a4387-edb0-4ee3-be1f-a896d42bd595"/>
    <rdfs:label>3.4 Fold </rdfs:label>
    <obo:OBI_0001937>3.4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/7faca321-698e-4bd3-af7e-f040a5bfff4d">
    <rdfs:label>quinidine-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8e139817-5975-4766-bcfc-2c36964511f8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8094f63a-0c2a-4d61-9b21-544f1d75dc97">
    <rdf:type rdf:resource="obo:RxNorm_5093"/>
    <rdfs:label>haloperidol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f1ff222d-4a93-4c1d-9a29-ed878aa90f6d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/2b03b9e5-2abb-4f39-a5eb-743c02e3a25f">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
    <rdfs:label>rivaroxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b44ef85d-70b1-4c10-be81-f991c333c58e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/76fec16e-798f-45d2-89ae-e3d25a1d9052">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/91b1c2f7-84c2-4442-8c3d-508004fefcfd">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/869e5609-2ffb-4408-be60-edc53a30683a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/84b5e089-bceb-48b0-8419-732bd503d579"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/f298382e-e9bd-42da-810a-fcba678d2697"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/424367a8-b207-4045-81b0-d52e4c66054c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ea265530-c277-4f0e-9a04-262259517a4c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/bd6c7567-2e4d-41df-8b3d-2781a19109cf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/3e05f657-db1d-4c9f-8f57-6de726a3d292">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/cc8722eb-56a9-4e67-bab9-99c9ffb0baee"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/8fe11237-6bc7-4121-86f1-3d63a00107e4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/40dcaf56-f431-4eb6-978c-a6c271633315">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/697ae7af-d4b8-451d-8c69-c5b3a18d18df">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/84269ca4-2b47-48a4-acce-2dd1478a9279"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/7bbfc0f2-29c9-426f-9727-f50995532194"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8973e520-8335-480c-b269-34d87100b6b8">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c4004c5d-f661-439b-b32e-b175b479b68b"/>
    <rdfs:label>paroxetine-pimozide drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/dd7de2cf-9644-4f9b-9500-daa62556dc22"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4ff0a35f-c2f9-431e-aa2e-8f38330d88ab">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f9d44548-ceb6-4554-8ab7-3df8b32fc10e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/0c4a0ecc-c030-4402-baf1-de9b9076a534"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/2fd60e54-855f-43f7-874f-a2f03f3ce6e2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0a13d3cf-c4d8-452a-b006-66fbc05e72e3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/3b72e6b9-b441-42cd-8202-19076e903f63"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b5d59481-a0f8-4d2e-a629-adcb77a3f694"/>
    <rdfs:label>duloxetine-theophylline interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/95ec2121-59a2-4fc7-9703-3c3e65abcc5a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/09645aa5-6133-493a-b97d-e1df10297d3d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/b4198df5-4a8e-4692-92df-3f8f45b7ea7a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/ad6a6fa3-182f-4331-bc7b-e8643719ed13"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7815ceda-2cb7-4a98-ab4d-baca871ef7af">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c2e92e62-56d1-48bf-8368-55dcc2d8a76f"/>
    <rdfs:label>6.73 UNK </rdfs:label>
    <obo:OBI_0001937>6.73</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/ed1f7717-0971-4956-ae99-2d1347cf2c32">
    <obo:OBI_0001937>up to 1000</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/9364dea1-ab9b-42d4-936f-48eb415c914a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4c98e8ae-2840-4d34-bc17-ae9704471673">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/cc86f635-0a61-48af-b9d1-f0158d31e982"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/5c601b95-6170-4e79-ba4d-2529f74390ae"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/d5db7234-410c-4a6b-af2a-0b63800eaed5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/930bfa8b-45af-4342-a1e7-3022857261b1">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>Atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/8191428d-7614-4b8b-83ae-d4ac9c570a81">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/acdc7d4d-6b5c-4d05-941c-e119a768ec10">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b6fac3a2-dba1-4d87-89a5-d07d82304ba3"/>
    <rdfs:label>34 Percent </rdfs:label>
    <obo:OBI_0001937>34</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3a96758c-9036-41a1-96d4-19fab0751f36">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/833ece6c-1c40-4208-8e75-5d616400071c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/eda3fc22-ba03-4b0e-a6ab-d5b4062c2631"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/506c5994-51e1-464b-b1e5-1bec5947514c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f1068821-c78b-492a-a5cd-f6ea99928d94">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/6c12a243-8faa-4d78-bf98-7d4f77596206">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f14bb0f9-8c97-4ca5-b196-9f0eaae0b72c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/6f375a13-4dd5-4a6a-b28a-3f630c633c00"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/67fefc6a-0dec-46ae-ae3c-42063772e0c2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/7b80a9e8-0c74-4aea-b4c0-5717b44199a2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/ab357cc4-9e5c-4c05-9363-b48ef1039998"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/ea396829-5c65-47c5-b7db-89261a428aad"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/9714cd78-f759-4ad1-85bb-3a4b3f587379">
    <rdfs:label>Efavirenz-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e0867042-385e-4962-8a47-9b90d9f20c6f">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/240a8d3a-8ecf-4f88-b883-61125c96982f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f451795a-ba16-4a00-aec4-860f6e93175f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/1519247b-3ddf-413c-b5d3-35e13dc306aa">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/538d2414-8551-4186-bd0d-bb5bb7a2fcba"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/fb75e80a-559f-43a9-b477-915136bc7194">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/698fa792-81a3-4000-905d-69d89f085b80"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/91e9a8de-807e-430b-9c52-e5d95cc84bbf"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/29d367d9-bea2-47e7-8234-c951ec5466f8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/cf877c1b-0643-4364-9307-39edecd56bd2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5cd5d7d3-8e4e-4137-bc79-097a9fefeb95"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/32cd239b-e5b8-4a0a-94ca-5dd9b0070160"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/2bc71a06-12ef-41bc-9070-108c31a61b70"/>
    <rdfs:label>Fluoxetine-olanzapine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/37a3e5ac-c143-48f3-bc75-f702261de720">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/2dfcd7d8-bdd4-4436-a140-987f6e80e069"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/9a55c276-00e8-4e3d-a068-d7c008e2556f"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/eb7324c5-8257-454d-978e-f20b9bac51bf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/00bbf255-af2c-4294-b459-63101fed1fdf">
    <rdf:type rdf:resource="obo:RxNorm_81864"/>
    <rdfs:label>alitretinoin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f142a687-98a6-4c60-859a-67d550b26f67">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/92df114d-5e82-478a-93fc-af58d450b56d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8ee16cb5-a7d7-43e3-ae73-8827cd93596e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/33988fb5-f597-41b7-964c-ee30bec536e9">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/6f570737-8ec5-446a-b61e-1791b541ab0a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e6470262-7e6f-4471-963d-fb89a76c2561"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/b24f89be-186c-43f7-92bf-4733bb891437"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/3d20db3e-3618-49d9-bace-8b041582cadc">
    <obo:OBI_0001937>600 to 1200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/6200a242-e7a6-4a11-948e-44bb167ccd34"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/470cba1f-3bb7-4ff2-929a-f450ded5a022">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/969c3496-c079-4a1e-9194-a53743e594ae">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/fffc4de5-cee7-42a5-9793-1e38b2455c8d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1ee56278-0d65-4be9-b618-7c95fa961caf">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c97345e0-2480-4592-8aa3-3abad094095e"/>
    <rdfs:label>simvastatin-digoxin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/78e3c1c0-d40d-40b3-ad3c-e96839150db9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/86b33ec0-9f8c-4290-ab79-fced6bb55d97">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0ed82569-715a-4450-a2ca-4f46ab0789be">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/fffe6762-a206-411d-b78f-3329c96ab5e0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/a1a77136-9c8f-497e-96af-5dd550d8492a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/d17ee1c9-132f-406d-ad0d-ae5d4d2b26c2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7d779453-10fd-436c-9d6b-a3972c77d0c5">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a1f92023-2205-49ad-90ae-47d17ac1e8cc"/>
    <rdfs:label>fluvoxamine maleate-alprazolam drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/afb6a18c-b429-4793-b34b-03e2b650c590"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/cfe35947-e985-47b8-885a-85dd1eaaec6f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e205f532-13f0-45a7-b7b7-adc22c5a901a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e24f0f0f-9f7b-4ec6-8edc-d38654223a92">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/112acac8-512d-471d-a409-fb6032b2caee"/>
    <rdfs:label>paroxetine-desipramine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/7867d1ad-8684-49b0-bb03-a3542c6b8358"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/96d9e6cc-fdb3-4421-a5a6-2226bc0b7766">
    <rdf:type rdf:resource="obo:RxNorm_2541"/>
    <rdfs:label>cimetidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/8ceeb6c9-6778-45eb-a064-cb5ad71729d7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/2b71aead-6f8b-49f4-9aad-125492c5a494">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/ffe48f97-f978-4caf-b1ec-7343f2a4bd58"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/28529d04-2971-4854-b8cc-db52caedb4ce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/4cb7c6cd-9309-41ba-97c0-701191d488ce">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/17d111e1-f5ae-4877-b9eb-9bc835ad7cca">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/6d73f9ab-7cdd-441c-a8a7-a601db8567dc">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a87338b2-a2d5-4e3b-bc8a-d8a3b74fb993">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/63e985fa-8f12-4ce9-ba35-c207f74180ae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/b1f068f0-83ba-4a8e-921a-f0016dbb286f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/c6bb5e1f-8574-4ac5-a8ad-bab49dfbd532"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/9b76d15f-e3d5-4f58-a2b6-0822b0c08bf6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d3b75c5d-102e-48b5-a84c-a7a20c143012">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/44e0fac4-f638-4065-be0b-f0f69797db89">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/18e1847c-ce00-42d7-a4c7-dcd6dcb9322d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/97f5483c-0d88-417b-8b2e-6472eb31d116"/>
    <rdfs:label>2.2 Fold </rdfs:label>
    <obo:OBI_0001937>2.2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/740c1036-b142-4ba4-ab49-b60856e69d6b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/a3789f3a-fe0f-4db1-b231-c6799bc694ed"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/d98976a5-cb46-4bc5-bbd8-b117b160e30d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/4b8a2828-2de3-4ba5-8cae-ad9a8822133d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/63e9ec44-a84a-437e-b231-23491467b949"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/753db53e-0406-4a9f-a79f-49607a520b7f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b31a0842-3e00-415f-9dbc-f5a489192b82">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/e736303a-9342-4a05-91af-ea3fa76d2a9e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/d254321d-df50-470a-bbb9-a78f796dd2bc"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/458a1b4f-af49-4cd7-9b2b-b85837bac936"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/9c3e8e50-949d-45ea-bfff-7a1e51867e16">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/68364ab9-2838-4f5f-ac87-67a6592609eb">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/f4a266a5-49ca-46d2-aee1-bb08efa79ccd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ba93f430-b11a-4b87-ac75-b4c3aa82e408">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/109223eb-f3a9-4c0b-9fe3-dc29706ae7e4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9c12918a-e658-4abd-9835-ccbe3108f42a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/8d931cfa-8db5-415f-b644-26ef8ff5113a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ef9d4420-4add-467e-a0db-9fd04a199c82"/>
    <rdfs:label>Clarithromycin-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/313882ed-1cfa-4f56-a32e-481fa1175136">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/41403f68-36a9-43d8-b738-cc8e9d0d378c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/1a85b3bc-91d6-40cd-b7bc-ac487ab2f5eb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/21823b49-c110-4194-9607-d9252f405640"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/ddc5e254-7ac0-46dc-8742-10b5ede61fbb">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/6a6d4e47-fd89-4bc8-b582-9aaf1b140c68">
    <rdfs:label>fluvoxamine-mexiletine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/b4671b94-815a-44d4-b2b4-aafeee21ba05">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/da198d51-26ac-4657-81d5-e26697847990"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/6bcc01b4-1cf7-4971-8b4b-a24624ec91b0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/92ab5f74-4486-4198-9051-8b83b2a66e9e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/7a3a6bf3-e2ba-49ef-833a-fd2357c12944">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e457dc20-22a3-4ca5-911e-d75abca7e2cf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/3a0a1102-6813-4ef7-b62a-15685cdfddff">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/b0cad47b-6dff-43f1-8570-9dd28a2c358f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/17d3a49b-35f5-4b83-a950-2da70aa40a9d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/8c235327-2365-4f9b-bb47-621f90b8112e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/053c9ab3-3f7f-4bd0-8e2c-11b232b866b1"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/027f73c6-ff00-4605-bef0-06db6a5efb44"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/6a7f433d-9e9f-478b-91d2-bd91d49c5b6b">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/d6cbb86b-ccf3-47b4-8c62-61fe3dd34e56"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/d3742a7d-fcae-4371-8ba7-5be56c3e7fe1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c48b6a1b-2f53-452a-8bc5-3a0af7fba119"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/9733a0ee-0745-48a0-81a5-d2b88b0fc388">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3be3d27e-51d8-47ec-825b-a29750b8d4c6">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/02d2cf27-1d7b-4ac0-a32c-e465fa218ddd"/>
    <rdfs:label>efavirenz-bupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3fa4b2f4-c90d-4ccf-9daf-030f6215fbbb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e0b2960d-e8a3-4c6c-af3c-4bc47d215925">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/cb489cda-cad2-4270-a219-eb43ca0b24ae">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/bbba346f-ad08-4759-9a23-85d8d448463b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/c64bcf8c-c574-4bec-b849-10f72b215fff"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/c9d17319-8cf5-44b1-8516-4cd2d1269fab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/235cc2af-e401-483d-a121-1d2ca5df07ff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/e0a56e76-dc84-47db-a097-809620ffe23a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/0aecfeef-9a0f-4637-a0d3-9666163c3481"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/222c4a27-c2ac-4513-970d-f01c52aaaa0d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/01e9ce39-0e04-4e32-b5bc-f0104ee490c7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/a8661068-a874-4033-b3d0-9319777dfab3">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/e57aeefe-ee7a-4431-bbf9-384888f209ae"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/f28893bc-95cb-4e81-82c4-5f0c768221d7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/2cd2d2da-dc16-4200-ba10-fcba6e5cc7ed">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/25a6dba2-ea03-4484-997f-f088b17bdb87"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/1737bbab-a0ed-4e02-bb47-a2b4d3eeb9e1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3d6532b3-df0f-4646-8edd-123cc4b2d4ae">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2946d417-3361-4607-8393-4ed37b85bf25"/>
    <rdfs:label>ritonavir-rivaroxaban drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/33ce23ec-ef7a-465f-8cba-135649d4e959"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/bb09364f-2ff3-4c66-affb-605756b30c2b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d0d8ec29-356d-41fa-b3bb-6f79883ca4d5">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8ad495f4-ba30-4234-b22c-b88203a2a44f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/443acb69-2ccb-427a-b2a9-8cbe2ab6153a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/4657a765-74b4-4dfb-aef8-68bb271252c5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/acf3d5cf-6af1-4b9b-95d0-8df0eabb83f4"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/6c68a7a1-6018-47ad-8c84-1848caf86f8d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a35fffef-d690-4793-9f35-199df9e38c99">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2b26e403-392b-4cef-a81a-4f7653ee3ca5"/>
    <rdfs:label>theophylline-nefazodone drug package clearance UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/30a44209-8a89-4fa3-aac9-493d33d89410"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/cfeb9be0-1d96-4d38-91d7-78fe14531960">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/78875ac9-df58-410d-86d2-77857db0787d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/0ad2caa2-3f9b-4092-b224-eccef3624a69"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/4ba45059-76a4-4f0b-912d-f202fcbf9ada">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f6be78b0-c26d-493b-986a-622c04d3f3ab">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/a11cd59e-a252-4042-b3ec-f2aaacd123ef"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/6c427e3d-331a-4acb-bc9e-b773b6eba757"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/38963665-df49-4c9e-8818-fe76160faff1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/df7cae32-0e77-49a5-8080-6c7c8788a50d">
    <rdfs:label>clarithromycin-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/bb3d9548-5397-4293-9f73-97d0a689eacf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/9286d137-3a09-4a07-b863-1a8d442564aa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6deed469-3429-45d5-a7b1-525fe44f1616">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1f004f07-e6a9-4411-961a-9e04f669b4e7"/>
    <rdfs:label>4 Fold </rdfs:label>
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6594ea95-2b1d-418e-8ffe-4ca6023859f4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/48c8570c-3d4a-4304-a401-6531ee56879a"/>
    <rdfs:label>LPV/r-Midazolam drug package clearance UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/292be4f3-197e-41e5-86db-c6f8365fe27e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/541a8cf6-94d8-4913-914f-7cce274de618">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/761915a5-ce28-4660-9dcf-c491edb6fcb1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/54973328-b7c1-4ef1-a033-afc13251aad2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/0907e07d-3fb0-467d-8801-0a1d2a748803">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/5cb61a55-69fa-47c7-aef1-e9b5f22e0601">
    <rdfs:label>Fluvastatin-indinavir DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f8ac87a6-0263-4b00-b2ad-a4f5315c1f11">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0b4351f5-1e91-4545-99ba-1d4927802f86">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/43e93392-1b82-4be0-a81c-457f4e416348"/>
    <rdfs:label>up to 20 Fold </rdfs:label>
    <obo:OBI_0001937>up to 20</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6953ff5e-7dc1-4043-af61-ffbbe9795b8c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e9bac850-c802-4c7d-8612-97cd2b14267f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f1ed1d52-86c4-4c99-a575-9d7b6f12d354"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/918b7a68-edde-4b00-ab44-962c1fc51a39"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4f8e8030-478e-4bdc-9b09-3a4a75e8a8ee"/>
    <rdfs:label>phenytoin-paroxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/80b2ef04-54ad-4fa7-b879-a58cccb065d9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9363b8c3-ad81-4b0e-8a7d-6ca3bb8f7346">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b7c88327-54f9-44c9-b0fe-3b7bd819d58f"/>
    <rdfs:label>2 to 3 Fold </rdfs:label>
    <obo:OBI_0001937>2 to 3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2b22d2e9-80f2-48c8-9655-a8a405afdaf0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/28e2136d-30bd-4661-96ad-62e367f845b5"/>
    <rdfs:label>duloxetine-warfarin drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/315c971a-70cb-42d0-8c64-6fff9a496591"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/08268554-4ea7-48bd-89dd-43f22250b0d5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/7535ce3d-33e6-4509-9934-585ac91da5be">
    <rdfs:label>ticagrelor-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/4fa9d1a0-f0db-400d-ac31-3af830f211bb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f3f80a24-45ae-4dd3-83b5-2058760ca516">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/950fd0d6-f748-4647-9070-f6b831b35064">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/04fb1fc1-4e05-4dcf-9084-5292edbca73f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/89805dc1-2752-4ad8-8314-7eac9bf80922">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ac8fa6d0-bde3-4819-afac-63c9feeda003">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/0d2d2ffd-c2c6-4050-b987-213eac4bcece">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f3623974-4f75-46c7-9825-cb19a5617f91"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/0b012def-2bf6-4691-a9ec-22a2d4f5a025"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/64cfd3bb-e3e6-4a1a-be3e-c95893268bd6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/e5c505d5-305d-4328-9eb6-df8565b097f4"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/e0867042-385e-4962-8a47-9b90d9f20c6f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/49b3669f-20e3-4388-9052-3059baac707c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/c5118780-a523-4fe9-8e84-591a938bef23"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/9eba9420-bd37-4e17-8c53-3c48150b9ffd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/aad9151c-45ee-4b1c-bebe-c6be54a90ef9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/52cc5444-8034-4c9e-8370-7c7eff7617ba"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/09ad1a51-38ee-40af-a1bf-89d56d98c79a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/cbf984e6-d3cd-4558-8865-788e7d13723b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/2d63c5f7-75f9-4ad9-9110-5958a33d2cc2">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/ac023c99-0d42-48db-9dd5-804affd020da"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/8443eed0-d14a-48b4-9bc4-7bc3e2bbcea2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/f71506a6-ad6c-4110-8a59-2c08b443855d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4c0993c8-3bf5-4ce0-9846-884dc1797cf8">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d8b8cc74-6eac-4a45-9e3e-086d7f736335"/>
    <rdfs:label>505 Percent </rdfs:label>
    <obo:OBI_0001937>505</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/6f024978-ecc9-419c-866e-ffc5341a62cc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/9711f25c-5683-4218-974b-d527d8e0e4ce">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/c30a690e-8e64-4094-9816-875eb269f419"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/773da590-7862-4979-9a12-d699511040f1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/e613c163-1943-4703-9fba-a0c59d72daf9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/15a6f392-9c02-490e-a422-83e7f6d78f5d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1aebf92e-f5ce-419e-982f-7d98db44975b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d7255c32-f384-49cf-830e-0af200d368a4"/>
    <rdfs:label>low-dose ASA-Edoxaban drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f8b684c2-eacb-41cb-962a-2b1e5287abed"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/bd0a588d-a5d3-4789-a6c0-3765818a8ddb">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/7dca689d-cffb-4a35-b80d-88d5c7e0f618"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/0df92e27-539d-4267-9c53-1285678ed9b4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/32862ddb-f65b-4b14-9b21-ce57b0cadc87">
    <rdfs:label>Nelfinavir-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/23b88546-3d0d-4f88-b547-e693da288c41">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/987135e4-5c9e-4602-88c5-c4b76f25ab2b"/>
    <rdfs:label>80 Percent </rdfs:label>
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/0dbf698c-7f2e-4d48-9907-a52393e75ef1">
    <rdf:type rdf:resource="obo:MeSH_D012293"/>
    <rdfs:label>rifampicin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6356fb74-6562-44e3-a0c9-e9fa077a49c0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/71cc067e-d22d-4840-8420-fe22e8427dfe">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/29ad7967-7197-440d-9495-f602bfcd4772"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/a99c8c81-da6f-4273-b4f0-e70e0b76e577"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/0cebeed6-dbce-4dc9-8445-5fa558bfbf53">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/74cd3447-0104-48af-aabe-ef449e095905">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/4fef27c0-dd33-433e-bccb-17fc3aa0ae52"/>
    <rdfs:label>ketoconazole-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1e9d1227-10d1-47a6-947c-790e1958c0eb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/fb3da981-0846-4844-8ef4-b613e253b72f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/da597342-9ac5-44b9-ac48-3c321262de7e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/392ca590-2fc6-4cdd-8afd-c3fccc52b93a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ffe48f97-f978-4caf-b1ec-7343f2a4bd58">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/ae600ad9-f86e-4bd6-a61e-d16ab92de80c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/7c345cb5-2f74-4ee6-93f5-111842d54b75">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/30a5d0b6-d1a6-4da9-aae7-1de854642709">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/9806818f-514e-4fb8-92a8-5c2a724157fd"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/d6178c14-565c-43bf-9035-8d16fa07a5dc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/0209fcf8-ee77-4a4a-930d-111a83b309fb">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/4eb77572-e8dd-4204-940d-3a3e70215659"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a08624b3-a3b6-4a27-917c-7d24564b65b5">
    <rdf:type rdf:resource="obo:RxNorm_8703"/>
    <rdfs:label>Fenofibrate</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/15b22b31-c903-4ca7-8ffb-a6fd89a753a9">
    <rdf:type rdf:resource="obo:RxNorm_2541"/>
    <rdfs:label>Cimetidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/d87b39a6-93a9-4cf1-94f9-ab259610f1a4">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/e523ccaf-3f43-45c1-8815-b4d083d5c49c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/c22ad2fe-f93f-451b-85c0-758e42ab66a3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/11cee2e7-7cb9-4afb-a336-66ee55d3f85c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/9a140730-a8ae-4538-bc63-e7d0e28e3b47"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/7e0a6379-4255-4551-a043-db6ec381f5ed"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9524a1d3-3c3a-4e87-aee4-d3acd9bd81d8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/27ac3dbc-98fe-43f6-8ea0-1f7767ef57b7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/687c1082-2abb-4235-a600-8600142d3a53">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b995a383-5428-4854-a261-562885b3ba17"/>
    <rdfs:label>6 Fold </rdfs:label>
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c833a95b-473e-406c-800a-a75c24459616">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/657145fe-f736-42cc-ad50-8219fdfc25f2"/>
    <rdfs:label>60 Percent </rdfs:label>
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c25ee9ba-031e-4690-9991-b65b718ea5ce">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c37f816b-e067-4e20-8340-9d8307e74041"/>
    <rdfs:label>3 to 6 Percent </rdfs:label>
    <obo:OBI_0001937>3 to 6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/1209c2a8-8147-49ca-a603-b8aeed13f75f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/b208d464-b1f2-4ea8-ae21-d4d0e7f4f2cb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7e07fdbe-478b-4146-a835-b09e00dc5f08">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/a7cb41da-1b83-4dd6-8ac5-5c9baf721077"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/023b99b8-4463-4596-929d-c7422995fd64">
    <obo:OBI_0001937>.4</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/9fe2e285-adde-4022-9ad6-fb77391c7241"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/23f62ab8-8ae4-4d4b-84d5-7c3ddb9e19a5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a547e9f9-3f38-468b-aa24-e91d2d814e84">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/550cc989-ba07-46d3-a3e5-5fe1f9083af7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/2488580e-d54b-4ac8-97be-d8626d7ebec8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c52edd28-fe4b-4bc4-8454-a1686fd52533">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/52d5a2f0-d308-417e-abcb-9b30f0a5cce4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/132b1f6b-3870-4c9a-a530-2332e6acff31">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/533de7a5-fabd-47ea-8219-aedd5119af40"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/322f7a41-991f-43e0-9031-76c933e20dde"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/cf468833-0d8a-4dab-a899-8ef0421ca8da"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4ff0a35f-c2f9-431e-aa2e-8f38330d88ab"/>
    <rdfs:label>phenytoin-mirtazapine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/a90dcc95-00b7-4ffa-b240-5c46549c16ea">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/b624491b-7caa-4b49-ad14-c4c0125d6fa7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/807a902b-fea2-4d81-99c8-98fe9c9c5c28"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/21208c87-ffaa-4715-a456-33fb9b24d452">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a0f73e2d-e7b0-4142-8033-51eb07a20d44"/>
    <rdfs:label>sitagliptin-simvastatin drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/6542d23d-de98-42b1-ba67-5b828c276c0a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/72380f48-8f5d-4a46-8e8b-20c9bff0ebe5">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
    <rdfs:label>fluoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/444b4b13-c90b-4f7b-931b-97a787fa955e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5b04eac7-68c8-4764-a749-b18de76afdd1"/>
    <rdfs:label>26 Percent </rdfs:label>
    <obo:OBI_0001937>26</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/9e2c4957-0826-48ad-9f4c-cc64e9911e27">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/d6907310-0988-4e47-8a9f-51d9a4c1657c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a8015da3-f974-4dd0-8816-7a15d6d39b4f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/a2099d1c-502f-4d99-88ab-f70796d83a4a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ee79073b-8a14-4368-af2f-235d4aab586e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/bca42331-b211-464e-9080-b97806a7c2ef"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/fb052b7a-5cd0-47d8-ae3a-3ca8b7f1698c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f32307b6-4ea5-4ba4-ada3-239b81d0b5cc"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9f480404-0411-4574-a1f8-a285badcdbaa"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e69a5752-f8f8-46d3-9cd2-5466bbc008d2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/561c361c-314a-4365-a1dc-89b24f67dead"/>
    <rdfs:label>Lexapro-metoprolol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/157451c9-7910-4079-a10a-4469549c6b18">
    <rdfs:label>ritonavir-threohydrobupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/32d9275a-db74-4eaa-afb9-1550940c2abe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c51a97b8-f543-4d41-b6e7-d0ef8c42e9ca">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9ae4aabb-6330-4c21-b2bd-4fa6bb2b4349"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/bafd4773-7bfb-4368-93a7-09f25aaa3378"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d12409e7-01e9-45da-b475-1702507b83f9">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>Fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/1c8b954e-c659-4f09-bcb7-2097f3956651">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/6f9ec935-cae7-4a43-928f-9db632cb90c2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/b6d8eefc-d235-4081-831b-5c7864ca3ff1"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/e046f9bb-88ac-4705-991e-ae23f1ab356d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a402d1ad-8f7b-4f88-8aed-28f4c92ac46f">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/4cb7c6cd-9309-41ba-97c0-701191d488ce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/de7c44c0-8458-4439-a1df-beb62065c221">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/4cd5c7e3-3b8b-4143-80b0-5d3562842b7a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/4f9ee689-106d-43fb-a0dd-28715e2c3ee6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8f29f857-644b-427c-ac38-53ef6ce3aff7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/66679f5e-1470-4170-bddd-d47d1e9faf1b"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3e044968-556f-44a0-ad7f-50c4719ec70a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/596f2ddc-0791-4a8a-99cc-9852618cebed"/>
    <rdfs:label>citalopram-pimozide drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/33c4d73f-305b-4763-b460-083718c289a8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/3de61a5f-b95f-4274-a65b-c8abad5d57f1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/43dae113-c4f2-40f8-863f-9f805fb347ef">
    <rdfs:label>amiodarone-warfarin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/5266a4f9-8592-4a32-9679-1b85fda45bac">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/578d79a9-202c-4e70-b109-12a86e890355"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/682dbc10-96d7-4dca-903e-7d7b5dcb8150">
    <rdf:type rdf:resource="obo:RxNorm_2556"/>
    <rdfs:label>citalopram</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/190de352-a082-42a2-b291-5c2528941ac2">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/398e8bf0-9728-4853-accc-413140049c1e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f75bcbbd-ff77-455a-8ab4-5a56bc8f5c8c"/>
    <rdfs:label>simvastatin-vildagliptin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/5e885535-a108-47c7-9ef7-d22ccf93bc30">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/c250d668-dc3f-4a06-b8e2-9bb888fc4dff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b94c31b6-3c21-4690-a8dc-d078bbd22235">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/7c0ead63-1a71-44b4-b473-f7f2a02b90e6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e62c2ee2-fa34-43d7-b596-67a3131fcfdd"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/5dfdcf46-7d83-4e24-a395-64a4ac2c6ec8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/018894e6-6018-4098-9ac1-278e7a620566">
    <rdfs:label>fluvoxamine-thioridazine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/0b5db9c2-bc10-4a71-8d79-01868cc96769">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3fb24fd0-a3d1-47fb-a44b-948d32e7698b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f5512921-f62a-4e24-81bb-1ad35dbb264c">
    <obo:OBI_0001937>150</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/bb306ee4-1323-4b19-b012-7c19abd2a3ba"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9251c0ab-6544-4c11-a305-fcbfb213ed7f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2156fb64-cd2a-4759-9a4c-a132c1634d72"/>
    <rdfs:label>paroxetine-tramadol drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/88d7535e-6d7f-40b9-965f-1383f16c62df"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/9b89a548-a0a5-4e6d-9ad3-2a1c0e5cfe68">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/4dac565b-7b7f-49d0-a0d7-72b405f43d52">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/282fe0f6-81d7-4343-bfb9-0b97aa9ee10b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/8738a6ce-374f-4218-a959-4257594a5cd8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/42123002-97ad-4880-ba76-6c588e62bddd">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/322ca4c8-4625-429a-8468-7799b224b5ef"/>
    <rdfs:label>16 Percent </rdfs:label>
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/89658235-9f90-4803-97ec-740cf34184b8">
    <rdfs:label>nefazodone-haloperidol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e4e5d194-649d-4165-bf82-38f2a4ecd27b">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/c2a176ce-03b7-43f5-83bc-7a7b3686cc49"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/0b7440e6-bc2a-4a8e-bddd-82a4f1d1513c">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
    <rdfs:label>warfarin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/041d5651-53f2-4430-85fa-719de137999b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f19ea343-cebe-4648-9b5e-a8527fba92f7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e882bab8-770d-4a44-9fa1-f9aefeb71633">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/31ecc4f6-141e-48a8-8f1d-edb7e5cacefb">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e73f301b-8df9-4df0-9c2e-7e76b685fd42"/>
    <rdfs:label>desvenlafaxine succinate-desipramine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/70543a42-0725-41c5-aee8-4d2208ac46cc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/28e2136d-30bd-4661-96ad-62e367f845b5">
    <rdfs:label>duloxetine-warfarin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/18c8ec17-f57e-4f01-bfdf-64695d7a8d37">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/083c1cba-6949-4f95-a5c2-6676975a83b3"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/7bdf8989-1932-4826-98ca-c5edfb3d218d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/83f52a78-7140-4d0f-ac53-a63f264e6b77">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/60945d33-3131-43a3-88c8-a95f761f07b4"/>
    <rdfs:label>Ticagrelor-atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5e12780c-d4c5-4742-a14c-a996d48f26df"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000187">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/02c15d57-593b-4c6d-96bd-c0d35140dbcc">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/ead19365-1c45-4909-998f-ca37f8f0b226"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/8ebd6d80-d4e4-40f5-81c8-2a5550661047"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/b88c4d20-d525-41af-9d30-bfc12f2d2b48"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/bf291f48-6158-4891-ad7f-8c8bbe080493">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/bc9da8a0-1972-41d7-8ada-2177faa3ed2c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000039">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d2a2c72d-a0c3-45d2-aa61-96c1f2c5e233">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/026caeea-ab26-46ca-862e-1db50416e483">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/42ef2e24-8f35-44fe-91ef-01adf966bf82">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/986d82d6-60ea-43fc-948a-61b35bfe1146">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/2fef924d-2083-41e7-95f7-11d0059860d2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/4c05120e-987a-49f9-a26e-6d9c481ede3d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/c9f57813-5c2d-4639-939b-de65a058c2cd">
    <obo:OBI_0001937>800</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/1f433ca0-f561-493a-a0c1-f4333aceca56"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/3a181f1b-e4e3-41ba-9fdb-3eb92f0d4ce8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3c5d851d-e85c-4f26-874d-39accdcf2b7b">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>Fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/2edd9076-777b-434c-9464-18bc20acb73e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f8466cc1-78e6-44b4-a6ac-10104794ebe7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d075c62b-6ae9-40fb-b5b0-67cb5a9cab17"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/538d9915-cc6e-401a-a8a8-9b0f86768584"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/f6bb234c-ca30-47e1-ae91-392929baeb6f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4eb6c170-f4c6-400c-9b76-9383dcf0ad1f"/>
    <rdfs:label>carbamazepine-selegiline interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/54cebd75-74b2-4815-933a-f1dd1d1a5724">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d980c166-5571-4c57-8bc5-51c2d4588f82">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/be5c09f6-26f5-41f4-8da8-43836ee0b013">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e3882a53-91e9-4feb-a985-fdcb6fe6978b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/b81d40bb-0e97-4504-b3b9-a42b4ebe4a6b">
    <obo:OBI_0001937>20-40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/99e81c48-f0eb-47fd-be83-615386f719e6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/56aef87d-68a7-4cbd-99f5-5dcf4c488cb4">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/cf54a823-ed7f-46d0-a44c-58d89f0c4aa4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1483247b-28ae-4c82-b758-2fe50f564d4d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2020a20e-9156-468e-aec6-c1b852c1574c"/>
    <rdfs:label>escitalopram-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8f3f9f3c-ecee-4240-8f71-6d7d58661ce0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8365f6ee-b873-4ec5-8998-78d05967ac03">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a1f92023-2205-49ad-90ae-47d17ac1e8cc"/>
    <rdfs:label>fluvoxamine maleate-alprazolam drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a3398a78-8612-4867-a716-c43a7153ace7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c4ddc33f-6784-4544-a243-9db2c211b0c0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c3db6c0f-7afe-4fbd-97e7-d85811cb13d2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/55e8d038-5254-4020-a4c6-bb8d63e0dc12"/>
    <rdfs:label>mCPP-desipramine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f28549e6-6efe-438d-a5c3-51078b79d797"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/53baa89e-2872-4616-a8c3-ba385388ac4b">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/cae55823-d22f-400a-88a4-e0d2d1681c7f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/bfa1a3b2-94e3-432b-b66c-6df144f6f44f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/8b0a44e0-0854-4083-9dad-e1e739824304"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6355223c-51c5-44c4-a545-f37779a5d92e">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/0a552900-5d1f-4e9b-af00-cafe4c321ae8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c805871c-4cd7-4df9-9bd3-5fcb6932bff6">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/62832dc5-51ac-4ff2-8f1c-1974ce8a0d07"/>
    <rdfs:label>divalproex sodium-INVEGA drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a1066f13-0004-49a6-9316-d3bbbaec309d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ecce83cf-2c3b-4d0d-83b2-1e8688658a1e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1138e1a2-deea-4049-bcf9-2a64de32fb0f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/7309d8e7-d6f2-4c39-b0ba-a48142c94b01">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/c78e585e-38ce-4099-a628-f8212f7c8183">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e5c57ac3-3f58-43e2-9aaa-e16b6157daa3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f569b44f-4ad8-4c9e-bd0d-a2a9fdc242ef"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4dab7ea9-5760-4bc3-923c-257b6605297e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e8582e79-3596-408c-8cdf-754afd5813ee"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e299b2f8-5449-416f-bfc5-471b0d70e9ce"/>
    <rdfs:label>cimetidine-citalopram interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0ac0e103-d2db-4030-a84b-1c24ea6dd88b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/57e6ae6c-2a8c-46e3-abd2-aa996e2bde0c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/458a1b4f-af49-4cd7-9b2b-b85837bac936">
    <rdf:type rdf:resource="obo:RxNorm_4719"/>
    <rdfs:label>Gemfibrozil</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/fc078c70-de97-42b8-a55e-991984e09f50">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/1bbfd3fb-9e8e-49f0-a3fb-0b283faf85e6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/720c2373-4372-40a4-87ef-a250a01b2cb9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/5da916c9-62a6-4549-804f-f8289e4631f6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/380320c4-0097-4e22-a575-93b2186f4a17">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/45302f6c-3578-4a83-94f4-5646a589dbf0">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
    <rdfs:label>dabigatran</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0b17211c-e260-441a-9f2a-2affc0e15d45">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e5b28db4-440c-4704-8759-8c26525fa71f"/>
    <rdfs:label>Fenofibrate-Atorvastatin drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/55386838-444f-494e-a5c6-c98d2ea4baba"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/96c80671-8292-4623-aa0e-cafa70122d6a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d52b451c-0c89-4822-87f4-c85899b5ce79">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c7487780-29cc-4e20-8e60-df560168a554">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/3f5e1d04-6095-4305-8c88-c6f6403f0225"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/0e5878a4-8702-4fb4-99cb-6d9b3607dce4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/056cc22e-a0c8-4089-b98b-a7d1a0d17ee9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/feff3b22-ed0d-4489-a0ad-ca3928460bcc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/aaffddcb-0f38-4164-ae98-3556510ae431">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/beeb996d-ac6f-4e00-abec-8a36703b1dda"/>
    <rdfs:label>cimetidine-zaleplon drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/6ee30c13-938a-4065-97eb-77cc8a19cc72"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/9524ff81-61c2-4248-9179-e72fb0284f1f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/716bf61f-a049-4825-a703-6b2a398e88ab"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/efc8bf2c-5e08-48ac-9b1a-c854011c8d28"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/7230edcf-2a34-4326-98e7-f0dbe8905d73">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/63a84665-f2ac-4579-a354-025e8376188d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f92b6174-e9d6-4b53-9e36-6b569b5ad772">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b4d1d277-8565-436c-aca5-05efc02fddff">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/15ffe190-418b-42b7-9d57-66be84a9c480"/>
    <rdfs:label>213 Percent </rdfs:label>
    <obo:OBI_0001937>213</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f0912d04-dd91-4f86-bf94-9f329e9d90d1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e2820eda-b6e7-44e7-a8d2-c71d1329e3df">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3cc337ef-df6e-4557-a63f-061dc54a0f99"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e14325c8-7367-4c68-822c-dded191a8393"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8a6a7d26-2ab0-4cfa-8e42-fdae25b5f824"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/11aa3ed6-8c8e-4dc0-a2aa-1b3577acce24"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/2890836e-4f41-4b58-8425-d051349d04c3"/>
    <rdfs:label>fenofibrate-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/bff5aa16-dbde-46c6-a46c-76f5942d2e1d">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/dafc125f-8acc-4d74-8f89-ca1d49b8f2de"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/7e66d91b-904e-4aeb-abcc-b0f00d33c8b0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/b5b0a7db-c0e4-4c9f-ab1f-7d0ba14757d6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a574eaee-775c-45ed-b4a4-9bd6d1ce0588">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d923f678-f519-46be-8587-c9db4b98d39d"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/fe610f1c-ac2f-4012-b9ba-cea9541263c2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/e3258c60-1959-4d26-ac0c-0ffa9d7ad0d9"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/58eedcfc-93c6-4c15-8d28-5457b78ba3c5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/7200fe99-40f1-4d7b-9b2b-ea7bb88d191e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/fcfb2075-d07a-405c-868b-16a95e6b5fac"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/78a710e2-e292-4270-ac67-0d4051b6ae7d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/dcf5dccc-cb7c-445d-a6ac-3e18c3cead72">
    <rdfs:label>Lexapro-metoprolol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/443f23c3-d95d-4f4c-b906-22d20f415c03">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f21d2068-86af-40ba-bda0-fee06a30a588">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/8b1d9f55-b3bc-4eb2-b1b8-83d435883449">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f9e90edb-475b-4440-b65e-d4ae61209949">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6c8ba36e-f762-40d9-941b-afdf625c5b90"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/dcdbaef8-7484-44e0-86c4-17710ef2edc2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/46b83b2f-7209-4dfd-ae69-849c235034c9"/>
    <rdfs:label>carbamazepine-ziprasidone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4c64e040-3d44-456a-b9a4-602b691b0c64">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8092fb35-adf6-4d04-a601-9fb774e24155"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/bbc184f8-87e0-4cfc-845e-026eccc480e8">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c203271b-b51e-4ebb-a5df-5772d649eda6"/>
    <rdfs:label>erythromycin-rivaroxaban drug package halflife  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5f7738fc-b6c3-4f0f-b976-082bb0f2f4da"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/68b8aa8d-f77c-4a5d-a571-1393f0c7f55a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/331df3d1-62e2-40ff-bc9b-e3037ceca202"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/90eb78ba-3582-4af0-af27-7fc5a79118bd"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/33764d40-248f-4e6a-a1f7-1d2762d5be56">
    <rdfs:label>ritonavir-hydroxybupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/06d5cf23-414d-4fa2-99ca-ef93236cad5f">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/53d76f76-8700-45ba-b781-80f346e012be"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/b158b02d-61e5-42ad-8cc2-a9a37bb39c46"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c1d24e13-5c4e-44ab-a32f-156ceb63f4a6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0af3fa8a-233b-4600-a114-ea662ef976c4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/31db27e9-f7d8-4b52-a4a7-3f92e009da7d">
    <rdf:type rdf:resource="obo:MeSH_C092333"/>
    <rdfs:label>hydroxynefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/f180f617-d915-4d2f-a86d-973f3b3c9c28">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c37f816b-e067-4e20-8340-9d8307e74041">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/77a8905d-6996-4d7c-90a8-d4af961e4ea1">
    <rdf:type rdf:resource="obo:RxNorm_325646"/>
    <rdfs:label>aliskiren</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/4d7173ff-e59e-4f51-9d99-906b960d3908">
    <rdfs:label>paroxetine-P95 DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/448f0136-5bfa-4236-96c6-6febdb7b0b6a">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/0eb61aac-b69a-4752-a0d8-5940fa40be68"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/16213f2e-38e9-4987-ba77-a87c337b1522"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/4a3a957b-1da2-4c8e-8e9e-eb4da899dc15"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e0143335-45a5-4086-9962-ceb566130d3e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/65285afe-7953-4416-b6c4-2c79ecb12119">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c8995e57-2336-4766-9b07-b7bb981e557e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/98e5f156-d5f7-4dc0-8634-e0c309c623ab">
    <obo:OBI_0001937>15</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/e64ca6f8-7b69-4b26-a90b-db8b60bc0eea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/df7d25ee-4fde-4444-b9d4-f32683a1d082">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/2e5a68c8-2916-4590-a8ad-1392622fd705">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/97f85ab5-07b6-438f-8864-b3cbc873b43f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/1b14fd76-6595-4d24-a9fd-efb950db34e3">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/c38161e8-d51a-45aa-af47-1b42ef201c18"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/b9de9d9a-8ff4-4006-8849-5106825cc4ed"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/2f823a2a-09c5-4e62-873a-1d8201d9a5d4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/2e5f6d19-6b30-4446-9e87-eb888d8ae03c">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/d6b6847c-bdb2-4c46-baa5-b5a94cb0f570"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/83c175a3-c31e-4552-ba48-8b6e56edf5d7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/81ab8fe9-8722-4c16-b696-5c2d170103df"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c54b6f79-62d9-4201-a154-6fe8a86f97a6">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1646203b-317c-4378-8e63-708e41859b44"/>
    <rdfs:label>fluvoxamine-duloxetine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d35216ca-0831-4dde-889d-74dd1d7e5471"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/9e11dda5-2558-4e54-9fa3-dae4f1921ad8">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/46b90223-23ed-439c-a2d5-877ff5fb6f5d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/3dea4f96-f808-4c84-abc0-895f6c3b3e30"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/831d8937-57de-4326-b6d1-31424ba3cd01">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6356fb74-6562-44e3-a0c9-e9fa077a49c0"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a8c8dfe3-b222-4218-acf4-2e3193b4f9b3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/862b5233-893c-465c-804c-3a3ac01b6d80">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5171ae0c-ca01-46c4-b5ec-56c728ab43f2"/>
    <rdfs:label>22.5 Percent </rdfs:label>
    <obo:OBI_0001937>22.5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2a150f84-a80f-4849-8a5b-0c378d419f09">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/c1273ab1-bdba-4cd3-9a5f-068e6598bcd1">
    <rdf:type rdf:resource="obo:RxNorm_2541"/>
    <rdfs:label>cimetidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/44d14cbd-2b63-4043-bd91-ab61fd84d152">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/0b84808e-eea9-4d20-96cb-efba78439838"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/58b32e72-b647-4e3b-9587-a74f5d092843">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1eb631f5-3e73-4fbd-a757-d8d5d385a6eb"/>
    <rdfs:label>15 Percent </rdfs:label>
    <obo:OBI_0001937>15</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9af2b640-1aaa-44c8-b897-495e62eca11d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/62832dc5-51ac-4ff2-8f1c-1974ce8a0d07"/>
    <rdfs:label>divalproex sodium-INVEGA drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1bf4fb39-c810-47c1-83f4-46a0bf6f7ad7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/fd3b28a2-f33c-46d1-a298-58d72301adaa">
    <obo:OBI_0001937>500</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/6b9887a2-cec4-4025-9272-2c1d6c9804c0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e17e20a0-9a21-4872-b771-5e9d782225d8">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0be2c5f5-c35e-421c-9b78-75688ba744f1"/>
    <rdfs:label>82 Percent </rdfs:label>
    <obo:OBI_0001937>82</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/8a1a8ee0-21fa-4574-980e-7b99d1aa6b8f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/137eed78-0127-4433-93ca-d9569d2bc431">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c203271b-b51e-4ebb-a5df-5772d649eda6"/>
    <rdfs:label>erythromycin-rivaroxaban drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/af1879e3-feb2-4957-8ed3-c9c31ce495b7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/cbd92749-b5da-4a10-9ebb-5dfc0efddf8d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d0b97814-6862-4cfe-87cf-944770ec02f6">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/10d92e48-cb46-4227-87a2-9b99de3b103e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ef198c29-d768-464d-bd1f-d64c0215422f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9e62d6a8-f187-491d-8c26-1904a0995a48"/>
    <rdfs:label>lopinavir/ritonavir-bupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d1d1a672-0721-4d60-9452-d6807957e459"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/5b1cd53f-6bd9-4dcd-a0a8-482673da17f9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/6ee43ecb-65cf-415f-b3bc-39329c2270b4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/e55e3c4d-69c3-4454-865b-293051c76a59"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a0f73e2d-e7b0-4142-8033-51eb07a20d44">
    <rdfs:label>sitagliptin-simvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d979ebe1-138d-4245-8213-13a031253bb4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/c861f167-ddef-4db2-b701-560abd60c9ec"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/1073bd15-0e0f-47fd-a8b0-93ec1d485ae0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4e0b8004-b31f-45d0-a9ff-85d3d9b17f53">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/db916e77-956f-4880-b964-34f8ee8a5b17"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/8b6e5759-2217-422d-a4e1-a5c629e5f93e">
    <rdf:type rdf:resource="obo:RxNorm_2541"/>
    <rdfs:label>cimetidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/bc37b6e0-13d3-474c-8680-37693fc26a81">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/d6fecf9d-43fd-4d6f-b11e-8c46e89d218d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/53e06de5-f3ee-424e-808c-abe439b36f54"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/18c8ec17-f57e-4f01-bfdf-64695d7a8d37"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/70a7ceae-1938-45f0-a9dc-2eafe41c020a">
    <rdf:type rdf:resource="obo:RxNorm_42463"/>
    <rdfs:label>pravastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f49d382c-a193-430a-b18a-a0591f015a9c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/1fcd6f4c-cec2-4a53-915c-c14e97411e61">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/81524f8d-8806-4c8c-a9c4-5d1d48372ce6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/67901149-79cb-40c5-892f-6aae73f17248"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/848f67e8-39e5-40bb-b5c4-aa7bfa317982"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/8051bda3-d61e-43cc-b17a-9b15649f291d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/2488580e-d54b-4ac8-97be-d8626d7ebec8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/dd5ad33c-61b5-4fd4-8a26-f936c32be61c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/260dc781-1ecd-41d5-9262-c904be65ea68"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/779b287c-cf16-4d3b-b073-801e8b19f0b3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/8f436b3a-1115-40a0-b2f7-76ad883f5713">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9251c0ab-6544-4c11-a305-fcbfb213ed7f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/0ac4e582-9084-4787-bb5f-f8d0fbf0fc99"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/0f92ff5f-139e-412d-87c8-a8664a812fe8"/>
    <rdfs:label>paroxetine-tramadol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/7bff9c9f-695d-41bf-a6fa-20bce3d9f690">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e2a588ee-34ff-4cd3-9b4c-fb0860bc9157"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/a12f7e43-4af3-4cbc-a1ad-c25f53e8c2d5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/5fee5bcd-3303-4dd8-8429-facd3428abf3">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/34f49d96-144d-4ad4-a53e-fe842babbed8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/d1471a71-6116-484e-91c6-5713389deee7"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/a436e178-1a2b-4065-b631-c45399d20a3d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/e9f02195-f989-434a-82f8-284eb5bfb4d5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/57e6ae6c-2a8c-46e3-abd2-aa996e2bde0c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/8a336e68-0b50-4e91-adda-2a00588316bc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/deaa5a4d-4829-4701-b28a-6f4ef9d5d389">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/3fdd365e-7885-4d7c-93f7-3ba7e2830b96"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b74a38c6-16f3-47dc-b05d-2ad8661faeb2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/f4d0e91f-0de6-4a92-8a18-169dbe53bdfe">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f92b6174-e9d6-4b53-9e36-6b569b5ad772"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/3fbb3dd4-471f-4f4e-b0e1-6ad64ffec69d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/60d6fff7-7c9f-467e-a8ea-19f4431b0c94">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/fa1152ee-b7cb-4c0a-993f-5c45a0cd9e5f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/5ed78f5b-7931-445c-b092-ae87862e522b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/20717910-8de5-4052-bcaa-d48457c52e6f">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/0d42bc7f-069f-4879-b615-32bd07804558"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/f8abb731-594a-46c1-915f-a7928ccc30f1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/0907b5c4-04d6-46bc-ad5a-1eb2b6996961"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/55998d99-8b18-4be4-a9ae-8f0689ded0c3">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1fa15e43-158e-4e24-9314-d43f3577077d"/>
    <rdfs:label>rifampin-dabigatran drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d4cb2dd8-a58d-4a67-8697-b0ee9c5548b8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/eb8889c6-a395-47b0-9a83-afe80162cd93">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d3d29f85-30ab-4e9b-ad5d-bbc6748a537a"/>
    <rdfs:label>2.66 Fold </rdfs:label>
    <obo:OBI_0001937>2.66</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a6bac5d1-20b7-4e9c-9fa8-9a5f65945133">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/5f628733-c6fa-4d7c-8109-652131ea0c0a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/4fa9d1a0-f0db-400d-ac31-3af830f211bb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/20e42212-8936-4924-b12e-e02505d8191a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b995a383-5428-4854-a261-562885b3ba17">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/cc1e0ed4-b3e4-488b-a24e-f684a79de660">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b8de460b-ebf6-4fb0-a1b7-9c156dd36e28"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/56784449-e18c-45c3-9160-21c3c892c7c8">
    <rdf:type rdf:resource="obo:MeSH_C062257"/>
    <rdfs:label>P95</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/61dd50bc-2640-42bf-a8aa-9ebfe651600b">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/fab26f6f-6707-4934-a202-477cc494e439"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/af56a9e1-4b80-4798-82b2-6810e9179a20"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/cabf554d-cc97-4364-aea5-63cddaf903a8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b0e19483-51bc-4e20-b455-d66c1c68913a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c37d0029-ee83-4518-803b-c80a4555b011">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/20717910-8de5-4052-bcaa-d48457c52e6f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/6ec84392-5abf-4ef6-9a12-3743a6e8444e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/3452d85e-d854-402c-b569-72fd2c95924e">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/b36f23bf-0671-4db4-88d3-a59e38d32f42"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/39c2505b-11e6-4956-9a31-c869d948bd8a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/e76297dd-2af1-4f14-b0c0-8569164e9b0d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/2a7938c3-e46e-4027-b1c2-bee56f55bda3">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/3b7f4527-3916-4527-9c97-073bdd088827"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/8b452737-bdab-4f06-baf2-7ae9b6268748"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/19a776aa-6535-4d49-9b42-561d71f9bee9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/756e8219-6ab5-4ff7-8ce3-79b3b1b2f9c1"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/f252a9bc-146d-4a73-85b5-ae74e79e0b64"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/5cebd0c8-401e-4604-824d-fbd6fb5de72a">
    <obo:OBI_0001937>300</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/fbdbbbf1-2328-4dfc-a9b7-1d4d59217276"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a3458f57-f85a-4b19-afbe-1a46afe89af7">
    <rdf:type rdf:resource="obo:RxNorm_8134"/>
    <rdfs:label>phenobarbital</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/0173f438-7933-41d9-a5d8-bfdd4f6f16c1">
    <rdf:type rdf:resource="obo:RxNorm_1599538"/>
    <rdfs:label>Edoxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/550cc989-ba07-46d3-a3e5-5fe1f9083af7">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/413334ea-1c1e-4f43-8427-b05fa50ba6fb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/9733a0ee-0745-48a0-81a5-d2b88b0fc388"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/8c8ca51c-f17e-4002-930f-f51081995994"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8f483ede-28ad-497f-b4b4-f29a49f2e418">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/4a526ff9-d11d-4928-ac39-64180d1cf302">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/7eb2b031-3c80-421f-9aaf-40772b410843">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f3532de8-91e8-4d78-b758-7c1d8765a1f9">
    <rdf:type rdf:resource="obo:RxNorm_72625"/>
    <rdfs:label>duloxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/17f5e824-a9c1-481e-a7d5-14d848fd02e5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/efc278bf-2349-44b0-90f4-4c48e12fa513">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/de10582f-304b-417e-8792-25d38b2c4c5b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/dcab768e-62aa-4732-be86-aa4861fcb0b6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/2f6d6e18-7a22-4535-afc5-48c8e383fa9c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/0cebeed6-dbce-4dc9-8445-5fa558bfbf53"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/4b16fb41-1a00-4575-a894-1953d176481e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/1f7ad670-6393-474a-977a-51c2a40289af">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/d79d4cda-51c9-47fa-adad-770f30b0bb71">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/eeb99e41-141a-40d3-ba64-9e817b263c24">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/40df4eea-4abe-4b3f-890a-458695a0619f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/ab8bf8e2-0885-4635-a0dc-ff179a29e218"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c740debb-a046-45d8-9b7b-d83fa15a749c">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/160a0c61-845c-40c5-b298-734500382978"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/66fba19f-8d2f-4fee-9697-863971806425">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/5cfe345e-6e29-4dae-8401-66adba18a704">
    <rdfs:label>fluoxetine-P88 DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/d75c0bd0-5829-4f0f-9118-948913faa47f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/a0c47a09-c9f2-467b-b1cf-00afd6a1eb89"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/727ae14c-7f6f-4f8e-8c08-85855d9a3a6a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/6f9ec935-cae7-4a43-928f-9db632cb90c2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/ea804a55-5158-4004-8978-a2acf058a9e4"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/16179399-a0cf-4483-b1d1-db7aaa34550a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/f5ab7d5b-e193-4bcd-8dca-c3ef4050d0cf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d61944ed-b5c1-4394-8ea7-66752836dfc2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/85624cc7-01c6-4220-a38b-3d37c7aa9e8d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a436e178-1a2b-4065-b631-c45399d20a3d">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1f233015-2590-4895-b076-36d00278d727">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/0008f46e-17c2-4253-aeb0-2f7baa8e3d58">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/83ab085c-6ddf-4b6b-b8a1-763da576182d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/13af5318-4716-4dec-a6ef-73ec06097437"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a7189495-3dd8-4042-8e79-64989087525a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/95c5bfcd-90b0-4414-a233-51677b6793a2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a6915cd0-1a19-4be3-a558-3d73a6764336">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/5bda6876-f645-48ea-87ec-0257c737b8d8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b94c6b6d-a158-4f4e-8e77-b76a48e7c054">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ecc31544-27f6-453c-948e-99e75dd4d76c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/fcfd5eac-f000-4a4b-8381-c8b93d025034"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/7d25d526-5bfb-4eb1-951d-9fb72c2f769f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/8fb204a7-a85b-4650-8b05-064bb9a3f16e"/>
    <rdfs:label>Gemfibrozil-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/8fc39943-0aad-4007-b46d-f641284f5f7e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/52deacd9-714e-4eb1-83f0-d26644b74923">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1998ac3e-71bb-4b11-9227-75f027d233f5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b8a9d274-e704-4883-b5c7-dd37b950f49b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/53abd8c8-a0d5-4d29-aa9e-d360a963c298">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/76e6a252-0041-402d-b604-0b107b597ba6"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/c740debb-a046-45d8-9b7b-d83fa15a749c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/823d6515-16e0-4799-8280-fee480257c2a">
    <rdf:type rdf:resource="obo:RxNorm_4077"/>
    <rdfs:label>estazolam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/60a09781-d785-4093-8f30-cdfc63dfe66e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/75410366-75ac-4ede-80a8-d6e81b083ca5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/81d66f62-65a2-480f-999d-da8e47484a15">
    <rdfs:label>Amlodipine-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/dc04a657-7699-4c4f-9a77-757b38443d70">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3f6d1e0c-7c86-434b-b7ef-776d0cc98fa0"/>
    <rdfs:label>ketoconazole-citalopram drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e3734013-24ff-4a49-9b41-3b1f6e34b320"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/1f283a5a-a9ad-418d-a9f6-642f058cab28">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/6ee72f83-7ca9-4702-b996-dd2f6aedd94e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/71f6f4c8-41d3-4f4d-9e5c-1c86d2d8516b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/9524ff81-61c2-4248-9179-e72fb0284f1f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/2a37d1a0-f4ae-48c9-b6e7-9de072bd6bce">
    <obo:OBI_0001937>325</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/9d21af16-1af0-48e3-a61a-6d77f9080f5d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/2a29f221-639a-4ad0-acb9-d62934cb124f">
    <obo:OBI_0001937>90</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/ccdf0146-fef8-4797-9c04-35b6f0f0652b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/da7ce45f-5977-4382-9df5-7fc3f5ee2c93">
    <rdf:type rdf:resource="obo:RxNorm_1827"/>
    <rdfs:label>buspirone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/951ec937-572c-434e-abc7-39a52fa16669">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/a8d00a46-c5c6-4862-bcd7-3480b020813a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/0c43c80a-3b8c-45b4-8134-1f7271f00adf"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1b854bbd-08d6-4688-95de-2da4d73c8eca">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ef7394a4-ae4c-4d2d-9186-7c7521e9c24d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/530b462b-312b-434c-ac7e-b9213d01be7f"/>
    <rdfs:label>37 Percent </rdfs:label>
    <obo:OBI_0001937>37</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/121a2a92-1782-41a9-b01c-5fb64ed127ae">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/4e038637-c4fe-4895-b4e2-ffcb74311571"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/fd2441d8-4fff-488b-86de-a51998b11494"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/7aa4471b-c32a-42fa-8bf0-fec684b873e3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/a86284a3-0d56-49dd-89ae-f1e89966be78">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/fb46fccc-cf39-4bf3-99b7-27c25980ce03">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9420f360-aad6-4b6f-9c38-9e74fbbe17a9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/9c7604a6-7f5a-4f21-b3af-e731328d6a95">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/29975cb0-70fe-4b4f-8e18-2be6faadebb5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/236bb7d9-8953-4144-9d9b-8ac3181feb01">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a14f698a-f096-49ae-aa08-68e19551b95b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/98137a10-d6c6-4f72-b637-dff18d55279c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6afe3cae-a3e2-4bec-9e62-b5c3e9cca47a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e7d923a7-05fe-4eea-b9e9-833b92421655"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/6beee335-b522-4d31-af09-da39c9ce4dfd"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/05ce1065-65bc-40a1-b099-df2cc038b6b8"/>
    <rdfs:label>cimetidine-threohydrobupropion and erythrohydrobupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/33ed0be1-bde0-4ac3-9cc0-d91364322969">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/5c601b95-6170-4e79-ba4d-2529f74390ae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1bba78ca-25d8-42eb-aadb-91554f31ad7e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e792491f-fb92-48d1-9ce6-3cf27d71c7d3"/>
    <rdfs:label>25 Percent </rdfs:label>
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1496d7c9-5297-40a3-a693-e7dfa1b78210">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d28dc431-4567-4006-ac34-bc6d399dbc63"/>
    <rdfs:label>57 Percent </rdfs:label>
    <obo:OBI_0001937>57</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/2d3b94f5-4ffb-4f11-924e-101645dd6c2c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e5f246a4-1887-4242-8fd5-1626e0d219f1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/38c2ac27-8391-4c67-b0f3-8f8fec3b818e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/985fc56c-0beb-4cce-a14b-688e1b4114c1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/8bdaedb9-6b51-4279-99e7-2225ed553f7f">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/6a32c094-5142-42aa-b06f-2834f8a46507"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/1a2fc70b-13a3-4727-8cf8-b1d0f89b61c5"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/70a7ceae-1938-45f0-a9dc-2eafe41c020a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/bd331bf6-6ce6-43cc-8762-cb9365e4469d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/27847559-a32c-4995-b04f-4e37f678a0c6"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/0f788a64-1708-42e6-a86d-339e1e1da541"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/34f25f73-1a60-445f-8b3c-96768108b0dd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c50c1273-24ff-4ecf-a5f0-16566a2402d5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/abc2ea33-fbcb-485b-9e6a-79f28a48e42d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/431dbc99-79af-4ffa-a5b8-41503e3fd181"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/50e58fce-b276-4911-866e-bed6e46f88cd"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/08761320-c884-4409-a6e2-4b7f244bfe3c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/7107ae95-da14-4d19-9255-8528ac1b08de"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/627fca80-b2b0-4766-b366-8f2d2b487ce5"/>
    <rdfs:label>fluconazole-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/30e50e16-2a42-49ca-8488-5c853723c40b">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/e798a672-c708-4d27-a40a-b1c09bb1aba9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/7fdab4ea-c771-43c6-8391-b55b199dc1d1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/9b547e9c-4721-49d5-8b61-49fdd021356c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/cb8d3fda-a688-4c67-a9d2-ca582fa1dc17">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/33eb0d7e-f050-4591-8e93-74c5156c1446"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f629b666-c47a-4e97-9140-c7ed333f17f9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/fd1eeffc-b36c-486b-9f1c-dbe56d663b24"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/5e78d210-cbcb-4b42-9f99-8edf10104dc6"/>
    <rdfs:label>ticagrelor-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/8a9e9888-e819-42f8-88e9-d80243dda6af">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/3c9dcdf4-0f09-4f46-beae-cca9b2a7acb3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e1c5c593-0b1d-4666-b236-168618eecbd5">
    <rdf:type rdf:resource="obo:MeSH_C580748"/>
    <rdfs:label>hydroxybupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0ba3ed95-a699-4ea8-8f8e-bde1d5a05d0c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/26331295-14b7-41c9-96c9-0910dfa2f56b"/>
    <rdfs:label>67 Percent </rdfs:label>
    <obo:OBI_0001937>67</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/adcf734c-4591-4ee7-a771-9f6b4267f4b1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ad01d58d-f033-41a4-9a83-a1f4df4abe04"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/ca1dbf51-6374-4304-a8ae-60af41fea7f7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/57904168-8a6c-4e49-80e8-d2aaddf994e5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f6edbff3-5ed9-44d2-a019-2ba6c8661cdb">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f46eb8ba-c69c-41f9-ad66-3447c9f171c4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/431f58aa-1513-4899-a0ec-fab69607dd72">
    <rdfs:label>BRINTELLIX-salicylic acid DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/1b1b4a3d-e127-4781-963e-e603db31e31c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ea162753-cf35-4ff5-831a-baec4061f24a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/7fad6f04-f38e-4829-86b7-f3e69fe44402"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/f1168b7a-65b9-4812-b256-0c9c8a4c93d9">
    <rdfs:label>high-dose ASA-Edoxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/23eed5cd-522b-42e1-a06c-f2ec68fa9645">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c867ebbe-31e6-4cf5-8b50-b7f99268d7f6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d15a3d91-83c7-4192-9763-fc8e8a73b9bd">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/64a605ae-d045-4e5a-a50b-710627c5a85b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/59baaee1-d247-4674-badc-c466089bcb07"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/cfeb9be0-1d96-4d38-91d7-78fe14531960"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/67b2c923-bce6-42ae-b4b0-17d51d1645c5">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/056768d2-4c0a-4007-9248-a0ad4990c74d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/78295fcc-49ab-4c77-8cb4-d499eb9fc61c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/89d0d571-e894-4ba7-8e91-87eaf91e3e55"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/e43ed4dc-2c76-456c-b2f7-ea072b888663"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/327e5390-9ce7-46d8-a5d0-4d98f3a13731">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/a64a83af-eb90-4b05-aa93-e122704d7c78"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/23f62ab8-8ae4-4d4b-84d5-7c3ddb9e19a5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/47edc485-0b13-4201-bd62-40c6280285ee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/4bf11f25-bddb-4a55-b0d1-677caa95b11d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/9ff5c9ae-6553-4c9a-a356-eccb37ec25e5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/e9a61d91-d37a-4431-8373-1b49fe30b63c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/a8d00a46-c5c6-4862-bcd7-3480b020813a">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/8f07082d-04cd-4962-aeaa-9dbd5e988fc8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/95d294c5-9534-4bb7-a5b6-119d57b7429d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/14693b80-da55-4ee8-a7bd-d01738a86fe7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/7ce7a6bc-f665-49cf-ae53-2b49c629ca56">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5c7c1714-0dbc-4d32-a07f-ccb07cbf2a7f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/d62ffe84-e341-4862-bca6-aa4960bc3494"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c503fc65-8997-48bf-a0bc-d75e1e077b40"/>
    <rdfs:label>fluvoxamine-N-desmethyldiazepam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/fdec4208-12c3-49a7-bcb2-7e91b3c49eca">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ef0bef17-d707-42d8-a89e-382afbf23d43"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/04a91aa0-dc97-4ebd-8fbe-582788d2433e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/f98eca25-f7ae-4e4e-a6e1-66cc3e2d7732"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/5fdfad55-83fd-4197-b20c-666efba78975"/>
    <rdfs:label>fluvoxamine-tacrine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/18a47a82-62d9-46fa-9645-75bb5496e989">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/380320c4-0097-4e22-a575-93b2186f4a17"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/4ec233d5-1d6b-4eca-ab65-d10a7f8acc83"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/7f334e1c-6144-4a0f-b96b-f14eebc2969c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/812d9ce4-68c2-4966-89c5-eb7e65200f6b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/8b3a7bb2-572d-4d10-8713-7bb57fd83c44"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/13a9812a-b9ee-4767-8d95-7fe9a63f1af6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2d5298c1-4659-4caa-9d45-4cfb3a26c58a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/130a2bb9-da83-42d2-beb7-7a1354b20f86"/>
    <rdfs:label>clopidogrel-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9d74c8f2-7383-44bd-b0c3-e805ad05f505"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/0f4faf32-d77b-4202-aea8-cf7cd23d1ec6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/1fd797aa-6d83-422b-ad6d-bde851e09e5d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/cab99c3c-fa74-4774-a6d0-4a9db12ab72b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/56f68ca7-d4a6-4e95-800a-b6b3dd0543f4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/a12f7e43-4af3-4cbc-a1ad-c25f53e8c2d5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/538e7a0f-839e-4948-a11d-fcf862ec0899">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/9b178713-ff18-42b5-becd-d2b608a19e59">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/bafc613d-d2bb-4e22-8c0b-7d7e1fc3a77c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/639a1984-c34b-42f1-9019-057ba85f227d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e2bd8032-b0ca-4f6d-88ba-7561480e45b6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/ead19365-1c45-4909-998f-ca37f8f0b226">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/6551114e-a43b-4110-838a-e2b80158dde5"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/56aef87d-68a7-4cbd-99f5-5dcf4c488cb4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/579a8d13-7dee-4733-97c9-7684571d0089">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/25f85adc-177a-45ad-b217-4567088002f8"/>
    <rdfs:label>nefazodone-alprazolam drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/93dc8cc0-b2ea-4ce8-94f7-d5fbb99e6c02"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/0d28e607-618b-4b29-92e3-692f44b026a7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c0554232-48ad-4d60-b8d4-c6e09949ef4b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e6470262-7e6f-4471-963d-fb89a76c2561">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/6488b176-d9f3-4ba3-857d-deb25a8f2383">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a53272b2-76f7-4d59-b24e-34d270019510">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/82d04f15-620a-4db8-8134-be61d7197ad2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/33310c79-7594-4a3d-afe5-1671086b8c73"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/48b39e97-af5d-4e2c-9b4e-ff605e409ba1">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/6fb9331f-82ff-471f-a876-6ab3af8e9fdc"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d669b070-fba6-476f-928a-5c5c7c73c964"/>
    <rdfs:label>Fluvastatin-indinavir interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/292a851e-7541-4712-8782-622cbd73475b">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/4dac565b-7b7f-49d0-a0d7-72b405f43d52"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/3b93d17e-b3d3-44f9-889e-157d787102df"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/180dd742-49f2-46b5-bfe7-31c924a6c813"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/01ba9264-ffd2-4822-8b47-946e676af0fe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/9f98353a-6a74-4d67-aae3-1f5d3046c293">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/cac8ce52-30b8-49fc-b962-3ba9fa199510">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/46824cd8-9448-487d-a4f4-8cb275f1b4e3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/3b687d2d-ad99-4e8f-81f5-0e0c3564d233">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5ed8983b-9238-4fbf-af8f-dc55494e572f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/92df4c62-2deb-4795-915c-1810f7e79d9b"/>
    <rdfs:label>68 Percent </rdfs:label>
    <obo:OBI_0001937>68</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c45f8516-07ec-44aa-b3da-dd37673addfa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/7ba45048-b861-455a-9df4-0a9db54a6990">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
    <rdfs:label>warfarin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a21f37dc-daaf-41d5-afe3-af4275b3f87d">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/49c472ee-1f00-44b8-8b46-8ed886a6a7aa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b7d8fcb4-850a-4c04-b811-af941de32d43">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/83781645-5e59-4cdb-913e-738ec5b8695c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/4a192cfa-a440-4100-84e5-50e52c93fd1c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/7e648baf-95ec-4282-999b-2cc575267125">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c4cb48f8-299a-4e80-96b1-ad934eefbc93">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e3395243-c95d-40c2-9204-6103c21551ab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/f7c40edf-14ae-4741-a23e-1312d7129e61">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/bff5aa16-dbde-46c6-a46c-76f5942d2e1d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/40a5f72d-93e0-4dc5-b33c-fbb880f6854b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/e933eeb8-df1c-47db-b1ff-f57b13ba7431">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/b18e892d-5897-4d74-b3db-466cfbf1964a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/a2019aa4-7782-438f-9b37-241a4339d4e7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/eb16fd1f-e6f3-45bc-a8bd-956f4dff2247">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/d5086adc-e490-4c7a-99f0-6822b48e97ff"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/846b8dcb-3ae2-44ed-8989-d4cec1afdb1a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/c9c26d79-76fe-44f3-a23d-f67ecb188f35"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/6b7d3da2-87c7-4fe7-bb35-98301b1e1b57">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/6c3de91e-6d99-4d2f-8837-047f83e6cd32"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/e14c8dd3-ae4d-42b0-9ae3-fa44e5dadd0b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/6f9e9fce-77cb-4090-a99f-1640a258ca51">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1eb631f5-3e73-4fbd-a757-d8d5d385a6eb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a402b89e-5fb9-41d5-9419-9b34c2cfdae4">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c2aa1caa-9475-4aa3-a0e1-e0554de955bb"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/5c1ad077-7494-4773-b49b-17595b29a013">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1315a434-205d-41b2-a875-7301ea178d91">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/700df1ea-212f-4c49-ba1b-14483b8a0e35"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5abbb564-fb7a-4995-8bbf-b7ca32f181a3">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3ef18615-1f57-4bb6-b67e-f0b394af34b5"/>
    <rdfs:label>telaprevir-atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1b7e430d-59bb-4436-be36-aafc5831ec34"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/435e4634-9940-48a4-8544-d5c456eb6976">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/fcfd5eac-f000-4a4b-8381-c8b93d025034">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f5a4d69d-e665-43d5-bc7c-2a7ce5880ae9"/>
    <rdfs:label>Gemfibrozil-Atorvastatin drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2cc90934-f417-4eb9-bef8-74c38a44c9a3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ceeb02a6-66b4-4ca8-96fc-2051271abba8">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/624a6860-a455-4b0e-ab2e-58f67ab2ddce"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/6ceb3136-7d3b-4743-bcf7-7c2b44ea3b78"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/57d964bf-982e-43a2-bf40-d32fd10b0b63"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/5c7b7f09-5430-419e-8c52-1a0b0ded0afe">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/2d1854cd-4769-4711-97cb-dc057f42fa7a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/da5733bb-acf6-4edb-bbfa-829a40aff7b3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/eb721979-dbfe-4035-be42-36ad03f107eb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/19fc70ac-d184-458e-a3a7-a4eef5ec1aa2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a2b8754d-7159-4d36-9c9c-9316c18165fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/16b4bdaa-6b38-459c-afce-751f5b295ba9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/869b6e3f-5d70-4848-9ba8-f022e45a6a6e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/917a9f19-d2d0-45f6-ab2f-8658a84f777f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/24cb0c44-325e-4e69-b035-6eec001950de">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f608793c-f623-464b-9dca-e17868a0b38a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/d8c57d91-7bb9-4e16-b5e7-a727dfd334e6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ebdc43d7-a75d-4848-94ff-e29442aeb63e">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/53e9241c-817c-470f-95ac-7a4a33ad3e45"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/cae59aaa-7639-4344-9821-9397fddcc223">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/fcfe6ab3-39f9-41e2-ac91-2757b062dd21"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/adcf734c-4591-4ee7-a771-9f6b4267f4b1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e7b48c0c-728f-4c36-9ea1-ca4b757229a9"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2f62f7e5-4c9f-4ea2-a0ab-2cc9ede86a08"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ca9099f4-51e2-4035-990e-d7abfc2fb888"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/63f14aa2-94b3-45a0-9b8a-6d9ca049db90"/>
    <rdfs:label>ketoconazole-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a13ec6f4-c468-47c5-a5fd-ca3bf2b8715e">
    <rdfs:label>fluvoxamine-duloxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/de3a4387-edb0-4ee3-be1f-a896d42bd595">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/51ef7159-07aa-4a5d-9d88-0a3040c2a4a2">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/5b0f3b62-75a3-42b4-8561-d4f3a75d08b3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/f086497b-b351-49b6-a25e-aad77f180c33"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/e005cd01-2e93-46ea-834f-5d03343b436d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/bae7304d-fd03-4646-92f0-51890eda08ed">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7ccad4dd-3a69-4908-95d1-5bc09f4684b4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/823febcd-f226-48a8-8ca5-8763900f1dfa">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3ef18615-1f57-4bb6-b67e-f0b394af34b5"/>
    <rdfs:label>telaprevir-atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/7b8ffb36-5e9b-465a-a4d2-2ca851dee6b8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ce02dbbb-3085-45e6-afa5-21e4947a8697">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d5fb4dff-ee5a-4fb0-81b4-b3010a72ba99"/>
    <rdfs:label>citalopram-ketoconazole drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e9ad7f40-317d-44a3-a153-d2d42cb144a5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/951bac78-d5ab-4bfe-8819-14cdc4166f3c">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/62141ead-c1b6-492e-8760-6694f886c6c8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/09855731-0bfb-4d07-b418-5d8da4a0122f"/>
    <rdfs:label>ketoconazole-alitretinoin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/917bea1d-df34-4fbc-ab61-145c3b7becc5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0a1b68f9-fcff-4def-8bba-c7e0473ebf26"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/32f138ef-c0fa-4e6f-94c8-770388242804"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d29819be-cad9-430b-8424-009ce0cebbbe">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/7ba77864-039d-4382-9a96-345b27125430"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d98ac424-d221-44de-a17f-ac85f1f0e317"/>
    <rdfs:label>amiodarone-warfarin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/58bfea74-7b33-48ab-8977-13bd43310653">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/49e78e0f-c165-4c1f-bcbf-942991dd2d36"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/6229768e-8ae0-41fb-87d3-2ce98921ce3e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/55cd20b3-cf2f-47dc-a0c1-f14883a7eae3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/407d5729-e866-470a-88c7-0f34574eb2e5">
    <rdf:type rdf:resource="obo:RxNorm_42463"/>
    <rdfs:label>pravastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/6725b134-a273-4fbc-917e-5e6281e8161b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/25a8d326-6ce7-4d8d-8cab-23e90f8ac365">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/efcf20b7-fbef-4828-b80c-6206b3cb1202">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e8a9ae5e-2ea0-483c-bd19-07b6fe4f7c6c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5e6a7a64-e6e2-4de0-bc0a-a1072852990f"/>
    <rdfs:label>39 Percent </rdfs:label>
    <obo:OBI_0001937>39</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/3ee3ed6c-fcd4-423a-b908-94ae0400fb3f">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/a67aa64b-a543-42bd-aa78-edcc9113b197"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/33e67acd-657f-4a8a-9651-219b524516dc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/84269ca4-2b47-48a4-acce-2dd1478a9279">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/14b7e968-40ef-45c7-9800-05cfa07ab122"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/9e6934ba-b8ca-492e-8941-3b19e94085cc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/3566f2ab-610c-4dad-a0d2-6846bc9b4105"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/130a2bb9-da83-42d2-beb7-7a1354b20f86">
    <rdfs:label>clopidogrel-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/16bccc54-22d3-4dac-8c29-ccdc68b4e5bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/286ad14b-f694-49d4-96a3-58638d43db6d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/5fdfad55-83fd-4197-b20c-666efba78975">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/d954a55a-b3cc-4ae9-846a-3f97c6aec556"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/3da5cd21-8167-4dc4-92e0-6ea94a8109b4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/02567497-10f9-4a41-83cf-eca0cf15f470">
    <rdfs:label>nefazodone-alprazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/563e8b76-5987-4d2f-8755-223132083908">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ff549df0-d1b8-4d64-970e-e9b77dedb3e9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/4ac8c400-8ca7-4eae-9ed5-b59784f5b702">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ce38d270-f3e0-4214-a186-11ec11cae73f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/777a03ce-f621-4e87-b7a2-0a68fc892b0a"/>
    <rdfs:label>2.3 Fold </rdfs:label>
    <obo:OBI_0001937>2.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/353761bc-9539-44ac-8b73-ad55a7bdbd49">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/b0eec3dc-3e3e-4f89-a9df-f0b8bedbd711"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/03c0ff50-785d-49be-8e1f-776db4c278f7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c0554232-48ad-4d60-b8d4-c6e09949ef4b"/>
    <rdfs:label>35 Percent </rdfs:label>
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/01c5d7be-e667-48aa-905f-a26e5df27b72">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/897ecf7e-0482-4144-a85b-5784b8dea75b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/6d90b412-6059-4040-9d8e-f30e18323da4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/a08a0286-f652-4aa0-a075-d64be8a783bc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/193d598c-8e9f-4412-9d54-999824e7cfeb">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8337e920-019a-4807-b53c-9ab1fd710c74"/>
    <rdfs:label>Fluvoxamine-alosetron drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3179e362-044b-443a-be3e-dc561d791bef"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/01bfe197-bea4-4aba-8247-e20a7eeff896">
    <rdfs:label>sertraline-tolbutamide DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d397a674-dfac-41df-9645-d8a33a4ba53a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0ccf9ee0-4737-4846-a46e-854bbadea0b8"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5b0ea7d2-76a9-4333-92d9-82d55fb33239"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/d5dada3f-6b33-48c6-a1d7-38531c4255e8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d833ab23-2da4-446c-8866-428cf4ab5739"/>
    <rdfs:label>Fluoxetine-olanzapine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/7a48a3bc-5651-4341-bf4b-37685d454112">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/aa8563c1-9435-48bd-b8f0-b3e9f4edce41"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/da10e685-9fb0-47d9-a5b0-874fd3cb5ad9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9b2eab30-b845-4328-a5c0-c5825e444157">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1a291661-cb02-4cd8-883d-ecb6a986be87">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/6c0e5b80-bc8a-4381-aba8-163339609539">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/897b9b93-3140-4982-8f62-b15acfec8962">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/79df6c4f-f1b5-4819-b898-6ff51c295180">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/48bda9ea-5e66-4c80-85bc-09ef7edcc8dc">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
    <rdfs:label>dabigatran</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1f61b05a-a96e-4755-afa7-d9aeb861fee6">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/30a5e6f0-9846-4f7c-9db4-af585787cf47"/>
    <rdfs:label>58 Percent </rdfs:label>
    <obo:OBI_0001937>58</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/0bac9740-1b89-4e3a-9a95-38fe62ee391e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/f9c4bfa3-7acf-427c-bc86-aa86ce18deda"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/2e08befb-5873-47b8-81e6-239eeb9ff8cf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a1daba60-e099-4413-b771-b5c44e19a6e5">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/ef829235-3f64-4b34-a823-318d8bed26db"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d1471a71-6116-484e-91c6-5713389deee7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/e57aeefe-ee7a-4431-bbf9-384888f209ae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/061155ce-0ef8-4c2c-926b-06f3a0e8d18e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/008e9bff-fafd-4864-9e10-3ed5bc01514b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/6a5fdbed-5323-4110-865e-a7f9277184cb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/e3cdc108-3501-4fbf-a080-f52e39d0c3be"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/fe196a03-7052-451f-a199-f4c62cafb3b6">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/f180f617-d915-4d2f-a86d-973f3b3c9c28"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/56bd36bb-ac2a-4b02-b4b5-7ba0eaff36cc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/e736303a-9342-4a05-91af-ea3fa76d2a9e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/be0d6d03-26ef-4cf3-a501-5caaf8c98a0d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/8ff84438-7180-489d-8009-c3038053b86f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/955f4b75-949f-4f36-8205-2e2212eade22">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/804e2a39-4a20-44b9-acb9-84f961b4de61"/>
    <rdfs:label>Cimetidine-Atorvastatin drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d08ed48d-e50b-4328-95b0-97135c6fe187"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/ebbbfa35-1b81-4ada-b5f2-61f6a3861da6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/73d32c77-e53c-4e29-a460-f9187a4d0735">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/71206a5f-7abe-4347-8cb0-447e1fc1a158"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/71ef0aa8-b367-465b-9acb-10ab32d2275e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/48435262-fad4-43fd-b8a8-1d5b4b3d0fe2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/080686b4-82e0-4ae4-bc3a-b47ca01ce645"/>
    <rdfs:label>ticagrelor-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a89da089-2b04-44ac-9970-d4e9727d470c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/9d818dab-e0dd-4829-8e75-afb45ad8baff">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/c4ddc33f-6784-4544-a243-9db2c211b0c0"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/459f8713-0315-4517-982f-3ad89a8bf14d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/eeaa4ff6-87b6-495e-a377-b979c9ff8e10">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1681220d-b990-40f8-9d4c-78463d750b95">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/254b40db-2158-44bb-b9fd-ec32efd3b503"/>
    <rdfs:label>40 Percent </rdfs:label>
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/69a6fe24-afb6-4f46-85d3-55e2b860f70f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/82fe2438-268c-482b-94b8-b12b8e930416">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d34f119b-2c0e-4a10-b931-162ab851e575">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/33a32fc9-464b-4165-b82f-fb6af07d10c1">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/cb096012-8689-4445-9fa6-dcc128dd0627"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7f6cb7af-51f6-46f6-982e-c43964a3b202">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/46824cd8-9448-487d-a4f4-8cb275f1b4e3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a5a5cdd7-232a-48ac-bf2c-b4ac7c240e6a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/afe85bba-e038-4fff-93e0-a940ad3c2c0f">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/acbd77ed-c5c2-4821-a1fd-910e701f85c0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/669772e8-bc77-4dc1-bec6-a127f9fdba62"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/79c1fd02-9cbc-475b-a258-9649254dd4a4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/947e3465-676a-45f5-9103-51db37a2adad">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ceb39617-6ed8-4fb9-9266-e20b2a248ccd">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/067415d7-48ee-45df-9889-9fe5b773cfa8"/>
    <rdfs:label>ketoconazole-mirtazapine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4203602e-ded5-4890-a611-06dbc64171af"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3aa0a750-c09a-4e0c-afb4-cae3c67758b2">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/127ca1f4-0fb4-4dbc-9f5e-e338ae626036">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/0275ff55-3fe3-4acd-af2d-6e2fcd0b3a7c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2e36a0dc-8e1e-4751-9e42-6db8848ee004">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/de88bb45-a4ac-491d-bc9c-215a38da17d2"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/56bec425-77a2-477e-8195-e938fabc9353">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/fcb01e46-4869-4357-ad0b-be1a89baeb29">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/fcd6a420-56b0-4981-a7ad-234daee536f8">
    <rdfs:label>lopinavir/ritonavir-Rosuvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/03a1eaec-22a1-4bcb-8a12-280977928f75">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2f6f5cf5-3684-4b32-805a-2ecae519fbf4"/>
    <rdfs:label>paroxetine-atomoxetine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2023e543-f9f4-4960-8401-85cf3d1c8ffe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/4fef27c0-dd33-433e-bccb-17fc3aa0ae52">
    <rdfs:label>ketoconazole-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/9d21af16-1af0-48e3-a61a-6d77f9080f5d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1d3c04aa-cfb6-4dd1-831f-0bb0c19eaf72">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/7f91c9c2-6997-4029-a1b4-ba2cbf0ab11b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/69bd4366-4a9f-4f51-ac1a-d8e4807d4fc7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/63df20a3-3b5e-46a5-9418-766ab2925fe5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/19a74bb8-fb5a-46bc-b9ec-fda3ec9eecd3">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/bba641a3-b696-4d19-b021-97622dbf3147"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/001cc46e-83e3-4078-a031-0c48ec8a9b6f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/e933eeb8-df1c-47db-b1ff-f57b13ba7431"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/427f28b3-fbb8-40c1-831e-a7fdc2cf4b7e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c485cfb6-3a46-4dd0-8b48-c069696d7445"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/8f0a9023-a8a7-42b6-a874-85604c916e7b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/8c5cedef-7288-4dc0-85ca-e7f7b1dbf560">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/af54a329-2907-4f3d-a86a-a2e6d3f36983">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/f05a91a0-0167-4d9a-8db9-ec39c903aaf0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/73543ac6-43f0-4b8d-8091-cd30aa645048"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/2a1e10fb-768b-4fc3-b6fd-64f5d32f66c5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/518a98a7-1794-4b7a-812f-77c18cafdee5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/ac8fa6d0-bde3-4819-afac-63c9feeda003"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/fbc04959-3545-4efe-bb4c-37e93112524c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f1f9d775-9bb7-48b3-a24e-ad2661f4ceef">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/18d63868-7cec-4d04-b7ad-3bc4717a6968">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/11a8af64-12ec-4f10-b2ff-7b39baf2b6f3"/>
    <rdfs:label>citalopram-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/cd1b5c0c-6494-454e-b194-491d6eb0d64d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f9d80dde-b2b5-47ee-b3a8-60ff18dfc3c3">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fbce6e87-31f3-44a8-8691-f574468e7277"/>
    <rdfs:label>fluvoxamine-theophylline drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/6010e480-33df-461d-8fa6-ffd6413000ef"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/501a1fe6-3a94-4e8f-b9c4-fe1f6ce16359">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/61e27f03-27a8-42bd-b372-23f4e3e687ba"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/0ca631de-53be-46cc-9c32-27aefa2f0566"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/438622ac-20ba-4e6b-9e36-a6638384960a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/50d0aa9a-5319-4f8f-8f83-f17bb4c80fdf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/944b39a1-7c4c-4aa1-a842-5ea0e573b19c">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c79f9069-ffae-436c-97f8-293c03c5e3dd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/65285afe-7953-4416-b6c4-2c79ecb12119"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/d5fb1d59-7cf0-4f7f-b45c-64447779e747"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/38d38f64-f8f7-49d9-9337-391bf5ff22fc">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/9455791c-9f34-4dfd-8629-75dfbfaf2a29"/>
    <rdfs:label>103 Percent </rdfs:label>
    <obo:OBI_0001937>103</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ea1eec9b-50e3-4501-a633-012cb8e5e71f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b1748cb3-fe2e-4c77-8a0d-a26010937772"/>
    <rdfs:label>35 Percent </rdfs:label>
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8a9048d7-76d2-44a4-a048-b859c5d6b2da">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/6297bc51-6667-43c1-ab11-4bf6bd8b4b98">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/1b637a73-022a-4459-86db-02bd01068a30"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/9d8d52ef-f911-46a4-9c66-3edf2fbdd4c7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1c8a365c-63b9-4a16-97a0-ff26ff8ea945">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/daad7a22-c5a4-4e58-8aa4-57e60dceddeb"/>
    <rdfs:label>rifampin-zolpidem drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4332af54-52a2-46d2-b71f-8fb52ecb0f0a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f8c4725d-f46c-4361-a353-aec113a5c18b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/d29434f7-56d0-410b-9c53-9b1b24c23005">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/2d41e52c-acf4-4db8-a145-e4b1e3ffffc6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/13e128c0-7f37-4450-806f-f6d11b81f2b5"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/93e3b072-4a80-4b6f-b48c-f9f04f44d2ac"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e70f9dcb-a511-4274-9663-0a3c6fd8fd6c">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/8fbabd17-2301-4e97-b3ee-d55698343dee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/9b4d3138-4444-46d6-a967-21421160343f">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>Atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0ac51298-26e4-401b-930b-c215c6d3c9ae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/8558d6b9-6116-42b4-bc2a-0e27a7a51041">
    <rdfs:label>risperidone-valproate DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f912615f-2290-4d9f-8260-2d01ea3cad43">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/6090de03-e2ad-406a-ace0-451a48bedfe0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0ed82569-715a-4450-a2ca-4f46ab0789be"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/cd2b6d2c-4182-448b-b569-d97c5c825e69"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/879a84e5-c581-4c9e-8324-5434e6c39b75">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/44b399af-fba6-45ac-97fa-4d305a8efa34">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f80fe858-0194-4aa3-8126-f9f3cb6ac4bf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/eb68f5ab-bae0-4131-8ce3-415e9d219751">
    <rdf:type rdf:resource="obo:RxNorm_1102261"/>
    <rdfs:label>telaprevir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/9bb9ef81-61d4-46ad-b88f-a760f36af046">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/92a9d96e-270c-4adc-a435-f16103be265b">
    <rdfs:label>clarithromycin-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/9b7143d4-62dc-44d7-95c3-7d290a57162c">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/f2b79b07-5c81-47ef-a118-9b088da25290"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/1403de88-0cee-41ea-be34-ad61c8e9e258">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d35b7267-58c5-4572-a07a-2ea1d14d5b6a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/8449a545-aa6d-4aa8-82d7-8f56ceaa91c2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c750a58b-b35d-4ad0-ba8a-e5187c898e07">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/a2d377aa-3dd0-4cb7-93fe-a88696bb7be7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/c6e89622-d585-4a8a-b6f7-271db3f0fc3e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/7b585c36-809d-4070-9a51-c45cafe4192c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f4043c0c-4f60-4686-96b2-fc130b4b97ae">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f5f09abd-bd41-490c-b2f6-4849f18ebb52">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/889701a0-2949-49ca-a750-869518690b25"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/eca41aaf-e9c9-4287-8456-884626494c3e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/762bc22e-c9c6-4665-ac32-2bebc06c22ab">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/6a174099-2695-4223-b63d-71a178280656"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/fcbbd5f8-9352-4e98-b1c6-d53fdde8bc7d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f98a14dc-c83b-43dc-b4f1-d118c93cd0d1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/171e632e-54f9-4396-85a0-a226c2c88b2d">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/72e3f3f4-4431-4d0e-bad3-e07845beddc1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/1dc7e990-6bc5-4245-87fb-f72b7ce0f12f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c7ee3f4e-7fe9-4bbc-8ca4-85c855c9474d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ca5539fa-3151-4286-a028-b8cc52fae7cc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f1000f64-1984-481f-af54-9c6333a8340c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/bf291f48-6158-4891-ad7f-8c8bbe080493"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/740ee1fc-3b03-4841-815c-09244a4d2c6b">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/7e648baf-95ec-4282-999b-2cc575267125"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/33dc3e9e-ef10-473a-9140-cf57addbac66">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/cd2b6d2c-4182-448b-b569-d97c5c825e69">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1a4b34bb-6345-4053-9ecf-c8c6b7167787">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1fde223a-43dd-4688-b6b9-0bde913ce28a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5ed52d20-27ac-43b2-8d48-bfca4871c741">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7faca321-698e-4bd3-af7e-f040a5bfff4d"/>
    <rdfs:label>quinidine-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/48dd4e7d-cffc-4019-9eb9-f062e8925b7d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/2d6b4b54-0e8b-4e49-b176-ea0e1b630413">
    <rdfs:label>desipramine-HO-NEF DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/6cdd3060-f55d-46a5-b6dd-ffe69cf5c469">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/cd6b18c6-55bd-4e57-a103-ce3e9a4ec6ee">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/72edfa62-9155-4a67-a7ee-b15782c4de41"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/0501130a-0e03-447a-881e-446c0df25f23"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/54e7120d-a290-42cb-afba-1da7011c4430">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d70e2086-851d-4390-96b6-5c434fa965cd"/>
    <rdfs:label>Nelfinavir-simvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/258ae4f5-1742-4986-bb44-44d7cad52aea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cf0c87d2-af87-4aa5-a7f1-70805418f2ec">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d6a40ef9-1f54-4e3b-9a66-5f939c158420"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b2db83c1-775f-41a1-80c7-a2ecc392d68f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/2db8e39f-0cc2-4493-aaef-c05a1bee18ec">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/d959032a-55e3-4112-bdbe-508a3234ef8b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/8ef91744-3c76-48d0-8424-ed3a32e212cc"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/560e42b8-c828-4930-b114-445275a4d528">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f21d121e-4ef9-4fcd-a25e-c96a2f51097e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/d92ef654-8b0a-4cb6-9ac9-fece5365026d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/9664de89-212c-4405-998f-10d0eade78f1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c827b323-b5e3-4604-8787-d210e3cbd3b4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/238bf766-d105-4795-a5ed-925c48423df0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/62f05145-79f8-448e-b1aa-11efdffde89c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c2d9d05d-1778-4e82-bece-b617cfd4f09b"/>
    <rdfs:label>sertraline-tolbutamide interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/a7bc137a-f3e7-4a79-aaa0-69124f9b98a0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d2cd6695-951a-4dd1-972f-033cb13ed88a">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/bb6146f9-5ccf-49e7-b608-1277dc643896"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/ff549df0-d1b8-4d64-970e-e9b77dedb3e9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/f1f7b236-446c-4229-9877-96d7fba2b203"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/5354fcb3-f754-4ebe-87c4-d28edf75d426">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/39a58fbf-5937-4484-8142-4ebe3fc68047">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/41d8da0b-994b-42c8-a2bc-346b78f6d57c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/9af4db3f-c507-4340-a7f1-ceccf2b756bf"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b26f30e9-4597-4a4f-82a8-be6f80ecb332">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/71619581-7954-41f5-be5e-ec16cba771c9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/2c7006dc-5ef6-4afc-a6d1-5b2196542f53"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/bd396e9b-22b1-4f29-8406-72ad6d05b11a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1619bb77-5a4c-4d5a-887f-7fae2726c618">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a9f7fa23-389a-47cf-a64d-d26b70c1f3d4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/0d40b3ee-a552-4e8a-8e4a-69aba2eec5f5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/2197dee0-bcf6-4ac2-88df-e76d077721e7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/cb489cda-cad2-4270-a219-eb43ca0b24ae"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/5beb7bc7-a653-4fbf-8f04-38c926df999d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/8f2b6154-c3b2-4b9e-b6ae-892da0a584a4">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/a45099c4-c4d2-490d-a851-229d5137b51f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/5e4c0136-c1ba-4080-a99f-b3e05ee609c9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/512fbf97-9a3d-4c73-b9d2-e5c9e1680848"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d28dc431-4567-4006-ac34-bc6d399dbc63">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/a11cd59e-a252-4042-b3ec-f2aaacd123ef">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/7f334e1c-6144-4a0f-b96b-f14eebc2969c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/45abed99-ab6e-4bf2-b3c8-cc5d6786b1b9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2bc4a1e5-7d96-40d6-953d-6c4165da99b2">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/24d47084-5e97-42b9-82b9-57b47a66c0db"/>
    <rdfs:label>10.7 Fold </rdfs:label>
    <obo:OBI_0001937>10.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b2707862-9b2f-4613-80eb-64329cf76d5d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/fd1eeffc-b36c-486b-9f1c-dbe56d663b24">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d72efbba-970b-4686-9e6c-f20c893dfcc4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/99057a62-cf38-4a38-a3aa-892f795d4404"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d35b7267-58c5-4572-a07a-2ea1d14d5b6a">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/77a8905d-6996-4d7c-90a8-d4af961e4ea1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/32b279eb-19db-4813-a121-ca48b4ea68a3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/2c00925a-2a69-42a7-a5f8-4e6c0b18551c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/eee2f389-7778-4f3f-b866-1a2113840ae4">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/efe3718a-d5dd-469c-9cba-97f07e3468ab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c8d858e8-f9ff-4778-988c-fc4519e30efb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/58ac3889-3b9a-40ee-97c9-3276aa5a7d1a">
    <rdfs:label>nefazodone-4-hydroxypropranolol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/306f9803-59a4-4e54-88b0-d2de4f45ef43">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1f08b593-d15f-48ab-a8b2-3d5e133fdc28"/>
    <rdfs:label>1.12 Fold </rdfs:label>
    <obo:OBI_0001937>1.12</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ba095cb7-0ae1-479b-9177-6c14145d4c17">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b8c4e318-ff7c-4811-958f-e7c6f18a00af">
    <rdfs:label>atorvastatin-norverapamil DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1eb2283e-40e1-49bf-8b26-d24b922791da">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/33c55323-6ab6-45f9-966c-ab6c94d248dc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/8a3df2a0-e831-4fe1-959e-165a688707c1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/685b6d53-9a29-4e53-889b-f0e0206eb1eb"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/85ecf884-17af-4396-9144-b59795fcc30a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/a90dcc95-00b7-4ffa-b240-5c46549c16ea"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/cf05ae3c-0fa6-4f39-94b7-1e759d1e0690"/>
    <rdfs:label>iloperidone-dextromethorphan interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/ac3fb19b-f5be-47fd-90ce-a7cd247f3e72">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/4215e5e1-98d3-417f-bd63-4c7a5bcf3016"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0bd6d6f9-7910-4b21-97c5-631203d06162">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/8a22178b-3059-484a-b48b-91284f35a965"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/a7bc137a-f3e7-4a79-aaa0-69124f9b98a0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/af0345fe-c8d8-4cb6-87fc-9d6348472a8d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d9265aeb-47cd-462a-9762-881726e94eeb">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/fa910407-39e1-4a36-9139-6d6b0c74e271">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/0134ff83-ed11-49c9-a6a7-dd41ca8c3642"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/c1b016f8-dc15-447a-875f-ce197f07fec1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/5378e523-ce88-42db-a803-98783f66996a">
    <rdf:type rdf:resource="obo:RxNorm_3443"/>
    <rdfs:label>Diltiazem</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/698b0fd6-5c20-4dd9-9979-1a9d5317d84a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f53b49dd-67f4-4db8-b9f8-19a53d706aa5"/>
    <rdfs:label>20 Fold </rdfs:label>
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0b4cbd9e-d699-4df6-997c-1863c5b0f972">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/b83f9298-10da-44ca-b1d9-27f3b448c7aa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/331096fe-f890-412e-b863-1ad24ecf1682">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0b4cbd9e-d699-4df6-997c-1863c5b0f972"/>
    <rdfs:label>40 Percent </rdfs:label>
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/3acb03d6-837c-4b40-b94f-2959cd831826">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/af738ed0-d3d1-4da6-bb0d-4843b43c33cd"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/2d2d6baa-0742-4d42-892f-d5883f8fc18c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/8d931cfa-8db5-415f-b644-26ef8ff5113a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/fd616104-35d5-4a1c-ad35-3f41696b3211"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/1626bab7-0cc0-442d-8dea-3bc2af4a7606"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/f675f5a3-687d-4566-99ef-848276fc6b63">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/42ef2e24-8f35-44fe-91ef-01adf966bf82"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/766c6788-df80-4afc-9cea-1811fa9792f5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c9d3b5cf-37c4-4529-b1b1-c7297308b43e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/39259810-d3a1-4194-bc60-6c1afef0af0d">
    <rdfs:label>fluoxetine-estazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000022">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/498f1ae5-182b-4213-a64e-4506a8097252">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/291708e7-5b01-417f-ab20-658193c2a674">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/d3265dc2-0ab1-4390-bb5e-184204d96ec5"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/a8904e69-bc1d-4157-afbe-0e5f3145eeaf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/2a1e10fb-768b-4fc3-b6fd-64f5d32f66c5">
    <rdf:type rdf:resource="obo:RxNorm_1191"/>
    <rdfs:label>low-dose ASA</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/7b571c1a-81ff-4ee4-a0c5-caa1d9886c8f">
    <rdfs:label>Fluoxetine-olanzapine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4e3915ef-d94c-4280-bef4-97d9d8344858">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/c606f8a1-af14-4d1c-a908-5279cc8d36e0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/642fe2c1-0fb1-4b96-aa42-a18617c76125">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/42762c6f-486e-4a0f-8778-3a357370b3dd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/3bf4a29a-4b85-42fd-8571-c12bef9691f4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4781e2ef-e9a8-40f3-8d58-454aeb26b852">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/021df09a-4603-4f47-b3eb-90eade24f182"/>
    <rdfs:label>35 Percent </rdfs:label>
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/bb097892-be34-4561-9de3-653778d1f113">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/079be0a3-a29c-49f4-bee6-3843561cc96f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/1110503d-e20a-4167-be3c-3b68f44f9f31">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/2cd486e9-9889-4c9f-8f49-a751004f22d2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e4ee9c1e-89b7-45e0-8150-b514abd2adb9">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/40c90b68-bac2-438f-9102-53e64317888b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/3c78867c-25ed-41ab-8549-494a45a45bb6"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/17c948a5-143e-4814-8a3b-cae6d2a22c22"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f569b44f-4ad8-4c9e-bd0d-a2a9fdc242ef">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/df904e02-0462-4cf9-b04d-011d59b11524"/>
    <rdfs:label>cimetidine-citalopram drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f6f86114-07eb-4136-a456-4e9b3cabad25"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/bd671dc3-2055-44cb-ab2b-15af8a520398">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2604a06c-24ea-4f4d-90e5-e367a6ff5ac1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/50cdc8d2-66e8-46df-8f9a-df0a8f8a06dd"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f18bf462-66db-4101-acee-92e8e1966584"/>
    <rdfs:label>clarithromycin-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4a6f8cab-a139-44e2-b713-01a4048124e4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/02d2cf27-1d7b-4ac0-a32c-e465fa218ddd"/>
    <rdfs:label>efavirenz-bupropion drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/96afb92c-c262-42c6-8d4d-749b7bec3bae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/25b02b58-9a79-4cd9-8ec2-6c4f68876d61">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c2aa1caa-9475-4aa3-a0e1-e0554de955bb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/95d294c5-9534-4bb7-a5b6-119d57b7429d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/9fd63d86-561f-4130-9e34-cd5aaf10276b">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e76297dd-2af1-4f14-b0c0-8569164e9b0d">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/18e6c8c1-1e1f-4c35-b9ab-2bf28fe06a8e">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8c7aebdd-a8ca-4b59-ada7-34eeb804008b">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/43543a1a-e7f6-425d-932d-04bc02a55e34"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/f0b09a4e-e095-41c4-a48e-fe02cc57b68e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e9f97057-0761-4f14-94dc-17338ee76a81">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/19736040-092c-4d41-b77e-0ebc01c91e78">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/c933ccb1-f817-4a17-9664-3c8bc506bfba">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/2f3bb89d-1f03-4271-a94e-304ed3a828ed"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/48dcbbec-2408-4c8e-bef5-3a9f22babd59">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/dd444d7e-d932-4879-8e5a-5b650053655d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/f8a9293d-fd34-4d20-9203-4989e4b6acce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/0e0852d3-ff7a-4941-8b0d-9308d7b6ce67">
    <rdfs:label>naproxen-Edoxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/37e85194-082e-495a-9453-4bec85f2348e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b1bb9f21-6e6b-49aa-b058-6e4739b1be94">
    <rdfs:label>fenofibrate-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/14693b80-da55-4ee8-a7bd-d01738a86fe7">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/fb814329-de96-40fb-b162-7674b01056c7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/b4e524bc-5d99-4d4c-afcb-d6c8f321d1cd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b35400b1-17c0-48f7-b836-e314b5be81d3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4511e162-adde-4669-b3cc-32bebd4eda38">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/fdc0bcc0-dbe5-4845-8b48-b2eeeb6682fe"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/8c0f72ee-568a-402e-874f-2dbd15d37a69">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/92d4e1a0-7e34-472f-9474-7ff6330c6021">
    <rdf:type rdf:resource="obo:RxNorm_2556"/>
    <rdfs:label>citalopram</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1bbd15da-58e8-4a17-838c-b8a6c19c443e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/25b78dc6-2e8b-48a7-ae4d-27272a8168c2">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a14f698a-f096-49ae-aa08-68e19551b95b"/>
    <rdfs:label>62 Percent </rdfs:label>
    <obo:OBI_0001937>62</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/90eb78ba-3582-4af0-af27-7fc5a79118bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/d8384583-553c-40ce-a2ef-24db189a9612">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/57910442-4138-46bb-a82a-a4c4c0d0b26e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/4dccb7b0-6bf3-44cc-94cb-619cd24c1727"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/55871332-8a99-4749-93da-968cc526cc32"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/461b76b2-0128-474a-a6e1-f3974afe2063">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/237a642d-4187-48c4-a439-b2af721204ea">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/800e4638-d6a0-45f3-a186-1925ef92ac67"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/b213d1b6-0c83-4d0c-b7d7-f48ce5f4b836"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/79e26490-c33e-4a5c-9e80-b6d981700bc1">
    <obo:OBI_0001937>20-40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/7eb2b031-3c80-421f-9aaf-40772b410843"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ec1556d4-16a0-48dc-ad37-98b278ba2161">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/91b1c2f7-84c2-4442-8c3d-508004fefcfd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/bc88e866-1ea3-4c8c-8636-3fc8d6bb485f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/dee17cce-f612-4677-9e30-652947eb317a">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/0d173e91-731c-482d-a3a0-406e582c7ddf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/28529d04-2971-4854-b8cc-db52caedb4ce">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/eaf1dee3-aade-4f5b-ab65-d7dd2d183a10"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d78ed45d-7271-4702-89ab-6ce3f306bc44">
    <rdfs:label>ketoconazole-P88 DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/41a60fe9-53b3-4268-883d-6fe4fdf56bdd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/41e08f27-3338-4079-9d5d-4d1f35320b31">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/48e1ba8b-16fe-426a-a54a-2a77532a7fd2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/df8247e4-df0e-4904-af0e-6831b53cd073"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/2711b900-a1b7-41d4-8d40-65f11a8a4b7c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/141693b3-99af-43c6-a9f2-bac9dcd0a5d2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/40e87289-6772-4556-b3fe-487a6d670d75">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/4c02e7f9-9d74-49cb-b5ca-aa0ba2727f39">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c4d67d0e-02da-4f94-8ef8-7fe9ddc34659">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/9fc49410-4f63-4d6b-b76d-b0a2014d6007">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/8a8d7141-1fa0-4c4f-9385-55d7025cb926">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/6ce883cf-b94e-4ee6-bb1c-9cab263f7955">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c9c2c8e5-8340-4bf1-8420-83459ba8cb6f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/af54a329-2907-4f3d-a86a-a2e6d3f36983"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/2a3b80b4-0498-4577-bf78-31165b278ff9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/34081298-c803-4882-aed2-362055e2b8ba">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/3df7e9fb-194b-4661-8884-7d569aeb3553"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/f4064019-6668-466c-818b-44c482d62b3e"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/68e29b5e-9f3f-4b60-b1d5-c40c0da9a131"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/6ee43ecb-65cf-415f-b3bc-39329c2270b4">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/53753f69-a759-42ea-b3ee-f4c29bcdcd2a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/58e7682d-4865-4542-87e3-47e0a18b9665"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/a01b5924-1acb-4712-884d-658a356be2a5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f5f044ba-b90b-4a2a-8905-42abe62f0722">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/6c3de91e-6d99-4d2f-8837-047f83e6cd32">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/27440e92-becb-4fcf-ac20-e8130b8555cf">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/9b5d0e6a-5207-4838-aff5-c1d2026a413e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/f4c12f17-6eab-43c4-8196-69388d07483d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/a6be6144-dc32-445a-8a33-c766fbaf465f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6f581fcd-fc86-4bc2-be53-665b58ac2336">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/770023a4-a72f-4970-a400-9b812de0c8b3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/51b50b55-5628-4e30-8dc3-b6dd920550bd">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
    <rdfs:label>dabigatran</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/44b32c80-905d-4721-bd59-a100a2c99e86">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1a1a5fd2-43e7-4085-96e5-75a5f8230224">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/3a23ff60-bcb9-4b5d-b041-3bedba953b0f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/6ff75771-a67e-493c-81c1-baa65c0f01c5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/aae8d494-6128-45b5-ba5f-01bb1c6c8eff"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/f549e76e-e1fc-4801-b757-63e9433763b7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/7a401a0d-649d-4321-acd0-705e6d1ee048">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/3acb03d6-837c-4b40-b94f-2959cd831826"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/3abe6009-a9f4-4255-adc6-ba1c1a661256"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/a3458f57-f85a-4b19-afbe-1a46afe89af7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/184cf550-e157-4a3e-b68a-185004b78168">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/8231c9af-bc4d-49b2-8aa3-dd59483441b0"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/ba345e30-dde9-47ef-adef-43166efdaf3e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7ab1df73-fc82-4a62-b9a5-816a2bb0c561">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/645dc5bd-47a0-48bb-bcae-fd0ee7186b2a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/dfc6edf9-b7e9-4061-964a-3d271a1fd020">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f87d336b-e321-4a32-95ec-8c6d18a8097e"/>
    <rdfs:label>paroxetine-duloxetine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/ee8b43d4-ecd4-432f-a888-5affa0d4c14e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/996e25ee-72d8-4baa-b911-3a42094bb4ae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d87bd7cd-604b-4e44-a437-fcc6c0c02170">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b0e19483-51bc-4e20-b455-d66c1c68913a"/>
    <rdfs:label>3 Fold </rdfs:label>
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7848d8fa-794b-4b50-b4f8-523573c4f9b6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7b983f04-9bf6-4e8f-94b2-9350f09dd939">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/0ef3ef5d-5963-40c1-b684-8eb3ae9b1709"/>
    <rdfs:label>Fosamprenavir-Atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/21f21c76-5334-472c-b111-4cb7507599ae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/0907b5c4-04d6-46bc-ad5a-1eb2b6996961">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/00f35bfb-9c2b-4947-9712-56e7feca7c6d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/d17078b5-3d7b-41df-8bfc-b1cf79f37e37"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/86ce23ae-fd19-4ddd-aef6-665c818684b9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/58d4a660-539a-4006-b5a8-b098e63ff8cc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/89782192-8cc1-4186-ba6c-c5f22dd9c81b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0476a8da-8c39-4731-baf3-30daaacd783a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/71731aee-ffee-4834-b314-6b618adda9d6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e8247d0c-355c-4e30-bf85-03e79c1a7d6c">
    <rdf:type rdf:resource="obo:RxNorm_72625"/>
    <rdfs:label>duloxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f2f593aa-95aa-4ea6-9dca-8faaa96d89c6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/c71ea55a-dbdc-4ab7-8134-425920525a7e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/cc3acd2e-4ee5-46bd-acbc-84eaf2048825"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/7efebdcf-7c30-46a5-93ed-92cc8caec7ce">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/bb6146f9-5ccf-49e7-b608-1277dc643896">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
    <rdfs:label>warfarin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/2799d2d3-85e7-405b-aac0-d9b7a2341f11">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/d6dfe378-0126-4772-bbd6-a11fe3d849fe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/540152a3-378e-43fb-b33b-657bed9b8a1a">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/6528842c-67b4-409b-9899-7ce2ce9ca024"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/546da4cc-2345-4d26-83db-cb42d48f66c9"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/396e6986-94e7-4098-94ab-4435ddb7f0c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/006a2123-0d01-4cf9-8e11-2e56dde1f900">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e96851dd-2542-4275-aa8f-a86785c37a84">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1646203b-317c-4378-8e63-708e41859b44"/>
    <rdfs:label>fluvoxamine-duloxetine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/fef377a6-97fd-42ed-b849-3eb81243a530"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/b624491b-7caa-4b49-ad14-c4c0125d6fa7">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/8b6bf554-9f53-480f-9859-709900a1693d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/a7c2820a-50f4-448f-9650-e3e69c43fde1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/53abd8c8-a0d5-4d29-aa9e-d360a963c298"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b158b02d-61e5-42ad-8cc2-a9a37bb39c46">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/4f8c95a0-35ae-4448-8f28-aa791b199299">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/504db04b-66c5-44b2-8da4-ab2a769dc97e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2129ddd5-3dd5-464a-a758-1c15c97300ad">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/47c5fcad-8363-436f-a6ef-2a3768b50b19">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/9030e004-3f55-4217-b700-83c9eedff7e1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/551e25a2-6c80-4dc4-91c6-6cc43ae2ccc1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/2a3b80b4-0498-4577-bf78-31165b278ff9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e58d9431-be37-4ee9-a417-c6f68b592ba7">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/5e5f725f-3f17-4a3d-891e-0cb29c6576fe"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/f27f678c-c1f1-485f-b1f6-137d4779347d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/2fb54560-9818-4675-8f83-d3cea421160c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/934bf530-a04a-4d92-a5e3-a81d10c0fb38">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3ba7f7f3-cdf1-4b90-88a3-cf6004d18bab">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/33c55323-6ab6-45f9-966c-ab6c94d248dc"/>
    <rdfs:label>44 Percent </rdfs:label>
    <obo:OBI_0001937>44</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2eeb5150-185a-49a0-bc03-ee6b88965c47">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/97c5a1d1-4d23-4018-93e1-29b4defea130">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/55ecfb5b-fad0-4471-9a70-e664e521d9be">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/60f09f76-cfbd-419a-b623-a5c76d69c294">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/114bfb4c-cf99-4e51-b839-2d26c573ca77">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ecce83cf-2c3b-4d0d-83b2-1e8688658a1e"/>
    <rdfs:label>3059 Percent </rdfs:label>
    <obo:OBI_0001937>3059</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/79d41f53-0892-40da-ac82-4212e7286d3d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/013e1d1a-0cfa-48f6-a571-bf6038740d57">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/4d5242fd-5b22-470d-94bd-45051a36ba00">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/58eedcfc-93c6-4c15-8d28-5457b78ba3c5">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f873bbc7-5a62-4882-89b3-1edc2d77f930"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/038231ff-ae74-4934-acf9-a2a52d5c0cfa">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/02601b00-7ddd-4ca6-825c-e28c767e9d5a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/438622ac-20ba-4e6b-9e36-a6638384960a">
    <rdf:type rdf:resource="obo:RxNorm_134527"/>
    <rdfs:label>Nelfinavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/00f35bfb-9c2b-4947-9712-56e7feca7c6d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2b10d0f8-0ac5-4538-bad2-9bc8ab8fd518">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8ff71628-c008-4c40-be2a-2dd9826d6e2a"/>
    <rdfs:label>unchanged None </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/cb24a13d-dcd0-404a-a6c6-213042b1f0bf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/c1b016f8-dc15-447a-875f-ce197f07fec1">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b34b6273-e22b-44ee-913c-27048381a99d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/cf54a823-ed7f-46d0-a44c-58d89f0c4aa4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4cb2b1cc-2900-44d1-afef-0bedadb8386e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/8cee6c50-ad1c-42f9-af8e-51f38876d7cd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/95c5bfcd-90b0-4414-a233-51677b6793a2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/98e41b7d-a96b-4f38-8e1e-f02849590c23">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/eb7da287-ab95-4604-9aa6-4304f9b0bcb3"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/99469024-0e7e-4c27-81fe-cfb49084d458"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/c7cf7e4f-d2b9-4805-8342-c5ef91debba9">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/8f216ab6-b6b2-4727-ab88-fad00b248a71">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/d0d60a70-446a-48f5-af64-2eade6faf585"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/1020ade9-a8a5-463c-8440-47d87c2f477d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/20ec6b62-fab3-4978-b1d6-c8561ad49232">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/812d9ce4-68c2-4966-89c5-eb7e65200f6b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d979ebe1-138d-4245-8213-13a031253bb4"/>
    <rdfs:label>amiodarone-warfarin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/96c1e48d-db4c-4595-ade7-745b827798e8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/7cb90937-cabd-4a3a-b606-399f2b075c6d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/6cc0c868-646e-48ea-8697-3f685dba97e0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/8522859e-2d8f-48e4-bb8d-b0d0c62fc0cb">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f087f2a9-24d4-46b8-a40c-d377230ee436"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/1519247b-3ddf-413c-b5d3-35e13dc306aa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/44ddbeeb-0cb6-48f6-bc27-80833351ffde">
    <rdfs:label>cimetidine-threohydrobupropion and erythrohydrobupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/42e2fb37-85be-4b41-bb54-4d6a50edcf4a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/d98976a5-cb46-4bc5-bbd8-b117b160e30d">
    <obo:OBI_0001937>125</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/4ac8c400-8ca7-4eae-9ed5-b59784f5b702"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/f83867b4-02bc-4096-874d-b9d72b365a92">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/b68c16e2-b5dc-4ba0-ae8a-fe8e9bfe3f15">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/7e6fcd41-451e-41aa-9477-9737c26a7603"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/b4671b94-815a-44d4-b2b4-aafeee21ba05"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/6a72256b-3f68-4d17-8bfc-434a129add78">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/4252f0ef-4713-40f2-94c9-dd433ba68101"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/5980b173-8ff1-46a2-8cdd-c172ceaf48f4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e43ed4dc-2c76-456c-b2f7-ea072b888663">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/6f570737-8ec5-446a-b61e-1791b541ab0a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/0e35855d-c8e2-4926-a499-eed233228319"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/d1ad57dc-0421-4908-b15f-578e5f3bc24e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8f00a3b4-ee55-4eac-ae1d-c8c4746936d0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c6300c70-0f0b-4cea-acec-17a548ab9c1f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/7665e82e-80aa-44e1-a0ff-a4699555143d">
    <rdfs:label>rosuvastatin-Lopinavir/Ritonavir DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/619fa831-01d7-4513-a519-8f3018019f87">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/8b1d9f55-b3bc-4eb2-b1b8-83d435883449"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/23da66e0-617a-4cbb-9c3e-0dfb2ccbdc2e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e577d438-f877-4701-b707-7684a6e49c69">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/50473ef2-7b82-4a94-8ab9-ca6bfdcec8b4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/2d63c5f7-75f9-4ad9-9110-5958a33d2cc2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/8c5cedef-7288-4dc0-85ca-e7f7b1dbf560"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/9183f606-a1e1-47f0-84b1-d54e590c1f5e">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/e78a37af-ff3b-46a7-9713-cb4f3a95d7c1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/2ad7d221-7883-4377-ab65-f60c489452b6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/aa203ac9-4944-4795-8953-93467beb4b49"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/73e2addf-dc7f-495b-a6c7-5e126f792ba1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/838f53a5-796a-470e-ab8b-f6dae02e9ab3"/>
    <rdfs:label>amiodarone-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/89b20d23-717a-4b1b-9f67-ece783df8b6b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/d7db7cd1-10d3-48f8-b5d0-0719ae5b5d48">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/26d6e12f-970f-4dd8-b46b-7a4bbc1a694b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/152a5928-492a-47b0-b2e1-134736dcb0eb"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/4e0b8004-b31f-45d0-a9ff-85d3d9b17f53"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c197f47b-c741-4b35-9bbf-32445228bc30">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/3db4203a-872b-45c2-8db7-f5d61d5340f6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/af507937-7220-4add-a1c7-b65a5774961e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/4c9e06ac-bd83-4ca8-a25a-e449be4169c2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7132773b-cc87-48e9-a408-8bbfc90ed6ee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1a85b3bc-91d6-40cd-b7bc-ac487ab2f5eb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/432cf43b-79e9-42ae-9a27-09d09bf8a34e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/23adab7c-564f-43fc-a25b-a48f6f063789">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/28099ae6-da34-418c-9fb5-6566dda628cd"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/16c6e98f-8696-4708-abfc-cce2b8eb8cbd"/>
    <rdfs:label>atorvastatin-Nelfinavir interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/d625aa4d-b884-4ca7-91fc-4edfb6db18e6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/30953b5e-13d4-45e6-a085-4a76bbc648e7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a144cf4b-8ef5-48fb-8279-7d0246349a1e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/0f8aa9a1-d83d-4207-9776-d883c2280c0c">
    <obo:OBI_0001937>.25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/3a048cff-3ee8-4283-a04e-f10cacec9526"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/9df28d1c-7296-4b21-b863-1efc3c158f06">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/c20746a8-81d9-45e0-9094-09f1311135d6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ee33d208-c3c5-4b1e-bf35-989759cabe5a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/448f0136-5bfa-4236-96c6-6febdb7b0b6a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/f7530807-44fe-4909-8fa9-da415a48e246"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d6b6847c-bdb2-4c46-baa5-b5a94cb0f570">
    <rdf:type rdf:resource="obo:RxNorm_10502"/>
    <rdfs:label>thioridazine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/517ffa83-4492-46b9-a6b3-a0531e3c604b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a05a1c82-9bc4-479b-8e12-abc695bf86bb"/>
    <rdfs:label>paroxetine-procyclidine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/58d5949d-1c75-43b4-b78b-af31ef27fa1f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/0854e330-45b1-4df6-98e0-e7604495a5b1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/06d5cf23-414d-4fa2-99ca-ef93236cad5f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/8ceeb6c9-6778-45eb-a064-cb5ad71729d7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/51292cdd-9236-45b1-9831-c6f8d6e5f8de">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/39259810-d3a1-4194-bc60-6c1afef0af0d"/>
    <rdfs:label>fluoxetine-estazolam drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5fa1defa-2287-4923-90f2-c07fa60e6c05"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ebcb972d-2e03-424b-a0f1-fb5f261c8a4a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/7c0ead63-1a71-44b4-b473-f7f2a02b90e6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/72ba9c9b-bb41-4c1e-a853-38c38270d8d8"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/dc23fe6b-dcb8-43d4-a073-083d2be0da74"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/9c22222b-2356-476f-afd4-ea76adcae691">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/20d014d7-bc59-41f5-b83e-fd98bda171dc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/548e9fd6-a40c-435b-ba0c-c90d6ae08730">
    <rdfs:label>buspirone-hydroxynefazodone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/9981a28a-7dbf-473e-9d04-b7cb91dfbf2c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ba3d5c9f-af37-4a79-bb25-71602a3206df"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/9762fecf-1ff1-4a7a-82bc-1df8d409fe01"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8c9ee1a1-521b-463d-a5e1-e5e94c5aa659">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a43712cb-703a-428e-a364-5cdecffcd6a3"/>
    <rdfs:label>6 Fold </rdfs:label>
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/4a8714fe-d147-41bd-9094-2df82390e448">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/240db595-d30a-4c47-af1e-cecc28966b27"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/e22cefd9-a27b-4047-9233-706cbddd3151"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f1ed1d52-86c4-4c99-a575-9d7b6f12d354">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/603e8c3b-1c10-42c6-b346-7128a140a8a7"/>
    <rdfs:label>phenytoin-paroxetine drug package halflife Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4781e2ef-e9a8-40f3-8d58-454aeb26b852"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/571ac632-e5a5-4b7e-9888-3197250db38e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/20950165-05b0-4101-966f-bcc2a31d4446">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/1accd094-e2d9-40a9-8d53-f5c6f3abb047"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/d2181ee2-053b-4786-9212-5e4d2bb2262f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/bee77236-ab9d-4281-bbd6-755d50a84edc">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
    <rdfs:label>warfarin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/2a1df8b5-d828-440e-bd7b-9ff690022591">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/aad9151c-45ee-4b1c-bebe-c6be54a90ef9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/1f90532b-7e2a-462b-92b7-097fb08926aa"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/7773b9f4-49c8-4bf3-8590-4145d7a44d83"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ee8b43d4-ecd4-432f-a888-5affa0d4c14e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1f233015-2590-4895-b076-36d00278d727"/>
    <rdfs:label>60 Percent </rdfs:label>
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/3a806ac5-327e-4012-860f-f671ca8ad7c7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/698fec2f-cabc-4f9c-b635-48bb9cf42192"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/b008f433-97ae-4d29-88c2-37b11b7df107"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/dd7de2cf-9644-4f9b-9500-daa62556dc22">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0c4d4f12-22c1-4b93-b16c-0aea152baf31"/>
    <rdfs:label>151 Percent </rdfs:label>
    <obo:OBI_0001937>151</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/4ba3cb09-a4d4-4be8-b9e2-e4cc8d4cd726">
    <rdfs:label>buspirone-nefazodone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d346fae0-cf17-43dd-9783-0496566877c8">
    <rdfs:label>sertraline-cisapride DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d4d247bd-aa07-4ea1-9b11-b9419f80c753">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/40c4eb5f-56b4-4b10-8198-b0e25cb13f3b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/8ea70688-d86d-4331-8c0f-419ad2e3c4a4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/7a76b681-d518-4573-8c26-03d5dac06770">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/5e83945d-b454-4008-bce4-6095ff51d09b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/78ec8ec7-2240-4ea1-aef1-e0d613c5d9bf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/711a8af5-9d9f-4fb7-92d4-af5ddc3a1376">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e9fa9b60-adba-4cd2-94ae-ca93694fb916">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fd05f8b1-d038-40f4-a473-693438f5feac">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5d303a7e-9813-4c37-9252-7aa4d7e4e8d3"/>
    <rdfs:label>82 Percent </rdfs:label>
    <obo:OBI_0001937>82</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3c5d3272-a746-44e6-8229-d8825e5c6355">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f75ec436-9045-4f7b-a2fa-691d28a330d6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/c36d1d4d-931a-41c7-9312-9fe5ae9d1b81">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/b8694f2f-fbd6-44eb-886d-a550c0649c30"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/c3ca0477-a3dc-4f57-96ce-04d21c73f1fc"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/7125d3bb-1318-4783-9d61-fa29427dc2f8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b6fac3a2-dba1-4d87-89a5-d07d82304ba3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/1d711b53-c1d1-46cb-9077-eff29ce5f0eb">
    <rdfs:label>midazolam-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/61e6516a-4899-4d7c-a9d3-9418a8810612">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
    <rdfs:label>carbamazepine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/30bdc844-dd03-4217-b6d6-971236162614">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
    <rdfs:label>rivaroxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/82386ec2-0818-44d3-948a-99a889be93d7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/93f0ce9b-3811-440b-81fd-f3bc03ae48e7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/4d664e9c-c0ec-476b-afe5-73fc60310e8d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/cef89f07-059d-4530-8d33-e907b54f13b6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/6d62c277-a386-41aa-b069-5d1bd7383216">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/586ce642-febe-44d3-86fe-e5acd947e2a4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/9a43dda8-e922-4e0d-ba1f-aa4d9a98a02d">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/cce9dd43-85e5-4a65-ae9e-8e97eece2bb4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/6eb22daa-5f63-491e-a5a7-100ce631d00b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/05d00429-1b05-4778-8e6a-a4de1db02fdc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/6f550478-9cbb-4ace-bc86-fd2bb608fd50"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/80c22176-4537-483b-9090-2dc25310634a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/1f08f5e2-d68a-4263-b923-7d106375e79f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/795f0faa-4bbc-48c3-be94-718202b9d5cd"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/937fe851-52db-46e8-a6d4-6dba452fc244">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f929b93a-0a00-4bf9-a539-a63978e2e5f9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ca6afacb-f01a-410e-8d4f-7b90ff7a81dd">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e5b28db4-440c-4704-8759-8c26525fa71f"/>
    <rdfs:label>Fenofibrate-Atorvastatin drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1315a434-205d-41b2-a875-7301ea178d91"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/b8052a68-01ea-408b-aef2-945423785f03">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/4525adbe-f22a-498e-901c-f4c331a38e88"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/70ac4f51-4988-42e1-83a7-4227387b44c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/6229768e-8ae0-41fb-87d3-2ce98921ce3e">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/52deacd9-714e-4eb1-83f0-d26644b74923"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e3734013-24ff-4a49-9b41-3b1f6e34b320">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6fa31c6d-0bbe-49ec-8e28-40101d465648"/>
    <rdfs:label>21 UNK </rdfs:label>
    <obo:OBI_0001937>21</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4e718484-4e35-4813-ad83-3b924210c684">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/6f50da79-c176-4910-a630-dd12a17bd233"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/7fc3c8f4-ee09-4cd2-949a-bae2719eaf91"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d58c57ff-aa27-4076-baa3-776b301ba043">
    <rdf:type rdf:resource="obo:MeSH_C558899"/>
    <rdfs:label>lopinavir/ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/611ac3aa-602b-4a76-9794-d3d71f185d4e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1cb799b8-fa37-449b-9440-9d09226084f0"/>
    <rdfs:label>sertraline-diazepam drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/aea51f7b-0b58-46f8-9603-ef5808c241b5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/95ae91f9-7a18-49e7-8333-1cb29c10eeb4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/932cdaf8-1597-4d6a-aa6c-24a253a9eda4">
    <rdf:type rdf:resource="obo:RxNorm_1116632"/>
    <rdfs:label>ticagrelor</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1150a303-c82d-4e4c-95a3-12b68f25d3b5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/9bc15167-6dc6-4e8b-80db-d5b25024587d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/066e8412-e661-4cc1-83b0-8153d61f79f3">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/ec640f72-bbf5-40cb-8031-967f47f47a48"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/459c991e-0795-4e90-9ea9-ad47b96f6a1c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/5d33659a-7c2d-4ac8-803b-8c083aa03d7f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/934dd5f6-1507-4ff3-9905-e57861597b32">
    <rdfs:label>iloperidone-dextromethorphan DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DRON_00000028">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/3c258985-392e-47cc-a3ee-19b9a59ed153">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8644c7aa-d63f-4428-9bd3-f2dfeef8b0fa">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/eb57ab57-9020-484f-a8c1-a1e1c41ef7e7"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/d0ddd18d-63bc-4055-a28e-642cb263cec2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/cd568527-6153-409d-a187-dc93ec75ef39">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/8b33f7e9-be30-4954-90df-53cec0c0922a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a7d415aa-c121-45aa-a948-16e7f661d943">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/26d6e12f-970f-4dd8-b46b-7a4bbc1a694b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/4add5820-3e01-4c2c-9eb9-80cf7d114397"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/2dc87e83-9446-419e-979e-69a86ee6fc7e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/7f89f01c-31d5-4df6-9262-7ad93463c857">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/0279bb12-2f69-45a4-95ba-9a898e1ff91e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/29ca3fa5-2f3c-49ca-9ca5-4c1ac3f184b7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/315da4c6-f021-4030-94a0-707e49083ad9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ba7d6253-f787-435c-b1bd-b2e3353d0583">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3fc6e024-a607-46bc-844c-98d156d9e5a1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c6269684-3e40-4bc8-8c63-eb5bc674e201">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/abe963c0-1e7e-4d07-b372-486ce843418f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/89782192-8cc1-4186-ba6c-c5f22dd9c81b"/>
    <rdfs:label>alitretinoin-simvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/54579513-cda5-406b-99c9-fc3cd2bfaf15">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/fe610f1c-ac2f-4012-b9ba-cea9541263c2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/0bdfde5b-7382-4100-8528-e205550573b9"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/a5754906-8ccd-4dbe-9f65-5ca60a5af629"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/dc3b2db8-3a33-4a12-9249-fe45824a992f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/9fbfbfca-3e19-4bbb-a7f8-af6a9d2a38e7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/16b85ef6-f6a5-401c-8945-952fd315a181"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/4bdd5c87-f40d-4e29-98b1-3fb8760b1a10">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/3dea4f96-f808-4c84-abc0-895f6c3b3e30">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/90e5924f-a064-42ba-a908-7dda3e3a92b0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b7ce7935-52ea-46f6-91f1-47e89c2b2a7a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/235742ed-653f-451c-ac12-5039f0db4a97"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/8230c455-3983-4c5a-a34c-a568250a0879"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ce79a32c-f0d6-4aef-99a6-ba668e49d075">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/daad7a22-c5a4-4e58-8aa4-57e60dceddeb"/>
    <rdfs:label>rifampin-zolpidem drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1f61b05a-a96e-4755-afa7-d9aeb861fee6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/4e760fa5-c28f-48ca-a1b1-b4b4ed0b4164">
    <rdfs:label>alitretinoin-ketoconazole DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/777a03ce-f621-4e87-b7a2-0a68fc892b0a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1ba14b72-85be-4971-968c-a4bb8ff8563f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a7d505e7-fb65-4331-926a-145bbc6b19d8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/bf731133-61d7-4b84-a3a8-d82e6a554923"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/aa2a85e6-e6d9-462e-b7e9-9e5980c0c79c"/>
    <rdfs:label>sertraline-zolpidem interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b4a77a95-e26d-490f-ac2d-1ea9d8438432">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/62308c3f-734f-44ae-a022-a44694548e87">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ecd9f036-13a2-4b7e-bd17-4851a4c8f332">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/699f4a31-a360-4d78-891d-e7f208ade776"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/2b678fbb-1e70-4450-9408-c4983332199a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8a22178b-3059-484a-b48b-91284f35a965">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1b3f7348-ad26-4bb5-9de2-112970920e11">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/58ef8579-ebf4-4540-98b8-a6d994824fc7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/243cd8cd-bf09-4efd-b012-15ae670bd8d5">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3ef18615-1f57-4bb6-b67e-f0b394af34b5"/>
    <rdfs:label>telaprevir-atorvastatin drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d44494a9-17ae-4b51-b44c-b460d2e3b5f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/683c51fe-a171-4711-8a12-8499e458dfe5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/2514290c-9c0b-4b71-88b8-22b2503b6c52">
    <rdf:type rdf:resource="obo:RxNorm_15996"/>
    <rdfs:label>mirtazapine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/fc938414-0689-4cd7-a585-e4a42c255928">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/60d27bfa-553f-4c30-bdfa-6c912ed257f5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/d9e04290-38ff-4139-8fe0-06fb90ca1941"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/fb2bf2b6-7312-4313-9bdd-85acbcce759a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/b16f24fe-0a44-4487-b0ad-75c8d6c370c9"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/be0964dd-6d2d-4f14-8300-debd10c92d86"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/2e0de49b-75e1-4276-9c09-f3c5d81e68e5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/44a1e1ba-9265-462e-a38f-087f7bbb4484"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b7cfb732-ebc7-4155-b27a-41f4ee767a43"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/63238a66-4712-4304-9c25-df27d3b4e16c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/054b8240-cfdf-4d8a-b65a-9ce905c6ce13"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/9e49c063-17c0-4f76-979f-9e4b7e7f5f15"/>
    <rdfs:label>nefazodone-triazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/35be9d13-fe90-4235-a313-c135e1f4b945">
    <rdf:type rdf:resource="obo:RxNorm_1116632"/>
    <rdfs:label>ticagrelor</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e3395243-c95d-40c2-9204-6103c21551ab">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/dbe9b745-f00a-43eb-9edd-0b21384924a1"/>
    <rdfs:label>1.12 Fold </rdfs:label>
    <obo:OBI_0001937>1.12</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/0df92e27-539d-4267-9c53-1285678ed9b4">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/99599321-a702-495a-a3f0-ee3c524c27b4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/d2561fc9-4360-4825-b890-c4c50376a2fa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/284bb365-c466-45ff-a8d1-eaf198537a00">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0c7900d1-58d5-46da-bea3-6f1f724605ba"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/2f5bd7da-81be-468e-aaf1-933146f42c66"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/9d8d52ef-f911-46a4-9c66-3edf2fbdd4c7">
    <obo:OBI_0001937>375</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/f5ab7d5b-e193-4bcd-8dca-c3ef4050d0cf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/6aad7248-0308-4754-8a1a-0fa675a54b30">
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/879a84e5-c581-4c9e-8324-5434e6c39b75"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/17f66371-2273-4ec7-b610-b0e0ec49c72d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/3b41d1e7-6a93-49b7-92e1-a5f2135aaae5">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/a4298eba-7740-4de8-94a1-e05ba6ad6730"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/d85d6a72-be5e-48e8-8c71-a5e47717aa7c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/7d6d5cb1-c231-4d0c-a496-21cae44f777e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c2fb9cf7-1405-4645-b876-6f648b8de254">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/553fb055-1384-4e41-b1d7-ad57f2e38e71"/>
    <rdfs:label>51 Percent </rdfs:label>
    <obo:OBI_0001937>51</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/65858975-b081-41e5-91c4-df75be61d130">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/515ecc8d-3020-4da0-829f-77b698169f86"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/273ad6ec-834b-474d-bbb3-68f5d73dd2f1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/dfb728e6-90c1-41a3-a4ac-84bc00432f67"/>
    <rdfs:label>atorvastatin-verapamil drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/862b5233-893c-465c-804c-3a3ac01b6d80"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/3e3cc75a-50ac-4fe1-9439-627deaa2d837">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/749186bf-ac91-4f33-80cd-e5559b4634b9"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/2364646f-2dba-4ace-9608-fc8060089e93"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ceb1ae4e-8cc4-4961-bf4c-6be488440641">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/32862ddb-f65b-4b14-9b21-ce57b0cadc87"/>
    <rdfs:label>Nelfinavir-atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/263ad17a-d06d-4da9-9c82-48ad360a91ed"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f3623974-4f75-46c7-9825-cb19a5617f91">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/9bccc7cf-f324-4cd0-86ee-b883e07b2975"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/495af8a6-3ad7-4c8d-a3eb-c67fad311bad"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/6b9d92f5-b094-4e8d-aa3e-c12d9dfbbe0d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/da597342-9ac5-44b9-ac48-3c321262de7e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/efb8d2b0-9dca-42e9-84c2-157f5b47512b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/6e38ffb5-c91a-4769-b3e3-464d6447b4bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/3cd270bd-792c-4157-bfad-f4bf9e7d9076">
    <rdf:type rdf:resource="obo:RxNorm_36437"/>
    <rdfs:label>sertraline</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b1021523-5907-4fc5-8336-a10b1550c23c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c6e655b9-afa7-4c5d-a8f9-f2bc65d0303b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e279f42f-f3db-414c-8422-b9ca2e56dc7a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2c16b8d4-1781-4f81-94fa-17e64cdd1876">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/728b9ecc-ded8-486c-abb1-d86b58faa77c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f15888b0-a765-4cfa-9d87-21fd33f43740"/>
    <rdfs:label>propranolol-m-chlorophenylpiperazine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/cdd074d2-3cfe-41b3-a588-89f9fbd1d9cf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/0e35855d-c8e2-4926-a499-eed233228319">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/dfd8ff03-6142-4b14-a0a8-62b7de039f4a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a6ae635a-1cc2-4710-8255-ec36cf1faaa6"/>
    <rdfs:label>4 Fold </rdfs:label>
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f1aec92a-fd0c-49a6-a544-e0730c379d57">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ee40d925-1d8c-4dca-bfc2-89e9f3147630"/>
    <rdfs:label>telaprevir-amlodipine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/cb1ace97-9284-448b-94b0-fe3a9c7b3874"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1464ff70-3f99-4e74-ab1f-7ce261f37d02">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f3aea126-cc66-4b3c-9a3f-cccf2a2f60b2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b25b66e1-5217-4fd8-bf30-008983c4f384">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/21876c45-f64f-43a5-9e9b-1c2a59903c2e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/012e5e59-60d9-41aa-ab08-d92f6b9dd810"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/20b2d06c-d3e3-4d96-89c8-d4f7a342819c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/112acac8-512d-471d-a409-fb6032b2caee"/>
    <rdfs:label>paroxetine-desipramine drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5fbfff70-a5b1-41b8-9288-c2eed221bf20"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/d17078b5-3d7b-41df-8bfc-b1cf79f37e37">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/dd5ec11e-e42c-4d58-9879-518f11931166"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/72edfa62-9155-4a67-a7ee-b15782c4de41">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/162bc3af-864d-4fd9-843f-beede58461fc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/915345b8-9fc7-4529-a484-7c2e38120862"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/e2d92971-be15-4327-8a13-c9efc1bfb2f3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/74095c40-55af-4f53-a5fe-2b914c541852">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/6a3e790d-1231-4a04-9617-da2bd8261c71">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/5d81d37e-7b55-4c53-8e14-a5ab3aadf7bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/8336032e-5342-4e3f-b3af-d3fa90de453b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/dc77aa49-1dea-4655-abd2-28c7173fcc90">
    <rdf:type rdf:resource="obo:RxNorm_9384"/>
    <rdfs:label>rifampin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/2c877226-80be-479e-8fa1-38dd98b1e2b7">
    <rdf:type rdf:resource="obo:RxNorm_42347"/>
    <rdfs:label>bupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/9f2953d4-bb75-4ec1-b882-18fbbe896c68">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8787e06c-3f1c-4ea9-970f-c50f3c4ff8bf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a1bcfc98-7a4e-46f3-b68d-cc7f0bdf8c51">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0c07f576-089a-4a02-8945-267b8f9ca7ac"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/5d81d37e-7b55-4c53-8e14-a5ab3aadf7bd"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/795f0faa-4bbc-48c3-be94-718202b9d5cd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/b25f3690-8f76-4118-9515-1bf8ae2b7f53">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/c1e130b6-e887-4923-8414-c56fb0a2b59c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/a985d94f-1761-44e5-b591-395878d331d0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/f3a5e649-6efe-4a0d-b7a3-cca83ae29ec5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/fd3affd7-2f19-4193-a394-fbf87d5975e1"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/3ee3ed6c-fcd4-423a-b908-94ae0400fb3f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/84330d55-8ca9-4262-8b74-21ad663f281c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0b012def-2bf6-4691-a9ec-22a2d4f5a025">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/90abe59c-5428-48d4-a24c-d57fe66ebcf5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/bb306ee4-1323-4b19-b012-7c19abd2a3ba">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fbd177a7-1667-4e6a-a32f-948439b56a97">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f929b93a-0a00-4bf9-a539-a63978e2e5f9"/>
    <rdfs:label>2.25 Fold </rdfs:label>
    <obo:OBI_0001937>2.25</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/5552262e-71ff-496f-abe1-149c70ddd57d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/97c4dacc-4dd2-4f95-944e-5ec7155f9464">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ad4ea86c-f5f7-4c12-8f26-0a0115a6e144"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/d1480691-b7e5-4c85-96ed-a99a79d3826e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/a5309d27-cde7-4ee7-b104-b94563719714">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/7bff9c9f-695d-41bf-a6fa-20bce3d9f690"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/0bb17378-28fd-43df-8643-30a24648594e"/>
    <rdfs:label>simvastatin-Nelfinavir interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4ad0389d-f292-4ce7-8d27-1384eeb2ad1d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/97515263-ac55-49e1-bfa7-d1d2ed7e7796"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/497dc4cf-4948-4fb2-a3c2-c3bb7100dfdb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c6bcea14-26e6-4305-9f63-564f2b88ceab">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d7255c32-f384-49cf-830e-0af200d368a4"/>
    <rdfs:label>low-dose ASA-Edoxaban drug package auc UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/08a46890-48f6-4c1b-8f0c-baa0474419bc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b900887f-acc7-474b-b3d8-52366937fd5e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a1f92023-2205-49ad-90ae-47d17ac1e8cc"/>
    <rdfs:label>fluvoxamine maleate-alprazolam drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/982f5b0b-6bb4-4185-bb9f-7992dc51eb8e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/77e45fd9-0575-472e-b142-32d9d214d86e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e277ea3d-890e-4fae-8e8e-862c79b8ebd8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/b0ddcfe5-2edf-4e3c-99a4-d19fc2cb6bf2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/1512a732-1df4-4a9e-a8ce-419a54ede351">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/6d953cc5-d4a6-4e7c-b40e-b3112c153007"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/9ff5c9ae-6553-4c9a-a356-eccb37ec25e5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1cd08aa6-a490-4b57-aa25-d8b8a69b9ce6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/5e92bb22-9a5f-44f7-a011-aa0644ba14c4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/dfac69f1-4e8f-47e2-9f07-3c5bff3b6842"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/5b3c71dc-1da4-4fac-9f87-32b9922a6e24"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/a0c72d6b-f84c-49ad-a5c1-d7d8fdbcce3e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/fc170e81-5b02-43fc-bd53-29c957e58e19">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/edda8213-b238-4ec9-8f93-0de010ecc435">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/2fba874f-4263-4c4f-9bd3-6d34e0d1ee92"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/f41db1f3-2544-412c-b278-57362b08f7b7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/4865ac5e-3a55-48a0-96d1-3b074611fe74">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/47b68633-bad5-4d94-9288-c1c6f1955f39"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/aa2a85e6-e6d9-462e-b7e9-9e5980c0c79c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b94c31b6-3c21-4690-a8dc-d078bbd22235"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/ebb36307-b993-4b3f-ab8d-fcdce75f294c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/4cd5c7e3-3b8b-4143-80b0-5d3562842b7a">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/1b391bd8-fec6-4e63-aa9e-dad1671262e0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/a643c6f9-47f7-4eab-8e3c-299a18fe29d8"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/97e4f681-b600-4438-8e54-2a1d0176a2fc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ad5d1e75-1a4e-465e-bc9e-7c94f170e6e2">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/2d1a2cfd-0676-4092-8d8a-26f448935fa5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/9c1cd9e9-8a0d-4c85-b0c2-20d317f4257f"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/933dc0c8-f710-42d8-841c-7d7c2d465c96"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/09c43a1c-55c2-428f-b3e5-61fa7f0970a4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/1b05b3f2-dd8f-488e-93c1-54b42f2a63f8">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000051">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c64a5899-a511-4d7b-aba0-155d1042f834">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/4945b8be-e927-4c58-b300-4a2f8ce8629c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/167be1ed-915d-4a18-a124-f9444bf27c35">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/d80580e3-0f8d-4855-a419-bd5f7360a342"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/148fd95d-f80a-4dc2-9829-c11a954b1b71">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e4218552-018a-4484-a431-d7d2c444d5f8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f3542bfe-459d-4871-a0e9-62e92d93f711">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/e5389509-61aa-466d-9470-e79f1011e015"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a43712cb-703a-428e-a364-5cdecffcd6a3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/254b40db-2158-44bb-b9fd-ec32efd3b503">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ac5a53d8-810d-48e6-9ea7-0183d4aba54a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e7297bcc-fd5d-4985-bbb4-6ab179edee90"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e757da49-1a70-4e85-b6a5-8a0c66686eea">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a89dfc31-30db-489a-85c9-7b6124c20c6d">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/d2055030-fefd-4fd7-98d6-b3d7b91d6f05"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b8e00255-269f-421d-9006-514e3b51657a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/703ea341-5e50-443c-92e1-ed664a960a7d">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f31fbe62-d838-4f2c-acd5-3a57d6d87a89"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ef409448-3199-4376-a092-6632a191663f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/cf877c1b-0643-4364-9307-39edecd56bd2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7b571c1a-81ff-4ee4-a0c5-caa1d9886c8f"/>
    <rdfs:label>Fluoxetine-olanzapine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1502c044-b141-40b4-b212-48366cdea6f1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/48bf28c0-0313-4cd6-a483-7e1f1bc373ff">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/3ef15fa3-900d-46d7-ad6f-cdc3add161d7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/5eb882a4-2628-4b11-b87a-f5640de774de"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d3ed8807-9591-4319-af94-9ed5af70ad96">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/202c344c-551e-4a03-9faf-0248638ef900"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ecaa1e0a-ee71-4f59-b72d-d85210d82aa2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/65a785e4-986c-4a3d-9b72-593c3014025e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f2f593aa-95aa-4ea6-9dca-8faaa96d89c6"/>
    <rdfs:label>carbamazepine-mirtazapine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ef18fc45-e169-4c1a-8613-d2fa31ce3135">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/55e8d038-5254-4020-a4c6-bb8d63e0dc12"/>
    <rdfs:label>mCPP-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3ba7f7f3-cdf1-4b90-88a3-cf6004d18bab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/df4eeab5-a0a6-4804-8577-cfa63ba3c268">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/b48a36a5-4cc2-4ae8-b0e7-c13e64026ff7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e757da49-1a70-4e85-b6a5-8a0c66686eea"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/c25d78fa-e08c-4438-a909-94aca53354fc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/ec171e8e-72e9-47e1-88b9-20bfc564526e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f11595a7-4b3a-48bf-973a-0fc1f74f8705">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/c20087d4-6299-45d0-927d-1009e73533c6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d0487c0b-f500-439f-8c0e-c39db24583d3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/59baaee1-d247-4674-badc-c466089bcb07">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8021b272-3cd1-4a5f-bfbc-4cd387d5f2d9">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2d794fd7-8bc8-4aa2-91f7-abdeae777be9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9c5a3129-a0be-482d-8a25-cc4e67bab08b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b0628d1d-ecbd-4c21-9d1a-01e09d287219"/>
    <rdfs:label>rifampin-pitavastatin drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/228463f6-e465-40bf-9885-889a696a9e33"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/fc50d33e-009d-4e82-942b-3ea6bbf9d5dc">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/652c8693-2d85-4c38-9b9d-3a45d59efc00"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b3b74f16-d8da-464b-9f50-fa9803059093"/>
    <rdfs:label>ciclosporin-alitretinoin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/5cf119b8-85be-4104-8e69-45ef2bfc8ab4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/3602bebc-c734-4e1f-8936-dd65e59759db">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/8bc53362-5301-497c-b844-deb42a5ff16b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/c8b3ed39-07c3-4a37-bb6e-9fa0abe10131">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/0262103f-bef2-4628-938d-bc91bcda2426"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/7dec8d1d-7675-4b32-8f82-8497285cb728">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/8929d5c9-edaa-43d5-a593-ad43dcc0c2c4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/b6ea9bfc-0bfc-4153-b28a-f5aad5c4a5a3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/51b58221-c7aa-43dd-b280-2bb3ab3567cb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/aec49331-746d-4280-87a1-4060ab93e193">
    <rdf:type rdf:resource="obo:RxNorm_301542"/>
    <rdfs:label>rosuvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f42ca07a-4527-4f4e-a433-c7a4f6ccc785">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/11a60cde-0032-471c-a7e5-49bfd3f8b959"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/50473ef2-7b82-4a94-8ab9-ca6bfdcec8b4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e18ea95c-1516-48ff-b8ac-770dbef155cb"/>
    <rdfs:label>Celexa-metoprolol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/030ee3cc-d906-47d6-af97-280105f78d1f">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/547da4ae-ffd9-4d06-846f-b36828173d72"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/945722c5-b907-45c4-bf50-5f02173dfef3">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b63e6426-2651-4003-88a6-fd8aa6c4d505"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3e8d1623-a943-497c-9a3c-c88284d11538">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/83aefdfd-5962-4bbd-8bf2-f68abbefdc7d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/216cf6ef-8879-4672-acc7-9072b3e58376"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/56178539-6d74-43f5-9b34-57dc5eb92499">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/2c963010-4405-438a-a737-45ecaeb1eb9b">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/0968f46a-1cf9-4a96-bf00-a5e7bfbd17ec"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/5478c53c-1ede-44e3-aa4d-232d40933dff"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/738a4400-cbba-4f05-8078-9fbc18b27b11"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/e57ef19b-2d55-4136-b93a-7cdec2f61666">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b0ddcfe5-2edf-4e3c-99a4-d19fc2cb6bf2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b8781828-801f-41a4-ad14-b1060fcde296">
    <rdfs:label>ABILIFY-fluoxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/6673f6c9-b5e0-4500-ac8c-3f1d82d8aac3">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ea3ff0ff-ab44-4246-bfd7-3a502aa3d85d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/49e23cfb-6757-4002-b600-8b3a16e09c7d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/785e8906-3484-4d0c-9c2d-23c06837231b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/053d6521-fb8c-4432-b649-7e39fda1893c">
    <rdf:type rdf:resource="obo:RxNorm_61381"/>
    <rdfs:label>olanzapine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7a097f29-8fd3-4e0e-b9ce-d254a6705cb6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/07cac830-267e-4717-b147-b4058d94551c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e73f301b-8df9-4df0-9c2e-7e76b685fd42"/>
    <rdfs:label>desvenlafaxine succinate-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b65170f6-fcf2-413f-a945-aac91d6f3a70"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/2655c038-8985-4015-9a4d-02a0ea82676a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f0a2d260-4707-4d0c-a0cd-1dedda6159a1">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/0cea493b-89f9-4d11-8a39-6b715a96590b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/17a2e7cc-7890-4b08-a306-dcaee87f1bb0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b3b74f16-d8da-464b-9f50-fa9803059093">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/7079a409-31ba-4938-bf2c-be8407dc31bd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/34fe2251-30ed-405a-ae5c-d77b6a3005e9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1d1dd96e-e936-476e-a603-939cea8327cb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4765f109-a480-4ce5-ab79-61c2eedca733">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8c6bacfa-1ff2-46d6-bc5a-a8d5f05e8f6c"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/5e9f12e0-16ea-44a0-a011-bcadad3e53a2">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/69f79a89-1638-46de-8214-b56da8db8f83"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/bb3a21f0-087b-400c-9695-351de13bd1ff">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/28989e0c-4a2d-4504-978e-709c291c5501"/>
    <rdfs:label>2 to 3 Fold </rdfs:label>
    <obo:OBI_0001937>2 to 3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/959e3f6f-4c22-487f-bd6b-dfbde94e185d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/0c99c781-b277-49c7-bd57-0a595868b91d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/3707aa2a-3722-4c3a-aff0-b5840ea71d87">
    <obo:OBI_0001937>15</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/c1e995d6-374a-41ec-bd30-13399fd1da4b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/26081c4a-bf77-488b-902d-18d7d28f693e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/bbe327be-d8c4-44d6-9c34-4b9d41d919c6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/34205252-ad46-4320-96e4-eba392a5e1ef">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ed0658e5-bb22-4bb9-9939-920c9e663eea">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/5a681502-af19-4ca9-9417-c0152c75006d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/4e8c7c4c-1cfc-4a11-b7f1-f0886b0125ec"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/94dc5a3d-c5c5-49af-afff-73cadfd4cb33">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c3932142-75c4-47cd-bfb8-39a68b5a1e10">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/f92ed9a1-9cdb-4c23-bdab-64fd685c358d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/a67aa64b-a543-42bd-aa78-edcc9113b197">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/20398355-f2d6-4871-bdee-611ec5ba617b">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/31db27e9-f7d8-4b52-a4a7-3f92e009da7d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/4a526ff9-d11d-4928-ac39-64180d1cf302"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/a8661068-a874-4033-b3d0-9319777dfab3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/81736fd6-2a8f-42c0-bfca-9c2aff470e2b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/4fc58038-be7b-40fa-a2cd-e8693db1211f"/>
    <rdfs:label>efavirenz-hydroxybupropion drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2c910fa6-715d-4a2e-8dc4-a10874e4094e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/088f9e41-cbca-4eda-849c-77e44e072e53">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/157451c9-7910-4079-a10a-4469549c6b18"/>
    <rdfs:label>ritonavir-threohydrobupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a09bf058-7ad4-497f-8ced-374939fa697a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/82d04f15-620a-4db8-8134-be61d7197ad2">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/dd25713b-2525-43d8-a5f9-b3de5f464c08"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/c7ee3f4e-7fe9-4bbc-8ca4-85c855c9474d"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/9798a56e-660e-42d9-94fe-1e397a0c806f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/236dec2f-e082-49be-9280-34eb0752e137">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/db7a149d-9810-409e-b78b-89fa27aeba74">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/be28cbfe-81ba-4a84-9489-ab4c25bdeedd">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/1f423686-f78f-4565-bc19-2acec051e4cd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/24844070-0153-482b-bb59-99ca420f6523"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/9d818dab-e0dd-4829-8e75-afb45ad8baff"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/13a84d96-44c6-4c96-b8db-8fe1c4a53baf">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3ea6ab57-2198-4c15-8087-016ccee0dc97"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/03745ec1-2574-4efd-b92e-696e9402f37d">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/601166d5-664d-4ae0-873b-6dd68b07d367"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/6f50da79-c176-4910-a630-dd12a17bd233">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/3d456406-61df-40d0-8e57-3eddca9becc5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/f8ac87a6-0263-4b00-b2ad-a4f5315c1f11"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/d7813bc2-71c7-4285-9a18-848d97486b50"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a9b9fb85-2629-493c-91a4-09c791a6a9e0">
    <rdf:type rdf:resource="obo:RxNorm_39993"/>
    <rdfs:label>zolpidem</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/669772e8-bc77-4dc1-bec6-a127f9fdba62">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/3052e03a-1982-46f1-8fab-459726131521">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/14f218d2-253c-4922-838c-03cf30a1b783">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/4fef27c0-dd33-433e-bccb-17fc3aa0ae52"/>
    <rdfs:label>ketoconazole-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/dcc0a60f-d60f-4e3e-aa1e-1f53f9234cd7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/50e0893d-3c9e-488f-9390-c7068dd3e481">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ffbe1fa1-9b5c-4468-a0e2-108d4da0d347"/>
    <rdfs:label>ambrisentan-warfarin drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a58a26e9-f19e-4678-b90f-2a5c95319944"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a5da7fe4-d667-481f-a083-34696692d331">
    <rdf:type rdf:resource="obo:RxNorm_1599538"/>
    <rdfs:label>Edoxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/749186bf-ac91-4f33-80cd-e5559b4634b9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/f5a4d69d-e665-43d5-bc7c-2a7ce5880ae9">
    <rdfs:label>Gemfibrozil-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/652c8693-2d85-4c38-9b9d-3a45d59efc00">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/9f535d64-3d62-4a04-a626-00faff6fe84c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/769d0615-b202-474f-bdd1-3dfb79b8801f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/720c2373-4372-40a4-87ef-a250a01b2cb9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/2a8da66f-d0b7-4d59-b637-8cd51f67c8ad">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/BFO_0000051">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/97fa0a69-241c-4bd5-8008-561b3be496f0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/5f11e92f-a308-4b9a-971e-ef19570190d6">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/a2c475ce-3af9-4f3d-bdf7-fc23417b85dc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/15a6f392-9c02-490e-a422-83e7f6d78f5d"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/5378e523-ce88-42db-a803-98783f66996a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ad3988c6-1d3f-45f7-9003-50aa6c3494e1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/0506f89f-eda0-4a20-9874-077cd7984f9f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/1fa15e43-158e-4e24-9314-d43f3577077d">
    <rdfs:label>rifampin-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/2e15e7a9-4d27-424a-bcea-47a551edd2d8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c1cfafa8-e7d1-4be5-9320-22bc09a55f5e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/26bb015a-aa73-4538-b59b-9e7119897aa3">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/03f05038-6e65-45b7-86b4-39424632df2b"/>
    <rdfs:label>ketoconazole-eszopiclone drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/71260a1b-1f31-4392-a5c4-b6f2c788671b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/29a57fc2-40df-4cfe-9945-b9491f6e7074">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f45c6cb4-1a3b-494f-a64c-fdb095fe0c92">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a6610ab2-ff1c-4237-856a-24f9ba3e0269"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/fb21140a-347d-46d8-8c37-3369086e76d9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c37c17be-9cbb-46b6-aea8-61894e961b34"/>
    <rdfs:label>buspirone-nefazodone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/f633b98e-a94d-40ea-8737-90fcde4e645f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/b0968ad0-eede-4803-a569-e01f700d1d4e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/62f2989f-affb-4305-b8ea-bdd084cc79c9"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/e4e5d194-649d-4165-bf82-38f2a4ecd27b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/d00f8ebb-448b-4781-9f82-941a51208f6b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4b3c7ccb-29e2-4bf0-b7d5-5663ee375d11">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/38c2ac27-8391-4c67-b0f3-8f8fec3b818e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1dbcdfd5-1bad-4e07-b634-6f5831dc4971">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a419b44f-a0a8-4839-942d-30dbe9f6ec11"/>
    <rdfs:label>ticagrelor-simvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a3d24f40-0045-481d-845c-6adc6564b3e8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/01a73931-2da2-4d23-8e7f-50f156dbadc3">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/4a8fbc39-4f4b-4362-80fc-957c7848265a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/8ecde3aa-0d7e-473a-92a3-be89837cd3b4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/614ad864-8cf2-4ad3-a234-80a35ba48f2e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9ae4aabb-6330-4c21-b2bd-4fa6bb2b4349">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/247e9bb6-af86-46e6-9fc3-b715acd79026"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/9c22222b-2356-476f-afd4-ea76adcae691"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/5bf2a60d-134d-4a90-9813-ed8ec19e417c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/028b8e86-89aa-4fde-953a-2628e778fac0">
    <rdf:type rdf:resource="obo:RxNorm_352393"/>
    <rdfs:label>ABILIFY</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/f655007d-2503-41dd-9ff2-873daad67cc0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1502c044-b141-40b4-b212-48366cdea6f1">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/58acfa7d-453d-4db7-bd77-75107336f7dc"/>
    <rdfs:label>16 Percent </rdfs:label>
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/73219aae-3c2f-4214-baa3-671e5632d933">
    <rdf:type rdf:resource="obo:MeSH_C062257"/>
    <rdfs:label>P95</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/a831d260-47a8-49f0-89ee-95d9f02fa6be">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/187288a6-8e5f-48b4-9690-f2a6198f0a9c">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
    <rdfs:label>warfarin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/d99d477a-d365-491e-82ca-6b490909412b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8611d363-7f29-4d70-b969-9e574ffa5f04">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/a1c9005b-2936-4dde-961f-aff09c0b8eaa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/c395defb-b003-43bb-8ecc-ebb86d9386f7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/97e3c719-e0e2-4dab-bc6c-cc97f81ceada">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/3f5e1d04-6095-4305-8c88-c6f6403f0225">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/a4c830c9-b02f-4d58-8181-292ead4a8ccc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/bce74a75-0d1e-4d0a-98dd-b8cb8dce86e4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/560e4a07-97e0-4bf2-a933-e61fb9b4ecf5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/fddf6460-155b-46dc-92b1-fbcd99f55af3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/a51eb96b-d646-425f-a450-0fdd8d90ccfb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/d0126dd0-0c76-422b-96a9-5bd86f8a440e">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/7795f68c-611a-4480-8d41-d7e1dccbb1eb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b39976df-acf9-480b-9ec9-994fc20bd73c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0ee1fdc9-79ef-4fee-aeb2-f75a1419cec2">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/4a2cebfb-4122-4a2f-9849-57f635271807"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/14e93378-6001-4708-81d4-f8e699072207"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/bbf98722-9063-480b-88e0-0ee3eb35b2d4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/7f3f3664-4ca3-4933-9adf-9443bac30197">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a2c87497-bce0-4ba6-8d01-e95d30dfe020"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/e4048013-7ab0-4508-ab0e-45bc69537f34"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e36bbaf6-ff11-4dca-bd5e-ec5025205b85">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ce0196b5-9dfe-439f-8383-5ca1cc7e1bbf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/46fe1ab0-0f57-4101-9c37-452b17f7f7a5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/1f296210-7306-4e1e-9357-33db8ed0f147">
    <rdfs:label>duloxetine-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/52e6c221-6bea-420b-9a48-9bccf16856f0">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/c8d92000-04fe-48fb-be85-8174e45cbe5b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/68f3cd06-7c4a-4d74-afba-41fadbdc729d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/cc9eb79a-d052-4be8-a5be-732613501393">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ce7e8043-57c2-4bfb-9b69-492ac4dd9952"/>
    <rdfs:label>Telaprevir-atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/18225e84-31ba-491a-8238-b6282d897ff4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/f92fccd0-d644-4ecb-852a-f7f8b99348cc">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/44e3dc5b-6707-4d7e-9319-d6454a1b6e55"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/dbb8ecea-0e11-4748-bb31-76aed02a55df"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/1e37a8e8-c79a-4cea-8e58-f9c332241dbc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d1c11970-69c1-4f89-99a8-133a405170b4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/2bc71a06-12ef-41bc-9070-108c31a61b70">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/99adee27-2398-4864-be62-61ed8976d9a4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/29a57fc2-40df-4cfe-9945-b9491f6e7074"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/f298382e-e9bd-42da-810a-fcba678d2697">
    <rdf:type rdf:resource="obo:RxNorm_2541"/>
    <rdfs:label>cimetidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/d5b9c5c2-7ae9-48c3-ae24-6674a1d538b3">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/26081c4a-bf77-488b-902d-18d7d28f693e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/d7a3bca8-0591-43e6-8d0e-c6053e62dbf9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/ec3be7ff-b6be-4c14-81d6-20804ffb2a08">
    <obo:OBI_0001937>240</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/5d7de48f-d925-4f40-aa75-e2e2f340033f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/76e6a252-0041-402d-b604-0b107b597ba6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ea6ce9c4-bca5-4084-a885-fceee8bcf939">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b45482c0-1691-4df7-a81f-a79836106108">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d548a39e-b6db-41a0-851c-ad97068b3007"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/831192bf-966a-4d0a-882b-59665fcfe10e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e885a28b-f1e0-464e-b89d-c0a9e5d4be01"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/1403de88-0cee-41ea-be34-ad61c8e9e258"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/7fcc1d32-e0c9-4344-821c-9fece7d3afd6"/>
    <rdfs:label>digoxin-aliskiren interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/2c00925a-2a69-42a7-a5f8-4e6c0b18551c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/3dc6514c-ed52-439e-94d1-bb3a3e34e2c6"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/e751fd1a-01b2-408d-aa8a-97e85e20e40c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/e0776127-154b-4189-8053-d0ce21ca8885">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/8455f414-3f0c-4330-a966-cc6e89c0e768">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
    <rdfs:label>ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9ecd930c-783a-4c6f-a8bc-1f772a3e315b">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ba7d6253-f787-435c-b1bd-b2e3353d0583"/>
    <rdfs:label>8 Fold </rdfs:label>
    <obo:OBI_0001937>8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/c8c37092-cda2-4407-a5e2-2897e15df769">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a48fe6d2-df31-4a00-98a3-e348318c9a79">
    <rdfs:label>phenobarbital-paroxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e9d79918-3710-4610-9c70-218173813c45">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7b751eb1-5875-4957-964e-e4f937675209"/>
    <rdfs:label>37 Percent </rdfs:label>
    <obo:OBI_0001937>37</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/4d20a842-f5ef-4917-b767-8af8779fb539">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/afe49f5a-56ff-49f2-b4da-63631020fbef">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/cef89f07-059d-4530-8d33-e907b54f13b6"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/969c3496-c079-4a1e-9194-a53743e594ae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/412f13e5-6c42-4291-b5aa-8a50f360c760">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/4a355e5e-467a-4d64-ab8b-d97d04f1a701"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/37a09f25-7176-400c-be2f-d9bb8a65b0aa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d3ffff0d-d7e4-49e0-9595-67b0024c8ffa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/20c6d79a-34a8-4626-a1ee-6c2ff56c009d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/283d5aa0-beac-42b9-a4e3-19f1e0882bae">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/5ffb5474-ef40-4195-9fe8-9141c3fc7887"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/2db8e39f-0cc2-4493-aaef-c05a1bee18ec"/>
    <rdfs:label>pravastatin-indinavir interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/bd1585e3-fd0b-43e3-aeb9-2b4e0b04653f">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/596ecb77-9592-4750-b6bd-78223a626cca"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/03410fc7-ac29-4602-afa8-3718000acc0f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/75c5f4dc-e280-4c96-b334-cade2112ad98"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1da57917-982e-4904-8195-25755f819f06">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ac7095c5-cf50-41b8-b706-c6fd54d98cb6"/>
    <rdfs:label>unchanged None </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/6eb0b4f8-4a5e-404f-abd8-1900224704d1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/dc20b241-8e76-4102-a953-9e0c626fe19d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ea5cba39-6076-4428-b471-d5f11719fea0"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a6021978-c335-4f98-a7ee-e58309301baf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1e6f150a-6eb8-4a49-a25a-636bcd299ca3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e299b2f8-5449-416f-bfc5-471b0d70e9ce">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/c470ef63-4291-4dbf-8914-d1a874c19314"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/53e309a0-bb6e-468a-b858-ca2524991be5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/d0d60a70-446a-48f5-af64-2eade6faf585">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/22efeafc-e3ef-43e3-8c54-532249842dcc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/c3093b03-1fd3-43f9-a4d9-7eb239eba970"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/8fb0b2c6-f7f9-48a2-a42d-4babfcac5f75"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b0b633c2-28c4-4161-8488-158845402156">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/5b3c71dc-1da4-4fac-9f87-32b9922a6e24">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/6423c44c-97f1-4ffc-92af-7ac15db49aa2">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/bf10ab87-698d-4d63-a6a0-93c3b1d0419d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/1601a711-9a94-4517-b0a2-95e197dab9f2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/68cfd9bf-6004-43a5-96b4-27e11e403c25"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/97235b20-f8b5-4d4a-9119-26b7a863e90e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/82b7f231-e5e8-4c1a-af0e-a5e615fd795e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/1e7df61a-067f-4638-84b1-c80d6dde597c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/b49d942b-5d41-4d3d-877b-46e6baadc628">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/4d936401-d7b9-4c05-81bb-59a5a446e603"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/85624cc7-01c6-4220-a38b-3d37c7aa9e8d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/291708e7-5b01-417f-ab20-658193c2a674"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/2f6f5cf5-3684-4b32-805a-2ecae519fbf4">
    <rdfs:label>paroxetine-atomoxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/6a174099-2695-4223-b63d-71a178280656">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3cdf6ead-54c9-41ca-b0f3-3ecbd07ba63e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/51a96e11-3df6-4a26-884f-c7d3962773b8"/>
    <rdfs:label>25.6 Percent </rdfs:label>
    <obo:OBI_0001937>25.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7fb1e4d6-3e1f-49bf-95dd-0908b226f988">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/7fc8df3f-1c9e-42b3-b6a1-9afe481a667e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/82e19c16-7f17-427f-ad86-54c3039df07b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/ad9ee930-7a71-4945-bbc6-d8d92fbbc5aa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d5cfdb10-9f99-4c6d-ab2b-525b9708f531">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d548a39e-b6db-41a0-851c-ad97068b3007">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ce1b8f94-4c45-4546-a0f4-d92c55a12f64"/>
    <rdfs:label>digoxin-aliskiren drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/cb8f4540-246b-44ee-8118-189b5d9122c3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/c53f7921-2f2c-4678-98d2-ca63fd7f0510">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0482b93a-90d7-4993-a368-caa24b926b79">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c4004c5d-f661-439b-b32e-b175b479b68b">
    <rdfs:label>paroxetine-pimozide DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/5edf4d1c-ec99-4cab-80b2-e827fa13aec6">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/76135f7b-1a8f-4f4c-872f-98aca086f520"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/b35400b1-17c0-48f7-b836-e314b5be81d3"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/942f7563-5b06-4727-876c-3e0c1a6dd6f3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/eb466507-f808-4590-9546-f8066ae0f2c4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f0175941-cf26-432b-a3b3-db730ba9612e">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/e3b9fa27-4f51-49be-a9e5-4866b6a58f3c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/fb079a28-cfb6-473d-96f4-07734aecc0e6">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/d93cd0bf-0830-4f33-85cd-9bfd696e7c3f">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/a831d260-47a8-49f0-89ee-95d9f02fa6be"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/d3265dc2-0ab1-4390-bb5e-184204d96ec5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/6a0d8231-e8b4-4dcc-ace3-f3d9c90d98f8">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f012d1b3-563a-49ff-ad8c-fa8b3b9d5631">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/c7624923-3f69-4919-b1dc-cda12ca030de"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/00478e7f-f9d0-43d6-aaa2-04b79f29ab58"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/4594a7d0-b4ca-4609-885b-f9fae695d6a1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7b01dc07-f316-4841-a9c4-eb9100e83021">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/614ad864-8cf2-4ad3-a234-80a35ba48f2e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4a2bb54e-7133-4422-8f6c-338d4f95f84a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e9d9b2a5-76b4-40cf-aa26-e5df8b943446"/>
    <rdfs:label>66 Percent </rdfs:label>
    <obo:OBI_0001937>66</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/769b416b-b84e-4f3b-8cff-e1a8ee6cbdf5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6cc82282-a5e1-457b-ac56-07c1aef7fbe4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0b17211c-e260-441a-9f2a-2affc0e15d45"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ca6afacb-f01a-410e-8d4f-7b90ff7a81dd"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/cfc7661d-5d38-4878-89e8-ea38d3187d8f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/bafb043a-ea04-439a-b97e-9b9ca120117e"/>
    <rdfs:label>Fenofibrate-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/f9c0a7a0-c2e1-4056-9718-2ffb06f3ae28">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/621ee2af-da99-4e27-a755-5cec9b80cf2c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c805871c-4cd7-4df9-9bd3-5fcb6932bff6"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9af2b640-1aaa-44c8-b897-495e62eca11d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/50d653c0-a02b-4d1a-96c0-22f4ac616d53"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d4428491-d559-4028-8d94-f9e69300da6f"/>
    <rdfs:label>divalproex sodium-INVEGA interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/45abed99-ab6e-4bf2-b3c8-cc5d6786b1b9">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/97fa0a69-241c-4bd5-8008-561b3be496f0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/6893912b-9e5b-40d9-93b5-4cef52b752cb">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/aabc68bb-107c-42f9-9023-d993faa9d4ab"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/5d51f5c2-6d61-4b5e-8d54-cb83d6c8b8db"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/240db595-d30a-4c47-af1e-cecc28966b27">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1e9d1227-10d1-47a6-947c-790e1958c0eb">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/fd81d61e-08aa-4003-89cf-9df7696e1d37"/>
    <rdfs:label>135 Percent </rdfs:label>
    <obo:OBI_0001937>135</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/44c0c43c-3b64-4bf9-8b69-bcba63fb25a6">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/bd331bf6-6ce6-43cc-8762-cb9365e4469d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/ff6da2fa-d697-4bc8-9a40-daa97dea5206"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/44ee6903-f719-4ab6-8711-1683454caf75"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c62d3bd3-b50e-4081-8062-2b8eff28d12f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0c517699-9e43-44e5-bdbd-c134df1eb782">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2946d417-3361-4607-8393-4ed37b85bf25"/>
    <rdfs:label>ritonavir-rivaroxaban drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8a1c8e23-c0da-4508-876b-9d2a2230cf61"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ac45c3e0-23f4-40db-9a62-30f3391c5a78">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/eaf1dee3-aade-4f5b-ab65-d7dd2d183a10">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/a9fe980a-b2f2-488e-8f3e-da970ab11cb2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f5dd14a6-2e65-46ff-85ec-1db2b7ae570d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ba3d5c9f-af37-4a79-bb25-71602a3206df">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/6d4d117e-facb-4ea6-8c8e-a6d96c461ebf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/e30012b9-af84-4929-9591-c4c73e553496"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/6004458c-aa89-4660-87b5-22929ec999dc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/8ced17d8-12c3-43f6-b8a4-b7cbd1375489">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f073430d-8e14-4b47-99a3-67ab8f280f1a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/942e9906-e738-4818-834a-4b4d1696a6b4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/ca03dea3-9efb-44dd-857b-00919c9f1ac8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f80fe858-0194-4aa3-8126-f9f3cb6ac4bf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4ecf5a61-4f23-4726-977f-d5be052694ae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1b10023e-e860-4994-a0b5-861763fd36cb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5e98c8eb-0bde-4dda-9d3d-ffa8a74f69eb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ab1e0e0b-4b0b-4861-9d1c-fe8228d6c219">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/523af6cf-e593-49e7-bff7-8fd8bcc2a5a0"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/62e1def7-1c0e-44e3-8f4e-3d188f1dce78">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/1a1b1285-aca4-4df9-b4ff-1eef68af535a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/2dcfe20d-140f-48f8-8e58-02f1e94070f0"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/11a2e600-208b-4555-aa04-a1b985b799af"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/416abd03-dcc0-41fb-a8f6-a59d206f0c0b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/9b7bc722-eb44-4697-ba74-a206b6b03e82">
    <obo:OBI_0001937>12</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/1bbce2ac-5a86-43d3-ba41-ab86aacd6870"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/fc0338c1-3e24-4081-8c43-bc2664ca7136">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/348e3e17-2874-4164-a7e1-83b81d214e00">
    <obo:OBI_0001937>150</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/f089e2d5-e0b5-4235-b909-5dfba27acf8b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/7fdabef8-8d0e-431e-8d99-f5cb6cd7aba4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/734a7d84-40bd-49ba-8867-5280b8ba2937">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f3f80a24-45ae-4dd3-83b5-2058760ca516"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/4ef3198f-d150-4c6b-acce-21486b54f047">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cb8f4540-246b-44ee-8118-189b5d9122c3">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6234162a-7034-4da8-9aef-a72f01d770be"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8e791b05-40b6-45fc-849c-e4fb77e62f81">
    <rdf:type rdf:resource="obo:RxNorm_57258"/>
    <rdfs:label>tizanidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/2946d417-3361-4607-8393-4ed37b85bf25">
    <rdfs:label>ritonavir-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/11a8af64-12ec-4f10-b2ff-7b39baf2b6f3">
    <rdfs:label>citalopram-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/dcbdf0ad-b343-497c-b4e8-cd14cbbd23d5">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/4d4c06d2-0bb8-4403-b974-041ec51b6c70"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/41a60fe9-53b3-4268-883d-6fe4fdf56bdd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/740c1036-b142-4ba4-ab49-b60856e69d6b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b5c6e0b9-4e9a-4026-9656-273d9062830c">
    <rdf:type rdf:resource="obo:RxNorm_10502"/>
    <rdfs:label>thioridazine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/7ac49247-faef-4a96-91c5-be9c2e7cf03c">
    <rdfs:label>warfarin-ambrisentan DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/eb935c06-69e2-4360-9912-844e8b5316bc">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/489b9253-95a3-4f63-9f25-f29a274a8b64"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/94cc04e8-0a2b-42f6-b388-28488b3a2cfe"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/1cb1a6e6-6387-472e-84e6-662aff5c2d7d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/3214796b-5965-414a-8639-807f6d9fe554">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/138533fd-0f4d-4220-a862-ed55d3c408be"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/229f9208-09e9-4948-80fc-ce42688f236e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/45f0b14b-9be1-4d68-b39e-fb58e662d86d">
    <rdf:type rdf:resource="obo:RxNorm_2541"/>
    <rdfs:label>cimetidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e22cefd9-a27b-4047-9233-706cbddd3151">
    <obo:OBI_0001937>75</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/66fba19f-8d2f-4fee-9697-863971806425"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/b5b0a7db-c0e4-4c9f-ab1f-7d0ba14757d6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/da74b9eb-c55f-4a26-90df-ec7761f9dc64"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/523d3c6f-0ae3-4003-bdc8-af7d4c0284e1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c190ce00-1dfc-417f-a463-8bd38d17d59f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/d0aff991-5f73-4b86-8cab-e74474e86403">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/800c5267-235b-4cd1-8ace-f65616508088">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/287a3efe-b41c-4204-9aa9-24c50780d8bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/97f5483c-0d88-417b-8b2e-6472eb31d116">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7fad6f04-f38e-4829-86b7-f3e69fe44402">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b25921bf-9d8e-409a-968b-16edf205ba1c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a7a22757-34c6-4432-9d9d-97753947ea46"/>
    <rdfs:label>10 Percent </rdfs:label>
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/7980fbfe-d35a-4381-b984-ddbf50a5ada4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/17292cf0-a399-406a-95ac-cf4dba5c6129">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/c6eb4ec5-822a-49e9-a7c1-692163b69a56">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/a75572ba-0e9f-47ac-a6b4-23f7fdf9d58f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/57904168-8a6c-4e49-80e8-d2aaddf994e5"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/429ce385-4a79-44f3-82da-39ea53660e28"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/380ebd36-bec2-46ce-b21b-ae9f09591910">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4eb6c170-f4c6-400c-9b76-9383dcf0ad1f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/d2d7ad2d-9527-4c81-889f-0eac701ec487"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/a2b8754d-7159-4d36-9c9c-9316c18165fb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ee3d028d-1b09-4d05-b0eb-31145c1fae48">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/cd466580-f261-42ba-8411-120fa2104aa2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/24844070-0153-482b-bb59-99ca420f6523">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8ea8a1fa-4735-479c-9103-718b0cb71300">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/18a97af2-17c2-4c1f-b8ea-efbb2c6b5db9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/aabc68bb-107c-42f9-9023-d993faa9d4ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/bc88e866-1ea3-4c8c-8636-3fc8d6bb485f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/5c9c6f2b-3179-44e3-b442-88826c8e543b">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/f70610bd-e26e-4484-9b74-ba497a528d6d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/8e3fb958-8825-4369-901e-ba70a8ed02a7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/5cdd068a-60ae-4ff3-a70c-2e6ee47349b7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e82f233d-0e01-4e7f-8a35-7979451bb314">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1073bd15-0e0f-47fd-a8b0-93ec1d485ae0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/d7b03a60-78cc-44d0-a016-ef8fb3ddbce0">
    <obo:OBI_0001937>75</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/1d5a81f5-b03c-4d63-9879-c3b301337b6e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/e83c3c5d-f2dc-4880-a8b3-ed532546c464">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8135c04e-19a1-46e1-bdf3-ed9c0e8af0e6">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/e96b0241-3d39-4ed0-8387-a5a99cef6977"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/2d1a2cfd-0676-4092-8d8a-26f448935fa5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/563e8b76-5987-4d2f-8755-223132083908"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/171e632e-54f9-4396-85a0-a226c2c88b2d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c9abe027-0ddc-47c0-bb61-cd82a6640a50">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/b7cbf4d0-84bf-4bd7-8281-8e77bfda5663"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/34205252-ad46-4320-96e4-eba392a5e1ef"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0720a629-9eda-4f2f-a876-31c36d5fa445">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/c31b60cc-7ee0-44c0-af35-f0febb8e635f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/987135e4-5c9e-4602-88c5-c4b76f25ab2b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/0d173e91-731c-482d-a3a0-406e582c7ddf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/55bf5162-a79a-4b71-a5ae-41be1eb95045">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/465885a5-54d4-4697-b0b1-6770f72a8bb0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/a45d121e-f6de-4d2b-8d9a-e2054f140275"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/97133475-1f25-426a-a720-65369ff007b6">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/56fc96c5-2974-410f-b175-e63db1244678"/>
    <rdfs:label>129.9 UNK </rdfs:label>
    <obo:OBI_0001937>129.9</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/78e3c1c0-d40d-40b3-ad3c-e96839150db9">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7fe30ec2-b681-400b-8b7f-54c8054e380a"/>
    <rdfs:label>.3ng//mL UNK </rdfs:label>
    <obo:OBI_0001937>.3ng//mL</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/436220e8-bdcb-4b8d-99c4-21d5f0c2d634">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/9031542c-d547-4662-a57f-20c701315ca5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6aba6023-dd6d-4286-9e7e-aed7a6eefacd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/7934f97d-bacc-42ad-8fc8-16250264cbd7">
    <rdfs:label>cimetidine-mirtazapine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e417e4b0-604a-4af4-beff-1dc26f513e4d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0e89f977-0645-4aee-b36b-ef717900a24b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/9981a28a-7dbf-473e-9d04-b7cb91dfbf2c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/5f1da6e8-e8af-4f72-a501-ac4d3c4db688"/>
    <rdfs:label>S-warfarin-nefazodone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/a8bef47c-085a-46f1-af8f-fc3a1bccedfe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/2c31df8b-4021-4e0f-8536-aca70f00c637">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4fa7777e-680d-4fb5-9d0c-f9c614bebfd6">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/478a90ae-026d-4eb7-8806-a2934d924785"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/5954c76d-4b13-41ca-b4fa-26d3f9de4df9">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f752c9af-b088-4c32-9990-d766d006cb12"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/75aad9e1-b6d8-439f-b592-971b5f42011a">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/4fdba76b-5c2f-482b-876a-5f7db5eb9d46"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/2b502cde-5e72-45be-b34f-5db5f7ff2996"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/4a23255c-02aa-42fa-a27e-d44ba5f64837"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/de182341-99b7-4d63-9697-ead9ca1cecbd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/fbdbbbf1-2328-4dfc-a9b7-1d4d59217276">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/dc23fe6b-dcb8-43d4-a073-083d2be0da74">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/729837c8-e4e8-4bcd-abfe-e37d5eec7ea9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/05ea9a72-143e-4403-9793-f8a47ac8baee">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/9c40502a-695e-407b-9c25-83499aecdb76"/>
    <rdfs:label>38 Percent </rdfs:label>
    <obo:OBI_0001937>38</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/99adee27-2398-4864-be62-61ed8976d9a4">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/5dbf73de-1633-44e1-a046-0445cbf290f5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/3d4ae97d-8224-4708-aedc-f4304b2d753f"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/18e6cd1e-4afa-4fd1-8442-2d1c88d2c9e2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c503fc65-8997-48bf-a0bc-d75e1e077b40">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/fece39f3-33c3-49b8-b794-4ddb0d6f04b1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/14e5a482-3ca5-4e80-984b-d9780cb90b05"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/1a875e3f-56b2-4a93-b124-da75b764f05e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/a1456300-0cb0-41a5-880f-97891e7bd7f4"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/ea2ebd5c-e6c6-4cd1-9a2c-6bfd15f68fc8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/61e94ddd-2874-415d-9a12-3f43fc1bc0af">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/dcbdf0ad-b343-497c-b4e8-cd14cbbd23d5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/a466d2ea-226f-4ec0-acd6-35fa40613f41"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d77d8f59-a987-4514-9a6e-c76e6e7f8023">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/fdf3b26d-44a4-47e1-93cf-fa71fcfddc98"/>
    <rdfs:label>UNKUNUNK UNK </rdfs:label>
    <obo:OBI_0001937>UNKUNUNK</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/4e038637-c4fe-4895-b4e2-ffcb74311571">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/456a9c75-6974-402f-9fe1-c23410323310">
    <rdfs:label>nefazodone-digoxin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/80d4ec3c-f5d6-43e9-83c5-410341cd1e92">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/7815ceda-2cb7-4a98-ab4d-baca871ef7af"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/016b40a3-087f-46c2-8b35-0d8aa7935631">
    <rdf:type rdf:resource="obo:RxNorm_42463"/>
    <rdfs:label>pravastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e8b2e01e-02cd-4624-b081-2ae34af159b0">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/cef88894-ad1f-49e6-a824-31ac3970a001"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/d670942d-5f49-4576-891d-b74a314d2c7c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/5a040c4a-6ff0-4de7-9474-4fdeef3752f5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1498ca78-d636-4ae3-bc64-909c4257b3d6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/30eded19-6ef8-4b54-b241-322c09b88752">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/a8bef47c-085a-46f1-af8f-fc3a1bccedfe"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/f903f9da-4ed6-40ff-b414-90462b710d7c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/99563b57-3bf2-43c9-afe1-37e0f6442d29">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/a60fc53c-5413-4d31-83dc-3a4290b24e76">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/d9a4c238-d0bb-40be-9bf9-4cb192039434">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/f656f63f-130e-489e-aa23-4c81e7fadbed"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/a6cdba51-9afa-40e9-bb24-b57aa653dc72"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/dfab37d8-cea9-4141-b219-da9fea336461">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/07be419f-c11c-4b91-8691-fa28cd900fbe"/>
    <rdfs:label>ketoconazole-rosuvastatin drug package cmax None information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2b10d0f8-0ac5-4538-bad2-9bc8ab8fd518"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0e6be0df-486b-4ef6-9769-f4a7634a858d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/711a8af5-9d9f-4fb7-92d4-af5ddc3a1376"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/b0214834-654d-4961-90e4-1094e3a548f7">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/0238783f-c223-4f4d-a01a-bdc23536dcb3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/1643b00a-b4c3-4673-a7a5-7777fdc1eb45">
    <rdf:type rdf:resource="obo:RxNorm_39993"/>
    <rdfs:label>zolpidem</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/bafb043a-ea04-439a-b97e-9b9ca120117e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ea523ab7-3591-45f8-8bf1-8fdbbc292eac"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/823d09e0-3fff-40fd-a648-a48ba41d1715"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/32b5e7cb-dcae-477d-8f75-a5d85d100b69">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c18f89cc-3bea-4d4d-819a-b51f8d5cc5da">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f9cfac66-1b42-4a49-a405-3993cda5e4f8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f53b49dd-67f4-4db8-b9f8-19a53d706aa5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/10561106-099a-4430-ac2f-72e5c021aa70">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/261535ef-f9e3-4404-8075-7d539fcf03a2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/f656f63f-130e-489e-aa23-4c81e7fadbed">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ce1b8f94-4c45-4546-a0f4-d92c55a12f64">
    <rdfs:label>digoxin-aliskiren DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b261b172-211d-4d96-b9a8-1335579fb3ea">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/6de7fe43-130c-4b1e-8bb3-65d9f33320d5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/7582a3e8-509a-4771-84bf-803dd9e21417"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/dc59e485-13bf-49e1-b469-d38ab0148154">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/698cad6f-af37-4915-b649-753c53e79a6d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/2b760f7f-f629-4517-af40-5ad4c6e0a509"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/5fdaa023-b093-4e8b-b3d3-e7d3135124bd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/60a7d301-aa30-4a55-9da5-e2340461670c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a05a1c82-9bc4-479b-8e12-abc695bf86bb"/>
    <rdfs:label>paroxetine-procyclidine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3beaf59a-c05a-40ab-b3dd-53297f40bc5a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7f357b5b-5903-4d43-93ff-04725ecc843e">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/1643b00a-b4c3-4673-a7a5-7777fdc1eb45"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/3a181f1b-e4e3-41ba-9fdb-3eb92f0d4ce8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/5aaf2344-b5b2-497d-a912-310ab520e9a2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/0abb8916-8ccc-407c-8951-1e7920a89036">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4dae4de4-72cb-43fd-9824-6e9b94e35da1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/16ae7387-79bc-4598-add3-cf2ccbecbb47"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/502d7301-e964-4804-8d11-6bb7665ffb84"/>
    <rdfs:label>paroxetine-P95 interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/69b979c8-caee-4215-a19c-947ce5737406">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/fddf6460-155b-46dc-92b1-fbcd99f55af3"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/8ed98b81-7862-4370-b88b-92cd493c609f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/96fe7ac4-c49a-49e6-b431-0e63b0b1576a">
    <rdf:type rdf:resource="obo:RxNorm_8787"/>
    <rdfs:label>propranolol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/9e27152e-0f0a-4820-a177-1a147a86b349">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8b3e8c69-e45d-4416-a221-46fd551bdb78"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/1b6a76e3-d555-45d2-9079-b4ec694ce05b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/59d6df7b-1ac4-4239-99eb-818adddbca34"/>
    <rdfs:label>risperidone-valproate interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/af507937-7220-4add-a1c7-b65a5774961e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/4add5820-3e01-4c2c-9eb9-80cf7d114397">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8337ff93-4162-46ac-ac9f-aa538b92379c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d8523f83-e62a-48a9-a6e9-74b3aefe3504"/>
    <rdfs:label>16 Percent </rdfs:label>
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a170b564-599b-4431-a29d-6b15a17c9112">
    <rdf:type rdf:resource="obo:RxNorm_35296"/>
    <rdfs:label>ramipril</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/7176ecc9-4838-4ecd-a368-7de961cdf23e">
    <rdf:type rdf:resource="obo:RxNorm_1102261"/>
    <rdfs:label>telaprevir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7d49c88f-347b-4e08-97a2-0663cb0dffdb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ea64d108-f5a9-4a17-bbc6-60d3550d2676">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/13a9f0bd-7bd5-40be-b18a-03e19ffe48c5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/afda653f-c257-480a-9fd5-6ae7751db10d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/379b79f3-f9fe-41c3-b290-666fdd8f6a7c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/202c344c-551e-4a03-9faf-0248638ef900">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b7101a9f-feee-4478-928a-2b21b74dc0ec"/>
    <rdfs:label>carbamazepine-mirtazapine drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c833a95b-473e-406c-800a-a75c24459616"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/df173eee-fc4c-4f35-bdd2-e0207a2af365">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ba378b03-8f42-4d0e-85c5-fa430576fcce"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/76f6ac30-485f-43b0-b0e6-f6e83945998c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d28786fb-badd-4788-a2af-2a2e3321fd05">
    <rdf:type rdf:resource="obo:RxNorm_1827"/>
    <rdfs:label>buspirone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8c499a00-645b-43b1-93dd-8e3332c2590b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/dba37ebe-758d-496c-a568-737ee72b0c20">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/25c269bc-faae-46ef-862c-ab7b5d72fdcf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/9583a8e8-9aca-4fbc-b928-49a169589e1a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/97fcfd49-73c1-4d48-ab57-b52ca94a389a">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
    <rdfs:label>carbamazepine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/ad25f63b-24d2-436b-9f42-aa2e3922ef51">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/d11a22ad-eb74-4928-b29d-fa1f30909f04"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/fb6a5d6d-3ebf-451f-b413-6499e547e533"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a89da089-2b04-44ac-9970-d4e9727d470c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d6631abe-20b0-4f7d-9238-ba422ac95a27"/>
    <rdfs:label>27 Percent </rdfs:label>
    <obo:OBI_0001937>27</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/1b391bd8-fec6-4e63-aa9e-dad1671262e0">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/0397998b-d23f-41cc-a821-c49e8c919918"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/cc3899a1-9896-4c5e-b968-b19512e49681"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/aed82200-6772-44db-9cf1-e300cd988730">
    <rdfs:label>vildagliptin-simvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/a1b1cf0a-e1d4-4148-ad77-84538490b978">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2790e62b-79b2-4738-9536-3b8114486357">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0ddb00e7-257e-49bc-b550-de1b9c608d55"/>
    <rdfs:label>4.3 Percent </rdfs:label>
    <obo:OBI_0001937>4.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ee95f8f6-dff8-4ea1-94ac-6be93c2b3dbc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/160a5f21-ca86-4f11-a433-31b7be20e3b0">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/36c07b4d-7044-4e4d-b6bf-4bfbbe10f7f7"/>
    <rdfs:label>49 Percent </rdfs:label>
    <obo:OBI_0001937>49</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/d10d29ba-a9d4-40cc-be85-ba4b438e792e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/725b387f-c201-4f43-af36-90d0c1f8bd28"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/380ebd36-bec2-46ce-b21b-ae9f09591910"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/57889954-a992-4cf7-94a9-575def6204dc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2d5298c1-4659-4caa-9d45-4cfb3a26c58a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3a04f444-0bb6-480f-a04d-2061a207cf3c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/7f91c9c2-6997-4029-a1b4-ba2cbf0ab11b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/30c2f576-d1fd-4613-9776-eb480d363c02"/>
    <rdfs:label>clopidogrel-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5f7738fc-b6c3-4f0f-b976-082bb0f2f4da">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6aba6023-dd6d-4286-9e7e-aed7a6eefacd"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/351c181a-14c6-438b-9361-5188fc32ef92">
    <rdf:type rdf:resource="obo:RxNorm_734064"/>
    <rdfs:label>desvenlafaxine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8b81e136-536f-4832-9a89-6458a072bdfd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/2d41e52c-acf4-4db8-a145-e4b1e3ffffc6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/6ff47e91-3d73-48e5-a957-48ad853d5b21"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/167be1ed-915d-4a18-a124-f9444bf27c35"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/444810b6-7359-4db2-b42b-f9f3656c564d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/887e469d-d33a-4c3b-b9e6-bc64be9c6f49">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/4c2af9da-eead-4450-8387-bfb0481c53a9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e5208d2a-030b-490f-a6fd-822e659f69d0"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/eb68f5ab-bae0-4131-8ce3-415e9d219751"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/6460d3f8-2cb2-4d22-a5a4-33989b479815">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/b8a9d274-e704-4883-b5c7-dd37b950f49b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/945722c5-b907-45c4-bf50-5f02173dfef3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/0c4a0ecc-c030-4402-baf1-de9b9076a534">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/af1879e3-feb2-4957-8ed3-c9c31ce495b7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1bfe6027-bf64-4de3-ab08-5317e68bfc2e"/>
    <rdfs:label>25 Percent </rdfs:label>
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/1066fca1-f6f1-4aa6-9ec6-f7f808a0aafa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/1257f8ec-6094-4ce4-a556-4b78d397d523">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/05e1650e-2347-4366-92bd-19ea6568c719"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/677bf773-3395-4738-be7a-dd1efbdc44bb"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/ef5f65b7-c104-48aa-a4bc-32ee7390dc1a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/9734717b-f57e-4471-9b13-0f3a5635cc38">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/67f8c655-1acc-4b54-91e3-0ad4e9676ee8">
    <rdf:type rdf:resource="obo:RxNorm_734064"/>
    <rdfs:label>desvenlafaxine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/85d45ff5-8e0e-4516-bfa9-58af5290c1a2">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/71203c32-5d1e-4c03-ab8a-fc0c8d88f9d6"/>
    <rdfs:label>95.8 UNK </rdfs:label>
    <obo:OBI_0001937>95.8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c2f25251-0fb6-41fb-873c-cdaecdee1331">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/1ed585f9-7832-483f-8370-49afe316d2a0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/ee95f8f6-dff8-4ea1-94ac-6be93c2b3dbc"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/d5086adc-e490-4c7a-99f0-6822b48e97ff">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/4423bb7f-42d0-4e84-9808-917c46406fdc"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/50eb5ab5-65e5-431c-9a57-dadf4586af67"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/9d617539-f303-4bf5-8f56-e41b2e8c63f2">
    <rdf:type rdf:resource="obo:RxNorm_8331"/>
    <rdfs:label>pimozide</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d8aa6048-7aff-4e8e-a864-88e146073d46">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/b1426033-aa2a-464d-80c9-29d6c66b09ec">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/54c0dcca-7353-4c4e-9fb5-17a92c95a33a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/7c345cb5-2f74-4ee6-93f5-111842d54b75"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/6071d432-1cb6-465d-bb42-a247bd9a70ad"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/e5c505d5-305d-4328-9eb6-df8565b097f4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/42e481a9-f4c7-43ba-a781-cbad152ad4d9">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/9664de89-212c-4405-998f-10d0eade78f1"/>
    <rdfs:label>27 Percent </rdfs:label>
    <obo:OBI_0001937>27</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/2c0306b6-64eb-4e8c-9aa2-12380a7f4f7e">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/93f0ce9b-3811-440b-81fd-f3bc03ae48e7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/1cb799b8-fa37-449b-9440-9d09226084f0">
    <rdfs:label>sertraline-diazepam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/f549e76e-e1fc-4801-b757-63e9433763b7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/aaf9d309-e75c-4460-a047-579da1e3ad96">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/7864fa86-6006-4334-b7f7-85e25b8bd154"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/2a3b2276-dde2-4d06-9c0b-1f1d5d09af04"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/33eb0d7e-f050-4591-8e93-74c5156c1446">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c9b951f7-d40b-4829-9991-2ffc9c3c4b59"/>
    <rdfs:label>ticagrelor-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/160a5f21-ca86-4f11-a433-31b7be20e3b0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3a7130b7-37b3-47e5-910a-105030e516d2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f96e1438-da1d-4165-a920-eb6a0dc51297">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/fc0815cc-2f35-455f-ad35-815634c333d8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/a4696cbd-952b-45ea-a911-25676870edd3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1ee56278-0d65-4be9-b618-7c95fa961caf"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ad43b5ef-4aa5-4b91-9fac-b30bd378b96f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/49d8aabb-2e59-469d-989b-f6c74350c103"/>
    <rdfs:label>simvastatin-digoxin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c6d92631-aa83-442b-b95b-b85f8b96b8c1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e8c6e606-bf45-4326-b27d-e29bf2d70218">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/6641719e-d6f4-4ec6-992f-ddcfc5e78e65">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/01a2ea06-6247-4d15-a2b9-45e0025decf6"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/d93cd0bf-0830-4f33-85cd-9bfd696e7c3f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/27ea3a56-b9aa-4921-ac7a-8824619dcd0c">
    <rdf:type rdf:resource="obo:RxNorm_2556"/>
    <rdfs:label>citalopram</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/55386838-444f-494e-a5c6-c98d2ea4baba">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/969f31a6-5be6-4479-905d-8f474849bc8f"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/22208621-d4a6-48d5-bc7b-7871a933f942">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/2a61862a-cdaf-44b7-970b-24dc8eb0a24e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/79e26490-c33e-4a5c-9e80-b6d981700bc1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/4eb77572-e8dd-4204-940d-3a3e70215659">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f1372d3e-f259-4e96-892c-f113729db207">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/1c1ccca0-a9fb-441b-bd12-5cdb5ae9cef1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/741b82ac-5e57-415a-ab33-8e557a276e4b"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/3ba4c468-ecb0-450b-9a3a-b1034e0949a1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/21ea4760-6b13-49fc-b607-7ec3b8e9c284">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d1a19c5c-6c27-4a2d-b355-82674f5ab9aa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/667d722d-937c-4070-9e48-7d3101a89900">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/c8b249e6-bb7b-4900-83cc-c182ec0923c9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e3a4ac5f-4448-4f54-aa0c-2305b2ede42c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/8e22d74b-68ad-4a36-a789-95ec77c89b2a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ce4bc3cf-e892-46cf-a81b-3ab8eda6e282"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/32cd7630-d611-4f4d-9210-ca13bae4b9d2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/90f83d2f-1d07-41db-a547-614eb99e3c83">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/46eb4abe-ebf0-475c-91cb-20719ac6a39c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f6caea8e-cbbc-4eb3-993b-2024d2370bf4">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/24eab3d0-2655-43be-9477-e7e88f660483"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/2703b8f9-ca86-4b0c-a0ba-1f5ee8d0f379">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8cb6371a-ada8-4884-a30c-c3f857a42354"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/51752c9b-6006-49d9-b2f9-49bcadb59a70"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/237a642d-4187-48c4-a439-b2af721204ea"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ca5539fa-3151-4286-a028-b8cc52fae7cc"/>
    <rdfs:label>fluvoxamine-ramelteon interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/94cc0d5e-c90d-4d73-a80e-95fe8df36531">
    <rdfs:label>duloxetine-warfarin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/62141ead-c1b6-492e-8760-6694f886c6c8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/c52939dd-0c9a-4bfe-b6c2-e13d5e68d2c6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/1761f2a4-ab83-4f50-9195-34ee042aae94"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/152a5928-492a-47b0-b2e1-134736dcb0eb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/882ce557-9540-4fbb-beb9-c859178869d9">
    <rdf:type rdf:resource="obo:MeSH_C496216"/>
    <rdfs:label>erythrohydrobupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/96e4857f-e20b-47b3-ac7e-2041de77577a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9a14d3f8-4ecd-4046-b4a6-71cc510ffef1">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/c8e2cede-bed4-48c4-a305-084f86eb785d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e5dfc94d-d276-462e-8e8d-fdd97821ea79"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/337d48da-1ced-4ee9-849d-7e92f44bb352"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e0d7945a-c7f4-4fe6-a9e5-75655659077f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e49dad5e-4a99-4a2c-8fc0-910002ab7fef">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a0a73788-5b82-4aa0-b9a4-bf6573f0ddcb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/a0e2a68e-6bb0-41e7-b85a-8027506fd73b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/31261fce-ff9e-427b-a3f2-686437ebf540">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/19f12591-7008-46a9-b995-fd57a9ea3577">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/fa910407-39e1-4a36-9139-6d6b0c74e271"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/b503a211-8d11-4018-b4d5-5bc4e5440f6e"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/618eb922-9dfb-4fc0-9f3f-0091be8de4f2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/7e90b2f3-c082-43db-9b77-b58ebf2ae3c5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/000ac45a-6690-4270-ad02-8a5e2c59ece6"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/0620f725-7ff7-4010-bf2e-feda1fb7955b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c9bde030-a434-4e6f-b9ba-f37962953274">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/94f7a34d-d9fc-413c-8ad6-d95594f8055b">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/144bde18-1ea0-4092-84af-768ffd3e3467"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/07b3c94e-1fe3-4146-a2ff-7e6afac46977"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/48dcbbec-2408-4c8e-bef5-3a9f22babd59"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ba1c81d6-9a37-487b-8ccb-48acd5830425">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/70ab7d17-64d0-4e89-a133-135eb224f2e2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/273ad6ec-834b-474d-bbb3-68f5d73dd2f1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/a2099d1c-502f-4d99-88ab-f70796d83a4a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3e8d1623-a943-497c-9a3c-c88284d11538"/>
    <rdfs:label>atorvastatin-verapamil interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/5db2e3b8-971d-4826-aa44-511dd166c402">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ae790707-34de-451c-9705-1edf5b6d0b1a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/48332a3a-2ce8-4046-b22a-0988c5da3a55"/>
    <rdfs:label>48 Percent </rdfs:label>
    <obo:OBI_0001937>48</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d847a651-9a40-4a41-997a-1b90fd2eda2e">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/9b76d15f-e3d5-4f58-a2b6-0822b0c08bf6">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/59efa2b0-d2be-48f5-a774-4ef6b3bf22d4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/9a140730-a8ae-4538-bc63-e7d0e28e3b47">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/24b83ea8-2d09-4051-8084-38a28a8dd9f0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/985fc56c-0beb-4cce-a14b-688e1b4114c1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/95113a80-8d14-4b92-9686-e56c94b2c15c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/1836cbe0-bba9-48c4-ae71-7466fc17273a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3cc337ef-df6e-4557-a63f-061dc54a0f99">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b1bb9f21-6e6b-49aa-b058-6e4739b1be94"/>
    <rdfs:label>fenofibrate-atorvastatin drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/bce5b6e7-4d42-47e0-a1b5-a3539a43748d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/36c26a00-76b5-4208-b502-75c7107449d3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d1d1a672-0721-4d60-9452-d6807957e459">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/92ab5f74-4486-4198-9051-8b83b2a66e9e"/>
    <rdfs:label>57 Percent </rdfs:label>
    <obo:OBI_0001937>57</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c43db15b-8469-45b9-8de9-5c30c5f3808c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/99dc92df-2fb7-469e-940b-0b45d47fafb6"/>
    <rdfs:label>49.1 Percent </rdfs:label>
    <obo:OBI_0001937>49.1</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/4a9e8916-b731-4341-a03a-c26cb876206c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/36c54fdd-1d7a-4db6-9b22-97d0e5388016">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/30b2fb0a-1e2b-419c-ad80-47754bf052da"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/0a3da9fd-eb34-49a4-b681-f547272a4e08"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/54973328-b7c1-4ef1-a033-afc13251aad2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a2199924-0124-42a0-9882-13348081d798">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/9f98353a-6a74-4d67-aae3-1f5d3046c293"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/756e8219-6ab5-4ff7-8ce3-79b3b1b2f9c1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/5d34d355-a5e3-4dd7-bc09-c84cb9392cbb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f81229d6-819d-41df-931b-9404b4063aa1">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/73b616de-5e6e-4f49-806d-5b28ccf3cb02"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/c44a0e2c-98f1-4f95-aa69-94b5304c606d"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/d28786fb-badd-4788-a2af-2a2e3321fd05"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/f063b94b-2b1a-4f43-b5b8-8bb00197d5bf">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/dfe47e9d-c135-458c-b1e7-cce7ae429d10">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/83d70ab2-76cb-4e48-8aa2-bdf01fb147f1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/be4d9bf9-9f9a-43c9-9781-3c375f3626e2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c37c17be-9cbb-46b6-aea8-61894e961b34">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a2bdaf53-c8e9-429a-aa2a-b8a133df1232"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/290e2ba1-a2ff-4f2f-9bae-f6161463a11d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/3d77376f-f58b-4b75-9c84-c2c16d6c5e7b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/c4d67d0e-02da-4f94-8ef8-7fe9ddc34659"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/7e07fdbe-478b-4146-a835-b09e00dc5f08"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a887d092-a637-4902-88ad-4445d5f3dba0">
    <rdfs:label>fluvoxamine-tacrine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/16c2300b-a61b-4f2f-aa07-5934dcef1cb4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/38f5de9d-d376-494e-a5dc-eb1c7c6428ad">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f98a14dc-c83b-43dc-b4f1-d118c93cd0d1"/>
    <rdfs:label>66 Percent </rdfs:label>
    <obo:OBI_0001937>66</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/346524c9-e273-4cf6-a108-2ff6d455ac62">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/72f6696a-7c65-4025-b318-78626e602666">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/25b02b58-9a79-4cd9-8ec2-6c4f68876d61"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/44d14cbd-2b63-4043-bd91-ab61fd84d152"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/5f17ab96-2d30-496d-9ae0-58bbfbd89abe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a5754906-8ccd-4dbe-9f65-5ca60a5af629">
    <rdf:type rdf:resource="obo:RxNorm_358274"/>
    <rdfs:label>ambrisentan</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e5f119de-c4f6-4466-8a91-d0ef35652335">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1bc144b3-1c08-4757-b9fc-1ba3afedd353"/>
    <rdfs:label>29 Percent </rdfs:label>
    <obo:OBI_0001937>29</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/02d1e99a-9e06-463f-95cd-44282a2685a1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ea9d38fe-3938-4d72-9401-e11f9861bc78"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/eacd8dd1-a52e-4777-b992-2b619201e46f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/53e06de5-f3ee-424e-808c-abe439b36f54">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8f20796f-6009-407b-a68f-dba83bcbbdf3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/254150ed-1333-478f-86b5-f691e5f051a0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/df51b531-c576-4733-9335-e6d0a508400a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c4ceeddc-1818-4180-ae98-19d36342ab1f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4348b884-5403-40e1-92f7-32696e3741eb"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/190eefb8-ae4d-46b6-8103-d05f77f3abfc"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b325e926-adae-44c6-9d3e-79ce446bc681"/>
    <rdfs:label>buspirone-hydroxynefazodone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8eec49f6-db86-43a9-ada4-7402e9ebbc83">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/e523ccaf-3f43-45c1-8815-b4d083d5c49c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/7051ff2a-7106-478a-9105-7b2fbf05134c">
    <rdfs:label>rifampin-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/4c0a3f2e-09ff-4b26-a191-c805b5b49f64">
    <rdf:type rdf:resource="obo:RxNorm_81864"/>
    <rdfs:label>alitretinoin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ef46e6df-b82a-4b28-b012-b7b685d036ac">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ced0ee5c-5c9a-4b76-9ac2-e682f7f77623">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4b3c7ccb-29e2-4bf0-b7d5-5663ee375d11"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5a8e1ec4-a92a-461b-995b-cb519dc3166e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/82a4026d-40e2-484e-ab43-66ef1f6828c6"/>
    <rdfs:label>Diltiazem-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c2fb9cf7-1405-4645-b876-6f648b8de254"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/68b987fd-8ef2-43fe-931b-212f7c5c5e3a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/2195235f-468c-44c2-904b-5a74488e96e8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/3f0fb5fb-64bf-4246-a8cc-b6a99cc414b9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/31f567fe-09ed-4b5a-90d8-c5b0aff866e6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/16154274-93a4-4492-929e-2c934388d1e6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/5cc37427-d3ac-4d56-b2be-b0fff400a42a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/ac8f7947-63a4-4d3c-83ce-ca80ed766c76"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/bc796f4c-7b47-4830-b838-2487acaae82e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ef18fc45-e169-4c1a-8613-d2fa31ce3135"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c3db6c0f-7afe-4fbd-97e7-d85811cb13d2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/b21bf82b-f6c9-4215-b6ea-58f98a8c655b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/72159c5c-a110-4945-9400-6d212beaed62"/>
    <rdfs:label>mCPP-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/7952b1d0-bab2-47ef-8b48-8c886859a1f3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/5b275c21-4510-4e0c-9c7f-18de08222817">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/d86fb4ea-d0d5-4b34-a9d2-f6ee20f4e877"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/605647ac-2520-4747-9bca-784e08849ff2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d2e0fd90-17fb-4111-81c9-755e46197d04">
    <rdfs:label>paroxetine-iloperidone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/012e5e59-60d9-41aa-ab08-d92f6b9dd810">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/240a8d3a-8ecf-4f88-b883-61125c96982f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/7f9e82d5-b357-40f2-84f5-80c029fe8734">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/dcf422b3-ea04-4302-bc85-d6668308b139">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/580c42e1-155e-44fb-b71f-c04c29d6ec1d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6132b4db-6d8f-4beb-a6fa-30979592e089"/>
    <rdfs:label>simvastatin-bosentan drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/14038ed8-d043-40ea-9cad-77199ca2c70e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f118f7f3-0c3b-480d-bd44-16468e0c7cfd">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/32b5e7cb-dcae-477d-8f75-a5d85d100b69"/>
    <rdfs:label>70 Fold </rdfs:label>
    <obo:OBI_0001937>70</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/a484c557-1c41-4b4d-9b57-7d859f7177be">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/744c600c-e7de-4a44-85d2-a3d44d111742">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/fd7fbb90-af53-4f93-8360-72ca14a702b8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/697bb640-6052-4940-a125-671098b280fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/339f4d23-38e5-4ddc-ac44-8775636bda77">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/35d4f6cb-b98a-4031-bba3-fef342015132"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/4af602e7-1ddb-45ec-a3b0-99b4af8405b3">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d52bd24e-4c45-4292-8973-250db4ce4332">
    <rdf:type rdf:resource="obo:MeSH_C496216"/>
    <rdfs:label>threohydrobupropion and erythrohydrobupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000050">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/cae37bc4-be2b-408a-9e0d-b0e1a040d47b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/088f9e41-cbca-4eda-849c-77e44e072e53"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/fb75e80a-559f-43a9-b477-915136bc7194"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/373b7c38-c4a7-4bd9-ac45-e248e2b36ef5"/>
    <rdfs:label>ritonavir-threohydrobupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/5a7aaeee-41e6-465f-a742-de7525ba7953">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/28bf0f7a-6886-49b0-bc31-f26da1ba6f9c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/2b678fbb-1e70-4450-9408-c4983332199a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c49fa560-e897-41d6-9018-2e97446d994a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/80f3bf06-21fd-4d01-8e43-8be71d931d9f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/6da1e857-815c-44d6-8876-4df51636e359">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d1d387ab-5d56-4e78-ab56-c293420f6243">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/0618bc8c-49c2-48e8-be0a-5854da82ad3c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/0f788a64-1708-42e6-a86d-339e1e1da541">
    <obo:OBI_0001937>7.5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/08fd8833-11be-4b08-acb1-616a72b1453c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/226ab3c5-f955-4ef4-9a6b-41be9738e86a">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4511e162-adde-4669-b3cc-32bebd4eda38"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a3cd6eb6-4790-4e4a-9254-3864c7d38d3e">
    <obo:OBI_0001937>400/100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/58ef8579-ebf4-4540-98b8-a6d994824fc7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/33038d08-c177-4f5c-8357-a6afce00538b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/90790605-e365-438b-92e0-9af4d4a3fd77">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/abe4f9a7-f9c1-4af0-9165-8c18adfd73eb"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/b43f8a14-67af-4bb8-aaf0-a3bfaba024df"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/31dde183-01da-4a9e-8914-cf63c4d904b7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://www.w3.org/2000/01/rdf-schema#label">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d71878d8-5f0a-43f1-9990-1d535e3ca254">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6594ea95-2b1d-418e-8ffe-4ca6023859f4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/951ec937-572c-434e-abc7-39a52fa16669"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/efaaf896-a5ab-400f-a820-64f35afb6a43"/>
    <rdfs:label>LPV/r-Midazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/7b214fff-f196-4a17-90f1-d1a3860ae875">
    <rdf:type rdf:resource="obo:RxNorm_9068"/>
    <rdfs:label>quinidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a0e2a68e-6bb0-41e7-b85a-8027506fd73b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ed05901d-c2e1-49af-b192-2a20be450821">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/fd6f961f-6101-4ba0-b282-881dfbae46dc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c2ae5c06-2227-4f57-8897-3aa44025b067">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5f72e0e9-1956-44fd-82cc-9a1eaa766254">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7faca321-698e-4bd3-af7e-f040a5bfff4d"/>
    <rdfs:label>quinidine-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/080a15f9-2ea9-4159-825d-347ac4a8fe89"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/11e730d3-2934-4366-9b67-5156105352da">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/1c300f13-3ac4-49c9-94e8-94f6753411a0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/33fd7308-4388-42df-a5a2-e1324bad1baf">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/8921734f-02ec-43d3-9ea6-dc9ad331ff1c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/c1cfafa8-e7d1-4be5-9320-22bc09a55f5e"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/1d5856b2-5dcc-463f-8a1d-815cb40550de"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4cdad6fb-b87e-4f2d-9354-bbefa3b36aac">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/510cc5c9-8e62-4120-b5de-d044e3bbe8f3"/>
    <rdfs:label>3 Fold </rdfs:label>
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/f05a91a0-0167-4d9a-8db9-ec39c903aaf0">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/0c577faf-9fbd-45d2-a6d3-a9cc75c82eda"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/7a004510-f9af-4b52-8b78-4b0cf4b51a0a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f2d916e8-554b-4d15-8e78-06d03267f077">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/62c7b602-ee41-4bcb-a81c-268ab600ba4a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/6f024978-ecc9-419c-866e-ffc5341a62cc"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/1f222d38-f26e-411c-b098-e8de46bba663">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/2c11adf1-8c80-467f-8fc5-8c18608aadb7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/8135c04e-19a1-46e1-bdf3-ed9c0e8af0e6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/c34c3962-a880-4019-9a0f-bd532ba93820">
    <rdf:type rdf:resource="obo:RxNorm_10594"/>
    <rdfs:label>ticlopidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/d166e63a-5503-4340-9ff7-94ad4af432f1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/8a7287a8-5c62-4044-80e8-acdf33b77b12">
    <rdfs:label>aspirin-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ae8ecfae-0737-41db-bdbc-f43bf42c1146">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/587eac2a-4826-4901-a8dc-af0d16692865"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/37f0acd6-d3a2-4df3-8f56-de4f9c3b2cce"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/096c0388-7fc8-4ad6-a9e2-6038bf04c48c">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c4a46425-f600-4989-bf05-2eca8e1c335b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/39a2b81b-3ab0-42d1-ba64-b3111f82d400"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/130757d9-7a93-434d-88e6-962fdccfe654"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2cc90934-f417-4eb9-bef8-74c38a44c9a3">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/fb68517b-1151-4c36-908f-60c4bda3200c"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/54308f05-d0f5-4b02-b7d9-533d2b9b244c">
    <rdfs:label>nefazodone-triazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/0e2f183b-e1ed-47e6-922c-d8692e02ba1a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d8da44a4-2f75-42e6-aeb3-e5faf4eb7a2e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a64a83af-eb90-4b05-aa93-e122704d7c78">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine CR</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/dab09e76-4786-4647-9b1b-2ff650fde46d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3d4ae97d-8224-4708-aedc-f4304b2d753f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/cc858249-f84d-4977-b126-2a71bc758a49">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e792491f-fb92-48d1-9ce6-3cf27d71c7d3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8361e857-73b4-455d-b64c-a8bdfd03ef91">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/eca41aaf-e9c9-4287-8456-884626494c3e"/>
    <rdfs:label>8.61 Fold </rdfs:label>
    <obo:OBI_0001937>8.61</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/312fe7ab-8ab0-4418-9b7a-e5c8bc57a8c0">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8644c7aa-d63f-4428-9bd3-f2dfeef8b0fa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/074b2ec5-8cfd-4e80-80be-752f2bd5379a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/47d864b4-0104-42e6-b688-4790309c49ee"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/11cee2e7-7cb9-4afb-a336-66ee55d3f85c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a3cae62a-4ae7-4bf4-abe2-7be0620c0706"/>
    <rdfs:label>ritonavir-erythrohydrobupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/006e52be-0149-47dc-a065-bd6dc05036e4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b9bf6c6f-b8c1-4dfb-ad59-84d2faa2f455">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f1168b7a-65b9-4812-b256-0c9c8a4c93d9"/>
    <rdfs:label>high-dose ASA-Edoxaban drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/97133475-1f25-426a-a720-65369ff007b6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/844d48ac-fa0b-4b2f-bbbb-ce0b4e1af820">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a45099c4-c4d2-490d-a851-229d5137b51f">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
    <rdfs:label>desipramine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/596047c1-5a16-4f19-9cb7-ff088f4c3176">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/42c66578-1538-40ee-8896-2b1d36f1d9ea">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/48bda9ea-5e66-4c80-85bc-09ef7edcc8dc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/e3272663-c62e-40bb-bd7f-e39bfff08f68"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/b0968ad0-eede-4803-a569-e01f700d1d4e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/500563d8-c8ae-49de-b83c-4dbe46205a4f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7c9d06e2-8684-4e74-8085-6536a1151927"/>
    <rdfs:label>16 Percent </rdfs:label>
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/85a045f4-d3df-41ba-8168-0f6c645a50ce">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/a6f80cb7-e4f8-4409-a2ec-d25238dd0937"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/93256f47-1291-45c0-a9b9-48a4ac7ed3c6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/a52244f7-f7f3-4bda-a810-f8b51c002ef8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0d6030dc-714b-4c09-ba51-5949dfe3ab3a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e36a2d05-24e6-453a-a9c8-a7aa235403a0"/>
    <rdfs:label>55 Percent </rdfs:label>
    <obo:OBI_0001937>55</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/dcf6cfff-5dac-4f09-9479-a863886e25d9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b6c03a14-a092-4bf0-a951-d9a0b93bd4ef">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/bd487d6e-7e4a-44a0-8814-1f2f3efd0eeb"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c43057b0-a16b-45e2-99be-b94689d12148"/>
    <rdfs:label>rosuvastatin-Lopinavir/Ritonavir interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c154298d-2aa5-48b1-aa83-babc05e6ad70">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1687b730-f996-4e74-8db1-0931cea4fcbd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/54f88c1e-6716-44b1-b70f-2f7da8be0ffc"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1dbcdfd5-1bad-4e07-b634-6f5831dc4971"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/19445e2a-7aca-4b5a-8f34-f3efbe425d10"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/992dfd16-1f45-4f12-8bec-b8b410d30f66"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/26fb563e-1a3d-4214-91c8-e55240da96e9"/>
    <rdfs:label>ticagrelor-simvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/47edc485-0b13-4201-bd62-40c6280285ee">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/0115bcb6-af2c-49fb-be12-3485fbbd1507"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/8a92615d-a614-4d8e-9807-2b64ba27391c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/46612123-b294-470d-ab78-0e986d2df2b4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/522b1726-7e32-4652-bfa7-ff309169511b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/abcb962a-3d93-41f7-9dc3-f6f459e4464e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/1597caad-d2d7-4e29-bb29-1fa88bbb3c98"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/5e7fb8dd-7a90-4e13-bd52-1bb2c2f08533">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/547fe4eb-cf8e-49ca-bf9c-e139976f17b3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/bc85b6fe-8760-4104-8ccb-24465b203b4b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/be252323-5879-4ac8-a47c-cb44eff00a47"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/b66f1494-d378-4440-ab43-837dcc75637c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a2cab852-5f4d-4fad-80ea-5097e1e5cef7"/>
    <rdfs:label>nefazodone-alprazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c19fbc2e-0f25-4455-9454-9f78b0b96297">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/9e0293f4-e049-4a24-bac1-a255720d9fb8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/3a8ea61d-d64f-490e-8a58-c40765077cc0">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/e1c5c593-0b1d-4666-b236-168618eecbd5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/1ca6767c-8a7d-4b2d-9e1e-90f7086615ee"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/59c9e6a3-468a-47f3-9648-fd4a08a57980"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d777d711-b9cc-4eef-add0-87f552917e35">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/229530f1-d764-4db0-b34d-f61ca41c3a05">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1998ac3e-71bb-4b11-9227-75f027d233f5"/>
    <rdfs:label>2.2 Fold </rdfs:label>
    <obo:OBI_0001937>2.2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/77cb183b-d5cb-4b14-9277-8963f58719e7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/0f92ff5f-139e-412d-87c8-a8664a812fe8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f5048a88-ec68-43ad-9fa9-e46b2039870d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/5fae11fa-96d2-4dfd-8381-e86dfa2ef9a9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2ca0f46e-7985-4b8f-ad78-61f4113df559">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/a4298eba-7740-4de8-94a1-e05ba6ad6730">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/9b2eab30-b845-4328-a5c0-c5825e444157"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/ac3fb19b-f5be-47fd-90ce-a7cd247f3e72"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/302b8843-d771-49f9-b652-d277b5d78149">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/3b41d1e7-6a93-49b7-92e1-a5f2135aaae5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/d00f8ebb-448b-4781-9f82-941a51208f6b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d37f385e-cf11-4563-9754-bff6befc0c3b">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a9a299a5-a2af-4ab0-a80c-f39d99858cda"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9a575a15-1f6f-4051-908a-9d1244796557">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/17f5e824-a9c1-481e-a7d5-14d848fd02e5"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/83ff5b49-bc06-4cb8-8704-54dee7781bb5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/23da66e0-617a-4cbb-9c3e-0dfb2ccbdc2e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/a04d0b31-c9d9-41ac-8393-c1e766ca3639"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/47075e5e-3afe-4b4c-927d-a6ac825e5f34">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/db58a73e-3a1a-4d5e-9559-b5b80a766140">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d6af9a65-7e66-4267-a6ee-1c97c32a504f"/>
    <rdfs:label>3 Fold </rdfs:label>
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/4e349618-ae67-4d6b-8183-eaea9dc288e3">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/e1005b45-019b-42f5-a959-9b906f6390ec"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/7efebdcf-7c30-46a5-93ed-92cc8caec7ce"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/f65309bf-9aea-4187-87a5-81946729aef5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0ecabc1b-db32-4859-bced-d0b5559c92f2">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7ccad4dd-3a69-4908-95d1-5bc09f4684b4"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/264b5c5f-b38d-41b8-91c9-fc7b3eb7659c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7bf8e37e-2afc-4442-88e0-8aaa83e71b1d"/>
    <rdfs:label>ticlopidine-bupropion drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1bc59e8c-3eea-49f6-b328-0fd0d8f45e7d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/5bf2a60d-134d-4a90-9813-ed8ec19e417c">
    <rdf:type rdf:resource="obo:RxNorm_32968"/>
    <rdfs:label>clopidogrel</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/3534588d-313b-49e4-87e7-9e41c3de44e2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/71203c32-5d1e-4c03-ab8a-fc0c8d88f9d6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/869da1b7-5731-46f0-9f33-739570220d8c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b34b6273-e22b-44ee-913c-27048381a99d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/43543a1a-e7f6-425d-932d-04bc02a55e34">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e62a4e6c-bd83-444e-be24-e6ab0c68571f"/>
    <rdfs:label>9.4 Fold </rdfs:label>
    <obo:OBI_0001937>9.4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/553fb055-1384-4e41-b1d7-ad57f2e38e71">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/0371a693-e81f-4ae8-a71e-6a60cefbfa51">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/79ab8d49-1835-4bfa-aafa-f96a0cbf55af"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/4f8c95a0-35ae-4448-8f28-aa791b199299"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/78f8867b-7921-442f-895a-6c5f35ed281d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/0db4b40a-ce39-4694-8bb6-193400c80b22">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/d98f30f3-9861-4e50-a367-2800282f5654"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/5954c76d-4b13-41ca-b4fa-26d3f9de4df9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f0123d44-566f-4147-9f4c-7a57af0b5b35">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f81229d6-819d-41df-931b-9404b4063aa1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/17b27d84-98fb-4fa4-ba06-7e98411a5663"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/32b279eb-19db-4813-a121-ca48b4ea68a3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ec29b768-9164-4896-8ae7-4316fad9dc21">
    <rdfs:label>simvastatin-Nelfinavir DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7fe30ec2-b681-400b-8b7f-54c8054e380a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/2ab63549-8fe0-443b-bfd7-852c0fd0b370">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/687a8b3b-32bc-47ab-945d-18c31dbe0272"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7b983f04-9bf6-4e8f-94b2-9350f09dd939"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/9643649d-19d3-4a55-9027-270a6da338a9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3bc312d2-c51f-469b-b340-f83c5437cc93"/>
    <rdfs:label>Fosamprenavir-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/64002740-da34-409e-84e0-88cb26bc213d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/07b779a0-ba31-49f2-89dc-74ca8283c736"/>
    <rdfs:label>34 Percent </rdfs:label>
    <obo:OBI_0001937>34</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ce1c73fb-e327-44d6-988b-389df8cded10">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/48d5e0bf-b5e4-4fa1-ab2e-0d5d84b3f69b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f0bf65ee-d95a-48fd-8b7b-8e293299033b">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/4115968f-e975-488e-b8cb-33170cc4c51a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0e4735b0-36c8-4b8d-a425-b38c0171451f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/daad7a22-c5a4-4e58-8aa4-57e60dceddeb">
    <rdfs:label>rifampin-zolpidem DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/f46d8d50-0a37-4444-9f1e-03aebade1ec8">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/62308c3f-734f-44ae-a022-a44694548e87"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/c3932142-75c4-47cd-bfb8-39a68b5a1e10"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/8193cd90-9347-48aa-901d-6697f8f518d6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/728b9ecc-ded8-486c-abb1-d86b58faa77c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/26986bd3-dfdb-4de3-b47d-c4ff247f8926"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/75d374a0-738c-402c-91ca-517c335f3fe4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/86acd64c-2517-4454-b3f5-26086cfabac4"/>
    <rdfs:label>propranolol-m-chlorophenylpiperazine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/2f19cdab-cf9c-4e11-a0a4-2b20dd555ba8">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/730494d7-c9f4-4200-bad7-fc81ee92d8bc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/ed2d8eb4-8e7f-4c76-987d-9c82273f97cd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/8a81de65-fbc4-47e9-bff5-c91f2eb8bfb1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f8abb731-594a-46c1-915f-a7928ccc30f1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d3c03b92-4460-4ee4-9446-bbad45dd5a9a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/98561723-032c-460f-b384-39093ec0b7f6">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/13bb78da-588f-4e4e-a86b-33ebd9bbca0f"/>
    <rdfs:label>ABILIFY-paroxetine CR drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/42e481a9-f4c7-43ba-a781-cbad152ad4d9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/c2638bba-69a9-44ca-9161-f73ecab511bb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/373a3a46-520f-4d9b-ab86-cdf38624bb21">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/71f6530d-0a99-4f46-a3d2-6cc84ddb2e16"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/db130446-2ac8-4f4f-8be8-081375980573"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/7a82a391-6bce-422d-97a2-93f0e2762cb7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/be4f83c2-4ceb-40cf-8d7a-ad370db73c47">
    <rdf:type rdf:resource="obo:RxNorm_74667"/>
    <rdfs:label>zaleplon</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/908f6fa5-7e84-46f0-938b-79365f444dc3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/8f1f4b64-0049-4d85-bbea-75aab2424acf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/2e15e7a9-4d27-424a-bcea-47a551edd2d8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4332af54-52a2-46d2-b71f-8fb52ecb0f0a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8f483ede-28ad-497f-b4b4-f29a49f2e418"/>
    <rdfs:label>36 Percent </rdfs:label>
    <obo:OBI_0001937>36</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/ec2983c8-cf18-45fd-b9ca-2e8a03913f25">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/5acf3a4c-ed0a-4ea6-8984-bc83dde8a8c1"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/8fe6bbcc-2182-4fce-b756-b5b97f864478"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/f0bd1461-58a0-4dda-8610-33d28a4d5bc4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/ccdf0146-fef8-4797-9c04-35b6f0f0652b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/5ffadcb5-6b03-4d0b-9a64-8afb5a5bc195">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/41403f68-36a9-43d8-b738-cc8e9d0d378c">
    <rdf:type rdf:resource="obo:RxNorm_15996"/>
    <rdfs:label>mirtazapine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/6ab96b3b-fe3a-440a-bba2-fb455e5bf918">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/db4366d5-0f44-4b53-810e-1d434581e1af"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/2c16b8d4-1781-4f81-94fa-17e64cdd1876"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/d21df397-318f-412f-a52a-c998991f346c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/29dc998f-2258-4e65-b8ec-223547efa028">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/c30490a5-0a7a-4554-9839-330765286e02"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/73868eca-1916-4fc5-862e-85f7b108acb0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/ef8024cf-c6e9-4993-a6f2-06ca59e31715">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f483c077-45a2-46db-a86d-d35a45377925"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/6bc964b6-9f6e-4965-adc2-e9b44ee856e7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/117d038e-c475-40a1-9252-a4596e6fb181">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/be42344b-e30f-426f-9fbe-151d884fc773">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/105a2c1f-1a2e-4854-9fb3-7ab8ec66f124">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/851b239f-95ea-437b-a5f3-d8e6e9a8c9bb">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/3da643e0-8ea6-4c00-9d98-d4a79b4683f0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/6bc82e70-178d-4d9b-8003-9d4f9479ad05">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/86d18c59-09da-4beb-ae4d-3b5e5af11041">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/6774ba76-1136-4875-95de-074cdbc2489f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/292ab7b7-d8aa-422e-837a-cb554b34cc73">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0fbf8629-edbc-44f2-af7c-ef554c26d3f5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/6ee34833-2612-43da-a4c1-a0f613a81c80"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/005af4b8-0d09-4a46-be58-f889f40247f1"/>
    <rdfs:label>ketoconazole-P95 interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b503a211-8d11-4018-b4d5-5bc4e5440f6e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/2dd63c17-f4df-4a9d-b224-d2da616400d4">
    <rdfs:label>nefazodone-triazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3e6ffbcb-f353-4aa8-89ff-f93f0fefd9a0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/37d958cf-e96a-4508-95d3-55d36aefed46"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/d608f3d8-16cc-43c0-a299-672d8324f7eb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/56512661-a82c-414e-b4d7-e3c960923548">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/9332be77-16c2-4316-9ded-67a2d4b9edea">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/d48d32c4-20fa-4690-8b9d-0168ec81e5a2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/09a67798-d205-4928-bf92-49980660eea7">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/5d8db9ce-25da-4498-b1fd-5023bf8c0a58"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/5cb6f12f-0f85-4c73-849a-f68a0aef1b55"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a41d12cb-e5b4-431f-8654-5d975d2c6e54">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/60c8877f-4310-46e6-8eb4-38ee96ec3f69">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a2d377aa-3dd0-4cb7-93fe-a88696bb7be7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/61e55179-5266-42f1-806f-7b472bb4c0a9">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/41a413a3-c28f-4120-bff1-15e6b5c1c803"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/8a81de65-fbc4-47e9-bff5-c91f2eb8bfb1">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/6f9e9fce-77cb-4090-a99f-1640a258ca51"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/19d17d70-631d-4f4a-984b-977269479476"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2dd0ceac-cc7e-497a-b30b-0cb7cc6eee13">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/571ac632-e5a5-4b7e-9888-3197250db38e"/>
    <rdfs:label>5.4 Fold </rdfs:label>
    <obo:OBI_0001937>5.4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/40c90b68-bac2-438f-9102-53e64317888b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/677a829b-eb86-4761-a2cf-c14b15762341"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/f4d53510-2ac5-4d58-a27d-d029fc5dc52f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/098aa643-7649-457c-a309-6b8c26434709">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/cd128c5c-4017-4379-adc3-66b8e546218a">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/69b979c8-caee-4215-a19c-947ce5737406"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/7bc74a8b-35ac-4b9f-80bb-6198c832e915"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/d0abb497-ad95-42a6-a908-c70ec488ae52"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/db1742cd-1ce0-4fae-a0ac-2705e3616248">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/88d19d2f-94fe-4b7e-b78e-e8e0f053f325">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/9f74238b-5cec-4c9e-a317-d222b16f9536">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/af214e6b-04b1-4dd0-9f04-52472c8d62fb"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a27b2fbb-fc23-4eca-9f71-d68f73af103a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b3af23ab-2a28-4ad3-89b6-10253f91b3d0">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/83ce02be-af18-4227-9b92-6b13124fc72b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ed1bd1b2-5b5d-48c3-b045-3c223a35cc2d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d3f1d279-9215-4a44-95a2-396e9f862c66">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/6e2d7942-1cb6-4b8e-9811-e4cbcc4c704e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/4040ba33-7602-440e-9def-174b92313bb1">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/daed34fc-bb1f-4407-bf17-a83762bb8c0a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/2c01ea0c-5d70-4a03-92c2-6721802939e5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/36794ed4-80e8-41c0-985a-4e5732181adb">
    <obo:OBI_0001937>150</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/eb84704a-b330-4b0d-9fa8-d47bef74c696"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1ac0978e-b571-4e0c-b696-7457654442db">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/29a5be20-955a-45a0-97c4-14d4461379fe">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/596f2ddc-0791-4a8a-99cc-9852618cebed"/>
    <rdfs:label>citalopram-pimozide drug package auc UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/be12c7c4-01d9-4c6c-bbb4-ed5127808327"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/185a89bb-cc17-4138-b8ae-1eedd345ed19">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/eeffa8a7-4b2e-469c-a1aa-4f1c4f927393">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/96a281ec-8b2b-498f-aa73-7f186ac54eac"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/532b0610-65e6-453f-88e6-b90dc4f05bdb"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/8e22d74b-68ad-4a36-a789-95ec77c89b2a"/>
    <rdfs:label>fluvoxamine-mexiletine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/390541df-1ac8-4c37-9474-9e1b635cb2ef">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/42e2fb37-85be-4b41-bb54-4d6a50edcf4a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a4fa3cc1-00dc-4070-b7c9-b1ebfd17786b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/45fd924d-b02b-461d-8642-6ef759693e93">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/addfdeae-2f9d-4380-80b9-880d5360304f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/dde5ef6e-3b78-41f8-a9ce-c4532573cddb"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/8b482f34-1e1e-4a49-ae0f-10012cd3fd54"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/5b1cd53f-6bd9-4dcd-a0a8-482673da17f9"/>
    <rdfs:label>sertraline-pimozide interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a179b573-1082-4ce2-994b-dcbaa9656e83">
    <obo:OBI_0001937>1250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/80f3bf06-21fd-4d01-8e43-8be71d931d9f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/44c849af-7b41-4691-ac16-def44f4e7df0">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/9f2953d4-bb75-4ec1-b882-18fbbe896c68"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/241a1828-1c2a-421d-bdce-58b4686e5ff0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/640260d7-4db7-440c-baca-7612f907b264"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4f783bc9-ff0b-4967-aacc-221c91cb990b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/b2836363-3fe3-43d2-8761-d5fbdd77fcc6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/32a892c4-c47b-4a8c-a0c8-13e87c2b37f3"/>
    <rdfs:label>ketoconazole-P88 interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c4676def-a67d-414b-bce1-9283b8f7622f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/32d53e8b-c6b0-4b11-94f2-6fd7647ee50b"/>
    <rdfs:label>8 Percent </rdfs:label>
    <obo:OBI_0001937>8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d489cbe8-acca-4b1a-8e40-66032577802f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/443f23c3-d95d-4f4c-b906-22d20f415c03"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6d1d25ae-01c6-4d43-af62-5c57af03e90c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/ed776fa7-934a-4584-9787-d4d751aeb3f9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/08268554-4ea7-48bd-89dd-43f22250b0d5"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/55ccd6e2-cf7e-45d7-a11b-535899cad581"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e30012b9-af84-4929-9591-c4c73e553496">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/fb68517b-1151-4c36-908f-60c4bda3200c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/39e0c66b-bcdd-4f76-a4eb-02a5cc746914">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1ac0978e-b571-4e0c-b696-7457654442db"/>
    <rdfs:label>2.3 Fold </rdfs:label>
    <obo:OBI_0001937>2.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/4e82beb3-d72f-4de7-b0f4-c19b0e0ce5c6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/00478e7f-f9d0-43d6-aaa2-04b79f29ab58">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/fcdc343c-c7d5-4d01-933e-0d79e272a57a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/f089e2d5-e0b5-4235-b909-5dfba27acf8b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/0d1777da-78d9-4356-9b70-a035a0cc766d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/9ac6b286-06f1-4098-9ea5-1fc32af71cf5"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/f877e543-c944-4e48-844f-95440c96f2c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/18b303b3-9b57-41b8-9676-a6d2a5f8a34e">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/42b1a18e-4d92-4b13-80ea-06f15fad05b1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/8a9a79e0-d220-45bf-b875-d3e629cc88c9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/a81fd31f-cb5f-440e-96d9-e9603b9df797">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/cac1d879-1374-40cb-ad07-2a9391d5c790"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/2a37d1a0-f4ae-48c9-b6e7-9de072bd6bce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/f205a2c7-221c-43e9-9f18-3152000dbf19">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/be28cbfe-81ba-4a84-9489-ab4c25bdeedd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/824c0b68-f359-4355-98d0-34747abd0105"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/bf44c46e-1776-49e9-979e-d3ab80866dda">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/d22121be-cfda-4b78-84a5-b3fb0b775d2d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d021a932-8f10-41f5-8870-247622602957"/>
    <rdfs:label>alitretinoin-ketoconazole interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/5fa4ab65-ea6b-4b9b-81ec-ea3861fc88c0">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/098aa643-7649-457c-a309-6b8c26434709"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/3fedaedf-3625-4686-a1cf-6d0f2558d825"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/64a605ae-d045-4e5a-a50b-710627c5a85b">
    <rdf:type rdf:resource="obo:MeSH_C580748"/>
    <rdfs:label>hydroxybupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/6cd7758f-edeb-403f-80ea-1455df6da3b6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/227f6873-2f6c-46bf-b9e0-4b27fd7bf9f0">
    <obo:OBI_0001937>1000</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/87373443-3dd4-4364-b172-a0871070c319"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ca2a492a-b89b-4a97-9cc3-7cce9f345139">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d3ad5f6c-f82a-46de-9892-d6958be42603">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/756ca92e-a8c1-4db0-a635-46696e90797c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ae7272f9-c58b-474b-8eff-d97dc6b0c439">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e2a588ee-34ff-4cd3-9b4c-fb0860bc9157">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/324102db-5069-4b71-ad4d-f5fa535cf77b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/7df78c44-1eee-4b14-81bb-228cc78c71d9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c77de934-2108-4381-97a7-4389a01a94dd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/eb7da287-ab95-4604-9aa6-4304f9b0bcb3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6774ba76-1136-4875-95de-074cdbc2489f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6159f06a-749a-4f27-a0ad-396e124fc903"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fef377a6-97fd-42ed-b849-3eb81243a530">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/88e5e80c-5e72-4e4d-b796-473b46fdf743"/>
    <rdfs:label>6 Fold </rdfs:label>
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9e4c9f44-6d50-4708-ac71-7b30c943853f">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/49a28fce-05be-441c-a5d7-7c0a39d67687"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/f912615f-2290-4d9f-8260-2d01ea3cad43"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/1b0fc29d-19ca-4d84-bbae-d770ac4d3804"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/ac5ed37d-dfa7-4fa9-9740-3c3e15510306">
    <rdf:type rdf:resource="obo:RxNorm_4719"/>
    <rdfs:label>Gemfibrozil</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/47155381-aa31-4848-ab41-48f9e5929c00">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ee40d925-1d8c-4dca-bfc2-89e9f3147630"/>
    <rdfs:label>telaprevir-amlodipine drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d7cc1ff8-3de7-4ee6-a346-e0f9f466c0b2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b575c4a7-6938-4ff2-ad73-26efda568ab0">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c9bde030-a434-4e6f-b9ba-f37962953274"/>
    <rdfs:label>106.3 UNK </rdfs:label>
    <obo:OBI_0001937>106.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8c52e9d6-8d40-47a1-901c-5f4b77bc59b4">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/eed3f659-6722-48e2-b9c0-11ab1af6b1dc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/bdb726ed-7b7a-40a3-a5f1-4b0280e71980">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e2220d51-e0b3-4c44-8462-63332be3aebc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/028382bd-616c-41a8-9a22-feb974f8edfd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/c4879954-7dab-49c2-bb9f-076fd42583be"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/c907d152-b9ac-4daf-9173-30ebbca1b9c2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/43e93392-1b82-4be0-a81c-457f4e416348">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/6c427e3d-331a-4acb-bc9e-b773b6eba757">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/55656233-b164-447e-987b-912d870edce3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6b01e7fe-84c8-4c5a-a0fa-33fa88b001dc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/fe522d81-eb45-4e05-b8b2-dfdd8a419622"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/11c65feb-667e-4dd2-94f6-096f6512b666"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/137eed78-0127-4433-93ca-d9569d2bc431"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/bbc184f8-87e0-4cfc-845e-026eccc480e8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/1b1b4a3d-e127-4781-963e-e603db31e31c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/81524f8d-8806-4c8c-a9c4-5d1d48372ce6"/>
    <rdfs:label>erythromycin-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ecc91a7e-8e15-4ff6-aad3-4a286d353022">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e49a9902-5513-4309-a248-38265f0cfa90">
    <rdf:type rdf:resource="obo:RxNorm_72625"/>
    <rdfs:label>duloxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/5cb6f12f-0f85-4c73-849a-f68a0aef1b55">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/f03b2979-df65-42c9-8141-7deb1cd3374e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/22687408-5cbe-43cb-8a56-e79e33ec80fc">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/94cc0d5e-c90d-4d73-a80e-95fe8df36531"/>
    <rdfs:label>duloxetine-warfarin drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/fbcdb079-3f78-4034-b10b-1f2b80c61593"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/00354305-041e-4b48-8a8d-963c3f8824f9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/424183ce-d988-4916-a726-a33692043557">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/65574052-3be2-4c23-8718-5c793e79573d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/40eafb2b-1574-4096-b4de-0e3b1fade627"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/8042783e-4881-4e53-b514-c0673eb218c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1546672c-53ba-49a9-b58f-63a5667c03d5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/1706a9c1-29c3-4171-b8df-4d991e59683a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/cbd834e3-32f0-47e3-80de-3fd1b914d3ec"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/8cbc3459-aa32-4811-8b3f-9c6b68803ca4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/5ffb5474-ef40-4195-9fe8-9141c3fc7887">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/4827eecc-0ab3-4c68-afa9-3504277e135e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/0f62ee31-84e3-4bd0-862b-e779a2b9cba1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/be4d9bf9-9f9a-43c9-9781-3c375f3626e2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/82fc03eb-17d3-4adf-9680-2ba33c63bcaa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/942f7563-5b06-4727-876c-3e0c1a6dd6f3">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
    <rdfs:label>ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a06a5406-a543-4ac5-9d14-36493f6e3e65">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
    <rdfs:label>fluoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/0683b8c6-7309-44fa-81ce-709a63a48ae9">
    <rdf:type rdf:resource="obo:RxNorm_703"/>
    <rdfs:label>amiodarone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a98cb549-baa3-4ca1-8b40-1e6cb41fad6e">
    <obo:OBI_0001937>800</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/6a3e790d-1231-4a04-9617-da2bd8261c71"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/d32cb991-4a0e-4bd3-b85c-6e565f4aefb3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/800e4638-d6a0-45f3-a186-1925ef92ac67">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/255d3d76-0810-4523-8d9a-3635f4eb9cb0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/17b9a00f-05d6-4874-aacc-418e87ffcaa4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/ff9c6337-93eb-408b-af73-e44a1756bd7f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0e5878a4-8702-4fb4-99cb-6d9b3607dce4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0a13d3cf-c4d8-452a-b006-66fbc05e72e3">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e7512fa2-57d2-44f8-b8ca-9277ebf4032a"/>
    <rdfs:label>duloxetine-theophylline drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e63ece20-8c98-4385-ba1a-084dadeceb7f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/7e9961eb-7c08-4ad4-9738-f87052664e08">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ae3c64ee-4a80-42fe-9a1b-ac31ceb3d585"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/cb8d9ae4-3777-42d5-bfd0-bbff1b0b0f9a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7d0369d5-6d54-4d92-9075-2f0d6614f9cb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b5eca149-c5cf-4d45-995b-3798479feffe">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3b8219a7-dd95-4e4a-b40f-38dd01640bed"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/62542748-6bd4-4488-a4cf-ea75f38c968c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d912e803-5e71-4049-a5c6-369f036b6480">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/931571b4-c5bd-4f7b-a5b7-b0a900726659"/>
    <rdfs:label>600 Percent </rdfs:label>
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/cc0e7573-f45e-4887-bd49-66ffaccf328e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/cfd86e68-05ed-402a-8885-80d1fd85824a"/>
    <rdfs:label>ritonavir-bupropion drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/91530390-e41b-4d7c-95b0-3090b5335086"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3fd411a6-0b68-4b44-84d7-c9e632f9b390">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/3b925756-e187-49ce-9f69-e94622e3c331">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/c197f47b-c741-4b35-9bbf-32445228bc30"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/c169efce-fd36-4516-883d-5248769a7946"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/103025ce-0e67-4811-ab68-26619605b14b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/f1b0e424-e4c7-4002-9e69-b7e95555377d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/48b014c0-f5c9-4788-b1f8-2c33b93d8706"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a1daba60-e099-4413-b771-b5c44e19a6e5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/4252f0ef-4713-40f2-94c9-dd433ba68101">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/92c9a1ad-e462-48e4-a6cf-55239528477d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/b17bddee-d81e-4a45-80a2-cd3df1da8545"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/18e98152-58c6-4117-98a7-55dd4e1fe26e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/a35217f8-cd04-4aad-b4a9-0153fe070333">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/28066e15-804e-45f0-9bea-9f4770df8b2c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/edaf8349-fe76-48a7-be0a-809d3b6e9e59"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b556f3ae-4e33-40b6-9181-09e3eb1f906a"/>
    <rdfs:label>nefazodone-4-hydroxypropranolol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/be12c7c4-01d9-4c6c-bbb4-ed5127808327">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c3199a21-8db8-41c1-b3e4-1b985257c91a"/>
    <rdfs:label>unchanged UNK </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/56cd2e96-90ac-46e5-b780-8ae246dd231e">
    <rdf:type rdf:resource="obo:RxNorm_1191"/>
    <rdfs:label>high-dose ASA</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/1f268171-3a23-4d3a-9652-0d13f83e6450">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/fd32cc19-5788-4708-be48-92ab94a6d7db"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/bf68f41f-c292-44f7-8bd3-e63ac28cca44"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/905ac333-ca3a-4a4a-89b2-22dd79be4094">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/6672e7bb-3045-443b-85d0-68782806bda5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f358a145-1858-4a2a-a598-97f6ca51a629"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/4ef0b359-01f2-4dfc-a701-353d9d11afda"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/55e60d89-75a1-47b4-b7f1-cacc227aa797">
    <rdf:type rdf:resource="obo:RxNorm_1116632"/>
    <rdfs:label>ticagrelor</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0f0801cf-8d6f-4525-a91a-6591c4263ff1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/f8b84337-4204-4a13-824f-640172308192">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/cf468833-0d8a-4dab-a899-8ef0421ca8da">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/313882ed-1cfa-4f56-a32e-481fa1175136"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/b71da498-da30-429e-a171-f7eb7b23e179"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/f9e56e17-2d58-4ee6-8aa1-61142953a713">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/1737bbab-a0ed-4e02-bb47-a2b4d3eeb9e1">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/d5c0bb41-18d8-4e4a-8f70-661217aff29c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/3fbb3dd4-471f-4f4e-b0e1-6ad64ffec69d">
    <obo:OBI_0001937>250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/229f9208-09e9-4948-80fc-ce42688f236e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/7605b712-3a83-465a-824f-f3f1191fc41f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/39a36dae-1586-4f4d-ab7b-72dd37730314">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/900e42cd-0419-464e-895f-2e98bb6ec1c0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/b49ff605-ecc7-4c5f-82db-7d3400e16b9a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/9950b47c-15ea-4e91-82e4-c3269b06f424"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ee15d4c9-38fe-4aea-9f8c-bbea0fee5f41">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6cce4d88-abdb-4abe-ad22-b4cdb542e747">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ed896f8f-2d25-4e6d-945e-99e8287a89d3"/>
    <rdfs:label>warfarin-Rosuvastatin drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/906a2359-6adb-42d8-aeeb-076d12ea253d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/b6d05029-a465-49b6-aa94-f41a18f38a58">
    <rdf:type rdf:resource="obo:RxNorm_1191"/>
    <rdfs:label>aspirin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b213d1b6-0c83-4d0c-b7d7-f48ce5f4b836">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/afd5fc1b-cbde-488f-8c78-102a937ce723">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f61da29e-c8a1-4dc3-80be-3047c60b5389">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/12f79744-8ef0-44ca-ad6a-d646571d606d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/a49d48cc-31af-48a7-9923-545e35af689c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/86e4891d-c9c0-4422-b389-481e61151d90"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/7a48a3bc-5651-4341-bf4b-37685d454112"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ae909dc1-d15c-415c-9236-702279ac0173"/>
    <rdfs:label>nefazodone-simvastatin acid interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/01cd286c-8e83-4c30-aff8-b8e9d2a52b65">
    <rdf:type rdf:resource="obo:RxNorm_9384"/>
    <rdfs:label>Rifampin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/54c0dcca-7353-4c4e-9fb5-17a92c95a33a">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
    <rdfs:label>rivaroxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/3ef18615-1f57-4bb6-b67e-f0b394af34b5">
    <rdfs:label>telaprevir-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e277ea3d-890e-4fae-8e8e-862c79b8ebd8">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/30bdc844-dd03-4217-b6d6-971236162614"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/27ffa609-de48-4152-a1d5-2540dc1c6345"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/2a098c77-d379-444f-97bb-d105cf9369c2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/78e815af-df0f-46ca-b4a2-ea8d6fe4a466">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/63a84665-f2ac-4579-a354-025e8376188d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a6915cd0-1a19-4be3-a558-3d73a6764336"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6ee30c13-938a-4065-97eb-77cc8a19cc72">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a65b96ce-136d-4e75-9324-e4181517a234"/>
    <rdfs:label>85 Percent </rdfs:label>
    <obo:OBI_0001937>85</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/22efeafc-e3ef-43e3-8c54-532249842dcc">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/c4791e28-441b-46c3-881b-14ea7bd19066"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/79cc95e1-51e1-4e26-a674-2e43ca4df15a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/31ce7571-3d4c-435e-aae3-2fbfc91f850a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/008b4b56-22b6-4f43-8906-9cb72af0c1fe"/>
    <rdfs:label>Fluvoxamine-tizanidine drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/ab64a4b9-a95e-45c3-8608-675b905310d4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/000ac45a-6690-4270-ad02-8a5e2c59ece6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/609f317a-9f4a-460c-94fb-23d03959eaa5">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/e70681b4-54d5-42cb-aa89-4479505ed3a7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/9d15d366-bb95-4fe7-92e5-9b0e154fa51c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/72380f48-8f5d-4a46-8e8b-20c9bff0ebe5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/54b9f694-011b-4d53-a74f-c536c4cabfde">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/353912c9-d062-495a-87c6-d81485cd78a0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/bca42331-b211-464e-9080-b97806a7c2ef">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/e3258c60-1959-4d26-ac0c-0ffa9d7ad0d9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e4ac6599-660b-4cf7-86f3-4f2d2b286c5d">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/b93440ce-41ce-422b-93b9-cd9b93f5f433"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/c571ff11-dc08-4a52-af3b-0f779a0e4b32"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/dd69a81b-c449-4dcb-aa98-ae0bc8c6ff8c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/10e484c4-be6e-421e-8eef-99e3db87180c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6878f08b-c8c9-4bc0-b0d0-bcadc0597250"/>
    <rdfs:label>4 Fold </rdfs:label>
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/213d82c4-886f-404d-93fd-0105cc3b4639">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0ee1fdc9-79ef-4fee-aeb2-f75a1419cec2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/ea27c5ba-086d-4237-91d1-9466729f50ab"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/34542de7-0f4e-4081-8a44-10215854e6b4">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/bf583425-bf28-485e-9562-187631ed531c"/>
    <rdfs:label>28.9% Percent </rdfs:label>
    <obo:OBI_0001937>28.9%</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3b7e4039-de0f-4038-a332-ccb9d4e3c230">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/838f53a5-796a-470e-ab8b-f6dae02e9ab3"/>
    <rdfs:label>amiodarone-dabigatran drug package clearance Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0c19da04-e693-496b-bd6f-f7a454e549f1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/6e68044e-0408-4532-a4d8-3e84fb6e23e5">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/d847a651-9a40-4a41-997a-1b90fd2eda2e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/fb88545a-f305-46ac-8dfc-f2a0c5aed20c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/8f513991-2e70-4ab9-b1b5-0c18be619a1f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a310fb71-aaa5-491a-9110-6253c3923180">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ca2a492a-b89b-4a97-9cc3-7cce9f345139"/>
    <rdfs:label>0.7 Fold </rdfs:label>
    <obo:OBI_0001937>0.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/429c0100-a00d-430e-a091-786a8ef5c224">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2020a20e-9156-468e-aec6-c1b852c1574c"/>
    <rdfs:label>escitalopram-desipramine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d83a2158-5d99-4b16-b8d9-7b87883c83f6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a3398a78-8612-4867-a716-c43a7153ace7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b4df2182-9d79-4864-92aa-18c7c019ae2b"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/e5e974a6-8341-47d6-8698-6be8a295bf72">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/6c9302fd-ab3b-4f76-84a6-d76408e5a405">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/1accd094-e2d9-40a9-8d53-f5c6f3abb047">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/2e527d03-58b0-4e39-bf87-252cd2159857"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/2f3c6205-2c58-496b-b774-a1e00208d586"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/bda71de5-ac3b-4f81-9774-0c46a687e1ef"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/998f6972-c216-404a-9f25-d4f1c698c11a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/6108e46d-2bdc-4b50-83b2-3f9f5707a3ac">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/7caf5f87-a4a6-4439-9424-466151056a15">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/63e985fa-8f12-4ce9-ba35-c207f74180ae">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6138deb0-0732-469b-866e-07cd3219fd5c"/>
    <rdfs:label>3.9 Fold </rdfs:label>
    <obo:OBI_0001937>3.9</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6d53680c-4c73-47e4-b010-f9882bdeb33f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d89dd4fd-00aa-4467-9546-cb9e2dbbf252"/>
    <rdfs:label>4.4 Fold </rdfs:label>
    <obo:OBI_0001937>4.4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/1bbce2ac-5a86-43d3-ba41-ab86aacd6870">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/915345b8-9fc7-4529-a484-7c2e38120862">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/9b4d3138-4444-46d6-a967-21421160343f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/a3fa2361-7e26-4946-8486-9bb82ce6be5e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/0acbbfde-fae1-44f6-b40b-1c539cd3e288"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/295f63e9-2390-424a-aa8e-9779ef82d2a2">
    <rdf:type rdf:resource="obo:RxNorm_42347"/>
    <rdfs:label>bupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/bb0f2ed5-64ef-4aed-b11d-99c01899d8d5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/28ea2988-b1f7-4777-a10b-52a91cc9f451">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a27b2fbb-fc23-4eca-9f71-d68f73af103a">
    <obo:OBI_0001937>5.2mg/kg/day</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/adbf1da1-228c-4e50-a6ad-f38505755508"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6c8ba36e-f762-40d9-941b-afdf625c5b90">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1cba581b-8f44-49fb-a329-f66b3314a0bf"/>
    <rdfs:label>carbamazepine-ziprasidone drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f4aa86ca-3d1c-4de3-a090-a4fbbbf09a80"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c8d11dc2-1f6a-4cc5-9f3b-8d099f7483fa">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6f318162-a94b-4174-a12a-1fe7498236f4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/6a72256b-3f68-4d17-8bfc-434a129add78"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b7a9132c-e2c3-4caa-8d72-967e2414e86e"/>
    <rdfs:label>ketoconazole-iloperidone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/ecc9a747-ee25-4804-b680-ae2b6222864a">
    <rdf:type rdf:resource="obo:RxNorm_301542"/>
    <rdfs:label>rosuvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/88d7535e-6d7f-40b9-965f-1383f16c62df">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c5a48337-1048-4cae-920f-aa147c5670a8"/>
    <rdfs:label>32 Percent </rdfs:label>
    <obo:OBI_0001937>32</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7653bd22-72a1-4a14-a28b-f32c28ab7243">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/0c577faf-9fbd-45d2-a6d3-a9cc75c82eda">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4070476e-74a7-46e9-b69d-78e85ad020ec">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/52ff3958-513a-452f-afa7-6921067fd2c0"/>
    <rdfs:label>42 Percent </rdfs:label>
    <obo:OBI_0001937>42</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5a744869-b20e-406e-8403-38b23ee43c7b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2d607520-51cc-47c7-8558-1302f42d172d"/>
    <rdfs:label>cimetidine-citalopram drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e8a9ae5e-2ea0-483c-bd19-07b6fe4f7c6c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/d3df2b93-c6cb-4616-988f-3fe9a71eb518">
    <obo:OBI_0001937>0.25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/fcc16f8f-dcb7-4fcd-b7d5-3701802e61a0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e9327f07-81df-455e-b0e7-9717bf4c72b0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/2f11fe91-0739-42fe-858b-696dcb6bb1bb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d77db73f-c376-47f6-a885-eaaad05ae1fd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/5d1de83a-a4f8-42d5-8311-1a16bd41a735"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6cf19447-cbae-42c1-9828-2282c2545d7c">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/432cf43b-79e9-42ae-9a27-09d09bf8a34e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/edc6b0b7-aff2-4c6d-aeec-bc796656c58a">
    <rdf:type rdf:resource="obo:RxNorm_3008"/>
    <rdfs:label>Cyclosporine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ba345e30-dde9-47ef-adef-43166efdaf3e">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/de4a53d8-692b-4185-a510-442c0c6d9fc7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1285a0e6-b9fe-4656-811c-b5796d55cc1a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f325ada3-8410-417d-a50c-6abea1b87435">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/2711b900-a1b7-41d4-8d40-65f11a8a4b7c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d493805f-8650-45a6-8a94-b4ee866bf785">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e63cf0e4-a9bf-4049-af03-21ae25a775a7"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/40c35519-0845-46cc-bc4a-703901306a4b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e36a2d05-24e6-453a-a9c8-a7aa235403a0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8cb6371a-ada8-4884-a30c-c3f857a42354">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d4b6cc8f-c54c-4ff9-a67d-9ba4dad7122f"/>
    <rdfs:label>fluvoxamine-ramelteon drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/26824e42-21e2-4c4e-9abc-5245757bb145"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/2890836e-4f41-4b58-8425-d051349d04c3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9de77aa2-20d0-47a2-a2d1-5b4c5e7accef"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/04fcfecf-3f74-438d-a32a-e9fbd2f4d909"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ea9d38fe-3938-4d72-9401-e11f9861bc78">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/3cd270bd-792c-4157-bfad-f4bf9e7d9076"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/01d2dc73-4fd1-4f8b-9335-d6dc0751cfe0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/7b0c95c7-0d65-40f0-80e6-8fc114488dc4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7e0a6379-4255-4551-a043-db6ec381f5ed">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/f1f7b236-446c-4229-9877-96d7fba2b203">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/4b1a15b6-51eb-4241-9c9c-223884db0d41"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/88d77725-6f70-4278-b85e-dd2232942a38"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b6034a7f-d648-47d8-88bb-136c8a4d9d31">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/028c3429-5b12-4f90-b1df-1cc5815daa78"/>
    <rdfs:label>pitavastatin-R-warfarin drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0ecabc1b-db32-4859-bced-d0b5559c92f2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/de790b04-6914-434f-85c4-0edb668e3cd0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/37393cb3-5ed6-4c5c-a83f-bf92cf0fb887">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d4ce8445-fe37-4683-a31f-a2a58b70e1b0"/>
    <rdfs:label>78 Percent </rdfs:label>
    <obo:OBI_0001937>78</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/69270385-4061-4c9f-99cb-5dcf4cb3dbde">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8fb07622-be68-45b8-ab27-a842e3638493">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5c63f7e5-f818-4012-be1b-9ac10f8b0665"/>
    <rdfs:label>bupropion-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/023e2700-9d97-4fb3-bd8c-a5a43a2c706f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/bccdbf71-cd06-413e-807b-2195570ac616">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/06b7aa95-d742-46ff-9482-b81b86655e58"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/607c4a64-a38f-41ab-95be-420568c37afd"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/fc6381e3-7c78-403c-9210-c8bee245b02b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a83f6487-1569-4265-8b24-624104c9a2e5">
    <rdfs:label>carbamazepine-methamphetamine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/da2eb2ad-b5fa-423a-81da-2d6f558faab5">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/45302f6c-3578-4a83-94f4-5646a589dbf0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/7b502faa-d6aa-4495-9695-0c1267fe7b9c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/6b7d3da2-87c7-4fe7-bb35-98301b1e1b57"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d6cbb86b-ccf3-47b4-8c62-61fe3dd34e56">
    <rdf:type rdf:resource="obo:RxNorm_2556"/>
    <rdfs:label>citalopram</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/764305a4-d323-458d-8b05-615b5f80dd97">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/5ffadcb5-6b03-4d0b-9a64-8afb5a5bc195"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/dd13b05b-4c9f-46d8-b28d-b4a11bfd7810">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a310fb71-aaa5-491a-9110-6253c3923180"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5207a518-77d7-4e01-8d96-d991e604262c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/22eab58a-aae9-43f4-bd4e-7ec0b2e758ab"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/10d92e48-cb46-4227-87a2-9b99de3b103e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a68a7360-5985-41f5-9771-adc070188066"/>
    <rdfs:label>23 Percent </rdfs:label>
    <obo:OBI_0001937>23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0e6d85fd-0877-48f7-a4b1-e51b1095feda">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d2a2c72d-a0c3-45d2-aa61-96c1f2c5e233"/>
    <rdfs:label>40 Percent </rdfs:label>
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/bb19cad8-b69d-42c5-8455-bf454b2ffecf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/614fb20f-1951-41e6-88db-5a8de7a5217f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/e94fdcfd-b9ae-4788-bd98-b7604c298a64">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/9c463f84-5f70-48d8-9fad-f170cec107f7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/ed05901d-c2e1-49af-b192-2a20be450821"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0b6e3211-ad9d-4ee8-9368-5fd4e38cfed7">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/54cd1058-c389-46c4-82a8-84733b2a5de7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b4492a7d-3fce-48c3-9382-b5e058329a27">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/fd3affd7-2f19-4193-a394-fbf87d5975e1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e3a7292f-8876-4bc5-b66b-95a56a91c52e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f695f975-3f35-4ad8-8211-4a39ce3b5f6f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/d1bcd60a-9ce6-4e0f-a864-473f6388213d">
    <obo:OBI_0001937>1250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/8024dc37-1be3-445e-b93c-e5028e9c2b12"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/a45d121e-f6de-4d2b-8d9a-e2054f140275">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/62f05145-79f8-448e-b1aa-11efdffde89c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/3ce76261-54dd-40ad-b3a9-ca2f61a8f4ea"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/15e984a8-9b8d-4a4a-a60f-90e6c05ea424"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002351">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6c68a7a1-6018-47ad-8c84-1848caf86f8d">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/614fb20f-1951-41e6-88db-5a8de7a5217f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e16b1d39-1246-4220-adcc-5fb32cad792b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/31817510-ef13-496f-83b3-d6aba321c623">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/18e6cd1e-4afa-4fd1-8442-2d1c88d2c9e2">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
    <rdfs:label>Fluoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/c22ad2fe-f93f-451b-85c0-758e42ab66a3">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b76fb580-8c3c-4dbc-a190-d68ef0b2c58d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3f07d279-3f2e-4f5f-b77d-a79c729f5d2b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/4a2defaf-2faa-4ba1-9c7e-4b173de203ae">
    <rdf:type rdf:resource="obo:MeSH_C558899"/>
    <rdfs:label>lopinavir/ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9dd6087f-92f0-4a5a-a858-d19919406b00">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f4b2f630-34f6-41ad-ab9d-1316a8989f69"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/fb88545a-f305-46ac-8dfc-f2a0c5aed20c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/da65ae01-b714-412f-a55b-da61a847592d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/2e527d03-58b0-4e39-bf87-252cd2159857">
    <rdf:type rdf:resource="obo:RxNorm_81864"/>
    <rdfs:label>alitretinoin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f9cfac66-1b42-4a49-a405-3993cda5e4f8">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6ce051b9-5152-4321-a6be-90b3c82d6cc1"/>
    <rdfs:label>2.4 Fold </rdfs:label>
    <obo:OBI_0001937>2.4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/26b1442d-8e63-493a-a24a-697e5ca35732">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f1d832df-9dc9-4c93-bc75-35b9f28b9ad4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d86150a4-87d2-4613-840f-68da6e0ab2b0"/>
    <rdfs:label>fluoxetine-P95 drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/930158f6-d8ac-44cb-a0ff-f0789c519a29"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/869b6e3f-5d70-4848-9ba8-f022e45a6a6e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/9646aac4-d530-42dc-808a-5dc925fcdd75">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3e1b8516-a41c-404e-a90b-789a9196c8e8">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/008b4b56-22b6-4f43-8906-9cb72af0c1fe"/>
    <rdfs:label>Fluvoxamine-tizanidine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/fb9d14ba-7b3a-44f0-8882-263ad29b11ed"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/0cca9d1c-48d6-4e2d-8791-d2041d66da2b">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/b08fd216-580f-4b65-81e4-5f2054da0882"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/d88d3156-2b6c-488a-9729-e7383f53a4c5">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/1e30374d-84a3-4617-9a70-e9edb09337c2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b36e9916-bdd4-4342-87fc-7f39c19671ae">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/09c43a1c-55c2-428f-b3e5-61fa7f0970a4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/bf583425-bf28-485e-9562-187631ed531c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/fffe6762-a206-411d-b78f-3329c96ab5e0">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f0912d04-dd91-4f86-bf94-9f329e9d90d1"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/24da1540-142f-4ede-8807-f92e80474d67"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/2c53f7a9-4dca-4a78-bd28-e721b8387980">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/c17bac51-dcf2-409c-9945-600a64e4e30a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7d8f1942-a157-4e7d-ac66-a5faf1f02d41">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/06718859-87ac-43f0-b151-e785206769b4">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/b598b10f-40ab-4713-9c0d-da6145d3e5f6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/41c36a64-175a-43c3-8272-8e08114f34b4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/905f33d5-6fe3-4295-9922-21493ee17cb3">
    <rdf:type rdf:resource="obo:RxNorm_8183"/>
    <rdfs:label>phenytoin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/50159e5f-4d2a-4c25-b2f6-ff0a3f685bdb">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/c9c09000-8d2f-407e-9cc7-d7c55ab19c73"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/5cebd0c8-401e-4604-824d-fbd6fb5de72a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b7b99f39-f6c6-4f7a-b33f-dc20bfd7bb8b">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/69a6fe24-afb6-4f46-85d3-55e2b860f70f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/cc04ba8a-5ec6-4698-bfba-4986198fe5f6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/f92ed9a1-9cdb-4c23-bdab-64fd685c358d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/f4bf70b9-e034-4515-ac66-35f3e69111a9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/5dfdcf46-7d83-4e24-a395-64a4ac2c6ec8">
    <rdf:type rdf:resource="obo:RxNorm_36437"/>
    <rdfs:label>sertraline</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/0ffcb7b5-3f5a-404b-af92-844ef2bbf1c2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/8b3679dc-4e1d-4e95-b29b-7864ce021845">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/d0676440-7f7d-458a-93ac-5e55b6eeace4">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/d2e35a29-7362-4c08-8378-5217dc3cc2f1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1b8b15a2-b1e1-4617-9ec2-bc55fd36e3ec">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/43a40816-45fb-4fa2-8892-45cc5c41d809">
    <rdfs:label>fluoxetine-iloperidone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ca4564d8-afa7-498c-8e30-709f8fc23cb2">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/a9fe980a-b2f2-488e-8f3e-da970ab11cb2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/15457828-276a-4031-b303-633dbb595c35">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/bdc9384d-8301-425d-aeea-248d559633ac"/>
    <rdfs:label>123 Percent </rdfs:label>
    <obo:OBI_0001937>123</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/083c1cba-6949-4f95-a5c2-6676975a83b3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e777748d-13b7-4eec-8572-543402dde2d1">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/32825558-c831-43b2-9c12-fd3ac6d635ce"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d6b4bb1d-b1f5-479e-b655-03278de2a774">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8a0cda4d-3ace-4b73-aa2b-df68189fde66"/>
    <rdfs:label>ketoconazole-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3f91b1d7-47e6-4018-9caa-89eda86a8659"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d06eb9a1-6126-4ca2-b205-871fb50c71f1">
    <rdf:type rdf:resource="obo:MeSH_D016572"/>
    <rdfs:label>ciclosporin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/8ab665ae-3f9e-40c9-a6ce-bf80d43c7c1e">
    <rdfs:label>fimasartan-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/09c4ea00-518c-4800-ac1e-4104851f070d">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/48312966-3f6a-4a69-91b5-1f16cdb066f8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/76f6ac30-485f-43b0-b0e6-f6e83945998c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/e5298329-a5eb-4356-bbcb-2f85007d6517"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cdd074d2-3cfe-41b3-a588-89f9fbd1d9cf">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/9af0988c-5ad2-4ad7-be9e-0b1730f29c53"/>
    <rdfs:label>28 Percent </rdfs:label>
    <obo:OBI_0001937>28</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/6bafe752-fe1f-474c-8366-66d86fad9178">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/f98286d6-983d-4699-83ca-422af06e13f9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/80d887ec-41c2-49b8-b41a-cc6e9ab26c6a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/82fe2438-268c-482b-94b8-b12b8e930416"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/7f2826af-5530-45e8-ad5b-982346e7b9f3">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>Atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/40edd4fd-b06a-434e-92b0-013082f1f3d0">
    <rdfs:label>Nelfinavir-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d6631abe-20b0-4f7d-9238-ba422ac95a27">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0065b19e-b70d-4833-9c00-425481ab9acb">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7ece7822-453e-4ccc-a598-3e3fcd644393"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/649a9b57-abf7-470b-9025-5c668e9e718e">
    <obo:OBI_0001937>1</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/c9af70d9-f314-4ef0-8a74-16a89293d574"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/730494d7-c9f4-4200-bad7-fc81ee92d8bc">
    <rdf:type rdf:resource="obo:RxNorm_61381"/>
    <rdfs:label>olanzapine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/4fd25565-f154-4441-a22f-39437243dc71">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/2655c038-8985-4015-9a4d-02a0ea82676a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/46ce77b6-1e28-4555-b9ec-287ca965d765"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/6528842c-67b4-409b-9899-7ce2ce9ca024">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/286ad14b-f694-49d4-96a3-58638d43db6d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/4ae8d021-4225-400e-8ada-8d253abf0d41"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/99edeea5-9daf-4533-883b-6d118dbfdc68">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e0b4058b-f0ba-41a8-a8eb-35b10ca3e990"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/416abd03-dcc0-41fb-a8f6-a59d206f0c0b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/804e2a39-4a20-44b9-acb9-84f961b4de61">
    <rdfs:label>Cimetidine-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/24024ef4-2ca6-405c-934b-228fe81a0400">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/53ec2e30-a2ef-454f-8910-81985ba4da5e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/9204db00-ab23-4f7b-a460-4538b7017dbb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c69a87ea-cc51-4195-9551-23c4e4bd65ab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/71bdd755-3e63-490a-bcd3-88cb76fc12de">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/26986bd3-dfdb-4de3-b47d-c4ff247f8926">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f15888b0-a765-4cfa-9d87-21fd33f43740"/>
    <rdfs:label>propranolol-m-chlorophenylpiperazine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/bf112beb-05c1-4df6-9c4d-2b2cc9cfda64"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/421837fc-e298-4f4d-8232-2e2df0fe2c74">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/4c51d6a9-8ee7-4a49-8ad9-51abbb922cc9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/7aa4471b-c32a-42fa-8bf0-fec684b873e3"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/e35dc0b7-23c2-40f5-b8a8-19c0c35a1ff4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0c7900d1-58d5-46da-bea3-6f1f724605ba">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/2a7938c3-e46e-4027-b1c2-bee56f55bda3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/4ffa4ba6-9554-48c1-b257-8409c2ba8d8a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/1f61fe30-6e89-4ebc-832b-a11aa728730d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ae373789-bace-43b4-8de5-2b1fa5b967c8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b6ea9bfc-0bfc-4153-b28a-f5aad5c4a5a3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/e58d9652-5ef0-4422-a43d-e15996d65bd3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/16213f2e-38e9-4987-ba77-a87c337b1522">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/c7624923-3f69-4919-b1dc-cda12ca030de">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/287a3efe-b41c-4204-9aa9-24c50780d8bd"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/b0cd8288-8782-4b89-b9da-b9360894ac89"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/adde5fb0-9925-4050-b5fe-390db0196eda">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d493805f-8650-45a6-8a94-b4ee866bf785"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1d90c0bd-67b8-4e91-b7ab-07e151d92efe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/8942920a-9a29-44a6-aa6c-3feae776b8a8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3be3d27e-51d8-47ec-825b-a29750b8d4c6"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4a6f8cab-a139-44e2-b713-01a4048124e4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/213d82c4-886f-404d-93fd-0105cc3b4639"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/0008f46e-17c2-4253-aeb0-2f7baa8e3d58"/>
    <rdfs:label>efavirenz-bupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/f4c12f17-6eab-43c4-8196-69388d07483d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e6c4cd60-e13f-4410-b16d-79b14e1d7548">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3ae6c92c-bfd5-4f98-8078-c05fc8984e01"/>
    <rdfs:label>desvenlafaxine succinate-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b2455b7d-7c63-4fc5-aea9-e13a83098e81"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9d8b6aba-65ee-4d4f-8dc2-81a75dbd23c5">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4afe8cc5-696c-4842-a754-80b19ebe5bad"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/34faea42-b354-4430-80bb-be6760da2c02">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/c9af70d9-f314-4ef0-8a74-16a89293d574">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/710d1cac-8f5e-474c-ab90-03f1089f7937">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/769d98df-3646-4724-9ca3-0861ac6c1c1d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/5823a121-b618-4767-80c9-d3989fd2934c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c2458604-0558-4663-9ef4-5605638f5216">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/5f11e92f-a308-4b9a-971e-ef19570190d6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/1cf27aa0-8f60-46f0-9ccd-87e9b2ca3b8b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/84cb3c5e-137b-48c4-8e50-47f17e20b1e6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/250349e6-77f6-4952-bc46-2ad69df1b44d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/98e5f156-d5f7-4dc0-8634-e0c309c623ab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c2cac448-f255-497a-a0c5-9e97604bae73">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7ac49247-faef-4a96-91c5-be9c2e7cf03c"/>
    <rdfs:label>warfarin-ambrisentan drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/586636b7-1ae2-45d8-a3f9-7c605c35858a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e4e1a279-b066-4409-afa3-942774b5aa40">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7f7c8ff0-be0b-477a-814c-6f7418092f6a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b8781828-801f-41a4-ad14-b1060fcde296"/>
    <rdfs:label>ABILIFY-fluoxetine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/7c3c1553-1289-43e5-a9b6-69f1910c8b9a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/fd14917f-c90b-4c6a-a59d-73f37d41d78a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d4df4bb7-151e-4963-8df0-405c4fb87378"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e244a1e1-0fda-4487-8eeb-7e90feb665c9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3102af17-4aba-411a-8ec1-9721b2bedf9a"/>
    <rdfs:label>nefazodone-simvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/9b0629be-ab6e-46f7-a596-15074032d4da">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/638ef7e9-a519-4a34-9cc8-d6bf0aa21cef">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/bf140959-a2c7-4c5e-8d5c-3450d589b111">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/3c258985-392e-47cc-a3ee-19b9a59ed153"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/75e7a84b-bad1-4b0a-8219-a0aeebfdf35d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/bdf54fd5-f73c-4e22-b2ef-08c86f26260f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/838f53a5-796a-470e-ab8b-f6dae02e9ab3">
    <rdfs:label>amiodarone-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/687a8b3b-32bc-47ab-945d-18c31dbe0272">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/0ef3ef5d-5963-40c1-b684-8eb3ae9b1709"/>
    <rdfs:label>Fosamprenavir-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/39e0c66b-bcdd-4f76-a4eb-02a5cc746914"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/dde5ef6e-3b78-41f8-a9ce-c4532573cddb">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/645313b7-8940-4a4d-bef5-22957fc2950c"/>
    <rdfs:label>sertraline-pimozide drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0e6d85fd-0877-48f7-a4b1-e51b1095feda"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/61d7858c-336c-45f7-bda9-65f414fe5af0">
    <rdf:type rdf:resource="obo:RxNorm_2556"/>
    <rdfs:label>citalopram</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/27ffa609-de48-4152-a1d5-2540dc1c6345">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/1c25e792-4209-4317-872e-5696210eff74">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/bfaa3e34-e32c-4920-b782-1f885142b051">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/476fadc3-11b2-4c72-b060-12c98723bf5c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/0162c0f3-5df9-4ab7-80b5-499de3633cc5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/7d1debfb-2623-40a9-8cde-e02b74576e2a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/d147ee65-7589-416c-b272-edc5c2405ede"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/74d5e04e-4672-445c-9cc3-01d72cb0ee18">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ce7e8043-57c2-4bfb-9b69-492ac4dd9952"/>
    <rdfs:label>Telaprevir-atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/42fb6219-0226-4cde-9dea-0f2ca53f815a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/7cd78f40-794c-4f73-80a6-8e84ad0f160f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c69a87ea-cc51-4195-9551-23c4e4bd65ab">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/85a1e6ee-9b2f-4e3d-98f8-dd2cd01bf19f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/783d0336-99b9-4995-a8bd-2de3d57bb885"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2d234798-cefd-42bd-b0ef-78286a1aa5c2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/4a3a957b-1da2-4c8e-8e9e-eb4da899dc15">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/015b212f-5b31-47d3-9d22-0259b2a72806"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/7b44e842-9faa-4830-8a7e-34b4af030fb3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/9ec6f2b4-5164-4d62-9a54-372d78320952">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/5bccc0c8-253b-4477-9b60-e7e6f0b58619"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/215d9ec8-4b05-4543-8607-edb93d2f1eda">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/1e37a8e8-c79a-4cea-8e58-f9c332241dbc"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/142fa3f4-4af5-48c3-a5f7-efade73dff0b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d7cc1ff8-3de7-4ee6-a346-e0f9f466c0b2">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/372222b5-03f6-45d1-8e6c-36e49950d310"/>
    <rdfs:label>67.6 Percent </rdfs:label>
    <obo:OBI_0001937>67.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/8bf867fc-0d43-4705-8c95-fef9cda1c73b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cb1ace97-9284-448b-94b0-fe3a9c7b3874">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a1a6691c-ddf0-46e5-ad2b-246e2d38983b"/>
    <rdfs:label>1.27 Fold </rdfs:label>
    <obo:OBI_0001937>1.27</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/9a675754-4f7d-49cb-a15b-1ba9184fa5e4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/76c24fac-388d-45e5-8a53-620d4f81d292">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/1cb1a6e6-6387-472e-84e6-662aff5c2d7d">
    <rdf:type rdf:resource="obo:RxNorm_4719"/>
    <rdfs:label>Gemfibrozil</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/97ca0039-9b6b-49fd-9696-856be8f2a952">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/685b6d53-9a29-4e53-889b-f0e0206eb1eb">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/934dd5f6-1507-4ff3-9905-e57861597b32"/>
    <rdfs:label>iloperidone-dextromethorphan drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/55c51d0a-f548-4c21-af0f-15c83640cb3a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8f3f9f3c-ecee-4240-8f71-6d7d58661ce0">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/feddb42f-69a6-4c4a-ab09-9ddf52f65534"/>
    <rdfs:label>100 Percent </rdfs:label>
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b4dfddb0-b74b-4512-bc4a-03b1a5ec8776">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f0093365-3ae2-4fd3-b04e-45a9ff39e674">
    <rdf:type rdf:resource="obo:RxNorm_9639"/>
    <rdfs:label>selegiline</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/4b1a15b6-51eb-4241-9c9c-223884db0d41">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/30a44209-8a89-4fa3-aac9-493d33d89410">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/96c80671-8292-4623-aa0e-cafa70122d6a"/>
    <rdfs:label>UNKUNK UNK </rdfs:label>
    <obo:OBI_0001937>UNKUNK</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/a7c2820a-50f4-448f-9650-e3e69c43fde1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/8ab32a83-8782-4209-baed-6d6989c3b1bf">
    <rdfs:label>ketoconazole-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/430a145b-07f2-4586-8f1c-e874afc56054">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f27ade03-ef86-4550-a9c1-b784f53a9621">
    <rdf:type rdf:resource="obo:RxNorm_115698"/>
    <rdfs:label>ziprasidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/9066342a-27be-4a78-bd90-d4f5dea37099">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e2d15bd5-fc04-4ac2-a0dd-cc76b851bdfa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6897ca0f-a4a2-4e88-8280-2b90208ca431">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6342c7b8-0429-4e17-ab42-9f7b314cb790"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/18a97af2-17c2-4c1f-b8ea-efbb2c6b5db9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/9de87178-1e94-4120-a42b-e4c18746ed9e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/2917b8b7-ebf5-4907-9bbe-04cb23dfc14c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/56512661-a82c-414e-b4d7-e3c960923548"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/db4ee669-2747-4859-abc3-8240a664f99d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/b768113d-9566-4f5c-abaa-039c9615cdae"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/41c36a64-175a-43c3-8272-8e08114f34b4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d4428491-d559-4028-8d94-f9e69300da6f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/6667577a-c0ba-403c-a310-a0a1002363cd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/fc7acd73-1118-4463-956c-be5c70e73b89"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a5ecde29-70cc-4242-aa6b-b6fb615e8770">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/df8247e4-df0e-4904-af0e-6831b53cd073">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/170f85c9-3932-41e7-9e7c-1d84e50a6f51"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/1420d5a0-e2d1-429c-b7da-04251a8487a4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/6893912b-9e5b-40d9-93b5-4cef52b752cb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/9a12da7c-6f7f-4dd3-8759-d5f835feba7d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7bd352b2-5f9b-4326-b675-68d453244759">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/a849e9f9-868e-4eb7-88fd-bc5c89ef287a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/0618bc8c-49c2-48e8-be0a-5854da82ad3c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/b4b0936d-f5cd-4670-a594-ee3730b6b096"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/c388cae5-ba01-4862-b0d7-85102abfdead">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/d06eb9a1-6126-4ca2-b205-871fb50c71f1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/eeaa4ff6-87b6-495e-a377-b979c9ff8e10"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/b68c16e2-b5dc-4ba0-ae8a-fe8e9bfe3f15"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/5eb2c603-735a-4f14-bcc0-21ca83c72961">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/7b5e52e0-253c-4c12-88b6-769199bbc0aa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/2e8f69ce-ddbf-4949-8ee2-789428df0853">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/a51ddc17-5bea-4835-a849-b2e5fd7889be"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/2edd9076-777b-434c-9464-18bc20acb73e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c15a88db-47e1-486f-b84c-d150dcc04ce9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/e3bdc836-73b6-4a0a-8d48-eaedc9fe6e67"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/6fd7dbb5-a802-4615-bdaf-0e7106eb59be"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b6c50ffe-06d4-4085-8848-cc254b6ad369">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/677007a4-f165-490d-add8-93c474f65a53"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3b8219a7-dd95-4e4a-b40f-38dd01640bed">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/19736040-092c-4d41-b77e-0ebc01c91e78"/>
    <rdfs:label>27 Percent </rdfs:label>
    <obo:OBI_0001937>27</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5bc7c2d7-60c8-4872-a888-9227d67606bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/b26b7974-935a-41ff-a831-046b736aef65">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/e154ed6b-74d3-4936-a7cc-88392a7141d5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f252a9bc-146d-4a73-85b5-ae74e79e0b64">
    <obo:OBI_0001937>60  or 120</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/e83c3c5d-f2dc-4880-a8b3-ed532546c464"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/02bac117-855e-44b6-8a7c-9bde2254dc87">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7c256de4-350b-4c3e-a04c-ecfa984c7f00"/>
    <rdfs:label>8.7 Fold </rdfs:label>
    <obo:OBI_0001937>8.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c7971b22-7a3e-4dd9-9cb8-402628b4308d">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9a575a15-1f6f-4051-908a-9d1244796557"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/fef1a4a8-4792-4808-8bcf-7857635a1c7b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9b81da8d-faec-4a89-af01-e67c37c3b1f2"/>
    <rdfs:label>mesoridazine-Fluvoxamine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/be686481-a168-4cc4-a52e-22c75e363f6c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/dbe348d2-c7c5-4236-a4cf-0b76d4a62a66">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b13fe44b-e43e-41ff-a3e2-6e3a525df0c6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/ad3988c6-1d3f-45f7-9003-50aa6c3494e1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e244a1e1-0fda-4487-8eeb-7e90feb665c9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/4fa28bc8-3c1c-41cd-9877-c8067cf22b9b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/d533fafc-5d9d-437e-ad97-edc4c2f2bb40"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/5dd2ea2c-43df-4c85-bef9-30564baaae9d">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/b32e4b59-ef86-4a75-8abb-9a5f5a310ff4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/8c499a00-645b-43b1-93dd-8e3332c2590b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/130e912e-0849-4d47-b456-a054f757f320"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8fe6bbcc-2182-4fce-b756-b5b97f864478">
    <obo:OBI_0001937>1000</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/f2f45a0e-4a1b-4992-870a-c3c21577b1df"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/af190f37-1177-4a46-a5cf-aaa661a4f241">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/536b7d26-04d7-4954-b85d-844dc78d0d24"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/343eefa3-b163-4ad6-a6c3-a7b0a0030660"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c15a88db-47e1-486f-b84c-d150dcc04ce9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c936a393-1081-4b73-a575-c7438b65a654">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d4ce8445-fe37-4683-a31f-a2a58b70e1b0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/cc2844ea-f92d-464a-a77d-75e1b5858ffe">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f6be78b0-c26d-493b-986a-622c04d3f3ab"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/061ef076-8002-46f6-9bb9-9ad62001dba3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/59efa2b0-d2be-48f5-a774-4ef6b3bf22d4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/9c1cd9e9-8a0d-4c85-b0c2-20d317f4257f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/17c948a5-143e-4814-8a3b-cae6d2a22c22">
    <rdf:type rdf:resource="obo:RxNorm_4450"/>
    <rdfs:label>fluconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e1005b45-019b-42f5-a959-9b906f6390ec">
    <rdf:type rdf:resource="obo:RxNorm_8787"/>
    <rdfs:label>propranolol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/f8c2abeb-5893-4df1-9538-2ca6a26ab01b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/bd2ffabd-eb2d-4fa4-abcc-f8a5c8e8b4d7">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/080686b4-82e0-4ae4-bc3a-b47ca01ce645"/>
    <rdfs:label>ticagrelor-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2bb351c2-2b94-423e-b45e-d90eeb9b9a03"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/73127c7a-43ff-4b21-a2e5-236fc88650ce">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/25146eb4-b541-465f-b01c-7e57d950a45f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/ff2e4c38-dbfe-49a0-b869-a2f0183631f5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/ae0162bd-a86b-4127-83f4-f0691220400f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/44e3dd5b-a3d0-4bb4-b212-1fd62c522ec7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/9d15d366-bb95-4fe7-92e5-9b0e154fa51c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/07418f09-8dbe-4081-881a-f8766d086164">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a13ec6f4-c468-47c5-a5fd-ca3bf2b8715e"/>
    <rdfs:label>fluvoxamine-duloxetine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8c9ee1a1-521b-463d-a5e1-e5e94c5aa659"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/14d95050-a9ba-493c-854f-c09b81f434a4">
    <rdfs:label>sertraline-zolpidem DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/bc94db7b-bf39-4360-8a54-f4ea6f740972">
    <rdfs:label>clopidogrel-fluvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/34495971-4b62-4a90-bf20-05f14f076a48">
    <obo:OBI_0001937>8 or 12</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/50d0523d-0855-426f-919a-dfe63f19b2a5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c31f453a-cee3-4fea-a0f5-0692f131645e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/d3d682bb-9bc4-40a8-8204-6014e025be7d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e0864362-e038-4301-bb9d-8429e87726d3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/05c5259c-1553-49ce-948a-7dcb6fc63d8b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/dbd9f6aa-dc38-4c25-bc39-a128e7d736d0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b126aafc-d513-464b-a66f-5f807d70d6e7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/8fbabd17-2301-4e97-b3ee-d55698343dee"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b5654b8e-c066-4c22-a056-b95db093c4e2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a35fffef-d690-4793-9f35-199df9e38c99"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/0b8aaf6b-533d-42ad-b0c6-7df3e6ee0793"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/9a8b1906-4dd0-4600-be00-4293984e03b1"/>
    <rdfs:label>theophylline-nefazodone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9c12918a-e658-4abd-9835-ccbe3108f42a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/795422df-c55b-474f-b087-ee64a24096a2"/>
    <rdfs:label>Clarithromycin-Atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2dd0ceac-cc7e-497a-b30b-0cb7cc6eee13"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1feb46e1-d072-4e8d-bc7e-431bc1469fd2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d346fae0-cf17-43dd-9783-0496566877c8"/>
    <rdfs:label>sertraline-cisapride drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c780eb58-7218-4950-bf22-9503e1928595"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/13f48ea8-f87f-4b1a-9a97-29c6a4491bf2">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/f0bd1461-58a0-4dda-8610-33d28a4d5bc4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/8449a545-aa6d-4aa8-82d7-8f56ceaa91c2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8dd3dd86-bf90-4ffe-8094-b72bcb368d8e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/9945c24b-e344-49b4-b05c-ff19667250b4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/02577fb0-a03b-4d8e-8807-88c769444945">
    <rdf:type rdf:resource="obo:RxNorm_81864"/>
    <rdfs:label>alitretinoin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/54a1bbe2-608a-460a-905f-121979eb0d49">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/3a0a1102-6813-4ef7-b62a-15685cdfddff"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/710d1cac-8f5e-474c-ab90-03f1089f7937"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/f8b84337-4204-4a13-824f-640172308192"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5d303a7e-9813-4c37-9252-7aa4d7e4e8d3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c571ff11-dc08-4a52-af3b-0f779a0e4b32">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/7d70781f-dd7b-408f-bbd8-7af2b3a50b23">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/20950165-05b0-4101-966f-bcc2a31d4446"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/7f3f3664-4ca3-4933-9adf-9443bac30197"/>
    <rdfs:label>simvastatin-alitretinoin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2320b785-29ef-4153-86ce-36dedaf6041c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fa646c6a-0601-4247-8b42-bea37c05de15"/>
    <rdfs:label>cimetidine-sertraline drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a402b89e-5fb9-41d5-9419-9b34c2cfdae4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3be120cf-7fc1-4e3e-ab12-e39478a4c269">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f0e4c96a-638b-4e90-810a-d7aafd9ce9a7"/>
    <rdfs:label>ritonavir-hydroxybupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/37393cb3-5ed6-4c5c-a83f-bf92cf0fb887"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c5118780-a523-4fe9-8e84-591a938bef23">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/af44b4dc-6147-4666-b266-f8985bd0bcc2">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/50b2ed02-2b81-4d6e-9c34-cc8bed50e500"/>
    <rdfs:label>unchanged None </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b93d629b-1862-4ae6-ac14-bcd78cd02f8d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/13ad7e25-fcbf-471f-bd7b-28468fbd0e6c"/>
    <rdfs:label>2.3 Fold </rdfs:label>
    <obo:OBI_0001937>2.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/8d05e013-baea-4cd4-ba1c-5ce640d1920d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f49a291e-9f27-42c9-8a56-3936d7a63610">
    <obo:OBI_0001937>7.5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/2799d2d3-85e7-405b-aac0-d9b7a2341f11"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/6bbae89e-4614-47fe-9d40-d91af78b837f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/bce74a75-0d1e-4d0a-98dd-b8cb8dce86e4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f0c1176f-229a-4598-ba81-fe232baa08cd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/01daaad0-5cfc-46c8-9ef6-2118de9c0e44">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/7a401a0d-649d-4321-acd0-705e6d1ee048"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/a6021978-c335-4f98-a7ee-e58309301baf"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/3c4b9fd7-a712-4c77-a9db-bfe9fd7bd16c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/57289382-1e9b-4d53-b489-ec44bc08f604">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/56178539-6d74-43f5-9b34-57dc5eb92499"/>
    <rdfs:label>1.8 Fold </rdfs:label>
    <obo:OBI_0001937>1.8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c478d6b3-0db3-4ecc-aaf5-77ca035e1254">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/416543a3-96f6-48a7-abb4-860fe4d2bd08"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/339f4d23-38e5-4ddc-ac44-8775636bda77"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/ed10f07f-2eb9-4e49-a378-ddf89878ceed">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/0c75ca52-3d8b-42f8-99c1-cd5505bfe641"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/90366c17-8e6a-48df-b164-736dba14e129"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/238bf766-d105-4795-a5ed-925c48423df0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/01bfe197-bea4-4aba-8247-e20a7eeff896"/>
    <rdfs:label>sertraline-tolbutamide drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/42123002-97ad-4880-ba76-6c588e62bddd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ad31d4de-8e22-4b01-8a59-8c7212930710">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/50395ff3-2979-49ad-90f4-ca681f119a00">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/ada9546a-53f1-40b3-94e0-19da426bea6b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/7caa5f4e-07b9-4a47-b6bb-92d1b8e8f3b8"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/320434b5-89bb-4f97-a96b-0f480f37772a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d4363833-18f4-4e99-ab5c-460bf46a5045">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
    <rdfs:label>rivaroxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/8a11a1dd-cc5a-4dbb-a12d-2ee949214263">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/4e349618-ae67-4d6b-8183-eaea9dc288e3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/0ac0e103-d2db-4030-a84b-1c24ea6dd88b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/720f4de5-1ad8-4232-b9b3-3d2156109571">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/34c70f38-ebd1-4116-91c8-bd077d5a27cb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/46a1b319-dd12-4042-a71f-6d874c2b4dba">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d32b5510-6117-48f5-bfc8-1dab597d1b80">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e3e5acda-13b1-4d2a-a864-3821f77fc4c5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/9a675754-4f7d-49cb-a15b-1ba9184fa5e4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5e12780c-d4c5-4742-a14c-a996d48f26df">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/006a2123-0d01-4cf9-8e11-2e56dde1f900"/>
    <rdfs:label>36 Percent </rdfs:label>
    <obo:OBI_0001937>36</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/c2f78b30-f73f-40d2-a74c-cbccdd17f16b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/2ec35a0c-50bc-44f8-9d88-3045771c351b">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/391c9975-b850-492f-928d-8a779f9aea9d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e56a6e8b-ca19-4028-af31-efc840af1b99">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e2220d51-e0b3-4c44-8462-63332be3aebc"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/edd2818c-a2f3-4025-9a61-db4edf342d36"/>
    <rdfs:label>fimasartan-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/55e8d038-5254-4020-a4c6-bb8d63e0dc12">
    <rdfs:label>mCPP-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/75d374a0-738c-402c-91ca-517c335f3fe4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d6212278-bf64-46ab-97aa-cacf502295ae"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/eb466507-f808-4590-9546-f8066ae0f2c4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/1568b15f-9ce5-4c28-a25d-9eab1f01efb1">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
    <rdfs:label>fluoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ecdebb15-0bdc-4ad6-9ed8-ef328451cfc1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c2cac448-f255-497a-a0c5-9e97604bae73"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5c2e5869-abda-4060-ab28-5313f6010709"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/73550e21-9f8b-493d-8239-7d90a10b3889"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/5d4bc1ba-00f1-4ba0-b4f3-915d9c61ffad"/>
    <rdfs:label>warfarin-ambrisentan interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/9ff7ae23-6fa7-41ec-8b9a-1e154b5df74c">
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/0e57a6b5-e0eb-40f5-b1bd-19a2e8c43315"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/0678880f-408b-41af-aa8b-3af428081e92">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/45e7d3fe-730c-4be2-b1d2-e78040479e8b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/fdb0f8ea-5ba9-4518-ad4d-b6e9b2521106">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e9a23e73-2703-4af4-8c8c-80ee434af2b0">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/914241e5-8c09-4291-9f69-8477f6468bc6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/10e42bc0-3d08-4ef9-b860-fded6be68811"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c57f66bb-3555-48af-a35f-a13a6adc198a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/87128548-c1c4-44c4-8fb9-d63d30e84e10">
    <rdfs:label>carbamazepine-INVEGA DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/98521497-029b-4f25-8274-dd0bc24f4253">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/746ecc54-bfe2-4803-b624-f9ecdd0e1dab">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/504db04b-66c5-44b2-8da4-ab2a769dc97e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/e10f6a57-97eb-4315-a4f9-5940eb7d48d5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/0ee5ca25-40e4-4e9d-bd6c-db55d8efcc86">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9262e358-bd29-4260-89e2-8f15fb23b798"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/54e7120d-a290-42cb-afba-1da7011c4430"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/6934c41b-23d2-4db2-b7f9-fd13cb5bf7ce"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/11898f24-59b4-4e5e-b74b-1017213f1581"/>
    <rdfs:label>Nelfinavir-simvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/3d456406-61df-40d0-8e57-3eddca9becc5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/9524a1d3-3c3a-4e87-aee4-d3acd9bd81d8"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/702c8c4f-7d22-46b9-bd6f-aa6e75bf9cda"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/71731aee-ffee-4834-b314-6b618adda9d6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/3ae6c92c-bfd5-4f98-8078-c05fc8984e01">
    <rdfs:label>desvenlafaxine succinate-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8fa7d9f9-ee5e-4d97-b49f-e3432e3d244a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e3171a7e-8fa8-4d09-acab-49169d228d32">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/90e5924f-a064-42ba-a908-7dda3e3a92b0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/32d53e8b-c6b0-4b11-94f2-6fd7647ee50b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a1765182-f8f4-4cfb-8106-d4be151d7a17">
    <rdfs:label>nefazodone-buspirone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/63c640c2-09b0-44af-ae55-4bc9e01b3e26">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3044281d-34e8-4489-9ff6-1f8b9143a147"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/580c42e1-155e-44fb-b71f-c04c29d6ec1d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/61e94ddd-2874-415d-9a12-3f43fc1bc0af"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/87063fb7-9e49-4469-829f-da7f2967c7cc"/>
    <rdfs:label>simvastatin-bosentan interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/836eee3b-28aa-4361-96c6-4f3c36645e9f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/9601fe3e-604c-4c2e-98ce-1301b4ae984f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b8ecbb8a-0f93-475b-ad8f-3a45b780c3d0">
    <rdfs:label>rifampin-zaleplon DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7ecf5ac0-d1b1-42a1-bce1-817f9a4c6d7c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/11b89e9b-b02a-4172-a889-f2727c30ef2e"/>
    <rdfs:label>28 Percent </rdfs:label>
    <obo:OBI_0001937>28</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/803d2183-2e3c-444f-bdf9-c153ed3914c9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/8345cc16-7dd7-4487-9043-01ddce8b498b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/ffcdb82c-733a-43a4-a2de-8850dcd18b27"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c170e66f-375a-4f56-a4d0-a7abc78819bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/83d70ab2-76cb-4e48-8aa2-bdf01fb147f1">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/e1e8d21c-5369-4777-8d3b-adc1ddae4931"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/6a8f0af6-e859-43d6-9f62-3dc409e4f28f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/ac7a02aa-9619-4257-a8d9-bd993890a91a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/84c276e7-931b-45c3-9fb4-2cad77af31aa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/6f550478-9cbb-4ace-bc86-fd2bb608fd50">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e5c87dac-7122-40a8-ab8c-1103e95ced93">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/702827ba-2d9d-416b-b167-86c056127e33"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b55a2b72-4488-4107-8490-6f0fff0a570a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/8ffbdadd-c825-4610-a27a-4798eb90f36e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/71cc067e-d22d-4840-8420-fe22e8427dfe"/>
    <rdfs:label>Nelfinavir-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/14e5a482-3ca5-4e80-984b-d9780cb90b05">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/0ed42a63-d1ad-4f99-a460-e81ff4b694a9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3ed33b93-dbde-48c7-b5a2-746f4bfa0f4e">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2157ddea-a3aa-47b1-b753-5248d8fbc504"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d52e19c2-bc86-4ae7-bfe8-89ea78528a34">
    <rdfs:label>Celexa-metoprolol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5bf5907f-f705-40cb-9a82-dea711273ba4">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a7bcab3a-a47f-40f9-8711-20d27ba81b5d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/761915a5-ce28-4660-9dcf-c491edb6fcb1">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/2514290c-9c0b-4b71-88b8-22b2503b6c52"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/60f09f76-cfbd-419a-b623-a5c76d69c294"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/09a67798-d205-4928-bf92-49980660eea7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c30490a5-0a7a-4554-9839-330765286e02">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/92cd64b1-98b9-4ba1-aaf5-bac4c5b74b0e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/83ab085c-6ddf-4b6b-b8a1-763da576182d">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/bbe4bd1a-945a-4ab4-b48e-8fc6c6673135"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/676a8946-6831-4568-9ff3-8c059e0ab619"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/069ffdf9-c9a6-4d23-ba68-ac96f9aebf6b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/5951b943-7578-46d4-a221-582ffb05945d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/eb935c06-69e2-4360-9912-844e8b5316bc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/7ad2fd93-6037-495b-8a66-38d42b956ea1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fc8b1c3a-74d4-47c8-ae3d-f24f5b1b7542">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5bc7c2d7-60c8-4872-a888-9227d67606bd"/>
    <rdfs:label>4.13 Fold </rdfs:label>
    <obo:OBI_0001937>4.13</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/cc621799-4e6b-4723-9eb0-918d0dad17ad">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0ade0a35-9c88-4a74-bc90-e6c234d29659"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/51292cdd-9236-45b1-9831-c6f8d6e5f8de"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e75153d1-ed12-48b1-842c-b0850df3a993"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/8ad2277c-adcd-4801-a8bb-ac50a82dcfc7"/>
    <rdfs:label>fluoxetine-estazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/2d2d6baa-0742-4d42-892f-d5883f8fc18c">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/9f3707e0-5667-43fd-85a4-9e9ce1e10439"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/32825558-c831-43b2-9c12-fd3ac6d635ce">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2bd2150f-fb12-4c5a-9859-fd20f83509a9">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/94818be6-6048-4782-bf72-37fee8bcac90"/>
    <rdfs:label>1.18 Fold </rdfs:label>
    <obo:OBI_0001937>1.18</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/cc5405c4-105c-4b5a-be9a-b400e8bfb5f9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/254de65d-9796-449c-b4bd-b7d76efbe083"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/4411576a-6ef5-441f-a55d-df5aebc6e4d8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/82556d95-8ba2-423b-bbde-1f03e439ea42">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a3561275-75b6-41b2-a1f2-6999ff20aa7e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/c1e608fd-228c-41bc-9234-79e4adf7e2b5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f695f975-3f35-4ad8-8211-4a39ce3b5f6f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/f11595a7-4b3a-48bf-973a-0fc1f74f8705"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ed79e968-3125-4426-8f71-312df56a9ada">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/6ec84392-5abf-4ef6-9a12-3743a6e8444e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/6cd0328d-639f-4e03-bc73-06ec95778d70">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/e39a3889-8572-42cc-836c-e221a9815960"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/06718859-87ac-43f0-b151-e785206769b4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/38f9dd51-a7fe-4bfb-90fb-b817121c1fa6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c125c72f-df36-4a35-b007-2e74122f4271">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/df4eeab5-a0a6-4804-8577-cfa63ba3c268"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/3ad0ee58-4a62-4126-b4d6-661c00634943"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f10ef4c3-560f-49ba-bd10-cb52fde68502">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/341711e3-5ac8-44cb-b0ea-a150e937cf9e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/9fa9bc67-6224-428b-9511-9be28335d354">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5a8e1ec4-a92a-461b-995b-cb519dc3166e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4efb7d8b-8f84-457d-bb2a-6033f2401be6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/a73a4b16-b59a-4b40-a711-05d4ed2b9658"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c2458604-0558-4663-9ef4-5605638f5216"/>
    <rdfs:label>Diltiazem-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/3b19c6d1-f905-4ab4-9a01-cbe3a946ddd6">
    <rdfs:label>clopidogrel-bupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/50e2fdde-2541-4e78-886f-19569db82ab4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/03582a47-3a64-4c98-99fb-18fd2c2d4ed3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/5d1de83a-a4f8-42d5-8311-1a16bd41a735">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b79a81b5-0c07-4d40-bb23-57bfe23ed006">
    <rdfs:label>pravastatin-indinavir DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d7d8de65-c9d4-4929-a4a9-6e3814d8d033">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/25f85adc-177a-45ad-b217-4567088002f8"/>
    <rdfs:label>nefazodone-alprazolam drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4765f109-a480-4ce5-ab79-61c2eedca733"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/a7bb669c-bc7c-4fcb-8262-804ce577e71a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/06c08fc7-d9f9-4b44-bca7-81524902b90a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/088907e9-b55b-40b8-a558-30ea726c8060"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/c25d78fa-e08c-4438-a909-94aca53354fc">
    <rdf:type rdf:resource="obo:RxNorm_72625"/>
    <rdfs:label>duloxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/a418e565-d409-4a9a-95dc-2cd6239fd623">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/914241e5-8c09-4291-9f69-8477f6468bc6">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>Atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/13cd5682-f371-4861-b0d5-ca3648c6c269">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/35fec6aa-a90b-4177-9f55-ac18333ced93"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/2c9e1229-a0b6-4026-8ef3-4e1d6346a330"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/dd2e718d-ce2f-4afc-bfd1-1d182cc5cb38"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/1626bab7-0cc0-442d-8dea-3bc2af4a7606">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f564a3e4-eb16-4b9f-a104-f1ce73a370d0">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/7ba45048-b861-455a-9df4-0a9db54a6990"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/bef3e7b4-41a7-4846-abfc-53a6195235db"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/29d1603f-b046-43d1-8800-b0b6c435acba"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/8337e920-019a-4807-b53c-9ab1fd710c74">
    <rdfs:label>Fluvoxamine-alosetron DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/d1456251-565a-4585-a219-0ef31af066db">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7aaece25-fe1c-4542-8a54-a5d6731c3f65"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/9945c24b-e344-49b4-b05c-ff19667250b4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c8335632-be19-4b8b-8ce0-df46cde493a0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/89d0d571-e894-4ba7-8e91-87eaf91e3e55">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/2c877226-80be-479e-8fa1-38dd98b1e2b7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/1d702a15-3f2f-4b88-996b-ddf23b25cbee"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/d9a4c238-d0bb-40be-9bf9-4cb192039434"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7e916354-58a5-421f-936f-31106591fdcf">
    <obo:OBI_0001937>500</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/a97f26ed-a112-480b-a60c-48e8ee140746"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a7842cac-0382-458d-af58-ed045325482f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d6af9a65-7e66-4267-a6ee-1c97c32a504f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/8d70c142-d815-46e0-8228-0ce48a62fe4b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e7b1c3a1-728a-4389-abb5-4d78e56be704">
    <rdf:type rdf:resource="obo:RxNorm_358274"/>
    <rdfs:label>ambrisentan</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/436e09f8-27fb-4d0e-b883-3532c373d57d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/a61a8791-dd65-4ce8-9f5f-01dc698be871">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/cc4b9ec1-575a-42d9-9f08-2a767c292165">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/130757d9-7a93-434d-88e6-962fdccfe654">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/39981798-6955-46af-a0e5-53bff3db6420">
    <rdfs:label>simvastatin-vildagliptin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e93325d9-1bd5-4f1a-bfc0-421fa99077f1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f5cb3205-9961-43af-84d0-b500acd9eb09">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b60f6025-ae8a-41db-b6c2-8b17421513b3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/9b856cf3-9371-4f9f-8832-3c1a9d5ca5a1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4c5199a7-9c3f-451c-827e-a83202133c92"/>
    <rdfs:label>paroxetine-iloperidone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f54a61f5-3150-4742-bfa3-172d67b76a28">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/ebbbfa35-1b81-4ada-b5f2-61f6a3861da6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/6200a242-e7a6-4a11-948e-44bb167ccd34">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/dc9062db-80f0-4ef3-b39f-6b05373ef12c">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/8545f528-2c73-4041-aa65-ae157253096d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/8be66c2b-f3d9-422f-aebf-f09afe1cef54">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/d7a34f8e-d3fd-4701-8f87-3088d5758c44"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/8b9150b7-0aad-489e-9fb7-1377870bbe90"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/3204bb22-906c-478c-b6a3-4b9cf50876fd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ff99f1f7-e876-4c88-b684-58268a4ffbb7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/55fac965-d236-49a7-8f3c-a806db94a3fa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/349148af-bbd4-4857-8405-61585f2188e9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5c63f7e5-f818-4012-be1b-9ac10f8b0665"/>
    <rdfs:label>bupropion-desipramine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e777748d-13b7-4eec-8572-543402dde2d1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/777105c2-272b-4347-b928-03a4bdb9dd66">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e0b4058b-f0ba-41a8-a8eb-35b10ca3e990">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/c55058fe-48a3-41ea-8001-3d50a0f24569"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/9dd0d9e9-ba85-488c-a9ab-5a7bc9525298"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/550ba7aa-7650-413e-bc3d-ec44dc77721b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1f08b593-d15f-48ab-a8b2-3d5e133fdc28">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2f2bce03-88a2-412d-a22c-01e7dd85090b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b732df7d-ca43-4d1a-8c8b-a96abdee264b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8c6bacfa-1ff2-46d6-bc5a-a8d5f05e8f6c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e9ca2f78-1328-445a-80d5-b2270af7a5c6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ed6a705e-b383-48be-aeed-423abbffd2b7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9e96cd37-4a4e-4e5c-946d-c1529b032953"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/f98286d6-983d-4699-83ca-422af06e13f9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b25b66e1-5217-4fd8-bf30-008983c4f384"/>
    <rdfs:label>Fluvoxamine-thioridazine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/fc8e3dd8-b733-43f3-81b3-bbe51dda2e8f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/bb75e72c-8281-4891-87fb-576c9a3be26a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/28fed70f-3c2d-4920-9cdc-514366cc8d8f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/6a7f433d-9e9f-478b-91d2-bd91d49c5b6b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/157cbda3-b70b-49eb-a8bc-c3c7c967fbef"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/f41db1f3-2544-412c-b278-57362b08f7b7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/03410fc7-ac29-4602-afa8-3718000acc0f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/abcb3981-acf5-4e90-8265-f07b95efd9e6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/770023a4-a72f-4970-a400-9b812de0c8b3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/54631c1c-f416-4f24-b89d-e87bfeb6c3c3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2b2aab14-e6cd-47f4-b0b5-fd337b432757">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8361e857-73b4-455d-b64c-a8bdfd03ef91"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a99c8c81-da6f-4273-b4f0-e70e0b76e577">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/17b27d84-98fb-4fa4-ba06-7e98411a5663">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/11c65feb-667e-4dd2-94f6-096f6512b666">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c203271b-b51e-4ebb-a5df-5772d649eda6"/>
    <rdfs:label>erythromycin-rivaroxaban drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5103b78e-ec52-46cb-b6a4-c99d3a031236"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8555421e-d47e-479a-8f85-efb8f2aad962">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/24ca19a8-f05b-429a-b1e6-7689eeeb8bf1"/>
    <rdfs:label>nefazodone-haloperidol drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/75944c3d-20cd-43f1-81d1-00d12298a50c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/1d5856b2-5dcc-463f-8a1d-815cb40550de">
    <rdf:type rdf:resource="obo:RxNorm_28031"/>
    <rdfs:label>itraconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/99fb116a-f2b3-43b5-aeba-5d2261c41f75">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5cfe345e-6e29-4dae-8401-66adba18a704"/>
    <rdfs:label>fluoxetine-P88 drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/bb3a21f0-087b-400c-9695-351de13bd1ff"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/4a5510ce-cb80-458a-9277-b2386e9cafa4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/c2697859-919a-4bc6-92fb-00122e611a73"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/fc8e3dd8-b733-43f3-81b3-bbe51dda2e8f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/4486ee2d-2ddd-4be8-913f-8b7bb3b33b2c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5a0fb2a8-bd70-4a62-89b5-9fbd26a00937">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c2ff8fee-a716-44f3-8b74-18de97b5b6bc"/>
    <rdfs:label>28.5 Percent </rdfs:label>
    <obo:OBI_0001937>28.5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/e39a3889-8572-42cc-836c-e221a9815960">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a5575832-917e-4de6-a676-670056590271">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/3e34b8ae-abed-4c83-9825-b297cea25107"/>
    <rdfs:label>134.6 UNK </rdfs:label>
    <obo:OBI_0001937>134.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/dd6d3ba5-7045-409b-8bd0-80502d140a5b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/33d8686c-80b1-4ca3-a3f2-08594800bfb4"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/bd392960-215b-4abe-a177-3c0af7711eae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/06b7aa95-d742-46ff-9482-b81b86655e58">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/ecc91a7e-8e15-4ff6-aad3-4a286d353022"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/9ff7ae23-6fa7-41ec-8b9a-1e154b5df74c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/5dbf73de-1633-44e1-a046-0445cbf290f5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f8c4725d-f46c-4361-a353-aec113a5c18b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/4156dd23-8501-4570-b3a2-82872b6e0d2f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6cb4518d-1dbb-4dee-9b6d-b1f0b94ea64c">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/6ddecc6c-5ae0-46aa-ab98-abc45272c3cd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f6591184-c1d4-4a60-9945-9d1a23983dc5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/725b387f-c201-4f43-af36-90d0c1f8bd28">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/84a892cb-385f-4244-bc8b-6d41702ece31"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/68640fd9-0e9a-4402-9b69-efc42f4dc9f5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/21a06d23-4037-47ec-852d-1521a20b0fa2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/8ade4d99-ca2e-4d25-8e1c-40699e9d00ed">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/187288a6-8e5f-48b4-9690-f2a6198f0a9c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/4fd77eb9-71ea-4cb8-9609-bd7573e2a5a4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/7732cefb-c1aa-49d5-b363-a8e734cb6130"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1b044deb-0557-4b1f-8c34-6f5ef123f79e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3f6d1e0c-7c86-434b-b7ef-776d0cc98fa0"/>
    <rdfs:label>ketoconazole-citalopram drug package auc UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/76c3cbab-4485-4ce7-b4ce-395d0291e4c5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/601166d5-664d-4ae0-873b-6dd68b07d367">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/645dc5bd-47a0-48bb-bcae-fd0ee7186b2a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/e6e41006-da4e-45db-894c-d389e30af942">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/19ee9458-1bf4-4458-9f0b-c833a406e248"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/c933ccb1-f817-4a17-9664-3c8bc506bfba"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/c8b3e1ce-02b1-420e-a2d0-b10e6520e0b9">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/87109388-467f-44aa-9e8e-54e501745aec"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/988716d8-e233-409a-ac1a-bf8e27f73122"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/58bfea74-7b33-48ab-8977-13bd43310653"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/407f061a-83ee-4549-bb16-bc40c586043f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/916ef748-9898-47ba-a727-ed98e4919dd4"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/de3ea3aa-0642-4a2b-a77d-cb99a57b66ff"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/886733a8-3fd7-488e-a9bb-e9e93ae2a643">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c9b951f7-d40b-4829-9991-2ffc9c3c4b59">
    <rdfs:label>ticagrelor-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3aeeeee0-7d16-411a-8c6d-997f5aa791cc">
    <rdf:type rdf:resource="obo:RxNorm_32968"/>
    <rdfs:label>clopidogrel</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/b4198df5-4a8e-4692-92df-3f8f45b7ea7a">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/a170b564-599b-4431-a29d-6b15a17c9112"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/449a1312-794e-4fc5-a99d-1cf802e7a1be"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/83ff5b49-bc06-4cb8-8704-54dee7781bb5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/eac6be78-d91b-4ed5-bb2a-8a36f3101dcc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c73fe4cc-f8bc-4570-8314-547be5a09105">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>Atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f13ccc5f-b7a0-416d-ba17-b5defefa6dfd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/6b521f1e-15be-4818-b96e-7a2feead0771">
    <rdf:type rdf:resource="obo:RxNorm_74667"/>
    <rdfs:label>zaleplon</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/287c203f-cd13-42e5-986b-1581b4f26027">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7051ff2a-7106-478a-9105-7b2fbf05134c"/>
    <rdfs:label>rifampin-dabigatran drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0ba3ed95-a699-4ea8-8f8e-bde1d5a05d0c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b1bf34c6-c839-462a-8842-099655d66014">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/609f317a-9f4a-460c-94fb-23d03959eaa5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/54cebd75-74b2-4815-933a-f1dd1d1a5724"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/0c8c9966-f8f2-4995-8a53-275597d9a8bb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/eb534b59-132b-4201-a8ff-258f73a00ddc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/a233450b-9f60-4f2d-ac60-d7bcd77911ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/729837c8-e4e8-4bcd-abfe-e37d5eec7ea9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/50ec6bc0-eaa8-47e6-b92e-a8a620831255">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/28532aa4-35d0-493b-b960-7745339e3892">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/959e3f6f-4c22-487f-bd6b-dfbde94e185d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/48312966-3f6a-4a69-91b5-1f16cdb066f8">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
    <rdfs:label>dabigatran</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/f2e6b029-e1e8-4d94-8939-2f16096d9b77">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/49af4144-6933-41e9-a4f4-86eb7361f4bf">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/ea1a208f-452e-4462-aead-b2bdefda47a2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/8a0cda4d-3ace-4b73-aa2b-df68189fde66">
    <rdfs:label>ketoconazole-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/6a790eb1-6e25-4957-aa3f-7f290f0efeec">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/eb16fd1f-e6f3-45bc-a8bd-956f4dff2247"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/1dd8eda7-a21b-4f74-8d45-52649a90e4f9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7dd941ff-caa3-4a2b-ad6b-d44bae40bf42">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/ab1e0e0b-4b0b-4861-9d1c-fe8228d6c219"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/fbc04959-3545-4efe-bb4c-37e93112524c">
    <obo:OBI_0001937>1</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/a52244f7-f7f3-4bda-a810-f8b51c002ef8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/39fb26db-e6ce-4d3c-a979-5c260a23a7bf">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c73fe4cc-f8bc-4570-8314-547be5a09105"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/61df9c73-65f7-41f3-84f1-0b85b01caf1a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/d5b9c5c2-7ae9-48c3-ae24-6674a1d538b3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/110d5d07-e009-4c51-8132-9a714e7a4851">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/a151fb77-4e69-44ae-95cc-7d19d0c5fc00"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/1e6f150a-6eb8-4a49-a25a-636bcd299ca3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/03f4940c-4482-4122-9d73-11ea143b4a81"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/41245714-b1e7-4b0f-8c75-f2f185c12d13">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/12c51a8e-c45d-4cde-8825-bc336427cfe1"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ae5ca3c2-f976-40b1-bdf7-f077d2c53ddf">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/d28a3711-82c8-4df1-89d7-6dac460d5459"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/a532dafc-2ec9-4a93-a437-3a6f669641ba"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/617806cc-06c2-4fb0-a870-bc5c00470dcd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/7fcc1d32-e0c9-4344-821c-9fece7d3afd6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/c6eb4ec5-822a-49e9-a7c1-692163b69a56"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/78ec8ec7-2240-4ea1-aef1-e0d613c5d9bf"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/999f9db8-0ef1-45f0-8f97-8fa7829f6928">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/7d2153ae-91db-4143-bd7f-b61bc32d6b81"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/886733a8-3fd7-488e-a9bb-e9e93ae2a643"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/cc86f635-0a61-48af-b9d1-f0158d31e982">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/7d2c8be3-f068-47b1-9b37-499d07e4805e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/a1c9005b-2936-4dde-961f-aff09c0b8eaa"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/77925fbc-6d4c-46a9-8bb4-9acf17857f26"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1ebbb807-28be-41fd-be3a-3a405f453b0d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d6ec6467-309f-473b-abce-ccdef6dd9d5c"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/0273001c-d386-4902-b907-d7bc5813105a">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/4d20a842-f5ef-4917-b767-8af8779fb539"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/2062c9b5-0899-4ad9-bb6a-4536f90ef06f">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/2ec35a0c-50bc-44f8-9d88-3045771c351b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/e128b0b5-cfc2-4aac-9328-06fc35293cff"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/3d77376f-f58b-4b75-9c84-c2c16d6c5e7b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/a06ffdc6-d293-4d6f-88d6-40aa650a9c1a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/edb0079d-66cb-40db-bcf9-02a748a0201b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/046159a1-19cf-4d5f-b35a-ce2781b9201f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/6650951d-4c42-4cd7-b91a-5e0c4e47ae55">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4ef63e3c-38a3-4c5f-a6f3-ddb94e1412c4">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/1823712e-102b-4234-9b71-35b4ed3124bb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c8fe86c2-5f94-482d-8f81-010111e2f02a">
    <rdf:type rdf:resource="obo:MeSH_C580748"/>
    <rdfs:label>hydroxybupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/59c10547-5448-4d8d-856e-a5b1d143c789">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2320b785-29ef-4153-86ce-36dedaf6041c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0155e29d-d926-455c-b63a-7fceaae44b57"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/eafae043-1744-4ba1-a1bb-af787f4490d1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/02d1e99a-9e06-463f-95cd-44282a2685a1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c4a46425-f600-4989-bf05-2eca8e1c335b"/>
    <rdfs:label>cimetidine-sertraline interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/836bc686-7218-44be-a2c5-e67481635670">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fcd2a123-c960-46b4-86bf-97cb7bf892f6"/>
    <rdfs:label>Boceprevir-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b93d629b-1862-4ae6-ac14-bcd78cd02f8d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b7f77bd6-77f9-4f60-ab56-2ade6ed43ba4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/4c8d4938-e15c-431c-8e80-672139bdc67a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/b3f97683-d073-4226-9830-d967bd05b7ac"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/d17bf65c-559e-4ae0-9609-89aa37acb076">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/10ff2b1a-ee13-466d-86aa-001daaa12ebd">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/eff3cd80-8ed4-4a5a-a319-992b90b71319"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/dc8abc97-952c-4c43-8e63-bb739de8726b"/>
    <rdfs:label>alitretinoin-ciclosporin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ea804a55-5158-4004-8978-a2acf058a9e4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d39eaf89-f47f-4ced-a045-101f321fd6ed">
    <rdf:type rdf:resource="obo:MeSH_C060062"/>
    <rdfs:label>mCPP</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4c5199a7-9c3f-451c-827e-a83202133c92">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/3452d85e-d854-402c-b569-72fd2c95924e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/1a1a5fd2-43e7-4085-96e5-75a5f8230224"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5b0ea7d2-76a9-4333-92d9-82d55fb33239">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/47127b9e-437e-4618-8acd-f071a8d8c6fb"/>
    <rdfs:label>Fluoxetine-olanzapine drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/83c46cba-197e-4a91-9e97-18bc749c6d6a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/1898bb8f-0184-49ef-a8aa-3333e2d03faa">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/fb2bf2b6-7312-4313-9bdd-85acbcce759a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/0178833f-5573-4691-b56f-6d12b6807c63"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/fa713175-d669-418f-9a10-91ba92e8bd7d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ad01d58d-f033-41a4-9a83-a1f4df4abe04">
    <rdfs:label>ketoconazole-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d217fae9-90c9-49f0-9e01-0208c938b26f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/97179005-7f41-40b3-8327-9ca53d10f313">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ca9c213e-d1e7-4d41-a829-8b7b2387f762"/>
    <rdfs:label>38 Percent </rdfs:label>
    <obo:OBI_0001937>38</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8a6a7d26-2ab0-4cfa-8e42-fdae25b5f824">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b1bb9f21-6e6b-49aa-b058-6e4739b1be94"/>
    <rdfs:label>fenofibrate-atorvastatin drug package halflife Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/34542de7-0f4e-4081-8a44-10215854e6b4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/80c251bb-b50e-49d9-9ec4-d27ed82bc59d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fcd6a420-56b0-4981-a7ad-234daee536f8"/>
    <rdfs:label>lopinavir/ritonavir-Rosuvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e9dee550-c586-47ec-bb79-2e55480f61b7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c3ca0477-a3dc-4f57-96ce-04d21c73f1fc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/b65b3a05-0477-4a66-8ad0-8116d3bafb42">
    <rdf:type rdf:resource="obo:RxNorm_36437"/>
    <rdfs:label>sertraline</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/0b8aaf6b-533d-42ad-b0c6-7df3e6ee0793">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/afe85bba-e038-4fff-93e0-a940ad3c2c0f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/1f7ad670-6393-474a-977a-51c2a40289af"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/44c82ce2-e2b9-4b74-b136-332ed68e6102">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/77efc248-ddf5-4db5-8b5b-fec210f5a970">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/66c15c8b-b6cb-495f-b986-c2fd9de80c3e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/56eaa93d-0476-4094-887a-87c373519049">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/cc8722eb-56a9-4e67-bab9-99c9ffb0baee">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c6a15d0d-1e3d-462f-9641-4c04a0e532d2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/16c2300b-a61b-4f2f-aa07-5934dcef1cb4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/ad38770c-3eb8-45e4-93e3-94294d5bc591"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/63b1d54a-702c-4186-aaa0-a685cc69c14a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/24642408-59b8-4d22-b8b5-9b74cc8c3f41">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/c19fbc2e-0f25-4455-9454-9f78b0b96297"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/c8cc53c1-07b6-406a-aaee-8cf8c9f0a5d1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b325e926-adae-44c6-9d3e-79ce446bc681">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/5f158438-5fae-422c-bf5f-b53cf3675b47"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/1d3c04aa-cfb6-4dd1-831f-0bb0c19eaf72"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b098049b-99dd-4da2-9aba-2b0c9c4b9a80">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/42a2c674-52ec-492f-8e44-e3ab8266a831"/>
    <rdfs:label>unchanged None </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/46b83b2f-7209-4dfd-ae69-849c235034c9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/066e8412-e661-4cc1-83b0-8153d61f79f3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/1c3944c3-f7e6-4fbe-b84e-968d01cbe114"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/7f61ff4c-2e7e-45a4-810c-f45d03273fb0">
    <rdf:type rdf:resource="obo:RxNorm_15996"/>
    <rdfs:label>mirtazapine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/b4b0936d-f5cd-4670-a594-ee3730b6b096">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/6bafe752-fe1f-474c-8366-66d86fad9178"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/9b7bc722-eb44-4697-ba74-a206b6b03e82"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/70a3ed14-3df8-4ae0-a679-aec1222af64c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/3a671fe7-1776-421d-b478-af6569ab63b2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/3ce76261-54dd-40ad-b3a9-ca2f61a8f4ea">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/d136b58c-1717-46c0-95c1-7f57601523c6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/71ef0aa8-b367-465b-9acb-10ab32d2275e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/dbf5982c-6dde-4829-8cbc-6aa21327ffd0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d7255c32-f384-49cf-830e-0af200d368a4">
    <rdfs:label>low-dose ASA-Edoxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e805406a-0baa-4a41-b2d7-a66520195703">
    <obo:OBI_0001937>8 or 12</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/8dfc3da6-efb0-4fda-ac50-ae45454874d1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a4c830c9-b02f-4d58-8181-292ead4a8ccc">
    <rdf:type rdf:resource="obo:MeSH_C102211"/>
    <rdfs:label>P88</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8eb0ed5d-ba39-492e-a39b-c770863ebe96">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e7de13ff-4eed-4a89-afab-dba10b16cbd0">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b4d1d277-8565-436c-aca5-05efc02fddff"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/22eab58a-aae9-43f4-bd4e-7ec0b2e758ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e58d371d-f475-4237-8c86-90ed4a37c9fc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/234f48df-f4c2-4a85-8c3d-bc9b041d5c06"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/52a5638c-f8ca-45b1-aec0-7be836a2fb26"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/028c3429-5b12-4f90-b1df-1cc5815daa78">
    <rdfs:label>pitavastatin-R-warfarin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/77083914-00d9-45a3-82ee-37a643b991dd">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/7a8d4dc9-2a50-43a8-950c-077084fec657"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/5b528b63-9d48-414f-8638-f55cf744b64d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/9e11dda5-2558-4e54-9fa3-dae4f1921ad8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/2d3b2852-1b73-4455-9af7-4fc67c38ef64">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/6df8ebe7-b8e3-43e6-af3a-323c4aa3ca8c">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>Atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/66c15c8b-b6cb-495f-b986-c2fd9de80c3e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d6907310-0988-4e47-8a9f-51d9a4c1657c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/831192bf-966a-4d0a-882b-59665fcfe10e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ce1b8f94-4c45-4546-a0f4-d92c55a12f64"/>
    <rdfs:label>digoxin-aliskiren drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/138efffe-9745-4536-ba3d-129a018a848c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/738a4400-cbba-4f05-8078-9fbc18b27b11">
    <rdf:type rdf:resource="obo:RxNorm_73178"/>
    <rdfs:label>iloperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/dff5591b-fd75-4c3e-9b4b-8035b2f667ad">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/81d66f62-65a2-480f-999d-da8e47484a15"/>
    <rdfs:label>Amlodipine-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c7e45778-bcc3-41d3-993a-ede62e143fc3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/360efb8e-3402-4e4d-a665-a52fc568c826">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/19ee9458-1bf4-4458-9f0b-c833a406e248">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/9dd0d9e9-ba85-488c-a9ab-5a7bc9525298">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/3a2734af-5668-49c0-86f6-fd016421d321">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1a9c8351-9581-4cd0-94bf-f952459fdc36">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ec3ba9bb-f559-4f6a-b251-5a929aec7f40"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/cc0e7573-f45e-4887-bd49-66ffaccf328e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/78295fcc-49ab-4c77-8cb4-d499eb9fc61c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/09ac0516-95d4-41cb-9d75-d124de3712fe"/>
    <rdfs:label>ritonavir-bupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/779b287c-cf16-4d3b-b073-801e8b19f0b3">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/a4622952-908b-4a75-9a52-4c03a90a2151"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/b8694f2f-fbd6-44eb-886d-a550c0649c30">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/d3b75c5d-102e-48b5-a84c-a7a20c143012"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/7e916354-58a5-421f-936f-31106591fdcf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/7e66d91b-904e-4aeb-abcc-b0f00d33c8b0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/78eac13d-9ac6-416d-be28-a2b7b4adc660">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9e62d6a8-f187-491d-8c26-1904a0995a48"/>
    <rdfs:label>lopinavir/ritonavir-bupropion drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c8f2f177-0207-4627-b5e3-ca76dd90d201"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/34451b1e-c1da-4ade-9a3f-80cded2dcdc5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/3e500173-a007-4f29-8a66-c454ba473307">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/9d617539-f303-4bf5-8f56-e41b2e8c63f2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/e1cadc44-7fbb-4f7f-9b12-1f2945176e4c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/7f1ad584-8fa3-4207-8697-f5794eeabc79"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/933dc0c8-f710-42d8-841c-7d7c2d465c96">
    <rdf:type rdf:resource="obo:RxNorm_1439824"/>
    <rdfs:label>BRINTELLIX</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/515ecc8d-3020-4da0-829f-77b698169f86">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ad0985ac-9d43-4fc3-878e-5fb02f90e340">
    <rdfs:label>paroxetine-phenytoin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3f8aae57-7785-450d-bc15-93578430fa23">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1bfa09c5-2204-45c1-83a6-b74e833b0358">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/eea423fb-0260-4c71-a623-c18b9e0fe7fe">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/5fc9d692-f167-4d40-8122-ec4fc8e2c186"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/127ca1f4-0fb4-4dbc-9f5e-e338ae626036"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/752ff96e-74f1-45d7-b182-306492436dfe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/3d7bb8bb-8da1-47b4-9724-58520d3ebfb6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/2d607520-51cc-47c7-8558-1302f42d172d">
    <rdfs:label>cimetidine-citalopram DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/fb814329-de96-40fb-b162-7674b01056c7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c57503df-c439-40f9-9a2d-2466de916a91">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1e802ede-ed14-4108-ad4f-a8cd0375af79"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/092c6457-1266-46c7-acb3-43f1c9d56095"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e1161ccd-2078-4769-8d45-b6c68adca380"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/85075b38-bf4c-4ddc-a4c9-4a694391056a"/>
    <rdfs:label>clopidogrel-fluvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7c4be16f-92ab-4a8b-80ce-066faf8d4c74">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/31261fce-ff9e-427b-a3f2-686437ebf540"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/32a26e41-2356-43f7-a95c-c8be417ca09e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/996458dd-649e-4681-9e34-073c140993f1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6ecd42f8-7fd0-4d98-aeb4-98e00c87a3de">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/287c02f5-6244-4908-823b-85a1b571c27a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/89e8b913-1833-471a-88f1-2f4093d184a1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/9fe2e285-adde-4022-9ad6-fb77391c7241">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c6c68d9d-4f8b-432b-8d3d-af09a4c2bf74">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/71019582-7044-4b16-994c-0d1d4591820a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b6be03a4-b5f0-4f4d-af1c-a2d183000409">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/ed152ad7-b975-44fe-80c6-f8b3c0d47a02">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a784c204-021b-46f3-98e7-feec73b57f58">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
    <rdfs:label>dabigatran</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c8d92000-04fe-48fb-be85-8174e45cbe5b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/3346f9b1-50a2-4af9-91a9-f53f565909f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/d97bf349-fba6-4e5d-b770-8852e39c28a4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/9accc574-087a-4419-99c9-2d0a7986efd5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/1038ec5b-f154-4986-bd42-c9ec1fbeb740"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3fbbb3f6-484f-41ab-a140-4d08830049c1">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d777d711-b9cc-4eef-add0-87f552917e35"/>
    <rdfs:label>17 Percent </rdfs:label>
    <obo:OBI_0001937>17</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/341711e3-5ac8-44cb-b0ea-a150e937cf9e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/62df7cb6-1b12-4223-90db-ed8774deb8ae"/>
    <rdfs:label>2.2 Fold </rdfs:label>
    <obo:OBI_0001937>2.2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/6f567555-5ceb-4f87-8967-2b480caa13f4">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/a9eda877-c7c7-4005-94a5-3b35c1b859fd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/4b1ba573-b053-4b23-9fb2-5d9fd26d9f89">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/0db4b40a-ce39-4694-8bb6-193400c80b22"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/1285a0e6-b9fe-4656-811c-b5796d55cc1a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/88d19d2f-94fe-4b7e-b78e-e8e0f053f325"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4b47d874-f0da-4ecf-a734-0b3ed5914a49">
    <obo:OBI_0001937>1250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/ca03dea3-9efb-44dd-857b-00919c9f1ac8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e8582e79-3596-408c-8cdf-754afd5813ee">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/9183f606-a1e1-47f0-84b1-d54e590c1f5e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/b801783a-3e4b-403b-8da2-e5ccf80f3ed3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b83cce80-bd7c-4728-b90b-2f4957729691">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/3c9dcdf4-0f09-4f46-beae-cca9b2a7acb3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/a939fa69-1482-4884-9708-085a05d5b126">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3ea6ab57-2198-4c15-8087-016ccee0dc97">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/17a2e7cc-7890-4b08-a306-dcaee87f1bb0"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/fd125fed-2c1f-4190-bb75-dc834bc687d3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/cd07b926-d0cd-49c7-84f4-2b404bad7394">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/6fb9331f-82ff-471f-a876-6ab3af8e9fdc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/77083914-00d9-45a3-82ee-37a643b991dd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/250e2852-775a-47e2-bb5d-387def3e26eb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/5980b173-8ff1-46a2-8cdd-c172ceaf48f4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0f909854-f862-45b5-96b2-45a3a1060813">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/a784c204-021b-46f3-98e7-feec73b57f58"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/d1a19c5c-6c27-4a2d-b355-82674f5ab9aa"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/4fd25565-f154-4441-a22f-39437243dc71"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/650672c4-b2a1-423c-b727-2938d28cb635">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/7b25d02a-1164-482d-b41d-98b948fcc8b5">
    <rdfs:label>paroxetine-9-hydroxyrisperidone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/07be419f-c11c-4b91-8691-fa28cd900fbe">
    <rdfs:label>ketoconazole-rosuvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/43ed05d2-a7fe-4719-911a-631a81073e6b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/70543a42-0725-41c5-aee8-4d2208ac46cc">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f28529a8-b581-4803-a08a-0234f68e345c"/>
    <rdfs:label>25 Percent </rdfs:label>
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c1c40cc4-8aef-47a0-a169-46c5e2fd07da">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/fc8b1c3a-74d4-47c8-ae3d-f24f5b1b7542"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/a920fbdf-3c5d-479a-85fe-b6be58ece4ee">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/be1c6291-3830-4b62-8b88-75f651324a7d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2500bbcb-0ceb-4b3b-bc70-ea307f3fc244"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9c5a3129-a0be-482d-8a25-cc4e67bab08b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/244a9959-eeb4-420a-85b0-ce5e73175a36"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/74883b56-d05e-48e4-8b9e-174fbddea7f8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a6bac5d1-20b7-4e9c-9fa8-9a5f65945133"/>
    <rdfs:label>rifampin-pitavastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b2eff157-1b0e-4846-bff3-8834cb20338b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a238ae03-baaf-462a-b097-363074e0dffb">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ee6bc9ed-cc37-45d2-b620-465b850eb89f"/>
    <rdfs:label>1.1 UNK </rdfs:label>
    <obo:OBI_0001937>1.1</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/7d2c8be3-f068-47b1-9b37-499d07e4805e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/3d07fae1-7932-497a-b239-29e70d0ff30d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/030ee3cc-d906-47d6-af97-280105f78d1f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c1d24e13-5c4e-44ab-a32f-156ceb63f4a6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/8787e06c-3f1c-4ea9-970f-c50f3c4ff8bf"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/84d4a7a2-b5ed-4b6f-a74c-20b1738288e6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/088b3470-73de-416d-aeef-1f2fdc83dac8">
    <rdf:type rdf:resource="obo:RxNorm_703"/>
    <rdfs:label>amiodarone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6d93bc6e-3e49-4797-accc-60ac193bd5ad">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c64f6410-3206-4b19-98fb-c3652e81d916"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/dfab37d8-cea9-4141-b219-da9fea336461"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/755d816d-8e03-4df7-b878-c6a44a454317"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b7ce7935-52ea-46f6-91f1-47e89c2b2a7a"/>
    <rdfs:label>ketoconazole-rosuvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e128e5b5-0b26-4b6d-af1f-e507901b3d5d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/c8b631a8-a39c-4138-ba6f-6b33de9a8282">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/54fd916e-ff35-4d85-9d3b-d6cdec3b2cb7">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/d6485b29-e471-4166-a31f-6ba637e2add0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/d6178c14-565c-43bf-9035-8d16fa07a5dc">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/38279c11-c2e4-4ddb-b352-d674f910fa37"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/a6d375cd-d9f1-467a-8e80-10967fb4c77b">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/6b521f1e-15be-4818-b96e-7a2feead0771"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/46ca3b7d-89d2-49d7-8503-6b078e64970b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/b86e760f-ecb6-4e38-88bc-c9ed4f3e8197"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/bf731133-61d7-4b84-a3a8-d82e6a554923">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7ac1b668-3557-470a-9148-6c589d3ddfe3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/b65793b6-2847-4856-837b-342d6a763cd0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/08761320-c884-4409-a6e2-4b7f244bfe3c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5fe050ea-4fb7-4016-8969-17f9f40be797"/>
    <rdfs:label>fluconazole-rivaroxaban drug package halflife  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/86427ee8-bcc6-4c4d-8c60-e75228040426"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/52190799-3fee-414b-b01a-b9c95bb4344e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/69270385-4061-4c9f-99cb-5dcf4cb3dbde"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/28066e15-804e-45f0-9bea-9f4770df8b2c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/58ac3889-3b9a-40ee-97c9-3276aa5a7d1a"/>
    <rdfs:label>nefazodone-4-hydroxypropranolol drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1a2299f2-1e04-469e-a8ef-3e90c2d2ab4e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/a73a4b16-b59a-4b40-a711-05d4ed2b9658">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/94f7a34d-d9fc-413c-8ad6-d95594f8055b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/dab09e76-4786-4647-9b1b-2ff650fde46d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/8a4fd8fe-2416-47a5-a595-e20c3abedc2f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/06b160b5-70f5-407a-9e37-c68199cf2902">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b4838738-8a70-4de4-a485-cd971d1172e3"/>
    <rdfs:label>30 Percent </rdfs:label>
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f1bf8b48-a89c-4cbf-a6b7-505e4cba7360">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/91b77e18-9354-407c-ad17-efc1792a472d">
    <rdf:type rdf:resource="obo:RxNorm_596"/>
    <rdfs:label>alprazolam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a9bb7dd2-36e3-46d6-912c-e93351393bfb">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/838f53a5-796a-470e-ab8b-f6dae02e9ab3"/>
    <rdfs:label>amiodarone-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9aaaddcc-a338-4c27-843b-9971ed116f1b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a3561275-75b6-41b2-a1f2-6999ff20aa7e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/31817510-ef13-496f-83b3-d6aba321c623"/>
    <rdfs:label>1.19 Fold </rdfs:label>
    <obo:OBI_0001937>1.19</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fd375bba-7009-4509-a2b2-d4976af3a94d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/436770e0-6436-47df-bf0f-082506501c7e"/>
    <rdfs:label>29 Percent </rdfs:label>
    <obo:OBI_0001937>29</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/81df3261-9b26-4597-92c4-aff4c632e84c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/726bbfcb-a5d0-482f-a9c6-d2c4077e9cae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/096f3012-c439-4e9e-95d2-a6823ea7a1a8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/2a098c77-d379-444f-97bb-d105cf9369c2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/60a09781-d785-4093-8f30-cdfc63dfe66e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/764305a4-d323-458d-8b05-615b5f80dd97"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a81b3663-5817-4180-b08c-3cbb18698d27">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/103025ce-0e67-4811-ab68-26619605b14b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/63238a66-4712-4304-9c25-df27d3b4e16c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/54308f05-d0f5-4b02-b7d9-533d2b9b244c"/>
    <rdfs:label>nefazodone-triazolam drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/55b84808-f2fb-4125-bcae-cc8d6b30952f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/433e5d47-c71b-4cd8-9d49-a35ab78d806c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/795422df-c55b-474f-b087-ee64a24096a2">
    <rdfs:label>Clarithromycin-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/0968f46a-1cf9-4a96-bf00-a5e7bfbd17ec">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/b23de519-06b8-439b-a3f5-85fef2947198"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a327385a-52dd-4dea-9e6a-b14cf528e620"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/79757ec7-824e-44d3-94dd-a0307345d76b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2dcfe20d-140f-48f8-8e58-02f1e94070f0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9f480404-0411-4574-a1f8-a285badcdbaa">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/dcf5dccc-cb7c-445d-a6ac-3e18c3cead72"/>
    <rdfs:label>Lexapro-metoprolol drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0065b19e-b70d-4833-9c00-425481ab9acb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a2019aa4-7782-438f-9b37-241a4339d4e7">
    <obo:OBI_0001937>150</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/62adf56b-9a17-4952-aeef-7240d6fd3fbd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/eeb2c870-6b7d-414a-a7f0-e30e5dabb262">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/49d08f47-9ff9-4861-bf19-a21ad4e5863b"/>
    <rdfs:label>nefazodone-propranolol drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/16955c7e-adc9-4f34-9859-f20be713b3f7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/97569c64-89b4-46c7-bd95-069dcbb94e2d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/2a3b2276-dde2-4d06-9c0b-1f1d5d09af04">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/ab79a539-6a96-454c-ba44-654d3f0b5cdf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/274ce7ee-0aed-4d30-9f26-fa483f9720db">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/ddedbbb8-abb3-4f1b-bb6a-f8ee10b8ea83">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/9fc49410-4f63-4d6b-b76d-b0a2014d6007"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/1bf39b5b-a39b-4330-99b9-81f46d0bb603"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/af56a9e1-4b80-4798-82b2-6810e9179a20">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7e53095f-7389-4507-94c7-3a2012ab4c4f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c5de43b5-bf51-4ec7-93cf-8b1e5ecccf8d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b2eff157-1b0e-4846-bff3-8834cb20338b"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/96752a77-3c24-46cc-b27d-c598f7369364">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e895d49f-9d1c-4af3-9740-de1ef6262218">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d0487c0b-f500-439f-8c0e-c39db24583d3"/>
    <rdfs:label>74 Percent </rdfs:label>
    <obo:OBI_0001937>74</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/4115968f-e975-488e-b8cb-33170cc4c51a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/0115bcb6-af2c-49fb-be12-3485fbbd1507">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/9643649d-19d3-4a55-9027-270a6da338a9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0398e321-abc9-4e45-b78d-0b100c339c5e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/c48c26d7-6ebb-4f79-a859-e559fee20c68"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/0b51a031-1616-4085-9233-4bae5e67f364">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/76d42296-4ad8-4fb1-a6b2-6b1ac72cb568">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000136">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/19be3c64-7445-400a-a573-9a1867a9924e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/22b2e92d-0bd7-46fd-93f0-945678bc083b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/8ea8a1fa-4735-479c-9103-718b0cb71300"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/73543ac6-43f0-4b8d-8091-cd30aa645048">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/9b6abdaa-a113-4a99-bf44-5e328d8bf91a">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/201bcf07-089b-4a11-8320-a0a5546177d4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0f9e598f-7fcc-4b1b-a206-9790e5eff1c3">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/9b0629be-ab6e-46f7-a596-15074032d4da"/>
    <rdfs:label>33 Fold </rdfs:label>
    <obo:OBI_0001937>33</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/68640fd9-0e9a-4402-9b69-efc42f4dc9f5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/df904e02-0462-4cf9-b04d-011d59b11524">
    <rdfs:label>cimetidine-citalopram DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001933">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/7d1debfb-2623-40a9-8cde-e02b74576e2a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a9cfcd2f-5d97-4d9e-bfed-1026ff055f7b">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/129d503a-f476-4c3e-bf8b-89e6178713d6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/2f10eea6-a7c1-4501-b720-25ae3c79c137">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/c1e130b6-e887-4923-8414-c56fb0a2b59c">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/4f860b16-f372-4439-bdfb-28771538f579"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/756ca92e-a8c1-4db0-a635-46696e90797c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/6cd0328d-639f-4e03-bc73-06ec95778d70"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/9dc77483-e611-4a1e-89e5-041d799ba716">
    <rdfs:label>alitretinoin-simvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1020ade9-a8a5-463c-8440-47d87c2f477d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/4f9fe61c-edff-47cf-af7d-4312f66617a4">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
    <rdfs:label>dabigatran</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/603e8c3b-1c10-42c6-b346-7128a140a8a7">
    <rdfs:label>phenytoin-paroxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/bf53c873-fa1b-4eb5-9199-76237e5a278e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/dc05a235-b5a2-4d7e-b4ef-740b6c3178af"/>
    <rdfs:label>38 Percent </rdfs:label>
    <obo:OBI_0001937>38</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/698fec2f-cabc-4f9c-b635-48bb9cf42192">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/7f61ff4c-2e7e-45a4-810c-f45d03273fb0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/ff65181a-7a84-4652-8adc-acbb983278c8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/09d0a2d3-4d3a-48b8-8424-860dfb0b5580"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/dfe5531a-a206-4f88-adc5-418d0a25045c">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/5ab276f2-4839-44f5-9a81-4effe2b04e80"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/44c82ce2-e2b9-4b74-b136-332ed68e6102"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/2154bbd3-ba28-443d-b217-89fa898c1d77"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/63e506b3-e630-4f60-8b78-4c464adc0687">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/291e0e49-3c9c-4785-84af-39816086a572"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/3a86321d-e2c4-4f08-b190-a82486c0170f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c5d87f8d-630a-4987-b71a-8787892a66c4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7b25d02a-1164-482d-b41d-98b948fcc8b5"/>
    <rdfs:label>paroxetine-9-hydroxyrisperidone drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b25921bf-9d8e-409a-968b-16edf205ba1c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1843772a-6f8a-479b-8488-092c7443b374">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f96e1438-da1d-4165-a920-eb6a0dc51297"/>
    <rdfs:label>3 Fold </rdfs:label>
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/4821fea4-c16c-421e-8fd3-97162fa8c34b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d8523f83-e62a-48a9-a6e9-74b3aefe3504">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/069ffdf9-c9a6-4d23-ba68-ac96f9aebf6b">
    <rdf:type rdf:resource="obo:RxNorm_195085"/>
    <rdfs:label>efavirenz</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/560edb46-5075-43d5-bdc1-619410dfcaad">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/11328eb3-95dc-4865-ba55-959f6994861b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/eeb2c870-6b7d-414a-a7f0-e30e5dabb262"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/8a11a1dd-cc5a-4dbb-a12d-2ee949214263"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/5864d383-6d81-44ac-8c9a-2836bcd7156b"/>
    <rdfs:label>nefazodone-propranolol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d70e2086-851d-4390-96b6-5c434fa965cd">
    <rdfs:label>Nelfinavir-simvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/2020a20e-9156-468e-aec6-c1b852c1574c">
    <rdfs:label>escitalopram-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e2d92971-be15-4327-8a13-c9efc1bfb2f3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/1f4a6a64-18ac-4643-a424-3a7d534a77ad">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/afbbbf2e-4684-41c9-837a-2ee80b08bbae"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/3fb24fd0-a3d1-47fb-a44b-948d32e7698b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a53fcd30-3add-4892-84dd-f71e09906256">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/628501ae-3958-4b86-a3d0-fb94447fc2cf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/2c562e0d-b9c1-4842-946e-e1ac3dc8761e"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/27ea3a56-b9aa-4921-ac7a-8824619dcd0c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/edaf8349-fe76-48a7-be0a-809d3b6e9e59">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/373a3a46-520f-4d9b-ab86-cdf38624bb21"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/466d64ad-8850-421f-b732-51e7879b0fed"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/f027950e-2415-4226-9e96-87c4913b6671">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/7fc3c8f4-ee09-4cd2-949a-bae2719eaf91">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/bf68f41f-c292-44f7-8bd3-e63ac28cca44">
    <obo:OBI_0001937>300 or 600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/54428eff-5893-4f5c-a5a7-3791cf5d6508"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f4b2f630-34f6-41ad-ab9d-1316a8989f69">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/7125d3bb-1318-4783-9d61-fa29427dc2f8">
    <rdf:type rdf:resource="obo:RxNorm_4053"/>
    <rdfs:label>Erythromycin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/373b7c38-c4a7-4bd9-ac45-e248e2b36ef5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/1b14fd76-6595-4d24-a9fd-efb950db34e3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/1bb34941-3a48-4a66-abb6-3a583e8c6ef2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a144cf4b-8ef5-48fb-8279-7d0246349a1e">
    <obo:OBI_0001937>160</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/0175bde7-d17a-4c04-8a36-0901f999e107"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/235742ed-653f-451c-ac12-5039f0db4a97">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/6641719e-d6f4-4ec6-992f-ddcfc5e78e65"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/a9cb37ad-84ea-4b8b-b8ba-fdccb8615c2a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/3fd411a6-0b68-4b44-84d7-c9e632f9b390"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e1a02383-1555-41ba-9de9-2a7ec261f18f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/dc1dee6a-f9b2-4d81-bfe9-f625acb8093c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6d3b62d6-b8ab-4537-828f-a2ccdf37b511"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/78f3ca6d-b686-4ede-bc49-7e4d0fff3a2a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/51a713d5-8841-4829-9009-2208070fb94d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/5951b943-7578-46d4-a221-582ffb05945d"/>
    <rdfs:label>Gemfibrozil-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/8ebd6d80-d4e4-40f5-81c8-2a5550661047">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/43f5521e-8ffc-4df7-ac67-45c057c4ae49">
    <rdf:type rdf:resource="obo:MeSH_C102211"/>
    <rdfs:label>P88</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/426c3576-a138-4f98-87d3-2e5c7368c1a9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001937">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/a97f26ed-a112-480b-a60c-48e8ee140746">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/da5733bb-acf6-4edb-bbfa-829a40aff7b3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b43679c6-5f9d-4398-8009-266da6767898">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/3d2c21a0-01f5-4b79-866f-7b47a17e85f1">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/6081a565-753f-4e54-a115-e562eae0e8d9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/38ee625e-3088-4a4c-b9e5-4e77a8d318f2">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/34451b1e-c1da-4ade-9a3f-80cded2dcdc5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/500c184f-4619-4670-b571-c7d36f472a53">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/35b7cc56-f10a-46a8-abd3-c9ab0a98a5c9"/>
    <rdfs:label>56 Percent </rdfs:label>
    <obo:OBI_0001937>56</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ed896f8f-2d25-4e6d-945e-99e8287a89d3">
    <rdfs:label>warfarin-Rosuvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/e308a137-5190-4d73-8eea-cdbb950b7461">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e1511fcd-eb73-445a-8369-3bfa645571a0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/862bca1a-d6b5-4a2c-bc42-6057d32d2cf4"/>
    <rdfs:label>lopinavir/ritonavir-hydroxybupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/7406f054-a015-44c4-97eb-a0e545b570bd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2c910fa6-715d-4a2e-8dc4-a10874e4094e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b44b6846-b835-49ae-b4fa-b0f34c2e06c0"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/27847559-a32c-4995-b04f-4e37f678a0c6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2f0f9bae-b8c4-414f-8dc7-d1c3082bd19f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/39e0d3f5-bec5-4f74-88b9-d3ce342b7ea6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0ade0a35-9c88-4a74-bc90-e6c234d29659">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/39259810-d3a1-4194-bc60-6c1afef0af0d"/>
    <rdfs:label>fluoxetine-estazolam drug package auc UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/28c35d7d-c411-47d9-bbfd-c1cf6d592a84"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ef161504-68cb-4c7c-ba55-aadfdc724208">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a83f6487-1569-4265-8b24-624104c9a2e5"/>
    <rdfs:label>carbamazepine-methamphetamine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d489cbe8-acca-4b1a-8e40-66032577802f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/70ac4f51-4988-42e1-83a7-4227387b44c1">
    <obo:OBI_0001937>800</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/1066fca1-f6f1-4aa6-9ec6-f7f808a0aafa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ba108e83-9376-4cf3-b59a-293ab9d69896">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/e08b76c5-2f2e-48ce-9a53-24c2e735b1fe"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/75410366-75ac-4ede-80a8-d6e81b083ca5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/cc112019-1d8f-49b7-a763-3a02d3c11a7e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c125b284-f986-47d3-befa-fb10e0187669">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6138de80-9b19-4f2e-8080-48a7551c15db"/>
    <rdfs:label>Erythromycin-Atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/bf53c873-fa1b-4eb5-9199-76237e5a278e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b1aa04d6-9b48-4b07-bdf9-72015afe6cc0">
    <rdf:type rdf:resource="obo:MeSH_C580748"/>
    <rdfs:label>hydroxybupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1f8c8148-2960-437b-aff2-2440e8bdf26b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3a04f444-0bb6-480f-a04d-2061a207cf3c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/130a2bb9-da83-42d2-beb7-7a1354b20f86"/>
    <rdfs:label>clopidogrel-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9da54d10-9195-426e-8c35-b60ae49694d9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/39a2b81b-3ab0-42d1-ba64-b3111f82d400">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/bd0130a3-76a0-40cc-8d9c-9da848caaec7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/63ff0a39-c13c-4f42-9337-e13ce65f247f"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/8b6e5759-2217-422d-a4e1-a5c629e5f93e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/2c01ea0c-5d70-4a03-92c2-6721802939e5">
    <obo:OBI_0001937>500</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/3a0db2b1-fccc-42ae-b505-079d57d01461"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d3d29f85-30ab-4e9b-ad5d-bbc6748a537a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/851da65c-10e7-4c89-9d2f-1fb23dcbb406">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/3a8ea61d-d64f-490e-8a58-c40765077cc0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/5d34d355-a5e3-4dd7-bc09-c84cb9392cbb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/9e3cb801-0a52-4ce0-8d88-232bdcca8eaf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/beeb996d-ac6f-4e00-abec-8a36703b1dda">
    <rdfs:label>cimetidine-zaleplon DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/1f433ca0-f561-493a-a0c1-f4333aceca56">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/55ccd6e2-cf7e-45d7-a11b-535899cad581">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/b8b3352a-eb1c-48f0-983c-adef3890f53b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/16b80980-e6d6-4cb5-8b33-de2ad9e7f264">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/96752a77-3c24-46cc-b27d-c598f7369364"/>
    <rdfs:label>31 Percent </rdfs:label>
    <obo:OBI_0001937>31</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/df0541f6-4112-4960-9f4d-b20ba702fb55">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/559cda18-99bd-4edb-97d9-6e7038d28fa5">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/25f85adc-177a-45ad-b217-4567088002f8"/>
    <rdfs:label>nefazodone-alprazolam drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/75ef31f9-387b-4f7e-ba08-fc4797e46eb7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/82a4026d-40e2-484e-ab43-66ef1f6828c6">
    <rdfs:label>Diltiazem-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/dd25713b-2525-43d8-a5f9-b3de5f464c08">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/ee3d028d-1b09-4d05-b0eb-31145c1fae48"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/e26f7491-ac0a-445a-a399-16714e918012"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/5cdd068a-60ae-4ff3-a70c-2e6ee47349b7">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/596047c1-5a16-4f19-9cb7-ff088f4c3176"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/3707aa2a-3722-4c3a-aff0-b5840ea71d87"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000124">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/ec1616fc-6660-47b6-940a-1020e2559daf">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/8e139817-5975-4766-bcfc-2c36964511f8"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/28532aa4-35d0-493b-b960-7745339e3892"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/cb35ac0d-576a-46f8-8147-643c5486eda8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8e92f789-f212-4bd2-92ee-507c1ca3ce45">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0aa07ad8-5f3d-447c-b35f-345664a9d426">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ee4406de-5aea-4dbd-bbb9-42d81565c1f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9806818f-514e-4fb8-92a8-5c2a724157fd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8da06815-83f1-4fea-a29e-a1eb02fae04b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/f539f72d-3fcd-4313-a600-93534a8abc0b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/d3f1d279-9215-4a44-95a2-396e9f862c66"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/6e1b4b9b-764e-4e5b-ac40-f8eb6f88a5c0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/5f158438-5fae-422c-bf5f-b53cf3675b47">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/64cfd3bb-e3e6-4a1a-be3e-c95893268bd6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/47d87488-5692-425d-800d-5ca6aa58052c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/0b0b8535-404d-4ed0-ae6e-fd316831c2e1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/109223eb-f3a9-4c0b-9fe3-dc29706ae7e4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/795422df-c55b-474f-b087-ee64a24096a2"/>
    <rdfs:label>Clarithromycin-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/6d53680c-4c73-47e4-b010-f9882bdeb33f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c0ec1385-935b-4f2e-ab35-7bd641788b46">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/31f567fe-09ed-4b5a-90d8-c5b0aff866e6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/05049e7d-f10c-4900-a960-209e80181513">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ef161504-68cb-4c7c-ba55-aadfdc724208"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/0371a693-e81f-4ae8-a71e-6a60cefbfa51"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f6e7342e-1c13-4f94-8e47-02ed248c7511"/>
    <rdfs:label>carbamazepine-methamphetamine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/a9eda877-c7c7-4005-94a5-3b35c1b859fd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/63ff0a39-c13c-4f42-9337-e13ce65f247f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f9785b05-8291-4d90-a57a-37647f728bd0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/9e6ff4ff-3432-4a2d-906c-a8dc7311fc9b">
    <obo:OBI_0001937>75</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/8198ca1d-145a-455d-abd3-3ec987a2d888"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d60a0b2c-f15c-40ef-ab38-43a04199af91">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8152e677-8208-4b2a-aed6-020eb5d08443"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a6e61cd9-5b86-4d1f-804a-462068a379f7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/d1456251-565a-4585-a219-0ef31af066db"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/580ba3c6-2595-4fda-b80c-9750a403ac55"/>
    <rdfs:label>low-dose ASA-Edoxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/5fe050ea-4fb7-4016-8969-17f9f40be797">
    <rdfs:label>fluconazole-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/639e09ed-9ad4-421b-bca9-d9d8112e297a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ccc88e80-4437-4c93-bf07-1cfac4e53649">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6e4e3c0e-1ca4-4815-ad25-8b955d1a0272"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c44a0e2c-98f1-4f95-aa69-94b5304c606d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5fbfff70-a5b1-41b8-9288-c2eed221bf20">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f3a846dc-fa45-4311-b77e-7ad2c967e0aa"/>
    <rdfs:label>3 Fold </rdfs:label>
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6bfb81d6-e6ac-4e82-952b-ef99b39be8bc">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/feff3b22-ed0d-4489-a0ad-ca3928460bcc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/9a55c276-00e8-4e3d-a068-d7c008e2556f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/75dd6152-8b03-41a8-83be-85d1a363d9cd">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/81df3261-9b26-4597-92c4-aff4c632e84c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/b77ee544-270c-42ea-965c-93e408bb850e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/3da5cd21-8167-4dc4-92e0-6ea94a8109b4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/95bbd96d-3c9c-43ff-8381-79075a308839">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/6c12a243-8faa-4d78-bf98-7d4f77596206"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/1bfa09c5-2204-45c1-83a6-b74e833b0358"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/964f8940-c391-45e3-9b26-01de6193b693"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/9d6100b6-18c9-4ee9-b53e-6ac29fe28433">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3c78867c-25ed-41ab-8549-494a45a45bb6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/f4cbc596-820b-4400-9fb8-71286df22c1e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/744c600c-e7de-4a44-85d2-a3d44d111742"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/11e730d3-2934-4366-9b67-5156105352da"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7b751eb1-5875-4957-964e-e4f937675209">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/3af69189-bef6-478d-9c50-bcdfc7b95173">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/14d0d0c0-48e7-4e22-88d9-1b0cf3f662de">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8b3b3870-4545-44e3-b8df-e597caee6fe6">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/41d7099a-d8e5-4661-b3c6-2c18d662c6ee"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/3470b26c-11dd-4340-8335-07605eefc06c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f13ccc5f-b7a0-416d-ba17-b5defefa6dfd"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a508b67a-31b7-46a9-be49-442670a394c3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/9906d783-188f-4d37-b32e-2f5afae0f69f">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>Atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4785f5da-f33d-4bf3-801e-a38e1479eb44">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/86e78a6e-02f0-4a70-b605-71817332c703"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/120bbf69-07ea-424f-a7d3-72047c6c0789">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/13d2d17b-d04b-481a-b78b-1684899ca654">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c69a7d69-dcf9-4564-be0a-d6fd1a1df7fe">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1f296210-7306-4e1e-9357-33db8ed0f147"/>
    <rdfs:label>duloxetine-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f3eb8af4-57da-47fe-b78a-71bf202d4dd3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/b08fd216-580f-4b65-81e4-5f2054da0882">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/08a46890-48f6-4c1b-8f0c-baa0474419bc">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a7842cac-0382-458d-af58-ed045325482f"/>
    <rdfs:label>99.9 UNK </rdfs:label>
    <obo:OBI_0001937>99.9</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9ad88e0d-48e4-41cf-becf-b1bc865289d4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/008b4b56-22b6-4f43-8906-9cb72af0c1fe"/>
    <rdfs:label>Fluvoxamine-tizanidine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0f9e598f-7fcc-4b1b-a206-9790e5eff1c3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/938723cc-ffff-4f3a-a948-3c8c0bbc31e2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/1678e017-2537-4aef-ae76-5cdb05a994de"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/b062e5c3-96d5-4774-8e1a-5bb32bf7ee49"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/23f6aaab-721f-4d84-b3d5-1173780a704a">
    <obo:OBI_0001937>4-8</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/191f071f-99f0-40e0-85bc-850c62ad4f31"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/fa646c6a-0601-4247-8b42-bea37c05de15">
    <rdfs:label>cimetidine-sertraline DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/413334ea-1c1e-4f43-8427-b05fa50ba6fb">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/4e9ff750-ef8f-465b-9f66-d9c77ac231a9"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/0fe5c60f-ba1a-475f-93a9-e9d62b3d928f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/5a040c4a-6ff0-4de7-9474-4fdeef3752f5">
    <rdf:type rdf:resource="obo:RxNorm_10438"/>
    <rdfs:label>theophylline</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/9eba9420-bd37-4e17-8c53-3c48150b9ffd">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/51df703d-a2c0-4f12-b8d9-9c835149afd5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1001f756-5767-4a51-941b-d2804ac1cd6d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/1af6974a-dcd3-4d67-95a1-665e5c8ac675">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/489b9253-95a3-4f63-9f25-f29a274a8b64">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/b69e243c-eb11-4f43-bfa9-374587acdd37"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/4e3915ef-d94c-4280-bef4-97d9d8344858"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/53457ab1-666c-4c3a-95d6-f206f0c6be05">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/07cac830-267e-4717-b147-b4058d94551c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/31ecc4f6-141e-48a8-8f1d-edb7e5cacefb"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/7925e893-775c-43d6-a7ce-7e9c9f5664b0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/62c2deab-1842-4ff8-9f6e-8e8fdf04e833"/>
    <rdfs:label>desvenlafaxine succinate-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/25146eb4-b541-465f-b01c-7e57d950a45f">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
    <rdfs:label>desipramine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e2d6ef7d-f3af-4087-a315-93a18f828442">
    <rdfs:label>erythromycin-zaleplon DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/79cc95e1-51e1-4e26-a674-2e43ca4df15a">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/0df8cbe3-c798-4427-aa5e-0c425169d362"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/961fc150-a4c3-459e-abd9-5caec0e3a585">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/926aafa9-5f66-4776-b093-522b815dffd4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e2f39a4b-9222-4519-8c3b-20a891543612"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/97fcfd49-73c1-4d48-ab57-b52ca94a389a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c9c09000-8d2f-407e-9cc7-d7c55ab19c73">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/af26c2c4-c33a-4ac7-b9cf-fe4fc2610626">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/7a3a6bf3-e2ba-49ef-833a-fd2357c12944"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/26d96f8a-b731-4510-9cc0-3fd6c1d1b723">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7d6315cd-5ac1-4d5e-ac9f-2d515be6d0ab"/>
    <rdfs:label>34 Percent </rdfs:label>
    <obo:OBI_0001937>34</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/4e1afd41-efa1-416e-a886-709add6f1a13">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/aba6e91a-13ce-4362-846f-052bf841a7f0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ecf777b2-be29-4567-ab2e-0274dee44008">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/720ba1f8-a346-4c9f-8ef3-ce7c55faa527">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a175b4fe-cb79-497f-a306-2a931e3191c8"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7ece7822-453e-4ccc-a598-3e3fcd644393">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7bbfc0f2-29c9-426f-9727-f50995532194">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f2081ddc-5ad2-46fc-954f-e502fe6a3339">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2bc1c347-b8e6-4385-8e97-f66e8142907a"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b38fe72b-6849-434b-8598-776df2475711">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/44c0c43c-3b64-4bf9-8b69-bcba63fb25a6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/bacdb2bf-71f1-4909-a67c-b580e9aa9dd6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e62a4e6c-bd83-444e-be24-e6ab0c68571f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/75ef31f9-387b-4f7e-ba08-fc4797e46eb7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0e4735b0-36c8-4b8d-a425-b38c0171451f"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/17b9a00f-05d6-4874-aacc-418e87ffcaa4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e5fdca92-921e-4479-83df-4096103227ae">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/7a66f940-332d-459d-91ba-12690476fb66"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/638ad0e6-cbec-4243-b419-850a9b861dde">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
    <rdfs:label>ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0ec33aa0-fd7b-4711-b5c4-773715b67152">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/3123e012-0042-465b-ba21-2e1d8766f157"/>
    <rdfs:label>21 Percent </rdfs:label>
    <obo:OBI_0001937>21</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/28ef60a9-1f36-49d6-a9ad-ecf53991f05e">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/9e637ad0-48df-44eb-8aac-b9c1c3b137ea"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/c77a1f6d-aaba-413b-bd9b-db05182e7a7e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/9de7cd47-ff11-4041-add9-d9dbad2d237e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/8fb204a7-a85b-4650-8b05-064bb9a3f16e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b31a0842-3e00-415f-9dbc-f5a489192b82"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/f9e56e17-2d58-4ee6-8aa1-61142953a713"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/482af706-c10b-4df1-a938-d2a0f2d7bc89">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e7297bcc-fd5d-4985-bbb4-6ab179edee90">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/cef88894-ad1f-49e6-a824-31ac3970a001">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/b4f7f2fc-f8ec-4439-a3ee-81344ae23da8"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/3d20db3e-3618-49d9-bace-8b041582cadc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/3a0db2b1-fccc-42ae-b505-079d57d01461">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/67122db7-ba09-441c-a245-4f68575873a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/34f49d96-144d-4ad4-a53e-fe842babbed8">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/6e38ffb5-c91a-4769-b3e3-464d6447b4bd"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/f0bf65ee-d95a-48fd-8b7b-8e293299033b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f42948e5-b056-4c35-ae4d-4328cea662f9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ac00624f-6db7-4e41-8dac-22a0a3405c08">
    <obo:OBI_0001937>300</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/8b1a82b8-6d58-44f1-bb05-3b70d7b7100d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/463d3b25-54b2-4847-8111-b836f9902ef0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/19198245-6b81-4505-a4e4-48a2e8aa665d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d50db35d-9b77-4aa2-aaff-9b68ee55463b"/>
    <rdfs:label>fluoxetine-triazole-dione drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d04c33ac-b12f-4142-9c4a-8087c583cb66"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0981484a-0f7f-446b-920e-994b0c4ad620">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/028c3429-5b12-4f90-b1df-1cc5815daa78"/>
    <rdfs:label>pitavastatin-R-warfarin drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d37f385e-cf11-4563-9754-bff6befc0c3b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/727f4404-ce06-4238-9613-98e5e5191d79">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/bb466ace-7018-4c4b-864f-2e9389b36d83">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/944b39a1-7c4c-4aa1-a842-5ea0e573b19c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/07a56634-0787-4c90-94c6-215b7e9dbffe"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/bfa2de5a-56a3-40a5-aed5-2f2d1910bce0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3f85cd07-d9e6-4349-90d1-b05b6ccac6ef">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/41715832-8b0f-4b8a-adef-b5c8254bd94b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/6ceb3136-7d3b-4743-bcf7-7c2b44ea3b78">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/112acac8-512d-471d-a409-fb6032b2caee">
    <rdfs:label>paroxetine-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/617b10b8-d864-4dec-8262-f1ae2e72a825">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/1c8b954e-c659-4f09-bcb7-2097f3956651"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/ed79e968-3125-4426-8f71-312df56a9ada"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/9dee8c86-9df6-4425-80bf-f51d66e57bf4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e58d9431-be37-4ee9-a417-c6f68b592ba7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/9a2506c5-485b-426e-8c95-6c2faabb6131"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e5a0d1e6-b9c7-4cdb-a982-2e80ee60288f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d021a932-8f10-41f5-8870-247622602957">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/61dd50bc-2640-42bf-a8aa-9ebfe651600b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/b2f6433b-30e8-4a39-8696-926cb946c3bc"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/580ba3c6-2595-4fda-b80c-9750a403ac55">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/1802526d-08e5-4f6d-9a74-b35f36fe222b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/56f68ca7-d4a6-4e95-800a-b6b3dd0543f4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/7a82a391-6bce-422d-97a2-93f0e2762cb7">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/7230edcf-2a34-4326-98e7-f0dbe8905d73"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/f0175941-cf26-432b-a3b3-db730ba9612e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1bc59e8c-3eea-49f6-b328-0fd0d8f45e7d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/433e5d47-c71b-4cd8-9d49-a35ab78d806c"/>
    <rdfs:label>38 Percent </rdfs:label>
    <obo:OBI_0001937>38</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/606e6430-776d-4328-bcf4-18989d3f2747">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/62df7cb6-1b12-4223-90db-ed8774deb8ae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d3ba6875-61b9-4fed-811e-5bb2d3f27d28">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/cdd66a1c-28ec-4bb1-ab92-9150e80e2ba8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/26312289-3ac6-4886-ba00-153029cfa94b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/270b5042-663d-4e30-ad0e-bdfe043ce838">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a627740e-9d2f-445a-ad0d-07ce97f30035">
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/30607766-a3b4-447b-bd33-28c3478d1ddb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/97974c0a-5fd4-4e4f-a155-8fe29bd4cc26">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/cf656625-6afe-4660-a48f-8e3689883e69">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2500bbcb-0ceb-4b3b-bc70-ea307f3fc244">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b0628d1d-ecbd-4c21-9d1a-01e09d287219"/>
    <rdfs:label>rifampin-pitavastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/940cc324-ce69-47e3-a009-14ccb573d389"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/b29721f1-d5e9-42b9-8713-efd7e1ea0307">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7406f054-a015-44c4-97eb-a0e545b570bd">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e0143335-45a5-4086-9962-ceb566130d3e"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/6c7f7f7d-20f1-4789-835f-7ed03d2152e3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/26d036da-8170-44a9-bde8-827c36ce4b31">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/cda25b24-6d1f-4a02-b326-0f2e7af203b1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/7ddfa393-c633-43bb-8ceb-3a0bdf9e63fc"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8854a81a-2267-49ff-9058-7ed90e28de33">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ee81cce7-7f56-4e5b-8438-2af298450dfd"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/d11a22ad-eb74-4928-b29d-fa1f30909f04">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7f14348f-075a-4809-8303-592450d72961">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e82f233d-0e01-4e7f-8a35-7979451bb314"/>
    <rdfs:label>12 Percent </rdfs:label>
    <obo:OBI_0001937>12</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/a2d5aae6-04e8-448a-a7c9-eaddc20ffd4a">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/64c22999-c246-4b39-8f27-c5aa1664299b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/c907d152-b9ac-4daf-9173-30ebbca1b9c2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/77a3d07c-a79f-435f-b4c5-0543680e5b60"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d77db73f-c376-47f6-a885-eaaad05ae1fd">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/8dc0673e-b0c4-4d64-aecb-2cbe4d0d1872"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/a86284a3-0d56-49dd-89ae-f1e89966be78"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/e60087fd-8d1a-4aba-b91f-b798d98e3231"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0f79bda4-1681-4551-b409-b62ccf521d03">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a5a5cdd7-232a-48ac-bf2c-b4ac7c240e6a"/>
    <rdfs:label>10 Percent </rdfs:label>
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/0b0b8535-404d-4ed0-ae6e-fd316831c2e1">
    <rdf:type rdf:resource="obo:RxNorm_1827"/>
    <rdfs:label>buspirone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/4815b9ef-1c44-454b-9754-59e78dfa77a0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/60945d33-3131-43a3-88c8-a95f761f07b4">
    <rdfs:label>Ticagrelor-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/689a120b-302e-4aa6-95a6-4c3d07070b0d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/112acac8-512d-471d-a409-fb6032b2caee"/>
    <rdfs:label>paroxetine-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2463b7ba-f822-4860-835d-16febcac2f02"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/741108ef-cc16-4e26-84ac-b092e1a2d528">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b6034a7f-d648-47d8-88bb-136c8a4d9d31"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0981484a-0f7f-446b-920e-994b0c4ad620"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/0d2d2ffd-c2c6-4050-b987-213eac4bcece"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b6bd1ab4-fc7f-4642-9d23-017ae3e48f0c"/>
    <rdfs:label>pitavastatin-R-warfarin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d169c62d-642e-4acf-bc07-f1f6000c1a40">
    <rdfs:label>ABILIFY-norfluoxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/bdc9384d-8301-425d-aeea-248d559633ac">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/acd88aa6-9bb8-492e-a809-c80acb59e2b7">
    <rdf:type rdf:resource="obo:RxNorm_596554"/>
    <rdfs:label>vildagliptin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c730d12d-c516-4983-8630-315e3fa41a35">
    <rdf:type rdf:resource="obo:MeSH_C496216"/>
    <rdfs:label>threohydrobupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/0175bde7-d17a-4c04-8a36-0901f999e107">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/89aa9c36-c2b2-4cb2-bab3-f7ab6ffdbfb7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1b9d2fc3-8622-46fc-92ef-68963ee8ebfa">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a574eaee-775c-45ed-b4a4-9bd6d1ce0588"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c77de934-2108-4381-97a7-4389a01a94dd">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/6302507b-e1b6-4acb-ae89-ddbe3bd3944c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/fc89183d-f731-42a6-908d-2adfc6910a4f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/07d0e9a2-b784-4635-82f8-a8955b88146e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/076b7248-e4c5-4c3a-95d0-dc5669335ccb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/8d05e013-baea-4cd4-ba1c-5ce640d1920d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ecc41041-c82e-4561-932a-a9deaa3ec2bb">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b70b36cf-6518-47fe-893f-c3417bba5873"/>
    <rdfs:label>rifampicin-rivaroxaban drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9bda6a77-b67a-41ff-a263-97ed49e03e19"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/510cc5c9-8e62-4120-b5de-d044e3bbe8f3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/beca171a-d486-414f-b999-047d82065e00">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e2818458-0d44-432b-9851-b3a03fd614a4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/edeb7fce-4539-40b7-9537-f8cdf4b575db">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/3b2be42f-64d3-47d4-8124-c320f87ebb3b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/77fd8535-9d9d-46c4-9d90-1777e4655ef7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f358a145-1858-4a2a-a598-97f6ca51a629">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/dc3b2db8-3a33-4a12-9249-fe45824a992f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/44e3dd5b-a3d0-4bb4-b212-1fd62c522ec7"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/40e87289-6772-4556-b3fe-487a6d670d75"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d6378915-8046-400c-93f4-2fcf4863c9d0">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c6259a7f-46dc-434b-96b3-8b5b5b1a8da5"/>
    <rdfs:label>no change UNK </rdfs:label>
    <obo:OBI_0001937>no change</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/db4366d5-0f44-4b53-810e-1d434581e1af">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/6c9302fd-ab3b-4f76-84a6-d76408e5a405"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/0209fcf8-ee77-4a4a-930d-111a83b309fb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8ac9fb6d-1617-4059-b327-83aeafca4cf5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/fcbbd5f8-9352-4e98-b1c6-d53fdde8bc7d">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/9f3de1f4-1873-42f8-97bd-4cab99d7c9e8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/79c2f152-7454-4b5c-9e05-6eb8038884fe">
    <rdf:type rdf:resource="obo:MeSH_D003708"/>
    <rdfs:label>N-desmethyldiazepam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/8c292608-ecfa-4f68-9aaf-d19dd592e515">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f72b2003-1129-42c2-ac3d-c473799e9bd5">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/68c1aee4-3ea3-47c7-b385-bb2f32f3b5bf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/8ad2277c-adcd-4801-a8bb-ac50a82dcfc7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/8070a92e-bbc2-4e5f-a637-c6d826447859"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/6cdd3060-f55d-46a5-b6dd-ffe69cf5c469"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/8cee6c50-ad1c-42f9-af8e-51f38876d7cd">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/27a5579c-38bd-4b97-b12f-a68a322b5de3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/996458dd-649e-4681-9e34-073c140993f1"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/15b22b31-c903-4ca7-8ffb-a6fd89a753a9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/1042fec7-8c6b-4344-8a48-2e6c4392a5d8">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
    <rdfs:label>dabigatran</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/28989e0c-4a2d-4504-978e-709c291c5501">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4021f576-455d-4f0f-9d7f-d0178e68d230">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/940bd346-1fe4-48f8-91aa-dd91aee57dfb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/60a9fac4-ba24-44cc-a3ca-05b1bf6d9d7d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/2b502cde-5e72-45be-b34f-5db5f7ff2996">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/846b8dcb-3ae2-44ed-8989-d4cec1afdb1a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8738a6ce-374f-4218-a959-4257594a5cd8">
    <obo:OBI_0001937>1400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f142a687-98a6-4c60-859a-67d550b26f67"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/91e9a8de-807e-430b-9c52-e5d95cc84bbf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/1fd797aa-6d83-422b-ad6d-bde851e09e5d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0630ed7b-5bd6-48ba-9bb0-be31b4ea688c">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/6bf8b8f3-eb15-4672-9aaf-b30fc015be89"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/95987da4-f1c8-4724-ab53-69416d4ec554"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/440350f5-6b1a-4638-a4f7-fad46f69e07e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a151fb77-4e69-44ae-95cc-7d19d0c5fc00">
    <rdf:type rdf:resource="obo:MeSH_C060062"/>
    <rdfs:label>mCPP</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/008b4b56-22b6-4f43-8906-9cb72af0c1fe">
    <rdfs:label>Fluvoxamine-tizanidine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/6bf4f2bb-400a-4e58-9480-afdfa108cd66">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/91530390-e41b-4d7c-95b0-3090b5335086">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0720a629-9eda-4f2f-a876-31c36d5fa445"/>
    <rdfs:label>62 Percent </rdfs:label>
    <obo:OBI_0001937>62</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/de98c711-03c5-4368-ba0a-02275b48c0f5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/a2d5aae6-04e8-448a-a7c9-eaddc20ffd4a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/621ad6c9-c520-465a-b950-a3aa47c5f954"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/cc090bdb-376f-4384-8e87-05034da1d6ac">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/be039064-ca8d-4221-bf70-aa4348545a54"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a649b8eb-caec-4dc4-adcc-c8ff15f0736b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/cabf554d-cc97-4364-aea5-63cddaf903a8">
    <rdf:type rdf:resource="obo:RxNorm_81864"/>
    <rdfs:label>alitretinoin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/7fc8df3f-1c9e-42b3-b6a1-9afe481a667e">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/34e37a92-6366-41a2-883c-b24a697753a7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e10f6a57-97eb-4315-a4f9-5940eb7d48d5">
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/8d70c142-d815-46e0-8228-0ce48a62fe4b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f4764b70-c2f2-49ad-9911-1e3a21f56fb6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b3333447-1b1d-4a80-965f-764fa02d2462"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e2f310eb-bdf6-4d4f-9734-f3a956354296"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/b4fe2901-08d5-4885-bb66-cb6bb2fe6ca3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/389679be-fdf8-4f41-b9d6-64e493a3d5f5"/>
    <rdfs:label>nefazodone-digoxin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9dbcf74d-3563-447e-978c-358898cb1bdf">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0d58d30e-1bd1-439f-9320-c8496c16da7b"/>
    <rdfs:label>40 Percent </rdfs:label>
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/bb53360d-f2b3-4163-b21e-ea8159166fbe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/561c361c-314a-4365-a1dc-89b24f67dead">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ea3da9d7-2275-467d-9f38-9cbffbb335db"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/091dff4e-e0bd-49ce-8a13-8ad80f8953dc"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/71260a1b-1f31-4392-a5c4-b6f2c788671b">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b347895e-1ce5-4a82-b4eb-e22065f17aa4"/>
    <rdfs:label>1.3 Fold </rdfs:label>
    <obo:OBI_0001937>1.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/65574052-3be2-4c23-8718-5c793e79573d">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
    <rdfs:label>desipramine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/a532dafc-2ec9-4a93-a437-3a6f669641ba">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b69d1934-6bcf-4eeb-812e-260e9f5637b2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c5d87f8d-630a-4987-b71a-8787892a66c4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/9ca28005-6cc1-4dce-bbb5-a252837854c3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/6672e7bb-3045-443b-85d0-68782806bda5"/>
    <rdfs:label>paroxetine-9-hydroxyrisperidone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5a34581a-ff6c-4bf1-aa43-8a42baa45772">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e17e20a0-9a21-4872-b771-5e9d782225d8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/342e8db4-f0f1-4763-9daf-2b7ada3d9ca1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/46f26bdd-04c0-47f8-bd81-8f316527e012"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/42c97f0b-2a9d-45e3-8446-9c3cfb309d6e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/875a9204-a973-42fe-8dd1-4e3b849893ec"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d2525dd5-7a44-473f-af71-9b43ccbc43ea"/>
    <rdfs:label>ticagrelor-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/8ea70688-d86d-4331-8c0f-419ad2e3c4a4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/ec4a8c16-5761-4df5-aa93-2cb62456d4cb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/57ecea77-665e-4014-941c-7250ccaf69a9">
    <rdf:type rdf:resource="obo:RxNorm_301542"/>
    <rdfs:label>Rosuvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/1e18d667-5d7d-4f2d-a179-34d70ba320aa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/aef68e55-c0ca-47af-adba-72994f08d407">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ea523ab7-3591-45f8-8bf1-8fdbbc292eac">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/3470b26c-11dd-4340-8335-07605eefc06c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/ae78234b-d525-4229-9429-45784ac8c1a0"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/a08624b3-a3b6-4a27-917c-7d24564b65b5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/eda3fc22-ba03-4b0e-a6ab-d5b4062c2631">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2d794fd7-8bc8-4aa2-91f7-abdeae777be9">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/01e9ce39-0e04-4e32-b5bc-f0104ee490c7"/>
    <rdfs:label>9.36 Fold </rdfs:label>
    <obo:OBI_0001937>9.36</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/2742be6e-257a-40da-ac5d-b721d7f476d5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/9be1687e-219d-4110-b634-0f067de4b27d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a81b3663-5817-4180-b08c-3cbb18698d27"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/adbe356a-8786-4db2-8c5b-3a14c7b2088e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/73aaf886-c78e-4ffc-b4dd-ece498c62d9e"/>
    <rdfs:label>30 Percent </rdfs:label>
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/0dba7581-9326-40e6-8b33-d8ae6051f450">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/43cd5039-95ea-42ea-b2ad-43dc88f02db4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/11328eb3-95dc-4865-ba55-959f6994861b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/49d08f47-9ff9-4861-bf19-a21ad4e5863b"/>
    <rdfs:label>nefazodone-propranolol drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3ec992a4-2277-4ba3-8951-34baec319fe0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3b48518e-5ae0-44ac-87f9-da15e222b6c8">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/960ab7aa-210d-4d97-8f40-e64a32f70f5c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7706fb73-4a06-4001-a221-fd1d8a4a07a7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c37d0029-ee83-4518-803b-c80a4555b011"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/db521399-e912-430a-99bf-997c85a55153"/>
    <rdfs:label>fluoxetine-mCPP interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/40df4eea-4abe-4b3f-890a-458695a0619f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/79c1fd02-9cbc-475b-a258-9649254dd4a4">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/80b0dd80-8163-442a-b34c-a89fc370b3f9"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/49af4144-6933-41e9-a4f4-86eb7361f4bf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8510cbb3-457d-40be-8041-72cf4fb62002">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/677bf773-3395-4738-be7a-dd1efbdc44bb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ce0196b5-9dfe-439f-8383-5ca1cc7e1bbf">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/592b453a-d76a-4bac-b168-82fc81c71a8d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/1be4414a-32a4-4071-9456-3b6505f54ab0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/3bd73386-f954-46c9-8048-a6f55de67999"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/2a787dad-384d-40ef-97ba-b7985b6cc17f">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d85d6a72-be5e-48e8-8c71-a5e47717aa7c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/4f9ee689-106d-43fb-a0dd-28715e2c3ee6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/bec0ee09-f5b0-4a1e-b5e9-3cf924cc934a">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/7f8b3c5f-05bc-41dd-97d7-1cd8d3b2039b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/54b67c86-d659-46d0-b8cf-38cbbd4fef7b"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/b65b3a05-0477-4a66-8ad0-8116d3bafb42"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/1bd793bf-2b6f-4a58-a909-4d87ae4b41f0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b949fe0c-48e3-4ebc-a035-3ea8d242f4bc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/e067d77c-31b7-479e-b504-bed6cb4e4d1b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/9e02dd1e-16b7-4025-b25b-3644125cd8e4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/2dd2f90d-9733-4d57-9a56-082f24e07620"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/8d28b749-35f3-43ce-9d8d-70e57a9bcd5f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a117c766-0116-42fa-90ce-adf545414384">
    <rdfs:label>simvastatin-alitretinoin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/ada9546a-53f1-40b3-94e0-19da426bea6b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/55981f42-071a-4659-ba29-b29591e4ab07"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/4ef63e3c-38a3-4c5f-a6f3-ddb94e1412c4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/21a06760-d4d7-4938-b9f3-e4c7d5e06af8">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/20114f79-dc8a-43f8-844b-49de03d91fe6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/2fb4c3cc-cd99-4f72-a358-5ac5bee70c63"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/2a1e70d1-f5c2-4d32-825f-bdb484d39d94"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/56fc96c5-2974-410f-b175-e63db1244678">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/700df1ea-212f-4c49-ba1b-14483b8a0e35">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3283c313-5861-4ce2-8e70-be33ab971611">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/3e349920-57d0-4fdd-8637-8ab409d3cdda"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/7af56365-33a6-483a-b590-cab0591558d4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/36c07b4d-7044-4e4d-b6bf-4bfbbe10f7f7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/bb33d718-b920-4a84-954d-e3b4f3628c1a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/079fe0c2-69e3-42cb-a959-a4c4ad46d950"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/2f1bad2c-cde1-46ce-a4b8-891b70ab3b95"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/466d64ad-8850-421f-b732-51e7879b0fed">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b71da498-da30-429e-a171-f7eb7b23e179">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/b9cb12c2-7a45-4e68-b0d2-d479b4f14c7f">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/09cbd935-682f-444a-9eb2-01fb1b9dcaa4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b58493c8-c841-4ef2-907b-4721f7124da6">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a7189495-3dd8-4042-8e79-64989087525a"/>
    <rdfs:label>37 Percent </rdfs:label>
    <obo:OBI_0001937>37</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/fcc16f8f-dcb7-4fcd-b7d5-3701802e61a0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/9175b4ca-0873-4a76-a099-f65095be13a5">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/5f4aba44-b446-477a-bebf-1ba4fefa33b1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7228c263-c99f-4266-aacd-dd4ab5fc4328">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1d711b53-c1d1-46cb-9077-eff29ce5f0eb"/>
    <rdfs:label>midazolam-rivaroxaban drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2e36a0dc-8e1e-4751-9e42-6db8848ee004"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/9af0988c-5ad2-4ad7-be9e-0b1730f29c53">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/026a2555-8f31-4d0c-ab81-f61453e82096">
    <rdfs:label>Gemfibrozil-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e070f1bf-a1ff-4832-a110-4ce122b3bad5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/1e49b8e6-b0df-406d-a57e-b2120caa1d6d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/8a8d7141-1fa0-4c4f-9385-55d7025cb926"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ee84993f-40a5-4dfd-903c-e666fbd0fe9f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/1314d9c0-c03a-4ee4-a186-be1ed2c12d59"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/d48d32c4-20fa-4690-8b9d-0168ec81e5a2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/bde1b4c0-cac7-4817-83b7-fc7b3df76d13">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/d35a5a4c-aef4-4971-89fb-8df4493da920"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/aa7a65cd-42dc-4910-8e84-55049a42116c">
    <rdf:type rdf:resource="obo:RxNorm_21212"/>
    <rdfs:label>clarithromycin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/2195235f-468c-44c2-904b-5a74488e96e8">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/b9788ddf-4886-483c-9889-3370f62d8a19"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/0d28e607-618b-4b29-92e3-692f44b026a7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/8b35ae84-65b1-4a53-8702-b5720a2b1329"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/c90f4981-7954-49c4-8135-3a89434b6642">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/9e2c4957-0826-48ad-9f4c-cc64e9911e27"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/8c97e556-167d-40d5-9ff8-cbcb3d93a927"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/e70f9dcb-a511-4274-9663-0a3c6fd8fd6c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/558f41ea-c515-4d14-a4c2-e3dd55662823">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/752ff96e-74f1-45d7-b182-306492436dfe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3e12bfac-3d5e-4b66-93e5-c48d84957364">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ea265530-c277-4f0e-9a04-262259517a4c"/>
    <rdfs:label>UNKUNUNK UNK </rdfs:label>
    <obo:OBI_0001937>UNKUNUNK</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a8904e69-bc1d-4157-afbe-0e5f3145eeaf">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/cab52234-3858-43c7-9ac7-6bc3fe707d7f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/3d2ff868-f3cb-4395-bd66-2d40b909805f">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/828ab0ba-9138-4c6a-85f6-b660e3e70d14"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/57d964bf-982e-43a2-bf40-d32fd10b0b63">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/7caf5f87-a4a6-4439-9424-466151056a15"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/d3df2b93-c6cb-4616-988f-3fe9a71eb518"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/0dce4150-fbac-4d6b-a253-848ab6f3da01">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a5d314dc-ca99-483d-b5fb-5a7b3d51db63">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/befa293c-0e6e-49c1-b7b9-356e39506b6b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/0c75ca52-3d8b-42f8-99c1-cd5505bfe641">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/c9e5a3a3-eeac-44dd-87a7-89a1665fdc37">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/62542748-6bd4-4488-a4cf-ea75f38c968c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/c1e995d6-374a-41ec-bd30-13399fd1da4b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1a2fc70b-13a3-4727-8cf8-b1d0f89b61c5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/20b3911b-7aed-4bde-8dba-11e63b0aa9f8">
    <rdf:type rdf:resource="obo:RxNorm_134527"/>
    <rdfs:label>Nelfinavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/2d16f9ca-2b9e-4e7a-8ab0-1c6f1cf5436c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/74d5e04e-4672-445c-9cc3-01d72cb0ee18"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/cc9eb79a-d052-4be8-a5be-732613501393"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c33e4e73-bb32-4b05-8e3b-bade0860e48c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/de7c44c0-8458-4439-a1df-beb62065c221"/>
    <rdfs:label>Telaprevir-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/85b81c36-73a5-43ba-9f75-5c6251cbe6d5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/6de7fe43-130c-4b1e-8bb3-65d9f33320d5">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/046273b4-ce8b-4922-aaac-38d53b84e80e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/c6e655b9-afa7-4c5d-a8f9-f2bc65d0303b"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/45f0b14b-9be1-4d68-b39e-fb58e662d86d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/fd2441d8-4fff-488b-86de-a51998b11494">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/378726ec-d9bb-43c8-970f-09b93a345f22"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/83ef305f-3c73-40fa-82cb-4e82b56dcce3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f7e98c65-5ae9-4a42-9260-99a89c390d67">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/51b63f5e-e036-43bb-8bd7-7968d2ff5436">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/59d59245-dbca-4a90-b5c9-a2c940e5ff41">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/3b83cdd0-fff6-4ef2-8f1f-a9dd694212cb"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/f5f09abd-bd41-490c-b2f6-4849f18ebb52"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/6a5f8b40-60b7-46be-be52-0a4e3aedacdb">
    <obo:OBI_0001937>250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/bfa2de5a-56a3-40a5-aed5-2f2d1910bce0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/d959032a-55e3-4112-bdbe-508a3234ef8b">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/01a73931-2da2-4d23-8e7f-50f156dbadc3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/fd125fed-2c1f-4190-bb75-dc834bc687d3"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/016b40a3-087f-46c2-8b35-0d8aa7935631"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/94500d48-831f-4e8d-84cd-d5a41cb036e3">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/33e67acd-657f-4a8a-9651-219b524516dc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/8fe1765f-3d52-401f-80e1-af3c3667476c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/97631c61-fa3e-44a1-9a14-f50e29115cfc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/17f66371-2273-4ec7-b610-b0e0ec49c72d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1b7e430d-59bb-4436-be36-aafc5831ec34">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/642829ff-e86d-4f76-901f-b5af996a2cc8"/>
    <rdfs:label>7.88 Fold </rdfs:label>
    <obo:OBI_0001937>7.88</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/2b760f7f-f629-4517-af40-5ad4c6e0a509">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/47d1eab3-b8b2-4565-9e44-cb5df758fd77">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f1d832df-9dc9-4c93-bc75-35b9f28b9ad4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/27440e92-becb-4fcf-ac20-e8130b8555cf"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/74734c2b-565e-427d-bf95-227fc3a8ba28"/>
    <rdfs:label>fluoxetine-P95 interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/a6411345-b3e3-480f-abb5-b6e2f212b0fa">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ab472491-30d2-44a6-af50-f07295fcefb1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/69b4447f-d50f-41eb-af7c-972baa931ef0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/697ae7af-d4b8-451d-8c69-c5b3a18d18df"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/36671ddc-1610-42ab-b5b6-8fbf32ce45ae"/>
    <rdfs:label>desvenlafaxine-midazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/de4cd0d1-cec9-4ff8-b9f9-8f4e889e4e22">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/1bd793bf-2b6f-4a58-a909-4d87ae4b41f0"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/38ee625e-3088-4a4c-b9e5-4e77a8d318f2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/5d7016bf-4199-4409-b777-dbf867752114">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/bd1585e3-fd0b-43e3-aeb9-2b4e0b04653f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/87bbb7bc-4544-4903-b114-013522fe30b2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/bb4a32c1-de62-4a03-9be8-2909be65968b">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/560e42b8-c828-4930-b114-445275a4d528"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/37a12a60-cc17-448b-b091-f9a6ed1e2d29"/>
    <rdfs:label>fenofibrate-pravastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/21ff6ddb-f366-4c8d-9488-3733fcb07681">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/52676b14-31cf-4fa9-89f8-22d1fdc91af1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/b1426033-aa2a-464d-80c9-29d6c66b09ec"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/b43679c6-5f9d-4398-8009-266da6767898"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/645313b7-8940-4a4d-bef5-22957fc2950c">
    <rdfs:label>sertraline-pimozide DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/1b6a76e3-d555-45d2-9079-b4ec694ce05b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/23ecea2f-a1a6-4603-8ec7-2be96eb26a4d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/1209c2a8-8147-49ca-a603-b8aeed13f75f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e9090168-abb4-4be5-a755-45c53fbbb7cf">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/5f108040-7aab-41fa-9fa9-4df1ab7b416a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/0447e8bd-d539-4df7-9580-a7a5c2d52503"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/215d9ec8-4b05-4543-8607-edb93d2f1eda"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/6138de80-9b19-4f2e-8080-48a7551c15db">
    <rdfs:label>Erythromycin-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/7515d6af-4f62-4433-88b4-b8b6c8ffbe1d">
    <rdf:type rdf:resource="obo:RxNorm_10438"/>
    <rdfs:label>theophylline</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8cbc3459-aa32-4811-8b3f-9c6b68803ca4">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/88dfaeb1-6f5c-4d3b-947a-6d02b7ac77eb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c780eb58-7218-4950-bf22-9503e1928595">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6014dae3-acae-432c-84a6-39bafe71da8c"/>
    <rdfs:label>35 Percent </rdfs:label>
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c33e4e73-bb32-4b05-8e3b-bade0860e48c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/6e68044e-0408-4532-a4d8-3e84fb6e23e5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/e93325d9-1bd5-4f1a-bfc0-421fa99077f1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/af65fd67-a7bb-429d-9eb4-76588f3ab9d6">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/b1dd137d-2ead-439c-b3df-73acdaf16c0d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/b7da1eb4-9c6b-4bc7-bcf3-e19dca6e2284"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/0157b271-755d-4a9c-9592-4fcaa5a859f3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/0226f9df-6b2d-4e4a-92ee-bbf7b0dcd926">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2df98180-5fe3-4f8a-9a17-1984ffd2b64f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f6feb58e-f62e-4f8f-83ca-41d7f4c43de9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f1168b7a-65b9-4812-b256-0c9c8a4c93d9"/>
    <rdfs:label>high-dose ASA-Edoxaban drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a5575832-917e-4de6-a676-670056590271"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ecc31544-27f6-453c-948e-99e75dd4d76c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f5a4d69d-e665-43d5-bc7c-2a7ce5880ae9"/>
    <rdfs:label>Gemfibrozil-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f668815a-26dd-4a0c-bd7b-4ee5dc278d74"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/6b07d894-1561-4903-a9c8-f93b43048e46">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/b34bbda0-405e-46e4-8924-08f016524ef2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/f5512921-f62a-4e24-81bb-1ad35dbb264c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0dc051dd-88e3-40a3-b3ad-c7e4a92ed807">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/4c258f21-64e0-4176-b488-e4e10ebb933f"/>
    <rdfs:label>nefazodone-atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/bb69fb4d-8b36-4d61-b0f3-0dd946732738"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d836ac9a-e2ea-47ea-a483-67610e255b87">
    <rdf:type rdf:resource="obo:RxNorm_1116632"/>
    <rdfs:label>Ticagrelor</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/942e9906-e738-4818-834a-4b4d1696a6b4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/2d21a922-b6f2-404e-bd35-54d68fd0b476">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
    <rdfs:label>ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f27f678c-c1f1-485f-b1f6-137d4779347d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f483c077-45a2-46db-a86d-d35a45377925">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1c3944c3-f7e6-4fbe-b84e-968d01cbe114">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/24d37f78-0642-4257-a75b-cc07be74c913">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/2ac4649c-e3a8-4198-bf45-b8b7f3eccde9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/3907d7ce-c089-47b3-a353-528a29fec829"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/97f85ab5-07b6-438f-8864-b3cbc873b43f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a25f9bdc-8968-43e8-9b82-bc8137a32b89">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0482b93a-90d7-4993-a368-caa24b926b79"/>
    <rdfs:label>1.7 Fold </rdfs:label>
    <obo:OBI_0001937>1.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ca6a45f7-a83e-4ef7-a17e-4f24c1ca3704">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/17ffc24c-b333-4195-8f2e-43f79e124635"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/976eef19-af50-4a8c-a915-9046e17cde79"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/a5be3b1c-786f-4ae1-ad3b-8e8316abbc2e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/dbd9f6aa-dc38-4c25-bc39-a128e7d736d0"/>
    <rdfs:label>erythromycin-zaleplon interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/93c5bb56-4f59-4ac0-95fd-b623d489a6d4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/393b97e1-193a-4969-b156-efc737d397bb">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/b8a32154-44b9-4cd1-a3ea-0a252ad82edc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/729c2a01-a4c0-48a9-84de-ae7aab6c9ae4">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e6240256-50f1-4a58-bda2-e480e2e0480d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a721164b-41de-4a75-af77-2c891e45dfdb">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/f1b0e424-e4c7-4002-9e69-b7e95555377d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/a6be6144-dc32-445a-8a33-c766fbaf465f"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/757d321c-f0bd-45a8-a8bc-bb0de3740ec5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7ab3ba42-f9c6-47cd-b601-252f77021d4b">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/5b6cb5d1-38bd-4b44-8a5b-81e9d2e1e88a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/abcb962a-3d93-41f7-9dc3-f6f459e4464e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/ceaa9172-a61c-44c7-baf0-fc4ff68bf806">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/dcab768e-62aa-4732-be86-aa4861fcb0b6">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/afc3ec98-3d37-4279-8714-1b5a38aba8fd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/13f7956f-0396-4c22-a665-471c14d77478">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a2e7e52f-f81d-4cb3-8ca6-00d731721f1f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a0aee07e-7e1f-4e80-88b6-7a45bcedb11f"/>
    <rdfs:label>ketoconazole-zolpidem drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/06b160b5-70f5-407a-9e37-c68199cf2902"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d3cd8816-9f5f-4b3f-8004-8bd9420c1dc8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/06ce8713-c35a-41b7-bf22-1f71239f3324"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/47c5fcad-8363-436f-a6ef-2a3768b50b19"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/617b10b8-d864-4dec-8262-f1ae2e72a825"/>
    <rdfs:label>carbamazepine-nefazodone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/62adf56b-9a17-4952-aeef-7240d6fd3fbd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/773da590-7862-4979-9a12-d699511040f1">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/7c04211e-1c63-44e8-be01-117479e469b0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/627fca80-b2b0-4766-b366-8f2d2b487ce5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e4ee9c1e-89b7-45e0-8150-b514abd2adb9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/aa75b6d1-bfe4-4f20-b44b-0b8324e410a3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/0c9cfb22-8d5c-466b-b240-1c897121df17">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/0dce4150-fbac-4d6b-a253-848ab6f3da01"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/dc1dee6a-f9b2-4d81-bfe9-f625acb8093c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/82871b62-132a-439a-8584-4cc12089c2ac"/>
    <rdfs:label>Gemfibrozil-atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/fd95dc2d-ca0e-4620-b260-f35ae531caa3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3a86321d-e2c4-4f08-b190-a82486c0170f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1ca6767c-8a7d-4b2d-9e1e-90f7086615ee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d98ac424-d221-44de-a17f-ac85f1f0e317">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/62e1def7-1c0e-44e3-8f4e-3d188f1dce78"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/7605b712-3a83-465a-824f-f3f1191fc41f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/88dfaeb1-6f5c-4d3b-947a-6d02b7ac77eb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/0707be02-c7ba-4038-84ee-45f447132393">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/333cfb97-3cf0-4e74-a33d-1d6743f60606"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/390cf457-f080-4cc8-8ebb-422c3c676247"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2463b7ba-f822-4860-835d-16febcac2f02">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a621235c-4503-4b1c-9506-96e4e67a415d"/>
    <rdfs:label>5 Fold </rdfs:label>
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/49d08f47-9ff9-4861-bf19-a21ad4e5863b">
    <rdfs:label>nefazodone-propranolol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/5a681502-af19-4ca9-9417-c0152c75006d">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c88d41a1-d0d5-4a65-96ee-d91a9a0302ce"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/5fb49657-b87d-49c9-8b68-5ce0a1927598"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/85a045f4-d3df-41ba-8168-0f6c645a50ce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/c6bdb0c8-fc2f-48a0-985f-60e2d0808120">
    <rdf:type rdf:resource="obo:RxNorm_596554"/>
    <rdfs:label>vildagliptin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/48332a3a-2ce8-4046-b22a-0988c5da3a55">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f18bf462-66db-4101-acee-92e8e1966584">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9d0076b7-4e84-41bc-94ff-c34debe9a7f9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/f7aafae3-c0ee-481d-aa55-84ca429ae3a3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/5d4bc1ba-00f1-4ba0-b4f3-915d9c61ffad">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/5bef21a3-d9e4-475b-83e6-bbcac8eebd0c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/8ca371f8-a859-484f-8c51-a8cdff25b717"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2bc20eba-a2df-4313-b000-68624a8343ca">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e55e3c4d-69c3-4454-865b-293051c76a59">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d2500c5e-0b78-487e-a6ee-ed6afc327a11">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/06f04b52-46a9-462d-9619-e249e2643be7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/1d5a81f5-b03c-4d63-9879-c3b301337b6e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/53482ccb-cf05-4568-a610-77cfa8936625">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/095df5a1-a86e-49f9-9193-a5e0a728145a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/6cf19447-cbae-42c1-9828-2282c2545d7c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/fa571d7a-1ef7-4f78-bca0-62a27c7d68b0">
    <obo:OBI_0001937>400/100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/a0ae8ed5-6952-4c23-b6de-d5ad67152c46"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/bb207f44-206f-47b4-97a4-3fb606618372">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/e2867d04-ef3f-4b38-af9e-df420f94cb66"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/428b88d3-e0ae-44ba-8e40-6d9829eb13fd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c396fc54-393c-4486-9d0f-c56d2fd897da">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/4f860b16-f372-4439-bdfb-28771538f579">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
    <rdfs:label>warfarin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2042a739-a3ba-4c7b-b5fa-6a5a635967f2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7bf8e37e-2afc-4442-88e0-8aaa83e71b1d"/>
    <rdfs:label>ticlopidine-bupropion drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4cd3ace8-c571-4d0d-b776-e32a34aa7169"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/71f6f4c8-41d3-4f4d-9e5c-1c86d2d8516b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/581da30a-e51e-4c2b-bb17-a0085a2e167c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/8e2faeb0-d95a-46e2-ad44-a92ef3935cb7">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/efcf20b7-fbef-4828-b80c-6206b3cb1202"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/54581c64-e95e-46a3-8d24-e85fda4b65c3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/9e637ad0-48df-44eb-8aac-b9c1c3b137ea">
    <rdf:type rdf:resource="obo:RxNorm_6926"/>
    <rdfs:label>mexiletine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b2dc058b-e11a-4d3a-b802-3963cbfe6dde">
    <rdfs:label>simvastatin-ramipril DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/6ee34833-2612-43da-a4c1-a0f613a81c80">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/1f3e4e57-e283-441e-8dd8-8ed88ac0e85e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/3b90ccf1-a8d2-4ab8-adb2-d8585105e75c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/6934c41b-23d2-4db2-b7f9-fd13cb5bf7ce">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/30e50e16-2a42-49ca-8488-5c853723c40b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/8051bda3-d61e-43cc-b17a-9b15649f291d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/5fb49657-b87d-49c9-8b68-5ce0a1927598">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/080686b4-82e0-4ae4-bc3a-b47ca01ce645">
    <rdfs:label>ticagrelor-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/73e4f621-d847-4d62-9760-b81342613f30">
    <rdf:type rdf:resource="obo:MeSH_D014859"/>
    <rdfs:label>S-warfarin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d9aaacfd-661f-40cf-9083-5f3fa18bf8c5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/3861caf1-0212-4c1f-80e4-3e0476bcddc5">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/823d6515-16e0-4799-8280-fee480257c2a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/9734717b-f57e-4471-9b13-0f3a5635cc38"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c478d6b3-0db3-4ecc-aaf5-77ca035e1254"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d5308a15-0436-4ab4-8dce-19471b58ad44">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ee40d925-1d8c-4dca-bfc2-89e9f3147630"/>
    <rdfs:label>telaprevir-amlodipine drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/ce38d270-f3e0-4214-a186-11ec11cae73f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/031bcfff-f5f3-4b55-a984-1a1b363f5a7e">
    <rdfs:label>zaleplon-diphenhydramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/de4a53d8-692b-4185-a510-442c0c6d9fc7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/ea2ebd5c-e6c6-4cd1-9a2c-6bfd15f68fc8">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/056768d2-4c0a-4007-9248-a0ad4990c74d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/eff8e79c-db89-4f71-8202-4e1be9a9eb76">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/8bb2d1b4-f80b-48ac-b568-90c7674739f8">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/f0093365-3ae2-4fd3-b04e-45a9ff39e674"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/e66e7636-e8d9-4ead-94f7-8d1dd475ee9c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/746ecc54-bfe2-4803-b624-f9ecdd0e1dab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/42b71c73-f1e3-4e8d-865f-c46e0e453b1d">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f8da64a4-7ab8-4577-b0ec-fbb2a09f7169">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1da23eb2-ca8a-43cb-b9f2-04252a066f62"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/a6e1abfb-9592-4253-b477-a9514aebd925"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/97c4dacc-4dd2-4f95-944e-5ec7155f9464"/>
    <rdfs:label>paroxetine-risperidone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/bd319810-e61b-44a7-a064-ecb469ec93f3">
    <rdfs:label>rosuvastatin-warfarin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/4948391d-3b50-4851-8776-2e9fee366d8c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4ff72daf-3da3-4db4-835a-abbb257bb25e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/134744cf-2421-4d07-a00f-bf5f76be9cda"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/656e708f-02cd-4446-b106-22cee303336c"/>
    <rdfs:label>carbamazepine-L-amphetamine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e74dcee1-5f18-4436-bf52-2fe89dde743b">
    <obo:OBI_0001937>300</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/ae83c8a6-df03-4322-a796-cea4546df345"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/2e83bb41-e8fb-40ec-80d3-6a514b58a362">
    <rdf:type rdf:resource="obo:RxNorm_7258"/>
    <rdfs:label>naproxen</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e711cbd3-7dd0-43f4-8f0e-8338d6ef1c8d">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/eeb99e41-141a-40d3-ba64-9e817b263c24"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/08279e00-2560-4256-b357-81602fba8520"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/c7cf7e4f-d2b9-4805-8342-c5ef91debba9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/56f44b9d-717b-4ed1-b612-7ee0316f75fc">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a609868a-88a5-406f-a5b9-2e8f8f67d55a"/>
    <rdfs:label>atorvastatin-aliskiren drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/bde0fd8c-0773-465e-89a7-8ecc3d66ee9c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0be2c5f5-c35e-421c-9b78-75688ba744f1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/69f26869-1103-470b-8032-993dc591f6e4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f5ad5c84-ae86-4f21-a29f-39d128cd13b9"/>
    <rdfs:label>rivaroxaban-midazolam drug package cmax None information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/895980da-6815-4c04-a50a-eab49468e654"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e44d933a-32b1-4638-8657-e16c392de85d">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/24642408-59b8-4d22-b8b5-9b74cc8c3f41"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/4e1afd41-efa1-416e-a886-709add6f1a13"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/04dec075-7054-476a-a70f-d82d3ad7b209"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://www.w3.org/1999/02/22-rdf-syntax-ns#type">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/09abbd4f-19c1-49b7-8f09-e5fa1be686ea">
    <rdf:type rdf:resource="obo:RxNorm_15996"/>
    <rdfs:label>mirtazapine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/42c97f0b-2a9d-45e3-8446-9c3cfb309d6e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7535ce3d-33e6-4509-9934-585ac91da5be"/>
    <rdfs:label>ticagrelor-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/fdfc6705-3048-4faf-b29e-8f8818f8c070"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/df14670c-fb1c-45c0-b750-e3e8f4ad8fb6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/fa671d0b-565a-48f8-bd9f-96281094d067"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/353417a0-a2a6-4269-8e1d-12e2b4debd8b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/13ca81fd-3527-4bfa-bad6-4bd611898c89">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/1bbfd3fb-9e8e-49f0-a3fb-0b283faf85e6">
    <rdf:type rdf:resource="obo:RxNorm_10318"/>
    <rdfs:label>tacrine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a93b4827-9271-4d07-ae33-d5a34de47914">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a34b4556-5ce4-429f-ba85-8f02f367142b">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/98d13db6-776c-4ae7-9dff-dc8ea3b2b9e9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/a0c47a09-c9f2-467b-b1cf-00afd6a1eb89">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/91b77e18-9354-407c-ad17-efc1792a472d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/78c82506-e00b-41ba-9f20-87665d9a7042"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/518a98a7-1794-4b7a-812f-77c18cafdee5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d41df977-7506-49b8-814f-d83eec25a896">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/185a89bb-cc17-4138-b8ae-1eedd345ed19"/>
    <rdfs:label>2.27 Fold </rdfs:label>
    <obo:OBI_0001937>2.27</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ae3c64ee-4a80-42fe-9a1b-ac31ceb3d585">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/89534875-4dba-4848-8779-47a0490d4a6e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e41bc718-8e3f-4c17-b5b4-3e5ce99fc37a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/e49a9902-5513-4309-a248-38265f0cfa90"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3ba4c468-ecb0-450b-9a3a-b1034e0949a1">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
    <rdfs:label>Fluoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/cf58c6d5-3530-4e7c-b5d3-f89eff4943dc">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2946d417-3361-4607-8393-4ed37b85bf25"/>
    <rdfs:label>ritonavir-rivaroxaban drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/ab5e76a1-212e-4406-82a2-bb41ce8d58ce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/c62eaa1d-d02e-484a-8a2f-fa196eb05df9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/fcd2a123-c960-46b4-86bf-97cb7bf892f6">
    <rdfs:label>Boceprevir-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/8d4457a8-0c10-42ae-bd09-b858be856c93">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f6353b33-550b-4332-84b3-29a74ba16a21"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/cd568527-6153-409d-a187-dc93ec75ef39"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/459f8713-0315-4517-982f-3ad89a8bf14d">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/277f7f19-8b6e-41e8-80a0-e95ddf8f8d6d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b44b6846-b835-49ae-b4fa-b0f34c2e06c0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/771c2ebe-8b7c-4a73-b922-e3613891b0db">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/5bda6876-f645-48ea-87ec-0257c737b8d8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/669572a9-a65a-49f7-8df0-b0f94ea6c206">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a661b0e5-2096-4bf0-9be4-697a6bc67bd1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/9affe979-aab9-4d4d-ba87-457dcb4c510b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/daed34fc-bb1f-4407-bf17-a83762bb8c0a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/dbcd53a3-134e-43fd-9e2d-88ef15f609d4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/a1b6ab4a-9fce-4a92-9caa-4780daeb0b27">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/de88bb45-a4ac-491d-bc9c-215a38da17d2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/191f071f-99f0-40e0-85bc-850c62ad4f31">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c96b058a-447f-4899-bbb8-cb54690920eb">
    <rdf:type rdf:resource="obo:MeSH_C036139"/>
    <rdfs:label>norfluoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/aa203ac9-4944-4795-8953-93467beb4b49">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/7cb90937-cabd-4a3a-b606-399f2b075c6d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/bde1b4c0-cac7-4817-83b7-fc7b3df76d13"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/0389a192-7823-4dbd-afd9-3fbbc320c0e2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/c47510f9-b342-4266-b707-67ff34dc3900">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/c169efce-fd36-4516-883d-5248769a7946">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/5c1ad077-7494-4773-b49b-17595b29a013"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/395453d8-de56-4bf7-b079-5c1e4d3d3f71">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a0f73e2d-e7b0-4142-8033-51eb07a20d44"/>
    <rdfs:label>sitagliptin-simvastatin drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/34d87b2b-d035-43f5-9e4f-d0ec0b2c9b0b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8360a428-3ced-4728-849a-a22a6aad39ee">
    <rdf:type rdf:resource="obo:RxNorm_73178"/>
    <rdfs:label>iloperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/afb6a18c-b429-4793-b34b-03e2b650c590">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0d8cad43-6a57-4cb9-80d9-65a67061c059"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/d1480691-b7e5-4c85-96ed-a99a79d3826e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1de0162f-4347-44c0-b6a4-79495eb5c1b1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a13ec6f4-c468-47c5-a5fd-ca3bf2b8715e"/>
    <rdfs:label>fluvoxamine-duloxetine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/75d9376a-5569-41cf-8919-315872401f04"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/50cdc8d2-66e8-46df-8f9a-df0a8f8a06dd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/da2eb2ad-b5fa-423a-81da-2d6f558faab5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/e334f69b-2784-4029-b36b-2e53703ea249"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/95358d30-342d-4a8d-955c-5db0c517033c">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9752387c-7c59-4951-9df1-a70a8ae982a8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/21f21c76-5334-472c-b111-4cb7507599ae">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/01ba9264-ffd2-4822-8b47-946e676af0fe"/>
    <rdfs:label>4.04 Fold </rdfs:label>
    <obo:OBI_0001937>4.04</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/4bbed0b9-f9ba-4466-a9cd-6b58ad7d21a1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/cfc7661d-5d38-4878-89e8-ea38d3187d8f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e9a23e73-2703-4af4-8c8c-80ee434af2b0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/31cc7aee-e938-4fb8-b873-5698484534b1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a7d505e7-fb65-4331-926a-145bbc6b19d8">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/14d95050-a9ba-493c-854f-c09b81f434a4"/>
    <rdfs:label>sertraline-zolpidem drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8c7f0cd7-66c1-41b8-a241-6ad9d9f35d8c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/adbf1da1-228c-4e50-a6ad-f38505755508">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/87bbb7bc-4544-4903-b114-013522fe30b2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5171ae0c-ca01-46c4-b5ec-56c728ab43f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/68127703-e00c-46e8-a44a-105e08c01c2e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/8bc53362-5301-497c-b844-deb42a5ff16b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9f39b970-45eb-4c49-a640-9904b6f53e2e">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/737b86a2-15dc-44c8-a686-57ca72d23055"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/5c2c40c4-c75f-41c3-a4f4-9c1efdffbcb8"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/efa8ab37-21cd-4b5f-b67c-7c6f18b0d0d4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ea162753-cf35-4ff5-831a-baec4061f24a">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/d4363833-18f4-4e99-ab5c-460bf46a5045"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/8b81e136-536f-4832-9a89-6458a072bdfd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/9df5ec78-06ba-47ab-91ec-3dfe552eb18e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/b4f52758-5962-4c0d-8188-1b694e8284ee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8b9150b7-0aad-489e-9fb7-1377870bbe90">
    <obo:OBI_0001937>180</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/bb097892-be34-4561-9de3-653778d1f113"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/737b86a2-15dc-44c8-a686-57ca72d23055">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/545df3f1-e453-488f-91ab-35eb28124499"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/04519c3e-92ef-42a6-b458-3643cf6dfe2e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/54b67c86-d659-46d0-b8cf-38cbbd4fef7b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/68cfd9bf-6004-43a5-96b4-27e11e403c25">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/41b797fb-9ffb-49bf-b254-255648a5a4bf"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/7dec54ee-627e-4b70-9c8c-8a651b9570d8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/2b91eb7a-2baf-4059-8139-4f209821a371">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/6551114e-a43b-4110-838a-e2b80158dde5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ba15efd1-af99-4967-bc3b-d66c2d2bf92b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/48dd4e7d-cffc-4019-9eb9-f062e8925b7d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ce1c73fb-e327-44d6-988b-389df8cded10"/>
    <rdfs:label>53 Percent </rdfs:label>
    <obo:OBI_0001937>53</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/663288c1-224f-434f-97c1-96867af94715">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/daad7a22-c5a4-4e58-8aa4-57e60dceddeb"/>
    <rdfs:label>rifampin-zolpidem drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/20b7c307-a02f-4168-a489-b8b343a02515"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/7a66f940-332d-459d-91ba-12690476fb66">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/97515263-ac55-49e1-bfa7-d1d2ed7e7796">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/2e08befb-5873-47b8-81e6-239eeb9ff8cf">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/6bbae89e-4614-47fe-9d40-d91af78b837f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ff7eb9dd-f05b-4ac8-b18d-4650f4c803ad">
    <rdfs:label>itraconazole-zolpidem DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/69a8bf6f-22e1-4504-84c2-a1e8f8f8117e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/038373dd-b85c-4f92-8d16-0a87fe4577a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f46eb8ba-c69c-41f9-ad66-3447c9f171c4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/7624a019-b7d7-426a-b187-5fa5dbef9514">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1b044deb-0557-4b1f-8c34-6f5ef123f79e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/dc04a657-7699-4c4f-9a77-757b38443d70"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e78dc6bf-40a0-4482-8f78-af82d9098c0d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/999f9db8-0ef1-45f0-8f97-8fa7829f6928"/>
    <rdfs:label>ketoconazole-citalopram interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c3d03a88-168c-4d67-96a5-2ed57ab69108">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/46ce77b6-1e28-4555-b9ec-287ca965d765">
    <obo:OBI_0001937>110</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/06f04b52-46a9-462d-9619-e249e2643be7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/5cc37427-d3ac-4d56-b2be-b0fff400a42a">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/afe49f5a-56ff-49f2-b4da-63631020fbef"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/4486ee2d-2ddd-4be8-913f-8b7bb3b33b2c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/7c0a45c9-4583-4c58-b626-7f7640fa3762"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/392ca590-2fc6-4cdd-8afd-c3fccc52b93a">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/21ff6ddb-f366-4c8d-9488-3733fcb07681"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b76fb580-8c3c-4dbc-a190-d68ef0b2c58d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/7ae2c55d-77b6-4221-a8e1-eba65fccb4ea">
    <rdf:type rdf:resource="obo:RxNorm_6918"/>
    <rdfs:label>metoprolol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/900e42cd-0419-464e-895f-2e98bb6ec1c0">
    <rdf:type rdf:resource="obo:RxNorm_3407"/>
    <rdfs:label>digoxin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/90366c17-8e6a-48df-b164-736dba14e129">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/c78e585e-38ce-4099-a628-f8212f7c8183"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/dfac69f1-4e8f-47e2-9f07-3c5bff3b6842">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/6279086e-546d-4e7f-8274-1ddee358376b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/14d0d0c0-48e7-4e22-88d9-1b0cf3f662de"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/fda0ad31-6760-4abf-a7f0-9d6b23a41948"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b63e6426-2651-4003-88a6-fd8aa6c4d505">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/2ad7d221-7883-4377-ab65-f60c489452b6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/40a5f72d-93e0-4dc5-b33c-fbb880f6854b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/7b5e52e0-253c-4c12-88b6-769199bbc0aa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/86e78a6e-02f0-4a70-b605-71817332c703">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/fb6a5d6d-3ebf-451f-b413-6499e547e533">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/ddaef579-d156-4423-98ec-d1622f181c89"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/ec640f72-bbf5-40cb-8031-967f47f47a48">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/348c8d72-8be0-43b3-a2a0-2446274236a7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/e1c99ec8-6fb6-4649-b1ed-b3652069c5cf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/bbb8ca14-611e-478c-8e25-079fd40497ff">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/99fb116a-f2b3-43b5-aeba-5d2261c41f75"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c7487780-29cc-4e20-8e60-df560168a554"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c130c70a-d701-48b5-bd53-fe9cebeab4c2"/>
    <rdfs:label>fluoxetine-P88 interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/757d321c-f0bd-45a8-a8bc-bb0de3740ec5">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e005ac7b-61e5-4f5a-b4e6-49acc71825b8">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a1765182-f8f4-4cfb-8106-d4be151d7a17"/>
    <rdfs:label>nefazodone-buspirone drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0b4351f5-1e91-4545-99ba-1d4927802f86"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/50b5cfb7-03a9-4abf-ab6e-2a8a0d94b867">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d65d0625-951a-4432-b91e-50283e4355f3">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2dd63c17-f4df-4a9d-b224-d2da616400d4"/>
    <rdfs:label>nefazodone-triazolam drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b648b864-cc41-4e37-a8b3-c63a8f598e81"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/33c4d73f-305b-4763-b460-083718c289a8">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/cd4c00e4-5db3-4d69-9424-888d7dd0d155"/>
    <rdfs:label>unchanged UNK </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d89dd4fd-00aa-4467-9546-cb9e2dbbf252">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/7a523e32-bd19-4e8c-af31-90a29c66bf76">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/dff5591b-fd75-4c3e-9b4b-8035b2f667ad"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4de28061-ed57-4a58-a291-7dd2c69b7a4f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/162bc3af-864d-4fd9-843f-beede58461fc"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/6754585b-a8c2-41ee-b4e2-aaa0c6c03cfb"/>
    <rdfs:label>Amlodipine-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/592d613d-e145-4bbd-8290-8d24be5830b5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/58ae41c7-f6df-4032-900a-1e45ea5d6ff7">
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/56bec425-77a2-477e-8195-e938fabc9353"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/8545f528-2c73-4041-aa65-ae157253096d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/fa1936cd-50a0-447a-9aac-e4f784f7a2ee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/ddaef579-d156-4423-98ec-d1622f181c89">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/99dc92df-2fb7-469e-940b-0b45d47fafb6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/cb71aefc-42b0-41e8-96ca-bfd64eebc201">
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b470556c-5409-4473-9b97-6a33a8179331"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e1161ccd-2078-4769-8d45-b6c68adca380">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0154ac24-ebd1-4d9d-9075-3d21a406bb89"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/3a7130b7-37b3-47e5-910a-105030e516d2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fa38e06a-b4d2-44cc-b43d-6b3fedc48085">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2922c3be-8279-4185-a8e7-b384a3adc4af"/>
    <rdfs:label>80 Percent </rdfs:label>
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/92e767a8-ef2f-4664-9822-43af5669d8e6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/85c1ca35-83af-49f6-971d-7b621fa3df4d">
    <rdf:type rdf:resource="obo:RxNorm_4053"/>
    <rdfs:label>erythromycin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/b7b4c740-a67c-4b4f-b016-cfc51954e197">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/013e1d1a-0cfa-48f6-a571-bf6038740d57"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7b44e842-9faa-4830-8a7e-34b4af030fb3">
    <obo:OBI_0001937>160</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/c2638bba-69a9-44ca-9161-f73ecab511bb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/157cbda3-b70b-49eb-a8bc-c3c7c967fbef">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f0c57e83-f8e1-4504-927a-cd64f9a3f813">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e5a3dc75-88e8-4497-8c7a-3a3f0e23806d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/287c203f-cd13-42e5-986b-1581b4f26027"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/a83d24bc-f33c-4e29-96de-7ffd6d426cd7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a547e9f9-3f38-468b-aa24-e91d2d814e84"/>
    <rdfs:label>rifampin-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/357b1141-1b7a-447a-9542-8332265b07b0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c6259a7f-46dc-434b-96b3-8b5b5b1a8da5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/092c6457-1266-46c7-acb3-43f1c9d56095">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/bc94db7b-bf39-4360-8a54-f4ea6f740972"/>
    <rdfs:label>clopidogrel-fluvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/7c6a55f6-1972-4f28-85a0-34852957ccd0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/5462da1b-5222-4400-b33b-ed6b04688bcf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/a14bfb9d-a062-423e-b600-b7bbc55d7efe">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/586ce642-febe-44d3-86fe-e5acd947e2a4"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/b26b7974-935a-41ff-a831-046b736aef65"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/5fdaa023-b093-4e8b-b3d3-e7d3135124bd">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/489101ea-590d-4112-b493-97d18c79eae0"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/2e7803ed-c49d-431f-9302-6df02bdc9b8f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/c50de28e-5f74-4099-96e2-1b727ac48a87">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c117fc19-dbf0-4a0c-b29a-daa77a680d4b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/1a4b34bb-6345-4053-9ecf-c8c6b7167787"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/00f55a70-4ba4-4b32-a6d5-da06d749d551"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/9c40502a-695e-407b-9c25-83499aecdb76">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/fff31f0d-f644-44f0-b624-0b22a34d235f">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/8191428d-7614-4b8b-83ae-d4ac9c570a81"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/da10e685-9fb0-47d9-a5b0-874fd3cb5ad9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4348b884-5403-40e1-92f7-32696e3741eb">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/548e9fd6-a40c-435b-ba0c-c90d6ae08730"/>
    <rdfs:label>buspirone-hydroxynefazodone drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3fbbb3f6-484f-41ab-a140-4d08830049c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0861678d-3c7f-4282-b5a4-ae1de2b18af9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f5ad5c84-ae86-4f21-a29f-39d128cd13b9"/>
    <rdfs:label>rivaroxaban-midazolam drug package halflife None information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1da57917-982e-4904-8195-25755f819f06"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/d2c0e86a-3dc6-448d-a2c0-85ebaafa3dfd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7a806c9f-6b8a-4ed9-8ec2-2ec31d09fd4b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a1a6691c-ddf0-46e5-ad2b-246e2d38983b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/33c09bba-8421-4c69-b48a-43da54b6d981">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/82d16f5c-8326-4377-89ae-d1f3fcb5e2e1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/628501ae-3958-4b86-a3d0-fb94447fc2cf">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/e0776127-154b-4189-8053-d0ce21ca8885"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/3f3cc292-472c-45d5-a348-e814709d21a1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4203602e-ded5-4890-a611-06dbc64171af">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2f0f9bae-b8c4-414f-8dc7-d1c3082bd19f"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/14a406d5-4a72-4590-ab4a-14d61a7fbf72">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/03a1eaec-22a1-4bcb-8a12-280977928f75"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e7871f10-3f7e-43fe-843a-b26ec6e42fba"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/8962abd0-ca57-43c6-9a49-490c7f036f43"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/9b6df932-e38c-4827-a12d-16108ee08665"/>
    <rdfs:label>paroxetine-atomoxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6793035e-cd24-41fb-84cf-67cb4cf75087">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c2e92e62-56d1-48bf-8368-55dcc2d8a76f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/4aaf566e-f567-48d6-8253-6b39a03fce10">
    <rdfs:label>ritonavir-threohydrobupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/fa5ec061-eb2f-41fd-90db-fb83df36ba29">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/4aaf566e-f567-48d6-8253-6b39a03fce10"/>
    <rdfs:label>ritonavir-threohydrobupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f2081ddc-5ad2-46fc-954f-e502fe6a3339"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/55717ba1-f671-4539-9868-3084fa2ddf76">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/18cfe96a-6565-4de9-910a-05aee042231d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/f1cb62cd-1b99-4962-bb85-b265a398bc62">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/b49d942b-5d41-4d3d-877b-46e6baadc628"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/897b9b93-3140-4982-8f62-b15acfec8962"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/5df8ca10-189c-4ec6-b43c-c5702d3e8c88">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/30eded19-6ef8-4b54-b241-322c09b88752"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/37c553f6-2d27-4413-8234-601d477e2e31"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/aadbe9d3-0bc4-41da-8bf5-3b171576905f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/7b0c95c7-0d65-40f0-80e6-8fc114488dc4">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/1fe03fe7-b5d0-4388-85e9-120bd9c86940"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/33a32fc9-464b-4165-b82f-fb6af07d10c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/1c4326d2-a70e-4356-b635-daa07eb02fa7">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/49b3669f-20e3-4388-9052-3059baac707c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/1c3171e1-59f6-438d-96fa-1a1b005f317e"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/61d7858c-336c-45f7-bda9-65f414fe5af0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e9fa88be-207f-49ca-9a0a-8f005e1d7d8b">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/9066342a-27be-4a78-bd90-d4f5dea37099"/>
    <rdfs:label>35 Percent </rdfs:label>
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a8490762-f846-4ff9-9572-aa46581094e3">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c2ae5c06-2227-4f57-8897-3aa44025b067"/>
    <rdfs:label>26 Percent </rdfs:label>
    <obo:OBI_0001937>26</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/04fcfecf-3f74-438d-a32a-e9fbd2f4d909">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/ea1a208f-452e-4462-aead-b2bdefda47a2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/7dca689d-cffb-4a35-b80d-88d5c7e0f618">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/4f5ad196-23ac-4943-a567-b1ed094d72ea">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/d34f119b-2c0e-4a10-b931-162ab851e575"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/3489e48d-8540-42b2-a6eb-110570f5e1c0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ac7095c5-cf50-41b8-b706-c6fd54d98cb6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b470556c-5409-4473-9b97-6a33a8179331">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f608793c-f623-464b-9dca-e17868a0b38a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/dc73288c-fae4-48e9-ac01-3924602f16aa">
    <rdf:type rdf:resource="obo:RxNorm_8703"/>
    <rdfs:label>fenofibrate</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/f9c8c86e-de1e-4e18-a476-e636a35bb488">
    <rdf:type rdf:resource="obo:RxNorm_4053"/>
    <rdfs:label>erythromycin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ba378b03-8f42-4d0e-85c5-fa430576fcce">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/df6b2ec3-eb46-47ab-a4a4-e3caa18c5771">
    <rdf:type rdf:resource="obo:RxNorm_11170"/>
    <rdfs:label>verapamil</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8a336e68-0b50-4e91-adda-2a00588316bc">
    <obo:OBI_0001937>50-200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/e613c163-1943-4703-9fba-a0c59d72daf9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/28bf0f7a-6886-49b0-bc31-f26da1ba6f9c">
    <rdf:type rdf:resource="obo:MeSH_C092333"/>
    <rdfs:label>hydroxynefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/8962abd0-ca57-43c6-9a49-490c7f036f43">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/87d25492-0c97-4b55-8663-e8f414eb5329"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/2601961e-a0b3-44da-a16e-4fab6e8c76fe"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/61304144-96fe-4ba8-bfe6-8b99e0987908">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/d35a5a4c-aef4-4971-89fb-8df4493da920">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/946195a4-3730-40ab-b818-9b91277e7b79">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/bd319810-e61b-44a7-a064-ecb469ec93f3"/>
    <rdfs:label>rosuvastatin-warfarin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a238ae03-baaf-462a-b097-363074e0dffb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/963185f7-b036-4b6e-86ee-333e9b03c835">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/006e52be-0149-47dc-a065-bd6dc05036e4"/>
    <rdfs:label>12 Percent </rdfs:label>
    <obo:OBI_0001937>12</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/847062a3-8989-4d5f-8064-194eb9237fff">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/6f1ebd1b-44ce-46e1-a8d6-e645498f30b8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/6cd7758f-edeb-403f-80ea-1455df6da3b6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/4d4c06d2-0bb8-4403-b974-041ec51b6c70">
    <rdf:type rdf:resource="obo:RxNorm_75207"/>
    <rdfs:label>bosentan</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/89b20d23-717a-4b1b-9f67-ece783df8b6b">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0f0801cf-8d6f-4525-a91a-6591c4263ff1"/>
    <rdfs:label>58 Percent </rdfs:label>
    <obo:OBI_0001937>58</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f31fbe62-d838-4f2c-acd5-3a57d6d87a89">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e6304817-2e73-40a4-82d2-db89c1e4a052"/>
    <rdfs:label>3.08 Fold </rdfs:label>
    <obo:OBI_0001937>3.08</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d21df397-318f-412f-a52a-c998991f346c">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/6ec5e333-69af-4e66-8f21-47be0fb81ccd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/24024ef4-2ca6-405c-934b-228fe81a0400"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/50d0aa9a-5319-4f8f-8f83-f17bb4c80fdf"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/a5be3b1c-786f-4ae1-ad3b-8e8316abbc2e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/a6d375cd-d9f1-467a-8e80-10967fb4c77b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/7d49c88f-347b-4e08-97a2-0663cb0dffdb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/5c251253-d0dd-4422-b5d8-7b05f19f5101">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/39e0d3f5-bec5-4f74-88b9-d3ce342b7ea6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/04456f51-e1c4-47d9-a01c-95d08482fe31">
    <obo:OBI_0001937>300</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/4bbed0b9-f9ba-4466-a9cd-6b58ad7d21a1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/8ca371f8-a859-484f-8c51-a8cdff25b717">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fd95dc2d-ca0e-4620-b260-f35ae531caa3">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4c50cc0d-5225-4227-9a22-c0bf37b4fa44"/>
    <rdfs:label>135 Percent </rdfs:label>
    <obo:OBI_0001937>135</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e26f7491-ac0a-445a-a399-16714e918012">
    <obo:OBI_0001937>50 to 200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/5d39958f-1434-4cda-9e7b-45f96119663d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d6ec6467-309f-473b-abce-ccdef6dd9d5c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/69d22402-17e2-4744-b9f0-9c690c42d48e">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/09645aa5-6133-493a-b97d-e1df10297d3d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f2e5aaa2-31d1-4b79-b736-9f342bbc0a43"/>
    <rdfs:label>simvastatin-ramipril interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/753f4a1e-f112-43d3-ba15-c8c8c28089b3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/54cd1058-c389-46c4-82a8-84733b2a5de7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/287c02f5-6244-4908-823b-85a1b571c27a"/>
    <rdfs:label>0.09 Fold </rdfs:label>
    <obo:OBI_0001937>0.09</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/be82b42d-8767-44c4-8c9e-4dcda7abdd22">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/b8a23913-2f0c-461e-91dd-506c289930ad"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/fd3b28a2-f33c-46d1-a298-58d72301adaa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/44e3dc5b-6707-4d7e-9319-d6454a1b6e55">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d86150a4-87d2-4613-840f-68da6e0ab2b0">
    <rdfs:label>fluoxetine-P95 DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/3b7f4527-3916-4527-9c97-073bdd088827">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8dc0673e-b0c4-4d64-aecb-2cbe4d0d1872">
    <rdf:type rdf:resource="obo:RxNorm_72625"/>
    <rdfs:label>duloxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/73550e21-9f8b-493d-8239-7d90a10b3889">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/cdacd43d-0a75-4afc-a3c1-491f15bd85ae"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/642fe2c1-0fb1-4b96-aa42-a18617c76125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/4255075e-1bbd-4310-b3aa-50eb4cca2de8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/110d5d07-e009-4c51-8132-9a714e7a4851"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/6b5d22be-1472-446a-831c-a0a8de53360f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/50d7908d-40a1-48e0-bbd6-df7b5ad1ddfa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e1c99ec8-6fb6-4649-b1ed-b3652069c5cf">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/6d62c277-a386-41aa-b069-5d1bd7383216"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/21823b49-c110-4194-9607-d9252f405640">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/4821fea4-c16c-421e-8fd3-97162fa8c34b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/bf140959-a2c7-4c5e-8d5c-3450d589b111"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ea3da9d7-2275-467d-9f38-9cbffbb335db">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/a7bb669c-bc7c-4fcb-8262-804ce577e71a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/20c6d79a-34a8-4626-a1ee-6c2ff56c009d"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/d3b702ab-4b17-40a8-b386-f33e44bdaca5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/b2836363-3fe3-43d2-8761-d5fbdd77fcc6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7ab14a57-3c67-4be0-b928-dfc1dd2a46c3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/1110503d-e20a-4167-be3c-3b68f44f9f31"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/0bb2ba9c-a625-4542-a514-13ed81f4cefb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/19a74bb8-fb5a-46bc-b9ec-fda3ec9eecd3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/50ec6bc0-eaa8-47e6-b92e-a8a620831255"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/0bdfde5b-7382-4100-8528-e205550573b9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1d02dac0-0cc8-4f74-944f-c152f3f54697">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ca21ec6f-34af-42ca-bf22-bfe6ddf32374"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/80c251bb-b50e-49d9-9ec4-d27ed82bc59d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/f7c40edf-14ae-4741-a23e-1312d7129e61"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/21306e1e-54cd-47fa-a3c2-bd6c9320361d"/>
    <rdfs:label>lopinavir/ritonavir-Rosuvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/324102db-5069-4b71-ad4d-f5fa535cf77b">
    <rdf:type rdf:resource="obo:RxNorm_134527"/>
    <rdfs:label>Nelfinavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/cb0d5d57-4a8d-4d18-8a38-8779aa24c51a">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/9bca3a1e-2d63-4644-af2f-9208f78b756d">
    <rdf:type rdf:resource="obo:MeSH_D016572"/>
    <rdfs:label>ciclosporin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/74883b56-d05e-48e4-8b9e-174fbddea7f8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/13cd5682-f371-4861-b0d5-ca3648c6c269"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/7cd71b6d-8c57-4d24-bcb0-aca775d8bcc8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e3272663-c62e-40bb-bd7f-e39bfff08f68">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b13fe44b-e43e-41ff-a3e2-6e3a525df0c6">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/5965ecd4-1bf2-41b3-a94c-cc41a7297b17"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/01fe2b4f-4926-4e06-85b8-653c9b9609a0"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/9cdfb5b3-4963-44fc-883d-ba57943fdc82"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e6e57d59-d30e-4aab-9593-4d8c2adecb30">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/8dfc3da6-efb0-4fda-ac50-ae45454874d1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/bf3c7eab-8692-45d5-9078-e70d3ef5614a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/9665aa0f-5678-4f6c-a069-8e69c65c9932"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/720f4de5-1ad8-4232-b9b3-3d2156109571"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ad6a6fa3-182f-4331-bc7b-e8643719ed13">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/70657530-bd5b-411d-a6f6-45be0e24f906">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/337d48da-1ced-4ee9-849d-7e92f44bb352">
    <rdf:type rdf:resource="obo:RxNorm_8703"/>
    <rdfs:label>fenofibrate</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/138533fd-0f4d-4220-a862-ed55d3c408be">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/4594a7d0-b4ca-4609-885b-f9fae695d6a1">
    <rdf:type rdf:resource="obo:RxNorm_352393"/>
    <rdfs:label>ABILIFY</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/dbf5982c-6dde-4829-8cbc-6aa21327ffd0">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/84c276e7-931b-45c3-9fb4-2cad77af31aa"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/227f6873-2f6c-46bf-b9e0-4b27fd7bf9f0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/78f1b1c1-44e6-4a79-91aa-0747d7fd3a2c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3ef18615-1f57-4bb6-b67e-f0b394af34b5"/>
    <rdfs:label>telaprevir-atorvastatin drug package halflife Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5a0fb2a8-bd70-4a62-89b5-9fbd26a00937"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/5e93378d-2564-4e63-b459-6580867e7584">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/a2ea7bd4-12ec-4134-b156-c32fcf737b74"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/aa973d4d-c8b1-4ffc-a359-a23ce7474078"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/9665aa0f-5678-4f6c-a069-8e69c65c9932">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/a3caeb32-d401-4dba-a2cd-4287e1032292">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/4c51d6a9-8ee7-4a49-8ad9-51abbb922cc9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/3bf4a29a-4b85-42fd-8571-c12bef9691f4"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a34b4556-5ce4-429f-ba85-8f02f367142b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8eb6911c-3307-41a5-a786-f1cb34c04f32">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e279f42f-f3db-414c-8422-b9ca2e56dc7a"/>
    <rdfs:label>23 Percent </rdfs:label>
    <obo:OBI_0001937>23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e1159487-76db-4ed1-9323-aa07d0cebba9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d9bde213-df98-46aa-af56-2500c23d5739">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1bbd15da-58e8-4a17-838c-b8a6c19c443e"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/d5fb1d59-7cf0-4f7f-b45c-64447779e747">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/e9a61d91-d37a-4431-8373-1b49fe30b63c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/02fce6b5-e050-4724-aa91-d682b8ad527c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d2181ee2-053b-4786-9212-5e4d2bb2262f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/37a12a60-cc17-448b-b091-f9a6ed1e2d29">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9a14d3f8-4ecd-4046-b4a6-71cc510ffef1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/0cab961a-ee41-4f2e-8bfc-8d0b3e6b6f84"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2c562e0d-b9c1-4842-946e-e1ac3dc8761e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e5a3dc75-88e8-4497-8c7a-3a3f0e23806d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7051ff2a-7106-478a-9105-7b2fbf05134c"/>
    <rdfs:label>rifampin-dabigatran drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/38f5de9d-d376-494e-a5dc-eb1c7c6428ad"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/cb8d9ae4-3777-42d5-bfd0-bbff1b0b0f9a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/6e373d97-b390-496d-9632-f229ca2a699b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/bb75e72c-8281-4891-87fb-576c9a3be26a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/ec52afcf-cfa5-4f6d-b6b9-85276aa63e36"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/de3ea3aa-0642-4a2b-a77d-cb99a57b66ff">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/78eb169d-891a-434b-844d-8b283545dfb4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b5354f22-674b-4ef3-bd61-8c01d801251a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3daee164-faa2-4753-8638-43eee965c2ce">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1466d0b8-422d-48b5-a8e1-bf5709930954"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b9862b54-0134-4b8a-875f-7a4e3bea8dde">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/282fe0f6-81d7-4343-bfb9-0b97aa9ee10b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1601a711-9a94-4517-b0a2-95e197dab9f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e4fd62e8-8eea-4e2c-ac6d-2bca93f38f1c">
    <rdfs:label>Cyclosporine-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/fd81d61e-08aa-4003-89cf-9df7696e1d37">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/98c5d49b-d441-447c-8b9a-fb0e73699e22">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/16effcdc-afd3-494c-acf8-7588fd72ecdc">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2129ddd5-3dd5-464a-a758-1c15c97300ad"/>
    <rdfs:label>2.1 Fold </rdfs:label>
    <obo:OBI_0001937>2.1</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/95d9a80b-85bc-492c-aaac-7eb4425510b3">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/067415d7-48ee-45df-9889-9fe5b773cfa8"/>
    <rdfs:label>ketoconazole-mirtazapine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9dbcf74d-3563-447e-978c-358898cb1bdf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b8a1d37e-398c-48b9-9af0-c875985e14c5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/3aa55ae8-12f2-4d8a-b530-13b6db2716e6">
    <rdf:type rdf:resource="obo:RxNorm_8331"/>
    <rdfs:label>pimozide</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/3b2be42f-64d3-47d4-8124-c320f87ebb3b">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/72f6696a-7c65-4025-b318-78626e602666"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/d9aaacfd-661f-40cf-9083-5f3fa18bf8c5"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/c6bdb0c8-fc2f-48a0-985f-60e2d0808120"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/8f1f4b64-0049-4d85-bbea-75aab2424acf">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/42b71c73-f1e3-4e8d-865f-c46e0e453b1d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/c8b249e6-bb7b-4900-83cc-c182ec0923c9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/53699a02-cda8-4768-a155-de2cddc5c6f7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/02fce6b5-e050-4724-aa91-d682b8ad527c">
    <obo:OBI_0001937>1</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/f655007d-2503-41dd-9ff2-873daad67cc0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/b15db153-ffa7-474a-999a-3a8306dff72b">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/79c2f152-7454-4b5c-9e05-6eb8038884fe"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/acab30d2-cd3e-4650-b87b-0c96a7e03f94"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/121a2a92-1782-41a9-b01c-5fb64ed127ae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/130e912e-0849-4d47-b456-a054f757f320">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/b2a85c88-c82d-4045-8e01-08c9eaaafe05"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/34495971-4b62-4a90-bf20-05f14f076a48"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a8e1f927-d764-4dcb-a137-05c4959fd173">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/2c2bbfca-5b00-4f82-80c9-cbf0122f86f1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e205f532-13f0-45a7-b7b7-adc22c5a901a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/be4f83c2-4ceb-40cf-8d7a-ad370db73c47"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0c07f576-089a-4a02-8945-267b8f9ca7ac">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/0d1777da-78d9-4356-9b70-a035a0cc766d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/09673ac1-cc27-4e7e-a3a0-434c3ffbc43f"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/33784ee1-a283-47b2-b3ba-50b487dfb4bf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/750358f7-132a-440c-8b12-7b3771fce59e">
    <rdf:type rdf:resource="obo:RxNorm_74667"/>
    <rdfs:label>zaleplon</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e67d7755-7f8d-4f82-ad5b-44c9f645810e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/33fd7308-4388-42df-a5a2-e1324bad1baf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/543e695f-73a5-47ee-b86e-82a5d1743511"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/7c04211e-1c63-44e8-be01-117479e469b0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/a6e1abfb-9592-4253-b477-a9514aebd925">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ed80b430-6129-4317-9ee1-2af4bb22d0c6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/3f8aae57-7785-450d-bc15-93578430fa23"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/2f8f13cd-90eb-43d8-a009-e1d39bdd2993">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a9a28a3a-3443-4220-a876-a29216e98198">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/449a1312-794e-4fc5-a99d-1cf802e7a1be">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/331df3d1-62e2-40ff-bc9b-e3037ceca202">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c96b058a-447f-4899-bbb8-cb54690920eb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/4bf11f25-bddb-4a55-b0d1-677caa95b11d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/44c3dc7f-964c-43be-b2e3-da78cf7fbf06"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/0262103f-bef2-4628-938d-bc91bcda2426">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f3eb8af4-57da-47fe-b78a-71bf202d4dd3">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a5a88f39-c781-467b-b2c8-e707dc57e620"/>
    <rdfs:label>3 Fold </rdfs:label>
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/b93440ce-41ce-422b-93b9-cd9b93f5f433">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/1af6974a-dcd3-4d67-95a1-665e5c8ac675"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/950fd0d6-f748-4647-9070-f6b831b35064"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/605647ac-2520-4747-9bca-784e08849ff2">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/469eec16-23cb-4ab4-99d8-c8aa4b45440d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1da23eb2-ca8a-43cb-b9f2-04252a066f62">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a0ce5ecf-7cbc-4820-86fa-502ec9569e0c"/>
    <rdfs:label>paroxetine-risperidone drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/6deed469-3429-45d5-a7b1-525fe44f1616"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/be252323-5879-4ac8-a47c-cb44eff00a47">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/02567497-10f9-4a41-83cf-eca0cf15f470"/>
    <rdfs:label>nefazodone-alprazolam drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/6265ea3e-2701-42d9-8d37-0e36402de598"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/da8af416-ee61-40a4-afc1-c1708041904d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/5e885535-a108-47c7-9ef7-d22ccf93bc30"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/dc9062db-80f0-4ef3-b39f-6b05373ef12c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7a371f4c-e859-42fc-a9cf-1cd462443274">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/905ac333-ca3a-4a4a-89b2-22dd79be4094"/>
    <rdfs:label>85 Percent </rdfs:label>
    <obo:OBI_0001937>85</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/8c8ca51c-f17e-4002-930f-f51081995994">
    <rdf:type rdf:resource="obo:RxNorm_9384"/>
    <rdfs:label>rifampin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/53699a02-cda8-4768-a155-de2cddc5c6f7">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/52cdc325-f0f4-447c-8bd6-631ec57f76f8"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/8ebfd728-9e99-4eb2-b191-85fa34a6556c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/550ba7aa-7650-413e-bc3d-ec44dc77721b">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/cd0d64e1-d61e-406a-8839-e3c68d43fab3">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5e6822b7-d5ac-4132-8d8c-53f23df8e93a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/4c05120e-987a-49f9-a26e-6d9c481ede3d">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/71bdd755-3e63-490a-bcd3-88cb76fc12de"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e0f05349-4b3f-469a-9dad-2e07f4d860a1">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/2c88c377-26d2-4e68-93da-96347894e11f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e45ecbfe-0179-4d83-8bbf-c50a76752c4a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ceb39617-6ed8-4fb9-9266-e20b2a248ccd"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/95d9a80b-85bc-492c-aaac-7eb4425510b3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/541a8cf6-94d8-4913-914f-7cce274de618"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a1e55b43-a646-4434-86f0-8c7fac1b591e"/>
    <rdfs:label>ketoconazole-mirtazapine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8ecde3aa-0d7e-473a-92a3-be89837cd3b4">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/bbe327be-d8c4-44d6-9c34-4b9d41d919c6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f6e7342e-1c13-4f94-8e47-02ed248c7511">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/37a3e5ac-c143-48f3-bc75-f702261de720"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/836623ec-4990-4407-8cb1-1b6abeecd523"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/b879a71a-695a-47c9-8288-54255b6e985e">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/3aa55ae8-12f2-4d8a-b530-13b6db2716e6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/f21d2068-86af-40ba-bda0-fee06a30a588"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/e7dee739-d609-450f-b0f0-c7740ef5731a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e5254f6c-4e81-4987-a39e-ba4ab7cf7a16">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/4b75ad88-10c8-43e5-976a-825d05dc58f9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/807a902b-fea2-4d81-99c8-98fe9c9c5c28">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/586636b7-1ae2-45d8-a3f9-7c605c35858a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d7835084-5e0b-4988-9dc9-c4977991a0f2"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4ae8d021-4225-400e-8ada-8d253abf0d41">
    <obo:OBI_0001937>500</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/a1b1cf0a-e1d4-4148-ad77-84538490b978"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ea9cf842-d1fd-4659-8da3-cb6e0137db41">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e0cbde2d-1ac5-410d-b6e6-f17b15ee7ecb">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/28ea2988-b1f7-4777-a10b-52a91cc9f451"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f877e543-c944-4e48-844f-95440c96f2c1">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/61304144-96fe-4ba8-bfe6-8b99e0987908"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/17e904de-1fdb-4004-af01-4a606e7aa748">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/6da1e857-815c-44d6-8876-4df51636e359"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/5823a121-b618-4767-80c9-d3989fd2934c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/ea8685ea-f1e6-4766-8f0f-6b280c08f3cd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/c48c26d7-6ebb-4f79-a859-e559fee20c68">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7891790e-69d3-4009-ab69-38b81b0c8e01">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/a51eb96b-d646-425f-a450-0fdd8d90ccfb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d7813bc2-71c7-4285-9a18-848d97486b50">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
    <rdfs:label>desipramine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/eb842cc8-95d6-48f6-90d6-2fe4475f4968">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/8bf867fc-0d43-4705-8c95-fef9cda1c73b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a3cd6eb6-4790-4e4a-9254-3864c7d38d3e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/bba641a3-b696-4d19-b021-97622dbf3147">
    <rdf:type rdf:resource="obo:RxNorm_9525"/>
    <rdfs:label>salicylic acid</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e5208d2a-030b-490f-a6fd-822e659f69d0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/79ab8d49-1835-4bfa-aafa-f96a0cbf55af">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/9c981278-52b9-4f82-bd75-3547d22a3b9e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/fe7f65b0-e639-47e2-aa91-759f02bd8685"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/cd6b18c6-55bd-4e57-a103-ce3e9a4ec6ee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d6a40ef9-1f54-4e3b-9a66-5f939c158420">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d4df4bb7-151e-4963-8df0-405c4fb87378">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c33f8a52-cc70-4894-a21b-df9965b482fa"/>
    <rdfs:label>nefazodone-simvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/084ba850-8ab0-4816-bee3-30aa95023084"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/587eac2a-4826-4901-a8dc-af0d16692865">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/7b80a9e8-0c74-4aea-b4c0-5717b44199a2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/c396fc54-393c-4486-9d0f-c56d2fd897da"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/3c5d851d-e85c-4f26-874d-39accdcf2b7b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4878b2cd-939d-4f08-9e30-00c3641d257b">
    <obo:OBI_0001937>750</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/482af706-c10b-4df1-a938-d2a0f2d7bc89"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/5d51f5c2-6d61-4b5e-8d54-cb83d6c8b8db">
    <obo:OBI_0001937>1</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/e0f0e5ad-2ff1-4afe-a475-4d5c8813f1f8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/99aff50e-8366-4eb1-8566-edb8681ffd2e">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8b3b3870-4545-44e3-b8df-e597caee6fe6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a9f7fa23-389a-47cf-a64d-d26b70c1f3d4">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/cc230916-cbfe-4395-b871-6ac593bd78d9"/>
    <rdfs:label>0.87 Fold </rdfs:label>
    <obo:OBI_0001937>0.87</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/5c77d9d1-78f3-4192-b074-0a0417cc2169">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/79800ed2-2318-42d3-849f-52e54e1bc1dd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/52e494b9-f528-4cef-96d5-7038db2eb0bd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/9c2381e2-d073-4d09-bd70-36c5b6c6ac9d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c6e89622-d585-4a8a-b6f7-271db3f0fc3e">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/a60fc53c-5413-4d31-83dc-3a4290b24e76"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/856d2073-a881-4106-a0eb-ec45fee9e72b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/ae388dff-9aec-4f5c-bfa8-4a7942301fc4"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/b549b0d1-7332-438c-b2dc-326b7f7acc65"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/d0d96d43-27c2-4c70-aa6e-e9f9f8882205">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/9ff5d7fc-c69d-4cc5-b488-027669616e00"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4e1949b0-9726-4a52-8417-cd7712f79295">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8ab32a83-8782-4209-baed-6d6989c3b1bf"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3dd497f8-2b1a-408c-9f24-802fa75cb78a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/04a91aa0-dc97-4ebd-8fbe-582788d2433e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a887d092-a637-4902-88ad-4445d5f3dba0"/>
    <rdfs:label>fluvoxamine-tacrine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f07afbe2-b6e9-4e21-8c31-387dc8405e80"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/09ac0516-95d4-41cb-9d75-d124de3712fe">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/d9a0772a-879b-409e-834b-d5aa31abac20"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/a3e8f7fb-e3ad-4316-a028-2f95819f1787"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/aa36921b-8364-46cf-821f-8f5b6ebb0796">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4cb035d9-decd-4321-badb-6556b5af8b06"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/bb35c4b4-8439-401a-ba88-234778de6bb2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/6eb22daa-5f63-491e-a5a7-100ce631d00b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4021f576-455d-4f0f-9d7f-d0178e68d230"/>
    <rdfs:label>atorvastatin-norverapamil interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d2033896-9abc-48a8-848b-62c15dcda51a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/52d5a2f0-d308-417e-abcb-9b30f0a5cce4"/>
    <rdfs:label>10 Percent </rdfs:label>
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f4aa86ca-3d1c-4de3-a090-a4fbbbf09a80">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/606e6430-776d-4328-bcf4-18989d3f2747"/>
    <rdfs:label>35 Percent </rdfs:label>
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1420d5a0-e2d1-429c-b7da-04251a8487a4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d962cf96-0f28-469d-a9d9-4a1a601a2896">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/addfdeae-2f9d-4380-80b9-880d5360304f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/645313b7-8940-4a4d-bef5-22957fc2950c"/>
    <rdfs:label>sertraline-pimozide drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/016d2e86-f457-4c8e-b04e-f3de4ac92ee3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7ac1b668-3557-470a-9148-6c589d3ddfe3">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/a9b9fb85-2629-493c-91a4-09c791a6a9e0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/8eec49f6-db86-43a9-ada4-7402e9ebbc83"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/14aad8e0-30ec-4717-9fe0-a3cb349c8e1b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a6ae635a-1cc2-4710-8255-ec36cf1faaa6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/23ecea2f-a1a6-4603-8ec7-2be96eb26a4d">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/dd25b3ab-ce64-4300-a493-0476f44855aa"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/f1f9d775-9bb7-48b3-a24e-ad2661f4ceef"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/ec2983c8-cf18-45fd-b9ca-2e8a03913f25"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/48684781-3261-4643-9168-009ab61ddd45">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/b57e2ff1-6152-466e-aa65-a35cc7eaa0a3"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/d1bcd60a-9ce6-4e0f-a864-473f6388213d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a16825c0-45e5-40c4-9923-1c34119b1351">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f49d382c-a193-430a-b18a-a0591f015a9c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/8070a92e-bbc2-4e5f-a637-c6d826447859">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/bd0a588d-a5d3-4789-a6c0-3765818a8ddb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/360efb8e-3402-4e4d-a665-a52fc568c826"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/fe097cd8-bbc5-4676-999d-f3197771d309"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/97c14337-3050-4dda-b2c4-3c8d3089554c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/39e2b1af-b8df-4cae-9e0a-4341b3dd1685"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/565d59bf-f5ac-4163-92af-6c8d5ee1fecf"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3283c313-5861-4ce2-8e70-be33ab971611"/>
    <rdfs:label>carbamazepine-hydroxynefazodone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/10a9a58e-989b-4570-bf81-bf692e920d82">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/888cfaee-767d-4ad0-9c35-7db9ac96ce11">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/cd19611c-b028-4bd9-8148-d053bcbdb973">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/23a9fece-481d-4b95-a74b-966c2fd4b397">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/95ceec07-20d0-41f9-8693-a31cb0fc4a2f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/497dc4cf-4948-4fb2-a3c2-c3bb7100dfdb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/92ab2faf-08df-4b15-b04f-49e495c2610d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/322ca4c8-4625-429a-8468-7799b224b5ef">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/abd076c1-c742-4e6a-946f-a4cbb25be722">
    <rdfs:label>carbamazepine-hydroxynefazodone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/371e58b4-6631-4e6d-9994-997d9bffca01">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/09abbd4f-19c1-49b7-8f09-e5fa1be686ea"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/fc0338c1-3e24-4081-8c43-bc2664ca7136"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/84cb3c5e-137b-48c4-8e50-47f17e20b1e6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/3e34b8ae-abed-4c83-9825-b297cea25107">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/1f3e4e57-e283-441e-8dd8-8ed88ac0e85e">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c7f99f46-1359-4b71-a1a4-4ab95df20877"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/f1bf8b48-a89c-4cbf-a6b7-505e4cba7360"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/a06ffdc6-d293-4d6f-88d6-40aa650a9c1a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2c0b8ac8-cdaf-4b13-8ed8-9f10f618556d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1e67006b-4579-4baf-ac36-e79fd623f4bc"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b32db24c-21f5-40a3-a054-95c5861f21bb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fbcdb079-3f78-4034-b10b-1f2b80c61593">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1dc14dd4-08a0-4ba3-8118-e2b307754c4a"/>
    <rdfs:label>no change UNK </rdfs:label>
    <obo:OBI_0001937>no change</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/20f05a25-1c9d-4126-9c83-8dcb4b9e81c6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f1068821-c78b-492a-a5cd-f6ea99928d94"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/c8b3ed39-07c3-4a37-bb6e-9fa0abe10131"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/547da4ae-ffd9-4d06-846f-b36828173d72">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/8ccf21e2-4fb4-4084-9a0b-1ed2b53f7d85">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/d08e1c97-22ef-4fb1-9aaa-5681b0083b15"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/4fb566fe-ffb7-437c-aa19-468f41f264a6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/79a6c176-8cea-42d8-94d4-3c1e90732242"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/c70ff1a5-0641-4261-93d0-f77ea8fccbbe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/727ae14c-7f6f-4f8e-8c08-85855d9a3a6a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/2420a771-1948-4dac-88a0-6d2a8f48030d">
    <rdfs:label>fluoxetine-mCPP DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/64c22999-c246-4b39-8f27-c5aa1664299b">
    <rdf:type rdf:resource="obo:RxNorm_3322"/>
    <rdfs:label>diazepam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3b93d17e-b3d3-44f9-889e-157d787102df">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/5bc53290-907c-4f07-aee5-89819611960e">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/10dd253b-9144-435b-bf05-5d05ef4753ce"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/70695ede-e35d-4806-a227-0c954fbc2064"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/184cf550-e157-4a3e-b68a-185004b78168"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/b7cbf4d0-84bf-4bd7-8281-8e77bfda5663">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/2b03b9e5-2abb-4f39-a5eb-743c02e3a25f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/5e772480-6e6a-450d-964d-11d93ffe2f89"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/7685c377-7402-4fa0-b3e5-311fbb4954e0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/0eb61aac-b69a-4752-a0d8-5940fa40be68">
    <rdf:type rdf:resource="obo:RxNorm_8787"/>
    <rdfs:label>propranolol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f6353b33-550b-4332-84b3-29a74ba16a21">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e0c11dd4-9137-45df-8c2f-8e1b0c739a05">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/bdf5d18c-5c3c-496e-ab0c-f9311360d44c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ae388257-7bbe-4d09-a18a-951853668457"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/9a759ee9-8cf3-438d-955a-3aed6c5b33a0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/9aa2f95d-1a71-4ca0-970a-e99fed8d907f"/>
    <rdfs:label>ritonavir-bupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/09ad1a51-38ee-40af-a1bf-89d56d98c79a">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/12f79744-8ef0-44ca-ad6a-d646571d606d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/46fe1ab0-0f57-4101-9c37-452b17f7f7a5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6ab6cc44-8377-4835-8ef4-e546c0f3a67f">
    <obo:OBI_0001937>120</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/d2561fc9-4360-4825-b890-c4c50376a2fa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/1e7df61a-067f-4638-84b1-c80d6dde597c">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/ed422d1c-0f56-4ac6-b33c-cb121460eee7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/848b3e14-b3c6-4828-82e4-3832991d15f4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/65f1b8f6-153b-41fa-ad6f-9b9ea931102d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f1aec92a-fd0c-49a6-a544-e0730c379d57"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/47155381-aa31-4848-ab41-48f9e5929c00"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d5308a15-0436-4ab4-8dce-19471b58ad44"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/73647379-80e9-4f4f-bb96-e34fce09df28"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c618984a-0db1-4838-b1c8-de21a2383d7c"/>
    <rdfs:label>telaprevir-amlodipine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/9eb40163-a47a-4c10-80c8-6facd0fd6149">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/436770e0-6436-47df-bf0f-082506501c7e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a3f1ca05-7b8c-483f-9555-4d79885d0fe8">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a1f92023-2205-49ad-90ae-47d17ac1e8cc"/>
    <rdfs:label>fluvoxamine maleate-alprazolam drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/fdf09702-862e-4d9b-92eb-93419d9aefbf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/bfbe4b84-0cf3-4954-9195-ef51e7e6eae9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/d6dfe378-0126-4772-bbd6-a11fe3d849fe"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/68364ab9-2838-4f5f-ac87-67a6592609eb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cd1b5c0c-6494-454e-b194-491d6eb0d64d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/697bb640-6052-4940-a125-671098b280fb"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/c43afa01-dbd1-470b-8c15-0bca8c0f25db">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/42a2c674-52ec-492f-8e44-e3ab8266a831">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/cab52234-3858-43c7-9ac7-6bc3fe707d7f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/99e81c48-f0eb-47fd-be83-615386f719e6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/2a61862a-cdaf-44b7-970b-24dc8eb0a24e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d9f9f0c2-fd8b-4e04-b560-9c8d9184aa4f">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/cfb53707-aa22-4f99-9471-fe05e4402be0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/f288f199-b261-47b4-95b5-7a04f56d538d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/b576f159-205c-4bf5-8046-e4e3ea3c9a7e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/acf3d5cf-6af1-4b9b-95d0-8df0eabb83f4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/bbf98722-9063-480b-88e0-0ee3eb35b2d4">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/c867ebbe-31e6-4cf5-8b50-b7f99268d7f6"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/7f6cb7af-51f6-46f6-982e-c43964a3b202"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8c7f0cd7-66c1-41b8-a241-6ad9d9f35d8c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e1159487-76db-4ed1-9323-aa07d0cebba9"/>
    <rdfs:label>43 Percent </rdfs:label>
    <obo:OBI_0001937>43</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/285dc2c4-b2eb-4952-985e-2dda8f91fd3f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/dd649ae9-d57e-4b61-a084-86d2cc235261"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/37bb90cb-a309-4757-9828-387e5bb91405"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ad5c6943-c03b-4437-83e0-05a90d2c0bcf">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d5fb4dff-ee5a-4fb0-81b4-b3010a72ba99"/>
    <rdfs:label>citalopram-ketoconazole drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0f79bda4-1681-4551-b409-b62ccf521d03"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0154ac24-ebd1-4d9d-9075-3d21a406bb89">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/984e571d-9746-4109-acd7-0b6223a4da9b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/d3ba6875-61b9-4fed-811e-5bb2d3f27d28"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/280ea108-1cdc-468a-85c2-f20b2945adf4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/d62ffe84-e341-4862-bca6-aa4960bc3494">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/b15db153-ffa7-474a-999a-3a8306dff72b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/98521497-029b-4f25-8274-dd0bc24f4253"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e5dfc94d-d276-462e-8e8d-fdd97821ea79">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c6571f06-58c5-4697-a9d7-5082244e78b4">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d1c56835-d123-4dfb-9422-5d80437ece23"/>
    <rdfs:label>65 UNK </rdfs:label>
    <obo:OBI_0001937>65</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/8042783e-4881-4e53-b514-c0673eb218c1">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/fa2089a0-be0e-4516-a465-39f2c865aab1"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/c0365e0a-2523-4187-995a-d57994681f84"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/4a03c597-8884-450f-91f9-32393208e87e">
    <rdf:type rdf:resource="obo:RxNorm_321988"/>
    <rdfs:label>escitalopram</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/f99ec1cb-2129-4086-b132-06c29a301df2">
    <rdf:type rdf:resource="obo:RxNorm_32968"/>
    <rdfs:label>clopidogrel</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/644c1961-fb23-4dcb-8654-e019c1e34d1c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/854537e4-006a-4f94-a0b9-db64851853f4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/d9809b05-1acb-43dc-a4d8-bf818599f9b5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/78c82506-e00b-41ba-9f20-87665d9a7042">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/81ab8fe9-8722-4c16-b696-5c2d170103df">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/b208d464-b1f2-4ea8-ae21-d4d0e7f4f2cb"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/dee17cce-f612-4677-9e30-652947eb317a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4f783bc9-ff0b-4967-aacc-221c91cb990b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d78ed45d-7271-4702-89ab-6ce3f306bc44"/>
    <rdfs:label>ketoconazole-P88 drug package clearance UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0824a9b8-0624-4a00-94a2-9598369cfd98"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ae59d5e5-c78f-47fb-8d58-ef5e6baa956d">
    <rdf:type rdf:resource="obo:RxNorm_114289"/>
    <rdfs:label>indinavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8ff84438-7180-489d-8009-c3038053b86f">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/20d014d7-bc59-41f5-b83e-fd98bda171dc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f26b510b-c598-4c0d-b1b7-c6f8e2a23058">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0af3fa8a-233b-4600-a114-ea662ef976c4"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7ae8ded5-280f-4a0b-9d3b-ec1a2fae4352">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2bd2150f-fb12-4c5a-9859-fd20f83509a9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/19047c54-e0ab-4297-95e7-041fd14f68ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6966c772-74c0-4cfe-af2f-b7cccdf4d5ee">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/16be633c-67f4-48df-9c1d-4220989a43a0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/04fb1fc1-4e05-4dcf-9084-5292edbca73f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/14038ed8-d043-40ea-9cad-77199ca2c70e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/88a45f00-1e2e-4300-bef0-5a5e4470fbab"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/027f73c6-ff00-4605-bef0-06db6a5efb44">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/639e09ed-9ad4-421b-bca9-d9d8112e297a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d72efbba-970b-4686-9e6c-f20c893dfcc4">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/1042fec7-8c6b-4344-8a48-2e6c4392a5d8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/8ce2bb60-b4ad-4738-ae78-e48358bc32ac"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/e94fdcfd-b9ae-4788-bd98-b7604c298a64"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/67b8cfdd-2010-42d2-ae19-dec32bb0dfed">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/a032f86e-975c-4676-9c08-918f1e372985"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/61d873c8-1b14-4e44-9f75-f8dfc8a36982"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2d4302ab-2293-4980-947b-b3945ab6c51d">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/791bb5a3-bd10-4755-bad5-a1166c237533"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/ea396829-5c65-47c5-b7db-89261a428aad">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/6650951d-4c42-4cd7-b91a-5e0c4e47ae55"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/55c66822-a06f-470f-baa9-9b98b19746db">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1dc42df0-e103-442d-9c9e-17761effdfb9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a48fe6d2-df31-4a00-98a3-e348318c9a79"/>
    <rdfs:label>phenobarbital-paroxetine drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1bba78ca-25d8-42eb-aadb-91554f31ad7e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0f62ee31-84e3-4bd0-862b-e779a2b9cba1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/13bb78da-588f-4e4e-a86b-33ebd9bbca0f">
    <rdfs:label>ABILIFY-paroxetine CR DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1827299f-e73f-4367-b5f3-4beb5dfb22a7">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7faca321-698e-4bd3-af7e-f040a5bfff4d"/>
    <rdfs:label>quinidine-dabigatran drug package clearance UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a7d5209f-d164-4cd2-a44e-393080fb4775"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8231c9af-bc4d-49b2-8aa3-dd59483441b0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/b86e760f-ecb6-4e38-88bc-c9ed4f3e8197">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/4982b7bd-c864-44de-888f-1187b4809b65"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/9a43dda8-e922-4e0d-ba1f-aa4d9a98a02d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/067415d7-48ee-45df-9889-9fe5b773cfa8">
    <rdfs:label>ketoconazole-mirtazapine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/cac1d879-1374-40cb-ad07-2a9391d5c790">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/163ea7af-31d5-4749-ac0c-ef53c838070d">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/87ad09fa-a49f-4df0-804b-9ecd77570b62"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/06ce8713-c35a-41b7-bf22-1f71239f3324">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a49e8ec8-1f5a-459d-ab97-f5b926e3ede8"/>
    <rdfs:label>carbamazepine-nefazodone drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/ee6a1e9c-3507-4255-870f-7a3981154e3e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/05423a2d-762d-4dd7-875b-17c7d0c96567">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/8929d5c9-edaa-43d5-a593-ad43dcc0c2c4">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/9f74238b-5cec-4c9e-a317-d222b16f9536"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/d51efbcf-a91a-4e54-83b3-f4f5a5c95938"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/edc6b0b7-aff2-4c6d-aeec-bc796656c58a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/2bbda85f-11f7-4ccc-af34-a517948031ed">
    <rdfs:label>fimasartan-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/5a4f164f-4eb1-4422-898e-983176eb281f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4483d493-e509-4240-9d99-9c21195af8e3"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ae0330ed-1e56-448f-90fd-7fe665782138"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7239fe7f-968f-4962-aa44-22da17afe21a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/49c64859-a682-4b52-9f9e-e414be370826"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/9de87178-1e94-4120-a42b-e4c18746ed9e"/>
    <rdfs:label>carbamazepine-INVEGA interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f55a250a-1136-4fe5-8e5f-72179dffdd04">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/5462da1b-5222-4400-b33b-ed6b04688bcf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/394f413d-872d-44c7-9a3e-3a4c90f0c8dd">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8337e920-019a-4807-b53c-9ab1fd710c74"/>
    <rdfs:label>Fluvoxamine-alosetron drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/687c1082-2abb-4235-a600-8600142d3a53"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/46b90223-23ed-439c-a2d5-877ff5fb6f5d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/14aad8e0-30ec-4717-9fe0-a3cb349c8e1b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/bb19cad8-b69d-42c5-8455-bf454b2ffecf"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/73867458-1cea-40ce-9302-55de86df8ac9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9e0c11ac-2085-43a8-b702-1cf48eafc45b">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d41df977-7506-49b8-814f-d83eec25a896"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/4fdba76b-5c2f-482b-876a-5f7db5eb9d46">
    <rdf:type rdf:resource="obo:MeSH_C558899"/>
    <rdfs:label>Lopinavir/Ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/234f48df-f4c2-4a85-8c3d-bc9b041d5c06">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/a2648f8a-fece-4fbb-862b-eb9c4e7128be"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/ecf777b2-be29-4567-ab2e-0274dee44008"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/ed776fa7-934a-4584-9787-d4d751aeb3f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/790e3edf-1e96-460f-8e29-961144dc5eaf">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/f27ade03-ef86-4550-a9c1-b784f53a9621"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/2a0daca1-e6b5-4414-9f28-2d68190eb950"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/8e0a169a-dbaa-40bb-95d8-c661d1141bfe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/2a1e70d1-f5c2-4d32-825f-bdb484d39d94">
    <rdf:type rdf:resource="obo:RxNorm_683693"/>
    <rdfs:label>desvenlafaxine succinate</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/7864fa86-6006-4334-b7f7-85e25b8bd154">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/d9e04290-38ff-4139-8fe0-06fb90ca1941">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/836623ec-4990-4407-8cb1-1b6abeecd523">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/eed3f659-6722-48e2-b9c0-11ab1af6b1dc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/5e772480-6e6a-450d-964d-11d93ffe2f89">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6f318162-a94b-4174-a12a-1fe7498236f4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b7d90297-4d1c-488f-8608-0fa0a53123d3"/>
    <rdfs:label>ketoconazole-iloperidone drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1496d7c9-5297-40a3-a693-e7dfa1b78210"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/d6485b29-e471-4166-a31f-6ba637e2add0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/0ac4e582-9084-4787-bb5f-f8d0fbf0fc99">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/6423c44c-97f1-4ffc-92af-7ac15db49aa2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/8a9e9888-e819-42f8-88e9-d80243dda6af"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/5e4c0136-c1ba-4080-a99f-b3e05ee609c9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fdf09702-862e-4d9b-92eb-93419d9aefbf">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/bee29656-08a6-402a-9fd9-4764269cb43d"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/389679be-fdf8-4f41-b9d6-64e493a3d5f5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e44d933a-32b1-4638-8657-e16c392de85d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/225e95e2-f59c-4ccb-9674-97186e08a9f9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/16be633c-67f4-48df-9c1d-4220989a43a0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/2fef924d-2083-41e7-95f7-11d0059860d2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/51880453-9c77-4897-9da3-2bc3bdf70f50">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/fc2f2bac-cb08-4dcd-9596-ed0ff34e01f7">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ffdbb6f4-17d4-4edc-88c6-c409699103f3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f9e63c26-8658-4d84-a6f1-dad5483fa6da"/>
    <rdfs:label>Lovastatin-verapamil interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/69abf7c0-1d30-4aec-bb14-680c61109e29">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/726bbfcb-a5d0-482f-a9c6-d2c4077e9cae"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/a627740e-9d2f-445a-ad0d-07ce97f30035"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d254321d-df50-470a-bbb9-a78f796dd2bc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/617806cc-06c2-4fb0-a870-bc5c00470dcd">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/8ee16cb5-a7d7-43e3-ae73-8827cd93596e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/7b01dc07-f316-4841-a9c4-eb9100e83021"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7d03122e-f623-4629-97af-2c5c40fa9805">
    <obo:OBI_0001937>8 or 12</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/996e25ee-72d8-4baa-b911-3a42094bb4ae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/969e6be6-bee6-4c63-834f-c59f9c9ccd7e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/8085138d-2923-4b69-bce4-12486f51801c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/2bc20eba-a2df-4313-b000-68624a8343ca"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/e0f05349-4b3f-469a-9dad-2e07f4d860a1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2bb351c2-2b94-423e-b45e-d90eeb9b9a03">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/3534588d-313b-49e4-87e7-9e41c3de44e2"/>
    <rdfs:label>24 Percent </rdfs:label>
    <obo:OBI_0001937>24</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/58854502-e276-4f3b-a777-c61e5199dad0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/891e9020-3375-4738-bba7-356dae901c19">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4cb2b7f0-70ca-41a1-aaaf-7e32da1c746e"/>
    <rdfs:label>21 Percent </rdfs:label>
    <obo:OBI_0001937>21</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/26fffdab-c35d-4db8-b8b7-206531703686">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d346fae0-cf17-43dd-9783-0496566877c8"/>
    <rdfs:label>sertraline-cisapride drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2aee3570-db0d-4451-ae11-8997521e14bb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/fcdd6f86-90f5-4db2-9dae-5c86ebcb6cc0">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f9785b05-8291-4d90-a57a-37647f728bd0"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/6355223c-51c5-44c4-a545-f37779a5d92e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/d7816972-2af7-4a42-93a2-6e9543811c09">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/5f17ab96-2d30-496d-9ae0-58bbfbd89abe"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/348e3e17-2874-4164-a7e1-83b81d214e00"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/9de7cd47-ff11-4041-add9-d9dbad2d237e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/49d1aa75-40df-4e19-bf9e-431113a5e4a5"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/05c0bbba-8a9c-4fcd-a1b7-340b8bd6abfc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/0f953442-7045-4d1c-af63-d62ea6fea76d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ff657b0a-107f-4197-9c5c-781a157bcf46">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/1a875e3f-56b2-4a93-b124-da75b764f05e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/6eb0b4f8-4a5e-404f-abd8-1900224704d1"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/593b2f74-e3f9-4f40-b32f-e06ccfb55b09"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/5bccc0c8-253b-4477-9b60-e7e6f0b58619">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1a7c49b6-0f50-4f55-b7db-64989c6a443e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/bbe4bd1a-945a-4ab4-b48e-8fc6c6673135">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/19a08913-e679-4818-acf9-49379a7ea062"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/9ec6f2b4-5164-4d62-9a54-372d78320952"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/69f79a89-1638-46de-8214-b56da8db8f83">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/a4f44f6f-679f-49aa-bf8d-903f0ba56f98">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/8c0f72ee-568a-402e-874f-2dbd15d37a69"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/4b47d874-f0da-4ecf-a734-0b3ed5914a49"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/769d0615-b202-474f-bdd1-3dfb79b8801f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/533dcaae-53ad-4424-824f-fbc6ed7b8acb">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/cb0d5d57-4a8d-4d18-8a38-8779aa24c51a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/b26f30e9-4597-4a4f-82a8-be6f80ecb332"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/6bd80d6d-862a-40e5-a75b-11a290672c60"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/8b0a44e0-0854-4083-9dad-e1e739824304">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/79757ec7-824e-44d3-94dd-a0307345d76b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/82dc2863-8453-459a-83a1-616c8b78d3b7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/44ee6903-f719-4ab6-8711-1683454caf75">
    <rdf:type rdf:resource="obo:RxNorm_6960"/>
    <rdfs:label>midazolam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/1823712e-102b-4234-9b71-35b4ed3124bb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ad13c11e-af6d-4e8c-ac8b-34173c0f8454">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b74cd949-6618-4ad5-a2b3-37805935f705">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d26c33e0-273f-44ae-a469-aff46c4428b4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/03f05038-6e65-45b7-86b4-39424632df2b"/>
    <rdfs:label>ketoconazole-eszopiclone drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/18e1847c-ce00-42d7-a4c7-dcd6dcb9322d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/fd6f961f-6101-4ba0-b282-881dfbae46dc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b70b36cf-6518-47fe-893f-c3417bba5873">
    <rdfs:label>rifampicin-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d55d9432-dd90-4dde-868d-a5a792e61c51">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8c48a422-b7e9-4cfc-a52c-82aa3794586e"/>
    <rdfs:label>buspirone-mCPP drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/791050c8-b32e-46e8-9b82-fa6d1e1012be"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c7e45778-bcc3-41d3-993a-ede62e143fc3">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/43ed05d2-a7fe-4719-911a-631a81073e6b"/>
    <rdfs:label>15 Percent </rdfs:label>
    <obo:OBI_0001937>15</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/9aa2f95d-1a71-4ca0-970a-e99fed8d907f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0630ed7b-5bd6-48ba-9bb0-be31b4ea688c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/c1e1a24b-b321-4415-8f29-91f60be48109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/133a829f-7f6a-4160-92a2-876404ab0ed8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/209994e8-422d-401b-a090-0a79002c7da4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/3f07d279-3f2e-4f5f-b77d-a79c729f5d2b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4cb035d9-decd-4321-badb-6556b5af8b06">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b8c4e318-ff7c-4811-958f-e7c6f18a00af"/>
    <rdfs:label>atorvastatin-norverapamil drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8f29f857-644b-427c-ac38-53ef6ce3aff7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/3fc10411-6a1e-48d7-8e70-b6b68487cff1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/502d7301-e964-4804-8d11-6bb7665ffb84">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e4ac6599-660b-4cf7-86f3-4f2d2b286c5d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/2b7ecd10-54af-4171-997f-9c98fa76fa04"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8b3e8c69-e45d-4416-a221-46fd551bdb78">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8558d6b9-6116-42b4-bc2a-0e27a7a51041"/>
    <rdfs:label>risperidone-valproate drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9868be4e-ff5f-41aa-9732-1578dcbb01fe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/91a0ee99-c6fb-4c21-953d-93a01e69478f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/e3d6b911-019f-4a4f-be98-dc0419aa1cd4"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/2c0306b6-64eb-4e8c-9aa2-12380a7f4f7e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/c15a98a7-0193-4018-8bd8-bd2f98fa03d2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a1855b32-f526-401f-872a-9a14c1909f14">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/68b10d93-e405-4b40-8363-a3fa4d8a9188"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/23a361e3-8b4f-46f4-9423-ddb4415ceab7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/cfb53707-aa22-4f99-9471-fe05e4402be0">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/397c5432-36d5-4c50-98ee-813b6d73f999">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f07afbe2-b6e9-4e21-8c31-387dc8405e80">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4e5bd5ed-56da-42b3-a793-cdb9fd31a13b"/>
    <rdfs:label>5 Fold </rdfs:label>
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/91786116-458d-4133-8bd9-670b336ede32">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/290e2ba1-a2ff-4f2f-9bae-f6161463a11d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/2b89680e-15cd-42b9-b2a8-60d826c8077c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b2b74e37-5444-47ed-bb7a-e27ed07ea868"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/e2d15bd5-fc04-4ac2-a0dd-cc76b851bdfa"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/aa8563c1-9435-48bd-b8f0-b3e9f4edce41">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/4da7c811-52bd-4b4c-bd0e-77b1589e0074"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/8dd3dd86-bf90-4ffe-8094-b72bcb368d8e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/f88d2a6b-cb55-4699-add4-ce5e60b29092"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/53509be9-9f7e-41b7-876c-15bc415b990d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/576c2331-a79e-45b9-9c5b-8ab898ec8c9b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/48435262-fad4-43fd-b8a8-1d5b4b3d0fe2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/bd2ffabd-eb2d-4fa4-abcc-f8a5c8e8b4d7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/3e05f657-db1d-4c9f-8f57-6de726a3d292"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c8698b82-e065-431d-b449-2ef4d86d1e30"/>
    <rdfs:label>ticagrelor-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/57ac5889-0c71-4449-9524-ee4cad4e90d7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/81d2b292-ff86-49f2-ad75-21bb2e015a7f"/>
    <rdfs:label>23 Percent </rdfs:label>
    <obo:OBI_0001937>23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/cd571c74-fefb-4ef3-8f32-7e5e204b09d8">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/3052e03a-1982-46f1-8fab-459726131521"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/2e5a68c8-2916-4590-a8ad-1392622fd705"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/9f535d64-3d62-4a04-a626-00faff6fe84c">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/4c0a3f2e-09ff-4b26-a191-c805b5b49f64"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/7f9e82d5-b357-40f2-84f5-80c029fe8734"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/e0a56e76-dc84-47db-a097-809620ffe23a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/7caa5f4e-07b9-4a47-b6bb-92d1b8e8f3b8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/56a520d5-4cb0-4cf8-81a4-bf7187669dcb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c6bcea14-26e6-4305-9f63-564f2b88ceab"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1aebf92e-f5ce-419e-982f-7d98db44975b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/883ae85e-649f-41a5-9454-ac8d17262154"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c9c2c8e5-8340-4bf1-8420-83459ba8cb6f"/>
    <rdfs:label>low-dose ASA-Edoxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/78e8f6c3-adb3-4c74-93b2-ba7b4699c86a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/aa75b6d1-bfe4-4f20-b44b-0b8324e410a3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/2dc87e83-9446-419e-979e-69a86ee6fc7e">
    <rdf:type rdf:resource="obo:RxNorm_2556"/>
    <rdfs:label>citalopram</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/09d0a2d3-4d3a-48b8-8424-860dfb0b5580">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/8d54e831-ee06-4ccd-a6a4-a445d4037886"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/86bbb725-07a9-4f1b-a35f-11765c6f6d8f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4ed00168-a5f6-4431-98a2-df2faa3e2e57">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/7b502faa-d6aa-4495-9695-0c1267fe7b9c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/28456d42-617e-418d-9c2e-17e378946d46">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1313388b-71e8-4acc-890d-b822694c68a7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/edda8213-b238-4ec9-8f93-0de010ecc435"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ae8ecfae-0737-41db-bdbc-f43bf42c1146"/>
    <rdfs:label>Fluvoxamine-sulforidazine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/16c6e98f-8696-4708-abfc-cce2b8eb8cbd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9e4c9f44-6d50-4708-ac71-7b30c943853f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/3de61a5f-b95f-4274-a65b-c8abad5d57f1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a22a76e2-22e5-43a9-bd25-92c483889dc5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/40721839-39d6-49a0-bfa2-1d4a29d47d65">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d55d9432-dd90-4dde-868d-a5a792e61c51"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/4255075e-1bbd-4310-b3aa-50eb4cca2de8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f0123d44-566f-4147-9f4c-7a57af0b5b35"/>
    <rdfs:label>buspirone-mCPP interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/6f1ebd1b-44ce-46e1-a8d6-e645498f30b8">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/e0b2960d-e8a3-4c6c-af3c-4bc47d215925"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/c15a98a7-0193-4018-8bd8-bd2f98fa03d2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/cd277088-8de3-4a6c-ab86-e942f44a2f5e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a661b0e5-2096-4bf0-9be4-697a6bc67bd1">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/52e6c221-6bea-420b-9a48-9bccf16856f0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/6a53762e-78fd-4f3b-8813-fe5d46bf8595"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/7de722c6-7599-4947-8814-76137e93fc3a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/2c2bbfca-5b00-4f82-80c9-cbf0122f86f1">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/3fc10411-6a1e-48d7-8e70-b6b68487cff1"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/298e5943-1edb-4611-8f76-68d30882dc4f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/50f9115f-8cc4-4685-9222-dc08c4089992">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d6212278-bf64-46ab-97aa-cacf502295ae">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/5ed394a4-0990-49eb-9f64-f038f776d447"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/c23e0217-9548-4572-88bb-63d1a2bf4199"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/724f926d-f137-4a70-a265-ad193273e59e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/f3a9cade-69dc-4c35-a5de-f805071a3f98">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0cf501bd-6e22-4ca3-9d4a-f62460e41fc9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4cb2b7f0-70ca-41a1-aaaf-7e32da1c746e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/06511998-ff1e-4b2a-b31a-457d1eb42d57">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7d8f1942-a157-4e7d-ac66-a5faf1f02d41"/>
    <rdfs:label>unchanged UNK </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/78711f76-18f0-4c9b-b5be-485d2ba7fdb8">
    <obo:OBI_0001937>180</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/c70ff1a5-0641-4261-93d0-f77ea8fccbbe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/f4e2a403-84f8-48c9-8714-2174e5b0f4b8">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/602dcbf8-c93c-4a80-9447-197b8aaf1082"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/e0cbde2d-1ac5-410d-b6e6-f17b15ee7ecb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/09855731-0bfb-4d07-b418-5d8da4a0122f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/381da467-6007-49cf-949f-342d0b555acc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/978930af-08a9-47d2-a4cf-79e843302290"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a3789f3a-fe0f-4db1-b231-c6799bc694ed">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/30c271c3-17f3-4f6b-a17b-8c3800b5ebef">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/32862ddb-f65b-4b14-9b21-ce57b0cadc87"/>
    <rdfs:label>Nelfinavir-atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/ce0b6865-f53a-482c-837e-08213923ce24"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/7e6fcd41-451e-41aa-9477-9737c26a7603">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e9a3eb11-bedd-443b-b424-b8164b4db749">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d15a3d91-83c7-4192-9763-fc8e8a73b9bd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/53bac7f4-bb8f-4465-8276-7e22c8f3ceeb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c6bb5e1f-8574-4ac5-a8ad-bab49dfbd532">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0c2b1f7d-8ae0-4ce5-aa83-e273bf1f55f2">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/1f268171-3a23-4d3a-9652-0d13f83e6450"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/a233450b-9f60-4f2d-ac60-d7bcd77911ab"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/3aeeeee0-7d16-411a-8c6d-997f5aa791cc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/af561cad-7645-4eb2-af6f-46aea18532bf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d0210341-5e24-41ba-b6c5-06acb9f7d509">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a1765182-f8f4-4cfb-8106-d4be151d7a17"/>
    <rdfs:label>nefazodone-buspirone drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b5527abb-d924-4b3f-a429-8f4bbdf0c7b9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/65a785e4-986c-4a3d-9b72-593c3014025e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/371e58b4-6631-4e6d-9994-997d9bffca01"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/cdd66a1c-28ec-4bb1-ab92-9150e80e2ba8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/080a15f9-2ea9-4159-825d-347ac4a8fe89">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b2db83c1-775f-41a1-80c7-a2ecc392d68f"/>
    <rdfs:label>56 Percent </rdfs:label>
    <obo:OBI_0001937>56</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c8249fa5-474a-4efb-bcad-416ba3c129f4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/675078ab-7588-4e57-ba76-7af6235a706c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f75bcbbd-ff77-455a-8ab4-5a56bc8f5c8c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/95bbd96d-3c9c-43ff-8381-79075a308839"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/d2c0e86a-3dc6-448d-a2c0-85ebaafa3dfd"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/13af5318-4716-4dec-a6ef-73ec06097437">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/86098b26-57e0-4225-997b-1d9f7fb66fe6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a556574a-5a5d-4994-a7ce-ce2d60e45dac">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/6b9887a2-cec4-4025-9272-2c1d6c9804c0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/4da7c811-52bd-4b4c-bd0e-77b1589e0074">
    <rdf:type rdf:resource="obo:MeSH_C063287"/>
    <rdfs:label>simvastatin acid</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d61a6200-c723-4f43-8ff8-6b91a59b9870">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/82e65fa1-f0fb-4fe3-864c-067d9176279a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/80cc89ea-305d-4427-a62b-9f4a55e4a47e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b121f063-385b-4b84-9e44-26f0aa2fbb1c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/26d036da-8170-44a9-bde8-827c36ce4b31"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f0848543-78bf-4644-b4d7-c3419c2a9504"/>
    <rdfs:label>Efavirenz-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/36671ddc-1610-42ab-b5b6-8fbf32ce45ae">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/3ab275db-be48-4f58-ac22-3f517feba1b7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/c6d92631-aa83-442b-b95b-b85f8b96b8c1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/9f3de1f4-1873-42f8-97bd-4cab99d7c9e8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/78875ac9-df58-410d-86d2-77857db0787d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/532b0610-65e6-453f-88e6-b90dc4f05bdb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/28ef60a9-1f36-49d6-a9ad-ecf53991f05e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/d5cfdb10-9f99-4c6d-ab2b-525b9708f531"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/76e1624e-3659-419b-ae7b-9f49741e4dcc">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/63aed29b-bbc8-41f3-9f82-78a2408134e6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/4491607a-d9a3-4de2-ab41-0ec633a83052">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/355e8c23-38ac-473b-b8d9-528bffbda78f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/9798a56e-660e-42d9-94fe-1e397a0c806f">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>Fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/1c300f13-3ac4-49c9-94e8-94f6753411a0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6adee156-dd4e-437b-b7db-81656ab08879">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8973e520-8335-480c-b269-34d87100b6b8"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2768b88c-691e-44c0-9abb-6578b9cf0326"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/4a727ebc-d4cb-4dc1-9d9d-28a14411b8b7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4a645ff8-58dc-4614-9a38-61b3054cbc0d"/>
    <rdfs:label>paroxetine-pimozide interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5b04eac7-68c8-4764-a749-b18de76afdd1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/aae8c465-0bb7-46d0-9cd8-d8e8fc186736">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2d6b4b54-0e8b-4e49-b176-ea0e1b630413"/>
    <rdfs:label>desipramine-HO-NEF drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/fe70220f-ec55-4538-9a82-e25401ef9848"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/52cdc49f-ee7a-41e2-beaf-1d5f0735c5d7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/48b93051-449b-4809-8c12-af67e85ef377">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/41b797fb-9ffb-49bf-b254-255648a5a4bf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ab49f37f-97cd-48da-862f-6162cc40f776">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1e5173f6-4f0f-4403-9ddb-b1760afbad2e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/69a8bf6f-22e1-4504-84c2-a1e8f8f8117e"/>
    <rdfs:label>22 Percent </rdfs:label>
    <obo:OBI_0001937>22</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/42b1a18e-4d92-4b13-80ea-06f15fad05b1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/9569560e-87c9-47ec-9bef-7b85ed653a8e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/725d00d1-cd96-412f-a0d2-8f4d6e43f161">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/28e2136d-30bd-4661-96ad-62e367f845b5"/>
    <rdfs:label>duloxetine-warfarin drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/169909b9-ff26-4c22-94c3-a7b0eedd5dbf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a58710ac-0c28-4aa8-9642-3c8ac1bdf424">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f2d45543-65ae-4032-bf92-619c170381be">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b8ecbb8a-0f93-475b-ad8f-3a45b780c3d0"/>
    <rdfs:label>rifampin-zaleplon drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/fa38e06a-b4d2-44cc-b43d-6b3fedc48085"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/31a9720c-b179-4a87-b275-268e112f00d6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/c90f4981-7954-49c4-8135-3a89434b6642"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/10a9a58e-989b-4570-bf81-bf692e920d82"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d9b8c837-1f78-4212-a458-8ee27bd3c867">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3be120cf-7fc1-4e3e-ab12-e39478a4c269"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/851da65c-10e7-4c89-9d2f-1fb23dcbb406"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b7f77bd6-77f9-4f60-ab56-2ade6ed43ba4"/>
    <rdfs:label>ritonavir-hydroxybupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f28529a8-b581-4803-a08a-0234f68e345c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d44494a9-17ae-4b51-b44c-b460d2e3b5f9">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/026caeea-ab26-46ca-862e-1db50416e483"/>
    <rdfs:label>87.8 Percent </rdfs:label>
    <obo:OBI_0001937>87.8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a9a299a5-a2af-4ab0-a80c-f39d99858cda">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/5b8300d8-7f2c-430f-ac70-ef311f79415c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/a83d24bc-f33c-4e29-96de-7ffd6d426cd7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/42c66578-1538-40ee-8896-2b1d36f1d9ea"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/4ef3198f-d150-4c6b-acce-21486b54f047"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/30a5e6f0-9846-4f7c-9db4-af585787cf47">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/eefd92ad-baca-4aa0-9ee1-891902da4f0f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/aef68e55-c0ca-47af-adba-72994f08d407"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/f3edd6a6-854a-4aa9-b734-d74d1ada296e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/e7986ab1-851d-4d8b-91fa-9729d648c1b6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/6c7f7f7d-20f1-4789-835f-7ed03d2152e3"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/412f13e5-6c42-4291-b5aa-8a50f360c760"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/c2f3d4f1-49ac-4a34-bddd-05dd33f37235">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/26a9090d-1b87-4806-a8c7-1cc45616fc35"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/cd7136f8-b285-4e38-b35f-07593e19bafc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/676a8946-6831-4568-9ff3-8c059e0ab619">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d694321d-a22e-44e5-bb34-ecb347f4ed8e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2922c3be-8279-4185-a8e7-b384a3adc4af">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d02a70ad-2abd-4c05-bdea-e85302327868">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/fb743b45-98e6-4e20-a70a-046336f0bf85">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b9bf6c6f-b8c1-4dfb-ad59-84d2faa2f455"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f6feb58e-f62e-4f8f-83ca-41d7f4c43de9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/3fc8c60b-f4c9-47f2-850e-49cc78c789a5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/66c12175-fc64-4fef-985d-dfcc1b70f66c"/>
    <rdfs:label>high-dose ASA-Edoxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/536b7d26-04d7-4954-b85d-844dc78d0d24">
    <rdf:type rdf:resource="obo:RxNorm_8331"/>
    <rdfs:label>pimozide</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/94cc04e8-0a2b-42f6-b388-28488b3a2cfe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c0365e0a-2523-4187-995a-d57994681f84">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/4815b9ef-1c44-454b-9754-59e78dfa77a0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/400b6f19-094c-4608-913e-fd0270116582">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/8a4e9345-751d-49c9-bd7b-df60e91db16c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/2ca0f46e-7985-4b8f-ad78-61f4113df559"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/d836ac9a-e2ea-47ea-a483-67610e255b87"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b2f6433b-30e8-4a39-8696-926cb946c3bc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ae66c6cc-c64c-4623-95d8-d843894c342a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/29a5be20-955a-45a0-97c4-14d4461379fe"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3e044968-556f-44a0-ad7f-50c4719ec70a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/48c04994-9124-46c7-9f93-7bedaf39b502"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/285dc2c4-b2eb-4952-985e-2dda8f91fd3f"/>
    <rdfs:label>citalopram-pimozide interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/d22121be-cfda-4b78-84a5-b3fb0b775d2d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f9a8bba0-25ea-4c44-9875-0e8c56d49a97"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/95ec2121-59a2-4fc7-9703-3c3e65abcc5a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/53cc7176-b463-406c-8261-12fec2332876">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2a1df414-20b6-4f57-9378-aed77600b69d"/>
    <rdfs:label>1.4 Fold </rdfs:label>
    <obo:OBI_0001937>1.4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/6160cf03-d7ce-4b15-87fa-3e9995b09ab0">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/e72ccc36-509e-45c2-a4f3-b723488eabe6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/fe38a3a1-b6f8-48dd-998f-2cfc36da7af4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/aba6c055-0c42-4489-85f2-5aecf907de5e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/9455791c-9f34-4dfd-8629-75dfbfaf2a29">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9de77aa2-20d0-47a2-a2d1-5b4c5e7accef">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/d625aa4d-b884-4ca7-91fc-4edfb6db18e6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e8c6e606-bf45-4326-b27d-e29bf2d70218"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/dc73288c-fae4-48e9-ac01-3924602f16aa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/488b180d-9e76-47a1-97e3-78ca0ace8c63">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/a4bae449-9b02-4175-904f-2df40aaf34e2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/eca8011f-503a-4c9f-863c-15952f7e5982">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1d732e9f-5afd-4752-8421-210384152cc0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3d1b5fd3-0b4e-4c43-bf20-6f132eb3519a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e69a5752-f8f8-46d3-9cd2-5466bbc008d2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/6db815bf-a566-4d71-9ee9-23a696315c7b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/947e3465-676a-45f5-9103-51db37a2adad"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/6beee335-b522-4d31-af09-da39c9ce4dfd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ad3211a5-97d4-4b39-b56b-371752b65cb0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/d8da44a4-2f75-42e6-aeb3-e5faf4eb7a2e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/8b1a82b8-6d58-44f1-bb05-3b70d7b7100d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/09673ac1-cc27-4e7e-a3a0-434c3ffbc43f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6d2a7e6a-50e9-44fa-8025-c6285b146097">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8ab32a83-8782-4209-baed-6d6989c3b1bf"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c65103ad-1c3a-447a-af65-ef4f48276461"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/30b2fb0a-1e2b-419c-ad80-47754bf052da">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/e28f33fd-61ad-47e8-bb01-1fac4d0f8e32"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/4e82beb3-d72f-4de7-b0f4-c19b0e0ce5c6"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/028b8e86-89aa-4fde-953a-2628e778fac0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/338a8392-9bfd-4bf6-abcf-1adcd5ec962c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/2a1df8b5-d828-440e-bd7b-9ff690022591"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/1b3f7348-ad26-4bb5-9de2-112970920e11"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e1138cf9-ac7c-4aeb-8c14-2e8457daedd4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5abbb564-fb7a-4995-8bbf-b7ca32f181a3"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/823febcd-f226-48a8-8ca5-8763900f1dfa"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/243cd8cd-bf09-4efd-b012-15ae670bd8d5"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/78f1b1c1-44e6-4a79-91aa-0747d7fd3a2c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ea64d108-f5a9-4a17-bbc6-60d3550d2676"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/24d37f78-0642-4257-a75b-cc07be74c913"/>
    <rdfs:label>telaprevir-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7f304db9-bcb1-4455-83fa-5d0e0c42aecd">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/df7cae32-0e77-49a5-8080-6c7c8788a50d"/>
    <rdfs:label>clarithromycin-rivaroxaban drug package halflife  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/52190799-3fee-414b-b01a-b9c95bb4344e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/84394a7c-e9ea-489d-bd51-af6f9f3a01e6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/72d8220b-43c5-4f02-95da-f7c075f2fef7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/5667dc57-9237-422b-a89d-0050dbf7206e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e6021b09-ee72-4194-bfd4-427e74d32447"/>
    <rdfs:label>fluvoxamine-thioridazine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/348c8d72-8be0-43b3-a2a0-2446274236a7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ad12f9b6-f7bc-4764-8188-4e4158a374f5">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/8360a428-3ced-4728-849a-a22a6aad39ee"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/cfe35947-e985-47b8-885a-85dd1eaaec6f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/f4e2a403-84f8-48c9-8714-2174e5b0f4b8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/227f4da4-5e60-4e00-8128-ee1daeab4578">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/e6e41006-da4e-45db-894c-d389e30af942"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/0506f89f-eda0-4a20-9874-077cd7984f9f"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/681f91b0-e71d-4e92-bd96-e269848f217d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/d147ee65-7589-416c-b272-edc5c2405ede">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/a6005e41-3668-490c-bfdf-8eaf034af1b5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f0848543-78bf-4644-b4d7-c3419c2a9504">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a64bb1b5-7dcc-46b2-aff3-5c3544a93b87"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/e0864362-e038-4301-bb9d-8429e87726d3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/010a0889-2fe3-47ab-9dd0-f82f040be2d3">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/0c99c781-b277-49c7-bd57-0a595868b91d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/1fa09777-9cea-4247-b6ce-77c909deb823"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0824a9b8-0624-4a00-94a2-9598369cfd98">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c64a5899-a511-4d7b-aba0-155d1042f834"/>
    <rdfs:label>UNKUNUNK UNK </rdfs:label>
    <obo:OBI_0001937>UNKUNUNK</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b008f433-97ae-4d29-88c2-37b11b7df107">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b1c6ef1d-ec1e-4562-83ed-f1d9c4097c4c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/fe522d81-eb45-4e05-b8b2-dfdd8a419622">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c203271b-b51e-4ebb-a5df-5772d649eda6"/>
    <rdfs:label>erythromycin-rivaroxaban drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/26d96f8a-b731-4510-9cc0-3fd6c1d1b723"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e0f31e90-901b-479c-8893-e14fed2c2f81">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/52a07c5e-8d0e-462e-953b-9c4dc17f983a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8555421e-d47e-479a-8f85-efb8f2aad962"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/9b178713-ff18-42b5-becd-d2b608a19e59"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/99edeea5-9daf-4533-883b-6d118dbfdc68"/>
    <rdfs:label>nefazodone-haloperidol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/cb3e41b3-e631-46bf-8b99-0d033b7e72a6">
    <rdfs:label>fluvoxamine-N-desmethyldiazepam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/21ace089-660b-4d95-89d3-d7406da77f05">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d217fae9-90c9-49f0-9e01-0208c938b26f"/>
    <rdfs:label>95 Percent </rdfs:label>
    <obo:OBI_0001937>95</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c6a15d0d-1e3d-462f-9641-4c04a0e532d2">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
    <rdfs:label>dabigatran</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/37049f6b-ccdb-40f4-9132-283ae975c9aa">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a48fe6d2-df31-4a00-98a3-e348318c9a79"/>
    <rdfs:label>phenobarbital-paroxetine drug package halflife Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/05ea9a72-143e-4403-9793-f8a47ac8baee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/fb21140a-347d-46d8-8c37-3369086e76d9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0b86bb5e-037c-4290-ae24-058498503914"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/c47510f9-b342-4266-b707-67ff34dc3900"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/97631c61-fa3e-44a1-9a14-f50e29115cfc">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/68081ccc-8ce3-45c7-ad64-8f18035f4745"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/68127703-e00c-46e8-a44a-105e08c01c2e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/8aee3c2f-07f8-4799-ab33-ab13ea07474d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/34fe2251-30ed-405a-ae5c-d77b6a3005e9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b556f3ae-4e33-40b6-9181-09e3eb1f906a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9f39b970-45eb-4c49-a640-9904b6f53e2e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/a3b09ccc-47ed-41ba-9acd-5eea7cfc40a6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/cc2c6cee-b91d-4601-8f66-0445da322e54">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ea84c43e-f141-4f0d-a1c9-5b3c5dcb2a0f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/46c8da89-64e7-4d11-bd0d-64f4b43d7166">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/71145e9c-a335-48d8-a300-965b65e1b044">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/db58a73e-3a1a-4d5e-9559-b5b80a766140"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/c8e2cede-bed4-48c4-a305-084f86eb785d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/8a8781bc-5d24-4e60-8a7b-b15f1a0f6e51"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/d48a962d-2cb3-4e2a-a799-e6624fa4c69e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/209994e8-422d-401b-a090-0a79002c7da4">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/5ebd0223-ebbc-4b63-8bd2-9b293bf36a10"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/61043ccb-bd74-41a5-8a5a-37efb8b12ea2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/6297bc51-6667-43c1-ab11-4bf6bd8b4b98"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2bcdf79d-4d3b-4e51-aef5-7293b192c93f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/431f58aa-1513-4899-a0ec-fab69607dd72"/>
    <rdfs:label>BRINTELLIX-salicylic acid drug package clearance UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3e12bfac-3d5e-4b66-93e5-c48d84957364"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ee6a1e9c-3507-4255-870f-7a3981154e3e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d3ffff0d-d7e4-49e0-9595-67b0024c8ffa"/>
    <rdfs:label>95 Percent </rdfs:label>
    <obo:OBI_0001937>95</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/d5ec9a09-6301-40d0-9493-bfc5777cbe38">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/0f953442-7045-4d1c-af63-d62ea6fea76d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/7c4be16f-92ab-4a8b-80ce-066faf8d4c74"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8ed8ef97-0bb0-4b54-bde6-749406efd7f1">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/aba6e91a-13ce-4362-846f-052bf841a7f0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/17543523-f1c2-499d-b946-eb5b76f7af62">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8f00a3b4-ee55-4eac-ae1d-c8c4746936d0"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/978930af-08a9-47d2-a4cf-79e843302290">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/51a96e11-3df6-4a26-884f-c7d3962773b8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/e0acd1d7-0dd5-4a21-ac57-8c3d4b2a640f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/bb53360d-f2b3-4163-b21e-ea8159166fbe"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/be91521f-daf8-4383-ab00-5796f06c05da"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/9accc574-087a-4419-99c9-2d0a7986efd5">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c849c276-1f74-4de4-b428-ad4f2836bd1f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/b39976df-acf9-480b-9ec9-994fc20bd73c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/fcdd3edb-2616-44d5-bd8f-1897ab8bb5ea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3105d758-ac24-4c98-a083-ddc8b9fe9f53">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5e6a7a64-e6e2-4de0-bc0a-a1072852990f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e7512fa2-57d2-44f8-b8ca-9277ebf4032a">
    <rdfs:label>duloxetine-theophylline DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4ff72daf-3da3-4db4-835a-abbb257bb25e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f9675909-966d-468b-8136-adb0cd5b4992"/>
    <rdfs:label>carbamazepine-L-amphetamine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/427f28b3-fbb8-40c1-831e-a7fdc2cf4b7e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c49fa560-e897-41d6-9018-2e97446d994a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/d32cb991-4a0e-4bd3-b85c-6e565f4aefb3"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/ca4564d8-afa7-498c-8e30-709f8fc23cb2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/5d33659a-7c2d-4ac8-803b-8c083aa03d7f">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
    <rdfs:label>carbamazepine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3f837fa3-3394-4ec5-9207-4eefdcc73a5c">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
    <rdfs:label>rivaroxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f8a9293d-fd34-4d20-9203-4989e4b6acce">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/ec171e8e-72e9-47e1-88b9-20bfc564526e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/0238783f-c223-4f4d-a01a-bdc23536dcb3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/9c463f84-5f70-48d8-9fad-f170cec107f7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/090beef7-be9c-4ed5-ad3c-da21c2023876">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/20da8e88-be33-46c5-971e-1b126069afa6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/1001f756-5767-4a51-941b-d2804ac1cd6d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/33ce23ec-ef7a-465f-8cba-135649d4e959">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a9a28a3a-3443-4220-a876-a29216e98198"/>
    <rdfs:label>153 Percent </rdfs:label>
    <obo:OBI_0001937>153</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a6e61cd9-5b86-4d1f-804a-462068a379f7">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/171536ad-8d57-46a5-ae4b-87975d0ef4fd"/>
    <rdfs:label>low-dose ASA-Edoxaban drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b575c4a7-6938-4ff2-ad73-26efda568ab0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/5fae11fa-96d2-4dfd-8381-e86dfa2ef9a9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/cf08e766-f5e7-4805-928c-eed04fd11c80">
    <obo:OBI_0001937>.2</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/875560b4-d291-4bb2-8c6b-d7de4ec48110"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/d264281d-db10-44b3-9811-070b4f36e4a1">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/fcdd6f86-90f5-4db2-9dae-5c86ebcb6cc0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/3fc6e024-a607-46bc-844c-98d156d9e5a1"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/4a03c597-8884-450f-91f9-32393208e87e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/70ab7d17-64d0-4e89-a133-135eb224f2e2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/dfb728e6-90c1-41a3-a4ac-84bc00432f67"/>
    <rdfs:label>atorvastatin-verapamil drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/782bd070-900a-4a36-b04f-25282ec86e28"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/3dbc7e26-0c44-4443-b423-9f0fd9425053">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/1ceb0d43-4fbf-4d40-a495-ccbfe299a533"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/6108e46d-2bdc-4b50-83b2-3f9f5707a3ac"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/de4cd0d1-cec9-4ff8-b9f9-8f4e889e4e22"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/3851e81c-310f-46de-a50e-3a2039decac9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/611ac3aa-602b-4a76-9794-d3d71f185d4e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/de98c711-03c5-4368-ba0a-02275b48c0f5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a1855b32-f526-401f-872a-9a14c1909f14"/>
    <rdfs:label>sertraline-diazepam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/5ac2bcdb-c43b-43d7-a69e-74ff421aa991">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/3cddeec5-12fa-4d27-a9df-874fce21553f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/06d051b8-7008-4908-a91a-7c141e301a24">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f7b73612-cd0f-4ee9-8761-00f2660a2ee3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8365f6ee-b873-4ec5-8998-78d05967ac03"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b900887f-acc7-474b-b3d8-52366937fd5e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7d779453-10fd-436c-9d6b-a3972c77d0c5"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a3f1ca05-7b8c-483f-9555-4d79885d0fe8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/d75c0bd0-5829-4f0f-9118-948913faa47f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/5837d5e6-4c43-425a-80d7-0634dc59a788"/>
    <rdfs:label>fluvoxamine maleate-alprazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3f0fb5fb-64bf-4246-a8cc-b6a99cc414b9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8152e677-8208-4b2a-aed6-020eb5d08443">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/171536ad-8d57-46a5-ae4b-87975d0ef4fd"/>
    <rdfs:label>low-dose ASA-Edoxaban drug package auc UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/076ee2aa-7912-47de-b008-28299efbf196"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b121f063-385b-4b84-9e44-26f0aa2fbb1c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9714cd78-f759-4ad1-85bb-3a4b3f587379"/>
    <rdfs:label>Efavirenz-Atorvastatin drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/debf7384-7455-46a7-a683-f40cb7d947de"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/d2e35a29-7362-4c08-8378-5217dc3cc2f1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/99f1f755-86a6-4655-87dd-e33713cdbef8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/49ca5313-c397-414b-a1b8-88fb1e909e38">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/3b687d2d-ad99-4e8f-81f5-0e0c3564d233"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/f54a61f5-3150-4742-bfa3-172d67b76a28"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/8921734f-02ec-43d3-9ea6-dc9ad331ff1c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/505cd36a-be94-4bc0-aecb-903ca49fd1e6"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/0273001c-d386-4902-b907-d7bc5813105a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/abc2ea33-fbcb-485b-9e6a-79f28a48e42d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5fe050ea-4fb7-4016-8969-17f9f40be797"/>
    <rdfs:label>fluconazole-rivaroxaban drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4070476e-74a7-46e9-b69d-78e85ad020ec"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/592b453a-d76a-4bac-b168-82fc81c71a8d">
    <rdf:type rdf:resource="obo:RxNorm_134527"/>
    <rdfs:label>NFV</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/4ccf2a5c-c72f-4fae-a704-94235e6482b9">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/54b5e732-ebf3-418b-9ee9-54e08e76a907"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/58854502-e276-4f3b-a777-c61e5199dad0"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/d39eaf89-f47f-4ced-a045-101f321fd6ed"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/afda653f-c257-480a-9fd5-6ae7751db10d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/ef146f1a-785f-49a8-b611-86138269ce5a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/ea9cf842-d1fd-4659-8da3-cb6e0137db41"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/b83cce80-bd7c-4728-b90b-2f4957729691"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c8795b37-8186-42a8-a8fb-ed04d0a942a7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d9809b05-1acb-43dc-a4d8-bf818599f9b5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/05bcfdde-96a1-4d75-9942-000719a2ae79">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c1c5e290-53cc-469e-bf1e-11b58471d201">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/028382bd-616c-41a8-9a22-feb974f8edfd">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/24907a55-efcb-490b-bfe1-8c3c55590431"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/94dc5a3d-c5c5-49af-afff-73cadfd4cb33"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/ddedbbb8-abb3-4f1b-bb6a-f8ee10b8ea83"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ac0727da-0655-4805-a051-5c35becc2b62">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/82d16f5c-8326-4377-89ae-d1f3fcb5e2e1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/63aed29b-bbc8-41f3-9f82-78a2408134e6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/eb84704a-b330-4b0d-9fa8-d47bef74c696">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/05d00429-1b05-4778-8e6a-a4de1db02fdc">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/75c9ffa0-93e3-40c2-8c78-8685b2399a87"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/36b6fee2-6411-4cdb-b96b-21df5006f68c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/7c8d4e1c-7ebf-441c-a9be-f9ab164272de"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/af2f888b-480e-4f5a-ae07-714a057a5dff">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/236dec2f-e082-49be-9280-34eb0752e137"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/8c52e9d6-8d40-47a1-901c-5f4b77bc59b4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/9186b9db-a0e7-449f-82cc-bf292b8f5912">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/60971688-9375-471b-a365-da2b0551ccf6"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/c9e5a3a3-eeac-44dd-87a7-89a1665fdc37"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/4215e5e1-98d3-417f-bd63-4c7a5bcf3016">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/34c70f38-ebd1-4116-91c8-bd077d5a27cb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f0c9e786-6819-42f3-bf60-61a5b9ba59e5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/6d6b6670-ee99-4a54-b4b0-5852ab878965">
    <rdf:type rdf:resource="obo:RxNorm_39993"/>
    <rdfs:label>zolpidem</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/cab99c3c-fa74-4774-a6d0-4a9db12ab72b">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/85e7a603-e56c-49fb-ba67-b91151f558cf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/90862867-0e4a-4dc9-aa5f-0c3f11a98f53">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/dbcd53a3-134e-43fd-9e2d-88ef15f609d4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/fd32cc19-5788-4708-be48-92ab94a6d7db">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/967b7996-37a0-45ee-96d5-6453771f4498">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8510cbb3-457d-40be-8041-72cf4fb62002"/>
    <rdfs:label>16 Percent </rdfs:label>
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ca9099f4-51e2-4035-990e-d7abfc2fb888">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f00d4b4b-4791-4b22-bdff-7f4754c3696d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/a5e54e85-ac61-4d6d-9f05-96c9c401c1a2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/16e9a083-83da-4a3c-8570-d16c14bbeba8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/517ffa83-4492-46b9-a6b3-a0531e3c604b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/60a7d301-aa30-4a55-9da5-e2340461670c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/3acf84a7-6b13-4a8e-aa6c-5a0933ccb18d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/51dac99f-5112-4ffc-9c61-d3a15bbf1224"/>
    <rdfs:label>paroxetine-procyclidine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/3dc6514c-ed52-439e-94d1-bb3a3e34e2c6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/69eb9816-088e-493d-9cd6-030d8b49d419">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/26b1442d-8e63-493a-a24a-697e5ca35732"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/f49a291e-9f27-42c9-8a56-3936d7a63610"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b77ee544-270c-42ea-965c-93e408bb850e">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/37a09f25-7176-400c-be2f-d9bb8a65b0aa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/bda71de5-ac3b-4f81-9774-0c46a687e1ef">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/2c53f7a9-4dca-4a78-bd28-e721b8387980"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/81ab1439-1d1f-4f61-82b8-b2744971e0d0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/bc85b6fe-8760-4104-8ccb-24465b203b4b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/02567497-10f9-4a41-83cf-eca0cf15f470"/>
    <rdfs:label>nefazodone-alprazolam drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/831d8937-57de-4326-b6d1-31424ba3cd01"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1656de2f-93bc-4f57-a098-c165ae4d46c8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c485cfb6-3a46-4dd0-8b48-c069696d7445">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/076b7248-e4c5-4c3a-95d0-dc5669335ccb">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/78e815af-df0f-46ca-b4a2-ea8d6fe4a466"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/9de2ecb5-9cdb-4861-968b-68df7298c4e5"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/2a787dad-384d-40ef-97ba-b7985b6cc17f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/fae81b14-e1ec-4539-9857-0cb073ffb010">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a0aee07e-7e1f-4e80-88b6-7a45bcedb11f"/>
    <rdfs:label>ketoconazole-zolpidem drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/ab8e0b9e-4262-488f-afe2-8fe750b7f12b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/c9d17319-8cf5-44b1-8516-4cd2d1269fab">
    <rdf:type rdf:resource="obo:RxNorm_36437"/>
    <rdfs:label>sertraline</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/323a0a99-edaa-4cab-924c-fdcf11edf080">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/9c7604a6-7f5a-4f21-b3af-e731328d6a95"/>
    <rdfs:label>16 Percent </rdfs:label>
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/89ad93f3-7340-4cd7-bb25-08a803889853">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8a0cda4d-3ace-4b73-aa2b-df68189fde66"/>
    <rdfs:label>ketoconazole-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d2514dc4-1162-4775-96d2-e3e9f4a5dfe3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/672eca94-7916-4c3b-a46b-72b22ef96720">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/98402913-3fa8-42b7-a385-ed52a835e227"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/56f44b9d-717b-4ed1-b612-7ee0316f75fc"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/211ca8e5-1440-4ad6-964b-face3e2eebee"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/000a1e8c-a2c7-4d5f-a50b-62ad7693104d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a1bcfc98-7a4e-46f3-b68d-cc7f0bdf8c51"/>
    <rdfs:label>atorvastatin-aliskiren interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/095c612d-47f8-4751-9fad-d1d7c5f12b0c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/37e85194-082e-495a-9453-4bec85f2348e"/>
    <rdfs:label>54 Percent </rdfs:label>
    <obo:OBI_0001937>54</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/fae99c72-5242-4bdb-b015-0f9bfcf7201f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0b86bb5e-037c-4290-ae24-058498503914">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/8fffa662-e96b-468c-8796-67c913d573b5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/1b8b15a2-b1e1-4617-9ec2-bc55fd36e3ec"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/2f6d6e18-7a22-4535-afc5-48c8e383fa9c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/05568e61-e257-469b-b291-e09ee986b282">
    <rdf:type rdf:resource="obo:MeSH_C558899"/>
    <rdfs:label>LPV/r</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3dd692ae-fccd-4174-b024-7653edd418ea">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/07c46def-cac4-4619-9be3-d3e454c3cfab"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/1e6a6067-244e-4329-b36e-f6c790d3dff6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/51a713d5-8841-4829-9009-2208070fb94d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/533dcaae-53ad-4424-824f-fbc6ed7b8acb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/254150ed-1333-478f-86b5-f691e5f051a0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b549b0d1-7332-438c-b2dc-326b7f7acc65">
    <obo:OBI_0001937>500</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/5354fcb3-f754-4ebe-87c4-d28edf75d426"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/e8d422ee-0881-4091-98f5-a37706909aeb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d0eb1bc1-68a3-40a5-81b3-791f1d9fc450">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/42fb6a7b-4f62-4df4-ac4f-24fb4c103229"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d4cb2dd8-a58d-4a67-8697-b0ee9c5548b8">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d2500c5e-0b78-487e-a6ee-ed6afc327a11"/>
    <rdfs:label>67 Percent </rdfs:label>
    <obo:OBI_0001937>67</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7b6d3db8-e7fd-4ab6-a8bd-479d716a6952">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/eca8011f-503a-4c9f-863c-15952f7e5982"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2768b88c-691e-44c0-9abb-6578b9cf0326">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c4004c5d-f661-439b-b32e-b175b479b68b"/>
    <rdfs:label>paroxetine-pimozide drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/25b78dc6-2e8b-48a7-ae4d-27272a8168c2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/260dc781-1ecd-41d5-9262-c904be65ea68">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/bdb5d62b-65ce-4ceb-8ddd-d33d585b74b4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/af65fd67-a7bb-429d-9eb4-76588f3ab9d6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/e0d7945a-c7f4-4fe6-a9e5-75655659077f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/390cf457-f080-4cc8-8ebb-422c3c676247">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/554ac588-01dc-4feb-b63d-340b57a633a9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/228463f6-e465-40bf-9885-889a696a9e33">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5e98c8eb-0bde-4dda-9d3d-ffa8a74f69eb"/>
    <rdfs:label>81.4 Percent </rdfs:label>
    <obo:OBI_0001937>81.4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/cdacd43d-0a75-4afc-a3c1-491f15bd85ae">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/e7b1c3a1-728a-4389-abb5-4d78e56be704"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/bdb726ed-7b7a-40a3-a5f1-4b0280e71980"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/ad25f63b-24d2-436b-9f42-aa2e3922ef51"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/dd444d7e-d932-4879-8e5a-5b650053655d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c88d41a1-d0d5-4a65-96ee-d91a9a0302ce">
    <rdf:type rdf:resource="obo:RxNorm_3498"/>
    <rdfs:label>diphenhydramine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/b5bd434e-4771-4943-9120-f70cc289ced1">
    <rdf:type rdf:resource="obo:RxNorm_203143"/>
    <rdfs:label>fluvoxamine maleate</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/58efa33e-7a20-4205-8365-ef33392cbef4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7f7c8ff0-be0b-477a-814c-6f7418092f6a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/55bf5162-a79a-4b71-a5ae-41be1eb95045"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/9e02dd1e-16b7-4025-b25b-3644125cd8e4"/>
    <rdfs:label>ABILIFY-fluoxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d17ee1c9-132f-406d-ad0d-ae5d4d2b26c2">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e9bac850-c802-4c7d-8612-97cd2b14267f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/603e8c3b-1c10-42c6-b346-7128a140a8a7"/>
    <rdfs:label>phenytoin-paroxetine drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/98d6a8be-1734-4012-813f-e362fb8b3a81"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ac87ec77-e2a9-4419-b1b7-1c743f8fe08f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/031bcfff-f5f3-4b55-a984-1a1b363f5a7e"/>
    <rdfs:label>zaleplon-diphenhydramine drug package clearance UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d77d8f59-a987-4514-9a6e-c76e6e7f8023"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/fbce6e87-31f3-44a8-8691-f574468e7277">
    <rdfs:label>fluvoxamine-theophylline DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/3eb0793d-428a-4e9b-ae32-bf3665f2b90f">
    <rdfs:label>phenytoin-mirtazapine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4e5bd5ed-56da-42b3-a793-cdb9fd31a13b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/10e42bc0-3d08-4ef9-b860-fded6be68811">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/e3bdc836-73b6-4a0a-8d48-eaedc9fe6e67">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c8f2f177-0207-4627-b5e3-ca76dd90d201">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/96c1e48d-db4c-4595-ade7-745b827798e8"/>
    <rdfs:label>57 Percent </rdfs:label>
    <obo:OBI_0001937>57</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/9eb59838-9920-470f-b7ab-028703dd6821">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d65d0625-951a-4432-b91e-50283e4355f3"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/901c24ed-a064-4074-92cd-1e8540539835"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d01de5ba-efd7-43fa-97c8-71f6f252fcde"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/6ec5e333-69af-4e66-8f21-47be0fb81ccd"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/40060fcb-8fbb-4bdc-8772-eca9a2fdc367"/>
    <rdfs:label>nefazodone-triazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a01b5924-1acb-4712-884d-658a356be2a5">
    <rdf:type rdf:resource="obo:RxNorm_36437"/>
    <rdfs:label>sertraline</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/55c51d0a-f548-4c21-af0f-15c83640cb3a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/95b832de-cd23-40bd-8a92-8a9389fabc52"/>
    <rdfs:label>17 Percent </rdfs:label>
    <obo:OBI_0001937>17</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/4d01aeda-1916-4a63-9b28-002cb8297999">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d3b702ab-4b17-40a8-b386-f33e44bdaca5">
    <rdf:type rdf:resource="obo:RxNorm_352741"/>
    <rdfs:label>Lexapro</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/2e3c8b7a-dd85-47e8-93f6-314231926648">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/af7a973f-17ab-4539-85e2-aa6218a442bd">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/94cc0d5e-c90d-4d73-a80e-95fe8df36531"/>
    <rdfs:label>duloxetine-warfarin drug package auc UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d6378915-8046-400c-93f4-2fcf4863c9d0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/6fd7dbb5-a802-4615-bdaf-0e7106eb59be">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/9bc15167-6dc6-4e8b-80db-d5b25024587d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a73d5dbe-c856-4ae7-ad38-0f719eb1baf9">
    <rdfs:label>Rifampin-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4f83c4e7-cb6b-40b1-9107-44e328ee32ea">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/fd2d074a-4a68-4050-82d0-3b3c77d95f8b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b722300b-f881-4654-9738-934f655377e6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7e36584f-f4a3-465b-ac30-bc0ed9c90b4b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a58a26e9-f19e-4678-b90f-2a5c95319944">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4f83c4e7-cb6b-40b1-9107-44e328ee32ea"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/74eecd8d-72c7-4946-9972-a5e7bb0ac0a7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ce7e8043-57c2-4bfb-9b69-492ac4dd9952">
    <rdfs:label>Telaprevir-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/30c2f576-d1fd-4613-9776-eb480d363c02">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0c2b1f7d-8ae0-4ce5-aa83-e273bf1f55f2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/f4bf70b9-e034-4515-ac66-35f3e69111a9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/28c35d7d-c411-47d9-bbfd-c1cf6d592a84">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4ed00168-a5f6-4431-98a2-df2faa3e2e57"/>
    <rdfs:label>unchanged UNK </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/596f2ddc-0791-4a8a-99cc-9852618cebed">
    <rdfs:label>citalopram-pimozide DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/16eaab52-3584-4be1-aa74-4225961d80e4">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/73219aae-3c2f-4214-baa3-671e5632d933"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/367b9d4d-5d81-4ef6-b484-7247fde28882"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c1f14673-3325-4b6e-b3fa-2d888417f659"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/4e47aee9-a75b-4048-971d-bed2b16d77be">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/964f8940-c391-45e3-9b26-01de6193b693">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/6d90b412-6059-4040-9d8e-f30e18323da4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/129d503a-f476-4c3e-bf8b-89e6178713d6">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/274ce7ee-0aed-4d30-9f26-fa483f9720db"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/61c35ec0-8f7a-466f-8864-9aecda977872">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/487ba226-9eb7-4ce7-b306-2ed54765e28e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/5266a4f9-8592-4a32-9679-1b85fda45bac"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0d8cad43-6a57-4cb9-80d9-65a67061c059">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/6c6ec2ee-0667-448f-a28e-7accafc94dcf">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/cc5405c4-105c-4b5a-be9a-b400e8bfb5f9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e7cb9505-f523-4ddd-8395-6a9c5dec71ef"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/fb079a28-cfb6-473d-96f4-07734aecc0e6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/eb57ab57-9020-484f-a8c1-a1e1c41ef7e7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/79a6ba79-adcd-45e5-a5c3-184eeaf9254f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a8c8dfe3-b222-4218-acf4-2e3193b4f9b3"/>
    <rdfs:label>23 Percent </rdfs:label>
    <obo:OBI_0001937>23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/76c717a8-c560-485a-9114-0336e5ef0a40">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/053d6521-fb8c-4432-b649-7e39fda1893c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/9c3e8e50-949d-45ea-bfff-7a1e51867e16"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/d5ec9a09-6301-40d0-9493-bfc5777cbe38"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4059da56-cbbb-4b5d-8966-6578bb2f1c83">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/ee78246a-6c5e-4edb-9a3c-e0e0dda8fa56"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/bafc613d-d2bb-4e22-8c0b-7d7e1fc3a77c">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/8094f63a-0c2a-4d61-9b21-544f1d75dc97"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/92cd64b1-98b9-4ba1-aaf5-bac4c5b74b0e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/a7e22eda-96cf-4952-8c86-7a2190e0f7c6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/e7113972-bd0e-48f7-a0f8-40f844dc2bd8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ee81cce7-7f56-4e5b-8438-2af298450dfd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/1646203b-317c-4378-8e63-708e41859b44">
    <rdfs:label>fluvoxamine-duloxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/4a8fbc39-4f4b-4362-80fc-957c7848265a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/10eb44a7-96ac-4cfd-a9c3-d4f1518ce94a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/880bee26-737f-4e17-abeb-93ba1a6423e3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c97345e0-2480-4592-8aa3-3abad094095e">
    <rdfs:label>simvastatin-digoxin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/86427ee8-bcc6-4c4d-8c60-e75228040426">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b5660b09-a1e1-431f-9302-612356dc800b"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/5ed394a4-0990-49eb-9f64-f038f776d447">
    <rdf:type rdf:resource="obo:MeSH_C015068"/>
    <rdfs:label>m-chlorophenylpiperazine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2c11adf1-8c80-467f-8fc5-8c18608aadb7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6ce051b9-5152-4321-a6be-90b3c82d6cc1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d669b070-fba6-476f-928a-5c5c7c73c964">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/51ef7159-07aa-4a5d-9d88-0a3040c2a4a2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/97e3c719-e0e2-4dab-bc6c-cc97f81ceada"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/0fe5c60f-ba1a-475f-93a9-e9d62b3d928f">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/3b3d404c-bb35-45b1-a982-cf063e0ce858"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/3420f168-f0a8-47d4-87a5-6445b660d9e9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/ba095cb7-0ae1-479b-9177-6c14145d4c17"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/4059da56-cbbb-4b5d-8966-6578bb2f1c83"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/1f66711f-3f1c-4c67-9df8-3810746b03a2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/2eeb5150-185a-49a0-bc03-ee6b88965c47"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/6800df50-d6a9-4212-97a6-14bd20e0e763"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/e49e9675-cfe4-4615-9e28-6f1d5823e306">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/9d9ac6ff-5d9f-4d39-baab-27f52a8eec8c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/13f48ea8-f87f-4b1a-9a97-29c6a4491bf2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/3e349920-57d0-4fdd-8637-8ab409d3cdda">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/8085138d-2923-4b69-bce4-12486f51801c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/5ff466c2-3f37-426e-a72a-bc559d998b4f"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/61e6516a-4899-4d7c-a9d3-9418a8810612"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1e67006b-4579-4baf-ac36-e79fd623f4bc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1926d4f7-6249-4fbd-ae2c-8b09991bf558">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/836bc686-7218-44be-a2c5-e67481635670"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2b091b26-4614-4dc0-90d4-8bf881ac7c14"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/27e60676-fec3-4f6e-bad9-8c889c213b2e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/eea423fb-0260-4c71-a623-c18b9e0fe7fe"/>
    <rdfs:label>Boceprevir-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/398e8bf0-9728-4853-accc-413140049c1e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d9e62898-f320-4960-bac4-eec79a3ab9ef"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/43abef45-185c-4665-a84e-823d35140cc1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/b36f23bf-0671-4db4-88d3-a59e38d32f42">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/4c02e7f9-9d74-49cb-b5ca-aa0ba2727f39"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/44c849af-7b41-4691-ac16-def44f4e7df0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/49c472ee-1f00-44b8-8b46-8ed886a6a7aa">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/934bf530-a04a-4d92-a5e3-a81d10c0fb38"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/505dd6e9-6055-4278-a21a-50c1cd7c1992">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/429ce385-4a79-44f3-82da-39ea53660e28">
    <rdf:type rdf:resource="obo:RxNorm_3407"/>
    <rdfs:label>digoxin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/8024dc37-1be3-445e-b93c-e5028e9c2b12">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/0e0a6e10-0d06-40b9-af2e-6f6537cd8960">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/ac50b298-f726-49c0-ab5f-569a4cabd3a9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/138efffe-9745-4536-ba3d-129a018a848c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/50b5cfb7-03a9-4abf-ab6e-2a8a0d94b867"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d08ed48d-e50b-4328-95b0-97135c6fe187">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6156c84a-caff-428d-8bc4-be7ca566aa3f"/>
    <rdfs:label>11 Percent </rdfs:label>
    <obo:OBI_0001937>11</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/aae17687-87a4-4ee7-b2c1-f78ed0e133d0">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/57eb8a14-4870-45d3-a2b3-4adc8ec1dc35"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/fa671d0b-565a-48f8-bd9f-96281094d067">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/0173f438-7933-41d9-a5d8-bfdd4f6f16c1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/74095c40-55af-4f53-a5fe-2b914c541852"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/803d2183-2e3c-444f-bdf9-c153ed3914c9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/b8393792-2f3d-4957-86c4-ccdf7c4b7e4b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/bb0c25a7-a912-4c41-8355-814be058a78e">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/cc858249-f84d-4977-b126-2a71bc758a49"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/db916e77-956f-4880-b964-34f8ee8a5b17">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7d36f7ce-e31a-4270-8bb1-0ccffa5ccc7b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/03f05038-6e65-45b7-86b4-39424632df2b"/>
    <rdfs:label>ketoconazole-eszopiclone drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/53cc7176-b463-406c-8261-12fec2332876"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/559dbafb-b891-471b-8d0c-25a699813bb5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f9d80dde-b2b5-47ee-b3a8-60ff18dfc3c3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/133a829f-7f6a-4160-92a2-876404ab0ed8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/6a5979e9-7238-4a9d-95e5-04244dddc682"/>
    <rdfs:label>fluvoxamine-theophylline interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/21f6ef7e-bad4-4020-82be-f864288bcde8">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/f3532de8-91e8-4d78-b758-7c1d8765a1f9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/5e83945d-b454-4008-bce4-6095ff51d09b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/cd571c74-fefb-4ef3-8f32-7e5e204b09d8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/43cd5039-95ea-42ea-b2ad-43dc88f02db4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/833ece6c-1c40-4208-8e75-5d616400071c">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/b8052a68-01ea-408b-aef2-945423785f03"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/78f8867b-7921-442f-895a-6c5f35ed281d"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/c1273ab1-bdba-4cd3-9a5f-068e6598bcd1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/596ecb77-9592-4750-b6bd-78223a626cca">
    <rdf:type rdf:resource="obo:RxNorm_1827"/>
    <rdfs:label>buspirone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f9a8bba0-25ea-4c44-9875-0e8c56d49a97">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/77d3ab27-4698-48c6-b8e8-75e3d7019b7b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/15540575-8c26-4155-853a-b6f4f3764dc7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/85321aad-3390-4a72-afe8-4b8b7cff4082"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3b90ccf1-a8d2-4ab8-adb2-d8585105e75c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/88d77725-6f70-4278-b85e-dd2232942a38">
    <obo:OBI_0001937>2 to 9</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/d8384583-553c-40ce-a2ef-24db189a9612"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/7c176684-d6bf-4493-8e21-71760af38f6d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/db521399-e912-430a-99bf-997c85a55153">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f3868aaf-ea68-45cd-92d6-b4b9864b3414"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/00354305-041e-4b48-8a8d-963c3f8824f9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/a4fbb28b-2f1b-4c11-8016-96c811e7bd12">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/26a9090d-1b87-4806-a8c7-1cc45616fc35">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3179e362-044b-443a-be3e-dc561d791bef">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1656de2f-93bc-4f57-a098-c165ae4d46c8"/>
    <rdfs:label>3 Fold </rdfs:label>
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4483d493-e509-4240-9d99-9c21195af8e3">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/87128548-c1c4-44c4-8fb9-d63d30e84e10"/>
    <rdfs:label>carbamazepine-INVEGA drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b58493c8-c841-4ef2-907b-4721f7124da6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b2a6fd53-f330-44cc-98c7-7135683eb769">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/8fc39943-0aad-4007-b46d-f641284f5f7e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c2d9d05d-1778-4e82-bece-b617cfd4f09b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/bec0ee09-f5b0-4a1e-b5e9-3cf924cc934a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/0678880f-408b-41af-aa8b-3af428081e92"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/63f14aa2-94b3-45a0-9b8a-6d9ca049db90">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/35fa2d32-2cb0-435f-ae32-b1c628e68380"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/6bcc01b4-1cf7-4971-8b4b-a24624ec91b0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/cf05ae3c-0fa6-4f39-94b7-1e759d1e0690">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/2c963010-4405-438a-a737-45ecaeb1eb9b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/2e3c8b7a-dd85-47e8-93f6-314231926648"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/eb1c833b-7e97-491e-8d6c-41586dc5a906">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9aaaddcc-a338-4c27-843b-9971ed116f1b">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/506c7343-01d0-41db-8650-3624d73e2a7a"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/eb721979-dbfe-4035-be42-36ad03f107eb">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/357b1141-1b7a-447a-9542-8332265b07b0"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/e74dcee1-5f18-4436-bf52-2fe89dde743b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/59d6df7b-1ac4-4239-99eb-818adddbca34">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/5df8ca10-189c-4ec6-b43c-c5702d3e8c88"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/0b51a031-1616-4085-9233-4bae5e67f364"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/4c2af9da-eead-4450-8387-bfb0481c53a9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f6d8fd28-26f2-4031-8a8e-74bac5221b2d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/4878b2cd-939d-4f08-9e30-00c3641d257b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/c868a84f-c80a-4c13-92f9-e11e986f2d17">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/d87b39a6-93a9-4cf1-94f9-ab259610f1a4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/95ae91f9-7a18-49e7-8333-1cb29c10eeb4"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/ac5ed37d-dfa7-4fa9-9740-3c3e15510306"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/869a67fe-83fe-4e4e-befa-b6632175d063">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/381da467-6007-49cf-949f-342d0b555acc">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/dd5ad33c-61b5-4fd4-8a26-f936c32be61c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/1d732e9f-5afd-4752-8421-210384152cc0"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/3c5d3272-a746-44e6-8229-d8825e5c6355"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a51f052e-1f14-4508-8d5e-5f2744a636a0">
    <rdf:type rdf:resource="obo:RxNorm_6779"/>
    <rdfs:label>mesoridazine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/2fba874f-4263-4c4f-9bd3-6d34e0d1ee92">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/efa0405e-9fb7-4119-b6e4-a75beb17cf7e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/8435f810-235b-46a5-8a51-4e1b6eaac8b3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/6be3ffce-c91e-41a2-8e7a-e6f2a989def5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/823d09e0-3fff-40fd-a648-a48ba41d1715">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/af214e6b-04b1-4dd0-9f04-52472c8d62fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/9b81da8d-faec-4a89-af01-e67c37c3b1f2">
    <rdfs:label>mesoridazine-Fluvoxamine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/0134ff83-ed11-49c9-a6a7-dd41ca8c3642">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/32da601a-9cdf-4945-8daa-2039c07bea8b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/68e56655-f55b-45a6-9cf3-7ea3fbb16e87">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2946d417-3361-4607-8393-4ed37b85bf25"/>
    <rdfs:label>ritonavir-rivaroxaban drug package halflife  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/6897ca0f-a4a2-4e88-8280-2b90208ca431"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/82e19c16-7f17-427f-ad86-54c3039df07b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1bce7b62-1f62-41d1-978e-fbb62fc40d4f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/b0eec3dc-3e3e-4f89-a9df-f0b8bedbd711">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ab472491-30d2-44a6-af50-f07295fcefb1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/908e1945-037e-4f71-a0b6-ed6f6ddf17cf"/>
    <rdfs:label>desvenlafaxine-midazolam drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/16b80980-e6d6-4cb5-8b33-de2ad9e7f264"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a2ea7bd4-12ec-4134-b156-c32fcf737b74">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/1b370765-372c-4b0e-bad1-813d440b4482">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/20f05a25-1c9d-4126-9c83-8dcb4b9e81c6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/4945b8be-e927-4c58-b300-4a2f8ce8629c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/9f501562-7389-4c4f-9c09-ce85fc690dfb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/5aaf2344-b5b2-497d-a912-310ab520e9a2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/9583a8e8-9aca-4fbc-b928-49a169589e1a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/f1d85724-b4de-4125-978c-eadb69d45d51"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/169909b9-ff26-4c22-94c3-a7b0eedd5dbf">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/424367a8-b207-4045-81b0-d52e4c66054c"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/65a660d5-fe50-485b-bcba-58970cbd783b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/7a037c2d-89be-4667-b680-2e1d121ac39e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/436e09f8-27fb-4d0e-b883-3532c373d57d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/30607766-a3b4-447b-bd33-28c3478d1ddb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0ea7ec2f-bbf4-47bd-b0f7-f334db64a0cb">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/fb8f62d5-cf82-4f49-8226-a5cb2705a9cc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/e3882a53-91e9-4feb-a985-fdcb6fe6978b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/6cb5e83d-df64-42af-8528-7aa9f631412e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/190eefb8-ae4d-46b6-8103-d05f77f3abfc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/20398355-f2d6-4871-bdee-611ec5ba617b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/da65ae01-b714-412f-a55b-da61a847592d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4de28061-ed57-4a58-a291-7dd2c69b7a4f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/81d66f62-65a2-480f-999d-da8e47484a15"/>
    <rdfs:label>Amlodipine-Atorvastatin drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/963185f7-b036-4b6e-86ee-333e9b03c835"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/dfb728e6-90c1-41a3-a4ac-84bc00432f67">
    <rdfs:label>atorvastatin-verapamil DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9c845358-e737-47c6-909d-27a7848bfe15">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1d711b53-c1d1-46cb-9077-eff29ce5f0eb"/>
    <rdfs:label>midazolam-rivaroxaban drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/dc20b241-8e76-4102-a953-9e0c626fe19d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/48c8570c-3d4a-4304-a401-6531ee56879a">
    <rdfs:label>LPV/r-Midazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ffbe1fa1-9b5c-4468-a0e2-108d4da0d347">
    <rdfs:label>ambrisentan-warfarin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d0abb497-ad95-42a6-a908-c70ec488ae52">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/bc96f850-9b80-48a9-83d5-647722cac972">
    <rdf:type rdf:resource="obo:RxNorm_74667"/>
    <rdfs:label>zaleplon</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4aa20736-09da-437b-8f2f-4ecac1313ad6">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6138de80-9b19-4f2e-8080-48a7551c15db"/>
    <rdfs:label>Erythromycin-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/fff790a0-880b-453a-9c93-10bd386da51b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a0fed08c-3a45-4227-8465-fc7bdea7d925">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/56e46392-4740-4c99-ae69-1c393c717cb4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/25db1d0b-a4dc-49ae-b51b-5277de187f43">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c69a7d69-dcf9-4564-be0a-d6fd1a1df7fe"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/d10d29ba-a9d4-40cc-be85-ba4b438e792e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/7e9961eb-7c08-4ad4-9738-f87052664e08"/>
    <rdfs:label>duloxetine-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/bfa1a3b2-94e3-432b-b66c-6df144f6f44f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/0acbbfde-fae1-44f6-b40b-1c539cd3e288">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/55ecfb5b-fad0-4471-9a70-e664e521d9be"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/b9cb12c2-7a45-4e68-b0d2-d479b4f14c7f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/60b33f52-8dcf-4797-9526-c5d40b747031">
    <rdfs:label>atorvastatin-Nelfinavir DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4cd3ace8-c571-4d0d-b776-e32a34aa7169">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/422f3177-79c0-47ed-a794-97010729e98d"/>
    <rdfs:label>85 Percent </rdfs:label>
    <obo:OBI_0001937>85</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b17e6a84-44d2-46db-b0e6-1e191a70f5ba">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/769d98df-3646-4724-9ca3-0861ac6c1c1d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/3e183a62-581d-40c5-8c35-74cd138868d7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/78882e2f-dd48-4718-9704-bd0451192421">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6ac160a5-9e3e-436f-9259-f208c73d9c73">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/14f218d2-253c-4922-838c-03cf30a1b783"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/74cd3447-0104-48af-aabe-ef449e095905"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/2d3b94f5-4ffb-4f11-924e-101645dd6c2c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/06a7817e-6947-4c3c-b99f-01551aee0cac"/>
    <rdfs:label>ketoconazole-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c6ea8ffb-7bd9-49d1-b420-941333603a31">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/fe5dbd45-fe9c-44a7-8004-453544d9c334">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/ccdbdbbc-205a-466b-9a3d-bba3023aca98">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b32db24c-21f5-40a3-a054-95c5861f21bb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/554ac588-01dc-4feb-b63d-340b57a633a9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3f91b1d7-47e6-4018-9caa-89eda86a8659">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/463d3b25-54b2-4847-8111-b836f9902ef0"/>
    <rdfs:label>153 Percent </rdfs:label>
    <obo:OBI_0001937>153</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/dbe9b745-f00a-43eb-9edd-0b21384924a1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/4a2cebfb-4122-4a2f-9849-57f635271807">
    <rdf:type rdf:resource="obo:RxNorm_42347"/>
    <rdfs:label>bupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ab5e76a1-212e-4406-82a2-bb41ce8d58ce">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/82fc03eb-17d3-4adf-9680-2ba33c63bcaa"/>
    <rdfs:label>60 Percent </rdfs:label>
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/0a3da9fd-eb34-49a4-b681-f547272a4e08">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/7c0a45c9-4583-4c58-b626-7f7640fa3762">
    <rdf:type rdf:resource="obo:RxNorm_203143"/>
    <rdfs:label>fluvoxamine maleate</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7078a972-63ed-440b-9037-526247da783a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1d90c0bd-67b8-4e91-b7ab-07e151d92efe"/>
    <rdfs:label>55 Percent </rdfs:label>
    <obo:OBI_0001937>55</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/00ffb083-447f-481f-9f1e-c38b84d316c2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/d7ef05d0-8ead-47b7-a6be-8639d4999daa"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/b7b99f39-f6c6-4f7a-b33f-dc20bfd7bb8b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/bd792ab4-d5e4-435e-873c-4d8ec593718f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/b8402365-8933-43f4-ad67-20672b22171a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/488b180d-9e76-47a1-97e3-78ca0ace8c63"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/68f677fd-ae7d-4cc9-96f0-51a9dcc2a099">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/f4d0e91f-0de6-4a92-8a18-169dbe53bdfe"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/06134813-3b66-430b-abd2-3f87df6c9a34"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/c34c3962-a880-4019-9a0f-bd532ba93820"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/435e6a5e-602e-45e5-92e4-dcbf4bd24873">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/62c7b602-ee41-4bcb-a81c-268ab600ba4a">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/1ea77120-4fc3-4a07-95e1-a52e94ec487b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/dada1100-32c9-4c75-8099-9ac2591bba9c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/3f837fa3-3394-4ec5-9207-4eefdcc73a5c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/4ffa4ba6-9554-48c1-b257-8409c2ba8d8a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9262e358-bd29-4260-89e2-8f15fb23b798">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d70e2086-851d-4390-96b6-5c434fa965cd"/>
    <rdfs:label>Nelfinavir-simvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4c0993c8-3bf5-4ce0-9846-884dc1797cf8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/883ae85e-649f-41a5-9454-ac8d17262154">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/1728aa36-23f3-4587-babb-acb93f66b4a5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/45e7d3fe-730c-4be2-b1d2-e78040479e8b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/47987236-48bc-4786-b613-0e8545ce9b45">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/0573f16d-6af1-48bb-ad77-e06eff0bdc43">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/fc49c8eb-8a0a-4a91-b33f-9883abf748e0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8884151d-2cb9-4452-b463-c5737302fa8c">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/2c31df8b-4021-4e0f-8536-aca70f00c637"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/c55058fe-48a3-41ea-8001-3d50a0f24569">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/4296d6c5-f979-4653-9bfd-027d7c2d336b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/deaa5a4d-4829-4701-b28a-6f4ef9d5d389"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/9969601f-0ccb-4b74-9bfb-c05d045d9e76">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ceb1ae4e-8cc4-4961-bf4c-6be488440641"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/30c271c3-17f3-4f6b-a17b-8c3800b5ebef"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e070f1bf-a1ff-4832-a110-4ce122b3bad5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c192d3ce-3d01-4990-99d0-b1ad3f1de8fb"/>
    <rdfs:label>Nelfinavir-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e9ad7f40-317d-44a3-a153-d2d42cb144a5">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a93b4827-9271-4d07-ae33-d5a34de47914"/>
    <rdfs:label>21 Percent </rdfs:label>
    <obo:OBI_0001937>21</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/564f915e-f87a-44e5-9f17-bd254a416963">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0db1c8d8-dc78-40c9-84a2-0bf85a0e9fa9"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/50b2ed02-2b81-4d6e-9c34-cc8bed50e500">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/5cd3f676-0444-4899-85fc-019c8d8d1242">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/98e41b7d-a96b-4f38-8e1e-f02849590c23"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/79f12197-0950-44ba-a7c1-1d3458c7b29a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/ecc9a747-ee25-4804-b680-ae2b6222864a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0e89f977-0645-4aee-b36b-ef717900a24b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/619011b3-c39a-4535-93bc-f2b667dcef89"/>
    <rdfs:label>S-warfarin-nefazodone drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4ca49225-35c1-4a02-8ecb-9a48b1036603"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/41d7099a-d8e5-4661-b3c6-2c18d662c6ee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/6ee72f83-7ca9-4702-b996-dd2f6aedd94e">
    <rdf:type rdf:resource="obo:RxNorm_686438"/>
    <rdfs:label>INVEGA</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ce79271b-5860-4e58-8553-a0789cd92fef">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ad12f9b6-f7bc-4764-8188-4e4158a374f5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/55fac965-d236-49a7-8f3c-a806db94a3fa"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/eed9bdca-e021-4f4f-b6ea-e683e26790b6">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/ced0ee5c-5c9a-4b76-9ac2-e682f7f77623"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/261535ef-f9e3-4404-8075-7d539fcf03a2">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/19047c54-e0ab-4297-95e7-041fd14f68ab"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/df70ecf2-d0b7-454e-a9ff-2b1208de1ab4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7934f97d-bacc-42ad-8fc8-16250264cbd7"/>
    <rdfs:label>cimetidine-mirtazapine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3daee164-faa2-4753-8638-43eee965c2ce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/dc4b81d2-1aba-474a-a55e-9325eefc0715">
    <rdf:type rdf:resource="obo:RxNorm_72625"/>
    <rdfs:label>duloxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/e5a14f0d-0ee5-41db-a495-fddbb478288c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/be5c09f6-26f5-41f4-8da8-43836ee0b013"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/44b399af-fba6-45ac-97fa-4d305a8efa34"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/54581c64-e95e-46a3-8d24-e85fda4b65c3">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/5b3ac571-cdf5-4c71-bae9-7edf7078bead"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/37bb90cb-a309-4757-9828-387e5bb91405">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/96a281ec-8b2b-498f-aa73-7f186ac54eac">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6a6d4e47-fd89-4bc8-b582-9aaf1b140c68"/>
    <rdfs:label>fluvoxamine-mexiletine drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/97179005-7f41-40b3-8327-9ca53d10f313"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e66e7636-e8d9-4ead-94f7-8d1dd475ee9c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/7a037c2d-89be-4667-b680-2e1d121ac39e">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/00ffb083-447f-481f-9f1e-c38b84d316c2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/f19ea343-cebe-4648-9b5e-a8527fba92f7"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/2d21a922-b6f2-404e-bd35-54d68fd0b476"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/7d25d526-5bfb-4eb1-951d-9fb72c2f769f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/23a9fece-481d-4b95-a74b-966c2fd4b397"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/2f10eea6-a7c1-4501-b720-25ae3c79c137"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/783d0336-99b9-4995-a8bd-2de3d57bb885">
    <obo:OBI_0001937>.25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/5cf119b8-85be-4104-8e69-45ef2bfc8ab4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/edb0079d-66cb-40db-bcf9-02a748a0201b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/c13553a3-9c2d-439b-adec-75019463f109">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/295f63e9-2390-424a-aa8e-9779ef82d2a2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/4d5242fd-5b22-470d-94bd-45051a36ba00"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/14e8ff3e-6c0f-49bf-8979-05b783b5a904"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a0aee07e-7e1f-4e80-88b6-7a45bcedb11f">
    <rdfs:label>ketoconazole-zolpidem DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/01a2ea06-6247-4d15-a2b9-45e0025decf6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/70695ede-e35d-4806-a227-0c954fbc2064">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/5f628733-c6fa-4d7c-8109-652131ea0c0a">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/19bae29e-2aa1-4093-ac46-41d048c8e047"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/461b76b2-0128-474a-a6e1-f3974afe2063"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/dc77aa49-1dea-4655-abd2-28c7173fcc90"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/efa8ab37-21cd-4b5f-b67c-7c6f18b0d0d4">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/0b218ad4-449d-4b99-954d-014ec065d6a1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/227f4da4-5e60-4e00-8128-ee1daeab4578"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/d845f180-8554-48d5-9f8b-0305d20c04e6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/560b8520-3a68-40a3-871b-e64653679774">
    <obo:OBI_0001937>2.5 or 5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/4a9e8916-b731-4341-a03a-c26cb876206c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/acded934-5d0f-4902-ba21-fa100cc7757a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a5c17a7f-1c22-4c97-a672-a3c863822333">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/2b71aead-6f8b-49f4-9aad-125492c5a494"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/dfd34c57-4832-4bb2-9e5e-c1b68d6761eb"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/73e4f621-d847-4d62-9760-b81342613f30"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f32cbff7-b32f-4ab7-b03d-6d74b490c6ff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/bb4dff37-c402-4bf6-9b7b-d9e5abff3267">
    <obo:OBI_0001937>90</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/a964b206-a323-4943-af5c-489025e9c8bd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6e1b4b9b-764e-4e5b-ac40-f8eb6f88a5c0">
    <obo:OBI_0001937>400/100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/ed152ad7-b975-44fe-80c6-f8b3c0d47a02"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f2e5aaa2-31d1-4b79-b736-9f342bbc0a43">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/fc7ff20d-d49f-4342-84aa-0dffa965267e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/e128e5b5-0b26-4b6d-af1f-e507901b3d5d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/50eb5ab5-65e5-431c-9a57-dadf4586af67">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/fd7fbb90-af53-4f93-8360-72ca14a702b8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6159f06a-749a-4f27-a0ad-396e124fc903">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/9b6df932-e38c-4827-a12d-16108ee08665">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/af0b2af0-f503-4f80-a6e9-8b3cbb0a634d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/afd5fc1b-cbde-488f-8c78-102a937ce723"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ced06f44-3861-4acd-b113-14e52ae332f8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/73e2addf-dc7f-495b-a6c7-5e126f792ba1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a9bb7dd2-36e3-46d6-912c-e93351393bfb"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3b7e4039-de0f-4038-a332-ccb9d4e3c230"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/dfe47e9d-c135-458c-b1e7-cce7ae429d10"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/2b89680e-15cd-42b9-b2a8-60d826c8077c"/>
    <rdfs:label>amiodarone-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a1066f13-0004-49a6-9316-d3bbbaec309d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/42762c6f-486e-4a0f-8778-3a357370b3dd"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b126aafc-d513-464b-a66f-5f807d70d6e7">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/3e3cc75a-50ac-4fe1-9439-627deaa2d837"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/db1742cd-1ce0-4fae-a0ac-2705e3616248"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/85c1ca35-83af-49f6-971d-7b621fa3df4d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/291e0e49-3c9c-4785-84af-39816086a572">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/69e5f6ff-499e-487d-bb5c-5da0d24e4f7f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/33038d08-c177-4f5c-8357-a6afce00538b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/49ca5313-c397-414b-a1b8-88fb1e909e38"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/82dc2863-8453-459a-83a1-616c8b78d3b7">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/065e2f8d-00c0-4801-91af-b6ddbae80793"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/fc7acd73-1118-4463-956c-be5c70e73b89">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0ae11e13-9134-41a7-a80c-cb26b5e363df">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/60945d33-3131-43a3-88c8-a95f761f07b4"/>
    <rdfs:label>Ticagrelor-atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/79a6ba79-adcd-45e5-a5c3-184eeaf9254f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/17c5cc06-bc63-45df-8ca8-96cd97225f84">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e4e1a279-b066-4409-afa3-942774b5aa40"/>
    <rdfs:label>26 Percent </rdfs:label>
    <obo:OBI_0001937>26</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/4827eecc-0ab3-4c68-afa9-3504277e135e">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/ae59d5e5-c78f-47fb-8d58-ef5e6baa956d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/ad5631fd-6399-4814-a067-6b98401182e3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/76217a6c-06c0-4c8d-8e82-2edc69cf1f54"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f58e466b-043e-4d5b-84e4-324ac8283a76">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/64e79dac-55ab-4f84-a6ef-a8ca77f2292e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/328a8627-ea34-4814-b59f-3acbd9cc3035"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/7e53095f-7389-4507-94c7-3a2012ab4c4f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/edd2818c-a2f3-4025-9a61-db4edf342d36">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/50395ff3-2979-49ad-90f4-ca681f119a00"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/e9ca2f78-1328-445a-80d5-b2270af7a5c6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/025c3bab-c2da-4f07-ae90-f61237b5442c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/b152c67e-b9ac-4c69-9680-cf486da68706"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/b17e6a84-44d2-46db-b0e6-1e191a70f5ba"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/65ab1a40-99b8-4658-81e3-36bc707f077c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e4fd62e8-8eea-4e2c-ac6d-2bca93f38f1c"/>
    <rdfs:label>Cyclosporine-atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2bc4a1e5-7d96-40d6-953d-6c4165da99b2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f086497b-b351-49b6-a25e-aad77f180c33">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/ff6da2fa-d697-4bc8-9a40-daa97dea5206">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/25a6dba2-ea03-4484-997f-f088b17bdb87">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/466af1fb-e800-486c-9a9a-698b96cc3e08">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2f8ce52c-2e81-45c5-9ec8-42e6b822a87f">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b6c50ffe-06d4-4085-8848-cc254b6ad369"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/73647379-80e9-4f4f-bb96-e34fce09df28">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/53baa89e-2872-4616-a8c3-ba385388ac4b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/97569c64-89b4-46c7-bd95-069dcbb94e2d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e751fd1a-01b2-408d-aa8a-97e85e20e40c">
    <obo:OBI_0001937>300</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/86098b26-57e0-4225-997b-1d9f7fb66fe6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/469eec16-23cb-4ab4-99d8-c8aa4b45440d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/8bece738-38a0-4d50-94f7-f246f9216428">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/c936a393-1081-4b73-a575-c7438b65a654"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/851b239f-95ea-437b-a5f3-d8e6e9a8c9bb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/a7cb41da-1b83-4dd6-8ac5-5c9baf721077">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b7cfa651-f183-49f1-9328-2f3875bae2d9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d26c33e0-273f-44ae-a469-aff46c4428b4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7d36f7ce-e31a-4270-8bb1-0ccffa5ccc7b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/26bb015a-aa73-4538-b59b-9e7119897aa3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/a377992b-39f9-4d84-a43e-11afacfdcf2e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/302b8843-d771-49f9-b652-d277b5d78149"/>
    <rdfs:label>ketoconazole-eszopiclone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f5048a88-ec68-43ad-9fa9-e46b2039870d">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/61c35ec0-8f7a-466f-8864-9aecda977872"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/f6591184-c1d4-4a60-9945-9d1a23983dc5"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/67b2c923-bce6-42ae-b4b0-17d51d1645c5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/4ca773d1-ece5-40a0-b0a6-b6408a1b9e30">
    <rdfs:label>ritonavir-erythrohydrobupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/bd0130a3-76a0-40cc-8d9c-9da848caaec7">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/8a1a8ee0-21fa-4574-980e-7b99d1aa6b8f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a98cb549-baa3-4ca1-8b40-1e6cb41fad6e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/222c4a27-c2ac-4513-970d-f01c52aaaa0d">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/2a8da66f-d0b7-4d59-b637-8cd51f67c8ad"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/bc24bb06-4938-4160-bd0d-911a6dfddc6e">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/564f915e-f87a-44e5-9f17-bd254a416963"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b85f711f-1752-4c94-a5a2-3b294050393a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4cd9508a-fc65-4c51-a5ac-ac4ff179f3e6"/>
    <rdfs:label>16 Percent </rdfs:label>
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f903f9da-4ed6-40ff-b414-90462b710d7c">
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/0c8c9966-f8f2-4995-8a53-275597d9a8bb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/abcf948d-a72b-4a38-9ede-7c05599d5e28">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8bf90a60-4adf-4f39-8c05-1e83d3c61efb">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1498ca78-d636-4ae3-bc64-909c4257b3d6"/>
    <rdfs:label>1.46 Fold </rdfs:label>
    <obo:OBI_0001937>1.46</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/79f12197-0950-44ba-a7c1-1d3458c7b29a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/1728aa36-23f3-4587-babb-acb93f66b4a5">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/a5da7fe4-d667-481f-a083-34696692d331"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/270b5042-663d-4e30-ad0e-bdfe043ce838"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/bf3c7eab-8692-45d5-9078-e70d3ef5614a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/0e2404a0-06e1-4b1f-81f7-a53e53c911d7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/26fb563e-1a3d-4214-91c8-e55240da96e9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/d3795d57-444d-418b-aeec-9a3992b3f1de"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/1a7c49b6-0f50-4f55-b7db-64989c6a443e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/724f926d-f137-4a70-a265-ad193273e59e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/33bbd116-9d97-4cb2-a038-1eb4fd2fb58e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/54fd916e-ff35-4d85-9d3b-d6cdec3b2cb7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b988274a-c409-4d1a-812d-04ec6a8d4e43">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2d4ada36-3b11-456a-a118-b75fbf3296eb"/>
    <rdfs:label>82 Percent </rdfs:label>
    <obo:OBI_0001937>82</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d8333b17-c2eb-45a4-ad40-d8570eb9e380">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/62695283-adc1-4726-8498-24101ef97cf5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/1f4a6a64-18ac-4643-a424-3a7d534a77ad"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/fffe5002-9478-4b17-859c-ecdb42edfccf"/>
    <rdfs:label>ritonavir-erythrohydrobupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/bc59b83d-98f8-4469-9b95-7d703adeae88">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/298e5943-1edb-4611-8f76-68d30882dc4f">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b44ef85d-70b1-4c10-be81-f991c333c58e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/77f277ab-ee98-49e8-8202-67e511d98741">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/81633804-edc3-49fc-a90f-a31b09b6f10b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/4a192cfa-a440-4100-84e5-50e52c93fd1c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/431dbc99-79af-4ffa-a5b8-41503e3fd181">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5fe050ea-4fb7-4016-8969-17f9f40be797"/>
    <rdfs:label>fluconazole-rivaroxaban drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/7ecf5ac0-d1b1-42a1-bce1-817f9a4c6d7c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/289e3198-8220-4dbc-a303-1acbfeb75752">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/26795978-4d9b-46c3-b4c7-91e0cfd11d13"/>
    <rdfs:label>32 Percent </rdfs:label>
    <obo:OBI_0001937>32</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/07c46def-cac4-4619-9be3-d3e454c3cfab">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/19a776aa-6535-4d49-9b42-561d71f9bee9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/bc0c6876-be29-47e4-816e-54a27b9ce13a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/e8247d0c-355c-4e30-bf85-03e79c1a7d6c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5c2e5869-abda-4060-ab28-5313f6010709">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7ac49247-faef-4a96-91c5-be9c2e7cf03c"/>
    <rdfs:label>warfarin-ambrisentan drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2e72fdae-9625-49a3-946e-cf3cae5a2c98"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/51df703d-a2c0-4f12-b8d9-9c835149afd5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/24b83ea8-2d09-4051-8084-38a28a8dd9f0">
    <rdf:type rdf:resource="obo:MeSH_C496216"/>
    <rdfs:label>erythrohydrobupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/fe7f65b0-e639-47e2-aa91-759f02bd8685">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/fa713175-d669-418f-9a10-91ba92e8bd7d">
    <rdf:type rdf:resource="obo:RxNorm_9384"/>
    <rdfs:label>rifampin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c1e57621-bfd2-4096-b11f-8e5a87cf9cd7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/68f677fd-ae7d-4cc9-96f0-51a9dcc2a099"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/70a3ed14-3df8-4ae0-a679-aec1222af64c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/dada1100-32c9-4c75-8099-9ac2591bba9c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/abe4f9a7-f9c1-4af0-9165-8c18adfd73eb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/065e2f8d-00c0-4801-91af-b6ddbae80793">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4fcf2341-36e1-4d11-9ba6-73968313118a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e6dbaf9b-5d41-451d-86c9-cd4dc186a72e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/fa5ec061-eb2f-41fd-90db-fb83df36ba29"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/abeed22a-bb9c-4dfc-ae63-ee5b46e5c59f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e49dad5e-4a99-4a2c-8fc0-910002ab7fef"/>
    <rdfs:label>ritonavir-threohydrobupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b808507a-43ae-420a-b61b-37b85f4403ef">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c31285f4-f922-4bfc-96c7-6eb50a4a7070"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/3da643e0-8ea6-4c00-9d98-d4a79b4683f0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7c9d06e2-8684-4e74-8085-6536a1151927">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/13e128c0-7f37-4450-806f-f6d11b81f2b5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/cbd834e3-32f0-47e3-80de-3fd1b914d3ec">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/10dd253b-9144-435b-bf05-5d05ef4753ce">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
    <rdfs:label>rivaroxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/19f16cee-18e1-4b36-a4bd-84ff21ae8cf5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/a484c557-1c41-4b4d-9b57-7d859f7177be"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/6d0a4ef6-af65-4c9a-91fc-2cbd3c9ec1fe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/60d27bfa-553f-4c30-bdfa-6c912ed257f5">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/8144e431-bdbc-4c4e-adff-48fcf913a113"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/c154298d-2aa5-48b1-aa83-babc05e6ad70"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/7b214fff-f196-4a17-90f1-d1a3860ae875"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c5a48337-1048-4cae-920f-aa147c5670a8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e1e8d21c-5369-4777-8d3b-adc1ddae4931">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
    <rdfs:label>dabigatran</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e08b76c5-2f2e-48ce-9a53-24c2e735b1fe">
    <rdf:type rdf:resource="obo:RxNorm_1599538"/>
    <rdfs:label>Edoxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a68a7360-5985-41f5-9771-adc070188066">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/853273e9-0e9c-4b88-ae0d-913064003cb9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/24ca19a8-f05b-429a-b1e6-7689eeeb8bf1">
    <rdfs:label>nefazodone-haloperidol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a9eddbbe-c945-4995-9e70-8100e9fd4bf2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/89658235-9f90-4803-97ec-740cf34184b8"/>
    <rdfs:label>nefazodone-haloperidol drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e9fa88be-207f-49ca-9a0a-8f005e1d7d8b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/267eed52-0c09-436d-b3f2-d145bb9c621e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8f3fd061-07a1-46f3-9789-ca5b08130014"/>
    <rdfs:label>38.8 Percent </rdfs:label>
    <obo:OBI_0001937>38.8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/00d03422-b020-4148-a696-67fd0dc62018">
    <rdfs:label>Fluvoxamine-sulforidazine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/c6c84e4e-19ed-4315-b1e1-218aa8fd14f3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/023e2700-9d97-4fb3-bd8c-a5a43a2c706f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7d4ef7bd-cb1a-4365-8df3-55dcc16ff5a2"/>
    <rdfs:label>5 Fold </rdfs:label>
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c3f9b580-2fc6-4e13-9ad6-ab51ebc71171">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/cdb2d85b-1983-4c74-8d87-ead65e835f5a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ee40d925-1d8c-4dca-bfc2-89e9f3147630">
    <rdfs:label>telaprevir-amlodipine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/9a2506c5-485b-426e-8c95-6c2faabb6131">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/640260d7-4db7-440c-baca-7612f907b264">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d78ed45d-7271-4702-89ab-6ce3f306bc44"/>
    <rdfs:label>ketoconazole-P88 drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/7078a972-63ed-440b-9037-526247da783a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/b768113d-9566-4f5c-abaa-039c9615cdae">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/f9f474de-8e90-43ba-b2ee-89c8edc25c34"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/6488b176-d9f3-4ba3-857d-deb25a8f2383"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/69eb9816-088e-493d-9cd6-030d8b49d419"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/52bd0ef8-7c5b-4d8a-b88e-54529c9d4586">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/396e6986-94e7-4098-94ab-4435ddb7f0c1">
    <rdf:type rdf:resource="obo:RxNorm_21212"/>
    <rdfs:label>Clarithromycin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/53ec2e30-a2ef-454f-8910-81985ba4da5e">
    <rdf:type rdf:resource="obo:RxNorm_10767"/>
    <rdfs:label>triazolam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fe70220f-ec55-4538-9a82-e25401ef9848">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/3303906a-a75e-422c-b246-ffb87a13970d"/>
    <rdfs:label>19 Percent </rdfs:label>
    <obo:OBI_0001937>19</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/a08a0286-f652-4aa0-a075-d64be8a783bc">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/0d8c46e3-dc40-43c3-8943-c4feb1bcf872"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/03745ec1-2574-4efd-b92e-696e9402f37d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/7bc74a8b-35ac-4b9f-80bb-6198c832e915">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b6d8eefc-d235-4081-831b-5c7864ca3ff1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/272c5e57-5293-41e3-91e3-87c272d4db65">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/3bc0042c-f67a-48c4-8bd0-225c2488ebff"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/fe5dbd45-fe9c-44a7-8004-453544d9c334"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/5a8ca62a-f5ad-4bce-9a68-907a35bb5eca">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/25373696-4c66-48f6-b3a7-36e89b071789">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/6725b134-a273-4fbc-917e-5e6281e8161b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b16f24fe-0a44-4487-b0ad-75c8d6c370c9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/dcdbaef8-7484-44e0-86c4-17710ef2edc2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/790e3edf-1e96-460f-8e29-961144dc5eaf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/4491607a-d9a3-4de2-ab41-0ec633a83052"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/8230c455-3983-4c5a-a34c-a568250a0879">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/7e1646fc-9aef-45f9-9820-7f40d77cbafe">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
    <rdfs:label>desipramine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8435f810-235b-46a5-8a51-4e1b6eaac8b3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/767dcdc5-b3ec-4464-a99e-c6959560eeed">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a419b44f-a0a8-4839-942d-30dbe9f6ec11">
    <rdfs:label>ticagrelor-simvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/698fa792-81a3-4000-905d-69d89f085b80">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c730d12d-c516-4983-8630-315e3fa41a35"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/ea6ce9c4-bca5-4084-a885-fceee8bcf939"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/2264e934-958e-4ca6-ac78-df592758360a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/1314d9c0-c03a-4ee4-a186-be1ed2c12d59">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/2933851b-5031-4a31-887c-2a2b8f1708ae"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/683c51fe-a171-4711-8a12-8499e458dfe5"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/01cd286c-8e83-4c30-aff8-b8e9d2a52b65"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/06134813-3b66-430b-abd2-3f87df6c9a34">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6878f08b-c8c9-4bc0-b0d0-bcadc0597250">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0476a8da-8c39-4731-baf3-30daaacd783a">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/bb207f44-206f-47b4-97a4-3fb606618372"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/1fde223a-43dd-4688-b6b9-0bde913ce28a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/00bbf255-af2c-4294-b459-63101fed1fdf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/63df20a3-3b5e-46a5-9418-766ab2925fe5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1d864c18-6bf7-4dba-86c5-2caf144114c6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d0210341-5e24-41ba-b6c5-06acb9f7d509"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e005ac7b-61e5-4f5a-b4e6-49acc71825b8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/5d7016bf-4199-4409-b777-dbf867752114"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/917bea1d-df34-4fbc-ab61-145c3b7becc5"/>
    <rdfs:label>nefazodone-buspirone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/304b27e4-c316-4db5-a95b-1f71c2bf10b2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f2d45543-65ae-4032-bf92-619c170381be"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ce03e7b2-4ff9-4b19-b09c-a6725a0a5925"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/6ff75771-a67e-493c-81c1-baa65c0f01c5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/8c0d75c3-d798-47dc-84f6-d0c63fdd0a26"/>
    <rdfs:label>rifampin-zaleplon interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/25f85adc-177a-45ad-b217-4567088002f8">
    <rdfs:label>nefazodone-alprazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e63cf0e4-a9bf-4049-af03-21ae25a775a7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b49ff605-ecc7-4c5f-82db-7d3400e16b9a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/bafd4773-7bfb-4368-93a7-09f25aaa3378">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b0628d1d-ecbd-4c21-9d1a-01e09d287219">
    <rdfs:label>rifampin-pitavastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0fbf8629-edbc-44f2-af7c-ef554c26d3f5">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/4b2d6a90-513f-454f-aa26-91d3cdf9d9a2"/>
    <rdfs:label>ketoconazole-P95 drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f45a2334-3ec3-40e1-a8d3-f67428212167"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/67a50874-a28f-4c71-a130-08e4f08c4b72">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/0162c0f3-5df9-4ab7-80b5-499de3633cc5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/7df05290-0430-4cd4-95bd-43ee32929e31"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/3299ffa8-55e0-4a0b-b904-1e9616d3b9ea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/a964b206-a323-4943-af5c-489025e9c8bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/cc5318ed-a2af-4622-ad72-7cc4e81cb3dd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/215657a7-f769-497e-92de-a17bdee60d4e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f5008afb-cd59-4bb1-a107-6fbdac9d32d8">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3ae6c92c-bfd5-4f98-8078-c05fc8984e01"/>
    <rdfs:label>desvenlafaxine succinate-desipramine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9d8b6aba-65ee-4d4f-8dc2-81a75dbd23c5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/e3d6b911-019f-4a4f-be98-dc0419aa1cd4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/8346a232-0e7b-4622-ba65-5ca10c8439a3">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/57ecea77-665e-4014-941c-7250ccaf69a9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/b3a7b6f2-98f6-483d-93b9-798e5748e0d0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/ac1033f5-35b2-487f-a629-b187061b7175"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/0bb17378-28fd-43df-8643-30a24648594e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/bb59cd58-eb08-40af-926c-3a24218c9792"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/e577d438-f877-4701-b707-7684a6e49c69"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/5e5f725f-3f17-4a3d-891e-0cb29c6576fe">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b4f7f2fc-f8ec-4439-a3ee-81344ae23da8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/171536ad-8d57-46a5-ae4b-87975d0ef4fd">
    <rdfs:label>low-dose ASA-Edoxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/440350f5-6b1a-4638-a4f7-fad46f69e07e">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
    <rdfs:label>ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/8b35ae84-65b1-4a53-8702-b5720a2b1329">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/b4f52758-5962-4c0d-8188-1b694e8284ee"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/fdee9c4f-0f32-4beb-a3f9-60e837c03425"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/546da4cc-2345-4d26-83db-cb42d48f66c9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/1f08f5e2-d68a-4263-b923-7d106375e79f">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/9fd63d86-561f-4130-9e34-cd5aaf10276b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/a8ea8de3-2aec-4cf2-9be2-855ff8aac05e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/0bac9740-1b89-4e3a-9a95-38fe62ee391e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b43f8a14-67af-4bb8-aaf0-a3bfaba024df">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/581da30a-e51e-4c2b-bb17-a0085a2e167c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/52a5638c-f8ca-45b1-aec0-7be836a2fb26">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/3df7e9fb-194b-4661-8884-7d569aeb3553">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/ebcb972d-2e03-424b-a0f1-fb5f261c8a4a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/75817aec-80b5-4f3f-a101-c856712ef944"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e4218552-018a-4484-a431-d7d2c444d5f8">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/9fb7b211-382d-49c6-91bb-db7259a9b50b"/>
    <rdfs:label>4.23 UNK </rdfs:label>
    <obo:OBI_0001937>4.23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b3a7b6f2-98f6-483d-93b9-798e5748e0d0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/5965ecd4-1bf2-41b3-a94c-cc41a7297b17">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/8be5524f-039a-4fe7-bbd8-aa7c6e6a5bb7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/adedc586-969a-44bc-bc9a-3038cfb21cb9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d9e62898-f320-4960-bac4-eec79a3ab9ef">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/acd88aa6-9bb8-492e-a809-c80acb59e2b7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/6bc82e70-178d-4d9b-8003-9d4f9479ad05"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/91a0ee99-c6fb-4c21-953d-93a01e69478f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/46efc7ad-b93e-43e7-bbd6-af11fe4e72eb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5123f702-c224-4323-b87a-1a6985be25f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/a3dd1296-4109-4968-a9ed-b9e2f6818caf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/3a8b1aff-fa44-4d62-8d94-14732c5afe72">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/6460d3f8-2cb2-4d22-a5a4-33989b479815"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/d8d02d8d-cb5d-44d7-8399-78ca78eb1bec"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/e5c4f34c-a290-465e-bb36-a773a2410e52"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/71007cf9-17bc-4075-85f8-ee0a438b693b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a4d4fd3b-6a1c-49eb-87d1-b57d07956bd1">
    <rdf:type rdf:resource="obo:RxNorm_134527"/>
    <rdfs:label>Nelfinavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/2ac4649c-e3a8-4198-bf45-b8b7f3eccde9">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/7e90b2f3-c082-43db-9b77-b58ebf2ae3c5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/60c8877f-4310-46e6-8eb4-38ee96ec3f69"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/7176ecc9-4838-4ecd-a368-7de961cdf23e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cf0a94f5-5f4c-4daf-976f-b9a310ad2f62">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e3a7292f-8876-4bc5-b66b-95a56a91c52e"/>
    <rdfs:label>21 Percent </rdfs:label>
    <obo:OBI_0001937>21</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/cf893ac2-33c8-423f-a41f-6eee6ea5f5e0">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/97235b20-f8b5-4d4a-9119-26b7a863e90e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/795213fd-a00c-4677-bcae-22f13652115e"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/2b91eb7a-2baf-4059-8139-4f209821a371"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/bc50a45a-360a-4f95-bce1-f5d823f13a3c">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/91786116-458d-4133-8bd9-670b336ede32"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/d7a3bca8-0591-43e6-8d0e-c6053e62dbf9">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/adb9b935-65ac-410f-9feb-bfc6f8d85d24"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b6e64c3d-2e28-4289-916a-13ee1edd1e3c">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/215657a7-f769-497e-92de-a17bdee60d4e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/055a76d0-b836-4ac1-a924-5f2559f03c69">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d169c62d-642e-4acf-bc07-f1f6000c1a40"/>
    <rdfs:label>ABILIFY-norfluoxetine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4e990102-ca52-41f9-b0dd-a53e2eeb52f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/a75572ba-0e9f-47ac-a6b4-23f7fdf9d58f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/51b58221-c7aa-43dd-b280-2bb3ab3567cb"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/0f8aa9a1-d83d-4207-9776-d883c2280c0c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/9110ab6b-16f6-4767-b257-27ff4c8d2310">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/e5e974a6-8341-47d6-8698-6be8a295bf72"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/649a9b57-abf7-470b-9025-5c668e9e718e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/698cad6f-af37-4915-b649-753c53e79a6d">
    <rdf:type rdf:resource="obo:RxNorm_134527"/>
    <rdfs:label>Nelfinavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d1653d38-e43f-4523-bd12-930a98f140bf">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f0c9e786-6819-42f3-bf60-61a5b9ba59e5"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/f15888b0-a765-4cfa-9d87-21fd33f43740">
    <rdfs:label>propranolol-m-chlorophenylpiperazine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/9a759ee9-8cf3-438d-955a-3aed6c5b33a0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/c13553a3-9c2d-439b-adec-75019463f109"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/6c0e5b80-bc8a-4381-aba8-163339609539"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/3693ef20-5581-41dd-89a9-9168719b7a66">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/01c5d7be-e667-48aa-905f-a26e5df27b72"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/26312289-3ac6-4886-ba00-153029cfa94b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/35b7cc56-f10a-46a8-abd3-c9ab0a98a5c9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/5478c53c-1ede-44e3-aa4d-232d40933dff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/372222b5-03f6-45d1-8e6c-36e49950d310">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/5d4d3cae-7bb9-4118-b0ab-f9957f94f1ae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/51dac99f-5112-4ffc-9c61-d3a15bbf1224">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0dd1b103-bd11-44e6-9810-3c21718dac28"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/ce54f0e1-f6ad-4dee-94da-ce62ffdb29cb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/0cd03a0b-6c20-48c8-942a-9a635b56f25f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/625ac8f5-e91e-4e7f-9b10-b6fe8a8dcbe8">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d9bde213-df98-46aa-af56-2500c23d5739"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/1761f2a4-ab83-4f50-9195-34ee042aae94">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/abe963c0-1e7e-4d07-b372-486ce843418f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d9f9f0c2-fd8b-4e04-b560-9c8d9184aa4f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/41e08f27-3338-4079-9d5d-4d1f35320b31"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c9df2253-0c00-4604-9ae1-058ef68910af">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b05524e8-ce4d-4cd4-908f-fcbeafae5985"/>
    <rdfs:label>ketoconazole-desvenlafaxine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c4676def-a67d-414b-bce1-9283b8f7622f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/1678e017-2537-4aef-ae76-5cdb05a994de">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/a7ca2f43-e4ac-4049-abbb-812fb1df3730">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/af7a973f-17ab-4539-85e2-aa6218a442bd"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/22687408-5cbe-43cb-8a56-e79e33ec80fc"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/7f2455c3-4d6d-4a59-a0af-a6e50e013f82"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3dd692ae-fccd-4174-b024-7653edd418ea"/>
    <rdfs:label>duloxetine-warfarin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4a645ff8-58dc-4614-9a38-61b3054cbc0d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/7ca5444b-6a19-4dbe-b927-7d28c507676c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/8c54c683-f58b-4ec6-a0fa-b3b25308deda"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6c82da57-5323-4371-9b34-f29981880c97">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/07418f09-8dbe-4081-881a-f8766d086164"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1de0162f-4347-44c0-b6a4-79495eb5c1b1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a5761af8-fa08-4bd1-ab4c-b181b658d2d9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/bbb9c368-4eff-44ea-94d5-a925fbf1c4e5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/284bb365-c466-45ff-a8d1-eaf198537a00"/>
    <rdfs:label>fluvoxamine-duloxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/618eb922-9dfb-4fc0-9f3f-0091be8de4f2">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f0f71f59-b932-4738-b63e-231dea8da004">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/d264281d-db10-44b3-9811-070b4f36e4a1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/353912c9-d062-495a-87c6-d81485cd78a0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/acd69e49-dca0-4f6d-9e50-63df8bea4d61">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/19bae29e-2aa1-4093-ac46-41d048c8e047">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/a939fa69-1482-4884-9708-085a05d5b126"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a16825c0-45e5-40c4-9923-1c34119b1351"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c203271b-b51e-4ebb-a5df-5772d649eda6">
    <rdfs:label>erythromycin-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/666506b0-c4c3-4f4c-a9b9-7a4895abd93a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/3e183a62-581d-40c5-8c35-74cd138868d7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/353761bc-9539-44ac-8b73-ad55a7bdbd49"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/13a9f0bd-7bd5-40be-b18a-03e19ffe48c5">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/d7c4dcc8-988b-4926-856d-fe964078a2b8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/55656233-b164-447e-987b-912d870edce3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/8d1a8a34-50e7-4ab0-bd54-4df67cc03f05"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f62b9133-9c7e-46d5-9468-a6e191e152a1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/6c6ec2ee-0667-448f-a28e-7accafc94dcf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/d2ef146d-b79e-4877-b382-9fb023d0decd"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/49e78e0f-c165-4c1f-bcbf-942991dd2d36">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/160d8ee6-0681-4846-8ddb-0b501825f474">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/725d00d1-cd96-412f-a0d2-8f4d6e43f161"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2b22d2e9-80f2-48c8-9655-a8a405afdaf0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/5a19d224-aae0-43fe-862a-16f440ddb40b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c125c72f-df36-4a35-b007-2e74122f4271"/>
    <rdfs:label>duloxetine-warfarin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/88d7ef14-edc4-4a75-9744-160b036bf214">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3eca0aab-9c52-407c-99c5-8939f7854d44"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/7f835c65-9d5e-4d39-b97f-02237b92a2cf"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e67d7755-7f8d-4f82-ad5b-44c9f645810e"/>
    <rdfs:label>itraconazole-zolpidem interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e885a28b-f1e0-464e-b89d-c0a9e5d4be01">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ce1b8f94-4c45-4546-a0f4-d92c55a12f64"/>
    <rdfs:label>digoxin-aliskiren drug package clearance  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2c0b8ac8-cdaf-4b13-8ed8-9f10f618556d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/263ad17a-d06d-4da9-9c82-48ad360a91ed">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a22a76e2-22e5-43a9-bd25-92c483889dc5"/>
    <rdfs:label>74 Percent </rdfs:label>
    <obo:OBI_0001937>74</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6342c7b8-0429-4e17-ab42-9f7b314cb790">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/50874ad2-9478-4e75-8515-72896004837a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1be4414a-32a4-4071-9456-3b6505f54ab0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/37c553f6-2d27-4413-8234-601d477e2e31">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/32dab344-191c-441f-be2c-9933ea52cd1f">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/50d653c0-a02b-4d1a-96c0-22f4ac616d53">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7bd352b2-5f9b-4326-b675-68d453244759"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/f633b98e-a94d-40ea-8737-90fcde4e645f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/17d3a49b-35f5-4b83-a950-2da70aa40a9d">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/4a49e6ae-465b-4ea1-8da8-2aac23cd44b5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/dae1fcf8-43ca-4603-8588-29f40c203a84">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4899a86b-4c33-4509-b47f-96f67a60262f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/3a671fe7-1776-421d-b478-af6569ab63b2"/>
    <rdfs:label>2.79 Fold </rdfs:label>
    <obo:OBI_0001937>2.79</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/0aafd103-6094-426e-a19b-fd7aed28f5e5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/5aeb9d13-7ac2-4e3d-86e0-1389e37b5ceb"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/7d03122e-f623-4629-97af-2c5c40fa9805"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/da74b9eb-c55f-4a26-90df-ec7761f9dc64">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/31197fbc-616b-4cac-bdfc-b20d3c2fc0ec">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/31cc7aee-e938-4fb8-b873-5698484534b1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000013">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/3ef15fa3-900d-46d7-ad6f-cdc3add161d7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/80d887ec-41c2-49b8-b41a-cc6e9ab26c6a">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/b5c6e0b9-4e9a-4026-9656-273d9062830c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/d1d387ab-5d56-4e78-ab56-c293420f6243"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/22fe50b1-b678-422d-9b30-6f895106ea73"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5d6f440b-1845-4236-aa0e-1ec06d16bcf4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a99ee8ed-db0b-49de-81cc-6caa96fcc430"/>
    <rdfs:label>citalopram-ketoconazole drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d2033896-9abc-48a8-848b-62c15dcda51a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/87063fb7-9e49-4469-829f-da7f2967c7cc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/02c15d57-593b-4c6d-96bd-c0d35140dbcc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/4cf32192-ab77-4c62-aaa9-2278e72a9f0e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c43057b0-a16b-45e2-99be-b94689d12148">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/5cd3f676-0444-4899-85fc-019c8d8d1242"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/c8995e57-2336-4766-9b07-b7bb981e557e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/305ee911-27bc-4366-ad84-84b16553da96">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c61220d4-9f25-483d-a6e1-a4f5e5ae3af6">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/42b9c0d4-a175-4d0f-9518-66e851c2816b"/>
    <rdfs:label>5 Fold </rdfs:label>
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/9da95729-7775-4438-8993-6b340e825661">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ea33ddb6-2530-4f19-bfc0-8994096f1ac7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/b0b633c2-28c4-4161-8488-158845402156"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/77d932e2-155d-40a9-9043-d56b24901701">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ad5d1e75-1a4e-465e-bc9e-7c94f170e6e2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/34f25f73-1a60-445f-8b3c-96768108b0dd"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/5aa02787-0896-4f36-beba-55fef5fadb9d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/bf112beb-05c1-4df6-9c4d-2b2cc9cfda64">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/117d038e-c475-40a1-9252-a4596e6fb181"/>
    <rdfs:label>23 Percent </rdfs:label>
    <obo:OBI_0001937>23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c117fc19-dbf0-4a0c-b29a-daa77a680d4b">
    <rdf:type rdf:resource="obo:MeSH_C496216"/>
    <rdfs:label>threohydrobupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/72904cd1-406f-4d67-9f61-25b6aeb4f56f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d33d7a19-1f00-46ba-b401-c6f282553736">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/dfe5531a-a206-4f88-adc5-418d0a25045c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/49e23cfb-6757-4002-b600-8b3a16e09c7d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/43abef45-185c-4665-a84e-823d35140cc1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9e96cd37-4a4e-4e5c-946d-c1529b032953">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9f5de77a-2c46-4d98-8a56-a99e1af50d90"/>
    <rdfs:label>Fluvoxamine-thioridazine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4cdad6fb-b87e-4f2d-9354-bbefa3b36aac"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/af28296c-94f1-471b-976a-b5e819aacad4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c54b6f79-62d9-4201-a154-6fe8a86f97a6"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e96851dd-2542-4275-aa8f-a86785c37a84"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e58d371d-f475-4237-8c86-90ed4a37c9fc"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/77f277ab-ee98-49e8-8202-67e511d98741"/>
    <rdfs:label>fluvoxamine-duloxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/eae20dd4-cda7-423c-a395-89e24413b81d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/637e54bd-19c6-4e80-90b4-80ef0e8a8de9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e5d04476-161a-494d-b79d-0002915da362">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/d7db7cd1-10d3-48f8-b5d0-0719ae5b5d48"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a8c55db0-8f4b-4228-9509-b058611dab95">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/a51ddc17-5bea-4835-a849-b2e5fd7889be">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/b769d440-5e45-4f53-9a16-bffc36efad1a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/79d41f53-0892-40da-ac82-4212e7286d3d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/9cbfb2ff-e030-4456-89af-e0fbc858290f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/4b2d6a90-513f-454f-aa26-91d3cdf9d9a2">
    <rdfs:label>ketoconazole-P95 DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/1072610d-49cd-4531-b961-5fa1e0b1df0d">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/33ed0be1-bde0-4ac3-9cc0-d91364322969"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/11a60cde-0032-471c-a7e5-49bfd3f8b959">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d52e19c2-bc86-4ae7-bfe8-89ea78528a34"/>
    <rdfs:label>Celexa-metoprolol drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f26b510b-c598-4c0d-b1b7-c6f8e2a23058"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d7ef05d0-8ead-47b7-a6be-8639d4999daa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2d4ada36-3b11-456a-a118-b75fbf3296eb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a99ee8ed-db0b-49de-81cc-6caa96fcc430">
    <rdfs:label>citalopram-ketoconazole DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/05eff585-cd49-4aa1-8c6b-1827110f45a4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3b19c6d1-f905-4ab4-9a01-cbe3a946ddd6"/>
    <rdfs:label>clopidogrel-bupropion drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/331096fe-f890-412e-b863-1ad24ecf1682"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/cb94f89c-a961-4bed-bc88-a54d127a86df">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/055a76d0-b836-4ac1-a924-5f2559f03c69"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/68b8aa8d-f77c-4a5d-a571-1393f0c7f55a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/14bb62f7-3bd5-4613-85bc-b448e94d60be"/>
    <rdfs:label>ABILIFY-norfluoxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/42952752-b0d0-4df5-874f-93e4d1c26268">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/55b84808-f2fb-4125-bcae-cc8d6b30952f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/cbf984e6-d3cd-4558-8865-788e7d13723b"/>
    <rdfs:label>4 Fold </rdfs:label>
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/adedc586-969a-44bc-bc9a-3038cfb21cb9">
    <obo:OBI_0001937>500</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/c3243589-50c8-43ae-a88e-f35b915c9132"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/142fa3f4-4af5-48c3-a5f7-efade73dff0b">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/506c5994-51e1-464b-b1e5-1bec5947514c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/73b616de-5e6e-4f49-806d-5b28ccf3cb02">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/2d4ad5ed-47e7-4cbd-a7e1-901ed4efbf21"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/5e9f12e0-16ea-44a0-a011-bcadad3e53a2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/ae0162bd-a86b-4127-83f4-f0691220400f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/befa293c-0e6e-49c1-b7b9-356e39506b6b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/65858975-b081-41e5-91c4-df75be61d130"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/5b0f3b62-75a3-42b4-8561-d4f3a75d08b3">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/e7113972-bd0e-48f7-a0f8-40f844dc2bd8"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/0e0a6e10-0d06-40b9-af2e-6f6537cd8960"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b05524e8-ce4d-4cd4-908f-fcbeafae5985">
    <rdfs:label>ketoconazole-desvenlafaxine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/62b5f68f-fc57-4fe4-b007-17956f41fc19">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/875560b4-d291-4bb2-8c6b-d7de4ec48110">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/7bc67ebb-eaf8-4572-b162-7b9d84d4641f">
    <rdf:type rdf:resource="obo:RxNorm_81864"/>
    <rdfs:label>alitretinoin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7aaece25-fe1c-4542-8a54-a5d6731c3f65">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/8c453d91-8c0d-4011-aedb-5b79e716289e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/c250d668-dc3f-4a06-b8e2-9bb888fc4dff"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/2cad879e-2e77-4a96-b4e1-38d1a47ec65f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/bd396e9b-22b1-4f29-8406-72ad6d05b11a">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/80cb7f28-cd17-47f2-962b-72c7478dc9f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8ff71628-c008-4c40-be2a-2dd9826d6e2a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/0aecfeef-9a0f-4637-a0d3-9666163c3481">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/03f05038-6e65-45b7-86b4-39424632df2b">
    <rdfs:label>ketoconazole-eszopiclone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/e5298329-a5eb-4356-bbcb-2f85007d6517">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/fc0815cc-2f35-455f-ad35-815634c333d8"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/d0126dd0-0c76-422b-96a9-5bd86f8a440e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/3907d7ce-c089-47b3-a353-528a29fec829">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a06025a1-f057-4baa-acdd-255273348fb5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/1a1b1285-aca4-4df9-b4ff-1eef68af535a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/a3dd1296-4109-4968-a9ed-b9e2f6818caf"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/163ea7af-31d5-4749-ac0c-ef53c838070d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/9a8b1906-4dd0-4600-be00-4293984e03b1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e8b2e01e-02cd-4624-b081-2ae34af159b0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/120bbf69-07ea-424f-a7d3-72047c6c0789"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/d48a962d-2cb3-4e2a-a799-e6624fa4c69e">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/75e7a84b-bad1-4b0a-8219-a0aeebfdf35d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000109">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/5bef21a3-d9e4-475b-83e6-bbcac8eebd0c">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/2742be6e-257a-40da-ac5d-b721d7f476d5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e3a4ac5f-4448-4f54-aa0c-2305b2ede42c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/bee77236-ab9d-4281-bbd6-755d50a84edc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c1e1a24b-b321-4415-8f29-91f60be48109">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e4b04221-aba4-4314-bab9-d40419677bf8">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8ab32a83-8782-4209-baed-6d6989c3b1bf"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package halflife  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c5de43b5-bf51-4ec7-93cf-8b1e5ecccf8d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c1f14673-3325-4b6e-b3fa-2d888417f659">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/1836cbe0-bba9-48c4-ae71-7466fc17273a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/e805406a-0baa-4a41-b2d7-a66520195703"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/29c0c9e5-2736-4cc2-be6f-db978c36b11b">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ae0330ed-1e56-448f-90fd-7fe665782138">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/87128548-c1c4-44c4-8fb9-d63d30e84e10"/>
    <rdfs:label>carbamazepine-INVEGA drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e9d79918-3710-4610-9c70-218173813c45"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/1bf39b5b-a39b-4330-99b9-81f46d0bb603">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/c2f78b30-f73f-40d2-a74c-cbccdd17f16b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/940cc324-ce69-47e3-a009-14ccb573d389">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/853273e9-0e9c-4b88-ae0d-913064003cb9"/>
    <rdfs:label>819.2 Percent </rdfs:label>
    <obo:OBI_0001937>819.2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/2fb54560-9818-4675-8f83-d3cea421160c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/05423a2d-762d-4dd7-875b-17c7d0c96567"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/a89dfc31-30db-489a-85c9-7b6124c20c6d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c719c1e7-bc5b-4157-be07-802f8a26d9dd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/73868eca-1916-4fc5-862e-85f7b108acb0">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/c31b60cc-7ee0-44c0-af35-f0febb8e635f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/28befd66-1e14-45d3-896f-3e68bfbd15b7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/42411163-8194-4161-b254-e4ae8a1b347f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3f658572-3570-43c6-bb1b-f68ced773c5b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/72dd7db5-fc85-4b9b-9ad4-a1dfc04bf0c2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4b39aac7-f0dd-4a7a-a7a0-c1cc9a46d042"/>
    <rdfs:label>aspirin-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/2b26e403-392b-4cef-a81a-4f7653ee3ca5">
    <rdfs:label>theophylline-nefazodone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8e3fb958-8825-4369-901e-ba70a8ed02a7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e78a37af-ff3b-46a7-9713-cb4f3a95d7c1">
    <rdf:type rdf:resource="obo:RxNorm_2556"/>
    <rdfs:label>citalopram</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0c43c80a-3b8c-45b4-8134-1f7271f00adf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5cd5d7d3-8e4e-4137-bc79-097a9fefeb95">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7b571c1a-81ff-4ee4-a0c5-caa1d9886c8f"/>
    <rdfs:label>Fluoxetine-olanzapine drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/967b7996-37a0-45ee-96d5-6453771f4498"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c11da532-2169-4f8b-8762-bf53ec0a35f4">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/df7d25ee-4fde-4444-b9d4-f32683a1d082"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/558f41ea-c515-4d14-a4c2-e3dd55662823"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/64b54752-0479-497d-b151-2b84fe287b51">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/de8c60b1-778b-406c-aeec-fff62659718e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a32feef8-ce82-47e6-81d1-f3bc42bad29c">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0155e29d-d926-455c-b63a-7fceaae44b57">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fa646c6a-0601-4247-8b42-bea37c05de15"/>
    <rdfs:label>cimetidine-sertraline drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/53f33c9f-5dac-4112-ae99-132db071f006"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/59c9e6a3-468a-47f3-9648-fd4a08a57980">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/f027950e-2415-4226-9e96-87c4913b6671"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/6f567555-5ceb-4f87-8967-2b480caa13f4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/14e8ff3e-6c0f-49bf-8979-05b783b5a904">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/10e90b5f-312a-46e5-8496-57cce3680169"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/00ebab02-d14b-4959-9e8a-2a1ad5028281"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/8b33f7e9-be30-4954-90df-53cec0c0922a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/bd487d6e-7e4a-44a0-8814-1f2f3efd0eeb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/75aad9e1-b6d8-439f-b592-971b5f42011a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/169893d8-d8d8-4c16-9b25-a9bd1442d285"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5009edef-4ff3-4b26-b54d-60be4594b41d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c52a26f5-ecd4-40cc-8749-a85518a3fd12">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c31f453a-cee3-4fea-a0f5-0692f131645e"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/a7e22eda-96cf-4952-8c86-7a2190e0f7c6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/771c2ebe-8b7c-4a73-b922-e3613891b0db"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/61e55179-5266-42f1-806f-7b472bb4c0a9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c5bfc30e-b915-4cfe-8f48-1143b5c3cb35">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e4fd62e8-8eea-4e2c-ac6d-2bca93f38f1c"/>
    <rdfs:label>Cyclosporine-atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/02bac117-855e-44b6-8a7c-9bde2254dc87"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/db130446-2ac8-4f4f-8be8-081375980573">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/2118f914-8969-4e1a-8d71-edeb110d1497">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e36bbaf6-ff11-4dca-bd5e-ec5025205b85"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/880dd0eb-4a87-44ee-ae71-e72cf210ac75"/>
    <rdfs:label>pravastatin-NFV interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f32307b6-4ea5-4ba4-ada3-239b81d0b5cc">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/dcf5dccc-cb7c-445d-a6ac-3e18c3cead72"/>
    <rdfs:label>Lexapro-metoprolol drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b988274a-c409-4d1a-812d-04ec6a8d4e43"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/31694e6b-9309-470f-8bcc-f2a88efd25f6">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/fae99c72-5242-4bdb-b015-0f9bfcf7201f"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/74739309-e6a9-4bf4-a353-87819db744ec">
    <rdfs:label>paroxetine-P88 DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/30767c9e-082b-41d8-bcb5-d8d473c78aac">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a0aee07e-7e1f-4e80-88b6-7a45bcedb11f"/>
    <rdfs:label>ketoconazole-zolpidem drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/adbe356a-8786-4db2-8c5b-3a14c7b2088e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/01a1d6bf-aa2c-4f73-b759-5d6d3d6d3827">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0000053">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/21306e1e-54cd-47fa-a3c2-bd6c9320361d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/282312c2-802e-4c2f-9d92-c464a0694508"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/ab49f37f-97cd-48da-862f-6162cc40f776"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a0a73788-5b82-4aa0-b9a4-bf6573f0ddcb">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/24cb0c44-325e-4e69-b035-6eec001950de"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/eb1c833b-7e97-491e-8d6c-41586dc5a906"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/fbf23bc3-c9c2-432b-a00d-45b65c62d658"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a3cae62a-4ae7-4bf4-abe2-7be0620c0706">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/2c0c954b-73b7-4dff-9a3e-3a3ef34de67b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/d99d477a-d365-491e-82ca-6b490909412b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/76332168-6074-4c5d-81fe-e7492100a9a1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/98561723-032c-460f-b384-39093ec0b7f6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/f25d3706-6aac-4f81-8acb-7f5a50f9718e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/36c54fdd-1d7a-4db6-9b22-97d0e5388016"/>
    <rdfs:label>ABILIFY-paroxetine CR interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/6b5d22be-1472-446a-831c-a0a8de53360f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/33d8686c-80b1-4ca3-a3f2-08594800bfb4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/005af4b8-0d09-4a46-be58-f889f40247f1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/3a8b1aff-fa44-4d62-8d94-14732c5afe72"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/f56213ba-8305-4a1a-9371-a75e4ae244a6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/33310c79-7594-4a3d-afe5-1671086b8c73">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ab8e0b9e-4262-488f-afe2-8fe750b7f12b">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/079be0a3-a29c-49f4-bee6-3843561cc96f"/>
    <rdfs:label>70 UNK </rdfs:label>
    <obo:OBI_0001937>70</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/591457cc-229b-430c-9fa5-942e441f83ea">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/bf30665c-29b0-43f9-a65d-54d179263591">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/aaffddcb-0f38-4164-ae98-3556510ae431"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a45e66ef-8eef-497b-bce6-f619f0b4c901"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ae6723b4-cc46-449d-a821-59f52a5eb8b5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3a96758c-9036-41a1-96d4-19fab0751f36"/>
    <rdfs:label>cimetidine-zaleplon interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/7818b70a-23df-48bb-99c3-2e4cdede5eef">
    <rdfs:label>Lovastatin-verapamil DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/710b80b9-00aa-41d3-bb31-497b608e2500">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7f357b5b-5903-4d43-93ff-04725ecc843e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/7d0369d5-6d54-4d92-9075-2f0d6614f9cb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/fc6381e3-7c78-403c-9210-c8bee245b02b">
    <rdf:type rdf:resource="obo:RxNorm_861634"/>
    <rdfs:label>pitavastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e849c6cb-b060-4199-aab9-bf243f221dd3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/1898bb8f-0184-49ef-a8aa-3333e2d03faa"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/52cdc49f-ee7a-41e2-beaf-1d5f0735c5d7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/4e9ff750-ef8f-465b-9f66-d9c77ac231a9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/ca02fa31-b825-4c51-bcef-96d92af542bc">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/6ce883cf-b94e-4ee6-bb1c-9cab263f7955"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/78711f76-18f0-4c9b-b5be-485d2ba7fdb8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/3bd73386-f954-46c9-8048-a6f55de67999">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/cb2b5e29-4b70-4da6-8ed9-b932f5dcfec1"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/a179b573-1082-4ce2-994b-dcbaa9656e83"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/33784ee1-a283-47b2-b3ba-50b487dfb4bf">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/24907a55-efcb-490b-bfe1-8c3c55590431">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/42d8b22a-71ee-4e7b-8db0-3eba32e92ef5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b3333447-1b1d-4a80-965f-764fa02d2462">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/456a9c75-6974-402f-9fe1-c23410323310"/>
    <rdfs:label>nefazodone-digoxin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/58b32e72-b647-4e3b-9587-a74f5d092843"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/5ebd0223-ebbc-4b63-8bd2-9b293bf36a10">
    <rdf:type rdf:resource="obo:RxNorm_10438"/>
    <rdfs:label>theophylline</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1f90532b-7e2a-462b-92b7-097fb08926aa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/4525adbe-f22a-498e-901c-f4c331a38e88">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c65103ad-1c3a-447a-af65-ef4f48276461">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b6cd5b13-beb3-473c-8cb6-f571431136f9"/>
    <rdfs:label>53 Percent </rdfs:label>
    <obo:OBI_0001937>53</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7abb44d7-4695-429a-8d49-df19807b8de9">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/7515d6af-4f62-4433-88b4-b8b6c8ffbe1d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/eb71cc9d-5a25-4296-b241-6fcc3a08d27e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/f92fccd0-d644-4ecb-852a-f7f8b99348cc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0398e321-abc9-4e45-b78d-0b100c339c5e">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/9906d783-188f-4d37-b32e-2f5afae0f69f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/b8e00255-269f-421d-9006-514e3b51657a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/e0acd1d7-0dd5-4a21-ac57-8c3d4b2a640f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5d320d83-77f6-4f32-8c1d-3263c8c6ad65">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7f30c8f7-33cd-4198-b72f-745210bd83aa"/>
    <rdfs:label>60 Percent </rdfs:label>
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/0aef6892-5f18-4f57-b349-1a7a8829b5d4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7228c263-c99f-4266-aacd-dd4ab5fc4328"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9c845358-e737-47c6-909d-27a7848bfe15"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7cd7179f-5570-4527-9cf0-9e0c70a9399f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/77e45fd9-0575-472e-b142-32d9d214d86e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b38fe72b-6849-434b-8598-776df2475711"/>
    <rdfs:label>midazolam-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/afbbbf2e-4684-41c9-837a-2ee80b08bbae">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/882ce557-9540-4fbb-beb9-c859178869d9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/9b89a548-a0a5-4e6d-9ad3-2a1c0e5cfe68"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/b878e64f-e68e-43ff-8f0d-530cb0921a22"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/c3d8858b-ca2e-4f17-9c53-505de938e080">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/250e2852-775a-47e2-bb5d-387def3e26eb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6265ea3e-2701-42d9-8d37-0e36402de598">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e2bd8032-b0ca-4f6d-88ba-7561480e45b6"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/3339271e-6842-4456-99e8-f3c374971f28">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/05c5259c-1553-49ce-948a-7dcb6fc63d8b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/6d492afa-5702-4970-95e8-a8c819523da9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/2c88c377-26d2-4e68-93da-96347894e11f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d86fb4ea-d0d5-4b34-a9d2-f6ee20f4e877">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/72e047a0-b781-4acf-aaba-26a550c2f9b0">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4fcf2341-36e1-4d11-9ba6-73968313118a"/>
    <rdfs:label>22 Percent </rdfs:label>
    <obo:OBI_0001937>22</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ffdbb6f4-17d4-4edc-88c6-c409699103f3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ae5ca3c2-f976-40b1-bdf7-f077d2c53ddf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/476fadc3-11b2-4c72-b060-12c98723bf5c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/2f3c6205-2c58-496b-b774-a1e00208d586">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c849c276-1f74-4de4-b428-ad4f2836bd1f">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>Atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/2f3bb89d-1f03-4271-a94e-304ed3a828ed">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8b452737-bdab-4f06-baf2-7ae9b6268748">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/4b0cc8c4-41a9-43d8-bdcd-31ef1efd26b1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/b18e892d-5897-4d74-b3db-466cfbf1964a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/693bf65c-8dc4-4b70-aea6-30b6f872ad84">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6e4e3c0e-1ca4-4815-ad25-8b955d1a0272">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/6667577a-c0ba-403c-a310-a0a1002363cd">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/1f66711f-3f1c-4c67-9df8-3810746b03a2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/4aad5fab-deab-4708-8fda-3ab315e9c832"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/3dbe29e9-3afb-48b7-bf4e-cff5e8a01cef"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4a321250-6768-4f2e-b096-3c5756f2cb03">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/693bf65c-8dc4-4b70-aea6-30b6f872ad84"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/6ee0da9b-3ed1-4baf-8dd1-17d7a08ae1ce">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/1802526d-08e5-4f6d-9a74-b35f36fe222b">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/75dd6152-8b03-41a8-83be-85d1a363d9cd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/6b9e150b-fdac-44c7-a72f-12cf913513dc"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/d2129154-b28a-4d6c-977a-863700f1d355"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/92912033-59bc-4fc3-a68f-9abd5fd1a5c2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/405ce9fd-4e45-4fb2-aacf-feeacf90f946">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/930bfa8b-45af-4342-a1e7-3022857261b1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/c395defb-b003-43bb-8ecc-ebb86d9386f7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/8c235327-2365-4f9b-bb47-621f90b8112e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/34d56ab4-f5c0-48d3-9ef0-893a162fb97e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/4b0cc8c4-41a9-43d8-bdcd-31ef1efd26b1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/6d4d117e-facb-4ea6-8c8e-a6d96c461ebf">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/ac50b298-f726-49c0-ab5f-569a4cabd3a9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/f88d2a6b-cb55-4699-add4-ce5e60b29092">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/92e767a8-ef2f-4664-9822-43af5669d8e6"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/f3542bfe-459d-4871-a0e9-62e92d93f711"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/84d4a7a2-b5ed-4b6f-a74c-20b1738288e6">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/a1b6ab4a-9fce-4a92-9caa-4780daeb0b27"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2cfe0a6e-219d-4672-8161-d63b4512293b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5c63f7e5-f818-4012-be1b-9ac10f8b0665"/>
    <rdfs:label>bupropion-desipramine drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/550e15c4-af4f-4126-b30d-2a3590d68f77"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7cd71b6d-8c57-4d24-bcb0-aca775d8bcc8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1f004f07-e6a9-4411-961a-9e04f669b4e7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/26824e42-21e2-4c4e-9abc-5245757bb145">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8ac9fb6d-1617-4059-b327-83aeafca4cf5"/>
    <rdfs:label>190 Fold </rdfs:label>
    <obo:OBI_0001937>190</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ab3730c1-6640-48ae-aad0-a10318a39771">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/cf893ac2-33c8-423f-a41f-6eee6ea5f5e0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/f0b09a4e-e095-41c4-a48e-fe02cc57b68e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/bb59cd58-eb08-40af-926c-3a24218c9792">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/4657a765-74b4-4dfb-aef8-68bb271252c5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/f7e98c65-5ae9-4a42-9260-99a89c390d67"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/ddc5e254-7ac0-46dc-8742-10b5ede61fbb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2e72fdae-9625-49a3-946e-cf3cae5a2c98">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f325ada3-8410-417d-a50c-6abea1b87435"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/80b0dd80-8163-442a-b34c-a89fc370b3f9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/8b3a7bb2-572d-4d10-8713-7bb57fd83c44">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/0b7440e6-bc2a-4a8e-bddd-82a4f1d1513c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/81e121a7-b36c-4ea2-b46b-8f178db8a538"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/f4cbc596-820b-4400-9fb8-71286df22c1e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/4aad5fab-deab-4708-8fda-3ab315e9c832">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/636667fa-c882-4599-9ff1-f04677d81a80">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
    <rdfs:label>warfarin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a629cdd6-2ab6-426a-9cc2-050384ec8f72">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/a81fd31f-cb5f-440e-96d9-e9603b9df797"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/ab1e23ea-cce2-4909-a466-94785f6b9e05"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/56cd2e96-90ac-46e5-b780-8ae246dd231e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/bfe2d678-fdeb-4043-8998-b8cfb1fc4e2b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000312">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/9a301705-c045-488e-aed7-aa5a572e1c17">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/22b2e92d-0bd7-46fd-93f0-945678bc083b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/e96b0241-3d39-4ed0-8387-a5a99cef6977">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e05292d7-c485-4605-89af-f42fa57a3ee3">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/804e2a39-4a20-44b9-acb9-84f961b4de61"/>
    <rdfs:label>Cimetidine-Atorvastatin drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/41245714-b1e7-4b0f-8c75-f2f185c12d13"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4f8e8030-478e-4bdc-9b09-3a4a75e8a8ee">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/27616bb4-d4f7-44b3-8310-9b8cda5dc97e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/3f1733a7-e333-4741-837e-fddc293e1aed"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/095e8f32-a2ed-4644-9e80-8ad3bd42753f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/67a50874-a28f-4c71-a130-08e4f08c4b72"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/591670f5-ad55-45b8-88fd-49f0c22898c4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f13d09e4-80ed-49ee-92a8-b73198f1790c">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/427ea5ac-bd32-4d3d-b984-188c41c69704">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/ca02fa31-b825-4c51-bcef-96d92af542bc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/675078ab-7588-4e57-ba76-7af6235a706c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/55e60d89-75a1-47b4-b7f1-cacc227aa797"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3a8df0f8-cf0e-4ccd-bed2-52eef4bc3dd9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d98f30f3-9861-4e50-a367-2800282f5654">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/74f133d1-d57a-451e-8834-ab0a3ec4da5a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/86db9720-8c22-4feb-83d2-cb557e6902a9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/82b7f231-e5e8-4c1a-af0e-a5e615fd795e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/5f4aba44-b446-477a-bebf-1ba4fefa33b1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b69e243c-eb11-4f43-bfa9-374587acdd37">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9bda6a77-b67a-41ff-a263-97ed49e03e19">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/cc2c6cee-b91d-4601-8f66-0445da322e54"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5c7c1714-0dbc-4d32-a07f-ccb07cbf2a7f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/cb3e41b3-e631-46bf-8b99-0d033b7e72a6"/>
    <rdfs:label>fluvoxamine-N-desmethyldiazepam drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/87105ab7-6c3b-4f77-bf0a-c1bed69f15f2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/bee29656-08a6-402a-9fd9-4764269cb43d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/ed422d1c-0f56-4ac6-b33c-cb121460eee7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/478a90ae-026d-4eb7-8806-a2934d924785">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/fcb01e46-4869-4357-ad0b-be1a89baeb29"/>
    <rdfs:label>3-4 Fold </rdfs:label>
    <obo:OBI_0001937>3-4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/bd392960-215b-4abe-a177-3c0af7711eae">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/3346f9b1-50a2-4af9-91a9-f53f565909f2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/5e901159-15e9-4ac9-a9db-2e4cddddd09e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e9c28e72-9ede-49ad-81b1-2fb008101347">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/67fefc6a-0dec-46ae-ae3c-42063772e0c2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/69520cb0-869d-4189-a6cc-7bb30184bb6d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/444810b6-7359-4db2-b42b-f9f3656c564d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/55717ba1-f671-4539-9868-3084fa2ddf76"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b8402365-8933-43f4-ad67-20672b22171a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b5527abb-d924-4b3f-a429-8f4bbdf0c7b9">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7132773b-cc87-48e9-a408-8bbfc90ed6ee"/>
    <rdfs:label>up to 50 Fold </rdfs:label>
    <obo:OBI_0001937>up to 50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/8b948550-b03f-469a-818f-aa45165ce4dd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/9b856cf3-9371-4f9f-8832-3c1a9d5ca5a1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e7fbf30c-4b2f-42fe-8fb0-28f9567d0226"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/5125b280-7fe1-4432-bd58-e63834949de3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/4fa28bc8-3c1c-41cd-9877-c8067cf22b9b">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/32dab344-191c-441f-be2c-9933ea52cd1f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/0cd03a0b-6c20-48c8-942a-9a635b56f25f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/ed10f07f-2eb9-4e49-a378-ddf89878ceed"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/44a1e1ba-9265-462e-a38f-087f7bbb4484">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/54308f05-d0f5-4b02-b7d9-533d2b9b244c"/>
    <rdfs:label>nefazodone-triazolam drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/dfd8ff03-6142-4b14-a0a8-62b7de039f4a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/53bac7f4-bb8f-4465-8276-7e22c8f3ceeb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e1b18179-fdbd-40fb-9c61-a642d0ebf762">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/6d6b6670-ee99-4a54-b4b0-5852ab878965"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/8da06815-83f1-4fea-a29e-a1eb02fae04b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/14c78d13-b21f-4b84-b52e-f06f35ed7bf4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/773d2d80-f410-4607-8288-da571026f513">
    <rdfs:label>ketoconazole-alitretinoin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/716bf61f-a049-4825-a703-6b2a398e88ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b2e429bc-956c-41c6-ad1b-792514cf169a">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1beeede7-3462-4db9-9bef-2c838e6c160d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/27616bb4-d4f7-44b3-8310-9b8cda5dc97e">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/7f89f01c-31d5-4df6-9262-7ad93463c857"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/6e2d7942-1cb6-4b8e-9811-e4cbcc4c704e"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/11e14d20-d442-4944-b120-7721887d5215"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/9c9e8b41-227a-4dd5-8b84-dd9499bff5cd">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/781ee796-5d51-4b2b-b0fe-f0a5fb390be0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9ac6b286-06f1-4098-9ea5-1fc32af71cf5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b7da1eb4-9c6b-4bc7-bcf3-e19dca6e2284">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0c4d4f12-22c1-4b93-b16c-0aea152baf31">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/ccf2c937-66ab-4bab-938e-5ba2623c6822">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9be1687e-219d-4110-b634-0f067de4b27d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1466d0b8-422d-48b5-a8e1-bf5709930954">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/f56213ba-8305-4a1a-9371-a75e4ae244a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/988716d8-e233-409a-ac1a-bf8e27f73122">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/58d5949d-1c75-43b4-b78b-af31ef27fa1f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c6ea8ffb-7bd9-49d1-b420-941333603a31"/>
    <rdfs:label>35 Percent </rdfs:label>
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/ae78234b-d525-4229-9429-45784ac8c1a0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ea27c5ba-086d-4237-91d1-9466729f50ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/608fbc8e-ac45-469b-9b36-f65118aef544">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/afcd4d64-b6dd-4981-804b-a7c5c90eaffe"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/105a2c1f-1a2e-4854-9fb3-7ab8ec66f124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/4916cbd0-9e4e-4e8b-86c4-fa986b30db1f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/5aeb9d13-7ac2-4e3d-86e0-1389e37b5ceb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7ab14a57-3c67-4be0-b928-dfc1dd2a46c3">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/43f5521e-8ffc-4df7-ac67-45c057c4ae49"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/ef46e6df-b82a-4b28-b012-b7b685d036ac"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/986d82d6-60ea-43fc-948a-61b35bfe1146"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c31285f4-f922-4bfc-96c7-6eb50a4a7070">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/225e95e2-f59c-4ccb-9674-97186e08a9f9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/6e313c31-c18f-4335-990a-1e9c1fe9e442">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/5beb7bc7-a653-4fbf-8f04-38c926df999d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3ec992a4-2277-4ba3-8951-34baec319fe0">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/fb46fccc-cf39-4bf3-99b7-27c25980ce03"/>
    <rdfs:label>14 Percent </rdfs:label>
    <obo:OBI_0001937>14</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/93dc8cc0-b2ea-4ce8-94f7-d5fbb99e6c02">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/fd2d074a-4a68-4050-82d0-3b3c77d95f8b"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/08279e00-2560-4256-b357-81602fba8520">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d7b78dab-d4f6-4cb5-aeab-b6eedc5eaf73">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/abf53425-ed16-4263-ab6e-defa9be92790">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/e154ed6b-74d3-4936-a7cc-88392a7141d5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d8606589-1cae-4839-b7ee-923d54f9f5a4">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/918b7a68-edde-4b00-ab44-962c1fc51a39">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7fb1e4d6-3e1f-49bf-95dd-0908b226f988"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/7653bd22-72a1-4a14-a28b-f32c28ab7243"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7c256de4-350b-4c3e-a04c-ecfa984c7f00">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/931571b4-c5bd-4f7b-a5b7-b0a900726659">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/47b68633-bad5-4d94-9288-c1c6f1955f39">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/460d2933-e601-4224-98f7-b2794d43cbfd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/343ed9c3-3007-4e61-9d1b-183820d80811"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/dcf6cfff-5dac-4f09-9479-a863886e25d9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/258ae4f5-1742-4986-bb44-44d7cad52aea">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d5ac4a6b-3d44-4150-ac1f-f5bb46f1885f"/>
    <rdfs:label>517 Percent </rdfs:label>
    <obo:OBI_0001937>517</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/27e60676-fec3-4f6e-bad9-8c889c213b2e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/405ce9fd-4e45-4fb2-aacf-feeacf90f946"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/fa1936cd-50a0-447a-9aac-e4f784f7a2ee"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8f3fd061-07a1-46f3-9789-ca5b08130014">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/908e1945-037e-4f71-a0b6-ed6f6ddf17cf">
    <rdfs:label>desvenlafaxine-midazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/98402913-3fa8-42b7-a385-ed52a835e227">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a609868a-88a5-406f-a5b9-2e8f8f67d55a"/>
    <rdfs:label>atorvastatin-aliskiren drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8bf90a60-4adf-4f39-8c05-1e83d3c61efb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/16955c7e-adc9-4f34-9859-f20be713b3f7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ff4d6a47-36c7-4998-9e4a-0988eb18a7cb"/>
    <rdfs:label>30 Percent </rdfs:label>
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/df34591d-c627-4682-9ecc-c57854bf12d9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8ab32a83-8782-4209-baed-6d6989c3b1bf"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/fd05f8b1-d038-40f4-a473-693438f5feac"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/3566f2ab-610c-4dad-a0d2-6846bc9b4105">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/acded934-5d0f-4902-ba21-fa100cc7757a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/58ae41c7-f6df-4032-900a-1e45ea5d6ff7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e5c4f34c-a290-465e-bb36-a773a2410e52">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/8d1a8a34-50e7-4ab0-bd54-4df67cc03f05">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/c190ce00-1dfc-417f-a463-8bd38d17d59f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/1072610d-49cd-4531-b961-5fa1e0b1df0d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/001cc46e-83e3-4078-a031-0c48ec8a9b6f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1313388b-71e8-4acc-890d-b822694c68a7">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/00d03422-b020-4148-a696-67fd0dc62018"/>
    <rdfs:label>Fluvoxamine-sulforidazine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/848c2b50-3da9-4db7-8ebf-4a8c30f28e16"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6138deb0-0732-469b-866e-07cd3219fd5c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/79a6c176-8cea-42d8-94d4-3c1e90732242">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/9e3cb801-0a52-4ce0-8d88-232bdcca8eaf"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/e9c28e72-9ede-49ad-81b1-2fb008101347"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/63e9ec44-a84a-437e-b231-23491467b949">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/35fec6aa-a90b-4177-9f55-ac18333ced93">
    <rdf:type rdf:resource="obo:RxNorm_861634"/>
    <rdfs:label>pitavastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d6fecf9d-43fd-4d6f-b11e-8c46e89d218d">
    <rdf:type rdf:resource="obo:MeSH_D000068882"/>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8f07082d-04cd-4962-aeaa-9dbd5e988fc8">
    <rdf:type rdf:resource="obo:RxNorm_6960"/>
    <rdfs:label>Midazolam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/a5e54e85-ac61-4d6d-9f05-96c9c401c1a2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/fa1152ee-b7cb-4c0a-993f-5c45a0cd9e5f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/6f1ba573-b666-4874-b28a-8682dde55e9d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/e703c6e3-4d6f-43d4-82ed-bc6ace7b9bfe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/084ba850-8ab0-4816-bee3-30aa95023084">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/bb09364f-2ff3-4c66-affb-605756b30c2b"/>
    <rdfs:label>20 Fold </rdfs:label>
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/c2a176ce-03b7-43f5-83bc-7a7b3686cc49">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/8b482f34-1e1e-4a49-ae0f-10012cd3fd54">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/3e500173-a007-4f29-8a66-c454ba473307"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/9569560e-87c9-47ec-9bef-7b85ed653a8e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ca1dbf51-6374-4304-a8ae-60af41fea7f7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d1d77612-115d-4635-92e2-578512f3951c"/>
    <rdfs:label>72 Percent </rdfs:label>
    <obo:OBI_0001937>72</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/3eb02e69-c155-4c4d-9ef8-dcc742695c46">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/008e9bff-fafd-4864-9e10-3ed5bc01514b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/edeb7fce-4539-40b7-9537-f8cdf4b575db"/>
    <rdfs:label>vildagliptin-simvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d5fb4dff-ee5a-4fb0-81b4-b3010a72ba99">
    <rdfs:label>citalopram-ketoconazole DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/550941ec-2bd6-48d4-a58e-acea8678345e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/126ba9e8-4870-410f-a191-0f9bf2d631c6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/cce9dd43-85e5-4a65-ae9e-8e97eece2bb4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/da97e678-0045-48dd-96fd-5175345d3dd1">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/767b3c7c-ca8f-4726-82b7-6cb8822deacb"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/831a01ff-87c0-4443-bff1-fbdf89fc04e2"/>
    <rdfs:label>fimasartan-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/082a617f-8791-435c-8fbe-85df8c3fdda6">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/c3d8858b-ca2e-4f17-9c53-505de938e080"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/37bac232-3b65-4998-a197-6775812e7df6">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/186553ff-c871-49cf-b83c-e6d313cf5a2f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6014dae3-acae-432c-84a6-39bafe71da8c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e6021b09-ee72-4194-bfd4-427e74d32447">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e997b0ef-ee57-4d16-90e5-a959df9ae656"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/d79d4cda-51c9-47fa-adad-770f30b0bb71"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1dd8eda7-a21b-4f74-8d45-52649a90e4f9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/f98eca25-f7ae-4e4e-a6e1-66cc3e2d7732">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/fc078c70-de97-42b8-a55e-991984e09f50"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/eafbf792-834c-4578-801f-d839c6174db1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/38279c11-c2e4-4ddb-b352-d674f910fa37">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/615c10bd-dbe5-4f87-be65-84d75eb92b7b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/fa2089a0-be0e-4516-a465-39f2c865aab1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/c0a0bc47-1c21-48d7-b0b9-54ca8adb47be">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/65481a30-a8c0-4209-b408-79774874f305"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/d959fce5-0d27-4f61-82d8-e314108b8b8d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/f3a5e649-6efe-4a0d-b7a3-cca83ae29ec5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/72159c5c-a110-4945-9400-6d212beaed62">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/4ccf2a5c-c72f-4fae-a704-94235e6482b9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/ee4406de-5aea-4dbd-bbb9-42d81565c1f2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/15e984a8-9b8d-4a4a-a60f-90e6c05ea424">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/78943d45-a025-4e43-8d4c-dea7cb2e04d8">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6793035e-cd24-41fb-84cf-67cb4cf75087"/>
    <rdfs:label>3-4 Fold </rdfs:label>
    <obo:OBI_0001937>3-4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/3ad0ee58-4a62-4126-b4d6-661c00634943">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/9e49c063-17c0-4f76-979f-9e4b7e7f5f15">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/1b370765-372c-4b0e-bad1-813d440b4482"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/a06025a1-f057-4baa-acdd-255273348fb5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/86dda032-8a39-4a25-bf29-b724542990ea">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/219b1fe3-3b08-4a6b-96e5-9ee784c5dc82"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/a4bae449-9b02-4175-904f-2df40aaf34e2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3385fe75-0dff-435a-a828-c1c21d4f02f7">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/fbd177a7-1667-4e6a-a32f-948439b56a97"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000576">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a6cdba51-9afa-40e9-bb24-b57aa653dc72">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/e8d422ee-0881-4091-98f5-a37706909aeb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/77fd8535-9d9d-46c4-9d90-1777e4655ef7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/65fd1642-b162-4db7-a8e1-4210affe30c7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/29ca3fa5-2f3c-49ca-9ca5-4c1ac3f184b7">
    <obo:OBI_0001937>300</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/a7deb1bf-feb5-4ecd-a73d-fb3d160decba"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a65b96ce-136d-4e75-9324-e4181517a234">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/19d17d70-631d-4f4a-984b-977269479476">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/498f1ae5-182b-4213-a64e-4506a8097252"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/869e5609-2ffb-4408-be60-edc53a30683a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/ee15d4c9-38fe-4aea-9f8c-bbea0fee5f41"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/c9f57813-5c2d-4639-939b-de65a058c2cd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/38963665-df49-4c9e-8818-fe76160faff1">
    <rdf:type rdf:resource="obo:RxNorm_683693"/>
    <rdfs:label>desvenlafaxine succinate</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/b576f159-205c-4bf5-8046-e4e3ea3c9a7e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/f65dd46b-e1de-4134-b620-188913193f11"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/740ee1fc-3b03-4841-815c-09244a4d2c6b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/8545ee95-8658-4457-be7a-6fc821ab3b44">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a8e1f927-d764-4dcb-a137-05c4959fd173"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/3a23ff60-bcb9-4b5d-b041-3bedba953b0f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b9788ddf-4886-483c-9889-3370f62d8a19">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
    <rdfs:label>desipramine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/dd2370b3-6c6f-42bb-84ae-a4bc8ce5cdfe">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/eefd92ad-baca-4aa0-9ee1-891902da4f0f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/5552262e-71ff-496f-abe1-149c70ddd57d"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/b5bd434e-4771-4943-9120-f70cc289ced1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/7ad2fd93-6037-495b-8a66-38d42b956ea1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3c75e4d3-4281-46ba-a7b2-63201b3304d1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/83c46cba-197e-4a91-9e97-18bc749c6d6a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/86db9720-8c22-4feb-83d2-cb557e6902a9"/>
    <rdfs:label>16 Percent </rdfs:label>
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/3489e48d-8540-42b2-a6eb-110570f5e1c0">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/5e7fb8dd-7a90-4e13-bd52-1bb2c2f08533"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b17bddee-d81e-4a45-80a2-cd3df1da8545">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/0c88304a-bd20-419b-8152-ecdbc946d1ad">
    <rdf:type rdf:resource="obo:RxNorm_2541"/>
    <rdfs:label>cimetidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/2264e934-958e-4ca6-ac78-df592758360a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/06d051b8-7008-4908-a91a-7c141e301a24"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/aae17687-87a4-4ee7-b2c1-f78ed0e133d0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f28549e6-6efe-438d-a5c3-51078b79d797">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1f8c8148-2960-437b-aff2-2440e8bdf26b"/>
    <rdfs:label>48 Percent </rdfs:label>
    <obo:OBI_0001937>48</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/93a7f36f-fb2a-43df-99db-d7cca0b42ac2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/530d49e8-7970-4ea9-a02c-4decff16e95d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ee33d208-c3c5-4b1e-bf35-989759cabe5a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/16154274-93a4-4492-929e-2c934388d1e6"/>
    <rdfs:label>fluvoxamine maleate-propranolol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ee4ca826-6387-46ed-b58a-0d44e722ce30">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f5f7f259-a039-4f3b-bcc1-5b199b556d62"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/4d664e9c-c0ec-476b-afe5-73fc60310e8d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/5ed31c36-09d1-491e-a031-5d30f343ceff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/cf80b867-0403-4494-852a-f970b5efa04c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/3b72e6b9-b441-42cd-8202-19076e903f63">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7abb44d7-4695-429a-8d49-df19807b8de9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/947a2b1b-545c-4952-a269-10ba78aa60cf"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/73355ba1-ae7c-4a71-9516-0e760471902c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/c8795b37-8186-42a8-a8fb-ed04d0a942a7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/ac00624f-6db7-4e41-8dac-22a0a3405c08"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/97a8b9b8-02e6-475d-8775-a13eb15f88be">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/fab26f6f-6707-4934-a202-477cc494e439">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/7fb2df72-8fe1-4eae-853b-44f58e0459a2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/b36e9916-bdd4-4342-87fc-7f39c19671ae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b4df2182-9d79-4864-92aa-18c7c019ae2b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4ca49225-35c1-4a02-8ecb-9a48b1036603">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8664dca2-9e96-45f0-abbc-c985debff92d"/>
    <rdfs:label>12 Percent </rdfs:label>
    <obo:OBI_0001937>12</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/cae55823-d22f-400a-88a4-e0d2d1681c7f">
    <rdf:type rdf:resource="obo:RxNorm_17767"/>
    <rdfs:label>amlodipine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d4b6cc8f-c54c-4ff9-a67d-9ba4dad7122f">
    <rdfs:label>fluvoxamine-ramelteon DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5fa1defa-2287-4923-90f2-c07fa60e6c05">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/9c785a69-5943-4bae-a467-a71d58db9dbd"/>
    <rdfs:label>unchanged UNK </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/aa973d4d-c8b1-4ffc-a359-a23ce7474078">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/bd6c7567-2e4d-41df-8b3d-2781a19109cf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/87373443-3dd4-4364-b172-a0871070c319">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/49d8aabb-2e59-469d-989b-f6c74350c103">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/cd128c5c-4017-4379-adc3-66b8e546218a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/d3d682bb-9bc4-40a8-8204-6014e025be7d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/19a08913-e679-4818-acf9-49379a7ea062">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d2514dc4-1162-4775-96d2-e3e9f4a5dfe3">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/fdb0f8ea-5ba9-4518-ad4d-b6e9b2521106"/>
    <rdfs:label>149 Percent </rdfs:label>
    <obo:OBI_0001937>149</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/593b2f74-e3f9-4f40-b32f-e06ccfb55b09">
    <rdf:type rdf:resource="obo:RxNorm_6472"/>
    <rdfs:label>Lovastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/f03b2979-df65-42c9-8141-7deb1cd3374e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/33bbd116-9d97-4cb2-a038-1eb4fd2fb58e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1f7a3342-1101-45ab-b89b-e5da792b9342">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/0a8f5753-1c65-486f-bf33-f408fe7ffee3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2042a739-a3ba-4c7b-b5fa-6a5a635967f2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/264b5c5f-b38d-41b8-91c9-fc7b3eb7659c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/18c38cf0-a4c0-45d1-a102-d1171291f400"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c1e57621-bfd2-4096-b11f-8e5a87cf9cd7"/>
    <rdfs:label>ticlopidine-bupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/7925e893-775c-43d6-a7ce-7e9c9f5664b0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/424183ce-d988-4916-a726-a33692043557"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/ac45c3e0-23f4-40db-9a62-30f3391c5a78"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/fd616104-35d5-4a1c-ad35-3f41696b3211">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/6df8ebe7-b8e3-43e6-af3a-323c4aa3ca8c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/2eea72c3-b927-45b0-92ca-6393e2528d92"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/29dc998f-2258-4e65-b8ec-223547efa028"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/7a8d4dc9-2a50-43a8-950c-077084fec657">
    <rdf:type rdf:resource="obo:RxNorm_114289"/>
    <rdfs:label>indinavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e47732ff-b283-4342-801b-47cc4a967f6b">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/17d99a9e-d76a-41ef-9650-ecce4fa48950"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/c9b878b9-ce63-4fa6-be31-f6320de1f5d5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ab357cc4-9e5c-4c05-9363-b48ef1039998">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/422f3177-79c0-47ed-a794-97010729e98d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b7101a9f-feee-4478-928a-2b21b74dc0ec">
    <rdfs:label>carbamazepine-mirtazapine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/ab8bf8e2-0885-4635-a0dc-ff179a29e218">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/47987236-48bc-4786-b613-0e8545ce9b45"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/089d85fb-e0e5-48de-a02a-e824bb5cc766">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
    <rdfs:label>carbamazepine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/be0d6d03-26ef-4cf3-a501-5caaf8c98a0d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/9b25a931-a0d5-4ef5-bab7-1c78109ca540">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/19198245-6b81-4505-a4e4-48a2e8aa665d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/f1cb62cd-1b99-4962-bb85-b265a398bc62"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b1bf34c6-c839-462a-8842-099655d66014"/>
    <rdfs:label>fluoxetine-triazole-dione interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ed5ea58c-6d73-4cac-b509-2203d8dfb034">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/13a2f1f0-66e6-4f61-8eb6-5438e4194f8a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/69f26869-1103-470b-8032-993dc591f6e4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0861678d-3c7f-4282-b5a4-ae1de2b18af9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/db4ee669-2747-4859-abc3-8240a664f99d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f2d916e8-554b-4d15-8e78-06d03267f077"/>
    <rdfs:label>rivaroxaban-midazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/9030e004-3f55-4217-b700-83c9eedff7e1">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/1b05b3f2-dd8f-488e-93c1-54b42f2a63f8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/50874ad2-9478-4e75-8515-72896004837a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/6e373d97-b390-496d-9632-f229ca2a699b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/c470ef63-4291-4dbf-8914-d1a874c19314">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/3339271e-6842-4456-99e8-f3c374971f28"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/bff38d7a-974f-432f-8114-08554c594a62"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/96d9e6cc-fdb3-4421-a5a6-2226bc0b7766"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/68e29b5e-9f3f-4b60-b1d5-c40c0da9a131">
    <rdf:type rdf:resource="obo:RxNorm_1116632"/>
    <rdfs:label>ticagrelor</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/7d6d5cb1-c231-4d0c-a496-21cae44f777e">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e2f310eb-bdf6-4d4f-9734-f3a956354296">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/456a9c75-6974-402f-9fe1-c23410323310"/>
    <rdfs:label>nefazodone-digoxin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/fd375bba-7009-4509-a2b2-d4976af3a94d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/0279bb12-2f69-45a4-95ba-9a898e1ff91e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/50e58fce-b276-4911-866e-bed6e46f88cd">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5fe050ea-4fb7-4016-8969-17f9f40be797"/>
    <rdfs:label>fluconazole-rivaroxaban drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e5f119de-c4f6-4466-8a91-d0ef35652335"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/53f33c9f-5dac-4112-ae99-132db071f006">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ed1bd1b2-5b5d-48c3-b045-3c223a35cc2d"/>
    <rdfs:label>24 Percent </rdfs:label>
    <obo:OBI_0001937>24</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/5f80426b-cf8b-4203-a4ab-26d8f534bd41">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/52ff3958-513a-452f-afa7-6921067fd2c0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/30953b5e-13d4-45e6-a085-4a76bbc648e7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/04e259b8-1b98-4eb5-a9d7-bb144e0714e2">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/759ac690-19f8-4367-9f9e-ec7ed5182852">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/c8b3e1ce-02b1-420e-a2d0-b10e6520e0b9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/97974c0a-5fd4-4e4f-a155-8fe29bd4cc26"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/dd8e55e8-42e9-4efb-b7ea-aa3bb5e9e099">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/c9d3b5cf-37c4-4529-b1b1-c7297308b43e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/ccdbdbbc-205a-466b-9a3d-bba3023aca98"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/bde0fd8c-0773-465e-89a7-8ecc3d66ee9c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/13d2d17b-d04b-481a-b78b-1684899ca654"/>
    <rdfs:label>1.5 Fold </rdfs:label>
    <obo:OBI_0001937>1.5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/624a6860-a455-4b0e-ab2e-58f67ab2ddce">
    <rdf:type rdf:resource="obo:RxNorm_10767"/>
    <rdfs:label>triazolam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/8696cec6-ef4f-4794-a3ff-355394836d75">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/186553ff-c871-49cf-b83c-e6d313cf5a2f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a77bb937-29e5-4fde-ab05-b713885424eb"/>
    <rdfs:label>0.84 Fold </rdfs:label>
    <obo:OBI_0001937>0.84</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b65793b6-2847-4856-837b-342d6a763cd0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/8aeec942-1b2a-4bbd-905d-14a28c051d1f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a27e3ce2-dac9-47e9-84dc-fd4109bbf986">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5009edef-4ff3-4b26-b54d-60be4594b41d"/>
    <rdfs:label>66 Percent </rdfs:label>
    <obo:OBI_0001937>66</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/49d1aa75-40df-4e19-bf9e-431113a5e4a5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0dd1b103-bd11-44e6-9810-3c21718dac28">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/dd8e55e8-42e9-4efb-b7ea-aa3bb5e9e099"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/435e6a5e-602e-45e5-92e4-dcbf4bd24873"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/18d184dc-620a-4047-9008-bc8d8c861aab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/b24f89be-186c-43f7-92bf-4733bb891437">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
    <rdfs:label>fluoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/14bb62f7-3bd5-4613-85bc-b448e94d60be">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f012d1b3-563a-49ff-ad8c-fa8b3b9d5631"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/1f7a3342-1101-45ab-b89b-e5da792b9342"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e29a97d9-8db3-49bb-8c26-040e6ad2dc36">
    <rdf:type rdf:resource="obo:RxNorm_35636"/>
    <rdfs:label>risperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d28a3711-82c8-4df1-89d7-6dac460d5459">
    <rdf:type rdf:resource="obo:RxNorm_11170"/>
    <rdfs:label>verapamil</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/8ef91744-3c76-48d0-8424-ed3a32e212cc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e4048013-7ab0-4508-ab0e-45bc69537f34">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/73aaf886-c78e-4ffc-b4dd-ece498c62d9e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/187995dc-0475-4623-b506-305fe354f725">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/656e708f-02cd-4446-b106-22cee303336c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/961fc150-a4c3-459e-abd9-5caec0e3a585"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/f6ea9ba8-2b77-4f80-b7a5-6ad8518ee985"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/b88c4d20-d525-41af-9d30-bfc12f2d2b48">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fb9d14ba-7b3a-44f0-8882-263ad29b11ed">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ea84c43e-f141-4f0d-a1c9-5b3c5dcb2a0f"/>
    <rdfs:label>12 Fold </rdfs:label>
    <obo:OBI_0001937>12</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/947a2b1b-545c-4952-a269-10ba78aa60cf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/a985d94f-1761-44e5-b591-395878d331d0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1bb34941-3a48-4a66-abb6-3a583e8c6ef2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/dafc125f-8acc-4d74-8f89-ca1d49b8f2de">
    <rdf:type rdf:resource="obo:RxNorm_301542"/>
    <rdfs:label>Rosuvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/f0e4c96a-638b-4e90-810a-d7aafd9ce9a7">
    <rdfs:label>ritonavir-hydroxybupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/dd2e718d-ce2f-4afc-bfd1-1d182cc5cb38">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/ae7272f9-c58b-474b-8eff-d97dc6b0c439"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/6aad7248-0308-4754-8a1a-0fa675a54b30"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/9cbf2649-b49e-4b60-9e52-617264d16216">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/eafbf792-834c-4578-801f-d839c6174db1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/875a9204-a973-42fe-8dd1-4e3b849893ec">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0f909854-f862-45b5-96b2-45a3a1060813"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/0cf501bd-6e22-4ca3-9d4a-f62460e41fc9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6d0a4ef6-af65-4c9a-91fc-2cbd3c9ec1fe">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/efb8d2b0-9dca-42e9-84c2-157f5b47512b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/b598b10f-40ab-4713-9c0d-da6145d3e5f6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/88e5e80c-5e72-4e4d-b796-473b46fdf743">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4fdfd259-f9c9-464b-8aa4-4d3199b27288">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/734a7d84-40bd-49ba-8867-5280b8ba2937"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/9c2381e2-d073-4d09-bd70-36c5b6c6ac9d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/a281ef46-8121-49e7-8822-7ee41c8c2abc"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/5c251253-d0dd-4422-b5d8-7b05f19f5101"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/8144e431-bdbc-4c4e-adff-48fcf913a113">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/638ef7e9-a519-4a34-9cc8-d6bf0aa21cef"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/ed1f7717-0971-4956-ae99-2d1347cf2c32"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4c9e06ac-bd83-4ca8-a25a-e449be4169c2">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b8a1d37e-398c-48b9-9af0-c875985e14c5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/976eef19-af50-4a8c-a915-9046e17cde79">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e2d6ef7d-f3af-4087-a315-93a18f828442"/>
    <rdfs:label>erythromycin-zaleplon drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d9411ec5-d158-4861-ae97-9fcd5b1aca37"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/cbba6fd1-d519-405f-99db-44c7839be42e">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/ac5a53d8-810d-48e6-9ea7-0183d4aba54a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/1bbc41a6-0674-49c2-af5a-557b1bcf14c1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a1f92023-2205-49ad-90ae-47d17ac1e8cc">
    <rdfs:label>fluvoxamine maleate-alprazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/3bc0042c-f67a-48c4-8bd0-225c2488ebff">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/60d6fff7-7c9f-467e-a8ea-19f4431b0c94"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/23eed5cd-522b-42e1-a06c-f2ec68fa9645"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/e179a2c0-4353-46f5-ad45-79c657342011"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/d5c0bb41-18d8-4e4a-8f70-661217aff29c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/7c8d4e1c-7ebf-441c-a9be-f9ab164272de">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/85b81c36-73a5-43ba-9f75-5c6251cbe6d5"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/9b7143d4-62dc-44d7-95c3-7d290a57162c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2aee3570-db0d-4451-ae11-8997521e14bb">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e2083a0d-0d25-40c7-b6a4-741d5ff34b36"/>
    <rdfs:label>35 Percent </rdfs:label>
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b32e4b59-ef86-4a75-8abb-9a5f5a310ff4">
    <rdf:type rdf:resource="obo:MeSH_C102211"/>
    <rdfs:label>P88</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/80cc89ea-305d-4427-a62b-9f4a55e4a47e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9714cd78-f759-4ad1-85bb-3a4b3f587379"/>
    <rdfs:label>Efavirenz-Atorvastatin drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b8112419-680c-49a3-a96d-a1260c2db47f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ce54f0e1-f6ad-4dee-94da-ce62ffdb29cb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/0ef3ef5d-5963-40c1-b684-8eb3ae9b1709">
    <rdfs:label>Fosamprenavir-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ea5cba39-6076-4428-b471-d5f11719fea0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/753db53e-0406-4a9f-a79f-49607a520b7f">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b949fe0c-48e3-4ebc-a035-3ea8d242f4bc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/4ec233d5-1d6b-4eca-ab65-d10a7f8acc83">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/d23c0de0-c28f-4744-a0d8-cbef49e081bf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/f65dd46b-e1de-4134-b620-188913193f11">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/09cbd935-682f-444a-9eb2-01fb1b9dcaa4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/19223920-2898-4e1c-8bcc-cc08d0cc5209">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/b8393792-2f3d-4957-86c4-ccdf7c4b7e4b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/9e6ea081-094d-4f5b-84c2-4768c4237296">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/5af816bc-c928-46de-9953-07e782969862"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ee84993f-40a5-4dfd-903c-e666fbd0fe9f"/>
    <rdfs:label>Rifampin-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/2cad879e-2e77-4a96-b4e1-38d1a47ec65f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/9e0293f4-e049-4a24-bac1-a255720d9fb8"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/f55a250a-1136-4fe5-8e5f-72179dffdd04"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d3742a7d-fcae-4371-8ba7-5be56c3e7fe1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ce832e81-d2e9-4d30-9b20-75572a03cc1c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/aea51f7b-0b58-46f8-9603-ef5808c241b5">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/86ce23ae-fd19-4ddd-aef6-665c818684b9"/>
    <rdfs:label>32 Percent </rdfs:label>
    <obo:OBI_0001937>32</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/e5389509-61aa-466d-9470-e79f1011e015">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/94818be6-6048-4782-bf72-37fee8bcac90">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8ce2bb60-b4ad-4738-ae78-e48358bc32ac">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a508b67a-31b7-46a9-be49-442670a394c3">
    <obo:OBI_0001937>160</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f233df73-3efc-48b3-aeed-a0b72bba09f5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/091dff4e-e0bd-49ce-8a13-8ad80f8953dc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/95b832de-cd23-40bd-8a92-8a9389fabc52">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/69e5f6ff-499e-487d-bb5c-5da0d24e4f7f">
    <rdf:type rdf:resource="obo:RxNorm_42347"/>
    <rdfs:label>bupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/de2718ad-2dac-4df2-9e1f-e3d5b3c8c09b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/946195a4-3730-40ab-b818-9b91277e7b79"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/39a58fbf-5937-4484-8142-4ebe3fc68047"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/0b218ad4-449d-4b99-954d-014ec065d6a1"/>
    <rdfs:label>rosuvastatin-warfarin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/131ca73e-5685-4856-8e81-2692bca31b3c">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/c17bac51-dcf2-409c-9945-600a64e4e30a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7f30c8f7-33cd-4198-b72f-745210bd83aa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/9fb7b211-382d-49c6-91bb-db7259a9b50b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ef0bef17-d707-42d8-a89e-382afbf23d43">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a887d092-a637-4902-88ad-4445d5f3dba0"/>
    <rdfs:label>fluvoxamine-tacrine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9ecd930c-783a-4c6f-a8bc-1f772a3e315b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/48b014c0-f5c9-4788-b1f8-2c33b93d8706">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/862bca1a-d6b5-4a2c-bc42-6057d32d2cf4">
    <rdfs:label>lopinavir/ritonavir-hydroxybupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/282312c2-802e-4c2f-9d92-c464a0694508">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/9b0c25a5-c3a5-474c-93dd-a243a886786c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/ec4a8c16-5761-4df5-aa93-2cb62456d4cb"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/d58c57ff-aa27-4076-baa3-776b301ba043"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/14c78d13-b21f-4b84-b52e-f06f35ed7bf4">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/ff1136ea-9118-497f-bffe-1c04b1abfcd2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/94500d48-831f-4e8d-84cd-d5a41cb036e3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/c6f48644-f7af-40f9-9c08-c1e4c7154d22">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
    <rdfs:label>fluoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/58e7682d-4865-4542-87e3-47e0a18b9665">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/aae8d494-6128-45b5-ba5f-01bb1c6c8eff">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/bc96f850-9b80-48a9-83d5-647722cac972"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/85a42adf-9ac7-46d5-ba4a-f7b5f0897dbf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/010a0889-2fe3-47ab-9dd0-f82f040be2d3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e7871f10-3f7e-43fe-843a-b26ec6e42fba">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2f6f5cf5-3684-4b32-805a-2ecae519fbf4"/>
    <rdfs:label>paroxetine-atomoxetine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/78943d45-a025-4e43-8d4c-dea7cb2e04d8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/50493499-cc17-4d23-b7c8-dc8c2d48a34f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/c0a0bc47-1c21-48d7-b0b9-54ca8adb47be"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/4e47aee9-a75b-4048-971d-bed2b16d77be"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2a1df414-20b6-4f57-9378-aed77600b69d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/46fbe63d-8d99-47bc-8c2b-fa6289ab872d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4aa20736-09da-437b-8f2f-4ecac1313ad6"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c125b284-f986-47d3-befa-fb10e0187669"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/5e448837-828c-4440-bf7e-92e549d95098"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/13b52262-5ae7-4aba-8fff-d01026cdd5ea"/>
    <rdfs:label>Erythromycin-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/16179399-a0cf-4483-b1d1-db7aaa34550a">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/dae1fcf8-43ca-4603-8588-29f40c203a84"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/00f55a70-4ba4-4b32-a6d5-da06d749d551">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/346524c9-e273-4cf6-a108-2ff6d455ac62"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/fff31f0d-f644-44f0-b624-0b22a34d235f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f975533f-18b0-4155-9114-48533e71f5c8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/59ac9b99-f71c-4c5f-a601-148ed8f793c9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b05524e8-ce4d-4cd4-908f-fcbeafae5985"/>
    <rdfs:label>ketoconazole-desvenlafaxine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a33a43d1-7a3c-43c4-9afa-5d039c7fd59f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/211ca8e5-1440-4ad6-964b-face3e2eebee">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a609868a-88a5-406f-a5b9-2e8f8f67d55a"/>
    <rdfs:label>atorvastatin-aliskiren drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/64002740-da34-409e-84e0-88cb26bc213d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/10e90b5f-312a-46e5-8496-57cce3680169">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b65170f6-fcf2-413f-a945-aac91d6f3a70">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c8249fa5-474a-4efb-bcad-416ba3c129f4"/>
    <rdfs:label>17 Percent </rdfs:label>
    <obo:OBI_0001937>17</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/4dccb7b0-6bf3-44cc-94cb-619cd24c1727">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2684942b-d0b4-4010-9ad8-d88df2bd1bf1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/8c54c683-f58b-4ec6-a0fa-b3b25308deda">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3a13fd86-489d-4fd3-b3d8-1b26bfaf06ef">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e882bab8-770d-4a44-9fa1-f9aefeb71633"/>
    <rdfs:label>8.6 Fold </rdfs:label>
    <obo:OBI_0001937>8.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/49a28fce-05be-441c-a5d7-7c0a39d67687">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/92912033-59bc-4fc3-a68f-9abd5fd1a5c2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/b6e64c3d-2e28-4289-916a-13ee1edd1e3c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/ac1033f5-35b2-487f-a629-b187061b7175">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/235cc2af-e401-483d-a121-1d2ca5df07ff"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/0dba7581-9326-40e6-8b33-d8ae6051f450"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2236e7da-2bb5-4f84-84c9-3d20c4a56bef">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/862bca1a-d6b5-4a2c-bc42-6057d32d2cf4"/>
    <rdfs:label>lopinavir/ritonavir-hydroxybupropion drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/fb539a56-6d64-4531-b488-a42b9a8e96af"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6fba21f2-5a1a-4bdb-9367-eaf2192ba40f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0dc051dd-88e3-40a3-b3ad-c7e4a92ed807"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/908f6fa5-7e84-46f0-938b-79365f444dc3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/095e8f32-a2ed-4644-9e80-8ad3bd42753f"/>
    <rdfs:label>nefazodone-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/854537e4-006a-4f94-a0b9-db64851853f4">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/5619e847-98e5-4a86-a12c-073b7ae7f9a8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/0ffcb7b5-3f5a-404b-af92-844ef2bbf1c2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/d7816972-2af7-4a42-93a2-6e9543811c09"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/f6f06364-a508-4ec1-87e5-bdac5303c4f5">
    <rdfs:label>Carbamazepine-olanzapine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/cd7136f8-b285-4e38-b35f-07593e19bafc">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/ae600ad9-f86e-4bd6-a61e-d16ab92de80c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/2f1bad2c-cde1-46ce-a4b8-891b70ab3b95">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/771dd1a8-83c2-4c52-89e7-3cccb390630e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/43a40816-45fb-4fa2-8892-45cc5c41d809"/>
    <rdfs:label>fluoxetine-iloperidone drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9363b8c3-ad81-4b0e-8a7d-6ca3bb8f7346"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/f09576cc-056e-4851-af0a-992045fde8e2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/0ca631de-53be-46cc-9c32-27aefa2f0566">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e45c1048-e2ab-4b71-a53c-1c2d195527ca">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/4b1ba573-b053-4b23-9fb2-5d9fd26d9f89"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/99f1f755-86a6-4655-87dd-e33713cdbef8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/4423bb7f-42d0-4e84-9808-917c46406fdc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/4a49e6ae-465b-4ea1-8da8-2aac23cd44b5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/07b3c94e-1fe3-4146-a2ff-7e6afac46977">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b23de519-06b8-439b-a3f5-85fef2947198">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4efb7d8b-8f84-457d-bb2a-6033f2401be6">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/82a4026d-40e2-484e-ab43-66ef1f6828c6"/>
    <rdfs:label>Diltiazem-Atorvastatin drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/6b80d8b8-9e05-42a9-815e-5f35f07b1958"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/fda0ad31-6760-4abf-a7f0-9d6b23a41948">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
    <rdfs:label>Carbamazepine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fff790a0-880b-453a-9c93-10bd386da51b">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/126ba9e8-4870-410f-a191-0f9bf2d631c6"/>
    <rdfs:label>33 Percent </rdfs:label>
    <obo:OBI_0001937>33</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/be1c6291-3830-4b62-8b88-75f651324a7d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b0628d1d-ecbd-4c21-9d1a-01e09d287219"/>
    <rdfs:label>rifampin-pitavastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b55a04f9-58d9-47bb-9ff6-d9fd34ded394"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f3868aaf-ea68-45cd-92d6-b4b9864b3414">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/522b1726-7e32-4652-bfa7-ff309169511b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/42d8b22a-71ee-4e7b-8db0-3eba32e92ef5"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/c6f48644-f7af-40f9-9c08-c1e4c7154d22"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9a1375a3-a94e-4684-b62d-c272524edf1f">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5207a518-77d7-4e01-8d96-d991e604262c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8ad495f4-ba30-4234-b22c-b88203a2a44f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ef409448-3199-4376-a092-6632a191663f"/>
    <rdfs:label>2.84 Fold </rdfs:label>
    <obo:OBI_0001937>2.84</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3abe6009-a9f4-4255-adc6-ba1c1a661256">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/a8ea8de3-2aec-4cf2-9be2-855ff8aac05e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/05e1650e-2347-4366-92bd-19ea6568c719">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/466af1fb-e800-486c-9a9a-698b96cc3e08"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/9949c376-5458-44b2-b545-c16c0b5289a7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a0ce5ecf-7cbc-4820-86fa-502ec9569e0c">
    <rdfs:label>paroxetine-risperidone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/cc230916-cbfe-4395-b871-6ac593bd78d9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/6a8f0af6-e859-43d6-9f62-3dc409e4f28f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ebb36307-b993-4b3f-ab8d-fcdce75f294c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/0b84808e-eea9-4d20-96cb-efba78439838">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/a9cb37ad-84ea-4b8b-b8ba-fdccb8615c2a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/824c0b68-f359-4355-98d0-34747abd0105">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/9774f26c-a367-484c-bd7d-932a7437346d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/0f6c3f3b-b115-43da-a087-d23ba430fa2d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e05292d7-c485-4605-89af-f42fa57a3ee3"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/955f4b75-949f-4f36-8205-2e2212eade22"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/d97bf349-fba6-4e5d-b770-8852e39c28a4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4cb2b1cc-2900-44d1-afef-0bedadb8386e"/>
    <rdfs:label>Cimetidine-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/dc05a235-b5a2-4d7e-b4ef-740b6c3178af">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/14e93378-6001-4708-81d4-f8e699072207">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/1e30374d-84a3-4617-9a70-e9edb09337c2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/7685c377-7402-4fa0-b3e5-311fbb4954e0">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/ff99f1f7-e876-4c88-b684-58268a4ffbb7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/7ab3ba42-f9c6-47cd-b601-252f77021d4b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/12f75402-3d3e-4b7d-ac00-31d6d227c417">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/efaaf896-a5ab-400f-a820-64f35afb6a43">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/8dd60598-707f-41aa-afb4-5d15b2c4cfe4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/637e54bd-19c6-4e80-90b4-80ef0e8a8de9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cb907e93-82c3-4bb5-9aed-b42820a85e0e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/096f3012-c439-4e9e-95d2-a6823ea7a1a8"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/98b61dc7-e6d6-4c3b-a276-fca353e5bac4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PATO_0000125">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/32cd7630-d611-4f4d-9210-ca13bae4b9d2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f21d121e-4ef9-4fcd-a25e-c96a2f51097e">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/407d5729-e866-470a-88c7-0f34574eb2e5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/c62eaa1d-d02e-484a-8a2f-fa196eb05df9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/762bc22e-c9c6-4665-ac32-2bebc06c22ab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e75153d1-ed12-48b1-842c-b0850df3a993">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/3861caf1-0212-4c1f-80e4-3e0476bcddc5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/71007cf9-17bc-4075-85f8-ee0a438b693b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f14bb0f9-8c97-4ca5-b196-9f0eaae0b72c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/34d87b2b-d035-43f5-9e4f-d0ec0b2c9b0b">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0a821336-e6ed-4654-a24e-e8b2419cfce4"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/56e46392-4740-4c99-ae69-1c393c717cb4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/81ab1439-1d1f-4f61-82b8-b2744971e0d0">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/0907e07d-3fb0-467d-8801-0a1d2a748803"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ec52afcf-cfa5-4f6d-b6b9-85276aa63e36">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/9219c4fc-17d4-4855-a4c9-1e0846c9ac92"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/4c006fd8-2cc6-4dea-971f-fd030e34735c">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/eac6be78-d91b-4ed5-bb2a-8a36f3101dcc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/6081a565-753f-4e54-a115-e562eae0e8d9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/32f138ef-c0fa-4e6f-94c8-770388242804">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/3fdd365e-7885-4d7c-93f7-3ba7e2830b96">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/0739f80c-e44e-4e26-8c93-a3bd11e38ee4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/98b8b23b-0450-44ff-959c-f7e04e819fd3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/329ca864-ec75-4e7e-bfe0-da31346b6e92"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/2911c829-0833-471f-baec-b8cc7ea36f58">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/abcb3981-acf5-4e90-8265-f07b95efd9e6"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/4cd473f2-d644-47c2-9f4b-ec72aaff58e6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/8dd60598-707f-41aa-afb4-5d15b2c4cfe4">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/eb842cc8-95d6-48f6-90d6-2fe4475f4968"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/f1ff222d-4a93-4c1d-9a29-ed878aa90f6d"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/05568e61-e257-469b-b291-e09ee986b282"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/02601b00-7ddd-4ca6-825c-e28c767e9d5a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ae373789-bace-43b4-8de5-2b1fa5b967c8"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f9e63c26-8658-4d84-a6f1-dad5483fa6da">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ff657b0a-107f-4197-9c5c-781a157bcf46"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/4ba45059-76a4-4f0b-912d-f202fcbf9ada"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/acab30d2-cd3e-4650-b87b-0c96a7e03f94">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ed2d8eb4-8e7f-4c76-987d-9c82273f97cd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/657145fe-f736-42cc-ad50-8219fdfc25f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b55a2b72-4488-4107-8490-6f0fff0a570a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/40edd4fd-b06a-434e-92b0-013082f1f3d0"/>
    <rdfs:label>Nelfinavir-Atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/229530f1-d764-4db0-b34d-f61ca41c3a05"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/6a5fdbed-5323-4110-865e-a7f9277184cb">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/f13d09e4-80ed-49ee-92a8-b73198f1790c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/8f20796f-6009-407b-a68f-dba83bcbbdf3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c11da532-2169-4f8b-8762-bf53ec0a35f4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/3a88c0dc-379e-4500-ae35-28ebabf8673c">
    <rdfs:label>amiodarone-warfarin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/897ecf7e-0482-4144-a85b-5784b8dea75b">
    <rdf:type rdf:resource="obo:RxNorm_35255"/>
    <rdfs:label>cisapride</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/08bded39-624e-4d01-92cc-588b3352ace7">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/bfe2d678-fdeb-4043-8998-b8cfb1fc4e2b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/7a50843d-479f-4676-b619-f0fb78402f3f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9d74c8f2-7383-44bd-b0c3-e805ad05f505">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4c836f74-c1a9-49ec-b939-d0c1ccf7a643"/>
    <rdfs:label>30 Percent </rdfs:label>
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e6304817-2e73-40a4-82d2-db89c1e4a052">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/0620f725-7ff7-4010-bf2e-feda1fb7955b">
    <obo:OBI_0001937>750</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/64b54752-0479-497d-b151-2b84fe287b51"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/046c4740-f036-49b5-b571-11cdaf2c0565">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e7030372-ac39-4bcc-b3b1-e7585463d394">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/682dbc10-96d7-4dca-903e-7d7b5dcb8150"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/b74a38c6-16f3-47dc-b05d-2ad8661faeb2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/71619581-7954-41f5-be5e-ec16cba771c9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/62832dc5-51ac-4ff2-8f1c-1974ce8a0d07">
    <rdfs:label>divalproex sodium-INVEGA DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/906a2359-6adb-42d8-aeeb-076d12ea253d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8fa7d9f9-ee5e-4d97-b49f-e3432e3d244a"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e3cdc108-3501-4fbf-a080-f52e39d0c3be">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d3ce6416-96e0-4174-800c-2e8d4afacbb5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2a93a852-6fff-4872-8ac9-4b4cdc741e31"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/9da95729-7775-4438-8993-6b340e825661"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4c98e8ae-2840-4d34-bc17-ae9704471673"/>
    <rdfs:label>paroxetine-phenytoin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/e2867d04-ef3f-4b38-af9e-df420f94cb66">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/72ba6748-b787-4ded-b4bb-e6c6e95398db">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/306f9803-59a4-4e54-88b0-d2de4f45ef43"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/4370d149-3ef0-4af5-a6fa-1f86df35226a">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/73ad772b-3067-4886-82dc-52fde126dc80"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/25a8d326-6ce7-4d8d-8cab-23e90f8ac365"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/28d39d0e-d2e9-4ce1-a6c8-cf7040c723fd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/2eea72c3-b927-45b0-92ca-6393e2528d92">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/940bd346-1fe4-48f8-91aa-dd91aee57dfb">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/ea5fd7d8-3088-4658-8b6d-51347cf9ca2f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/358839e3-6aef-43f5-9696-7bbafd1742e9"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/096c0388-7fc8-4ad6-a9e2-6038bf04c48c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6156c84a-caff-428d-8bc4-be7ca566aa3f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/18e98152-58c6-4117-98a7-55dd4e1fe26e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/61a6609d-40ef-4b09-806a-5b4a7e924d8f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/a34cb6ce-85bf-431d-8be3-f2b6ec52df7e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/6b9e150b-fdac-44c7-a72f-12cf913513dc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/4fb566fe-ffb7-437c-aa19-468f41f264a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1176f444-e7b8-4076-92d7-162dc9537fa0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/771dd1a8-83c2-4c52-89e7-3cccb390630e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ce79271b-5860-4e58-8553-a0789cd92fef"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ee4ca826-6387-46ed-b58a-0d44e722ce30"/>
    <rdfs:label>fluoxetine-iloperidone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7cd7179f-5570-4527-9cf0-9e0c70a9399f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1d711b53-c1d1-46cb-9077-eff29ce5f0eb"/>
    <rdfs:label>midazolam-rivaroxaban drug package halflife  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c52a26f5-ecd4-40cc-8749-a85518a3fd12"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/4f66bf17-d204-4cfa-9fca-292f0e8fa615">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/66e70b9f-4d63-4869-9345-6cff9281e2a1">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/53509be9-9f7e-41b7-876c-15bc415b990d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/131ca73e-5685-4856-8e81-2692bca31b3c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8443eed0-d14a-48b4-9bc4-7bc3e2bbcea2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c9bb5a8c-8cd9-4180-b51f-1c6f0a1c1996">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/74739309-e6a9-4bf4-a353-87819db744ec"/>
    <rdfs:label>paroxetine-P88 drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/712f3ee7-eff2-43db-be2d-0523694da65e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/c2697859-919a-4bc6-92fb-00122e611a73">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/f4043c0c-4f60-4686-96b2-fc130b4b97ae"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/34d56ab4-f5c0-48d3-9ef0-893a162fb97e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/ec1616fc-6660-47b6-940a-1020e2559daf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/bbb9c368-4eff-44ea-94d5-a925fbf1c4e5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/21f6ef7e-bad4-4020-82be-f864288bcde8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/a0e2ca6f-95d3-4635-9fe3-529c6d346c00"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/353417a0-a2a6-4269-8e1d-12e2b4debd8b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/1fe03fe7-b5d0-4388-85e9-120bd9c86940">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/cc3899a1-9896-4c5e-b968-b19512e49681">
    <obo:OBI_0001937>750</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/650672c4-b2a1-423c-b727-2938d28cb635"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/af738ed0-d3d1-4da6-bb0d-4843b43c33cd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/94416516-9401-4330-824b-142bc1e143bc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/54579513-cda5-406b-99c9-fc3cd2bfaf15"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/76fec16e-798f-45d2-89ae-e3d25a1d9052"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/61043ccb-bd74-41a5-8a5a-37efb8b12ea2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c33f8a52-cc70-4894-a21b-df9965b482fa">
    <rdfs:label>nefazodone-simvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e7cb9505-f523-4ddd-8395-6a9c5dec71ef">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/095df5a1-a86e-49f9-9193-a5e0a728145a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/af0345fe-c8d8-4cb6-87fc-9d6348472a8d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/01532a45-2014-49e9-bd2d-1c71e07f0e29"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/e5d04476-161a-494d-b79d-0002915da362"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/0501130a-0e03-447a-881e-446c0df25f23">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/800c5267-235b-4cd1-8ace-f65616508088"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d6532c26-d3cf-4ac8-9a4d-090225a61c77">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/9319ab9e-2930-4106-ad4b-b0da0ec667f6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/5f6c084c-2a25-4470-b2ba-a9a825dada8e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/1fcd6f4c-cec2-4a53-915c-c14e97411e61"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/5ab276f2-4839-44f5-9a81-4effe2b04e80">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/4ef00918-9e65-44ef-91a7-ec19fca8ae1a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/6bfb81d6-e6ac-4e82-952b-ef99b39be8bc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/8f513991-2e70-4ab9-b1b5-0c18be619a1f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/fa9c50d9-8139-453e-808e-c3b02804d4ef"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/b0214834-654d-4961-90e4-1094e3a548f7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b989d5d6-3734-4079-b2ec-e2c1268cd45d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/320699c3-0ad8-4c23-af4c-603244ef7790">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/750358f7-132a-440c-8b12-7b3771fce59e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/e16b1d39-1246-4220-adcc-5fb32cad792b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/08bded39-624e-4d01-92cc-588b3352ace7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/5eb882a4-2628-4b11-b87a-f5640de774de">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/dba37ebe-758d-496c-a568-737ee72b0c20"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e18ea95c-1516-48ff-b8ac-770dbef155cb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/8dd93a58-dacb-4e20-ba25-b005f775a256"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/90abe59c-5428-48d4-a24c-d57fe66ebcf5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a6610ab2-ff1c-4237-856a-24f9ba3e0269">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/4ba3cb09-a4d4-4be8-b9e2-e4cc8d4cd726"/>
    <rdfs:label>buspirone-nefazodone drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/57ac5889-0c71-4449-9524-ee4cad4e90d7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/d2d7ad2d-9527-4c81-889f-0eac701ec487">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/3db4203a-872b-45c2-8db7-f5d61d5340f6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/b1c6ef1d-ec1e-4562-83ed-f1d9c4097c4c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/61fa0a3e-b59a-4a89-a4a9-94b7ba69e4db"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d5f109a2-39e0-4b3a-8e11-98d118d09eea">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1ad915db-d995-459e-aef4-ebf2130c29c5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/cd3a9351-c4b8-4fb2-854d-8f86bbf945e0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d226a71e-cbab-4ea8-afc3-a695ca60e98d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/61613245-17ba-4a81-ba74-f8ed1accf480"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/43b7310f-9fc5-4114-ae6b-2397ef4ca381">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/785e8906-3484-4d0c-9c2d-23c06837231b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/25373696-4c66-48f6-b3a7-36e89b071789"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/95ceec07-20d0-41f9-8693-a31cb0fc4a2f">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>Atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/d2ef146d-b79e-4877-b382-9fb023d0decd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/f4f6ded2-8aec-48e1-a070-bd547a1e42d5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/09c4ea00-518c-4800-ac1e-4104851f070d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/32d9275a-db74-4eaa-afb9-1550940c2abe"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/29d1603f-b046-43d1-8800-b0b6c435acba">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/b7eefc55-f448-4352-b28b-2ed9b0acb1c6"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/38befda2-0eb2-4a31-b3a1-f37a2913fb26"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/6cb5e83d-df64-42af-8528-7aa9f631412e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/e703c6e3-4d6f-43d4-82ed-bc6ace7b9bfe"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/cf08e766-f5e7-4805-928c-eed04fd11c80"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/04519c3e-92ef-42a6-b458-3643cf6dfe2e">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b732df7d-ca43-4d1a-8c8b-a96abdee264b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/da52201b-4556-4344-b101-ad142e9f6530">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/fae81b14-e1ec-4539-9857-0cb073ffb010"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a2e7e52f-f81d-4cb3-8ca6-00d731721f1f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/30767c9e-082b-41d8-bcb5-d8d473c78aac"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/710b80b9-00aa-41d3-bb31-497b608e2500"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/31a9720c-b179-4a87-b275-268e112f00d6"/>
    <rdfs:label>ketoconazole-zolpidem interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/30bb79f0-2130-4c7f-afa3-4e7060b18ede">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/73127c7a-43ff-4b21-a2e5-236fc88650ce"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/2cd486e9-9889-4c9f-8f49-a751004f22d2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/021df09a-4603-4f47-b3eb-90eade24f182">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c2ff8fee-a716-44f3-8b74-18de97b5b6bc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/a4622952-908b-4a75-9a52-4c03a90a2151">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/dcc0a60f-d60f-4e3e-aa1e-1f53f9234cd7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7a097f29-8fd3-4e0e-b9ce-d254a6705cb6"/>
    <rdfs:label>138 Percent </rdfs:label>
    <obo:OBI_0001937>138</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fb539a56-6d64-4531-b488-a42b9a8e96af">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/9774f26c-a367-484c-bd7d-932a7437346d"/>
    <rdfs:label>31 Percent </rdfs:label>
    <obo:OBI_0001937>31</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/72d8220b-43c5-4f02-95da-f7c075f2fef7">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/018894e6-6018-4098-9ac1-278e7a620566"/>
    <rdfs:label>fluvoxamine-thioridazine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1843772a-6f8a-479b-8488-092c7443b374"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/755d816d-8e03-4df7-b878-c6a44a454317">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d183f021-d6fd-45a9-89cb-9975ee23d6b3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/0af2a4e4-3fb7-49b7-a324-cf4a3e20c010"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/157772c1-0466-4bca-a499-87faa8e2dab1">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/bcdab818-831b-4248-94a9-3381663047be"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/848c2b50-3da9-4db7-8ebf-4a8c30f28e16">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6950ba91-d22f-48f0-8c74-0f6ecb0c7a2c"/>
    <rdfs:label>3 Fold </rdfs:label>
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/4258b3dd-b425-4f4c-8d66-2e4e6761a1fd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c9bb5a8c-8cd9-4180-b51f-1c6f0a1c1996"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e9ae109a-ee0b-4863-a296-4ff12d01b768"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ab3730c1-6640-48ae-aad0-a10318a39771"/>
    <rdfs:label>paroxetine-P88 interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c57f66bb-3555-48af-a35f-a13a6adc198a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/89e8b913-1833-471a-88f1-2f4093d184a1"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/c0ec1385-935b-4f2e-ab35-7bd641788b46"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/a1456300-0cb0-41a5-880f-97891e7bd7f4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/5d7de48f-d925-4f40-aa75-e2e2f340033f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/12c51a8e-c45d-4cde-8825-bc336427cfe1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d67ac1b7-f602-4f5e-a617-27a4de0f5c85">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0af2a4e4-3fb7-49b7-a324-cf4a3e20c010">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/781ee796-5d51-4b2b-b0fe-f0a5fb390be0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/015b212f-5b31-47d3-9d22-0259b2a72806">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/13a2f1f0-66e6-4f61-8eb6-5438e4194f8a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f5ad5c84-ae86-4f21-a29f-39d128cd13b9"/>
    <rdfs:label>rivaroxaban-midazolam drug package auc None information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/af44b4dc-6147-4666-b266-f8985bd0bcc2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f3a846dc-fa45-4311-b77e-7ad2c967e0aa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ed80b430-6129-4317-9ee1-2af4bb22d0c6">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/e29a97d9-8db3-49bb-8c26-040e6ad2dc36"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/44e0fac4-f638-4065-be0b-f0f69797db89"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/82be4c4d-a1bb-480f-a62b-6e0b7986ab79"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/46f66f17-dabb-4603-ad52-5b41a6cbfa60">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/73ef8910-101d-4482-9e03-3694cdf47d34">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/df0541f6-4112-4960-9f4d-b20ba702fb55"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/71019582-7044-4b16-994c-0d1d4591820a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/46efc7ad-b93e-43e7-bbd6-af11fe4e72eb"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/ef829235-3f64-4b34-a823-318d8bed26db">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/000a1e8c-a2c7-4d5f-a50b-62ad7693104d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/5c7b7f09-5430-419e-8c52-1a0b0ded0afe"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/13f7956f-0396-4c22-a665-471c14d77478"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/71483148-c83d-4473-bb3b-652b0f49d476">
    <rdf:type rdf:resource="obo:RxNorm_215928"/>
    <rdfs:label>Celexa</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/4955a927-edec-437f-bde6-2deb320d1a8b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ad5c6943-c03b-4437-83e0-05a90d2c0bcf"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ce02dbbb-3085-45e6-afa5-21e4947a8697"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/9dee8c86-9df6-4425-80bf-f51d66e57bf4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/daffcc3f-b593-41d4-8c14-573fa04dd466"/>
    <rdfs:label>citalopram-ketoconazole interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/fc0d0bdd-682b-4ac2-a01d-6fc538abf47a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/40eafb2b-1574-4096-b4de-0e3b1fade627">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/24da1540-142f-4ede-8807-f92e80474d67">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/fcdc343c-c7d5-4d01-933e-0d79e272a57a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/11aa3ed6-8c8e-4dc0-a2aa-1b3577acce24">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/bc6dc3a7-a2df-4407-8b5c-8f63b8930ead"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/70657530-bd5b-411d-a6f6-45be0e24f906"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/52aa070a-6385-449b-8e0f-8181e7b89bbf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ce0b6865-f53a-482c-837e-08213923ce24">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1eb2283e-40e1-49bf-8b26-d24b922791da"/>
    <rdfs:label>122 Percent </rdfs:label>
    <obo:OBI_0001937>122</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/58acfa7d-453d-4db7-bd77-75107336f7dc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/7d2153ae-91db-4143-bd7f-b61bc32d6b81">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/efc278bf-2349-44b0-90f4-4c48e12fa513"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/10eb44a7-96ac-4cfd-a9c3-d4f1518ce94a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/51880453-9c77-4897-9da3-2bc3bdf70f50"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/78f3ca6d-b686-4ede-bc49-7e4d0fff3a2a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/82871b62-132a-439a-8584-4cc12089c2ac"/>
    <rdfs:label>Gemfibrozil-atorvastatin drug package halflife Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3cdf6ead-54c9-41ca-b0f3-3ecbd07ba63e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/1ea77120-4fc3-4a07-95e1-a52e94ec487b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/46f66f17-dabb-4603-ad52-5b41a6cbfa60"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/4785f5da-f33d-4bf3-801e-a38e1479eb44"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/992dfd16-1f45-4f12-8bec-b8b410d30f66">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0bd6d6f9-7910-4b21-97c5-631203d06162"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/0ac51298-26e4-401b-930b-c215c6d3c9ae"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/369bf54f-96ab-4373-aec2-ac396a22e541">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/dfc6edf9-b7e9-4061-964a-3d271a1fd020"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/2f11fe91-0739-42fe-858b-696dcb6bb1bb"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/460d2933-e601-4224-98f7-b2794d43cbfd"/>
    <rdfs:label>paroxetine-duloxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/3125723b-413e-43c9-90e6-478010547b8e">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/92df114d-5e82-478a-93fc-af58d450b56d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e1cadc44-7fbb-4f7f-9b12-1f2945176e4c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d8d02d8d-cb5d-44d7-8399-78ca78eb1bec">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/f7530807-44fe-4909-8fa9-da415a48e246">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/95a39d1f-6490-4a08-a1e5-982e27e2598a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/daa0a8f8-96e6-4462-8c1a-00b463b14f2c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/55998d99-8b18-4be4-a9ae-8f0689ded0c3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/0854e330-45b1-4df6-98e0-e7604495a5b1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e849c6cb-b060-4199-aab9-bf243f221dd3"/>
    <rdfs:label>rifampin-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/5f6c084c-2a25-4470-b2ba-a9a825dada8e">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c9ae98d6-7d2c-4972-9977-efa8331a475d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/d61944ed-b5c1-4394-8ea7-66752836dfc2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/1706a9c1-29c3-4171-b8df-4d991e59683a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7c6a55f6-1972-4f28-85a0-34852957ccd0">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/9de704f5-8413-495f-8cd1-426dc801359a"/>
    <rdfs:label>15.7 Percent </rdfs:label>
    <obo:OBI_0001937>15.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/01532a45-2014-49e9-bd2d-1c71e07f0e29">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/60971688-9375-471b-a365-da2b0551ccf6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/4a727ebc-d4cb-4dc1-9d9d-28a14411b8b7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/af190f37-1177-4a46-a5cf-aaa661a4f241"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/19fc70ac-d184-458e-a3a7-a4eef5ec1aa2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/26795978-4d9b-46c3-b4c7-91e0cfd11d13">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1e802ede-ed14-4108-ad4f-a8cd0375af79">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/bc94db7b-bf39-4360-8a54-f4ea6f740972"/>
    <rdfs:label>clopidogrel-fluvastatin drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4ad0389d-f292-4ce7-8d27-1384eeb2ad1d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/73ad772b-3067-4886-82dc-52fde126dc80">
    <rdf:type rdf:resource="obo:RxNorm_8718"/>
    <rdfs:label>procyclidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2f62f7e5-4c9f-4ea2-a0ab-2cc9ede86a08">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ad01d58d-f033-41a4-9a83-a1f4df4abe04"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package halflife  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/17543523-f1c2-499d-b946-eb5b76f7af62"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/cb096012-8689-4445-9fa6-dcc128dd0627">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/459c991e-0795-4e90-9ea9-ad47b96f6a1c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f4064019-6668-466c-818b-44c482d62b3e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/dbb8ecea-0e11-4748-bb31-76aed02a55df">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/6f1ba573-b666-4874-b28a-8682dde55e9d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/2e7803ed-c49d-431f-9302-6df02bdc9b8f">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/b83f9298-10da-44ca-b1d9-27f3b448c7aa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/2dd2f90d-9733-4d57-9a56-082f24e07620">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/0f4faf32-d77b-4202-aea8-cf7cd23d1ec6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/3105d758-ac24-4c98-a083-ddc8b9fe9f53"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/ef608786-2e28-4d58-ae27-347ed82299f5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/244a9959-eeb4-420a-85b0-ce5e73175a36">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b0628d1d-ecbd-4c21-9d1a-01e09d287219"/>
    <rdfs:label>rifampin-pitavastatin drug package halflife Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/267eed52-0c09-436d-b3f2-d145bb9c621e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/c861f167-ddef-4db2-b701-560abd60c9ec">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/cc090bdb-376f-4384-8e87-05034da1d6ac"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/fca2de3c-1a7c-43e1-bcdd-021601f59133"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/0683b8c6-7309-44fa-81ce-709a63a48ae9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e41bc718-8e3f-4c17-b5b4-3e5ce99fc37a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/9ff5d7fc-c69d-4cc5-b488-027669616e00">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6d44c3c6-8897-4033-b8d9-7d5906b326f8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/fef1a4a8-4792-4808-8bcf-7857635a1c7b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/f205a2c7-221c-43e9-9f18-3152000dbf19"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3e6ffbcb-f353-4aa8-89ff-f93f0fefd9a0"/>
    <rdfs:label>mesoridazine-Fluvoxamine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/0397998b-d23f-41cc-a821-c49e8c919918">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/681f91b0-e71d-4e92-bd96-e269848f217d">
    <rdf:type rdf:resource="obo:RxNorm_301542"/>
    <rdfs:label>rosuvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/75d9376a-5569-41cf-8919-315872401f04">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c1c5e290-53cc-469e-bf1e-11b58471d201"/>
    <rdfs:label>2.5 Fold </rdfs:label>
    <obo:OBI_0001937>2.5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3bc312d2-c51f-469b-b340-f83c5437cc93">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/292a851e-7541-4712-8782-622cbd73475b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/a556574a-5a5d-4994-a7ce-ce2d60e45dac"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/98568a71-3a3c-4ca5-ab76-9e042c9b8e50">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/394f413d-872d-44c7-9a3e-3a4c90f0c8dd"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/193d598c-8e9f-4412-9d54-999824e7cfeb"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/bb466ace-7018-4c4b-864f-2e9389b36d83"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a53272b2-76f7-4d59-b24e-34d270019510"/>
    <rdfs:label>Fluvoxamine-alosetron interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/880dd0eb-4a87-44ee-ae71-e72cf210ac75">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/8bdaedb9-6b51-4279-99e7-2225ed553f7f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/fc0d0bdd-682b-4ac2-a01d-6fc538abf47a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/3fedaedf-3625-4686-a1cf-6d0f2558d825">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/7309d8e7-d6f2-4c39-b0ba-a48142c94b01"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/333cfb97-3cf0-4e74-a33d-1d6743f60606">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/343eefa3-b163-4ad6-a6c3-a7b0a0030660">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ec3ba9bb-f559-4f6a-b251-5a929aec7f40">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/cfd86e68-05ed-402a-8885-80d1fd85824a"/>
    <rdfs:label>ritonavir-bupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a27e3ce2-dac9-47e9-84dc-fd4109bbf986"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a98d4f7e-7b05-4933-be99-ad92631fcf2c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/e64ca6f8-7b69-4b26-a90b-db8b60bc0eea">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f45a2334-3ec3-40e1-a8d3-f67428212167">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8d22d984-86dd-4776-afca-130cfe844433"/>
    <rdfs:label>35 Percent </rdfs:label>
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c4791e28-441b-46c3-881b-14ea7bd19066">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/fa9c50d9-8139-453e-808e-c3b02804d4ef">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/02722441-7c50-4043-b099-b986214b424a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2d607520-51cc-47c7-8558-1302f42d172d"/>
    <rdfs:label>cimetidine-citalopram drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1dae5f6f-caa2-468c-a105-65542d3f34c3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2a72d51e-903b-4520-9247-f704adcaa020">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2f5cdbb3-95cc-4cab-9b5b-1d85481ac4ca"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fdfc6705-3048-4faf-b29e-8f8818f8c070">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c719c1e7-bc5b-4157-be07-802f8a26d9dd"/>
    <rdfs:label>29 Percent </rdfs:label>
    <obo:OBI_0001937>29</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/15ffe190-418b-42b7-9d57-66be84a9c480">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/47d87488-5692-425d-800d-5ca6aa58052c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f6d8fd28-26f2-4031-8a8e-74bac5221b2d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0ddb00e7-257e-49bc-b550-de1b9c608d55">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7c3c1553-1289-43e5-a9b6-69f1910c8b9a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/046c4740-f036-49b5-b571-11cdaf2c0565"/>
    <rdfs:label>18 Percent </rdfs:label>
    <obo:OBI_0001937>18</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/fe38a3a1-b6f8-48dd-998f-2cfc36da7af4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ab64a4b9-a95e-45c3-8608-675b905310d4">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/85180b33-657f-43f2-b408-33367d10a676"/>
    <rdfs:label>3 Fold </rdfs:label>
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b7c88327-54f9-44c9-b0fe-3b7bd819d58f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2157ddea-a3aa-47b1-b753-5248d8fbc504">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d02a70ad-2abd-4c05-bdea-e85302327868"/>
    <rdfs:label>2.29 Fold </rdfs:label>
    <obo:OBI_0001937>2.29</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f752c9af-b088-4c32-9990-d766d006cb12">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/88a45f00-1e2e-4300-bef0-5a5e4470fbab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1ad915db-d995-459e-aef4-ebf2130c29c5">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/50f9115f-8cc4-4685-9222-dc08c4089992"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/76217a6c-06c0-4c8d-8e82-2edc69cf1f54">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/f3a9cade-69dc-4c35-a5de-f805071a3f98"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/90862867-0e4a-4dc9-aa5f-0c3f11a98f53"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/64906532-2fa6-4d69-b0bf-911232b969cc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c5bfc30e-b915-4cfe-8f48-1143b5c3cb35"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/65ab1a40-99b8-4658-81e3-36bc707f077c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/80c22176-4537-483b-9090-2dc25310634a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/7dec8d1d-7675-4b32-8f82-8497285cb728"/>
    <rdfs:label>Cyclosporine-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/75c5f4dc-e280-4c96-b334-cade2112ad98">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/382cf374-29c7-4253-9bc4-ca14a1975187"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/560b8520-3a68-40a3-871b-e64653679774"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/7fdab4ea-c771-43c6-8391-b55b199dc1d1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/180dd742-49f2-46b5-bfe7-31c924a6c813">
    <rdf:type rdf:resource="obo:RxNorm_358262"/>
    <rdfs:label>Fosamprenavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/f5ad5c84-ae86-4f21-a29f-39d128cd13b9">
    <rdfs:label>rivaroxaban-midazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/9b547e9c-4721-49d5-8b61-49fdd021356c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/bae7304d-fd03-4646-92f0-51890eda08ed"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/e4be7ef3-dc4d-41cd-a759-79777c174729"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5103b78e-ec52-46cb-b6a4-c99d3a031236">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a5ecde29-70cc-4242-aa6b-b6fb615e8770"/>
    <rdfs:label>38 Percent </rdfs:label>
    <obo:OBI_0001937>38</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/2ef1a9a6-3323-4227-af2f-44e7933826e0">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/6ad1705a-6a71-49f3-9752-881493d1f5b4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/dc8c1b6e-6382-4903-8683-fe1dedf5ef58"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/7bc67ebb-eaf8-4572-b162-7b9d84d4641f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/3f1733a7-e333-4741-837e-fddc293e1aed">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8ebfd728-9e99-4eb2-b191-85fa34a6556c">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/cd07b926-d0cd-49c7-84f4-2b404bad7394"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/1038ec5b-f154-4986-bd42-c9ec1fbeb740">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/144bde18-1ea0-4092-84af-768ffd3e3467">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>Atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/9f501562-7389-4c4f-9c09-ce85fc690dfb">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000001">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/9204db00-ab23-4f7b-a460-4538b7017dbb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/aadbe9d3-0bc4-41da-8bf5-3b171576905f">
    <rdf:type rdf:resource="obo:RxNorm_35636"/>
    <rdfs:label>risperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/416543a3-96f6-48a7-abb4-860fe4d2bd08">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a34cb6ce-85bf-431d-8be3-f2b6ec52df7e">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/969e6be6-bee6-4c63-834f-c59f9c9ccd7e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b37c3d2d-5408-4163-a94f-ef0463e7766d">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
    <rdfs:label>warfarin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/81633804-edc3-49fc-a90f-a31b09b6f10b">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/16b4bdaa-6b38-459c-afce-751f5b295ba9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/3de7b2ab-a707-4a36-8f31-39079cd7b1f4"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/4af602e7-1ddb-45ec-a3b0-99b4af8405b3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/495af8a6-3ad7-4c8d-a3eb-c67fad311bad">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/3b83cdd0-fff6-4ef2-8f1f-a9dd694212cb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/529d2ab4-7b92-4199-a45b-9e290f2c5368">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/1257f8ec-6094-4ce4-a556-4b78d397d523"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/b989d5d6-3734-4079-b2ec-e2c1268cd45d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/5a40fd98-21ba-4daa-a7db-1fde655c4864">
    <rdf:type rdf:resource="obo:RxNorm_38400"/>
    <rdfs:label>atomoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ff4d6a47-36c7-4998-9e4a-0988eb18a7cb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/98d13db6-776c-4ae7-9dff-dc8ea3b2b9e9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/ae83c8a6-df03-4322-a796-cea4546df345">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/caac560e-044e-4642-8c98-8470c9f27a12">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ef9d4420-4add-467e-a0db-9fd04a199c82">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/540152a3-378e-43fb-b33b-657bed9b8a1a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/7fdabef8-8d0e-431e-8d99-f5cb6cd7aba4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/f71506a6-ad6c-4110-8a59-2c08b443855d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/f09576cc-056e-4851-af0a-992045fde8e2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/9b6abdaa-a113-4a99-bf44-5e328d8bf91a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b6bd1ab4-fc7f-4642-9d23-017ae3e48f0c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/bccdbf71-cd06-413e-807b-2195570ac616"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/187995dc-0475-4623-b506-305fe354f725"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/5fc9d692-f167-4d40-8122-ec4fc8e2c186">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/7200fe99-40f1-4d7b-9b2b-ea7bb88d191e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/44b32c80-905d-4721-bd59-a100a2c99e86"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/fed71a47-bcb7-4dcb-b43f-6b184b0a15d8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a09bf058-7ad4-497f-8ced-374939fa697a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2a150f84-a80f-4849-8a5b-0c378d419f09"/>
    <rdfs:label>38 Percent </rdfs:label>
    <obo:OBI_0001937>38</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/53753f69-a759-42ea-b3ee-f4c29bcdcd2a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/2197e73a-a17a-434c-aa7a-d255563ce64b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/b2a6fd53-f330-44cc-98c7-7135683eb769"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/cfd86e68-05ed-402a-8885-80d1fd85824a">
    <rdfs:label>ritonavir-bupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/6279086e-546d-4e7f-8274-1ddee358376b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/777105c2-272b-4347-b928-03a4bdb9dd66"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/8a925687-0fdb-469c-8a73-e95cad07345e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/a032f86e-975c-4676-9c08-918f1e372985">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c8fe86c2-5f94-482d-8f81-010111e2f02a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/0226f9df-6b2d-4e4a-92ee-bbf7b0dcd926"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/5fa4ab65-ea6b-4b9b-81ec-ea3861fc88c0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/61e27f03-27a8-42bd-b372-23f4e3e687ba">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/0389a192-7823-4dbd-afd9-3fbbc320c0e2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/3090ef0c-f127-4dc4-9886-d4724cd51fcb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/d608f3d8-16cc-43c0-a299-672d8324f7eb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/5619e847-98e5-4a86-a12c-073b7ae7f9a8">
    <rdf:type rdf:resource="obo:MeSH_C092333"/>
    <rdfs:label>HO-NEF</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f1d85724-b4de-4125-978c-eadb69d45d51">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/fc170e81-5b02-43fc-bd53-29c957e58e19"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/ef5f65b7-c104-48aa-a4bc-32ee7390dc1a">
    <rdf:type rdf:resource="obo:RxNorm_42347"/>
    <rdfs:label>bupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/358839e3-6aef-43f5-9696-7bbafd1742e9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6afe3cae-a3e2-4bec-9e62-b5c3e9cca47a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/44ddbeeb-0cb6-48f6-bc27-80833351ffde"/>
    <rdfs:label>cimetidine-threohydrobupropion and erythrohydrobupropion drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/500563d8-c8ae-49de-b83c-4dbe46205a4f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/92df4c62-2deb-4795-915c-1810f7e79d9b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0189cb7f-2358-4888-b6e0-cf10802296bb">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/3b925756-e187-49ce-9f69-e94622e3c331"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e6e57d59-d30e-4aab-9593-4d8c2adecb30"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/b3d1b2e3-f767-482e-acf0-4bfbe8135393"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c130c70a-d701-48b5-bd53-fe9cebeab4c2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ddae3568-3e3e-4a68-90eb-567b683459ac"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/56535874-44a7-4cdf-9e2b-db5e0034ea88"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9752387c-7c59-4951-9df1-a70a8ae982a8">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/98b61dc7-e6d6-4c3b-a276-fca353e5bac4"/>
    <rdfs:label>2.2 Fold </rdfs:label>
    <obo:OBI_0001937>2.2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/37d958cf-e96a-4508-95d3-55d36aefed46">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/8e2faeb0-d95a-46e2-ad44-a92ef3935cb7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/51b63f5e-e036-43bb-8bd7-7968d2ff5436"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/a51f052e-1f14-4508-8d5e-5f2744a636a0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/7107ae95-da14-4d19-9255-8528ac1b08de">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/5bc53290-907c-4f07-aee5-89819611960e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/f77180e4-9bfc-4965-870d-b2b61b013b53"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d183f021-d6fd-45a9-89cb-9975ee23d6b3">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/aec49331-746d-4280-87a1-4060ab93e193"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/63b1d54a-702c-4186-aaa0-a685cc69c14a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c750a58b-b35d-4ad0-ba8a-e5187c898e07"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/be0964dd-6d2d-4f14-8300-debd10c92d86">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/7c176684-d6bf-4493-8e21-71760af38f6d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/a7deb1bf-feb5-4ecd-a73d-fb3d160decba">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0e46fe02-2b55-46c0-ad5c-3d72f587416c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/1c1ccca0-a9fb-441b-bd12-5cdb5ae9cef1">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/cb35ac0d-576a-46f8-8147-643c5486eda8"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/f0a2d260-4707-4d0c-a0cd-1dedda6159a1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/8f0334ac-09b3-4828-8cae-60bf9a5dd5d0">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/1b0fc29d-19ca-4d84-bbae-d770ac4d3804">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/1fa09777-9cea-4247-b6ce-77c909deb823">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/a96762f8-51aa-4aa9-953c-8e311612e8d0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/9ae32c83-d2c5-489f-bf52-9003c495c94e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1dae5f6f-caa2-468c-a105-65542d3f34c3">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a58710ac-0c28-4aa8-9642-3c8ac1bdf424"/>
    <rdfs:label>43 Percent </rdfs:label>
    <obo:OBI_0001937>43</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/e60087fd-8d1a-4aba-b91f-b798d98e3231">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/ba15efd1-af99-4967-bc3b-d66c2d2bf92b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/4c006fd8-2cc6-4dea-971f-fd030e34735c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/dfd34c57-4832-4bb2-9e5e-c1b68d6761eb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6800df50-d6a9-4212-97a6-14bd20e0e763">
    <obo:OBI_0001937>1000</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/89805dc1-2752-4ad8-8314-7eac9bf80922"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/c23e0217-9548-4572-88bb-63d1a2bf4199">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/22fe50b1-b678-422d-9b30-6f895106ea73">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/77285508-c038-4fd1-ba1c-2da718b625a7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/e66c5a4b-d4a2-4574-a647-8d621d375687"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/216cf6ef-8879-4672-acc7-9072b3e58376">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d923f678-f519-46be-8587-c9db4b98d39d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/65481a30-a8c0-4209-b408-79774874f305">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a1c1fbcf-f130-4d07-a6db-7e025d2b850e">
    <rdf:type rdf:resource="obo:RxNorm_36437"/>
    <rdfs:label>sertraline</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ae388257-7bbe-4d09-a18a-951853668457">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/153243ba-b722-4a3d-821f-25638e830ea0"/>
    <rdfs:label>ritonavir-bupropion drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0ec33aa0-fd7b-4711-b5c4-773715b67152"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/378726ec-d9bb-43c8-970f-09b93a345f22">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3299ffa8-55e0-4a0b-b904-1e9616d3b9ea">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/428b88d3-e0ae-44ba-8e40-6d9829eb13fd">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b4c4cd69-2808-4ed6-877c-d968012c3cc9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/62c2deab-1842-4ff8-9f6e-8e8fdf04e833">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/21a06760-d4d7-4938-b9f3-e4c7d5e06af8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/55cd20b3-cf2f-47dc-a0c1-f14883a7eae3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/422876da-49c3-4391-abfb-ab244933ca71">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/df7cae32-0e77-49a5-8080-6c7c8788a50d"/>
    <rdfs:label>clarithromycin-rivaroxaban drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/03c0ff50-785d-49be-8e1f-776db4c278f7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6010e480-33df-461d-8fa6-ffd6413000ef">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/fe32d582-57a5-46c4-9f66-98a2b59f5609"/>
    <rdfs:label>3 Fold </rdfs:label>
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/795213fd-a00c-4677-bcae-22f13652115e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/3f3cc292-472c-45d5-a348-e814709d21a1">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/eaf941ab-1269-46c9-9242-7a78379bbc85"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/964dac96-c151-4a18-bb24-b1b888eb61bb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/328bda45-1a12-416f-9fc7-33552c303e94">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/28d07599-d8ad-4216-88e1-af676eee9fdb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/f2f45a0e-4a1b-4992-870a-c3c21577b1df">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/9c785a69-5943-4bae-a467-a71d58db9dbd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c64f6410-3206-4b19-98fb-c3652e81d916">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/07be419f-c11c-4b91-8691-fa28cd900fbe"/>
    <rdfs:label>ketoconazole-rosuvastatin drug package auc None information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b098049b-99dd-4da2-9aba-2b0c9c4b9a80"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/c38161e8-d51a-45aa-af47-1b42ef201c18">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/96e4857f-e20b-47b3-ac7e-2041de77577a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/082a617f-8791-435c-8fbe-85df8c3fdda6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/eacd8dd1-a52e-4777-b992-2b619201e46f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/55981f42-071a-4659-ba29-b29591e4ab07">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e9202c2e-a556-452d-8141-f4d3757c5c69">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/400b6f19-094c-4608-913e-fd0270116582"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/1546672c-53ba-49a9-b58f-63a5667c03d5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/f87d336b-e321-4a32-95ec-8c6d18a8097e">
    <rdfs:label>paroxetine-duloxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/27a5579c-38bd-4b97-b12f-a68a322b5de3">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/727f4404-ce06-4238-9613-98e5e5191d79"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/04456f51-e1c4-47d9-a01c-95d08482fe31"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/54b5e732-ebf3-418b-9ee9-54e08e76a907">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/c8d858e8-f9ff-4778-988c-fc4519e30efb"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/d7b03a60-78cc-44d0-a016-ef8fb3ddbce0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0cac4bd9-c3ff-4dd3-bc1d-2f4dd7db27b5">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/15457828-276a-4031-b303-633dbb595c35"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/84b5e089-bceb-48b0-8419-732bd503d579">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f9058844-17c3-4c22-82bf-d81732aced29">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/4fc58038-be7b-40fa-a2cd-e8693db1211f"/>
    <rdfs:label>efavirenz-hydroxybupropion drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9dd6087f-92f0-4a5a-a858-d19919406b00"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/5f1da6e8-e8af-4f72-a501-ac4d3c4db688">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a5c17a7f-1c22-4c97-a672-a3c863822333"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/5d4d3cae-7bb9-4118-b0ab-f9957f94f1ae"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/fffe5002-9478-4b17-859c-ecdb42edfccf">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/5edf4d1c-ec99-4cab-80b2-e827fa13aec6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/3ac318ee-3987-4611-bdff-d57d21dc577a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c64bcf8c-c574-4bec-b849-10f72b215fff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ccd0fc1b-9834-4bb8-b3b0-8391934e5715">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1bc144b3-1c08-4757-b9fc-1ba3afedd353">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/9b5d0e6a-5207-4838-aff5-c1d2026a413e">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/56784449-e18c-45c3-9160-21c3c892c7c8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/3e360ced-ab20-4244-912c-1d87ba882c7f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/42713934-75e9-428b-8ace-89ad25b8bae2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/ee78246a-6c5e-4edb-9a3c-e0e0dda8fa56">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8092fb35-adf6-4d04-a601-9fb774e24155">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/31197fbc-616b-4cac-bdfc-b20d3c2fc0ec"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8368f3e9-119b-4c19-9912-bcec9fd28539">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e9dee550-c586-47ec-bb79-2e55480f61b7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/990e1123-143e-4752-bd33-6f43a93bcb90"/>
    <rdfs:label>4.7 Fold </rdfs:label>
    <obo:OBI_0001937>4.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/d5dada3f-6b33-48c6-a1d7-38531c4255e8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/6160cf03-d7ce-4b15-87fa-3e9995b09ab0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/49050239-4ff7-4eff-a9ea-c1769190e554"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/17ffc24c-b333-4195-8f2e-43f79e124635">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e2d6ef7d-f3af-4087-a315-93a18f828442"/>
    <rdfs:label>erythromycin-zaleplon drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c98376bc-631d-4608-a8dd-69ceb4320a49"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ff1136ea-9118-497f-bffe-1c04b1abfcd2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/9f5de77a-2c46-4d98-8a56-a99e1af50d90">
    <rdfs:label>Fluvoxamine-thioridazine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/fdf3b26d-44a4-47e1-93cf-fa71fcfddc98">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1c2861a1-53f2-4d99-a6c6-fac4a2a64a4d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b6be03a4-b5f0-4f4d-af1c-a2d183000409"/>
    <rdfs:label>158 Percent </rdfs:label>
    <obo:OBI_0001937>158</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/6a32c094-5142-42aa-b06f-2834f8a46507">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/28d07599-d8ad-4216-88e1-af676eee9fdb"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/f397f428-7cc0-456d-967f-bd8c484dc349"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/a96762f8-51aa-4aa9-953c-8e311612e8d0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/4c96701c-e1c3-45b4-8319-2bff1f82970a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/bb35c4b4-8439-401a-ba88-234778de6bb2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b8c4e318-ff7c-4811-958f-e7c6f18a00af"/>
    <rdfs:label>atorvastatin-norverapamil drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2790e62b-79b2-4738-9536-3b8114486357"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c5a6d3d4-0f6a-49df-bd8c-8047d7ab34a2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/e3b9fa27-4f51-49be-a9e5-4866b6a58f3c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/3e360ced-ab20-4244-912c-1d87ba882c7f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/e7e20627-4f68-40d2-aaa9-9e70d8f49dbf">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/5ed31c36-09d1-491e-a031-5d30f343ceff"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/3d2ff868-f3cb-4395-bd66-2d40b909805f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/e7dee739-d609-450f-b0f0-c7740ef5731a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/880bee26-737f-4e17-abeb-93ba1a6423e3"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/73d32c77-e53c-4e29-a460-f9187a4d0735"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/4a355e5e-467a-4d64-ab8b-d97d04f1a701">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/29ad7967-7197-440d-9495-f602bfcd4772">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/a4f44f6f-679f-49aa-bf8d-903f0ba56f98"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/3f85cd07-d9e6-4349-90d1-b05b6ccac6ef"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/20b3911b-7aed-4bde-8dba-11e63b0aa9f8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/5ed78f5b-7931-445c-b092-ae87862e522b">
    <obo:OBI_0001937>400/100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/74eecd8d-72c7-4946-9972-a5e7bb0ac0a7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b3f97683-d073-4226-9830-d967bd05b7ac">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/d2ffdb82-4856-450e-b991-59d18c75c4c4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/c4879954-7dab-49c2-bb9f-076fd42583be">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6b5850cc-45a6-4397-ad43-39fccbe71cdd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1483247b-28ae-4c82-b758-2fe50f564d4d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/429c0100-a00d-430e-a091-786a8ef5c224"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/1512a732-1df4-4a9e-a8ce-419a54ede351"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f0f71f59-b932-4738-b63e-231dea8da004"/>
    <rdfs:label>escitalopram-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/702827ba-2d9d-416b-b167-86c056127e33">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/40edd4fd-b06a-434e-92b0-013082f1f3d0"/>
    <rdfs:label>Nelfinavir-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e895d49f-9d1c-4af3-9740-de1ef6262218"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/4308c9d1-1de4-475d-b715-ef7d9fab3294">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e6c4cd60-e13f-4410-b16d-79b14e1d7548"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f5008afb-cd59-4bb1-a107-6fbdac9d32d8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/30bb79f0-2130-4c7f-afa3-4e7060b18ede"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/cc2844ea-f92d-464a-a77d-75e1b5858ffe"/>
    <rdfs:label>desvenlafaxine succinate-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7ddfa393-c633-43bb-8ceb-3a0bdf9e63fc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/565ac880-dbe2-4073-980d-ba6fdbb7a7b3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/76c717a8-c560-485a-9114-0336e5ef0a40"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/62c2af75-ce36-444e-a18d-70baa33460d6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e75fbc0d-fa14-4708-aede-4576f8f29bde">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/77b93e02-e158-49cb-9b74-532be4623d71"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f2bb2e21-e9cf-4719-a652-5b84aab8618e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/df14670c-fb1c-45c0-b750-e3e8f4ad8fb6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/090beef7-be9c-4ed5-ad3c-da21c2023876"/>
    <rdfs:label>naproxen-Edoxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d7835084-5e0b-4988-9dc9-c4977991a0f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d1c56835-d123-4dfb-9422-5d80437ece23">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d8869bcf-bcea-46f1-865e-c275d476d044">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/56535874-44a7-4cdf-9e2b-db5e0034ea88">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a175b4fe-cb79-497f-a306-2a931e3191c8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/47f4c33f-230f-4d45-9ba6-dc86047c6f39">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/5a19d224-aae0-43fe-862a-16f440ddb40b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f564a3e4-eb16-4b9f-a104-f1ce73a370d0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/0e2841c9-5a99-4ef8-8015-2d8e1c544d3d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/998235cc-c707-48f9-9349-01d4560e32a0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8fb07622-be68-45b8-ab27-a842e3638493"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/349148af-bbd4-4857-8405-61585f2188e9"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2cfe0a6e-219d-4672-8161-d63b4512293b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/68b987fd-8ef2-43fe-931b-212f7c5c5e3a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/529d2ab4-7b92-4199-a45b-9e290f2c5368"/>
    <rdfs:label>bupropion-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/77285508-c038-4fd1-ba1c-2da718b625a7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/b3d1b2e3-f767-482e-acf0-4bfbe8135393">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/69bd4366-4a9f-4f51-ac1a-d8e4807d4fc7">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/4f9fe61c-edff-47cf-af7d-4312f66617a4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/1b854bbd-08d6-4688-95de-2da4d73c8eca"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/9432953d-7a15-48a0-916e-110ce5a465eb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ac7e6919-e54b-4a66-87c1-e5998312eee4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/33764d40-248f-4e6a-a1f7-1d2762d5be56"/>
    <rdfs:label>ritonavir-hydroxybupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8eb6911c-3307-41a5-a786-f1cb34c04f32"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/97cab7ea-ea11-4590-80be-a1026fc4c5bf">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/96e267d1-b942-4dd2-a219-c1b9fc006a4e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/05eff585-cd49-4aa1-8c6b-1827110f45a4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/63e506b3-e630-4f60-8b78-4c464adc0687"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c51a97b8-f543-4d41-b6e7-d0ef8c42e9ca"/>
    <rdfs:label>clopidogrel-bupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c0740c0f-daed-4b5a-90a9-893848cb28f8">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/8a9a79e0-d220-45bf-b875-d3e629cc88c9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d3b792ad-4324-4177-9992-caa87ff86e5d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/46f26bdd-04c0-47f8-bd81-8f316527e012">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7535ce3d-33e6-4509-9934-585ac91da5be"/>
    <rdfs:label>ticagrelor-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/444b4b13-c90b-4f7b-931b-97a787fa955e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/0157b271-755d-4a9c-9592-4fcaa5a859f3">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/34faea42-b354-4430-80bb-be6760da2c02"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/5eb2c603-735a-4f14-bcc0-21ca83c72961"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5e6822b7-d5ac-4132-8d8c-53f23df8e93a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a5d314dc-ca99-483d-b5fb-5a7b3d51db63"/>
    <rdfs:label>0.92 Fold </rdfs:label>
    <obo:OBI_0001937>0.92</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/022bc8b6-9c65-4460-8ab6-fd262b0c4d73">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/df34591d-c627-4682-9ecc-c57854bf12d9"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6d2a7e6a-50e9-44fa-8025-c6285b146097"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4e1949b0-9726-4a52-8417-cd7712f79295"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e4b04221-aba4-4314-bab9-d40419677bf8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/608fbc8e-ac45-469b-9b36-f65118aef544"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/669572a9-a65a-49f7-8df0-b0f94ea6c206"/>
    <rdfs:label>ketoconazole-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/9df5ec78-06ba-47ab-91ec-3dfe552eb18e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/0b7032f1-c98e-45e9-bb0c-728fc85204b6"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/9175b4ca-0873-4a76-a099-f65095be13a5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0d58d30e-1bd1-439f-9320-c8496c16da7b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/fd5321e8-3dd4-4c11-8bcf-87d33c4e3442">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
    <rdfs:label>carbamazepine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/61a6609d-40ef-4b09-806a-5b4a7e924d8f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/d80580e3-0f8d-4855-a419-bd5f7360a342">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/280ea108-1cdc-468a-85c2-f20b2945adf4">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/46a1b319-dd12-4042-a71f-6d874c2b4dba"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/4865ac5e-3a55-48a0-96d1-3b074611fe74"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b7cfb732-ebc7-4155-b27a-41f4ee767a43">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/54308f05-d0f5-4b02-b7d9-533d2b9b244c"/>
    <rdfs:label>nefazodone-triazolam drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2a736997-87c0-40b9-85fe-14e7ec136153"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/3123e012-0042-465b-ba21-2e1d8766f157">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/642829ff-e86d-4f76-901f-b5af996a2cc8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/85a1e6ee-9b2f-4e3d-98f8-dd2cd01bf19f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/be686481-a168-4cc4-a52e-22c75e363f6c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/72b575af-124a-4a2d-bb8a-0a137b63bff3"/>
    <rdfs:label>3 Fold </rdfs:label>
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/06a7817e-6947-4c3c-b99f-01551aee0cac">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/6ab96b3b-fe3a-440a-bba2-fb455e5bf918"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/d0ddd18d-63bc-4055-a28e-642cb263cec2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/6ff47e91-3d73-48e5-a957-48ad853d5b21">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8b6bf554-9f53-480f-9859-709900a1693d">
    <rdf:type rdf:resource="obo:RxNorm_3289"/>
    <rdfs:label>dextromethorphan</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/47127b9e-437e-4618-8acd-f071a8d8c6fb">
    <rdfs:label>Fluoxetine-olanzapine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f9d44548-ceb6-4554-8ab7-3df8b32fc10e">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/3420f168-f0a8-47d4-87a5-6445b660d9e9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/1d1dd96e-e936-476e-a603-939cea8327cb"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/905f33d5-6fe3-4295-9922-21493ee17cb3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/54428eff-5893-4f5c-a5a7-3791cf5d6508">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a77bb937-29e5-4fde-ab05-b713885424eb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a5761af8-fa08-4bd1-ab4c-b181b658d2d9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a13ec6f4-c468-47c5-a5fd-ca3bf2b8715e"/>
    <rdfs:label>fluvoxamine-duloxetine drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d87bd7cd-604b-4e44-a437-fcc6c0c02170"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e9ae109a-ee0b-4863-a296-4ff12d01b768">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/5dd2ea2c-43df-4c85-bef9-30564baaae9d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/40c35519-0845-46cc-bc4a-703901306a4b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/44c3dc7f-964c-43be-b2e3-da78cf7fbf06">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/99563b57-3bf2-43c9-afe1-37e0f6442d29"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/b81d40bb-0e97-4504-b3b9-a42b4ebe4a6b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/b4fe2901-08d5-4885-bb66-cb6bb2fe6ca3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0ea7ec2f-bbf4-47bd-b0f7-f334db64a0cb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/eae20dd4-cda7-423c-a395-89e24413b81d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/917a9f19-d2d0-45f6-ab2f-8658a84f777f">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/0e85c164-6da9-47f0-a6a2-e6003d3aa34d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/45c8a483-5168-4bcc-a000-f728c3b3e4d4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d6b4bb1d-b1f5-479e-b655-03278de2a774"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/89ad93f3-7340-4cd7-bb25-08a803889853"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/8fe1765f-3d52-401f-80e1-af3c3667476c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/6090de03-e2ad-406a-ace0-451a48bedfe0"/>
    <rdfs:label>ketoconazole-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3fa4b2f4-c90d-4ccf-9daf-030f6215fbbb">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/753f4a1e-f112-43d3-ba15-c8c8c28089b3"/>
    <rdfs:label>55 Percent </rdfs:label>
    <obo:OBI_0001937>55</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1cf27aa0-8f60-46f0-9ccd-87e9b2ca3b8b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/13a9812a-b9ee-4767-8d95-7fe9a63f1af6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6f375a13-4dd5-4a6a-b28a-3f630c633c00">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/93c5bb56-4f59-4ac0-95fd-b623d489a6d4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/99057a62-cf38-4a38-a3aa-892f795d4404">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/6132b4db-6d8f-4beb-a6fa-30979592e089">
    <rdfs:label>simvastatin-bosentan DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/32a892c4-c47b-4a8c-a0c8-13e87c2b37f3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f5a755df-0b08-4a11-8ae3-7136bb4a9863"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/17292cf0-a399-406a-95ac-cf4dba5c6129"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4e990102-ca52-41f9-b0dd-a53e2eeb52f9">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4fda4fa9-66ee-40a2-b8ef-13bbf93b87a9"/>
    <rdfs:label>36 Percent </rdfs:label>
    <obo:OBI_0001937>36</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ce4bc3cf-e892-46cf-a81b-3ab8eda6e282">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/1f8d4745-41d4-4898-a2ce-31669393f0f0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/b4492a7d-3fce-48c3-9382-b5e058329a27"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/aa6e5542-6920-401b-996b-5541cbda3cb2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/616e65fb-9a63-4f18-93df-0bb7865d282b">
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/7b585c36-809d-4070-9a51-c45cafe4192c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/78a710e2-e292-4270-ac67-0d4051b6ae7d">
    <obo:OBI_0001937>800</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/8a4fd8fe-2416-47a5-a595-e20c3abedc2f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7bdf8989-1932-4826-98ca-c5edfb3d218d">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/38f9dd51-a7fe-4bfb-90fb-b817121c1fa6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/7795f68c-611a-4480-8d41-d7e1dccbb1eb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/250349e6-77f6-4952-bc46-2ad69df1b44d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/f7248a0d-eb5a-49f8-9d1e-54b9888ca391">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f00d4b4b-4791-4b22-bdff-7f4754c3696d">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c51f2f9f-75c8-4fb3-9b9f-74c9bd5a6dbe"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/e457dc20-22a3-4ca5-911e-d75abca7e2cf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/f46d8d50-0a37-4444-9f1e-03aebade1ec8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d1d77612-115d-4635-92e2-578512f3951c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/530edb0a-6748-44e6-90c8-115ce18f07ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/bacdb2bf-71f1-4909-a67c-b580e9aa9dd6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/7732cefb-c1aa-49d5-b363-a8e734cb6130">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/3a1463a3-f195-4831-83d3-d671d8bfee82"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/d88d3156-2b6c-488a-9729-e7383f53a4c5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/7193ecb3-6659-41ae-b9d4-c2ef627fd226">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/2062c9b5-0899-4ad9-bb6a-4536f90ef06f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/46c8da89-64e7-4d11-bd0d-64f4b43d7166"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1f30fea6-220b-463c-a956-414bb7f68746">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f1f840bc-8618-4b98-9817-24708fba4b55"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cdb2d85b-1983-4c74-8d87-ead65e835f5a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/01a1d6bf-aa2c-4f73-b759-5d6d3d6d3827"/>
    <rdfs:label>3 to 4 Fold </rdfs:label>
    <obo:OBI_0001937>3 to 4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/4212c34b-e7e9-4709-a2fd-6f813e52caf8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/aba6c055-0c42-4489-85f2-5aecf907de5e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/ccd0fc1b-9834-4bb8-b3b0-8391934e5715"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/157772c1-0466-4bca-a499-87faa8e2dab1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/bfe98b32-1062-449f-b94b-e310dc4505a9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f8b684c2-eacb-41cb-962a-2b1e5287abed">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/77cb183b-d5cb-4b14-9277-8963f58719e7"/>
    <rdfs:label>103.2 UNK </rdfs:label>
    <obo:OBI_0001937>103.2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ee79073b-8a14-4368-af2f-235d4aab586e">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/df6b2ec3-eb46-47ab-a4a4-e3caa18c5771"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/1150a303-c82d-4e4c-95a3-12b68f25d3b5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/af2f888b-480e-4f5a-ae07-714a057a5dff"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/5f108040-7aab-41fa-9fa9-4df1ab7b416a">
    <rdf:type rdf:resource="obo:RxNorm_42347"/>
    <rdfs:label>bupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/170f85c9-3932-41e7-9e7c-1d84e50a6f51">
    <rdf:type rdf:resource="obo:RxNorm_596"/>
    <rdfs:label>alprazolam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a2c87497-bce0-4ba6-8d01-e95d30dfe020">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/69520cb0-869d-4189-a6cc-7bb30184bb6d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/f75ec436-9045-4f7b-a2fa-691d28a330d6"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/a32feef8-ce82-47e6-81d1-f3bc42bad29c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e128b0b5-cfc2-4aac-9328-06fc35293cff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/8e0a169a-dbaa-40bb-95d8-c661d1141bfe">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/3e6a56b3-40a0-461d-abd2-d8a581f89dca"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/bc50a45a-360a-4f95-bce1-f5d823f13a3c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ea33ddb6-2530-4f19-bfc0-8994096f1ac7">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/88a68636-bef7-4823-be9c-b60bfd870224"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/4f66bf17-d204-4cfa-9fca-292f0e8fa615"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/73355ba1-ae7c-4a71-9516-0e760471902c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ed493891-24b8-4365-9df4-6eb559b144dd">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f6f06364-a508-4ec1-87e5-bdac5303c4f5"/>
    <rdfs:label>Carbamazepine-olanzapine drug package clearance Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/cf0c87d2-af87-4aa5-a7f1-70805418f2ec"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/550e15c4-af4f-4126-b30d-2a3590d68f77">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d67ac1b7-f602-4f5e-a617-27a4de0f5c85"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/77b93e02-e158-49cb-9b74-532be4623d71">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/0e0852d3-ff7a-4941-8b0d-9308d7b6ce67"/>
    <rdfs:label>naproxen-Edoxaban drug package auc UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/ebc555f9-5d0a-43b4-85a6-784b6b2c4d75"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/17d99a9e-d76a-41ef-9650-ecce4fa48950">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/545df3f1-e453-488f-91ab-35eb28124499">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2023e543-f9f4-4960-8401-85cf3d1c8ffe">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e5a0d1e6-b9c7-4cdb-a982-2e80ee60288f"/>
    <rdfs:label>6-8 Fold </rdfs:label>
    <obo:OBI_0001937>6-8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/ea8685ea-f1e6-4766-8f0f-6b280c08f3cd">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/e58d9652-5ef0-4422-a43d-e15996d65bd3"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/e970f9b3-9fa7-4367-b1c9-2231c6e38b23"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2ba8650d-d24f-458c-aff4-8b6e7e6ba4e4">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4a321250-6768-4f2e-b096-3c5756f2cb03"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/0d8c46e3-dc40-43c3-8943-c4feb1bcf872">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f1000f64-1984-481f-af54-9c6333a8340c">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/407f061a-83ee-4549-bb16-bc40c586043f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/21ea4760-6b13-49fc-b607-7ec3b8e9c284"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/04e259b8-1b98-4eb5-a9d7-bb144e0714e2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/076ee2aa-7912-47de-b008-28299efbf196">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/40dcaf56-f431-4eb6-978c-a6c271633315"/>
    <rdfs:label>102.3 UNK </rdfs:label>
    <obo:OBI_0001937>102.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/24eab3d0-2655-43be-9477-e7e88f660483">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e2818458-0d44-432b-9851-b3a03fd614a4"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/e28f33fd-61ad-47e8-bb01-1fac4d0f8e32">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/d8869bcf-bcea-46f1-865e-c275d476d044"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/77efc248-ddf5-4db5-8b5b-fec210f5a970"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/d954a55a-b3cc-4ae9-846a-3f97c6aec556">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/c1e608fd-228c-41bc-9234-79e4adf7e2b5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/9eb40163-a47a-4c10-80c8-6facd0fd6149"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/6a0d8231-e8b4-4dcc-ace3-f3d9c90d98f8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/846c61e3-7269-4cab-b284-b9519ece5066">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/2c7006dc-5ef6-4afc-a6d1-5b2196542f53">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/9cdfb5b3-4963-44fc-883d-ba57943fdc82">
    <rdf:type rdf:resource="obo:RxNorm_21212"/>
    <rdfs:label>clarithromycin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/329ca864-ec75-4e7e-bfe0-da31346b6e92">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e5b28db4-440c-4704-8759-8c26525fa71f">
    <rdfs:label>Fenofibrate-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6b80d8b8-9e05-42a9-815e-5f35f07b1958">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b1021523-5907-4fc5-8336-a10b1550c23c"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a2648f8a-fece-4fbb-862b-eb9c4e7128be">
    <rdf:type rdf:resource="obo:RxNorm_72625"/>
    <rdfs:label>duloxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d83a2158-5d99-4b16-b8d9-7b87883c83f6">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/54b9f694-011b-4d53-a74f-c536c4cabfde"/>
    <rdfs:label>40 Percent </rdfs:label>
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/9de2ecb5-9cdb-4861-968b-68df7298c4e5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/231cfea1-4248-4b7e-9b3d-9004ad668f9c">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
    <rdfs:label>ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/5864d383-6d81-44ac-8c9a-2836bcd7156b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/efeb072c-bd36-4dd6-a9cd-a4d7618ca670"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/667d722d-937c-4070-9e48-7d3101a89900"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f629b666-c47a-4e97-9140-c7ed333f17f9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c9b951f7-d40b-4829-9991-2ffc9c3c4b59"/>
    <rdfs:label>ticagrelor-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c6571f06-58c5-4697-a9d7-5082244e78b4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/767b3c7c-ca8f-4726-82b7-6cb8822deacb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/42366b46-18ae-4cf7-8418-d149671971b6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/bdf54fd5-f73c-4e22-b2ef-08c86f26260f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/07b779a0-ba31-49f2-89dc-74ca8283c736">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/6208aeba-0fdb-474b-8e68-b3aed330333a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/382cf374-29c7-4253-9bc4-ca14a1975187">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3beaf59a-c05a-40ab-b3dd-53297f40bc5a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/888cfaee-767d-4ad0-9c35-7db9ac96ce11"/>
    <rdfs:label>37 Percent </rdfs:label>
    <obo:OBI_0001937>37</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/24f5fde0-71a1-4cd8-82ac-d83d04d7523b">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/3c821f4b-d9d7-4b5c-804c-edd8d1085aa7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/038373dd-b85c-4f92-8d16-0a87fe4577a6"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/932cdaf8-1597-4d6a-aa6c-24a253a9eda4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/533de7a5-fabd-47ea-8219-aedd5119af40">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3eb0793d-428a-4e9b-ae32-bf3665f2b90f"/>
    <rdfs:label>phenytoin-mirtazapine drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9e5963ba-5023-46c3-adc5-c660279f4782"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/fdee9c4f-0f32-4beb-a3f9-60e837c03425">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/787019a7-b113-4530-a818-3deffe1768e2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/465885a5-54d4-4697-b0b1-6770f72a8bb0">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/a06a5406-a543-4ac5-9d14-36493f6e3e65"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/d7b78dab-d4f6-4cb5-aeab-b6eedc5eaf73"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/22208621-d4a6-48d5-bc7b-7871a933f942"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/8c3d92e7-a430-42ca-958d-99256dc21e70">
    <rdf:type rdf:resource="obo:RxNorm_195085"/>
    <rdfs:label>Efavirenz</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/77d3ab27-4698-48c6-b8e8-75e3d7019b7b">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/bff38d7a-974f-432f-8114-08554c594a62">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/39e2b1af-b8df-4cae-9e0a-4341b3dd1685">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/abd076c1-c742-4e6a-946f-a4cbb25be722"/>
    <rdfs:label>carbamazepine-hydroxynefazodone drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/21ace089-660b-4d95-89d3-d7406da77f05"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/13ad7e25-fcbf-471f-bd7b-28468fbd0e6c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/f4a266a5-49ca-46d2-aee1-bb08efa79ccd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/99599321-a702-495a-a3f0-ee3c524c27b4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/3a048cff-3ee8-4283-a04e-f10cacec9526">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/68f3cd06-7c4a-4d74-afba-41fadbdc729d">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/e067d77c-31b7-479e-b504-bed6cb4e4d1b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/002f6283-eca7-4c69-87ce-c9b2599e0f91">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/7582a3e8-509a-4771-84bf-803dd9e21417">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/87d25492-0c97-4b55-8663-e8f414eb5329">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/5a40fd98-21ba-4daa-a7db-1fde655c4864"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/9ae32c83-d2c5-489f-bf52-9003c495c94e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/76dc032b-555c-46c2-9cf0-bae64a0903a2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a849e9f9-868e-4eb7-88fd-bc5c89ef287a">
    <rdf:type rdf:resource="obo:RxNorm_686438"/>
    <rdfs:label>INVEGA</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/36b6fee2-6411-4cdb-b96b-21df5006f68c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/11898f24-59b4-4e5e-b74b-1017213f1581">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/501a1fe6-3a94-4e8f-b9c4-fe1f6ce16359"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/b4dfddb0-b74b-4512-bc4a-03b1a5ec8776"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/8e463903-315b-462c-aa4f-dc5e93f372a6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/59ac9b99-f71c-4c5f-a601-148ed8f793c9"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c9df2253-0c00-4604-9ae1-058ef68910af"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c2f25251-0fb6-41fb-873c-cdaecdee1331"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/07d0e9a2-b784-4635-82f8-a8955b88146e"/>
    <rdfs:label>ketoconazole-desvenlafaxine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/a6af2b1b-0ea7-4068-b586-897e464f7992">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9ad88e0d-48e4-41cf-becf-b1bc865289d4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3e1b8516-a41c-404e-a90b-789a9196c8e8"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/31ce7571-3d4c-435e-aae3-2fbfc91f850a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/8ced17d8-12c3-43f6-b8a4-b7cbd1375489"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d32b5510-6117-48f5-bfc8-1dab597d1b80"/>
    <rdfs:label>Fluvoxamine-tizanidine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/18c38cf0-a4c0-45d1-a102-d1171291f400">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e9090168-abb4-4be5-a755-45c53fbbb7cf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/3a8df0f8-cf0e-4ccd-bed2-52eef4bc3dd9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/01d2dc73-4fd1-4f8b-9335-d6dc0751cfe0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/0cea493b-89f9-4d11-8a39-6b715a96590b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/42fb6219-0226-4cde-9dea-0f2ca53f815a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7da3f221-31ae-4740-9da8-cc725e27122c"/>
    <rdfs:label>7.88 Fold </rdfs:label>
    <obo:OBI_0001937>7.88</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/088907e9-b55b-40b8-a558-30ea726c8060">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/0275ff55-3fe3-4acd-af2d-6e2fcd0b3a7c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b4c4cd69-2808-4ed6-877c-d968012c3cc9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d136b58c-1717-46c0-95c1-7f57601523c6">
    <rdf:type rdf:resource="obo:RxNorm_10635"/>
    <rdfs:label>tolbutamide</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/93ca85e5-f6d5-43a7-ac70-bca8cc62d6a2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1dc42df0-e103-442d-9c9e-17761effdfb9"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/37049f6b-ccdb-40f4-9132-283ae975c9aa"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/7193ecb3-6659-41ae-b9d4-c2ef627fd226"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/01daaad0-5cfc-46c8-9ef6-2118de9c0e44"/>
    <rdfs:label>phenobarbital-paroxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/bcdab818-831b-4248-94a9-3381663047be">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/13b52262-5ae7-4aba-8fff-d01026cdd5ea">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/c36d1d4d-931a-41c7-9312-9fe5ae9d1b81"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/355e8c23-38ac-473b-b8d9-528bffbda78f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/053c9ab3-3f7f-4bd0-8e2c-11b232b866b1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d08e1c97-22ef-4fb1-9aaa-5681b0083b15">
    <rdf:type rdf:resource="obo:MeSH_D000661"/>
    <rdfs:label>L-amphetamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e2f39a4b-9222-4519-8c3b-20a891543612">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8a92615d-a614-4d8e-9807-2b64ba27391c">
    <obo:OBI_0001937>37.5-50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/01fc2c93-9366-4a71-a061-74870f2e46bb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4411576a-6ef5-441f-a55d-df5aebc6e4d8">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/36c26a00-76b5-4208-b502-75c7107449d3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/01fc2c93-9366-4a71-a061-74870f2e46bb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/52a07c5e-8d0e-462e-953b-9c4dc17f983a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/24ca19a8-f05b-429a-b1e6-7689eeeb8bf1"/>
    <rdfs:label>nefazodone-haloperidol drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/06511998-ff1e-4b2a-b31a-457d1eb42d57"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/6a53762e-78fd-4f3b-8813-fe5d46bf8595">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b769d440-5e45-4f53-9a16-bffc36efad1a">
    <rdf:type rdf:resource="obo:RxNorm_5093"/>
    <rdfs:label>haloperidol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/848f67e8-39e5-40bb-b5c4-aa7bfa317982">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/4296d6c5-f979-4653-9bfd-027d7c2d336b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1a2299f2-1e04-469e-a8ef-3e90c2d2ab4e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d1c11970-69c1-4f89-99a8-133a405170b4"/>
    <rdfs:label>14 Percent </rdfs:label>
    <obo:OBI_0001937>14</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/a1a77136-9c8f-497e-96af-5dd550d8492a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/c9c26d79-76fe-44f3-a23d-f67ecb188f35">
    <rdf:type rdf:resource="obo:RxNorm_9384"/>
    <rdfs:label>rifampin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/25f25b65-d53c-4a43-bb4f-f7a5845b8fd1">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5ef0a918-13c1-4604-aea9-aa0272e6f8ba"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a5d95cde-8108-4d03-91f7-18e22317948f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/565d59bf-f5ac-4163-92af-6c8d5ee1fecf">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/5a7aaeee-41e6-465f-a742-de7525ba7953"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/3d1b5fd3-0b4e-4c43-bf20-6f132eb3519a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/791050c8-b32e-46e8-9b82-fa6d1e1012be">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/9a12da7c-6f7f-4dd3-8759-d5f835feba7d"/>
    <rdfs:label>9 Percent </rdfs:label>
    <obo:OBI_0001937>9</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0e2841c9-5a99-4ef8-8015-2d8e1c544d3d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/5a246237-f232-4ee7-b4df-210988feac5c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3d6532b3-df0f-4646-8edd-123cc4b2d4ae"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0c517699-9e43-44e5-bdbd-c134df1eb782"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/cf58c6d5-3530-4e7c-b5d3-f89eff4943dc"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/68e56655-f55b-45a6-9cf3-7ea3fbb16e87"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/52676b14-31cf-4fa9-89f8-22d1fdc91af1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/65a660d5-fe50-485b-bcba-58970cbd783b"/>
    <rdfs:label>ritonavir-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/858bf9df-7aed-4af7-be44-42319211d29f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c3ff739a-17b1-459a-90fe-fe5b34532911">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5ed52d20-27ac-43b2-8d48-bfca4871c741"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5f72e0e9-1956-44fd-82cc-9a1eaa766254"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1827299f-e73f-4367-b5f3-4beb5dfb22a7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/f4f6ded2-8aec-48e1-a070-bd547a1e42d5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/fc938414-0689-4cd7-a585-e4a42c255928"/>
    <rdfs:label>quinidine-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/85321aad-3390-4a72-afe8-4b8b7cff4082">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/76c24fac-388d-45e5-8a53-620d4f81d292"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/b7b4c740-a67c-4b4f-b016-cfc51954e197"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/9e6934ba-b8ca-492e-8941-3b19e94085cc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a327385a-52dd-4dea-9e6a-b14cf528e620">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/0ed42a63-d1ad-4f99-a460-e81ff4b694a9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f7304571-a029-4cd7-a3cb-454f8035a868">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e1511fcd-eb73-445a-8369-3bfa645571a0"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2236e7da-2bb5-4f84-84c9-3d20c4a56bef"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/67b8cfdd-2010-42d2-ae19-dec32bb0dfed"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/272c5e57-5293-41e3-91e3-87c272d4db65"/>
    <rdfs:label>lopinavir/ritonavir-hydroxybupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e2083a0d-0d25-40c7-b6a4-741d5ff34b36">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/afc3ec98-3d37-4279-8714-1b5a38aba8fd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/61df9c73-65f7-41f3-84f1-0b85b01caf1a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/46ca3b7d-89d2-49d7-8503-6b078e64970b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/efe3718a-d5dd-469c-9cba-97f07e3468ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/48c04994-9124-46c7-9f93-7bedaf39b502">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/b879a71a-695a-47c9-8288-54255b6e985e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/6e313c31-c18f-4335-990a-1e9c1fe9e442"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6542d23d-de98-42b1-ba67-5b828c276c0a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/98c5d49b-d441-447c-8b9a-fb0e73699e22"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/8dd93a58-dacb-4e20-ba25-b005f775a256">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/c2f3d4f1-49ac-4a34-bddd-05dd33f37235"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/97ca0039-9b6b-49fd-9696-856be8f2a952"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/71483148-c83d-4473-bb3b-652b0f49d476"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b9327431-66db-4575-a448-f472f6b010fe">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/937fe851-52db-46e8-a6d4-6dba452fc244"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/9de704f5-8413-495f-8cd1-426dc801359a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/7f1ad584-8fa3-4207-8697-f5794eeabc79">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/abcf948d-a72b-4a38-9ede-7c05599d5e28"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/90f83d2f-1d07-41db-a547-614eb99e3c83"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/a5f3cc07-c393-47a7-b9b5-aa922e9e76dc">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/d3b792ad-4324-4177-9992-caa87ff86e5d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/6bd8e3ca-3181-4f3b-b377-4b2107d616c3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/247e9bb6-af86-46e6-9fc3-b715acd79026">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/3139981e-f21f-4314-ad43-20ebf5b2ddae"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/9e6ff4ff-3432-4a2d-906c-a8dc7311fc9b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/16b85ef6-f6a5-401c-8945-952fd315a181">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/4b75ad88-10c8-43e5-976a-825d05dc58f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/dca31b4f-4fd4-4682-8496-4cc3c23400a1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ac87ec77-e2a9-4419-b1b7-1c743f8fe08f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ed0658e5-bb22-4bb9-9939-920c9e663eea"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/8545ee95-8658-4457-be7a-6fc821ab3b44"/>
    <rdfs:label>zaleplon-diphenhydramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2fb4c3cc-cd99-4f72-a358-5ac5bee70c63">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/11a2e600-208b-4555-aa04-a1b985b799af">
    <rdf:type rdf:resource="obo:RxNorm_703"/>
    <rdfs:label>amiodarone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e970f9b3-9fa7-4367-b1c9-2231c6e38b23">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/12f75402-3d3e-4b7d-ac00-31d6d227c417"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/5acf3a4c-ed0a-4ea6-8984-bc83dde8a8c1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f288f199-b261-47b4-95b5-7a04f56d538d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/4a23255c-02aa-42fa-a27e-d44ba5f64837">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/3d7bb8bb-8da1-47b4-9724-58520d3ebfb6"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/fa571d7a-1ef7-4f78-bca0-62a27c7d68b0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/677007a4-f165-490d-add8-93c474f65a53">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
</rdf:RDF>
